,datetime,title,source,link,sentiment_class,sentiment_score
0,6/30/2006 2:27:00 PM,"Vertex Pharmaceuticals and Tibotec Pharmaceuticals, a Johnson & Johnson Company, Announce Plans for Global Health Initiative to Increase Worldwide Prevention, Diagnosis and Treatment of HCV",PR Newswire,/news/stocks/vertex-pharmaceuticals-and-tibotec-pharmaceuticals-a-johnson-&-johnson-company-announce-plans-for-global-health-initiative-to-increase-worldwide-prevention-diagnosis-and-treatment-of-hcv-1001238385,negative,0.8177620768547058
1,12/20/2006 11:37:00 PM,Johnson & Johnson Completes Acquisition of Pfizer Consumer Healthcare,PR Newswire,/news/stocks/johnson-johnson-completes-acquisition-of-pfizer-consumer-healthcare-1002273502,positive,0.8553056120872498
2,9/23/2016 6:40:21 PM,"BRIEF-Janssen Biotech submits application for approval of sirukumab in U.S. for rheumatoid arthritis (GSK, JNJ)",Reuters,/news/stocks/brief-janssen-biotech-submits-application-for-approval-of-sirukumab-in-u-s-for-rheumatoid-arthritis-gsk-jnj-1001416187,negative,0.7556669116020203
3,9/23/2016 10:30:23 PM,"BRIEF-Achillion announces data from phase 2 trial for combination treatment for Genotype 1 Treatment-Na√Øve HCV (ACHN, JNJ)",Reuters,/news/stocks/brief-achillion-announces-data-from-phase-2-trial-for-combination-treatment-for-genotype-1-treatment-naive-hcv-achn-jnj-1001416124,negative,0.5463489294052124
4,9/26/2016 6:20:22 PM,BRIEF-Janssen Biotech says FDA approves STELARA (ustekinumab) (JNJ),Reuters,/news/stocks/brief-janssen-biotech-says-fda-approves-stelara-ustekinumab-jnj-1001418635,negative,0.8015375137329102
5,9/26/2016 7:30:22 PM,FDA approves J&J's autoimmune drug Stelara for Crohn's disease (JNJ),Reuters,/news/stocks/fda-approves-j&js-autoimmune-drug-stelara-for-crohns-disease-jnj-1001418766,negative,0.7212360501289368
6,9/28/2016 4:50:21 PM,BRIEF-Tracon Pharmaceuticals announces a strategic licensing collaboration for two Janssen Oncology assets and a $5 mln equity investment from Johnson & Johnson Innovation - JJDC Inc (JNJ),Reuters,/news/stocks/brief-tracon-pharmaceuticals-announces-a-strategic-licensing-collaboration-for-two-janssen-oncology-assets-and-a-$5-mln-equity-investment-from-johnson-&-johnson-innovation-jjdc-inc-jnj-1001423841,negative,0.8204419016838074
7,10/3/2016 10:10:21 AM,"Novartis psoriasis drug maintains efficacy after 4 years - study (JNJ, AMGN)",Reuters,/news/stocks/novartis-psoriasis-drug-maintains-efficacy-after-4-years-study-jnj-amgn-1001431486,negative,0.9123477935791016
8,10/3/2016 11:00:21 AM,"J&J psoriasis drug tops placebo, Humira in late stage study (JNJ)",Reuters,/news/stocks/j&j-psoriasis-drug-tops-placebo-humira-in-late-stage-study-jnj-1001431490,positive,0.8518206477165222
9,10/3/2016 11:30:24 AM,"Morphosys moves closer to getting first antibody drug on market (MOR, BAYN, JNJ)",Reuters,/news/stocks/morphosys-moves-closer-to-getting-first-antibody-drug-on-market-mor-bayn-jnj-1001431705,negative,0.8469599485397339
10,10/3/2016 12:10:22 PM,"Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001431817,neutral,0.6420669555664062
11,10/3/2016 2:20:21 PM,"RPT-Big Pharma vs Big Pharma in court battles over biosimilar drugs (SAN, SHP, BIIB, JNJ, MRK, LLY, PFE, AMGN)",Reuters,/news/stocks/rpt-big-pharma-vs-big-pharma-in-court-battles-over-biosimilar-drugs-san-shp-biib-jnj-mrk-lly-pfe-amgn-1001432682,neutral,0.5524706840515137
12,10/5/2016 1:10:26 AM,"UPDATE 3-J&J warns diabetic patients: Insulin pump vulnerable to hacking (JNJ, MDT, PFE)",Reuters,/news/stocks/update-3-j&j-warns-diabetic-patients-insulin-pump-vulnerable-to-hacking-jnj-mdt-pfe-1001436547,neutral,0.5905588865280151
13,10/5/2016 11:30:22 AM,"BRIEF-U.S. FDA warns about the risk of Hepatitis B (BMY, GILD, JNJ, MRK)",Reuters,/news/stocks/brief-u-s-fda-warns-about-the-risk-of-hepatitis-b-bmy-gild-jnj-mrk-1001436685,neutral,0.5751609802246094
14,10/5/2016 1:30:24 PM,"PRESS DIGEST - Wall Street Journal - Oct 5 (CRM, BLK, 8630, ENH, JNJ)",Reuters,/news/stocks/press-digest-wall-street-journal-oct-5-crm-blk-8630-enh-jnj-1001436934,positive,0.9358034729957581
15,10/5/2016 10:20:21 PM,BRIEF-U.S. Department of Homeland Security warns on vulnerabilities in J&J insulin pumps (JNJ),Reuters,/news/stocks/brief-u-s-department-of-homeland-security-warns-on-vulnerabilities-in-j&j-insulin-pumps-jnj-1001439013,neutral,0.8893699645996094
16,10/7/2016 2:40:27 PM,"BRIEF-Astrazeneca divests rights to Rhinocort Aqua outside US (AZN, JNJ)",Reuters,/news/stocks/brief-astrazeneca-divests-rights-to-rhinocort-aqua-outside-us-azn-jnj-1001442619,positive,0.9346607327461243
17,10/10/2016 12:40:22 AM,"BRIEF-Genmab  says U.S. FDA grants priority review for daratumumab in relapsed multiple myeloma (GEN, JNJ)",Reuters,/news/stocks/brief-genmab-says-u-s-fda-grants-priority-review-for-daratumumab-in-relapsed-multiple-myeloma-gen-jnj-1001444863,negative,0.8637720942497253
18,10/11/2016 10:50:23 PM,"BRIEF-FDA concludes Xarelto clinical trial results not affected by Alere's INRatio (ALR, JNJ, BAYN)",Reuters,/news/stocks/brief-fda-concludes-xarelto-clinical-trial-results-not-affected-by-aleres-inratio-alr-jnj-bayn-1001450092,neutral,0.4767972230911255
19,10/11/2016 11:00:20 PM,"U.S. FDA clears Xarelto blood thinner despite faulty trial device (BAYN, ALR, JNJ, PFE)",Reuters,/news/stocks/u-s-fda-clears-xarelto-blood-thinner-despite-faulty-trial-device-bayn-alr-jnj-pfe-1001450199,negative,0.5444692969322205
20,10/17/2016 12:40:22 PM,"Wall St Week Ahead-Investors seek profit turnaround to drive stocks higher (JNJ, MSFT, GE, BAC)",Reuters,/news/stocks/wall-st-week-ahead-investors-seek-profit-turnaround-to-drive-stocks-higher-jnj-msft-ge-bac-1001458024,negative,0.9386282563209534
21,10/18/2016 2:40:23 AM,"Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001460992,positive,0.886904239654541
22,10/18/2016 8:20:19 AM,"UPDATE 1-Pfizer set to start shipping Remicade biosimilar next month (JNJ, 068270, PFE)",Reuters,/news/stocks/update-1-pfizer-set-to-start-shipping-remicade-biosimilar-next-month-jnj-068270-pfe-1001461028,positive,0.6134666204452515
23,10/18/2016 2:30:22 PM,J&J quarterly sales rise 4.2 pct (JNJ),Reuters,/news/stocks/j&j-quarterly-sales-rise-4-2-pct-jnj-1001462296,negative,0.922876238822937
24,10/18/2016 2:50:20 PM,BRIEF-Johnson & Johnson reports Q3 EPS $1.53 (JNJ),Reuters,/news/stocks/brief-johnson-&-johnson-reports-q3-eps-$1-53-jnj-1001462388,positive,0.7418517470359802
25,10/18/2016 2:50:20 PM,"UPDATE 1-J&J quarterly revenue, profit edge past Street (JNJ)",Reuters,/news/stocks/update-1-j&j-quarterly-revenue-profit-edge-past-street-jnj-1001462383,negative,0.7051829099655151
26,10/18/2016 4:30:21 PM,BRIEF-Ortho Regenerative announces changes in executive leadership (JNJ),Reuters,/news/stocks/brief-ortho-regenerative-announces-changes-in-executive-leadership-jnj-1001462692,positive,0.8475999236106873
27,10/18/2016 8:30:24 PM,J&J says stable patients likely to stay with Remicade (JNJ),Reuters,/news/stocks/j&j-says-stable-patients-likely-to-stay-with-remicade-jnj-1001463054,negative,0.804793655872345
28,10/18/2016 10:40:20 PM,"UPDATE 4-J&J shares lose ground on fears of Pfizer's answer to Remicade (JNJ, PFE)",Reuters,/news/stocks/update-4-j&j-shares-lose-ground-on-fears-of-pfizers-answer-to-remicade-jnj-pfe-1001463467,neutral,0.965657651424408
29,10/20/2016 11:38:23 PM,BRIEF-J&J sets quarterly cash dividend of $0.80 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-080-per-share-2016-10,positive,0.887834370136261
30,10/25/2016 3:52:21 PM,BRIEF-Janssen Therapeutics receives funding from a special RFA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-therapeutics-receives-funding-from-a-special-rfa-2016-10,negative,0.6761122941970825
31,11/8/2016 1:36:17 PM,BRIEF-British artificial intelligence firm announces license agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-british-artificial-intelligence-firm-announces-license-agreement-with-janssen-2016-11,negative,0.8021379113197327
32,11/9/2016 6:28:14 PM,"Drug stocks rip higher after Trump's upset victory signals easing pressure on prices (MRK, PFE, AMGN, JNJ, AGN, ABBV, SNY, NVS, AZN, GSK, IBB)",Business Insider,http://www.businessinsider.com/drug-company-stocks-morning-after-election-2016-11,negative,0.9015561938285828
33,11/9/2016 10:16:20 PM,"J&J vaccine plus Gilead immune booster shows promise as HIV fighter (JNJ, GILD)",Reuters,http://www.businessinsider.com/r-jj-vaccine-plus-gilead-immune-booster-shows-promise-as-hiv-fighter-2016-11,negative,0.9299511909484863
34,11/10/2016 5:06:17 PM,"BRIEF-Genmab says combination of drugs from J&J, Amgen will be tested in study (GEN, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-combination-of-drugs-from-jj-amgen-will-be-tested-in-study-2016-11,positive,0.5980872511863708
35,11/10/2016 5:40:18 PM,"BRIEF-Janssen reports clinical trial collaboration and supply agreement with Amgen to evaluate Daratumumab in combination with Carfilzomib (AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-reports-clinical-trial-collaboration-and-supply-agreement-with-amgen-to-evaluate-daratumumab-in-combination-with-carfilzomib-2016-11,negative,0.9236637353897095
36,11/14/2016 8:22:18 AM,"J&J arthritis drug goes up against Humira, with mixed results (JNJ)",Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-goes-up-against-humira-with-mixed-results-2016-11,negative,0.8876290917396545
37,11/14/2016 12:22:20 PM,"Drugmakers improve access for poor, GSK ranked top (GSK, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-drugmakers-improve-access-for-poor-gsk-ranked-top-2016-11,negative,0.8904619812965393
38,11/14/2016 8:22:19 PM,The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11,negative,0.5357690453529358
39,11/14/2016 10:14:20 PM,BRIEF-Janssen Pharma says new late-stage results from pioneer AF-PCI study meets main goal (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharma-says-new-late-stage-results-from-pioneer-af-pci-study-meets-main-goal-2016-11,negative,0.7444353103637695
40,11/15/2016 2:36:18 AM,"BRIEF-Paulson & Co cuts share stake in Alexion Pharmaceuticals, Johnson & Johnson (ALXN, FDX, EBAY, JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-cuts-share-stake-in-alexion-pharmaceuticals-johnson--johnson-2016-11,positive,0.5103520750999451
41,11/15/2016 1:32:20 PM,RPT-The Novartis house that Vasella built gets extreme makeover (JNJ),Reuters,http://www.businessinsider.com/r-rpt-the-novartis-house-that-vasella-built-gets-extreme-makeover-2016-11,negative,0.7606014609336853
42,11/15/2016 4:20:21 PM,BRIEF-Janssen's Guselkumab shows promise in psoriatic arthritis treatment in Phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssens-guselkumab-shows-promise-in-psoriatic-arthritis-treatment-in-phase-2-trial-2016-11,negative,0.9494247436523438
43,11/16/2016 1:24:18 PM,BRIEF-Samsung Biologics says it wins $261.8 mln order from Cilag GmbH International (JNJ),Reuters,http://www.businessinsider.com/r-brief-samsung-biologics-says-it-wins-2618-mln-order-from-cilag-gmbh-international-2016-11,negative,0.9363553524017334
44,11/16/2016 10:24:21 PM,BRIEF-Janssen announces data from two late-stage studies for sirukumab in RA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-data-from-two-late-stage-studies-for-sirukumab-in-ra-2016-11,positive,0.5289684534072876
45,11/17/2016 3:26:32 PM,BRIEF-Janssen submits application to FDA seeking approval of anti-interleukin-23 monoclonal antibody guselkumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-application-to-fda-seeking-approval-of-anti-interleukin-23-monoclonal-antibody-guselkumab-2016-11,negative,0.8378108739852905
46,11/21/2016 10:56:52 PM,"BRIEF-Genmab announces U.S. FDA approval of Darzalex (Daratumumab) for relapsed multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-us-fda-approval-of-darzalex-daratumumab-for-relapsed-multiple-myeloma-2016-11,negative,0.6350835561752319
47,11/25/2016 5:56:17 AM,J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11,positive,0.8654661178588867
48,11/25/2016 5:56:17 AM,BRIEF-J&J said to make takeover approach for Swiss drugmaker Actelion - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-said-to-make-takeover-approach-for-swiss-drugmaker-actelion---bloomberg-2016-11,positive,0.8632349371910095
49,11/25/2016 7:28:21 AM,"UPDATE 1-J&J makes takeover approach for Swiss drugmaker Actelion -Bloomberg (JNJ, ABT)",Reuters,http://www.businessinsider.com/r-update-1-jj-makes-takeover-approach-for-swiss-drugmaker-actelion--bloomberg-2016-11,positive,0.7884476780891418
50,11/25/2016 11:28:18 AM,"Costly leukaemia pill wins UK green light after price cut (JNJ, PFE, BMY, 4523)",Reuters,http://www.businessinsider.com/r-costly-leukaemia-pill-wins-uk-green-light-after-price-cut-2016-11,negative,0.905751645565033
51,11/25/2016 6:02:43 PM,"CONFIRMED: Johnson & Johnson is looking to buy a nearly $20 billion drugmaker (ATLN, JNJ)",Business Insider,http://www.businessinsider.com/actelion-confirms-johnson-and-johnson-offer-2016-11,negative,0.5861822366714478
52,11/25/2016 6:54:20 PM,"US STOCKS-Wall St hit record highs as consumer staples, techs gain (JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-record-highs-as-consumer-staples-techs-gain-2016-11,negative,0.896360456943512
53,11/25/2016 6:54:20 PM,BRIEF-J&J confirms discussions with Actelion regarding potential deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-confirms-discussions-with-actelion-regarding-potential-deal-2016-11,positive,0.8629759550094604
54,11/25/2016 6:54:20 PM,Actelion confirms Johnson & Johnson approach (JNJ),Reuters,http://www.businessinsider.com/r-actelion-confirms-johnson--johnson-approach-2016-11,positive,0.8747128248214722
55,11/28/2016 3:11:41 PM,The drugmaker that Johnson & Johnson is looking to buy could significantly boost its takeover price,Reuters,http://www.businessinsider.com/r-actelions-ambitious-independent-minded-ceo-will-drive-up-takeover-price-2016-11,negative,0.9367399215698242
56,11/29/2016 10:20:15 AM,"PRESS DIGEST- Financial Times - Nov 29 (TSCO, BT., JNJ, SPD)",Reuters,http://www.businessinsider.com/r-press-digest--financial-times---nov-29-2016-11,positive,0.9384834170341492
57,11/29/2016 12:02:07 PM,"Actelion shares plunge on report it eyes ""complicated"" J&J deal (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shares-plunge-on-report-it-eyes-complicated-jj-deal-2016-11,neutral,0.9600856304168701
58,11/29/2016 12:02:07 PM,"Swiss stocks - Factors to watch on Nov.29 (PAXN, AIRE, VCH, ESUN, ALPN, COPN, JNJ)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-nov29-2016-11,positive,0.9435597062110901
59,11/29/2016 1:36:10 PM,European shares steady as firmer banks offset weaker miners (JNJ),Reuters,http://www.businessinsider.com/r-european-shares-steady-as-firmer-banks-offset-weaker-miners-2016-11,negative,0.7399137616157532
60,11/29/2016 4:56:10 PM,BRIEF-Depuy Synthes says new UK joint registry data confirms positive early results for Depuy Synthes Attune Knee system (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-says-new-uk-joint-registry-data-confirms-positive-early-results-for-depuy-synthes-attune-knee-system-2016-11,negative,0.9483932256698608
61,11/29/2016 8:10:05 PM,"BRIEF-Actelion has given J&J access to some of its financial information as part of the deal negotiations - Bloomberg, citing sources (JNJ)",Reuters,http://www.businessinsider.com/r-brief-actelion-has-given-jj-access-to-some-of-its-financial-information-as-part-of-the-deal-negotiations---bloomberg-citing-sources-2016-11,positive,0.9194818735122681
62,11/30/2016 2:00:05 PM,"BRIEF-Achillion announces initiation of patient dosing by Janssen in phase 2B study (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-initiation-of-patient-dosing-by-janssen-in-phase-2b-study-2016-11,positive,0.8976402878761292
63,11/30/2016 5:30:05 PM,Rejecting J&J could leave Actelion with 'lot of explaining to do',Reuters,http://www.businessinsider.com/r-rejecting-jj-could-leave-actelion-with-lot-of-explaining-to-do-2016-11,neutral,0.9575982093811035
64,12/1/2016 12:04:06 PM,"Swiss stocks - Factors to watch on Dec 1 (STMN, JNJ, ESUN, FORN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-dec-1-2016-12,positive,0.9368701577186584
65,12/2/2016 3:14:03 AM,Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12,negative,0.48371902108192444
66,12/2/2016 5:32:09 AM,UPDATE 1-Johnson & Johnson hit with over $1 bln verdict on hip implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-hit-with-over-1-bln-verdict-on-hip-implants-2016-12,neutral,0.800952672958374
67,12/2/2016 6:34:06 PM,EU health regulator warns some hep C drugs could reactivate hep B,Reuters,http://www.businessinsider.com/r-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12,neutral,0.942558765411377
68,12/2/2016 7:16:03 PM,"UPDATE 1-EU health regulator warns some hep C drugs could reactivate hep B (JNJ, BMY, GILD)",Reuters,http://www.businessinsider.com/r-update-1-eu-health-regulator-warns-some-hep-c-drugs-could-reactivate-hep-b-2016-12,neutral,0.926931619644165
69,12/2/2016 8:24:03 PM,"Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12,positive,0.774887204170227
70,12/5/2016 1:00:05 AM,"RPT-Actelion's silence has hedge funds betting big on J&J deal (MON, JNJ, SUN, SIK, SGO)",Reuters,http://www.businessinsider.com/r-rpt-actelions-silence-has-hedge-funds-betting-big-on-jj-deal-2016-12,positive,0.5817010402679443
71,12/5/2016 3:36:06 AM,Novartis CEO plays down prospects for Actelion bid: Blick,Reuters,http://www.businessinsider.com/r-novartis-ceo-plays-down-prospects-for-actelion-bid-blick-2016-12,neutral,0.9057379364967346
72,12/5/2016 11:56:05 PM,"BRIEF-Sanofi to explore counterbid for Actelion amid J&J talks - Bloomberg, citing sources (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-brief-sanofi-to-explore-counterbid-for-actelion-amid-jj-talks---bloomberg-citing-sources-2016-12,positive,0.8996670246124268
73,12/6/2016 12:18:07 AM,"Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12,positive,0.897873044013977
74,12/6/2016 5:40:10 AM,"UPDATE 1-Sanofi exploring bid for Actelion amid J&J talks - Bloomberg (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-exploring-bid-for-actelion-amid-jj-talks---bloomberg-2016-12,positive,0.8939583897590637
75,12/6/2016 12:00:07 PM,"DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,neutral,0.8780308961868286
76,12/6/2016 2:02:03 PM,"RPT-DEALTALK-Trump's corporate tax holiday could spur pharma M&A (JNJ, AGN, MSFT, ACAD, MRK, LLY, PFE, AMGN, AAPL, BMY, INCY, GILD)",Reuters,http://www.businessinsider.com/r-rpt-dealtalk-trumps-corporate-tax-holiday-could-spur-pharma-ma-2016-12,neutral,0.9314919114112854
77,12/6/2016 7:06:03 PM,BRIEF-Janssen Research & Development reports final Phase 2 data for ibrutinib (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-reports-final-phase-2-data-for-ibrutinib-2016-12,positive,0.9319599866867065
78,12/6/2016 7:26:03 PM,BRIEF-AbbVie reports positive Phase 2 data for ibrutinib in cGVHD patients (JNJ),Reuters,http://www.businessinsider.com/r-brief-abbvie-reports-positive-phase-2-data-for-ibrutinib-in-cgvhd-patients-2016-12,negative,0.9509865045547485
79,12/8/2016 5:54:04 PM,"BUZZ-DJI: On a run (XLI, DIA, GS, AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-on-a-run-2016-12,positive,0.9234013557434082
80,12/9/2016 3:49:52 PM,"Under Trump, the medical device industry will likely be the first to benefit from tax cuts",Reuters,http://www.businessinsider.com/r-under-trump-congress-likely-to-pull-plug-on-medical-device-tax-2016-12,negative,0.8367525339126587
81,12/14/2016 1:34:03 AM,BRIEF-Johnson & Johnson says it has ended discussions with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-it-has-ended-discussions-with-actelion-2016-12,positive,0.5986453890800476
82,12/14/2016 1:44:07 AM,J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-jj-ends-takeover-talks-with-actelion-2016-12,positive,0.7260899543762207
83,12/14/2016 2:10:07 AM,UPDATE 1-J&J ends takeover talks with Actelion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ends-takeover-talks-with-actelion-2016-12,positive,0.6688499450683594
84,12/14/2016 3:40:03 AM,BRIEF-Actelion says in discussions with another party regarding possible strategic transaction (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-in-discussions-with-another-party-regarding-possible-strategic-transaction-2016-12,positive,0.8664976358413696
85,12/14/2016 4:14:03 PM,"BRIEF-FDA clears wireless integration for WellDoc, Lifescan project (JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-clears-wireless-integration-for-welldoc-lifescan-project-2016-12,positive,0.5928327441215515
86,12/15/2016 7:08:03 AM,"PRESS DIGEST- Wall Street Journal - Dec 15 (YHOO, VZ, VIV, MS, VOW3, SAN, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---dec-15-2016-12,positive,0.9451293349266052
87,12/15/2016 2:52:03 PM,BRIEF-Veritex Holdings public offering of 3.9 mln shares priced at $22.50/share,Reuters,http://www.businessinsider.com/r-brief-veritex-holdings-public-offering-of-39-mln-shares-priced-at-2250/share-2016-12,positive,0.9330973625183105
88,12/16/2016 6:02:03 AM,Sanofi discusses $275 per Actelion share for potential deal: Bloomberg,Reuters,http://www.businessinsider.com/r-sanofi-discusses-275-per-actelion-share-for-potential-deal-bloomberg-2016-12,positive,0.9365376234054565
89,12/23/2016 10:49:48 PM,"Johnson & Johnson's on-again, off-again pursuit of Actelion is back on (JNJ, ALIOF)",Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnsons-actelion-pharmaceuticals-aquisition-2016-12,positive,0.9141700267791748
90,12/28/2016 1:18:05 PM,"BRIEF-Achillion announces clinical milestone for the advancement of JNJ-4178 (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-clinical-milestone-for-the-advancement-of-jnj-4178-2016-12,positive,0.7802304625511169
91,12/29/2016 11:00:05 PM,"BRIEF-Mylan launches generic Concerta tablets (JNJ, MYL)",Reuters,http://www.businessinsider.com/r-brief-mylan-launches-generic-concerta-tablets-2016-12,positive,0.856754720211029
92,12/30/2016 7:52:03 AM,"Swiss stocks - Factors to watch on Friday (JNJ, ALPN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-friday-2016-12,positive,0.9132986664772034
93,1/3/2017 12:48:03 PM,BRIEF-Johnson & Johnson announces quarterly dividend for Q1 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-quarterly-dividend-for-q1-2017-2017-1,positive,0.5994912385940552
94,1/3/2017 7:32:06 PM,BRIEF-J&J's DePuy Synthes acquires technology from Interventional Spine Inc (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-depuy-synthes-acquires-technology-from-interventional-spine-inc-2017-1,positive,0.6874608397483826
95,1/4/2017 7:00:05 AM,Judge halves $1 bln award in J&J hip implants case (JNJ),Reuters,http://www.businessinsider.com/r-judge-halves-1-bln-award-in-jj-hip-implants-case-2017-1,neutral,0.7102134823799133
96,1/6/2017 8:10:03 AM,"J&J, Actelion approach Swiss takeover board over deal structure -paper (JNJ, SAN)",Reuters,http://www.businessinsider.com/r-jj-actelion-approach-swiss-takeover-board-over-deal-structure--paper-2017-1,positive,0.935884952545166
97,1/11/2017 2:44:03 PM,"BRIEF-Bird Rock Bio receives approval to start first in human clinical trial for Namacizumab, enters into agreement with GE Healthcare for process development and scale-up to provide clinical phase...",Reuters,http://www.businessinsider.com/r-brief-bird-rock-bio-receives-approval-to-start-first-in-human-clinical-trial-for-namacizumab-enters-into-agreement-with-ge-healthcare-for-process-development-and-scale-up-to-provide-clinical-phase-2-cgmp-material-2017-1,negative,0.8995556235313416
98,1/11/2017 7:16:03 PM,"UPDATE 1-Trump says pharmaceutical companies ""getting away with murder"" (MYL, LMT, BA, PFE, JNJ, GILD, IBB)",Reuters,http://www.businessinsider.com/r-update-1-trump-says-pharmaceutical-companies-getting-away-with-murder-2017-1,positive,0.8361964821815491
99,1/12/2017 1:48:06 AM,BRIEF-Orthocell announces collaboration with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-orthocell-announces-collaboration-with-johnson--johnson-2017-1,positive,0.8055623173713684
100,1/14/2017 6:42:15 AM,Johnson & Johnson will begin disclosing drug price increases (JNJ),Business Insider Contributor ,http://www.businessinsider.com/johnson-and-johnson-drug-price-increases-2017-1,positive,0.809387743473053
101,1/20/2017 8:40:07 AM,"INSIGHT-Sanofi's M&A misses frustrate some investors in drugmaker (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-insight-sanofis-ma-misses-frustrate-some-investors-in-drugmaker-2017-1,neutral,0.8617132902145386
102,1/20/2017 2:54:10 PM,BRIEF-Ethicon Endo-Surgery announces acquisition of Megadyne Medical Products (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-endo-surgery-announces-acquisition-of-megadyne-medical-products-2017-1,positive,0.941149115562439
103,1/23/2017 9:30:05 AM,UPDATE 1-Actelion's Opsumit drug missed trial endpoint - doctor (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelions-opsumit-drug-missed-trial-endpoint---doctor-2017-1,neutral,0.7979817986488342
104,1/23/2017 2:40:07 PM,"UPDATE 1-Silgan buys WestRock's dispensers unit for about $1 bln (SLGN, CPB, JNJ, KR, PEP)",Reuters,http://www.businessinsider.com/r-update-1-silgan-buys-westrocks-dispensers-unit-for-about-1-bln-2017-1,positive,0.9023758769035339
105,1/23/2017 3:54:05 PM,"Trump to company executives: We think we can cut regulations by 75 pct (JNJ, GLW, IP, LMT, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-trump-to-company-executives-we-think-we-can-cut-regulations-by-75-pct-2017-1,negative,0.7173711657524109
106,1/23/2017 5:50:05 PM,"CEO's discussed tax, regulations and trade with Trump -Liveris (DOW, JNJ, GLW, IP, LMT, X, WHR, TSLA)",Reuters,http://www.businessinsider.com/r-ceos-discussed-tax-regulations-and-trade-with-trump--liveris-2017-1,positive,0.9446430802345276
107,1/24/2017 12:58:05 PM,BRIEF-Johnson & Johnson reports Q4 adj. earnings $1.58 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-reports-q4-adj-earnings-158-per-share-2017-1,positive,0.8149960041046143
108,1/24/2017 4:26:05 PM,BRIEF-J&J sees 2017 effective tax rate 19-20 percent (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sees-2017-effective-tax-rate-19-20-percent-2017-1,positive,0.8811612725257874
109,1/25/2017 2:04:05 PM,"BRIEF-Pacira Pharmaceuticals collaborates with Depuy Synthes to support promotion, education and training of exparel in orthopedics (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-pharmaceuticals-collaborates-with-depuy-synthes-to-support-promotion-education-and-training-of-exparel-in-orthopedics-2017-1,negative,0.7992503046989441
110,1/26/2017 9:08:05 AM,UPDATE 1-Johnson & Johnson to buy Actelion for $30 bln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-to-buy-actelion-for-30-bln-2017-1,positive,0.8952932953834534
111,1/26/2017 10:28:15 AM,Johnson & Johnson will buy Swiss biotech firm Actelion for $30 billion (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson-johnson-to-buy-actelion-for-30-bln-2017-1,positive,0.928566575050354
112,1/26/2017 1:45:57 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://www.businessinsider.com/opening-bell-january-26-2017-2017-1,positive,0.946307361125946
113,1/26/2017 3:35:20 PM,"10 things you need to know today (SPY, SPX, QQQ, DIA, RBS, JNJ, EBAY)",Business Insider,http://markets.businessinsider.com/news/stocks/opening-bell-january-26-2017-2017-1-1001697085,positive,0.9414228796958923
114,1/26/2017 4:22:05 PM,BRIEF-DePuy Synthes receives FDA clearance for cement-augmented pedicle screw systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-receives-fda-clearance-for-cement-augmented-pedicle-screw-systems-2017-1,negative,0.9357060790061951
115,1/26/2017 6:24:08 PM,Advisers could land $100 million payday from Actelion sale (JNJ),Reuters,http://www.businessinsider.com/r-advisers-could-land-100-million-payday-from-actelion-sale-2017-1,positive,0.83110511302948
116,1/26/2017 6:40:13 PM,"M&A boost helps European shares stay at one-year high (JNJ, STM, DGE, RBS)",Reuters,http://www.businessinsider.com/r-ma-boost-helps-european-shares-stay-at-one-year-high-2017-1,negative,0.9373507499694824
117,1/26/2017 10:22:49 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://www.businessinsider.com/closing-bell-january-26-2017-2017-1,positive,0.9421433806419373
118,1/26/2017 10:52:53 PM,"STOCKS GO NOWHERE: Here's what you need to know (CAT, VZ, CHTR, JNJ)",Business Insider,http://markets.businessinsider.com/news/stocks/closing-bell-january-26-2017-2017-1-1001699144,positive,0.9421433806419373
119,1/27/2017 2:56:06 PM,UPDATE 1-Drugmaker AbbVie's quarterly revenue misses estimates (JNJ),Reuters,http://www.businessinsider.com/r-update-1-drugmaker-abbvies-quarterly-revenue-misses-estimates-2017-1,positive,0.7552079558372498
120,1/27/2017 10:08:06 PM,J&J loses venue fight for talc lawsuits in Missouri,Reuters,http://www.businessinsider.com/r-jj-loses-venue-fight-for-talc-lawsuits-in-missouri-2017-1,neutral,0.843472421169281
121,1/27/2017 10:30:08 PM,BRIEF-Fitch affirms Johnson & Johnson's IDR at 'AAA'; outlook stable (JNJ),Reuters,http://www.businessinsider.com/r-brief-fitch-affirms-johnson--johnsons-idr-at-aaa-outlook-stable-2017-1,negative,0.8439348936080933
122,1/31/2017 2:34:07 PM,"Actelion, Syngenta takeovers set to shake up Swiss SMI index",Reuters,http://www.businessinsider.com/r-actelion-syngenta-takeovers-set-to-shake-up-swiss-smi-index-2017-1,positive,0.901752233505249
123,1/31/2017 3:16:07 PM,BRIEF-ChemDiv announces multi-year hit identification collaboration with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-chemdiv-announces-multi-year-hit-identification-collaboration-with-janssen-2017-1,negative,0.8433247804641724
124,1/31/2017 3:18:04 PM,"BUZZ-DJI: Post-election rally on shaky ground (BA, IBM, AAPL, GS, DIA, DIS, JNJ)",Reuters,http://www.businessinsider.com/r-buzz-dji-post-election-rally-on-shaky-ground-2017-1,neutral,0.9288178086280823
125,1/31/2017 4:10:07 PM,"Trump meets with drugmakers, seeks lower prices, U.S. production (MRK, JNJ, CELG, LLY, AMGN)",Reuters,http://www.businessinsider.com/r-trump-meets-with-drugmakers-seeks-lower-prices-us-production-2017-1,positive,0.6421660780906677
126,1/31/2017 7:06:07 PM,"UPDATE 3-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-3-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1,negative,0.909467875957489
127,1/31/2017 9:30:07 PM,"UPDATE 4-Trump pushes drugmakers for lower prices, more U.S. production (JNJ, MRK, LLY, AMGN, CELG)",Reuters,http://www.businessinsider.com/r-update-4-trump-pushes-drugmakers-for-lower-prices-more-us-production-2017-1,negative,0.9122521281242371
128,1/31/2017 10:40:10 PM,"UPDATE 1-Roche said to consider options for Diabetes unit- Bloomberg (JNJ, BAYN, KKR, 6752)",Reuters,http://www.businessinsider.com/r-update-1-roche-said-to-consider-options-for-diabetes-unit--bloomberg-2017-1,positive,0.8831456303596497
129,2/1/2017 11:40:10 PM,"BRIEF-J&J says upon termination of transaction agreement, under some circumstances, Actelion may be obligated to pay co a fee (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-upon-termination-of-transaction-agreement-under-some-circumstances-actelion-may-be-obligated-to-pay-co-a-fee-2017-2,positive,0.9037541151046753
130,2/2/2017 2:36:04 PM,BRIEF-Janssen Human Microbiome Institute announces multiple collaborations to accelerate translation of microbiome science into health solutions (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-human-microbiome-institute-announces-multiple-collaborations-to-accelerate-translation-of-microbiome-science-into-health-solutions-2017-2,negative,0.9068920016288757
131,2/6/2017 5:38:08 PM,BRIEF-Renova Therapeutics enters into agreement to receive Stresscopin investigational new drug file from Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-renova-therapeutics-enters-into-agreement-to-receive-stresscopin-investigational-new-drug-file-from-janssen-2017-2,negative,0.9044325947761536
132,2/8/2017 10:06:11 AM,"UPDATE 1-Drugmaker Sanofi sees weak 2017 earnings, not in hurry for M&A (SAN, JNJ, REGN, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-drugmaker-sanofi-sees-weak-2017-earnings-not-in-hurry-for-ma-2017-2,neutral,0.9732018709182739
133,2/8/2017 5:08:09 PM,"BRIEF-Bayer late-stage rivaroxaban trial meets primary endpoint early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-late-stage-rivaroxaban-trial-meets-primary-endpoint-early-2017-2,negative,0.7147147059440613
134,2/8/2017 7:54:11 PM,Bayer's blood thinner also effective for artery disease,Reuters,http://www.businessinsider.com/r-bayers-blood-thinner-also-effective-for-artery-disease-2017-2,negative,0.5573164820671082
135,2/10/2017 7:22:09 AM,"Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2,negative,0.8417466282844543
136,2/10/2017 1:08:09 PM,"RPT-Purdue seeks rule that would give it edge in Canadian painkiller market (JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-rpt-purdue-seeks-rule-that-would-give-it-edge-in-canadian-painkiller-market-2017-2,negative,0.809509813785553
137,2/10/2017 2:30:09 PM,EMA panel recommends that use of Actelion's Uptravi may continue,Reuters,http://www.businessinsider.com/r-ema-panel-recommends-that-use-of-actelions-uptravi-may-continue-2017-2,positive,0.8507855534553528
138,2/10/2017 2:54:10 PM,UPDATE 1-EMA panel says that use of Actelion's Uptravi may continue (JNJ),Reuters,http://www.businessinsider.com/r-update-1-ema-panel-says-that-use-of-actelions-uptravi-may-continue-2017-2,positive,0.8388009667396545
139,2/10/2017 7:04:09 PM,"BRIEF-Bayer says phase III compass study shows efficacy of Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-says-phase-iii-compass-study-shows-efficacy-of-xarelto-2017-2,negative,0.8654778003692627
140,2/13/2017 1:36:10 PM,BRIEF-Akebia Therapeutics provides update on Janssen deal (JNJ),Reuters,http://www.businessinsider.com/r-brief-akebia-therapeutics-provides-update-on-janssen-deal-2017-2,positive,0.9410772323608398
141,2/14/2017 7:58:10 AM,"Actelion, being bought by J&J, says FY profit rose 26 pct (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-being-bought-by-jj-says-fy-profit-rose-26-pct-2017-2,negative,0.9521745443344116
142,2/14/2017 8:18:10 AM,"UPDATE 1-Actelion, being bought by J&J, says FY core net income rose 27 pct (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-actelion-being-bought-by-jj-says-fy-core-net-income-rose-27-pct-2017-2,negative,0.9543126821517944
143,2/15/2017 1:00:10 AM,"BRIEF-Paulson & Co takes share stake in Achaogen, dissolves in J&J (JNJ)",Reuters,http://www.businessinsider.com/r-brief-paulson--co-takes-share-stake-in-achaogen-dissolves-in-jj-2017-2,positive,0.8606703877449036
144,2/15/2017 1:12:12 PM,Integra LifeSciences To Buy J & J Codman Neurosurgery Business For $1.045 Bln ,RTTNews,/news/stocks/integra-lifesciences-to-buy-j-j-codman-neurosurgery-business-for-1-045-bln-1001752636,positive,0.9287640452384949
145,2/15/2017 1:38:11 PM,"BRIEF-Integra Lifesciences plans to acquire Codman neurosurgery business from Johnson & Johnson for $1.045 bln (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-plans-to-acquire-codman-neurosurgery-business-from-johnson--johnson-for-1045-bln-2017-2,positive,0.9182143807411194
146,2/15/2017 1:44:11 PM,"UPDATE 1-Integra offers to buy J&J's Codman neurosurgery business (JNJ, IART)",Reuters,http://www.businessinsider.com/r-update-1-integra-offers-to-buy-jjs-codman-neurosurgery-business-2017-2,positive,0.8232863545417786
147,2/15/2017 2:46:10 PM,"BRIEF-Integra Lifesciences says Depuy Synthes entitled to get termination fee of $60 million if co fails to complete deal (IART, JNJ)",Reuters,http://www.businessinsider.com/r-brief-integra-lifesciences-says-depuy-synthes-entitled-to-get-termination-fee-of-60-million-if-co-fails-to-complete-deal-2017-2,neutral,0.9323588609695435
148,2/15/2017 3:06:13 PM,BRIEF-X-Chem expands collaboration with Janssen in inflammatory diseases (JNJ),Reuters,http://www.businessinsider.com/r-brief-x-chem-expands-collaboration-with-janssen-in-inflammatory-diseases-2017-2,negative,0.9437580704689026
149,2/15/2017 3:18:10 PM,BRIEF-Trianni signs licensing agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-trianni-signs-licensing-agreement-with-janssen-2017-2,negative,0.9083475470542908
150,2/16/2017 7:50:11 AM,Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2,positive,0.9319970607757568
151,2/16/2017 9:44:10 AM,UPDATE 1-Actelion says J&J's $280 per share offer to start March 3 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-actelion-says-jjs-280-per-share-offer-to-start-march-3-2017-2,positive,0.9252787828445435
152,2/16/2017 9:52:10 AM,BRIEF-Swiss Takeover Commission OKs J&J offer for Actelion (JNJ),Reuters,http://www.businessinsider.com/r-brief-swiss-takeover-commission-oks-jj-offer-for-actelion-2017-2,positive,0.9184220433235168
153,2/16/2017 11:04:12 AM,"UPDATE 2-How Sanofi lost out to J&J in $30 bln battle for Actelion (SAN, JNJ)",Reuters,http://www.businessinsider.com/r-update-2-how-sanofi-lost-out-to-jj-in-30-bln-battle-for-actelion-2017-2,positive,0.7624643445014954
154,2/17/2017 1:08:10 PM,"EU mergers and takeovers (Feb 17) (6753, 2354, TKA, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-17-2017-2,positive,0.9484501481056213
155,2/17/2017 4:20:11 PM,BRIEF-Ethicon announces agreement to acquire Torax Medical (JNJ),Reuters,http://www.businessinsider.com/r-brief-ethicon-announces-agreement-to-acquire-torax-medical-2017-2,positive,0.5858929753303528
156,2/21/2017 3:32:12 PM,"EU mergers and takeovers (Feb 21) (MAERSK , ACA, UCG, JNJ, TECD, AVT, SIE, MENT, NKT, AKE, KKR, 6501, 6581, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-21-2017-2,positive,0.9490551948547363
157,2/22/2017 6:42:12 PM,"Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2,positive,0.5978724360466003
158,2/22/2017 7:36:13 PM,"EU mergers and takeovers (Feb 22) (KKR, 6501, 6581, JNJ, ABT, TECD, AVT, SIE, MENT, NKT, AKE, 2502, ABI, 2317, 005930, HAR, MCRO, GFK, COL, BEAV, MQG, PETG, FFH, AIG, AHL1V, 8031, GAM, BX, NG.",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-feb-22-2017-2,positive,0.950030505657196
159,2/22/2017 9:00:12 PM,"Genmab's Darzalex could achieve peak annual sales of $9 bln -CEO (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-genmabs-darzalex-could-achieve-peak-annual-sales-of-9-bln--ceo-2017-2,positive,0.5465623140335083
160,2/22/2017 9:28:12 PM,"UPDATE 1-Genmab and J&J's cancer drug set for blockbuster sales this year (GEN, JNJ, GILD, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-genmab-and-jjs-cancer-drug-set-for-blockbuster-sales-this-year-2017-2,negative,0.7297852635383606
161,2/23/2017 5:48:17 PM,Trump tells CEOs he plans to bring back millions of jobs,Reuters,http://www.businessinsider.com/r-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2,positive,0.7233976125717163
162,2/23/2017 5:52:12 PM,"UPDATE 1-Trump tells CEOs he plans to bring back millions of jobs (GE, LMT, DOW, IP, F, JNJ, GLW, MRK, CAT, MMM, X, ADM, GD, WHR, 067900)",Reuters,http://www.businessinsider.com/r-update-1-trump-tells-ceos-he-plans-to-bring-back-millions-of-jobs-2017-2,positive,0.6531839370727539
163,2/24/2017 1:44:12 PM,"BRIEF-EMA recommends approval of Daiichi Sankyo's anticoagulant (4568, JNJ, GEN)",Reuters,http://www.businessinsider.com/r-brief-ema-recommends-approval-of-daiichi-sankyos-anticoagulant-2017-2,positive,0.7681344151496887
164,2/27/2017 4:05:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786515,negative,0.9303171038627625
165,2/27/2017 4:53:00 PM,Ortho Clinical Diagnostics Awarded Top Honor for Global Excellence in Customer Service,PR Newswire,/news/stocks/ortho-clinical-diagnostics-awarded-top-honor-for-global-excellence-in-customer-service-1001786683,negative,0.9303171038627625
166,2/27/2017 8:50:13 PM,"J&J says kept drug price increases below 10 pct since 2012 (JNJ, MRK, AGN, NOVO )",Reuters,http://www.businessinsider.com/r-jj-says-kept-drug-price-increases-below-10-pct-since-2012-2017-2,positive,0.7101498246192932
167,2/27/2017 11:30:13 PM,BRIEF-Johnson & Johnson says received a subpoena in Feb. from the U.S. attorney's office for the District of Massachusetts (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-received-a-subpoena-in-feb-from-the-us-attorneys-office-for-the-district-of-massachusetts-2017-2,positive,0.4179380238056183
168,2/28/2017 12:22:24 AM,The world's biggest drugmaker just pulled back the curtain on drug pricing (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-breakdown-on-drug-pricing-2017-2,neutral,0.4707593023777008
169,3/3/2017 9:42:20 AM,"UPDATE 1-Japan's GPIF posts record $92 bln quarterly gain thanks to stock rally (8306, 9433, JNJ, MSFT, 7267, 9432, 7203, XOM, AAPL)",Reuters,http://www.businessinsider.com/r-update-1-japans-gpif-posts-record-92-bln-quarterly-gain-thanks-to-stock-rally-2017-3,negative,0.9298763275146484
170,3/3/2017 2:00:22 PM,"BRIEF-Johnson & Johnson's Janssen says new results from second phase 3 study show significant efficacy of guselkumab (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnsons-janssen-says-new-results-from-second-phase-3-study-show-significant-efficacy-of-guselkumab-2017-3,negative,0.9449673891067505
171,3/3/2017 10:40:20 PM,J&J wins fourth trial in talc product liability lawsuits,Reuters,http://www.businessinsider.com/r-jj-wins-fourth-trial-in-talc-product-liability-lawsuits-2017-3,negative,0.8023351430892944
172,3/3/2017 11:04:20 PM,UPDATE 1-J&J wins trial in talc product liability lawsuits (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-trial-in-talc-product-liability-lawsuits-2017-3,negative,0.8895720839500427
173,3/6/2017 10:00:21 AM,BRIEF-Janssen provides Nuevolution with further technology access fee payment (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-provides-nuevolution-with-further-technology-access-fee-payment-2017-3,negative,0.5966392159461975
174,3/6/2017 1:44:21 PM,UPDATE 1-TG Therapeutics' leukemia drug clears hurdle in key study (JNJ),Reuters,http://www.businessinsider.com/r-update-1-tg-therapeutics-leukemia-drug-clears-hurdle-in-key-study-2017-3,negative,0.7508827447891235
175,3/7/2017 1:25:00 PM,"Drug Makers Stocks Under Scanner -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-pfizer-merck-abbvie-and-johnson-johnson-1001810747,neutral,0.6821770071983337
176,3/7/2017 4:30:22 PM,"US STOCKS-Wall St slips as Trump tweet pummels drug stocks (JNJ, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-trump-tweet-pummels-drug-stocks-2017-3,neutral,0.9550221562385559
177,3/7/2017 5:56:21 PM,"US STOCKS-Wall St pares losses as techs offset pharma decline (JNJ, AAPL, MSFT, DISH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-pares-losses-as-techs-offset-pharma-decline-2017-3,neutral,0.9129452109336853
178,3/8/2017 5:42:22 PM,"INSIGHT-'It's like kumbaya': Trump's genial private meetings with CEOs jar with public attacks (JNJ, MRK, LLY, CELG, AMGN, GM, F, CPB, TGT, LUV, UAL, DAL)",Reuters,http://www.businessinsider.com/r-insight-its-like-kumbaya-trumps-genial-private-meetings-with-ceos-jar-with-public-attacks-2017-3,positive,0.8371442556381226
179,3/9/2017 5:54:22 PM,"US STOCKS-S&P, Dow on track to snap 3-day losing streak as banks gain (JNJ, AAPL, AIG)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-on-track-to-snap-3-day-losing-streak-as-banks-gain-2017-3,negative,0.6732838749885559
180,3/9/2017 7:44:22 PM,"US STOCKS-Wall St fights to hold on to gains as oil slips again (CVX, JNJ, AAPL, SIG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-fights-to-hold-on-to-gains-as-oil-slips-again-2017-3,neutral,0.8606253266334534
181,3/9/2017 9:46:22 PM,"US STOCKS-Wall St slips as energy shares fall further; banks pare gains (JNJ, AAPL)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slips-as-energy-shares-fall-further-banks-pare-gains-2017-3,neutral,0.9649677276611328
182,3/9/2017 10:52:27 PM,US STOCKS-Wall St ends up slightly; energy shares rebound (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ends-up-slightly-energy-shares-rebound-2017-3,negative,0.6905443072319031
183,3/9/2017 11:12:25 PM,"GLOBAL MARKETS-Oil prices slump amid ample supply, gold falls (UKX, BP., BLT, GLEN, JNJ, XOM, WFC)",Reuters,http://www.businessinsider.com/r-global-markets-oil-prices-slump-amid-ample-supply-gold-falls-2017-3,neutral,0.9673621654510498
184,3/13/2017 4:17:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829909,negative,0.9417600631713867
185,3/13/2017 4:35:00 PM,Ortho Clinical Diagnostics Announces Expansion Of Global Agreement With Astute Medical For NephroCheck Test,PR Newswire,/news/stocks/ortho-clinical-diagnostics-announces-expansion-of-global-agreement-with-astute-medical-for-nephrocheck-test-1001829985,negative,0.9417600631713867
186,3/14/2017 7:00:00 AM,Johnson & Johnson Names Winners of First Africa Innovation Challenge,PR Newswire,/news/stocks/johnson-johnson-names-winners-of-first-africa-innovation-challenge-1001831566,negative,0.5122067332267761
187,3/14/2017 12:56:24 PM,"BRIEF-Pacira says phase 4 study shows its drug reduces opioid consumption and postsurgical pain in patients undergoing total knee arthroplasty (PCRX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-pacira-says-phase-4-study-shows-its-drug-reduces-opioid-consumption-and-postsurgical-pain-in-patients-undergoing-total-knee-arthroplasty-2017-3,negative,0.9368368983268738
188,3/14/2017 4:30:50 PM,"An experimental vaccine could leave the world far better prepared for the next Ebola outbreak (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3,negative,0.7419734597206116
189,3/14/2017 5:40:24 PM,"RPT-Two-part Ebola vaccine offers long-lasting protection (JNJ, BAVA, MRK)",Reuters,http://www.businessinsider.com/r-rpt-two-part-ebola-vaccine-offers-long-lasting-protection-2017-3,negative,0.7164936661720276
190,3/15/2017 8:22:45 AM,BRIEF-Actelion says drug discovery business to be called Idorsia (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-drug-discovery-business-to-be-called-idorsia-2017-3,positive,0.9464208483695984
191,3/15/2017 1:50:42 PM,BRIEF-J&J CEO Alex Gorsky's 2016 total compensation $26.9 mln (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-ceo-alex-gorskys-2016-total-compensation-269-mln-2017-3,positive,0.9235907196998596
192,3/18/2017 3:18:46 PM,"J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study (JNJ, BAYN, PFE)",Reuters,http://www.businessinsider.com/r-jj-and-bayers-xarelto-cuts-recurrence-of-dangerous-blood-clots-in-study-2017-3,negative,0.6829161047935486
193,3/19/2017 9:12:46 PM,Newer type 2 diabetes drugs show heart protective quality in study,Reuters,http://www.businessinsider.com/r-newer-type-2-diabetes-drugs-show-heart-protective-quality-in-study-2017-3,negative,0.7342519760131836
194,3/23/2017 1:40:45 PM,BRIEF-Johnson & Johnson says to pause all YouTube digital advertising globally (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-to-pause-all-youtube-digital-advertising-globally-2017-3,neutral,0.5520284175872803
195,3/23/2017 1:54:45 PM,"J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3,neutral,0.8619781732559204
196,3/23/2017 2:16:50 PM,"UPDATE 1-J&J latest to suspend ads from YouTube over offensive videos (JNJ, VZ, T, MKS)",Reuters,http://www.businessinsider.com/r-update-1-jj-latest-to-suspend-ads-from-youtube-over-offensive-videos-2017-3,neutral,0.8756166696548462
197,3/24/2017 4:42:45 AM,YouTube's bid to grab TV dollars imperiled by advertiser revolt,Reuters,http://www.businessinsider.com/r-youtubes-bid-to-grab-tv-dollars-imperiled-by-advertiser-revolt-2017-3,neutral,0.4682478606700897
198,3/28/2017 3:30:49 PM,Twitter to let advertisers buy video ads on Periscope,Reuters,http://www.businessinsider.com/r-twitter-to-let-advertisers-buy-video-ads-on-periscope-2017-3,positive,0.9287564158439636
199,3/28/2017 3:52:49 PM,"BRIEF-Ligand announces licensing partner Janssen has filed an IND for an antibody discovered using the OmniAB Technology (LGND, JNJ)",Reuters,http://www.businessinsider.com/r-brief-ligand-announces-licensing-partner-janssen-has-filed-an-ind-for-an-antibody-discovered-using-the-omniab-technology-2017-3,neutral,0.6084770560264587
200,3/28/2017 7:06:47 PM,"US STOCKS-Dow on track to snap 8-day losing streak as banks gain (BAC, GS, JPM, AAPL, GM, TSLA, 700)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-on-track-to-snap-8-day-losing-streak-as-banks-gain-2017-3,negative,0.7082509994506836
201,3/28/2017 7:06:47 PM,U.S. senator launches probe into five top opioid drugmakers,Reuters,http://www.businessinsider.com/r-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3,neutral,0.6439038515090942
202,3/28/2017 8:40:47 PM,"UPDATE 1-U.S. senator launches probe into five top opioid drugmakers (JNJ, MYL, DEPO)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-launches-probe-into-five-top-opioid-drugmakers-2017-3,positive,0.801138699054718
203,3/29/2017 8:23:58 AM,"Johnson & Johnson just launched a $100,000 burnout prevention bootcamp for CEOs (JNJ)",Business Insider,http://www.businessinsider.com/johnson-johnson-ceos-burnt-out-2017-3,positive,0.8319420218467712
204,3/29/2017 8:26:49 AM,"PRESS DIGEST- New York Times business news - March 29 (005930, 9984, 700, TSLA, BLK)",Reuters,http://www.businessinsider.com/r-press-digest--new-york-times-business-news---march-29-2017-3,positive,0.9367399215698242
205,3/30/2017 7:04:50 PM,"BRIEF-Genmab A/S says Phase II study in NHL will not proceed (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-a-s-says-phase-ii-study-in-nhl-will-not-proceed-2017-3,positive,0.6718995571136475
206,3/31/2017 1:30:48 AM,"DEALS-Trump helps make cross-border M&A great again (JNJ, ULVR, AKZA, PPG, RB., MJN, BARC, BAC)",Reuters,http://www.businessinsider.com/r-deals-trump-helps-make-cross-border-ma-great-again-2017-3,negative,0.9029463529586792
207,3/31/2017 7:00:00 AM,Johnson & Johnson Publishes Interim Result for Actelion Tender Offer and Declares the Tender Offer Successful,PR Newswire,/news/stocks/johnson-&-johnson-publishes-interim-result-for-actelion-tender-offer-and-declares-the-tender-offer-successful-1001550374,positive,0.9372537136077881
208,3/31/2017 7:12:02 AM,Johnson & Johnson Announces Interim Result For Actelion Tender Offer ,RTTNews,/news/stocks/johnson-johnson-announces-interim-result-for-actelion-tender-offer-1001884307,positive,0.8401275277137756
209,3/31/2017 7:50:50 AM,"Swiss stocks - Factors to watch on March 31 (JNJ, HELN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-march-31-2017-3,positive,0.9281012415885925
210,3/31/2017 12:14:48 PM,"Deals of the day-Mergers and acquisitions (AVGO, 6502, JNJ, CM, PVTB, BX, 10015031, ROSN, MNZS, BN, 2881)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-3,positive,0.9431670308113098
211,4/4/2017 5:58:00 PM,"Ortho Clinical Diagnostics to Present Data on Early Detection Of Acute Kidney Injury, Total Lab Automation and Transfusion Medicine at MEDLAB Asia Pacific 2017",PR Newswire,/news/stocks/ortho-clinical-diagnostics-to-present-data-on-early-detection-of-acute-kidney-injury-total-lab-automation-and-transfusion-medicine-at-medlab-asia-pacific-2017-1001895502,positive,0.8306341171264648
212,4/5/2017 8:12:50 AM,"Swiss stocks - Factors to watch on April 5 (JNJ, GAM, LECN, VONN, VAHN)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-april-5-2017-4,positive,0.9365664124488831
213,4/5/2017 1:10:52 PM,"Actelion shareholders back R&D spinoff, keep J&J deal on track (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-shareholders-back-rd-spinoff-keep-jj-deal-on-track-2017-4,positive,0.8215878009796143
214,4/6/2017 2:20:52 AM,Experts want special clinics to prescribe ketamine as antidepressant,Reuters,http://www.businessinsider.com/r-experts-want-special-clinics-to-prescribe-ketamine-as-antidepressant-2017-4,positive,0.727226972579956
215,4/6/2017 3:16:53 PM,U.S. trade group hacked with Chinese software ahead of Xi summit,Reuters,http://www.businessinsider.com/r-us-trade-group-hacked-with-chinese-software-ahead-of-xi-summit-2017-4,neutral,0.7569944262504578
216,4/7/2017 12:36:57 PM,BRIEF-PeptiDream enters into collaboration with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-peptidream-enters-into-collaboration-with-janssen-pharmaceuticals-2017-4,negative,0.6593167185783386
217,4/7/2017 1:58:53 PM,EMA gives green light to Actelion's Uptravi after safety review,Reuters,http://www.businessinsider.com/r-ema-gives-green-light-to-actelions-uptravi-after-safety-review-2017-4,negative,0.8601610660552979
218,4/7/2017 2:18:12 PM,PeptiDream Reports Discovery Collaboration Agreement With Janssen ,RTTNews,/news/stocks/peptidream-reports-discovery-collaboration-agreement-with-janssen-1001906569,negative,0.9011738300323486
219,4/10/2017 12:10:00 PM,"Drug Makers Stocks on Investors' Radar -- Pfizer, Merck, Johnson & Johnson, and AbbVie",PR Newswire,/news/stocks/drug-makers-stocks-on-investors-radar-pfizer-merck-johnson-johnson-and-abbvie-1001909734,positive,0.9021657705307007
220,4/10/2017 2:14:58 PM,"BRIEF-Geron Corp and Janssen Research & Development LLC has completed second internal data reviews of Imerge and Imbark (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-corp-and-janssen-research--development-llc-has-completed-second-internal-data-reviews-of-imerge-and-imbark-2017-4,positive,0.5242346525192261
221,4/11/2017 10:37:10 AM,"Swiss billionaire Wyss gets nearly 10 pct of Molecular Partners (JNJ, AGN)",Reuters,http://www.businessinsider.com/r-swiss-billionaire-wyss-gets-nearly-10-pct-of-molecular-partners-2017-4,negative,0.7452705502510071
222,4/12/2017 1:22:17 PM,BRIEF-Phagelux announces collaboration with Johnson & Johnson Innovation for new antibacterial solution (JNJ),Reuters,http://www.businessinsider.com/r-brief-phagelux-announces-collaboration-with-johnson--johnson-innovation-for-new-antibacterial-solution-2017-4,negative,0.9047848582267761
223,4/17/2017 2:33:07 PM,BRIEF-Janssen receives Health Canada approval of Darzalex by priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-health-canada-approval-of-darzalex-by-priority-review-2017-4,negative,0.6957791447639465
224,4/18/2017 12:40:00 PM,Johnson & Johnson Reports 2017 First-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-first-quarter-results-1001926238,positive,0.6684455275535583
225,4/18/2017 12:48:12 PM,Johnson & Johnson Q1 Profit Rises 4%,RTTNews,/news/stocks/johnson-johnson-q1-profit-rises-4-1001926265,negative,0.9225355982780457
226,4/18/2017 12:59:08 PM,BRIEF-Johnson & Johnson Q1 earnings per share $1.61 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q1-earnings-per-share-161-2017-4,positive,0.7361222505569458
227,4/18/2017 1:01:05 PM,J&J's quarterly sales rise 1.6 pct (JNJ),Reuters,http://www.businessinsider.com/r-jjs-quarterly-sales-rise-16-pct-2017-4,negative,0.9426905512809753
228,4/18/2017 1:21:06 PM,"BRIEF-Genmab Q1 net sales of Darzalex at $255 million (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-q1-net-sales-of-darzalex-at-255-million-2017-4,positive,0.9397628307342529
229,4/18/2017 1:21:06 PM,UPDATE 1-J&J revenue misses on lower-than-expected pharmaceutical sales (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-revenue-misses-on-lower-than-expected-pharmaceutical-sales-2017-4,neutral,0.9700552225112915
230,4/18/2017 1:35:33 PM,Johnson & Johnson Q1 Profit Tops Estimates; Lifts FY17 View ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-lifts-fy17-view-1001926523,negative,0.926973819732666
231,4/18/2017 1:41:08 PM,"US STOCKS-Futures dip as investors weigh tax cut delays, earnings (BAC, GS, UNH, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-dip-as-investors-weigh-tax-cut-delays-earnings-2017-4,neutral,0.9665839672088623
232,4/18/2017 1:55:03 PM,"UPDATE 1-Cardinal Health to buy Medtronic units for $6.1 bln (CAH, MDT, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-cardinal-health-to-buy-medtronic-units-for-61-bln-2017-4,positive,0.6708352565765381
233,4/18/2017 2:00:00 PM,5 Stocks to Watch as Canada Gets Hooked on Cannabis,PR Newswire,/news/stocks/5-stocks-to-watch-as-canada-gets-hooked-on-cannabis-1001926681,positive,0.8382822871208191
234,4/18/2017 3:33:03 PM,"US STOCKS-Wall St set to open lower as earnings gather pace (GS, BAC, MS, WFC, JPM, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-earnings-gather-pace-2017-4,neutral,0.9630159735679626
235,4/18/2017 3:53:03 PM,BRIEF-Johnson & Johnson sees Actelion adding 35-50 cents to 2018 EPS (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-sees-actelion-adding-35-50-cents-to-2018-eps-2017-4,negative,0.7297093868255615
236,4/18/2017 3:57:05 PM,"EU mergers and takeovers (April 18) (COL, LEA, JNJ, KKR, SAF, RR., BOL, VIV, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-18-2017-4,positive,0.9517852663993835
237,4/18/2017 4:39:03 PM,"US STOCKS-Wall St falls as Goldman, J&J results disappoint (JNJ, GS, MS, WFC, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-goldman-jj-results-disappoint-2017-4,neutral,0.9683998823165894
238,4/18/2017 6:07:05 PM,"US STOCKS-Weak Goldman, J&J results drag down Wall Street (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-goldman-jj-results-drag-down-wall-street-2017-4,neutral,0.9657508134841919
239,4/18/2017 6:53:06 PM,"WRAPUP 2-U.S. housing starts drop; automobiles undercut factory output (GS, JNJ)",Reuters,http://www.businessinsider.com/r-wrapup-2-us-housing-starts-drop-automobiles-undercut-factory-output-2017-4,neutral,0.9723931550979614
240,4/18/2017 7:13:05 PM,"US STOCKS-Wall St down as Goldman, J&J's results disappoint (JNJ, GS, BAC, NFLX, UNH)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-down-as-goldman-jjs-results-disappoint-2017-4,neutral,0.9671811461448669
241,4/18/2017 8:49:03 PM,"US STOCKS-Wall Sheet falls as Goldman, J&J weigh (JNJ, CAH, BAC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-sheet-falls-as-goldman-jj-weigh-2017-4,neutral,0.9542616605758667
242,4/18/2017 9:36:48 PM,Johnson & Johnson Leading The Pharmaceutical Sector Lower ,RTTNews,/news/stocks/johnson-johnson-leading-the-pharmaceutical-sector-lower-1001928365,positive,0.8997349739074707
243,4/18/2017 10:27:03 PM,"US STOCKS-Goldman Sachs, J&J pull Wall Street lower (JNJ, CAH, MDT, BAC)",Reuters,http://www.businessinsider.com/r-us-stocks-goldman-sachs-jj-pull-wall-street-lower-2017-4,neutral,0.9251890778541565
244,4/19/2017 1:55:06 PM,"US STOCKS-Futures rise as earnings take center stage (MS, AXP, EBAY, QCOM, GS, JNJ, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-rise-as-earnings-take-center-stage-2017-4,negative,0.9277714490890503
245,4/19/2017 4:51:04 PM,"EU mergers and takeovers (April 19) (EDF, AREVA, SAF, RR., BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-19-2017-4,positive,0.9514936804771423
246,4/20/2017 4:51:04 PM,"BRIEF-Genmab to present seven abstracts at annual ASCO meeting (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-to-present-seven-abstracts-at-annual-asco-meeting-2017-4,positive,0.9337684512138367
247,4/20/2017 6:31:07 PM,"EU mergers and takeovers (April 20) (RR., 3653, SAF, AVGO, BRCD, BOL, VIV, KKR, 6752, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-20-2017-4,positive,0.9519568085670471
248,4/21/2017 3:15:05 PM,"UPDATE 1-Valeant prices psoriasis treatment at $3,500 per month (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-valeant-prices-psoriasis-treatment-at-3500-per-month-2017-4,positive,0.928935170173645
249,4/21/2017 9:51:09 PM,"EMA panel recommends nod for Sanofi, Regeneron's arthritis drug (SAN, REGN, JNJ, LLY, INCY)",Reuters,http://www.businessinsider.com/r-ema-panel-recommends-nod-for-sanofi-regenerons-arthritis-drug-2017-4,positive,0.6911615133285522
250,4/21/2017 10:13:04 PM,"BRIEF-FDA approves Renflexis, biosimilar to Remicade (MRK, JNJ)",Reuters,http://www.businessinsider.com/r-brief-fda-approves-renflexis-biosimilar-to-remicade-2017-4,negative,0.719455897808075
251,4/22/2017 2:51:04 AM,"U.S. FDA approves Samsung Bioepis' copy of J&J's Remicade -company (JNJ, AMGN, MRK, PFE, 068270)",Reuters,http://www.businessinsider.com/r-us-fda-approves-samsung-bioepis-copy-of-jjs-remicade--company-2017-4,positive,0.6302808523178101
252,4/24/2017 10:12:54 AM,Janssen Holding Acquires 92.51% Of Actelion ,RTTNews,/news/stocks/janssen-holding-acquires-92-51-of-actelion-1001940983,positive,0.9372010231018066
253,4/24/2017 12:21:05 PM,"India to expand access to J&J's TB drug this year (JNJ, 4578)",Reuters,http://www.businessinsider.com/r-india-to-expand-access-to-jjs-tb-drug-this-year-2017-4,negative,0.9059770107269287
254,4/24/2017 1:11:08 PM,"RPT-INSIGHT-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-rpt-insight-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,positive,0.8234217166900635
255,4/24/2017 3:21:10 PM,"EU mergers and takeovers (April 24) (6752, KKR, GE, BHI, BOL, VIV, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, TEF, CS, LIN, JNJ, EDF, AREVA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-24-2017-4,positive,0.9505015015602112
256,4/24/2017 5:05:05 PM,"J&J, Novartis and Takeda in talks for Brazil's Hypermarcas, sources say (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas-sources-say-2017-4,positive,0.7104398012161255
257,4/24/2017 5:31:10 PM,"UPDATE 1-J&J, Novartis and Takeda in talks for Brazil's Hypermarcas -sources (JNJ, 4502, HYPE3, BBDC4)",Reuters,http://www.businessinsider.com/r-update-1-jj-novartis-and-takeda-in-talks-for-brazils-hypermarcas--sources-2017-4,positive,0.49525654315948486
258,4/24/2017 5:35:06 PM,"EMERGING MARKETS-Brazil real, Mexico peso strengthen on French vote (HYPE3, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-emerging-markets-brazil-real-mexico-peso-strengthen-on-french-vote-2017-4,negative,0.9186445474624634
259,4/24/2017 7:39:00 PM,Johnson & Johnson to Host Pharmaceutical Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-pharmaceutical-business-review-1001943321,positive,0.9419378042221069
260,4/24/2017 8:17:06 PM,"UPDATE 1-NASH: The next untapped pharma market gives investors many options (PFE, BMY, GILD, AGN, MRK, JNJ, DRRX)",Reuters,http://www.businessinsider.com/r-update-1-nash-the-next-untapped-pharma-market-gives-investors-many-options-2017-4,positive,0.7897846698760986
261,4/25/2017 3:11:10 PM,"Japan's Otsuka aims to apply for TB drug approval in India in 90 days (4578, JNJ)",Reuters,http://www.businessinsider.com/r-japans-otsuka-aims-to-apply-for-tb-drug-approval-in-india-in-90-days-2017-4,positive,0.7043421268463135
262,4/25/2017 3:11:10 PM,"US STOCKS-Wall St set to open higher as earnings take center stage (CAT, MCD, BIIB, CNC, T, TSN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-higher-as-earnings-take-center-stage-2017-4,negative,0.9364098906517029
263,4/25/2017 5:29:10 PM,"EU mergers and takeovers (April 25) (BOL, VIV, SAF, 600115, EDF, 8058, VOW3, 6201, 2354, TIT, BMW, DAI, PAH3, F, KKR, TEF, CS, LIN, JNJ, AREVA, GE, BHI)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-25-2017-4,positive,0.9509918689727783
264,4/26/2017 10:46:06 PM,"Digital ad spend jumps 22 percent to $72.5 bln in 2016 -report (VZ, JNJ)",Reuters,http://www.businessinsider.com/r-digital-ad-spend-jumps-22-percent-to-725-bln-in-2016--report-2017-4,negative,0.9336728453636169
265,4/27/2017 7:59:06 AM,BRIEF-Actelion says J&J deal on track to close towards end of Q2 (JNJ),Reuters,http://www.businessinsider.com/r-brief-actelion-says-jj-deal-on-track-to-close-towards-end-of-q2-2017-4,positive,0.8071949481964111
266,4/27/2017 10:01:11 AM,"UPDATE 1-Strong pharma unit drives Bayer earnings beat (BAYN, MON, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-update-1-strong-pharma-unit-drives-bayer-earnings-beat-2017-4,negative,0.9419052600860596
267,4/27/2017 5:29:06 PM,BRIEF-J&J increase qtrly dividend by 5 pct to $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-increase-qtrly-dividend-by-5-pct-to-084-per-share-2017-4,negative,0.9150402545928955
268,4/28/2017 12:49:07 PM,"CORRECTED-UPDATE 2-Valeant prices psoriasis treatment at $3,500 per month (April 21) (VRX, LLY, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-update-2-valeant-prices-psoriasis-treatment-at-3500-per-month-april-21-2017-4,positive,0.9364179372787476
269,4/28/2017 3:05:09 PM,"Global med-tech firms, India locked in tussle after stent price sting (ABT, BSX, JNJ, MDT, ABBOTINDIA)",Reuters,http://www.businessinsider.com/r-global-med-tech-firms-india-locked-in-tussle-after-stent-price-sting-2017-4,neutral,0.9078989624977112
270,4/28/2017 3:21:07 PM,"Deals of the day-Mergers and acquisitions (SIE, BBD., AKZA, PPG, 1880, 9437, OML, KOTAKBANK, BAYN, MON, ZC, SAF, KKR, TTS, APO, 600887, DG, SU, ATL, ALV)",Reuters,http://www.businessinsider.com/r-deals-of-the-day-mergers-and-acquisitions-2017-4,positive,0.9414942264556885
271,4/28/2017 3:51:09 PM,"BRIEF-Genmab announces new late stage combination study of Daratumumab in multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-announces-new-late-stage-combination-study-of-daratumumab-in-multiple-myeloma-2017-4,positive,0.6000761389732361
272,4/28/2017 4:41:09 PM,"EU mergers and takeovers (April 28) (BMW, DAI, PAH3, F, RTO, 6201, 2354, VIV, TIT, KKR, TEF, CS, LIN, JNJ, EDF, AREVA, GE, BHI, SAF, 600115, 8058, ANA)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-april-28-2017-4,positive,0.9512503743171692
273,4/28/2017 10:53:12 PM,BRIEF-Janssen Research & Development submits supplemental application to FDA to update prescribing information for Xarelto (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-research--development-submits-supplemental-application-to-fda-to-update-prescribing-information-for-xarelto-2017-4,positive,0.9072040915489197
274,5/1/2017 2:13:00 PM,Johnson & Johnson Introduces Two New Interactive Experiences Showcasing More Than 130 Years Of Healthcare Innovation,PR Newswire,/news/stocks/johnson-johnson-introduces-two-new-interactive-experiences-showcasing-more-than-130-years-of-healthcare-innovation-1001965506,positive,0.7012912631034851
275,5/3/2017 10:30:04 PM,"Bayer, J&J win first product liability trial over Xarelto (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-first-product-liability-trial-over-xarelto-2017-5,negative,0.9143948554992676
276,5/3/2017 11:10:05 PM,"UPDATE 1-Bayer, J&J win first trial over Xarelto bleeding risks (BAYN, JNJ, BMY)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-first-trial-over-xarelto-bleeding-risks-2017-5,negative,0.9144780039787292
277,5/5/2017 2:44:03 AM,J&J ordered to pay $110 million in talc product liability trial (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-110-million-in-talc-product-liability-trial-2017-5,neutral,0.7930114269256592
278,5/5/2017 3:54:05 AM,UPDATE 1-J&J ordered to pay $110 million in U.S. talc-powder trial (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-110-million-in-us-talc-powder-trial-2017-5,neutral,0.7285088896751404
279,5/5/2017 5:00:52 AM,Johnson & Johnson Ordered To Pay $110 Mln In Talc-Powder Trial ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-110-mln-in-talc-powder-trial-1001982133,neutral,0.9337190985679626
280,5/5/2017 8:03:00 PM,Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-ubs-global-healthcare-conference-1001985138,positive,0.7879930138587952
281,5/6/2017 3:02:05 AM,BRIEF-Janssen Pharmaceuticals says evidence shows oral invokana 300 mg demonstrates comparable A1C reduction (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceuticals-says-evidence-shows-oral-invokana-300-mg-demonstrates-comparable-a1c-reduction-2017-5,negative,0.9349145889282227
282,5/8/2017 11:06:03 PM,"BRIEF-J&J says in March 2017, New Jersey attorney general division of consumer affairs issued subpoena to Janssen Pharmaceuticals (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-says-in-march-2017-new-jersey-attorney-general-division-of-consumer-affairs-issued-subpoena-to-janssen-pharmaceuticals-2017-5,positive,0.5453404784202576
283,5/9/2017 1:20:04 AM,J&J discloses U.S. probe related to arthritis drugs (JNJ),Reuters,http://www.businessinsider.com/r-jj-discloses-us-probe-related-to-arthritis-drugs-2017-5,positive,0.900539755821228
284,5/10/2017 6:10:02 PM,"UPDATE 1-Sanofi says has no ""absolute need"" to do acquisitions (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-update-1-sanofi-says-has-no-absolute-need-to-do-acquisitions-2017-5,positive,0.910224974155426
285,5/11/2017 8:16:00 PM,Johnson & Johnson to Participate in the Jefferies 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-jefferies-2017-global-healthcare-conference-668201,positive,0.7815356850624084
286,5/12/2017 7:46:05 PM,"EU mergers and takeovers (May 12) (AVGO, BRCD, KKR, TEF, LIN, 2354, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-12-2017-5,positive,0.9510487914085388
287,5/15/2017 12:15:00 PM,"Drug Makers Stocks Under Scanner -- Alliqua BioMedical, AbbVie, Johnson & Johnson, and Merck",PR Newswire,/news/stocks/drug-makers-stocks-under-scanner-alliqua-biomedical-abbvie-johnson-johnson-and-merck-1002012055,neutral,0.4808368682861328
288,5/15/2017 12:26:05 PM,"U.S. companies push hard for lower tax rate on offshore profits (AAPL, MSFT, PFE, GE, JNJ, MRK, XOM, IBM, CSCO)",Reuters,http://www.businessinsider.com/r-us-companies-push-hard-for-lower-tax-rate-on-offshore-profits-2017-5,negative,0.5808895230293274
289,5/15/2017 2:14:03 PM,"Israel's BiomX raises $24 mln in private funding round (JNJ, 4502)",Reuters,http://www.businessinsider.com/r-israels-biomx-raises-24-mln-in-private-funding-round-2017-5,negative,0.8530305027961731
290,5/15/2017 3:54:07 PM,BRIEF-Depuy Synthes awarded U.S. Department of Defense contract for orthopaedic products (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-awarded-us-department-of-defense-contract-for-orthopaedic-products-2017-5,negative,0.9144741892814636
291,5/15/2017 6:06:07 PM,"EU mergers and takeovers (May 15) (2354, GS, RF, JLL, NK, JNJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-15-2017-5,positive,0.9514480233192444
292,5/15/2017 6:40:05 PM,BRIEF-J&J appoints Jane Griffiths to head Actelion unit (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-appoints-jane-griffiths-to-head-actelion-unit-2017-5,positive,0.935839831829071
293,5/15/2017 7:30:02 PM,"South Korea's Celltrion sees rapid take-off for Roche drug copy (068270, JNJ, MRK)",Reuters,http://www.businessinsider.com/r-south-koreas-celltrion-sees-rapid-take-off-for-roche-drug-copy-2017-5,negative,0.8742907047271729
294,5/15/2017 9:26:05 PM,"US STOCKS-Wall St hit records as technology, energy stocks rise (JNJ, CSCO, SYMC, XOM, CVX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-hit-records-as-technology-energy-stocks-rise-2017-5,negative,0.6504136323928833
295,5/15/2017 9:53:40 PM,Johnson & Johnson Posting Strong Gain On Upgrade By JPMorgan ,RTTNews,/news/stocks/johnson-johnson-posting-strong-gain-on-upgrade-by-jpmorgan-1002014293,negative,0.9370558261871338
296,5/16/2017 5:16:09 AM,"UPDATE 1-New York county sues Purdue, J&J over opioid marketing (JNJ, TEVA, ENDP)",Reuters,http://www.businessinsider.com/r-update-1-new-york-county-sues-purdue-jj-over-opioid-marketing-2017-5,neutral,0.8443042635917664
297,5/16/2017 5:36:10 PM,BRIEF-Livanova announces Thad Huston as chief financial officer (JNJ),Reuters,http://www.businessinsider.com/r-brief-livanova-announces-thad-huston-as-chief-financial-officer-2017-5,positive,0.9332247376441956
298,5/17/2017 1:26:03 AM,"U.S. FDA warns of foot, leg amputations with J&J diabetes drug (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-us-fda-warns-of-foot-leg-amputations-with-jj-diabetes-drug-2017-5,neutral,0.8133893609046936
299,5/17/2017 12:44:00 PM,Johnson & Johnson Showcases Strong Pipeline of Transformational Medicines at its Pharmaceutical Business Review Meeting,PR Newswire,/news/stocks/johnson-&-johnson-showcases-strong-pipeline-of-transformational-medicines-at-its-pharmaceutical-business-review-meeting-683092,negative,0.8726391792297363
300,5/17/2017 1:16:07 PM,BRIEF-J&J says expects more than 10 new products to launch or file for regulatory approval by 2021 (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-expects-more-than-10-new-products-to-launch-or-file-for-regulatory-approval-by-2021-2017-5,positive,0.6700353026390076
301,5/17/2017 4:18:55 PM,The world's largest drugmaker thinks it has 11 billion-dollar drugs in the pipeline ‚Äî here's what they treat (JNJ),Business Insider,http://www.businessinsider.com/johnson-and-johnson-blockbuster-drug-potentials-by-2021-2017-5,positive,0.8844572305679321
302,5/18/2017 12:20:07 PM,Johnson & Johnson offers EU concessions over Actelion deal (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-offers-eu-concessions-over-actelion-deal-2017-5,negative,0.9152174592018127
303,5/18/2017 5:10:09 PM,"EU mergers and takeovers (May 18) (JNJ, IJ, EDF, AREVA, VIV, TIT, GE, BHI, SAF, 600115, 8058, ANA, RTO, QCOM, NXPI, 600626, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-18-2017-5,positive,0.9512693285942078
304,5/19/2017 2:30:05 AM,"For millions of Chinese with rare diseases, some relief in sight (CELG, BMY, JNJ, SHP, SAN, PFE, MRK, SAPL, ALXN)",Reuters,http://www.businessinsider.com/r-for-millions-of-chinese-with-rare-diseases-some-relief-in-sight-2017-5,negative,0.8676335215568542
305,5/19/2017 7:12:03 AM,"Janssen files suit in U.S. to block sale of Samsung Bioepis' Remicade copy (JNJ, AMGN)",Reuters,http://www.businessinsider.com/r-janssen-files-suit-in-us-to-block-sale-of-samsung-bioepis-remicade-copy-2017-5,neutral,0.7900747656822205
306,5/19/2017 8:36:03 PM,"EU mergers and takeovers (May 19) (SAF, 600115, EDF, 8058, 521, C14, BX, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-19-2017-5,positive,0.9508469104766846
307,5/22/2017 4:36:02 PM,"Cross-border M&A between U.S. and European firms at 10 year high (HUN, ULVR, UNA, JNJ, AKZA, PPG, RB., MJN)",Reuters,http://www.businessinsider.com/r-cross-border-ma-between-us-and-european-firms-at-10-year-high-2017-5,negative,0.7715175747871399
308,5/23/2017 12:52:02 PM,"UPDATE 1-UK competition watchdog accuses Merck of obstructing biosimilars (MRK, 068270, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-uk-competition-watchdog-accuses-merck-of-obstructing-biosimilars-2017-5,neutral,0.9463047981262207
309,5/23/2017 7:50:05 PM,"EU mergers and takeovers (May 23) (9101, 9104, 9107, FTI, LIN, RDSA, EDF, AREVA, VIV, TIT, GE, BHI, ANA, RTO, QCOM, NXPI, 600626, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 521, C14, BX)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-23-2017-5,positive,0.9489671587944031
310,5/24/2017 7:26:05 PM,J&J settles drug manufacturing probe by U.S. states for $33 million (JNJ),Reuters,http://www.businessinsider.com/r-jj-settles-drug-manufacturing-probe-by-us-states-for-33-million-2017-5,neutral,0.5074793100357056
311,5/24/2017 8:24:05 PM,UPDATE 1-J&J settles drug manufacturing probe by U.S. states for $33 mln (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-settles-drug-manufacturing-probe-by-us-states-for-33-mln-2017-5,neutral,0.8491998314857483
312,5/25/2017 11:32:16 AM,Biotech Stocks Facing FDA Decision In June ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-june-1002042040,positive,0.7687873244285583
313,5/30/2017 11:30:07 AM,"Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5,neutral,0.7272360920906067
314,5/30/2017 11:30:07 AM,"RPT-Novartis has assets to sell, investors wary of what it might buy (GSK, MRK, BMY, AZN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-novartis-has-assets-to-sell-investors-wary-of-what-it-might-buy-2017-5,neutral,0.5483747720718384
315,5/30/2017 1:36:07 PM,BRIEF-Protagonist Therapeutics signs deal with J&J to develop bowel drug (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-signs-deal-with-jj-to-develop-bowel-drug-2017-5,negative,0.757675290107727
316,5/30/2017 2:12:06 PM,BRIEF-Protagonist Therapeutics says will be responsible for conduct of Phase 1 clinical trial for PTG-200 (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-says-will-be-responsible-for-conduct-of-phase-1-clinical-trial-for-ptg-200-2017-5,positive,0.8610717058181763
317,5/30/2017 3:14:05 PM,US STOCKS-Wall St set to open lower as investors digest data (JNJ),Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-as-investors-digest-data-2017-5,neutral,0.9522609710693359
318,5/30/2017 4:30:08 PM,"US STOCKS-Wall St opens slightly lower as investors digest data (JNJ, ATW, ESV)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-slightly-lower-as-investors-digest-data-2017-5,neutral,0.9535783529281616
319,5/31/2017 3:58:05 PM,"US STOCKS-Wall St flat as oil offsets gains in tech, healthcare (JNJ, EXAS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-oil-offsets-gains-in-tech-healthcare-2017-5,negative,0.8157589435577393
320,5/31/2017 5:48:06 PM,"Ohio is suing 5 drug companies over the opioid crisis (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-ohio-sues-five-drug-companies-over-opioid-crisis-2017-5,neutral,0.9027553796768188
321,5/31/2017 6:40:25 PM,"EU mergers and takeovers (May 31) (GE, BHI, 9984, FIG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 2317, RDSA, 521, C14, BX, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-may-31-2017-5,positive,0.95195472240448
322,6/1/2017 7:12:03 AM,"PRESS DIGEST - Wall Street Journal - June 1 (GS, JNJ, TEVA, AGN, ENDP)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---june-1-2017-6,positive,0.9428988695144653
323,6/1/2017 4:56:05 PM,"EU mergers and takeovers (June 1) (HLDX, GS, UG, GM, BNP, GLE, DG, DUFN, MQG, RTO, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, FIG, 9101, 9104, 9107, FTI, LIN)",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-1-2017-6,positive,0.9509334564208984
324,6/1/2017 10:12:08 PM,"BRIEF-‚ÄçJanssen Sciences Ireland UC -VIIV Healthcare made regulatory submissions to EMA,FDA for dolutegravir and rilpivirine‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-sciences-ireland-uc--viiv-healthcare-made-regulatory-submissions-to-emafda-for-dolutegravir-and-rilpivirine-2017-6,negative,0.63529372215271
325,6/2/2017 12:01:23 PM,State Sues Big Pharma For Opioid Carnage ,RTTNews,/news/stocks/state-sues-big-pharma-for-opioid-carnage-1002062739,neutral,0.8716987371444702
326,6/3/2017 1:46:06 PM,Study shows early Zytiga use improves prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-study-shows-early-zytiga-use-improves-prostate-cancer-survival-2017-6,negative,0.9448679685592651
327,6/3/2017 10:24:05 PM,UPDATE 1-Early use of J&J's Zytiga extends prostate cancer survival (JNJ),Reuters,http://www.businessinsider.com/r-update-1-early-use-of-jjs-zytiga-extends-prostate-cancer-survival-2017-6,negative,0.9290522933006287
328,6/6/2017 1:18:08 AM,"MOVES-Credit Suisse hires Rapkin for healthcare investment banking (JPM, JNJ, FRE, AKRX, UNH, HCA, DVA)",Reuters,http://www.businessinsider.com/r-moves-credit-suisse-hires-rapkin-for-healthcare-investment-banking-2017-6,positive,0.788609504699707
329,6/8/2017 1:30:03 AM,"Trump FBI nominee's corporate legal work could exclude him from some probes (JNJ, T, DBK, CVS, GM, WFC, GSK, 7312, LMT)",Reuters,http://www.businessinsider.com/r-trump-fbi-nominees-corporate-legal-work-could-exclude-him-from-some-probes-2017-6,positive,0.608754575252533
330,6/8/2017 10:06:03 AM,"Actelion antibiotic misses mark on one study, hits it on another (JNJ)",Reuters,http://www.businessinsider.com/r-actelion-antibiotic-misses-mark-on-one-study-hits-it-on-another-2017-6,neutral,0.5205857157707214
331,6/8/2017 1:20:08 PM,"EU mergers and takeovers (June 8) (RTO, DD, FMC, BNP, CBK, SAZ, QCOM, NXPI, JNJ, IJ, RHI, MAGG3, GS, RF, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, GLE,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-8-2017-6,positive,0.949635922908783
332,6/8/2017 11:32:08 PM,"UPDATE 1-U.S. FDA asks Endo to withdraw Opana ER opioid; shares fall (ENDP, TEVA, JNJ, AGN)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-asks-endo-to-withdraw-opana-er-opioid-shares-fall-2017-6,neutral,0.9687212705612183
333,6/9/2017 1:32:05 PM,EU approves J&J purchase of Actelion subject to conditions (JNJ),Reuters,http://www.businessinsider.com/r-eu-approves-jj-purchase-of-actelion-subject-to-conditions-2017-6,positive,0.9130040407180786
334,6/9/2017 4:58:05 PM,BRIEF-ClinicalTrials.gov says Janssen's study of niraparib suspends recruitment (JNJ),Reuters,http://www.businessinsider.com/r-brief-clinicaltrialsgov-says-janssens-study-of-niraparib-suspends-recruitment-2017-6,neutral,0.9026325345039368
335,6/9/2017 5:30:00 PM,"Johnson & Johnson Announces Expected Settlement of Actelion Tender Offer on June 16, 2017",PR Newswire,/news/stocks/johnson-johnson-announces-expected-settlement-of-actelion-tender-offer-on-june-16-2017-1002082475,positive,0.8994849920272827
336,6/9/2017 5:58:05 PM,Johnson & Johnson expects to complete of Actelion offer on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-expects-to-complete-of-actelion-offer-on-june-16-2017-6,positive,0.929080069065094
337,6/9/2017 6:28:05 PM,UPDATE 1-Johnson & Johnson expects to complete Actelion purchase on June 16 (JNJ),Reuters,http://www.businessinsider.com/r-update-1-johnson--johnson-expects-to-complete-actelion-purchase-on-june-16-2017-6,positive,0.9039189219474792
338,6/9/2017 6:52:03 PM,"BRIEF-J&J Spokesperson says study enrollment in Niraparib is on temporary hold, anticipates re-opening enrollment soon ‚Äç‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-jj-spokesperson-says-study-enrollment-in-niraparib-is-on-temporary-hold-anticipates-re-opening-enrollment-soon--2017-6,neutral,0.8825736045837402
339,6/9/2017 6:52:03 PM,"EU mergers and takeovers (June 9) (JNJ, GS, RF, FMC, DD, EDF, QCOM, NXPI, IJ, RHI, MAGG3, JLL, NK, 9984, 2317, RDSA, 521, C14, BX, MQG, FIG, 9101, 9104, 9107, FTI, LIN, UG, GM, BNP, GLE, DG, DUFN,...",Reuters,http://www.businessinsider.com/r-eu-mergers-and-takeovers-june-9-2017-6,positive,0.9505598545074463
340,6/9/2017 8:34:05 PM,"BRIEF-Johnson & Johnson says expects settlement of Actelion tender offer on June 16, 2017 (JNJ)",Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-expects-settlement-of-actelion-tender-offer-on-june-16-2017-2017-6,positive,0.9162541031837463
341,6/12/2017 12:54:05 PM,BRIEF-Tesaro says Janssen updated clinicaltrials.gov website to reflect janssen had placed temporary enrollment hold in the galahad ‚Äç‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-tesaro-says-janssen-updated-clinicaltrialsgov-website-to-reflect-janssen-had-placed-temporary-enrollment-hold-in-the-galahad--2017-6,neutral,0.8051682710647583
342,6/12/2017 1:48:04 PM,"BRIEF-Qualcomm announces agreement with Lifescan Inc (QCOM, JNJ)",Reuters,http://www.businessinsider.com/r-brief-qualcomm-announces-agreement-with-lifescan-inc-2017-6,negative,0.6171510219573975
343,6/12/2017 5:08:03 PM,"BRIEF-Metlife names Susan Podlogar Chief Human Resources Officer (MET, JNJ)",Reuters,http://www.businessinsider.com/r-brief-metlife-names-susan-podlogar-chief-human-resources-officer-2017-6,positive,0.9311386942863464
344,6/12/2017 11:12:05 PM,"Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6,negative,0.8135434985160828
345,6/12/2017 11:52:03 PM,"UPDATE 1-Bayer, J&J win second U.S. trial over Xarelto bleeding risks (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-jj-win-second-us-trial-over-xarelto-bleeding-risks-2017-6,negative,0.8813121914863586
346,6/13/2017 12:30:07 AM,"J&J diabetes drug shows heart benefit in large safety study (JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-jj-diabetes-drug-shows-heart-benefit-in-large-safety-study-2017-6,negative,0.911771297454834
347,6/13/2017 3:15:13 AM,J&J And Bayer Win Second Trial On Xarelto Bleeding Risks ,RTTNews,/news/stocks/j-j-and-bayer-win-second-trial-on-xarelto-bleeding-risks-1002087149,negative,0.8353486657142639
348,6/13/2017 3:26:08 PM,BRIEF-Pulmatrix licenses novel drug candidates from Respivert (JNJ),Reuters,http://www.businessinsider.com/r-brief-pulmatrix-licenses-novel-drug-candidates-from-respivert-2017-6,negative,0.7570541501045227
349,6/14/2017 1:18:03 PM,Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6,negative,0.9390735626220703
350,6/14/2017 1:18:03 PM,"BRIEF-Janssen says Phase 3 data shows anti-TNF Alpha Simponi Aria significantly improved arthritis, skin manifestations (JNJ)",Reuters,http://www.businessinsider.com/r-brief-janssen-says-phase-3-data-shows-anti-tnf-alpha-simponi-aria-significantly-improved-arthritis-skin-manifestations-2017-6,negative,0.9413670897483826
351,6/14/2017 1:28:06 PM,"BRIEF-J&J says Pimodivir alone or in combination with oseltamivir demonstrated a significant reduction in viral load in adults with Influenza A (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-brief-jj-says-pimodivir-alone-or-in-combination-with-oseltamivir-demonstrated-a-significant-reduction-in-viral-load-in-adults-with-influenza-a-2017-6,negative,0.9265514612197876
352,6/14/2017 1:48:06 PM,"UPDATE 1-Johnson & Johnson's flu drug succeeds in mid-stage trial (JNJ, VRTX)",Reuters,http://www.businessinsider.com/r-update-1-johnson--johnsons-flu-drug-succeeds-in-mid-stage-trial-2017-6,negative,0.9179571270942688
353,6/14/2017 2:34:07 PM,BRIEF-Johnson & Johnson says are working with medical University of South Carolina (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-are-working-with-medical-university-of-south-carolina-2017-6,negative,0.5198810696601868
354,6/14/2017 4:10:07 PM,"US STOCKS-Wall St flat as banks fall after weak data; Fed eyed (JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-banks-fall-after-weak-data-fed-eyed-2017-6,neutral,0.9519543051719666
355,6/14/2017 5:32:03 PM,"US STOCKS-Weak data weighs on bank stocks; Fed rate decision looms (XOM, CVX, JNJ, MSFT, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-weak-data-weighs-on-bank-stocks-fed-rate-decision-looms-2017-6,neutral,0.9598982334136963
356,6/14/2017 6:44:14 PM,BRIEF-Janssen presents long term phase 3 efficacy and safety data of Sirukumab (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-presents-long-term-phase-3-efficacy-and-safety-data-of-sirukumab-2017-6,positive,0.752021849155426
357,6/14/2017 6:58:05 PM,"US STOCKS-Oil drop, weak data weigh on Wall St; Fed move looms (XOM, CVX, JNJ, ALXN, BIIB, HRB)",Reuters,http://www.businessinsider.com/r-us-stocks-oil-drop-weak-data-weigh-on-wall-st-fed-move-looms-2017-6,neutral,0.9595026969909668
358,6/14/2017 10:46:04 PM,BRIEF-Minerva Neurosciences enters amendment to co-development and license agreement with Janssen Pharmaceutica NV (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-enters-amendment-to-co-development-and-license-agreement-with-janssen-pharmaceutica-nv-2017-6,negative,0.8471895456314087
359,6/15/2017 1:04:03 AM,"Google bets on European biotech drugs, backs new fund (GSK, SAN, JNJ, AAPL, MSFT, GEN)",Reuters,http://www.businessinsider.com/r-google-bets-on-european-biotech-drugs-backs-new-fund-2017-6,positive,0.8159474730491638
360,6/15/2017 8:08:03 PM,"U.S. state attorneys general probe opioid drug companies (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-us-state-attorneys-general-probe-opioid-drug-companies-2017-6,positive,0.7005851864814758
361,6/16/2017 7:10:19 AM,Johnson & Johnson Closes Acquisition Of Actelion ,RTTNews,/news/stocks/johnson-johnson-closes-acquisition-of-actelion-1002098255,positive,0.8984814882278442
362,6/16/2017 9:38:05 AM,Actelion spin-off Idorsia makes market debut at 10 Sfr per share (JNJ),Reuters,http://www.businessinsider.com/r-actelion-spin-off-idorsia-makes-market-debut-at-10-sfr-per-share-2017-6,positive,0.6085562109947205
363,6/16/2017 7:54:06 PM,"BRIEF-Genmab says U.S. FDA approves darzalex in combination with pomalidomide and dexamethasone for relapsed or refractory multiple myeloma (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-says-us-fda-approves-darzalex-in-combination-with-pomalidomide-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma-2017-6,negative,0.898592472076416
364,6/20/2017 2:00:00 PM,"Douglas Wallace, Ph.D., Wins 2017 Dr. Paul Janssen Award for Biomedical Research",PR Newswire,/news/stocks/douglas-wallace-ph-d-wins-2017-dr-paul-janssen-award-for-biomedical-research-1002107304,negative,0.6373090147972107
365,6/20/2017 4:42:05 PM,"Exxon, BP support Republican elders' climate proposal (XOM, RDSA, FP, GM, JNJ, PEP, BP.)",Reuters,http://www.businessinsider.com/r-exxon-bp-support-republican-elders-climate-proposal-2017-6,positive,0.5689100623130798
366,6/20/2017 10:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1002109462,positive,0.9199506640434265
367,6/21/2017 1:18:03 AM,"U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6,neutral,0.9487156271934509
368,6/21/2017 1:10:09 PM,"RPT-U.S. Supreme Court ruling threatens massive talc litigation against J&J (JNJ, BMY, BAYN, GSK, MCK)",Reuters,http://www.businessinsider.com/r-rpt-us-supreme-court-ruling-threatens-massive-talc-litigation-against-jj-2017-6,neutral,0.9463071823120117
369,6/21/2017 4:00:00 PM,S&P 500 Buybacks Fall 17.5% Year-over-Year to $133.1 Billion for Q1 2017,PR Newswire,/news/stocks/s-p-500-buybacks-fall-17-5-year-over-year-to-133-1-billion-for-q1-2017-1002112472,neutral,0.9629760980606079
370,6/21/2017 4:02:05 PM,"US STOCKS-Wall St slightly higher on healthcare; oil steadies (UNH, JNJ, ADBE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-higher-on-healthcare-oil-steadies-2017-6,negative,0.8904519081115723
371,6/21/2017 4:12:07 PM,"Missouri attorney general sues opioid manufacturers (JNJ, ENDP)",Reuters,http://www.businessinsider.com/r-missouri-attorney-general-sues-opioid-manufacturers-2017-6,neutral,0.7802478075027466
372,6/21/2017 5:30:03 PM,"UPDATE 1-Missouri attorney general sues opioid manufacturers (JNJ, ENDP, TEVA, AGN)",Reuters,http://www.businessinsider.com/r-update-1-missouri-attorney-general-sues-opioid-manufacturers-2017-6,neutral,0.7807028889656067
373,6/22/2017 2:04:00 PM,Johnson & Johnson Releases 2016 Health for Humanity Report,PR Newswire,/news/stocks/johnson-johnson-releases-2016-health-for-humanity-report-1002115911,positive,0.9283782839775085
374,6/22/2017 5:42:03 PM,"US STOCKS-Gains in healthcare stocks lift Wall Street (UNH, JNJ, GILD, ACN)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-healthcare-stocks-lift-wall-street-2017-6,negative,0.9330371618270874
375,6/22/2017 7:18:05 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (UNH, JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6,negative,0.9358311295509338
376,6/22/2017 9:10:08 PM,"US STOCKS-Wall St rises on oil rebound, gains in healthcare stocks (JNJ, GILD, ACN, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-rises-on-oil-rebound-gains-in-healthcare-stocks-2017-6,negative,0.924217164516449
377,6/26/2017 12:10:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- Pfizer, Merck, AbbVie, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-pfizer-merck-abbvie-and-johnson-johnson-1002123019,positive,0.9454298615455627
378,6/28/2017 2:54:03 PM,BRIEF-FDA grants priority review of Xarelto SNDA to reduce risk of recurrent VTE (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-grants-priority-review-of-xarelto-snda-to-reduce-risk-of-recurrent-vte-2017-6,negative,0.902191698551178
379,6/29/2017 4:52:03 PM,BRIEF-Depuy Synthes announces U.S. Launch of Viper and Expedium Fenestrated Screw Systems (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-announces-us-launch-of-viper-and-expedium-fenestrated-screw-systems-2017-6,positive,0.7700314521789551
380,6/29/2017 6:26:06 PM,"U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6,positive,0.6504507064819336
381,6/29/2017 10:00:03 PM,"UPDATE 1-U.S. IRS probes drug company-funded patient assistance charity (JNJ, BAYN, TEVA, BIIB)",Reuters,http://www.businessinsider.com/r-update-1-us-irs-probes-drug-company-funded-patient-assistance-charity-2017-6,neutral,0.6838725805282593
382,7/3/2017 8:24:06 AM,"RPT-Big pharma turns to AI to speed drug discovery, GSK signs deal (GSK, MRK, JNJ, SAN, PFE)",Reuters,http://www.businessinsider.com/r-rpt-big-pharma-turns-to-ai-to-speed-drug-discovery-gsk-signs-deal-2017-7,negative,0.6345846056938171
383,7/4/2017 11:38:03 AM,Australian class action suit filed against Johnson & Johnson over pelvic mesh (JNJ),Reuters,http://www.businessinsider.com/r-australian-class-action-suit-filed-against-johnson--johnson-over-pelvic-mesh-2017-7,neutral,0.91904217004776
384,7/6/2017 4:36:05 PM,"Robot wars: knee surgery marks new battleground for companies (SYK, SN., ISRG, JNJ)",Reuters,http://www.businessinsider.com/r-robot-wars-knee-surgery-marks-new-battleground-for-companies-2017-7,negative,0.8091825842857361
385,7/7/2017 12:48:03 AM,BRIEF-Capricor Therapeutics retains full rights to CAP-1002 as Janssen Biotech decides not to exercise option (JNJ),Reuters,http://www.businessinsider.com/r-brief-capricor-therapeutics-retains-full-rights-to-cap-1002-as-janssen-biotech-decides-not-to-exercise-option-2017-7,positive,0.9405416250228882
386,7/8/2017 8:38:00 AM,Commercial Hydrogen Announces New Board Member,PR Newswire,/news/stocks/commercial-hydrogen-announces-new-board-member-1001831570,positive,0.8849655389785767
387,7/10/2017 5:40:03 PM,"US STOCKS-Gains in technology stocks prop up Wall St (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks-gains-in-technology-stocks-prop-up-wall-st-2017-7,negative,0.9320209622383118
388,7/10/2017 6:52:03 PM,"US STOCKS- Wall St up as technology shares hold gains (MSFT, AAPL, NVDA, JNJ, MDT, JPM, WFC, C, AMZN, UNH, ANF, APO, JOPP)",Reuters,http://www.businessinsider.com/r-us-stocks--wall-st-up-as-technology-shares-hold-gains-2017-7,negative,0.9261106252670288
389,7/10/2017 10:04:08 PM,"Arena's heart-lung drug meets main goal in mid-stage study (ARNA, JNJ, 4523)",Reuters,http://www.businessinsider.com/r-arenas-heart-lung-drug-meets-main-goal-in-mid-stage-study-2017-7,positive,0.5955362319946289
390,7/10/2017 10:46:11 PM,"Here‚Äôs how much the 10 largest pharmaceutical companies spend on R&D (PFE, AMGN, NVS, ROG, MRK, SNY, JNJ, GILD, GSK, ABBV)",Business Insider,http://www.businessinsider.com/largest-pharmaceutical-companies-by-prescription-sales-and-rd-2017-7,positive,0.9493331909179688
391,7/11/2017 1:40:07 AM,"FBI director nominee Wray earned $9.2 million in law practice last year (WFC, JNJ, HIL, STI, AAPL, WMT, XOM)",Reuters,http://www.businessinsider.com/r-fbi-director-nominee-wray-earned-92-million-in-law-practice-last-year-2017-7,positive,0.9108412265777588
392,7/11/2017 7:34:05 AM,"Sanofi to buy vaccines biotech group Protein Sciences (SAN, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-sanofi-to-buy-vaccines-biotech-group-protein-sciences-2017-7,positive,0.9205771088600159
393,7/13/2017 5:30:08 PM,"US STOCKS-Wall St flat as focus shifts to quarterly earnings (AMZN, MCD, JNJ, CELG, JPM, WFC, C, TGT, WMT, COST, YNDX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-focus-shifts-to-quarterly-earnings-2017-7,neutral,0.9486539363861084
394,7/13/2017 10:18:06 PM,BRIEF-Janssen announces FDA approval of Tremfya (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-tremfya-2017-7,positive,0.7978249788284302
395,7/14/2017 4:00:31 AM,FDA Oks Janssen' Tremfya To Treat Moderate To Severe Plaque Psoriasis ,RTTNews,/news/stocks/fda-oks-janssen-tremfya-to-treat-moderate-to-severe-plaque-psoriasis-1002173036,negative,0.7919973134994507
396,7/14/2017 11:42:03 AM,"BRIEF-Morphosys CEO sees 5 months of guselkumab royalties this year (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-ceo-sees-5-months-of-guselkumab-royalties-this-year-2017-7,positive,0.8257080912590027
397,7/14/2017 1:48:03 PM,"Novartis stocks drug cabinet with ""Big-3"" arthritis blockbusters (AMGN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-novartis-stocks-drug-cabinet-with-big-3-arthritis-blockbusters-2017-7,positive,0.8232624530792236
398,7/14/2017 7:01:00 PM,"Affinion Group, Inc. to Hold Informational Call to Discuss Results for the Quarter Ended June 30, 2017",PR Newswire,/news/stocks/affinion-group-inc-to-hold-informational-call-to-discuss-results-for-the-quarter-ended-june-30-2017-1001855621,positive,0.9400336146354675
399,7/17/2017 1:26:05 PM,"US STOCKS-Futures little changed ahead of big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-little-changed-ahead-of-big-earnings-2017-7,positive,0.7586184740066528
400,7/17/2017 2:52:11 PM,"US STOCKS-Wall St set to open flat in run-up to big earnings (BAC, MS, GS, MSFT, IBM, JNJ, NFLX, BLK, PG)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-in-run-up-to-big-earnings-2017-7,neutral,0.7558087110519409
401,7/17/2017 3:54:09 PM,"US STOCKS-Wall St opens flat as investors await big earnings (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-flat-as-investors-await-big-earnings-2017-7,neutral,0.9206967353820801
402,7/17/2017 5:12:03 PM,"US STOCKS-Wall St holds steady as investors await big earnings (MSFT, IBM, JNJ, NFLX, AAPL, JPM, C, WFC, BAC, MS, GS, BLK, BGC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-holds-steady-as-investors-await-big-earnings-2017-7,negative,0.8487842082977295
403,7/17/2017 7:02:03 PM,"US STOCKS-Wall St slightly up as earnings season picks up pace (MSFT, IBM, JNJ, NFLX, JPM, C, WFC, BAC, MS, GS, BLK, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-slightly-up-as-earnings-season-picks-up-pace-2017-7,negative,0.9406326413154602
404,7/17/2017 7:08:08 PM,BRIEF-J&J sets quarterly cash dividend of $0.84 per share (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-sets-quarterly-cash-dividend-of-084-per-share-2017-7,positive,0.8822187781333923
405,7/18/2017 12:46:20 PM,Johnson & Johnson Q2 Earnings Rise 3%,RTTNews,/news/stocks/johnson-johnson-q2-earnings-rise-3-1002181984,negative,0.9425033926963806
406,7/18/2017 1:06:13 PM,BRIEF-Johnson & Johnson Q2 earnings per share $1.40 (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-q2-earnings-per-share-140-2017-7,positive,0.7388387322425842
407,7/18/2017 1:06:13 PM,J&J reports dip in quarterly profit (JNJ),Reuters,http://www.businessinsider.com/r-jj-reports-dip-in-quarterly-profit-2017-7,neutral,0.9687398672103882
408,7/18/2017 1:19:46 PM,Genmab To Receive Royalties On DARZALEX Sales From Janssen Biotech - Quick Facts ,RTTNews,/news/stocks/genmab-to-receive-royalties-on-darzalex-sales-from-janssen-biotech-quick-facts-1002182141,positive,0.8217276930809021
409,7/18/2017 1:22:08 PM,UPDATE 1-J&J raises 2017 profit forecast; Q2 earnings beat Street (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-raises-2017-profit-forecast-q2-earnings-beat-street-2017-7,negative,0.5557947754859924
410,7/18/2017 1:22:08 PM,"US STOCKS-Futures flat as investors gauge big companies' earnings (UNH, JNJ, IBM, UAL, NFLX, BAC, JPM, WFC, C, HOG)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-gauge-big-companies-earnings-2017-7,neutral,0.9574077129364014
411,7/18/2017 1:36:13 PM,"Johnson & Johnson Q2 Profit Down, But Adj. EPS Tops View; Lifts 2017 Outlook ",RTTNews,/news/stocks/johnson-johnson-q2-profit-down-but-adj-eps-tops-view-lifts-2017-outlook-1002182245,neutral,0.8215467929840088
412,7/18/2017 3:08:04 PM,"US STOCKS-Wall St set to open lower on tepid earnings, policy gridlock (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-lower-on-tepid-earnings-policy-gridlock-2017-7,neutral,0.965699315071106
413,7/18/2017 3:52:08 PM,"US STOCKS-Wall St opens lower on dull earnings, healthcare logjam (BAC, GS, JPM, WFC, C, HOG, UNH, JNJ, IBM, UAL, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-opens-lower-on-dull-earnings-healthcare-logjam-2017-7,neutral,0.9703837037086487
414,7/18/2017 10:58:03 PM,"US STOCKS-Nasdaq hits record on Netflix boost; Dow dragged by Goldman (GS, NFLX, JNJ, HOG, CMG)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-hits-record-on-netflix-boost-dow-dragged-by-goldman-2017-7,positive,0.48242658376693726
415,7/19/2017 11:58:08 AM,"UPDATE 1-China adds blockbuster drugs to insurance list after price cuts (CELG, JNJ, AZN, NOVO )",Reuters,http://www.businessinsider.com/r-update-1-china-adds-blockbuster-drugs-to-insurance-list-after-price-cuts-2017-7,negative,0.5701689720153809
416,7/21/2017 1:28:05 PM,BRIEF-EU Medicines Agency recommends approval J&J unit's Symtuza drug for HIV (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-recommends-approval-jj-units-symtuza-drug-for-hiv-2017-7,negative,0.5636442303657532
417,7/21/2017 1:48:03 PM,Janssen-Cilag's HIV drug gets EU regulatory panel's nod (JNJ),Reuters,http://www.businessinsider.com/r-janssen-cilags-hiv-drug-gets-eu-regulatory-panels-nod-2017-7,negative,0.9073716402053833
418,7/24/2017 10:28:08 AM,BRIEF-Johnson & Johnson announces encouraging first-in-human clinical data for investigational HIV preventive vaccine (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-announces-encouraging-first-in-human-clinical-data-for-investigational-hiv-preventive-vaccine-2017-7,negative,0.945001482963562
419,7/24/2017 10:28:09 AM,"HIV fight advances with new drug cocktails, fresh vaccine hopes (GILD, GSK, MRK, JNJ)",Reuters,http://www.businessinsider.com/r-hiv-fight-advances-with-new-drug-cocktails-fresh-vaccine-hopes-2017-7,negative,0.8591089844703674
420,7/24/2017 2:02:05 PM,"Samsung Bioepis launches U.S. sales of Remicade biosmiliar (JNJ, PFE, AZN)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-launches-us-sales-of-remicade-biosmiliar-2017-7,negative,0.68516606092453
421,7/24/2017 5:40:07 PM,"US STOCKS-S&P, Dow lower as Johnson & Johnson drags (JNJ, AMZN, HAL, CALM, WBMD, KKR)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-johnson--johnson-drags-2017-7,neutral,0.9600012302398682
422,7/24/2017 6:34:03 PM,"GLOBAL MARKETS-U.S. dollar, bond yields climb, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-climb-with-focus-on-fed-2017-7,negative,0.8012131452560425
423,7/24/2017 7:04:03 PM,"UPDATE 1-Merck, Samsung Bioepis launch discounted U.S. Remicade alternative (MRK, JNJ, PFE, AMGN)",Reuters,http://www.businessinsider.com/r-update-1-merck-samsung-bioepis-launch-discounted-us-remicade-alternative-2017-7,negative,0.5694882273674011
424,7/24/2017 7:08:03 PM,"US STOCKS-S&P, Dow lower as J&J drags; Nasdaq hits record (JNJ, HAL, CALM, HIBB, DKS, FL, FINL, AMZN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-lower-as-jj-drags-nasdaq-hits-record-2017-7,neutral,0.9148703217506409
425,7/24/2017 9:18:08 PM,"GLOBAL MARKETS-U.S. dollar, bond yields edge up, with focus on Fed (JNJ)",Reuters,http://www.businessinsider.com/r-global-markets-us-dollar-bond-yields-edge-up-with-focus-on-fed-2017-7,negative,0.9007526636123657
426,7/24/2017 10:32:03 PM,"US STOCKS-Nasdaq, tech shine as earnings pick up; Dow, S&P lag (NFLX, AMZN, JNJ, HAL, HIBB, DKS, FL, FINL)",Reuters,http://www.businessinsider.com/r-us-stocks-nasdaq-tech-shine-as-earnings-pick-up-dow-sp-lag-2017-7,negative,0.7493863105773926
427,7/25/2017 6:40:05 AM,"PRESS DIGEST- Wall Street Journal - July 25 (005930, JNJ, DAI, BKS)",Reuters,http://www.businessinsider.com/r-press-digest--wall-street-journal---july-25-2017-7,positive,0.9281356930732727
428,7/25/2017 2:58:03 PM,BRIEF-Janssen announces Phase 3 pivotal study results for darunavir-based complete treatment regimen (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-phase-3-pivotal-study-results-for-darunavir-based-complete-treatment-regimen-2017-7,negative,0.6402477622032166
429,7/25/2017 8:38:00 PM,"Report: More than 15,000 Adverse Events Linked to Xarelto in 2016",PR Newswire,/news/stocks/report-more-than-15-000-adverse-events-linked-to-xarelto-in-2016-1002203317,neutral,0.5725852847099304
430,7/27/2017 10:54:03 AM,"UPDATE 1-Bavarian expands J&J deal to HIV and hepatitis B vaccines, shares jump (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-expands-jj-deal-to-hiv-and-hepatitis-b-vaccines-shares-jump-2017-7,neutral,0.4857127070426941
431,7/27/2017 5:22:06 PM,"US STOCKS-Wall St adds to record rally on strong earnings (VZ, AMGN, JNJ, CELG, UPS, AMZN, INTC, SBUX, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-adds-to-record-rally-on-strong-earnings-2017-7,negative,0.9342145919799805
432,7/27/2017 7:14:08 PM,"US STOCKS-Wall St trims gains as tech stocks weigh (AAPL, VZ, AMZN, INTC, AMGN, JNJ, CELG, UPS)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-trims-gains-as-tech-stocks-weigh-2017-7,neutral,0.5555031299591064
433,7/27/2017 7:42:05 PM,"U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7,negative,0.663704514503479
434,7/27/2017 9:12:08 PM,"UPDATE 1-U.S. Senator expands opioid probe to distributors, drugmakers (ENDP, TEVA, AGN, JNJ, MYL, DEPO, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-update-1-us-senator-expands-opioid-probe-to-distributors-drugmakers-2017-7,negative,0.59212327003479
435,7/28/2017 2:24:06 PM,"UPDATE 1-AbbVie's profit beats on robust Humira demand (AMGN, CHRS, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbvies-profit-beats-on-robust-humira-demand-2017-7,negative,0.9327202439308167
436,7/31/2017 2:42:03 PM,J&J arthritis drug sirukumab raises safety concerns - FDA staff (JNJ),Reuters,http://www.businessinsider.com/r-jj-arthritis-drug-sirukumab-raises-safety-concerns---fda-staff-2017-7,neutral,0.6133266091346741
437,7/31/2017 3:00:04 PM,"UPDATE 1-J&J arthritis drug sirukumab raises safety concerns -FDA staff (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-jj-arthritis-drug-sirukumab-raises-safety-concerns--fda-staff-2017-7,positive,0.6050631999969482
438,8/2/2017 9:52:03 PM,U.S. FDA panel votes against approval of J&J arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-panel-votes-against-approval-of-jj-arthritis-drug-2017-8,neutral,0.6868817806243896
439,8/3/2017 6:48:01 AM,"FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps ",RTTNews,/news/stocks/fda-panel-snubs-jnj-chmp-seeks-more-data-from-pbyi-tbph-on-watch-agrx-slumps-1002228543,neutral,0.9060508012771606
440,8/4/2017 8:17:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-barclays-global-consumer-staples-conference-552971,positive,0.7722388505935669
441,8/4/2017 8:28:00 PM,Johnson & Johnson to Participate in the 2017 Wells Fargo 12th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2017-wells-fargo-12th-annual-healthcare-conference-1001938540,positive,0.6501746773719788
442,8/4/2017 10:57:08 PM,"Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8,positive,0.5043379068374634
443,8/6/2017 7:02:03 PM,"RPT-Wall St Week Ahead-Amazon shadow looms large ahead of retail earnings (AMZN, WMT, TGT, WFM, SPTN, DF, MCD, MMM, JNJ, CVS)",Reuters,http://www.businessinsider.com/r-rpt-wall-st-week-ahead-amazon-shadow-looms-large-ahead-of-retail-earnings-2017-8,positive,0.630078136920929
444,8/7/2017 3:32:06 PM,BRIEF-DePuy Synthes collaborates with Medical Enterprises Distribution to co-market ME1000 (JNJ),Reuters,http://www.businessinsider.com/r-brief-depuy-synthes-collaborates-with-medical-enterprises-distribution-to-co-market-me1000-2017-8,positive,0.6459323763847351
445,8/8/2017 9:02:03 PM,"US STOCKS-Wall Street clings to gains with tech leading (AAPL, JNJ, WFC)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-clings-to-gains-with-tech-leading-2017-8,negative,0.9139724969863892
446,8/9/2017 8:17:03 PM,"BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8,positive,0.5199103951454163
447,8/10/2017 7:42:03 AM,"RPT-BRIEF-Genmab CEO confident to close some tech deals this year (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-brief-genmab-ceo-confident-to-close-some-tech-deals-this-year-2017-8,negative,0.7692707180976868
448,8/10/2017 12:15:00 PM,"Technical Snapshots for These Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/technical-snapshots-for-these-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002247897,positive,0.9072645306587219
449,8/10/2017 2:02:03 PM,"How AI robots hunt new drugs for crippling nerve disease (IBM, GSK, JNJ, SAN, MRK, MSFT)",Reuters,http://www.businessinsider.com/r-how-ai-robots-hunt-new-drugs-for-crippling-nerve-disease-2017-8,positive,0.9275450706481934
450,8/10/2017 7:42:05 PM,"BUZZ- DJI: From hot to not (BA, AAPL, GS, MCD, JNJ, KO, UKX)",Reuters,http://www.businessinsider.com/r-buzz--dji-from-hot-to-not-2017-8,positive,0.9274467825889587
451,8/14/2017 2:27:08 PM,BRIEF-Cerecor Inc Q2 loss per share $0.14 (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerecor-inc-q2-loss-per-share-014-2017-8,neutral,0.9554567933082581
452,8/14/2017 3:47:00 PM,Johnson & Johnson to Participate in 2017 Morgan Stanley Global Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-2017-morgan-stanley-global-health-care-conference-1002255625,positive,0.7506749629974365
453,8/16/2017 3:12:06 PM,India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-india-introduces-price-controls-for-knee-implants-2017-8,positive,0.8472791314125061
454,8/16/2017 5:57:05 PM,UPDATE 1-India introduces price controls for knee implants (JNJ),Reuters,http://www.businessinsider.com/r-update-1-india-introduces-price-controls-for-knee-implants-2017-8,positive,0.7967014312744141
455,8/16/2017 7:42:10 PM,BRIEF-J&J says leaving White House manufacturing council (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-says-leaving-white-house-manufacturing-council-2017-8,neutral,0.6883687973022461
456,8/18/2017 11:37:17 PM,"Bayer, J&J win third U.S. trial over Xarelto bleeding risk (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-jj-win-third-us-trial-over-xarelto-bleeding-risk-2017-8,negative,0.7195535898208618
457,8/21/2017 7:52:16 PM,J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8,neutral,0.9205699563026428
458,8/21/2017 8:22:10 PM,UPDATE 1-J&J ordered to pay $417 mln in trial over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-ordered-to-pay-417-mln-in-trial-over-talc-cancer-risks-2017-8,neutral,0.784325122833252
459,8/21/2017 11:59:52 PM,JNJ To Pay Dearly For Talc-cancer Connection ,RTTNews,/news/stocks/jnj-to-pay-dearly-for-talc-cancer-connection-1002273437,neutral,0.5069642066955566
460,8/22/2017 7:22:03 AM,"PRESS DIGEST-New York Times business news - Aug 22 (VZ, S, T, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest-new-york-times-business-news---aug-22-2017-8,positive,0.92186439037323
461,8/24/2017 7:42:03 AM,"Swiss stocks - Factors to watch on Aug 24 (PFE, JNJ, VONN, SPSN, IMPN, KOMN, WARN, SIK)",Reuters,http://www.businessinsider.com/r-swiss-stocks---factors-to-watch-on-aug-24-2017-8,positive,0.94305020570755
462,8/24/2017 5:12:03 PM,"CORRECTED-Florida set to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-corrected-florida-set-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,positive,0.7169998288154602
463,8/24/2017 10:22:16 PM,BRIEF-Protagonist Therapeutics announces closing of Janssen license (JNJ),Reuters,http://www.businessinsider.com/r-brief-protagonist-therapeutics-announces-closing-of-janssen-license-2017-8,positive,0.6544478535652161
464,8/24/2017 11:07:15 PM,"UPDATE 1-Florida to carry out execution with drug not previously used in lethal injections (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-florida-to-carry-out-execution-with-drug-not-previously-used-in-lethal-injections-2017-8,negative,0.5968480110168457
465,8/25/2017 3:52:03 AM,"Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8,positive,0.7839431762695312
466,8/25/2017 7:02:04 AM,"UPDATE 1-Samsung, Biogen version of AbbVie's Humira approved in Europe (BIIB, AMGN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-samsung-biogen-version-of-abbvies-humira-approved-in-europe-2017-8,positive,0.6772659420967102
467,8/25/2017 1:07:03 PM,"Bavarian Nordic says first milestone payment under new J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-bavarian-nordic-says-first-milestone-payment-under-new-jj-deal-could-be-in-2019-2017-8,positive,0.9092164039611816
468,8/25/2017 1:57:03 PM,"UPDATE 1-Bavarian Nordic says first milestone payment under J&J deal could be in 2019 (BAVA, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bavarian-nordic-says-first-milestone-payment-under-jj-deal-could-be-in-2019-2017-8,positive,0.8897900581359863
469,8/25/2017 2:42:05 PM,BRIEF-Minerva Neurosciences announces European Commission approval of amendment of MIN-202 agreement with Janssen (JNJ),Reuters,http://www.businessinsider.com/r-brief-minerva-neurosciences-announces-european-commission-approval-of-amendment-of-min-202-agreement-with-janssen-2017-8,negative,0.8413398861885071
470,8/25/2017 5:27:11 PM,Florida Execution Using New Anesthetic Drug Turns Controversial ,RTTNews,/news/stocks/florida-execution-using-new-anesthetic-drug-turns-controversial-1002285787,negative,0.5833079814910889
471,8/27/2017 11:27:08 AM,"Bayer, J&J in frame for bigger anti-clotting market opportunity (BAYN, JNJ, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-jj-in-frame-for-bigger-anti-clotting-market-opportunity-2017-8,negative,0.7578001618385315
472,8/29/2017 2:23:52 PM,Biotech Stocks Facing FDA Decision In September ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-1002291346,positive,0.6874357461929321
473,8/30/2017 3:42:03 PM,"BUZZ- DJI tight range nears end (, , BA, AAPL, MCD, IBM, GS, UKX, KO, JNJ)",Reuters,http://www.businessinsider.com/r-buzz--dji-tight-range-nears-end-2017-8,positive,0.8134490847587585
474,8/31/2017 10:57:08 PM,BRIEF-Macrogenics announces termination of duvortuxizumab collaboration (JNJ),Reuters,http://www.businessinsider.com/r-brief-macrogenics-announces-termination-of-duvortuxizumab-collaboration-2017-8,neutral,0.5487403869628906
475,9/5/2017 3:05:00 PM,National Awards Program Seeking North Carolina's Top Youth Volunteers Of 2018,PR Newswire,/news/stocks/national-awards-program-seeking-north-carolina-s-top-youth-volunteers-of-2018-1001630845,negative,0.7696558237075806
476,9/7/2017 9:22:14 PM,"New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, ABC, CAH)",Reuters,http://www.businessinsider.com/r-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9,positive,0.5287688374519348
477,9/7/2017 10:02:12 PM,"UPDATE 1-New Mexico sues opioid drug manufacturers, distributors (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-sues-opioid-drug-manufacturers-distributors-2017-9,neutral,0.8186452388763428
478,9/8/2017 10:37:04 PM,"UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,positive,0.8491860628128052
479,9/11/2017 8:04:00 AM,Johnson & Johnson Consumer Inc. Debuts New Scientific Data at the European Academy of Dermatology and Venerology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-debuts-new-scientific-data-at-the-european-academy-of-dermatology-and-venerology-annual-meeting-1002356606,positive,0.9253301024436951
480,9/11/2017 10:07:03 AM,"RPT-UPDATE 1-Germany's Merck hires JP Morgan to sell consumer health (MRK, JPM, PG, JNJ, GSK, 4502, ABT, PFE, BAYN, MON, SAN, GIS, RB.)",Reuters,http://www.businessinsider.com/r-rpt-update-1-germanys-merck-hires-jp-morgan-to-sell-consumer-health-2017-9,positive,0.7386980652809143
481,9/11/2017 10:07:03 AM,"BRIEF-Achillion announces termination of worldwide collaboration for hepatitis c with Janssen (ACHN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-achillion-announces-termination-of-worldwide-collaboration-for-hepatitis-c-with-janssen-2017-9,neutral,0.5885143280029297
482,9/11/2017 12:03:25 PM,Medivir Stock Down As Janssen To Discontinue Development Of JNJ-4178 ,RTTNews,/news/stocks/medivir-stock-down-as-janssen-to-discontinue-development-of-jnj-4178-1002357446,neutral,0.9666610360145569
483,9/11/2017 1:52:35 PM,Integra LifeSciences To Sell Certain Neurosurgery Assets To Natus Medical ,RTTNews,/news/stocks/integra-lifesciences-to-sell-certain-neurosurgery-assets-to-natus-medical-1002357885,positive,0.9467060565948486
484,9/13/2017 12:25:00 PM,"Breakfast Technical Briefing on Drug Makers Stocks -- AbbVie, AstraZeneca, Bristol Myers Squibb, and Johnson & Johnson",PR Newswire,/news/stocks/breakfast-technical-briefing-on-drug-makers-stocks-abbvie-astrazeneca-bristol-myers-squibb-and-johnson-johnson-1002365439,positive,0.9458073973655701
485,9/13/2017 3:00:00 PM,Johnson & Johnson Launches Dr. Paul Janssen Project to Catalyze and Convene Champions of Science Across Generations and Geographies,PR Newswire,/news/stocks/johnson-johnson-launches-dr-paul-janssen-project-to-catalyze-and-convene-champions-of-science-across-generations-and-geographies-1002366163,positive,0.8003384470939636
486,9/14/2017 10:02:03 AM,"Astra's Farxiga results may open up type 1 diabetes opportunity (AZN, LLY, JNJ)",Reuters,http://www.businessinsider.com/r-astras-farxiga-results-may-open-up-type-1-diabetes-opportunity-2017-9,negative,0.7758440375328064
487,9/14/2017 5:32:03 PM,"UPDATE 3-Pfizer, Astellas prostate cancer drug promising in late-stage trial (PFE, 4503, JNJ)",Reuters,http://www.businessinsider.com/r-update-3-pfizer-astellas-prostate-cancer-drug-promising-in-late-stage-trial-2017-9,positive,0.5101777911186218
488,9/14/2017 10:32:16 PM,BRIEF-Janssen submits supplemental New Drug Application to U.S. FDA for Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-us-fda-for-zytiga-2017-9,positive,0.7976992130279541
489,9/14/2017 11:15:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-&-johnson-to-host-investor-conference-call-on-third-quarter-results-675144,positive,0.9196440577507019
490,9/15/2017 1:57:03 PM,BRIEF-EU Medicines Agency publishes recommendations for Sept 2017 (JNJ),Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-publishes-recommendations-for-sept-2017-2017-9,positive,0.9158310890197754
491,9/15/2017 2:07:03 PM,European panel recommends approval of J&J's psoriasis drug (JNJ),Reuters,http://www.businessinsider.com/r-european-panel-recommends-approval-of-jjs-psoriasis-drug-2017-9,negative,0.7224668264389038
492,9/15/2017 2:12:03 PM,"Samsung Bioepis wins EU endorsement for first Herceptin copy (MYL, BIOCON, 068270, AMGN, JNJ, 4502)",Reuters,http://www.businessinsider.com/r-samsung-bioepis-wins-eu-endorsement-for-first-herceptin-copy-2017-9,negative,0.8877671957015991
493,9/15/2017 2:42:10 PM,"UPDATE 1-European panel backs Janssen's psoriasis drug (JNJ, MOR)",Reuters,http://www.businessinsider.com/r-update-1-european-panel-backs-janssens-psoriasis-drug-2017-9,negative,0.7663701772689819
494,9/18/2017 4:00:00 PM,"Q2 2017 S&P 500 Buybacks Fall 9.8% from Q1, to $120.1 Billion",PR Newswire,/news/stocks/q2-2017-s-p-500-buybacks-fall-9-8-from-q1-to-120-1-billion-1002379146,neutral,0.9663825035095215
495,9/19/2017 6:42:09 PM,"BRIEF-NY A.G. Schneiderman, coalition of AGs expand investigation into opioid crisis (AGN, ENDP, JNJ, TEVA, ABC, CAH, MCK)",Reuters,http://www.businessinsider.com/r-brief-ny-ag-schneiderman-coalition-of-ags-expand-investigation-into-opioid-crisis-2017-9,positive,0.8860936760902405
496,9/20/2017 3:22:17 PM,PFE Claims J&J Engaged In Unlawful Conduct To Stifle Competition From Inflectra ,RTTNews,/news/stocks/pfe-claims-j-j-engaged-in-unlawful-conduct-to-stifle-competition-from-inflectra-1002387484,neutral,0.9421245455741882
497,9/20/2017 3:42:03 PM,"BRIEF-‚ÄçPfizer files lawsuit against Johnson & Johnson‚Äã (JNJ, PFE)",Reuters,http://www.businessinsider.com/r-brief-pfizer-files-lawsuit-against-johnson--johnson-2017-9,neutral,0.6125757694244385
498,9/20/2017 3:47:03 PM,"Pfizer sues Johnson & Johnson over Remicade biosimilar (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-pfizer-sues-johnson--johnson-over-remicade-biosimilar-2017-9,neutral,0.9202054142951965
499,9/20/2017 4:22:03 PM,"UPDATE 1-Pfizer files suit against J&J over Remicade contracts (PFE, JNJ, UNH, AET, CI)",Reuters,http://www.businessinsider.com/r-update-1-pfizer-files-suit-against-jj-over-remicade-contracts-2017-9,neutral,0.8609936833381653
500,9/21/2017 7:01:37 AM,"FDA Nod For ABMD, AERI Faces FDA Panel In Oct, IPCI Put On Notice, PFE Sues JNJ ",RTTNews,/news/stocks/fda-nod-for-abmd-aeri-faces-fda-panel-in-oct-ipci-put-on-notice-pfe-sues-jnj-1002392403,positive,0.8899357318878174
501,9/21/2017 7:02:03 AM,"PRESS DIGEST - Wall Street Journal - Sept 21 (2498, 6502, AAPL, PFE, JNJ)",Reuters,http://www.businessinsider.com/r-press-digest---wall-street-journal---sept-21-2017-9,positive,0.9375851154327393
502,9/21/2017 1:52:03 PM,BRIEF-Provention Bio announces licensing agreements with Janssen for two clinical-stage immunology assets (JNJ),Reuters,http://www.businessinsider.com/r-brief-provention-bio-announces-licensing-agreements-with-janssen-for-two-clinical-stage-immunology-assets-2017-9,negative,0.5359916687011719
503,9/21/2017 3:07:03 PM,"YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-your-money-three-tips-for-smart-dividend-etf-plays-2017-9,positive,0.9230957627296448
504,9/22/2017 12:12:14 AM,"RPT-YOUR MONEY-Three tips for smart dividend ETF plays (BLK, MSFT, JNJ, PEP, MMM, 11)",Reuters,http://www.businessinsider.com/r-rpt-your-money-three-tips-for-smart-dividend-etf-plays-2017-9,positive,0.927291989326477
505,9/22/2017 10:37:21 PM,U.S. FDA rejects J&J's arthritis drug (JNJ),Reuters,http://www.businessinsider.com/r-us-fda-rejects-jjs-arthritis-drug-2017-9,neutral,0.8843916654586792
506,9/22/2017 11:02:07 PM,"UPDATE 1-U.S. FDA declines to approve J&J arthritis drug (JNJ, SAN, REGN, LLY, PFE)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-declines-to-approve-jj-arthritis-drug-2017-9,neutral,0.8860206604003906
507,9/26/2017 11:52:12 PM,"U.S. picks companies to help make rules for advanced personal health monitors (AAPL, DXCM, 005930, JNJ)",Reuters,http://www.businessinsider.com/r-us-picks-companies-to-help-make-rules-for-advanced-personal-health-monitors-2017-9,positive,0.8897092938423157
508,9/27/2017 5:27:06 PM,"FTC allows Integra to buy J&J‚Äôs Codman neuro business, with conditions (IART, JNJ)",Reuters,http://www.businessinsider.com/r-ftc-allows-integra-to-buy-jjs-codman-neuro-business-with-conditions-2017-9,positive,0.8699831366539001
509,9/27/2017 6:02:03 PM,"UPDATE 1-U.S. FTC approves Integra purchase of J&J‚Äôs Codman business (IART, JNJ, BABY)",Reuters,http://www.businessinsider.com/r-update-1-us-ftc-approves-integra-purchase-of-jjs-codman-business-2017-9,positive,0.6064315438270569
510,9/28/2017 7:52:12 PM,"UPDATE 1-Washington state sues opioid manufacturer Purdue Pharma (TEVA, JNJ, ENDP, AGN)",Reuters,http://www.businessinsider.com/r-update-1-washington-state-sues-opioid-manufacturer-purdue-pharma-2017-9,neutral,0.8754121661186218
511,9/28/2017 8:27:17 PM,"UPDATE 1-Abbott wins U.S. antitrust approval to buy Alere with conditions (ABT, ALR, QDEL, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-abbott-wins-us-antitrust-approval-to-buy-alere-with-conditions-2017-9,negative,0.8061344027519226
512,9/29/2017 1:52:13 PM,Biotech Stocks Facing FDA Decision In October ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-october-1002845284,positive,0.635016918182373
513,9/29/2017 2:07:03 PM,"Merck to stop development of hepatitis C treatments (MRK, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-merck-to-stop-development-of-hepatitis-c-treatments-2017-9,neutral,0.5342976450920105
514,9/29/2017 6:22:03 PM,"US invests $170 million in late-stage Ebola vaccines, drugs (MRK, JNJ, REGN)",Reuters,http://www.businessinsider.com/r-us-invests-170-million-in-late-stage-ebola-vaccines-drugs-2017-9,positive,0.8104274272918701
515,10/2/2017 2:22:03 PM,BRIEF-Janssen submits supplemental new drug application to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-supplemental-new-drug-application-to-fda-2017-10,positive,0.8841436505317688
516,10/2/2017 5:52:06 PM,"US STOCKS-Wall Street hits record high on boost from tech, healthcare (JNJ, GILD, MSFT, INTC, XOM, CVX, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-street-hits-record-high-on-boost-from-tech-healthcare-2017-10,negative,0.9337397813796997
517,10/2/2017 7:22:05 PM,"US STOCKS-S&P, Dow at record highs as financials, healthcare climb (JNJ, GILD, JPM, C, XOM, GM, JWN)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-at-record-highs-as-financials-healthcare-climb-2017-10,negative,0.8107295632362366
518,10/2/2017 10:01:00 PM,Johnson & Johnson Announces Completion of Codman Neurosurgery Divestiture to Integra LifeSciences Holding Corporation,PR Newswire,/news/stocks/johnson-johnson-announces-completion-of-codman-neurosurgery-divestiture-to-integra-lifesciences-holding-corporation-1002055951,positive,0.9288353323936462
519,10/5/2017 1:22:03 PM,"BRIEF-J&J diabetes care company Animas to close operations and exit insulin pump market (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-brief-jj-diabetes-care-company-animas-to-close-operations-and-exit-insulin-pump-market-2017-10,neutral,0.8190412521362305
520,10/5/2017 2:37:03 PM,"J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10,positive,0.831106960773468
521,10/5/2017 2:57:05 PM,"UPDATE 1-J&J's diabetes care unit to exit insulin pump business (JNJ, MDT)",Reuters,http://www.businessinsider.com/r-update-1-jjs-diabetes-care-unit-to-exit-insulin-pump-business-2017-10,positive,0.7644687294960022
522,10/5/2017 10:27:14 PM,"BRIEF-Bayer's Navigate Esus study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayers-navigate-esus-study-halted-early-2017-10,neutral,0.5016010403633118
523,10/6/2017 7:02:03 AM,"INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10,positive,0.8623496294021606
524,10/6/2017 7:37:03 AM,"RPT-INSIGHT-Awaiting better days, multinationals keep Venezuela units alive - barely (F, CLX, KMB, GIS, GM, CL, JNJ)",Reuters,http://www.businessinsider.com/r-rpt-insight-awaiting-better-days-multinationals-keep-venezuela-units-alive---barely-2017-10,positive,0.835615336894989
525,10/6/2017 7:52:03 AM,"Bayer says Phase III Xarelto study halted early (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-bayer-says-phase-iii-xarelto-study-halted-early-2017-10,neutral,0.6563712358474731
526,10/6/2017 9:57:08 AM,"BRIEF-Bayer keeps forecast for peak Xarelto annual sales (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-bayer-keeps-forecast-for-peak-xarelto-annual-sales-2017-10,positive,0.8960760831832886
527,10/6/2017 10:52:03 AM,"UPDATE 1-Bayer sticks by Xarelto sales estimate despite study setback (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-bayer-sticks-by-xarelto-sales-estimate-despite-study-setback-2017-10,negative,0.9136637449264526
528,10/11/2017 3:42:03 PM,BRIEF-Janssen submits NDA for Apalutamide(ARN-509) to FDA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-submits-nda-for-apalutamidearn-509-to-fda-2017-10,positive,0.8761672377586365
529,10/11/2017 4:07:03 PM,"US STOCKS-Wall St treads water; financials drop ahead of reports (KR, JPM, C, GE, JNJ, MU)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-treads-water-financials-drop-ahead-of-reports-2017-10,neutral,0.9682649374008179
530,10/11/2017 5:42:04 PM,"US STOCKS-Wall St flat; financials drop ahead of earnings (JPM, C, WMT, CL, GE, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-financials-drop-ahead-of-earnings-2017-10,neutral,0.9671958088874817
531,10/11/2017 6:19:38 PM,Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies ,RTTNews,/news/stocks/johnson-johnson-posting-notable-gain-after-upgrade-by-jefferies-1003846253,negative,0.9391953349113464
532,10/11/2017 7:12:08 PM,"US STOCKS-Dow inches up to record-high on gains in J&J, Wal-Mart (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-inches-up-to-record-high-on-gains-in-jj-wal-mart-2017-10,negative,0.9401459097862244
533,10/11/2017 9:47:03 PM,"US STOCKS-Wall St ticks higher with eyes on earnings (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-with-eyes-on-earnings-2017-10,negative,0.8521286845207214
534,10/11/2017 10:47:07 PM,"US STOCKS-Wall St ticks higher to record close; eyes on earnings, Fed (JNJ, WMT, KR, JPM, C, GE)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-ticks-higher-to-record-close-eyes-on-earnings-fed-2017-10,negative,0.7559754252433777
535,10/12/2017 4:12:03 PM,"NIH partners 11 drugmakers to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-nih-partners-11-drugmakers-to-accelerate-cancer-therapy-research-2017-10,negative,0.7635126113891602
536,10/12/2017 4:40:00 PM,Treasure Investments Corporation Releases Scripophily and Americana Currency Collections for Auctions,PR Newswire,/news/stocks/treasure-investments-corporation-releases-scripophily-and-americana-currency-collections-for-auctions-1001755642,positive,0.9500933885574341
537,10/12/2017 6:27:06 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,negative,0.84027498960495
538,10/12/2017 10:12:15 PM,"UPDATE 1-US NIH, 11 drugmakers partner to accelerate cancer therapy research (BMY, MRK, PFE, JNJ, AMGN, CELG, GILD, GSK)",Reuters,http://www.businessinsider.com/r-update-1-us-nih-11-drugmakers-partner-to-accelerate-cancer-therapy-research-2017-10,negative,0.84027498960495
539,10/13/2017 2:07:11 PM,"BRIEF-EU Medicines Agency provides recommendations for October 2017 (AZN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-eu-medicines-agency-provides-recommendations-for-october-2017-2017-10,positive,0.9348413348197937
540,10/13/2017 5:42:07 PM,BRIEF-CHMP issues positive opinion on Janssen‚Äôs ZYTIGA (JNJ),Reuters,http://www.businessinsider.com/r-brief-chmp-issues-positive-opinion-on-janssens-zytiga-2017-10,negative,0.9281991124153137
541,10/13/2017 10:27:08 PM,BRIEF-Johnson & Johnson says FDA approves Stelara for adolescents with moderate to severe plaque psoriasis (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approves-stelara-for-adolescents-with-moderate-to-severe-plaque-psoriasis-2017-10,negative,0.7206217646598816
542,10/13/2017 11:07:07 PM,J&J psoriasis drug gets expanded U.S. approval for teens (JNJ),Reuters,http://www.businessinsider.com/r-jj-psoriasis-drug-gets-expanded-us-approval-for-teens-2017-10,negative,0.9335260391235352
543,10/16/2017 9:07:13 PM,BRIEF-Cerveau Technologies announces research collaboration agreement with Janssen Pharmaceuticals (JNJ),Reuters,http://www.businessinsider.com/r-brief-cerveau-technologies-announces-research-collaboration-agreement-with-janssen-pharmaceuticals-2017-10,negative,0.7313974499702454
544,10/17/2017 12:40:00 PM,Johnson & Johnson Reports 2017 Third-Quarter Results:,PR Newswire,/news/stocks/johnson-johnson-reports-2017-third-quarter-results-1004608091,positive,0.5696130990982056
545,10/17/2017 12:46:47 PM,Johnson & Johnson Q3 Income Rises 11%,RTTNews,/news/stocks/johnson-johnson-q3-income-rises-11-1004608117,negative,0.9358730316162109
546,10/17/2017 1:14:17 PM,Johnson & Johnson Lifts FY17 Forecast As Q3 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-lifts-fy17-forecast-as-q3-results-top-estimates-1004611195,negative,0.8782760500907898
547,10/17/2017 1:27:08 PM,"UPDATE 1-Pharma business, Actelion buy drive J&J's profit beat (JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pharma-business-actelion-buy-drive-jjs-profit-beat-2017-10,positive,0.7934017181396484
548,10/17/2017 1:37:15 PM,"US STOCKS-Futures flat as investors assess earnings from big names (MS, GS, JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-futures-flat-as-investors-assess-earnings-from-big-names-2017-10,neutral,0.9617597460746765
549,10/17/2017 3:02:08 PM,"US STOCKS-Wall St set to open flat as big bank results fail to cheer (JNJ, UNH, HON, PG, UAL, AA, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-set-to-open-flat-as-big-bank-results-fail-to-cheer-2017-10,neutral,0.9379503726959229
550,10/17/2017 3:22:18 PM,"J&J's Puerto Rico plants running, can't rule out shortages (JNJ)",Reuters,http://www.businessinsider.com/r-jjs-puerto-rico-plants-running-cant-rule-out-shortages-2017-10,positive,0.857085108757019
551,10/17/2017 4:17:03 PM,"US STOCKS-Wall St flat as losses in financials offset healthcare gains (GS, MS, UNH, JNJ, AAPL, BA, BBD., NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-flat-as-losses-in-financials-offset-healthcare-gains-2017-10,negative,0.5201705694198608
552,10/17/2017 5:47:03 PM,"US STOCKS-Dow breaches 23,000-mark for the first time (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-breaches-23000-mark-for-the-first-time-2017-10,neutral,0.5761311650276184
553,10/17/2017 7:02:03 PM,J&J wins reversal of $72 million verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-jj-wins-reversal-of-72-million-verdict-over-talc-cancer-risks-2017-10,negative,0.8139040470123291
554,10/17/2017 7:07:03 PM,"US STOCKS-Dow tops 23,000-mark for the first time on strong earnings (UNH, JNJ, GS, MS, GE, MSFT, INTC, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-tops-23000-mark-for-the-first-time-on-strong-earnings-2017-10,negative,0.9433671832084656
555,10/17/2017 8:12:08 PM,UPDATE 1-J&J wins reversal of $72 mln verdict over talc cancer risks (JNJ),Reuters,http://www.businessinsider.com/r-update-1-jj-wins-reversal-of-72-mln-verdict-over-talc-cancer-risks-2017-10,negative,0.9042247533798218
556,10/17/2017 9:37:03 PM,"US STOCKS-Dow hits 23,000-mark, then backs off (GS, UNH, JNJ, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-hits-23000-mark-then-backs-off-2017-10,positive,0.5544840693473816
557,10/17/2017 10:47:04 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10,positive,0.6399699449539185
558,10/17/2017 11:37:03 PM,"US STOCKS-Dow pierces 23,000 but finishes below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-finishes-below-milestone-2017-10,positive,0.5972989201545715
559,10/18/2017 12:22:03 AM,"US STOCKS-Dow pierces 23,000 but ends below milestone (UNH, JNJ, THC, GS, NFLX, IBM)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-pierces-23000-but-ends-below-milestone-2017-10,positive,0.8346311450004578
560,10/18/2017 5:56:27 AM,Johnson & Johnson Wins Reversal Of First St. Louis Talc-Cancer Verdict ,RTTNews,/news/stocks/johnson-johnson-wins-reversal-of-first-st-louis-talc-cancer-verdict-1004718217,negative,0.6789127588272095
561,10/18/2017 3:02:03 PM,BRIEF-Trovagene's PCM-075 demonstrates Synergy with Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-trovagenes-pcm-075-demonstrates-synergy-with-zytiga-2017-10,negative,0.9102019667625427
562,10/19/2017 12:27:18 PM,BRIEF-‚ÄçJohnson & Johnson Medical GmbH to acquire Surgical Process Institute‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-medical-gmbh-to-acquire-surgical-process-institute-2017-10,positive,0.9272109270095825
563,10/19/2017 12:50:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2017,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2017-1004893120,neutral,0.7035967111587524
564,10/19/2017 1:22:07 PM,BRIEF-Arcturus Therapeutics to collaborate with Johnson & Johnson (JNJ),Reuters,http://www.businessinsider.com/r-brief-arcturus-therapeutics-to-collaborate-with-johnson--johnson-2017-10,negative,0.7306004166603088
565,10/20/2017 10:32:08 PM,BRIEF-Janssen receives two FDA approvals for SIMPONI ARIA for treatment of active psoriatic arthritis (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-receives-two-fda-approvals-for-simponi-aria-for-treatment-of-active-psoriatic-arthritis-2017-10,negative,0.9442425966262817
566,10/21/2017 2:12:19 AM,California judge tosses $417 mln talc cancer verdict against J&J (JNJ),Reuters,http://www.businessinsider.com/r-california-judge-tosses-417-mln-talc-cancer-verdict-against-jj-2017-10,neutral,0.5820435285568237
567,10/22/2017 4:34:33 AM,California Court Overturns $417 Mln Verdict Linking J&J Baby Powder With Cancer ,RTTNews,/news/stocks/california-court-overturns-417-mln-verdict-linking-j-j-baby-powder-with-cancer-1005201613,neutral,0.9265795350074768
568,10/23/2017 4:17:03 PM,"UPDATE 1-Smith & Nephew to buy Rotation Medical for up to $210 mln (SN., SYK, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-smith--nephew-to-buy-rotation-medical-for-up-to-210-mln-2017-10,positive,0.8371862769126892
569,10/23/2017 7:22:03 PM,"US STOCKS-Losses in GE keep Wall St in check (GE, AAPL, INTC, JNJ, CELG, SLB, HAL, MAT)",Reuters,http://www.businessinsider.com/r-us-stocks-losses-in-ge-keep-wall-st-in-check-2017-10,neutral,0.9460093975067139
570,10/24/2017 4:07:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BAC, JPM, GM, WHR, BIIB, CNC, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10,negative,0.9073180556297302
571,10/24/2017 5:42:03 PM,"US STOCKS-3M, Caterpillar lift Dow to record high (MMM, CAT, UTX, MCD, BIIB, CNC, JNJ, JPM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-3m-caterpillar-lift-dow-to-record-high-2017-10,negative,0.9023404717445374
572,10/24/2017 7:02:06 PM,"US STOCKS-Dow rallies on strong earnings from 3M, Caterpillar (MMM, CAT, MCD, BIIB, CNC, JNJ, BAC, JPM, GM, WHR)",Reuters,http://www.businessinsider.com/r-us-stocks-dow-rallies-on-strong-earnings-from-3m-caterpillar-2017-10,negative,0.9152756929397583
573,10/25/2017 2:12:15 PM,BRIEF-Janssen Pharmaceutica says Phase 3 Amber study achieved its primary endpoint‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-pharmaceutica-says-phase-3-amber-study-achieved-its-primary-endpoint-2017-10,negative,0.9315751791000366
574,10/25/2017 2:37:12 PM,"UPDATE 1-Baxter expects $70 mln hit to 4th-qtr sales from Hurricane Maria (BAX, MRK, JNJ, PFE, GSK, MDT, DEPO, AMGN, BMY, LLY, AZN)",Reuters,http://www.businessinsider.com/r-update-1-baxter-expects-70-mln-hit-to-4th-qtr-sales-from-hurricane-maria-2017-10,negative,0.8058122396469116
575,10/25/2017 5:27:00 PM,Johnson & Johnson to Participate in the 26th Annual Credit Suisse Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-26th-annual-credit-suisse-health-care-conference-1005589294,negative,0.6029020547866821
576,10/25/2017 8:11:01 PM,Judge Overturns Verdict In J&J Baby Powder Verdict ,RTTNews,/news/stocks/judge-overturns-verdict-in-j-j-baby-powder-verdict-1005604075,neutral,0.9124125838279724
577,10/30/2017 12:02:08 PM,"Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10,positive,0.9282996654510498
578,10/30/2017 12:52:15 PM,BRIEF-J&J's Janssen announces Imbruvica as the first approved treatment for chronic graft-versus-host disease granted by Health Canada priority review (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-janssen-announces-imbruvica-as-the-first-approved-treatment-for-chronic-graft-versus-host-disease-granted-by-health-canada-priority-review-2017-10,negative,0.7112403512001038
579,10/30/2017 1:32:07 PM,BRIEF-Johnson & Johnson says FDA approved 10 mg dose of Xarelto for reducing continued risk for recurrent venous thromboembolism‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-says-fda-approved-10-mg-dose-of-xarelto-for-reducing-continued-risk-for-recurrent-venous-thromboembolism-2017-10,negative,0.9371289014816284
580,10/30/2017 2:52:12 PM,"UPDATE 1-Investor group presses U.S. drug companies on opioid controls (ABC, CAH, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-investor-group-presses-us-drug-companies-on-opioid-controls-2017-10,positive,0.9029824733734131
581,10/31/2017 1:27:08 PM,"BRIEF-Geron announces fast track designation grant for imetelstat (GERN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-geron-announces-fast-track-designation-grant-for-imetelstat-2017-10,negative,0.8084538578987122
582,10/31/2017 1:47:19 PM,"BRIEF-Halozyme - ‚ÄçJanssen Biotech initiated first phase 3 clinical trial evaluating subcutaneous delivery of Darzalex (HALO, JNJ)",Reuters,http://www.businessinsider.com/r-brief-halozyme---janssen-biotech-initiated-first-phase-3-clinical-trial-evaluating-subcutaneous-delivery-of-darzalex-2017-10,negative,0.7475973963737488
583,11/2/2017 7:02:03 PM,"U.S. Congress to hold hearing on Allergan tribal patent deal (AGN, JNJ, MYL)",Reuters,http://www.businessinsider.com/r-us-congress-to-hold-hearing-on-allergan-tribal-patent-deal-2017-11,positive,0.9434607625007629
584,11/5/2017 12:37:03 AM,"J&J's Stelara shows promise against lupus in study (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-jjs-stelara-shows-promise-against-lupus-in-study-2017-11,negative,0.9360602498054504
585,11/6/2017 10:42:03 AM,"Bayer in bid to broaden use of anti-clotting drug Xarelto (BAYN, JNJ, MON, PFE, BMY)",Reuters,http://www.businessinsider.com/r-bayer-in-bid-to-broaden-use-of-anti-clotting-drug-xarelto-2017-11,negative,0.8729289174079895
586,11/6/2017 2:47:03 PM,BRIEF-J&J's Stelara shows positive results in treatment of systemic lupus erythematosus in phase 2 trial (JNJ),Reuters,http://www.businessinsider.com/r-brief-jjs-stelara-shows-positive-results-in-treatment-of-systemic-lupus-erythematosus-in-phase-2-trial-2017-11,negative,0.9519513845443726
587,11/8/2017 4:27:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; stable outlook,Moodys,/news/bonds/johnson-amp-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-stable-outlook-1007303842,negative,0.8219636082649231
588,11/13/2017 11:07:03 AM,BRIEF-Zymeworks announces license agreement with Johnson & Johnson Innovation (JNJ),Reuters,http://www.businessinsider.com/r-brief-zymeworks-announces-license-agreement-with-johnson--johnson-innovation-2017-11,negative,0.8577170372009277
589,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872498,negative,0.5811452865600586
590,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007872494,negative,0.5811452865600586
591,11/13/2017 2:04:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-&-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-586831,negative,0.5811452865600586
592,11/13/2017 2:27:00 PM,Johnson & Johnson Innovation Launches Digital Beauty QuickFire Challenge to Tackle some of the Toughest Consumer Skincare Problems,PR Newswire,/news/stocks/johnson-johnson-innovation-launches-digital-beauty-quickfire-challenge-to-tackle-some-of-the-toughest-consumer-skincare-problems-1007874103,negative,0.5811452865600586
593,11/15/2017 2:12:03 PM,BRIEF-Jannsen Inc says‚Äç Health Canada has approved Tremfya for treatment of adult moderate to severe plaque Psoriasis‚Äã (JNJ),Reuters,http://www.businessinsider.com/r-brief-jannsen-inc-says-health-canada-has-approved-tremfya-for-treatment-of-adult-moderate-to-severe-plaque-psoriasis-2017-11,negative,0.8978722095489502
594,11/15/2017 5:52:03 PM,"Astellas faces U.S. probe over patient assistance charity support (4503, PFE, JNJ, UTHR, GILD, VRX, CELG)",Reuters,http://www.businessinsider.com/r-astellas-faces-us-probe-over-patient-assistance-charity-support-2017-11,neutral,0.8980137705802917
595,11/20/2017 4:32:03 PM,BRIEF-‚ÄçJanssen-Cilag says European Commission approves expanded use of Zytiga (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-cilag-says-european-commission-approves-expanded-use-of-zytiga-2017-11,negative,0.8050230145454407
596,11/20/2017 6:47:00 PM,Johnson & Johnson to Participate in the Citi 2017 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-citi-2017-global-healthcare-conference-520043,positive,0.7232053279876709
597,11/21/2017 3:02:03 PM,"J&J multiple myeloma drug succeeds in first-line combination study (JNJ, 4502, CELG)",Reuters,http://www.businessinsider.com/r-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11,negative,0.9370051622390747
598,11/21/2017 3:52:03 PM,BRIEF-Janssen seeks expanded use of Darzalex from EMA (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-seeks-expanded-use-of-darzalex-from-ema-2017-11,negative,0.6892002820968628
599,11/21/2017 6:37:03 PM,"UPDATE 1-J&J multiple myeloma drug succeeds in first-line combination study (JNJ, GEN, 4502, CELG)",Reuters,http://www.businessinsider.com/r-update-1-jj-multiple-myeloma-drug-succeeds-in-first-line-combination-study-2017-11,negative,0.9371819496154785
600,11/21/2017 9:12:05 PM,"U.S. FDA approves first two-drug HIV regimen (GSK, 4507, GILD, JNJ, PFE)",Reuters,http://www.businessinsider.com/r-us-fda-approves-first-two-drug-hiv-regimen-2017-11,positive,0.5633715391159058
601,11/22/2017 12:22:03 AM,"UPDATE 1-U.S. FDA approves first two-drug HIV regimen from GSK (GSK, PFE, 4507, JNJ, GILD)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-first-two-drug-hiv-regimen-from-gsk-2017-11,positive,0.4980044364929199
602,11/22/2017 12:32:03 AM,BRIEF-Janssen announces FDA approval of Juluca for the treatment of HIV-1 infection (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-announces-fda-approval-of-juluca-for-the-treatment-of-hiv-1-infection-2017-11,negative,0.6171274781227112
603,11/28/2017 1:07:03 PM,"New ETF joins fight against sexual harassment in workplace (AAPL, MSFT, JNJ)",Reuters,http://www.businessinsider.com/r-new-etf-joins-fight-against-sexual-harassment-in-workplace-2017-11,positive,0.8643637895584106
604,11/29/2017 8:12:03 PM,"U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,positive,0.7578281760215759
605,11/29/2017 9:17:05 PM,"UPDATE 1-U.S. says patient charity helped drugmakers, revokes approval (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-us-says-patient-charity-helped-drugmakers-revokes-approval-2017-11,positive,0.6831169724464417
606,11/29/2017 9:52:04 PM,"BRIEF-Genmab Achieves $20 Million Milestone In Daratumumab Collaboration With Janssen (GEN, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genmab-achieves-20-million-milestone-in-daratumumab-collaboration-with-janssen-2017-11,negative,0.9178670048713684
607,11/30/2017 8:07:03 AM,Hopes for HIV vaccine buoyed by start of second big trial (JNJ),Reuters,http://www.businessinsider.com/r-hopes-for-hiv-vaccine-buoyed-by-start-of-second-big-trial-2017-11,negative,0.9339703917503357
608,11/30/2017 11:07:05 AM,"UPDATE 1-New vaccine, long-acting drug trials buoy hopes in HIV fight (JNJ, GSK)",Reuters,http://www.businessinsider.com/r-update-1-new-vaccine-long-acting-drug-trials-buoy-hopes-in-hiv-fight-2017-11,negative,0.8524080514907837
609,11/30/2017 4:08:00 PM,Moody's: Pharma manufacturers and distributors face rising risks related to US opioid crisis,Moodys,/news/bonds/moody-s-pharma-manufacturers-and-distributors-face-rising-risks-related-to-us-opioid-crisis-1010065274,neutral,0.9176852107048035
610,11/30/2017 4:22:03 PM,"BRIEF-Moody's Says Pharma Manufacturers, Distributors Face Rising Risks Related To U.S. Opioid Crisis (ENDP, JNJ, TEVA)",Reuters,http://www.businessinsider.com/r-brief-moodys-says-pharma-manufacturers-distributors-face-rising-risks-related-to-us-opioid-crisis-2017-11,neutral,0.7841907739639282
611,11/30/2017 9:34:00 PM,Johnson & Johnson to Participate in the BMO Capital Markets Healthcare Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-bmo-capital-markets-healthcare-conference-552620,positive,0.8245230913162231
612,12/4/2017 9:07:03 AM,Idorsia to get $230 mln from J&J in latest hypertension deal (JNJ),Reuters,http://www.businessinsider.com/r-idorsia-to-get-230-mln-from-jj-in-latest-hypertension-deal-2017-12,negative,0.8589515089988708
613,12/5/2017 8:07:04 AM,"BRIEF-Morphosys Says Licensee Janssen Receives Approval For Tremfya In Canada (MOR, JNJ)",Reuters,http://www.businessinsider.com/r-brief-morphosys-says-licensee-janssen-receives-approval-for-tremfya-in-canada-2017-12,negative,0.7642733454704285
614,12/5/2017 2:52:04 PM,BRIEF-Imbruvica Plus Rituximab Phase 3 Innovate Trial In Rare Waldenstr√∂m's Macroglobulinemia Met Primary Endpoint (JNJ),Reuters,http://www.businessinsider.com/r-brief-imbruvica-plus-rituximab-phase-3-innovate-trial-in-rare-waldenstrms-macroglobulinemia-met-primary-endpoint-2017-12,positive,0.5463391542434692
615,12/5/2017 7:02:03 PM,"Jury orders Bayer, J&J to pay $29 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-jury-orders-bayer-jj-to-pay-29-million-in-xarelto-lawsuit-2017-12,neutral,0.842075526714325
616,12/5/2017 8:37:04 PM,"UPDATE 1-Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit (BAYN, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-jury-orders-bayer-jj-to-pay-28-million-in-xarelto-lawsuit-2017-12,neutral,0.8392756581306458
617,12/6/2017 2:12:09 PM,"BRIEF-Genomic Health Announces Research Collaboration with Janssen Pharma (GHDX, JNJ)",Reuters,http://www.businessinsider.com/r-brief-genomic-health-announces-research-collaboration-with-janssen-pharma-2017-12,negative,0.574373185634613
618,12/7/2017 6:47:04 PM,BRIEF-J&J considers sale of anti-dandruff shampoo Nizoral - Bloomberg (JNJ),Reuters,http://www.businessinsider.com/r-brief-jj-considers-sale-of-anti-dandruff-shampoo-nizoral---bloomberg-2017-12,positive,0.938020646572113
619,12/10/2017 4:32:03 PM,"'Unheard of' responses to bluebird CAR-T therapy seen in myeloma study (JNJ, CELG, GILD)",Reuters,http://www.businessinsider.com/r-unheard-of-responses-to-bluebird-car-t-therapy-seen-in-myeloma-study-2017-12,positive,0.711732804775238
620,12/14/2017 1:02:03 AM,"Bumper crop of new drugs fails to lift big pharma R&D returns (BION, NOVO , PFE, SAN, GSK, JNJ, AZN, MRK, LLY, BMY, 4502, AMGN, BIIB, CELG, GILD)",Reuters,http://www.businessinsider.com/r-bumper-crop-of-new-drugs-fails-to-lift-big-pharma-rd-returns-2017-12,neutral,0.7240303158760071
621,12/14/2017 7:22:05 PM,"US STOCKS-S&P, Dow flat as healthcare losses offset by tech, media gains (DIS, NFLX, CMCSA, JNJ, VZ, T, CTL)",Reuters,http://www.businessinsider.com/r-us-stocks-sp-dow-flat-as-healthcare-losses-offset-by-tech-media-gains-2017-12,neutral,0.6043390035629272
622,12/14/2017 9:12:03 PM,"US STOCKS-Wall St falls as investors fret about tax bill passage (DIS, NFLX, CMCSA, JNJ)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-falls-as-investors-fret-about-tax-bill-passage-2017-12,neutral,0.9588493704795837
623,12/15/2017 2:22:03 AM,"UPDATE 1-Pfizer's Xeljanz gets FDA nod as joint disease treatment (PFE, JNJ)",Reuters,http://www.businessinsider.com/r-update-1-pfizers-xeljanz-gets-fda-nod-as-joint-disease-treatment-2017-12,negative,0.8645578026771545
624,12/19/2017 2:20:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1011641653,positive,0.9188656806945801
625,12/19/2017 2:30:00 PM,Johnson & Johnson to Participate in 36th Annual JP Morgan Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-36th-annual-jp-morgan-health-care-conference-1011641907,positive,0.8051589131355286
626,12/19/2017 9:32:03 PM,"FDA medical device proposal may skirt the law - legal experts (AAPL, JNJ)",Reuters,http://www.businessinsider.com/r-fda-medical-device-proposal-may-skirt-the-law---legal-experts-2017-12,positive,0.7522581219673157
627,12/20/2017 9:57:05 AM,Johnson & Johnson fined 25 mln euros by French competition watchdog (JNJ),Reuters,http://www.businessinsider.com/r-johnson--johnson-fined-25-mln-euros-by-french-competition-watchdog-2017-12,neutral,0.9592273235321045
628,12/20/2017 11:42:06 AM,"UPDATE 1-France fines J&J 25 mln euros over painkilller patch (JNJ, TEVA, SAN)",Reuters,http://www.businessinsider.com/r-update-1-france-fines-jj-25-mln-euros-over-painkilller-patch-2017-12,negative,0.7331302165985107
629,12/20/2017 9:52:03 PM,"UPDATE 1-New Mexico adds Insys, Mallinckrodt to opioid epidemic lawsuit (JNJ, AGN, ENDP, TEVA, MCK, CAH, ABC)",Reuters,http://www.businessinsider.com/r-update-1-new-mexico-adds-insys-mallinckrodt-to-opioid-epidemic-lawsuit-2017-12,positive,0.8903144001960754
630,12/20/2017 10:17:04 PM,"BRIEF-U.S. Fda Approves New Diabetes Drug From Merck And Pfizer (MRK, PFE, JNJ, LLY, AZN)",Reuters,http://www.businessinsider.com/r-brief-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.7861426472663879
631,12/20/2017 10:27:06 PM,"U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.8601289391517639
632,12/20/2017 10:42:03 PM,"UPDATE 1-U.S. FDA approves new diabetes drug from Merck and Pfizer (MRK, PFE, AZN, JNJ, LLY)",Reuters,http://www.businessinsider.com/r-update-1-us-fda-approves-new-diabetes-drug-from-merck-and-pfizer-2017-12,negative,0.8735406398773193
633,12/21/2017 1:22:04 PM,Indian minister writes to Modi urging price caps on 20 medical devices (JNJ),Reuters,http://www.businessinsider.com/r-indian-minister-writes-to-modi-urging-price-caps-on-20-medical-devices-2017-12,neutral,0.5550710558891296
634,12/21/2017 11:37:03 PM,BRIEF-Janssen Enters Collaboration And License Agreement With China's Legend Biotech To Develop CAR-T Cancer Therapy (JNJ),Reuters,http://www.businessinsider.com/r-brief-janssen-enters-collaboration-and-license-agreement-with-chinas-legend-biotech-to-develop-car-t-cancer-therapy-2017-12,negative,0.9212294816970825
635,12/22/2017 1:02:03 AM,"BRIEF-Genscript Biotech Says US, Ireland Units ‚Äç& Janssen Biotech Enter Collaboration & License Agreement ‚Äã (JNJ)",Reuters,http://www.businessinsider.com/r-brief-genscript-biotech-says-us-ireland-units--janssen-biotech-enter-collaboration--license-agreement--2017-12,positive,0.5269103646278381
636,12/27/2017 4:22:03 PM,"US STOCKS-Wall St little changed; oil drop weighs on energy shares (COP, CVX, NVDA, AAPL, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-wall-st-little-changed-oil-drop-weighs-on-energy-shares-2017-12,neutral,0.7638410925865173
637,12/27/2017 5:42:08 PM,"US STOCKS-Tech, healthcare stocks prop up Wall Street (AAPL, COP, CVX, JNJ, PFE, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-tech-healthcare-stocks-prop-up-wall-street-2017-12,negative,0.8959800601005554
638,12/27/2017 7:07:03 PM,"US STOCKS-Healthcare, tech stocks prop up Wall Street (MSFT, AAPL, CXO, DVN, UNH, JNJ, TSLA)",Reuters,http://www.businessinsider.com/r-us-stocks-healthcare-tech-stocks-prop-up-wall-street-2017-12,negative,0.9228543639183044
639,1/2/2018 12:45:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2018,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2018-1002302613,neutral,0.6483067274093628
640,1/2/2018 12:52:03 PM,BRIEF-Johnson & Johnson Declares Cash Dividend For Q1 2018 Of $0.84 Per Share On Co's Common Stock (JNJ),Reuters,http://www.businessinsider.com/r-brief-johnson--johnson-declares-cash-dividend-for-q1-2018-of-084-per-share-on-cos-common-stock-2018-1,positive,0.8286545276641846
641,1/2/2018 2:22:04 PM,BRIEF-Syros Announces Clinical Supply Agreement With Janssen To Evaluate SY-1425 (JNJ),Reuters,http://www.businessinsider.com/r-brief-syros-announces-clinical-supply-agreement-with-janssen-to-evaluate-sy-1425-2018-1,negative,0.8704128265380859
642,1/2/2018 8:12:05 PM,FDA issues recall on J&J heart device (JNJ),Reuters,http://www.businessinsider.com/r-fda-issues-recall-on-jj-heart-device-2018-1,neutral,0.741368293762207
643,1/2/2018 8:27:14 PM,BRIEF-FDA Issues Class I Recall Of Reprocessed Agilis Steerable Introducer Sheath By Sterilmed (JNJ),Reuters,http://www.businessinsider.com/r-brief-fda-issues-class-i-recall-of-reprocessed-agilis-steerable-introducer-sheath-by-sterilmed-2018-1,positive,0.721306324005127
644,1/3/2018 2:32:03 PM,BRIEF-Landmark Schizophrenia Data Receive FDA Approval For Inclusion In Invega Sustenna (Paliperidone Palmitate) Label (JNJ),Reuters,http://www.businessinsider.com/r-brief-landmark-schizophrenia-data-receive-fda-approval-for-inclusion-in-invega-sustenna-paliperidone-palmitate-label-2018-1,negative,0.918156087398529
645,1/3/2018 9:00:00 PM,Dr. Paul Janssen Award for Biomedical Research Issues 2018 Call for Nominations to Celebrate Champions of Science,PR Newswire,/news/stocks/dr-paul-janssen-award-for-biomedical-research-issues-2018-call-for-nominations-to-celebrate-champions-of-science-1012444286,positive,0.8636711239814758
646,1/7/2018 3:50:22 PM,New Drugs Approved In December ,RTTNews,/news/stocks/new-drugs-approved-in-december-1012620046,positive,0.6225224137306213
647,1/9/2018 3:38:00 AM,Small Business Funding Solutions: What to Do Differently in 2018,PR Newswire,/news/stocks/small-business-funding-solutions-what-to-do-differently-in-2018-1001655459,positive,0.9065390825271606
648,1/9/2018 3:11:00 PM,Moody's: US pharmaceutical companies' cash holdings set to decline under new tax law,Moodys,/news/bonds/moody-s-us-pharmaceutical-companies-cash-holdings-set-to-decline-under-new-tax-law-1012731176,neutral,0.9666052460670471
649,1/17/2018 9:03:00 PM,"Ortho-Clinical Diagnostics SA -- Moody's affirms Ortho-Clinical's ratings, outlook revised to stable",Moodys,/news/bonds/ortho-clinical-diagnostics-sa-moody-s-affirms-ortho-clinical-s-ratings-outlook-revised-to-stable-1013174029,negative,0.866441547870636
650,1/23/2018 9:13:41 AM,"Earnings In Focus: Jan. 23 (FUL, ATI, JNJ, PG, VZ) ",RTTNews,/news/stocks/earnings-in-focus-jan-23-ful-ati-jnj-pg-vz-1013685346,positive,0.9266109466552734
651,1/23/2018 12:40:00 PM,Johnson & Johnson Reports 2017 Fourth-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2017-fourth-quarter-results--694806,positive,0.5244160890579224
652,1/23/2018 12:45:25 PM,Johnson & Johnson Q4 Earnings Rise 10%,RTTNews,/news/stocks/johnson-johnson-q4-earnings-rise-10-1013703855,negative,0.9386103749275208
653,1/23/2018 1:27:38 PM,Johnson & Johnson Q4 Results Top Estimates; Sees FY18 Profit Above View ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-sees-fy18-profit-above-view-1013707581,negative,0.7121527194976807
654,1/23/2018 6:01:00 PM,Forty of the Nation's Most Promising Young Scientists Named Finalists in Regeneron Science Talent Search 2018,PR Newswire,/news/stocks/forty-of-the-nation-s-most-promising-young-scientists-named-finalists-in-regeneron-science-talent-search-2018-1001688777,negative,0.797315239906311
655,1/25/2018 5:59:00 PM,Bayer Shares the Risk with Cotton Farmers,PR Newswire,/news/stocks/bayer-shares-the-risk-with-cotton-farmers-703862,positive,0.8673564791679382
656,1/31/2018 8:18:00 PM,Johnson & Johnson to Participate in the Leerink Partners 7th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-leerink-partners-7th-annual-global-healthcare-conference-1014710803,positive,0.5705146789550781
657,2/1/2018 2:30:00 PM,MeiraGTx Receives Rare Pediatric Disease Designation for A002 for the Treatment of Achromatopsia Due to Mutations in the CNGB3 Gene,PR Newswire,/news/stocks/meiragtx-receives-rare-pediatric-disease-designation-for-a002-for-the-treatment-of-achromatopsia-due-to-mutations-in-the-cngb3-gene-1001718908,negative,0.8510878682136536
658,2/7/2018 4:58:00 PM,Johnson & Johnson to Participate in RBC Capital Markets 2018 Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-rbc-capital-markets-2018-global-healthcare-conference-1015054422,positive,0.8583295941352844
659,2/8/2018 2:30:00 PM,Janssen and Johnson & Johnson to Provide Webcast Presentation on Phase 3 Data for Apalutamide and the Janssen Prostate Cancer Strategy and Portfolio,PR Newswire,/news/stocks/janssen-and-johnson-johnson-to-provide-webcast-presentation-on-phase-3-data-for-apalutamide-and-the-janssen-prostate-cancer-strategy-and-portfolio-1015121273,positive,0.9098451137542725
660,2/8/2018 4:10:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Johnson & Johnson (JNJ)",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-announces-investigation-of-johnson-johnson-jnj-1015127765,neutral,0.5646185874938965
661,2/8/2018 5:41:00 PM,Johnson & Johnson to Participate in the 2018 CAGNY Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-cagny-conference-1015133630,positive,0.8189847469329834
662,2/9/2018 6:48:07 AM,"FDA Nod For JNJ, CORI Awaits Results In Q2, MDGL's HeFH Data Fails To Impress ",RTTNews,/news/stocks/fda-nod-for-jnj-cori-awaits-results-in-q2-mdgl-s-hefh-data-fails-to-impress-1015183062,neutral,0.7770134806632996
663,2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222120,positive,0.7567868232727051
664,2/9/2018 4:30:00 PM,"SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against Johnson & Johnson (JNJ) & Lead Plaintiff Deadline: April 9, 2018",PR Newswire,/news/stocks/shareholder-alert-bronstein-gewirtz-grossman-llc-notifies-investors-of-class-action-against-johnson-johnson-jnj-lead-plaintiff-deadline-april-9-2018-1015222116,positive,0.7567868232727051
665,2/16/2018 4:03:00 PM,Johnson & Johnson Consumer Presents New Scientific Research At 2018 American Academy of Dermatology Annual Meeting,PR Newswire,/news/stocks/johnson-johnson-consumer-presents-new-scientific-research-at-2018-american-academy-of-dermatology-annual-meeting-1016029591,positive,0.9263683557510376
666,2/20/2018 2:53:00 AM,J&J Reportedly Explores Sale Of $2 Bln Sterilization Division ,RTTNews,/news/stocks/j-j-reportedly-explores-sale-of-2-bln-sterilization-division-1016384446,positive,0.8254997730255127
667,2/20/2018 10:43:00 PM,Johnson & Johnson to Participate in Cowen 38th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-cowen-38th-annual-healthcare-conference-1016490049,positive,0.8185366988182068
668,2/23/2018 3:00:00 PM,"Milliman: Public pension funding improves by $60 billion, funded ratio climbs to 73.1% in 2017 Q4",PR Newswire,/news/stocks/milliman-public-pension-funding-improves-by-60-billion-funded-ratio-climbs-to-73-1-in-2017-q4-1001785596,negative,0.9482225179672241
669,3/5/2018 3:22:13 PM,New Drugs Approved In February ,RTTNews,/news/stocks/new-drugs-approved-in-february-1018015655,positive,0.6458381414413452
670,3/6/2018 8:52:00 PM,Johnson & Johnson to Participate in Barclays Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-healthcare-conference-1018169448,positive,0.8034949898719788
671,3/8/2018 10:33:00 PM,"Judge's Order Sets 1,200 Xarelto Product Liability Lawsuits for Separate Jury Trials",PR Newswire,/news/stocks/judge-s-order-sets-1-200-xarelto-product-liability-lawsuits-for-separate-jury-trials-1018455278,positive,0.5915191769599915
672,3/13/2018 6:59:00 PM,"Lifshitz & Miller LLP Announces Investigation of 8point3 Energy Partners LP, Grandpoint Capital, Inc., Hardinge Inc., Johnson & Johnson, LJM Funds Management Ltd., Nationstar Mortgage Holdings Inc.",PR Newswire,/news/stocks/lifshitz-miller-llp-announces-investigation-of-8point3-energy-partners-lp-grandpoint-capital-inc-hardinge-inc-johnson-johnson-ljm-funds-management-ltd-nationstar-mortgage-holdings-inc-1002161243,positive,0.5804692506790161
673,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849153,positive,0.6222528219223022
674,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849140,positive,0.6222528219223022
675,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849144,positive,0.6222528219223022
676,3/16/2018 12:30:00 PM,"Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1018849145,positive,0.6222528219223022
677,3/16/2018 12:38:52 PM,J&J Gets Binding Offer From Platinum Equity To Buy LifeScan Unit For $2.1 Bln ,RTTNews,/news/stocks/j-j-gets-binding-offer-from-platinum-equity-to-buy-lifescan-unit-for-2-1-bln-1018849187,negative,0.7488361597061157
678,3/19/2018 5:25:00 PM,Syracuse Creative Agency Expands into Southern Tier,PR Newswire,/news/stocks/syracuse-creative-agency-expands-into-southern-tier-1002179054,negative,0.7053846716880798
679,3/20/2018 2:24:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1018945975,positive,0.9213520288467407
680,3/20/2018 9:15:00 PM,Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson,PR Newswire,/news/stocks/dominic-j-caruso-to-retire-as-chief-financial-officer-of-johnson-johnson-1018958892,positive,0.8371418714523315
681,4/3/2018 1:54:24 PM,Will These Drugs Reach Blockbuster Status? ,RTTNews,/news/stocks/will-these-drugs-reach-blockbuster-status-1020339832,positive,0.7288854122161865
682,4/6/2018 6:24:53 AM,"J&J, Imerys Ordered To Pay $37 Mln In Case Over Talc Cancer Risks ",RTTNews,/news/stocks/j-j-imerys-ordered-to-pay-37-mln-in-case-over-talc-cancer-risks-1020647379,neutral,0.9513902068138123
683,4/10/2018 10:15:00 PM,Horizon Technology Finance Announces Renewal of Credit Facility,PR Newswire,/news/stocks/horizon-technology-finance-announces-renewal-of-credit-facility-564055,positive,0.6117008924484253
684,4/11/2018 2:53:47 AM,FDA Approves First Contact Lens With Light-adaptive Technology ,RTTNews,/news/stocks/fda-approves-first-contact-lens-with-light-adaptive-technology-1021112699,negative,0.6364906430244446
685,4/17/2018 12:40:00 PM,Johnson & Johnson Reports 2018 First-Quarter Results:,PR Newswire,/news/stocks/johnson-&-johnson-reports-2018-first-quarter-results--1001599660,positive,0.6633399128913879
686,4/17/2018 12:50:28 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1021431007,negative,0.7109436988830566
687,4/17/2018 1:02:11 PM,Johnson & Johnson Increases Sales Guidance; Plans Supply Chain Actions ,RTTNews,/news/stocks/johnson-johnson-increases-sales-guidance-plans-supply-chain-actions-1021431726,positive,0.775668203830719
688,4/18/2018 12:41:00 AM,FreeBackgroundCheck.org Announces Members Area Upgrades,PR Newswire,/news/stocks/freebackgroundcheck-org-announces-members-area-upgrades-1001600515,positive,0.939354658126831
689,4/24/2018 2:00:00 PM,Unison Reports Fast Company Growth Supported by Strategic Hires and New Market Expansion,PR Newswire,/news/stocks/unison-reports-fast-company-growth-supported-by-strategic-hires-and-new-market-expansion-1001957720,negative,0.9533326029777527
690,4/24/2018 10:01:00 PM,Johnson & Johnson to Participate in the 2018 Deutsche Bank 43rd Annual Health Care Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-2018-deutsche-bank-43rd-annual-health-care-conference-1022160611,positive,0.7847023606300354
691,4/26/2018 4:26:00 PM,Johnson & Johnson Announces Dividend Increase of 7.1%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-7-1-1022412658,negative,0.9099465608596802
692,4/28/2018 5:35:58 AM,Biotech Stocks Facing FDA Decision In May ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-may-1022627793,positive,0.8298407793045044
693,4/30/2018 2:47:38 PM,Cytori Updates On US Manufacturing And EU Approval Plans For ATI-0918 ,RTTNews,/news/stocks/cytori-updates-on-us-manufacturing-and-eu-approval-plans-for-ati-0918-1022889295,positive,0.9124888181686401
694,5/2/2018 6:00:00 PM,Johnson & Johnson to Host Consumer and Medical Devices Business Review,PR Newswire,/news/stocks/johnson-johnson-to-host-consumer-and-medical-devices-business-review-1001658284,positive,0.8828191161155701
695,5/3/2018 7:18:00 PM,Johnson & Johnson to Participate in the 2018 UBS Global Health Care Conference,PR Newswire,/news/stocks/johnson-&-johnson-to-participate-in-the-2018-ubs-global-health-care-conference-657014,positive,0.7828727960586548
696,5/5/2018 2:00:00 PM,New Phase 3 Data Show Esketamine Nasal Spray Demonstrated Rapid Improvements in Depressive Symptoms in Patients with Treatment-Resistant Depression,PR Newswire,/news/stocks/new-phase-3-data-show-esketamine-nasal-spray-demonstrated-rapid-improvements-in-depressive-symptoms-in-patients-with-treatment-resistant-depression-1023481483,negative,0.9534634947776794
697,5/5/2018 2:09:03 PM,A depression drug that researchers have called 'the most important discovery in half a century' just got a big lift (JNJ),Business Insider,http://www.businessinsider.com/depression-medication-treatment-ketamine-2018-5,negative,0.9335405826568604
698,5/7/2018 10:53:00 PM,LifeScan Global Corporation -- Moody's assigns B2 CFR to LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b2-cfr-to-lifescan-global-corporation-1023685176,positive,0.8689335584640503
699,5/8/2018 7:47:04 AM,"It's Raining FDA Approvals, MSON Muscling Up, RDHL To Report Data In Aug. ",RTTNews,/news/stocks/it-s-raining-fda-approvals-mson-muscling-up-rdhl-to-report-data-in-aug-1023720441,positive,0.8559165596961975
700,5/29/2018 4:15:14 AM,Juries Weigh Cases Over Alleged Harms Of Johnson & Johnson Baby Powder ,RTTNews,/news/stocks/juries-weigh-cases-over-alleged-harms-of-johnson-johnson-baby-powder-1025660907,neutral,0.8484252691268921
701,5/29/2018 4:53:00 PM,Johnson & Johnson to Participate in the Goldman Sachs 39th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-goldman-sachs-39th-annual-global-healthcare-conference-1025725224,positive,0.6310989856719971
702,6/1/2018 9:05:50 AM,"Celgene Appoints J&J's David Elkins As EVP, CFO, Succeeding Peter Kellogg ",RTTNews,/news/stocks/celgene-appoints-j-j-s-david-elkins-as-evp-cfo-succeeding-peter-kellogg-1026083080,positive,0.9313219785690308
703,6/5/2018 2:00:00 PM,Johnson & Johnson Announces Progress Toward Health for Humanity Goals,PR Newswire,/news/stocks/johnson-johnson-announces-progress-toward-health-for-humanity-goals-1026560176,negative,0.6456692218780518
704,6/6/2018 10:46:00 PM,Johnson & Johnson Announces Binding Offer from Fortive Corporation to Acquire Advanced Sterilization Products (ASP),PR Newswire,/news/stocks/johnson-johnson-announces-binding-offer-from-fortive-corporation-to-acquire-advanced-sterilization-products-asp-1026756589,negative,0.5574831962585449
705,6/6/2018 11:07:28 PM,Fortive Offers To Buy J&J's Advance Sterilization Product Biz For $2.8 Bln ,RTTNews,/news/stocks/fortive-offers-to-buy-j-j-s-advance-sterilization-product-biz-for-2-8-bln-1026757669,positive,0.870468020439148
706,6/7/2018 4:07:00 PM,ISG Awarded IT Services Contract by State of Texas,PR Newswire,/news/stocks/isg-awarded-it-services-contract-by-state-of-texas-1001772800,negative,0.9326006174087524
707,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886164,negative,0.52357417345047
708,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886155,negative,0.52357417345047
709,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1026886154,negative,0.52357417345047
710,6/12/2018 10:01:00 PM,"Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc.",PR Newswire,/news/stocks/johnson-johnson-announces-acceptance-of-binding-offer-from-platinum-equity-to-acquire-lifescan-inc-1002095213,negative,0.52357417345047
711,6/12/2018 10:19:22 PM,Johnson & Johnson Accepts Platinum Equity's Offer To Buy LifeScan For $2.1 Bln ,RTTNews,/news/stocks/johnson-johnson-accepts-platinum-equity-s-offer-to-buy-lifescan-for-2-1-bln-1026886960,positive,0.6177780628204346
712,6/15/2018 2:30:00 AM,"Kyros Law is Investigating Claims on Behalf of Invokana users: 1,100 Invokana Lawsuits Alleging Diabetic Ketoacidosis, Kidney Injury, Amputations and Heart Complications Filed.",PR Newswire,/news/stocks/kyros-law-is-investigating-claims-on-behalf-of-invokana-users-1-100-invokana-lawsuits-alleging-diabetic-ketoacidosis-kidney-injury-amputations-and-heart-complications-filed-1027052699,neutral,0.9272688627243042
713,6/15/2018 11:00:00 PM,LifeScan Global Corporation -- Moody's downgrades LifeScan Global's term loan B rating to B2 from B1,Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-global-s-term-loan-b-rating-to-b2-from-b1-1027141162,neutral,0.7477312088012695
714,6/18/2018 2:27:00 PM,FDA Approves the Next Generation of Customized LASIK Treatment with iDESIGN Refractive Studio,PR Newswire,/news/stocks/fda-approves-the-next-generation-of-customized-lasik-treatment-with-idesign-refractive-studio-1027167302,negative,0.7147449254989624
715,6/18/2018 2:39:34 PM,Johnson & Johnson Vision: FDA Approves IDESIGN Refractive Studio - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-vision-fda-approves-idesign-refractive-studio-quick-facts-1027167394,positive,0.6914626359939575
716,6/19/2018 11:09:23 AM,Alliance Pharma To Buy Rights To J&J's Nizoral In APAC For ¬£60 Mln; Stock Up ,RTTNews,/news/stocks/alliance-pharma-to-buy-rights-to-j-j-s-nizoral-in-apac-for-60-mln-stock-up-1027192834,negative,0.5135775804519653
717,6/19/2018 4:04:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1027202865,positive,0.9199506640434265
718,6/28/2018 11:23:31 AM,STADA Buys EMEA Rights To J&J's Medicated Anti-dandruff Shampoo Nizoral ,RTTNews,/news/stocks/stada-buys-emea-rights-to-j-j-s-medicated-anti-dandruff-shampoo-nizoral-1027325596,positive,0.8361602425575256
719,7/13/2018 3:19:58 AM,J&J Ordered To Pay $4.69 Bln In Baby Powder Case ,RTTNews,/news/stocks/j-j-ordered-to-pay-4-69-bln-in-baby-powder-case-1027364374,neutral,0.9527513384819031
720,7/13/2018 12:51:07 PM,"10 things you need to know before the opening bell (SPY, SPX, QQQ, DIA, JNJ, T, JPM, WFC, C)",Business Insider,http://www.businessinsider.com/stock-market-news-opening-bell-july-13-2018-2018-7,positive,0.9483835697174072
721,7/13/2018 5:01:00 PM,Johnson & Johnson -- Moody's: Talc award against J&J is credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-talc-award-against-j-j-is-credit-negative-1027366484,positive,0.8539794087409973
722,7/13/2018 9:33:56 PM,Johnson & Johnson Posting Notable Loss But Well Off Lows ,RTTNews,/news/stocks/johnson-johnson-posting-notable-loss-but-well-off-lows-1027367008,neutral,0.7864537835121155
723,7/16/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-q2-earnings-preview-1027369916,positive,0.9278756380081177
724,7/17/2018 12:52:30 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1027373268,negative,0.6643639206886292
725,7/17/2018 12:56:53 PM,Johnson & Johnson Updates FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-updates-fy18-outlook-quick-facts-1027373283,positive,0.9300280213356018
726,7/17/2018 10:49:00 PM,"MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc.",Moodys,/news/bonds/medplast-holdings-inc-moody-s-assigns-b2-cfr-to-medplast-holdings-inc-1027375790,positive,0.8620077967643738
727,9/18/2018 9:23:35 AM,"Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam ",RTTNews,/news/stocks/pharma-companies-avoid-3-8-bln-in-tax-per-year-says-oxfam-1027542053,negative,0.7368782758712769
728,10/2/2018 6:20:14 AM,Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity ,RTTNews,/news/stocks/johnson-johnson-closes-sale-of-lifescan-business-to-platinum-equity-1027581261,positive,0.9371856451034546
729,10/4/2018 9:19:00 AM,"Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US",Moodys,/news/bonds/moody-s-biosimilars-a-growing-challenge-biotech-drugs-with-european-market-developing-more-quickly-than-the-us-1027589140,negative,0.8536537885665894
730,10/4/2018 2:21:26 PM,Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen ,RTTNews,/news/stocks/arrowhead-enters-3-7-bln-license-and-collaboration-deals-with-janssen-1027590345,negative,0.8035460710525513
731,10/15/2018 3:01:24 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-quarter-earnings-preview-q3-1027616785,positive,0.9278756380081177
732,10/16/2018 12:46:13 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1027620272,negative,0.6677944660186768
733,10/16/2018 1:08:25 PM,Johnson & Johnson Boosts FY18 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy18-outlook-quick-facts-1027620458,negative,0.9030033946037292
734,10/23/2018 9:38:23 AM,Johnson & Johnson To Buy Remaining Stake In Japan's Ci:z In ¬•230 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-remaining-stake-in-japan-s-ci-z-in-230-bln-deal-1027642569,positive,0.9374688267707825
735,12/13/2018 3:48:06 AM,J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases ,RTTNews,/news/stocks/j-j-reportedly-willing-to-pay-400-million-plus-in-hip-device-cases-1027804575,negative,0.7556562423706055
736,12/14/2018 6:24:50 AM,Janssen's Daratumumab SNDA In Japan Triggers $2 Mln Milestone Payment To Genmab ,RTTNews,/news/stocks/janssen-s-daratumumab-snda-in-japan-triggers-2-mln-milestone-payment-to-genmab-1027808788,negative,0.8004549145698547
737,12/14/2018 5:12:11 PM,Johnson & Johnson tumbles after report says it knew for decades that its baby powder contained asbestos (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-asbestos-sinks-stock-2018-12-1027810884,neutral,0.9651999473571777
738,12/14/2018 6:31:57 PM,J&J Posting Steep Loss On Reported Knowledge Of Asbestos In Baby Powder ,RTTNews,/news/stocks/j-j-posting-steep-loss-on-reported-knowledge-of-asbestos-in-baby-powder-1027811132,neutral,0.9719220995903015
739,12/14/2018 7:00:05 PM,"Almost $40 billion has been erased from Johnson & Johnson's market value, but JPMorgan says the selling is overdone (JNJ)",Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-sell-off-an-overreaction-jpmorgan-2018-12-1027811184,neutral,0.9599597454071045
740,12/14/2018 7:11:05 PM,Johnson & Johnson Down 8% On Report Of Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-down-8-on-report-of-asbestos-in-baby-powder-1027811213,neutral,0.9697104096412659
741,12/18/2018 1:30:18 AM,"Johnson & Johnson Authorizes $5 Billion Buyback, Reaffirms FY Guidance ",RTTNews,/news/stocks/johnson-johnson-authorizes-5-billion-buyback-reaffirms-fy-guidance-1027815688,negative,0.7668419480323792
742,1/11/2019 1:18:23 PM,Johnson & Johnson Issues Update On Offer For Ci:z Holdings - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-issues-update-on-offer-for-ci-z-holdings-quick-facts-1027861865,positive,0.942362368106842
743,1/18/2019 4:01:31 PM,"J&J, Apple To Collaborate In Research Study Involving Apple Watch ",RTTNews,/news/stocks/j-j-apple-to-collaborate-in-research-study-involving-apple-watch-1027879765,negative,0.7520681023597717
744,1/21/2019 3:01:26 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-quarter-earnings-preview-q4-1027882798,positive,0.9182448983192444
745,1/22/2019 12:44:25 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1027885249,negative,0.7201688289642334
746,1/22/2019 1:40:53 PM,Johnson & Johnson Q4 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q4-results-top-estimates-1027885557,positive,0.8021098971366882
747,1/22/2019 2:36:04 PM,Johnson & Johnson is sliding after guidance comes up short (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-revenue-profit-earnings-stock-price-2019-1-1027885862,neutral,0.9650335311889648
748,1/23/2019 4:14:01 AM,J&J Reaches $120 Mln Settlement With 46 Attorneys General Over Hip Implants ,RTTNews,/news/stocks/j-j-reaches-120-mln-settlement-with-46-attorneys-general-over-hip-implants-1027887817,neutral,0.7279554605484009
749,2/5/2019 2:30:56 AM,J&J Reportedly Agrees To Resolve Most Pinnacle Hip-Device Lawsuits ,RTTNews,/news/stocks/j-j-reportedly-agrees-to-resolve-most-pinnacle-hip-device-lawsuits-1027922794,negative,0.9198147058486938
750,2/5/2019 4:52:00 PM,Johnson & Johnson -- Moody's -  Talc-related lawsuits could increase risk to Johnson & Johnson‚Äôs strong credit profile,Moodys,/news/bonds/johnson-johnson-moody-s-talc-related-lawsuits-could-increase-risk-to-johnson-johnson-s-strong-credit-profile-1027926321,neutral,0.8645678758621216
751,2/12/2019 8:51:06 PM,A depression drug that's been called 'the most important discovery in half a century' just got a big step closer to FDA approval (JNJ),Business Insider,https://www.businessinsider.com/new-depression-drug-esketamine-jnj-fda-closer-approval-2019-1,negative,0.8670374155044556
752,2/13/2019 3:21:04 PM,Johnson & Johnson is buying a Silicon Valley surgical-robotics startup for $3.4 billion (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-acquires-auris-health-surgical-robots-for-34-billion-2019-2,positive,0.8551905155181885
753,2/13/2019 3:26:18 PM,J&J's Ethicon Agrees To Acquire Auris Health For About $3.4 Billion In Cash ,RTTNews,/news/stocks/j-j-s-ethicon-agrees-to-acquire-auris-health-for-about-3-4-billion-in-cash-1027949736,positive,0.8269581198692322
754,2/15/2019 10:07:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1027957857,positive,0.8249449133872986
755,2/21/2019 2:39:04 PM,Johnson & Johnson was subpoenaed by the DOJ and the SEC over baby powder safety (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-baby-powder-subpoena-doj-sec-queries-stock-falls-2019-2-1027972093,neutral,0.9070896506309509
756,2/27/2019 4:51:26 AM,Biotech Stocks Facing FDA Decision In March ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-1027987182,positive,0.7348417639732361
757,3/6/2019 2:03:05 AM,"Regulators just approved the first new depression drug since the 1980s, and some see blockbuster potential (JNJ)",Business Insider,https://www.businessinsider.com/esketamine-depression-drug-approved-fda-johnson-johnson-antidepressant-2019-2,negative,0.6488021016120911
758,3/6/2019 3:01:45 AM,FDA Okays Janssen's Nasal Spray Medication For Treatment-resistant Depression ,RTTNews,/news/stocks/fda-okays-janssen-s-nasal-spray-medication-for-treatment-resistant-depression-1028007062,negative,0.6918228268623352
759,3/8/2019 6:36:06 PM,"Dispensed: Change at the FDA, insurance startup financials for 2018, and the first new depression drug in 35 years",Business Insider,https://www.businessinsider.com/dispensed-weekly-healthcare-newsletter-march-8-2019-3,positive,0.7338274121284485
760,3/14/2019 9:25:14 PM,Johnson & Johnson Ordered To Pay $29 Mln In Latest Talcum Cancer Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-29-mln-in-latest-talcum-cancer-case-1028032239,neutral,0.9402387738227844
761,3/22/2019 6:02:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028050916,negative,0.808785080909729
762,3/25/2019 11:44:00 AM,Alcon Inc. -- Moody's assigns Baa2 issuer rating to Alcon; stable outlook,Moodys,/news/bonds/alcon-inc-moody-s-assigns-baa2-issuer-rating-to-alcon-stable-outlook-1028055051,negative,0.808785080909729
763,3/25/2019 7:41:59 PM,"Bayer, Johnson & Johnson To Pay $775 Mln To Settle Xarelto Lawsuits ",RTTNews,/news/stocks/bayer-johnson-johnson-to-pay-775-mln-to-settle-xarelto-lawsuits-1028056729,positive,0.6798047423362732
764,4/4/2019 5:16:01 AM,10 Best Selling Drugs Of 2018 ,RTTNews,/news/stocks/10-best-selling-drugs-of-2018-1028084412,positive,0.7440220713615417
765,4/15/2019 3:01:27 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnsonjohnson-stock-price-q1-earnings-preview-1028110928,positive,0.9342256188392639
766,4/16/2019 12:49:25 PM,Johnson & Johnson Q1 adjusted earnings of $2.10 per share,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-of-2-10-per-share-1028113977,positive,0.8321962952613831
767,4/16/2019 3:15:04 PM,Johnson & Johnson's net earnings dropped 14% in the first-quarter (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-q1-earnings-shares-rise-after-earnings-beat-2019-4-1028115029,neutral,0.974744439125061
768,5/1/2019 8:39:00 PM,Jabil Inc. -- Moody's upgrades Jabil to Baa3; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-upgrades-jabil-to-baa3-outlook-stable-1028159025,negative,0.9361634850502014
769,5/9/2019 5:06:55 AM,"Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln ",RTTNews,/news/stocks/takeda-to-sell-dry-eye-drug-surgical-patch-to-novartis-j-j-for-up-to-5-7-bln-1028184178,positive,0.7471144199371338
770,5/15/2019 12:58:12 PM,J&J Plans To Execute All Levers Of Capital Allocation Strategy ,RTTNews,/news/stocks/j-j-plans-to-execute-all-levers-of-capital-allocation-strategy-1028202651,positive,0.7490697503089905
771,6/3/2019 10:51:00 PM,"Moody's  ‚Äì Ability to absorb opioid-related lawsuits will vary widely among drug makers, distributors",Moodys,/news/bonds/moody-s-ability-to-absorb-opioid-related-lawsuits-will-vary-widely-among-drug-makers-distributors-1028250300,positive,0.9185123443603516
772,6/12/2019 8:22:08 PM,Dow Jones Today: Stocks Are Spinning Their Wheels,InvestorPlace,/news/stocks/dow-jones-today-stocks-are-spinning-their-wheels-1028275487,positive,0.6641080379486084
773,6/20/2019 6:48:34 PM,5 Boring Stocks to Buy This Summer,InvestorPlace,/news/stocks/5-boring-stocks-to-buy-this-summer-1028296950,positive,0.8615565299987793
774,6/24/2019 3:04:56 PM,How Chinese Culture Could Affect the Future of 3M Stock,InvestorPlace,/news/stocks/chinese-culture-future-3m-stock-1028303878,positive,0.8320539593696594
775,6/24/2019 10:31:00 PM,LifeScan Global Corporation -- Moody's announces completion of a periodic review of ratings of LifeScan Global Corporation,Moodys,/news/bonds/lifescan-global-corporation-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-lifescan-global-corporation-1028303411,positive,0.8798283338546753
776,6/25/2019 4:46:38 PM,3 Healthcare Stocks to Buy With the Market Near All-Time Highs,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-with-the-market-near-all-time-highs-1028307938,negative,0.6229497790336609
777,6/25/2019 7:51:21 PM,3 Biopharma Stocks to Buy for Income,InvestorPlace,/news/stocks/3-biopharma-stocks-to-buy-for-income-1028307925,positive,0.9193856716156006
778,6/27/2019 1:10:05 PM,"Microsoft Stock Is Overvalued, but Still a Solid Long-Term Bet",InvestorPlace,/news/stocks/microsoft-stock-long-term-bet-1028315914,negative,0.9156023859977722
779,7/10/2019 5:55:21 PM,Is Shopify Stock Getting Ahead of Its Fundamentals?,InvestorPlace,/news/stocks/is-shopify-stock-getting-ahead-of-its-fundamentals-1028344461,positive,0.5952984094619751
780,7/12/2019 7:34:31 PM,Johnson & Johnson Baby Powder News: JNJ Stock Drops on Investigation,InvestorPlace,/news/stocks/johnson-johnson-baby-powder-news-jnj-stock-1028350343,neutral,0.9527471661567688
781,7/12/2019 7:39:04 PM,J&J tumbles amid reports the DOJ launched a criminal investigation into whether it lied about its baby powder's cancer risks (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnson-and-johnson-stock-price-reaction-reported-doj-investigation-baby-powder-2019-7-1028349902,neutral,0.9607986211776733
782,7/12/2019 7:46:29 PM,4 Healthcare Stocks That Are Feeling Sick ¬†,InvestorPlace,/news/stocks/4-healthcare-stocks-that-are-feeling-sick-1028350342,neutral,0.7167696356773376
783,7/12/2019 8:16:12 PM,"4 Top Stock Trades for Monday:JNJ, SQ, ILMN, ACB",InvestorPlace,/news/stocks/4-top-stock-trades-for-mondayjnj-sq-ilmn-acb-1028350340,positive,0.9313157796859741
784,7/12/2019 8:31:29 PM,Dow Jones Today: A Fantastic Friday,InvestorPlace,/news/stocks/dow-jones-today-a-fantastic-friday-1028350337,positive,0.8602321743965149
785,7/13/2019 3:41:26 PM,Johnson & Johnson Stock Sinks As U.S. Probes Baby Powder ,RTTNews,/news/stocks/johnson-johnson-stock-sinks-as-u-s-probes-baby-powder-1028350459,neutral,0.9420632719993591
786,7/15/2019 1:11:14 PM,Johnson & Johnson Stock Facing Negative Catalysts Ahead of Q2 Results,InvestorPlace,/news/stocks/johnson-johnson-stock-facing-negative-catalysts-ahead-of-q2-results-1028354769,neutral,0.9701735973358154
787,7/15/2019 1:24:12 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Ford and Square",InvestorPlace,/news/stocks/mondays-vital-data-options-trading-johnson-johnson-ford-and-square-1028354768,positive,0.9225240349769592
788,7/15/2019 3:01:21 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnsonjohnson-q2-earnings-preview-1028352611,positive,0.9338979721069336
789,7/15/2019 8:22:50 PM,"Dow Jones Today: China, Earnings Anticipation Stall Stocks on Monday",InvestorPlace,/news/stocks/dow-jones-today-china-earnings-anticipation-stall-stocks-on-monday-1028354735,neutral,0.933067798614502
790,7/16/2019 12:46:35 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1028355756,negative,0.6643639206886292
791,7/16/2019 12:57:32 PM,Johnson & Johnson Boosts FY19 Sales Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-sales-outlook-quick-facts-1028355784,negative,0.911094069480896
792,7/16/2019 5:17:49 PM,"Johnson & Johnson Earnings: JNJ Stock Dips Despite Q2 Beat, Raised Guidance",InvestorPlace,/news/stocks/johnson-johnson-earnings-beat-estimates-jnj-stock-down-1028358971,neutral,0.9404555559158325
793,7/16/2019 7:18:20 PM,"5 Top Stock Trades for Wednesday: JNJ, WFC, UBER, APRN, ROKU",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-jnj-wfc-uber-aprn-roku-1028358956,positive,0.928128182888031
794,7/16/2019 7:35:06 PM,Judge To Weigh $17 Bln Opioid Case Against Johnson & Johnson ,RTTNews,/news/stocks/judge-to-weigh-17-bln-opioid-case-against-johnson-johnson-1028357861,neutral,0.618377149105072
795,7/16/2019 8:17:35 PM,Dow Jones Today: Earnings Disappointments,InvestorPlace,/news/stocks/dow-jones-today-earnings-disappointments-1028358952,neutral,0.9578289985656738
796,7/17/2019 4:18:52 PM,These 6 SPDR ETFs and Amazon Tell Me the Rally Is Over,InvestorPlace,/news/stocks/these-6-spdr-etfs-and-amazon-tell-me-the-rally-is-over-1028363024,positive,0.5278091430664062
797,7/22/2019 6:55:40 PM,5 Dow Jones Stocks to Sell Before the Market Slumps,InvestorPlace,/news/stocks/5-dow-jones-stocks-to-sell-before-the-market-slumps-1028374199,positive,0.6780311465263367
798,7/23/2019 3:14:49 PM,Opioid Crisis: Trials As Well As Tribulations ,RTTNews,/news/stocks/opioid-crisis-trials-as-well-as-tribulations-1028376600,positive,0.8198062777519226
799,7/24/2019 1:29:03 PM,Johnson & Johnson Could Turn Around After its Strong Earnings,InvestorPlace,/news/stocks/johnson-johnson-could-turn-around-after-strong-earnings-1028383028,negative,0.9476338028907776
800,7/24/2019 1:51:29 PM,Is Johnson & Johnson Stock Losing Its Shine?,InvestorPlace,/news/stocks/is-johnson-johnson-stock-losing-its-shine-1028383025,neutral,0.9468405842781067
801,7/26/2019 7:55:03 AM,Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal ,RTTNews,/news/stocks/janssen-s-late-stage-study-on-relapsing-multiple-sclerosis-meets-primary-goal-1028387423,positive,0.8806390166282654
802,7/26/2019 1:47:39 PM,Janssen Gets CHMP Positive Opinion For Stelara - Quick Facts ,RTTNews,/news/stocks/janssen-gets-chmp-positive-opinion-for-stelara-quick-facts-1028388259,negative,0.9008700251579285
803,7/29/2019 12:26:47 PM,Why Johnson & Johnson Stock Isn‚Äôt a Buy‚Ä¶ Yet,InvestorPlace,/news/stocks/why-johnson-johnson-stock-isnt-a-buy-yet-1028395885,positive,0.9194797873497009
804,7/29/2019 7:52:04 PM,"5 Top Stock Trades for Tuesday: SHOP, NFLX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-tuesday-shop-nflx-jnj-1028395850,positive,0.9231193661689758
805,8/5/2019 8:35:43 PM,Stock Market Today: Time to Hope for ‚ÄòTurnaround Tuesday‚Äô,InvestorPlace,/news/stocks/stock-market-today-time-to-hope-for-turnaround-tuesday-1028419252,negative,0.593231201171875
806,8/14/2019 11:10:21 AM,JNJ Stock Is a Way Better Investment Than Bonds or CDs,InvestorPlace,/news/stocks/jnj-stock-is-a-way-better-investment-than-bonds-or-cds-1028447984,negative,0.6679369807243347
807,8/15/2019 4:05:03 PM,3 Stocks to Buy on Almost Any Dip,InvestorPlace,/news/stocks/3-stocks-to-buy-on-almost-any-dip-1028451497,positive,0.8289897441864014
808,8/16/2019 6:35:00 PM,Jabil Inc. -- Moody's assigns Prime-3 short term rating to Jabil's new $1.8 billion commercial paper program,Moodys,/news/bonds/jabil-inc-moody-s-assigns-prime-3-short-term-rating-to-jabil-s-new-1-8-billion-commercial-paper-program-1028453311,positive,0.7579614520072937
809,8/20/2019 7:11:01 PM,"3 Healthcare Stocks to Trade: UNH, JNJ and PFE",InvestorPlace,/news/stocks/3-healthcare-stocks-to-trade-unh-jnj-and-pfe-1028461453,positive,0.9377426505088806
810,8/21/2019 1:43:28 PM,"Johnson & Johnson Stock Is a Gamble, but an Interesting One",InvestorPlace,/news/stocks/johnson-johnson-stock-is-a-gamble-but-an-interesting-one-1028464947,positive,0.9109662175178528
811,8/22/2019 8:29:08 PM,"Stock Market Today: Boeing Takes Flight, Manufacturing Slumps",InvestorPlace,/news/stocks/stock-market-today-boeing-takes-flight-manufacturing-slumps-1028468412,neutral,0.964020311832428
812,8/23/2019 6:37:40 PM,Will Lawsuits Sink Johnson & Johnson Stock?,InvestorPlace,/news/stocks/lawsuits-jnj-stock-probably-not-1028470702,neutral,0.6193097829818726
813,8/26/2019 12:47:29 PM,Biotech Stocks Facing FDA Decision In September 2019 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-september-2019-1028472695,positive,0.827917218208313
814,8/26/2019 8:26:00 PM,Dow Jones Today: The Return of Trade Optimism,InvestorPlace,/news/stocks/the-dow-jones-industrial-surged-monday-amid-nice-trade-chatter-1028475023,positive,0.8377541303634644
815,8/26/2019 8:34:50 PM,"Stock Market Today: Biotech in Focus, Trade Talks Steady Stocks",InvestorPlace,/news/stocks/stock-market-today-biotech-in-focus-trade-talks-steady-stocks-1028475022,negative,0.5053693652153015
816,8/26/2019 11:57:28 PM,Johnson & Johnson Ordered To Pay $572 Million For Oklahoma Opioid Crisis ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-572-million-for-oklahoma-opioid-crisis-1028474595,neutral,0.850912868976593
817,8/27/2019 1:18:47 PM,J2 Global Unit Acquires BabyCenter From Johnson & Johnson - Quick Facts ,RTTNews,/news/stocks/j2-global-unit-acquires-babycenter-from-johnson-johnson-quick-facts-1028476166,positive,0.9020528197288513
818,8/27/2019 3:18:05 PM,J&J was ordered to pay $572 million for helping fuel the opioid epidemic. The company's market cap increased $15 billion in response. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-572-million-opioid-crisis-settlement-stock-price-2019-8,negative,0.6815376281738281
819,8/27/2019 4:40:22 PM,J&J Opioid Ruling 2019: 13 Things to Know,InvestorPlace,/news/stocks/jj-opioid-ruling-2019-13-things-to-know-1028478913,positive,0.9326829314231873
820,8/27/2019 5:12:04 PM,The $572 million fine Johnson & Johnson has to pay for its role in the opioid epidemic is only 4% of its annual profit (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-judgement-small-part-of-2018-profit-2019-8,positive,0.7802304029464722
821,8/27/2019 8:12:28 PM,"5 Top Stock Trades for Wednesday: CMG, SBUX, JNJ",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-cmg-sbux-jnj-1028478901,positive,0.9212615489959717
822,8/27/2019 8:13:44 PM,"Dow Jones Today: Not Much Activity, But That‚Äôs OK",InvestorPlace,/news/stocks/dow-stocks-were-mostly-sluggish-today-and-thats-alright-1028478900,positive,0.797851026058197
823,8/28/2019 5:26:00 PM,Johnson & Johnson International Fin Svc Co -- Moody's affirms J&J at Aaa; revises outlook to negative,Moodys,/news/bonds/johnson-johnson-international-fin-svc-co-moody-s-affirms-j-j-at-aaa-revises-outlook-to-negative-1028481456,negative,0.4767831861972809
824,8/30/2019 3:37:52 PM,3 Large-Cap Stocks to Sell in September,InvestorPlace,/news/stocks/3-large-cap-stocks-sell-september-1028488909,positive,0.9143410325050354
825,8/30/2019 5:43:28 PM,It‚Äôs Time to Short Johnson & Johnson Stock,InvestorPlace,/news/stocks/its-time-to-short-johnson-johnson-stock-1028488901,positive,0.8511730432510376
826,9/4/2019 3:35:01 PM,EU Okays Expanded Use Of Janssen's STELARA ,RTTNews,/news/stocks/eu-okays-expanded-use-of-janssen-s-stelara-1028498117,negative,0.8560087084770203
827,9/5/2019 8:16:39 PM,"Dow Jones Today: Finally, Some Relief on the Trade Front",InvestorPlace,/news/stocks/dow-stocks-were-boosted-by-some-good-news-on-the-trade-front-1028504009,negative,0.7006545662879944
828,9/10/2019 2:55:17 PM,10 Healthcare Stocks to Buy Despite the Headlines,InvestorPlace,/news/stocks/10-healthcare-stocks-to-buy-despite-the-headlines-1028514931,positive,0.49671414494514465
829,9/16/2019 9:48:58 AM,OxyContin Maker Purdue Pharma Files For Bankruptcy Protection ,RTTNews,/news/stocks/oxycontin-maker-purdue-pharma-files-for-bankruptcy-protection-1028525612,neutral,0.763647198677063
830,9/18/2019 10:40:19 AM,"JNJ Stock Is Undervalued, but Not Compelling Given These Headwinds",InvestorPlace,/news/stocks/jnj-stock-undervalued-not-compelling-headwinds-1028536192,negative,0.6562449336051941
831,9/19/2019 4:10:24 PM,Buy This If You Like Johnson & Johnson Stock But Hate the Lawsuits ¬†,InvestorPlace,/news/stocks/buy-this-if-you-like-johnson-johnson-stock-but-hate-the-lawsuits-1028539745,positive,0.8937894105911255
832,9/20/2019 12:44:35 PM,There‚Äôs a Lot More Trouble Looming for JNJ Stock Than You Might Think,InvestorPlace,/news/stocks/damage-johnson-and-johnson-1028542274,neutral,0.756502091884613
833,9/20/2019 3:58:30 PM,3 Dow Stocks That Could Keep Going Lower,InvestorPlace,/news/stocks/3-dow-stocks-that-could-keep-going-lower-mmm-wba-jnj-1028542254,positive,0.7490230798721313
834,9/20/2019 7:17:16 PM,Should Johnson & Johnson Investors Worry About Opioid Lawsuits?,InvestorPlace,/news/stocks/should-johnson-johnson-investors-worry-about-opioid-lawsuits-1028542244,positive,0.5976389050483704
835,9/23/2019 7:25:20 PM,Long-Term Investors Should Consider Buying SHOP Stock Near $250,InvestorPlace,/news/stocks/long-term-investors-should-consider-buying-shop-stock-near-250-1028546632,positive,0.854231059551239
836,9/24/2019 1:58:02 PM,Why Contrarians May Want to Take a Look at JNJ Stock,InvestorPlace,/news/stocks/why-contrarians-may-want-to-take-a-look-at-jnj-stock-1028550815,positive,0.9324418902397156
837,9/24/2019 5:57:56 PM,6 Dow Jones Industrial Average Stocks to Buy Right Now,InvestorPlace,/news/stocks/6-dow-jones-industrial-average-stocks-to-buy-right-now-1028550791,positive,0.9204747676849365
838,9/26/2019 2:47:18 PM,Don‚Äôt Ignore the Johnson and Johnson Pharmaceutical Pipeline,InvestorPlace,/news/stocks/johnson-johnson-drug-pipeline-underappreciated-1028558195,positive,0.8949278593063354
839,9/27/2019 10:27:19 AM,Should You Buy Johnson & Johnson Stock in October?,InvestorPlace,/news/stocks/should-you-buy-johnson-johnson-stock-in-october-1028560688,positive,0.9365558624267578
840,9/27/2019 7:34:40 PM,7 Big Biotech Stocks to Watch,InvestorPlace,/news/stocks/7-big-biotech-stocks-to-watch-1028560645,positive,0.9301358461380005
841,9/30/2019 5:20:47 PM,Can Johnson and Johnson Stock Overcome Opiod Implications?,InvestorPlace,/news/stocks/can-johnson-and-johnson-stock-overcome-opiod-implications-1028565214,positive,0.8496933579444885
842,10/1/2019 11:44:44 AM,Johnson & Johnson Can Overcome Its Legal Issues,InvestorPlace,/news/stocks/legal-issues-problem-johnson-johnson-stock-1028569362,negative,0.8247592449188232
843,10/1/2019 2:24:43 PM,Negative Press Presents a Buying Opportunity with JNJ Stock,InvestorPlace,/news/stocks/negative-press-opportunity-jnj-stock-1028569347,neutral,0.8843162655830383
844,10/1/2019 5:27:02 PM,Microsoft Stock Is Still a Good Pick for One Type of Investor,InvestorPlace,/news/stocks/valuations-msft-serve-investor-well-1028569331,positive,0.8058505058288574
845,10/2/2019 3:21:33 AM,J&J Settles With Two Ohio Counties Ahead Of Upcoming Opioid Trial ,RTTNews,/news/stocks/j-j-settles-with-two-ohio-counties-ahead-of-upcoming-opioid-trial-1028569091,neutral,0.5459243655204773
846,10/2/2019 5:42:04 PM,"Johnson & Johnson climbs after settling two opioid epidemic lawsuits, allowing it to avoid an upcoming federal trial (JNJ)",Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jumps-on-opioid-lawsuit-settlement-2019-10,negative,0.9377744197845459
847,10/2/2019 8:11:19 PM,Stock Market Today: October Rolls in With a Bang,InvestorPlace,/news/stocks/stock-market-today-october-rolls-in-with-a-bang-1028572822,negative,0.8455447554588318
848,10/2/2019 8:12:57 PM,"Dow Jones Today: Houston, We‚Äôve Got a Growth Problem",InvestorPlace,/news/stocks/more-slack-data-points-stung-the-dow-jones-today-1028572821,negative,0.5470151305198669
849,10/3/2019 12:45:55 PM,3 Reasons Why Johnson and Johnson Stock Will Get Back on Track,InvestorPlace,/news/stocks/3-reasons-johnson-and-johnson-jnj-will-rally-1028575957,positive,0.8375355005264282
850,10/3/2019 1:57:00 PM,3 Things Investors Should Know About the Opioid Lawsuits Against Johnson & Johnson,InvestorPlace,/news/stocks/jnj-stock-opioid-lawsuits-1028575952,positive,0.9274178147315979
851,10/7/2019 6:51:22 PM,Why Johnson & Johnson Stock Is Not a Screaming Buy,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-not-screaming-buy-1028581887,positive,0.9226393103599548
852,10/9/2019 3:55:12 AM,J&J Ordered To Pay $8 Bln In Case Over Male Breast Growth On Anti-psychotic Drug ,RTTNews,/news/stocks/j-j-ordered-to-pay-8-bln-in-case-over-male-breast-growth-on-anti-psychotic-drug-1028585334,neutral,0.960385262966156
853,10/9/2019 3:57:05 PM,J&J slides after jury orders it to pay $8 billion in male breast-growth case (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/jnj-stock-price-falls-risperdal-male-breast-growth-jury-decision-2019-10-1028587229,neutral,0.9606561660766602
854,10/9/2019 6:22:30 PM,Jury: JNJ Must Pay $8 Billion Over Male Breast Growth Tied to Risperdal Drug,InvestorPlace,/news/stocks/jnj-must-pay-8-billion-in-risperdal-lawsuit-1028588698,positive,0.5017287135124207
855,10/9/2019 8:07:10 PM,Stock Market Today: Johnson & Johnson Gets Served Again,InvestorPlace,/news/stocks/stock-market-today-jnj-gets-served-again-1028588690,negative,0.568056046962738
856,10/9/2019 9:40:00 PM,Johnson & Johnson -- Moody's: Risperdal verdict adds to J&J's litigation risk,Moodys,/news/bonds/johnson-johnson-moody-s-risperdal-verdict-adds-to-j-j-s-litigation-risk-1028588177,neutral,0.9389442801475525
857,10/11/2019 4:03:26 PM,Johnson & Johnson Stock Has Limited Upside,InvestorPlace,/news/stocks/johnson-and-johnson-stock-mixed-bag-limited-upside-1028594594,neutral,0.9101839065551758
858,10/11/2019 8:17:27 PM,Stock Market Today: Let‚Äôs Make a Deal,InvestorPlace,/news/stocks/stock-market-today-lets-make-a-deal-1028594574,positive,0.90934818983078
859,10/14/2019 3:01:15 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnsonjohnson-q3-quarterly-earnings-preview-stock-1028596463,positive,0.9278756380081177
860,10/14/2019 4:51:27 PM,Should Investors Buy Shopify Stock After Its Recent Decline?,InvestorPlace,/news/stocks/should-investors-buy-shopify-stock-after-its-recent-decline-1028597930,neutral,0.6758788824081421
861,10/14/2019 7:59:43 PM,Johnson and Johnson Stock Still Significantly Undervalued,InvestorPlace,/news/stocks/johnson-stock-significantly-undervalued-1028597917,neutral,0.918654203414917
862,10/14/2019 8:26:33 PM,Stock Market Today: Stocks Hit Snooze Ahead of Earnings,InvestorPlace,/news/stocks/stock-market-today-stocks-hit-snooze-ahead-of-earnings-1028597915,neutral,0.5712857842445374
863,10/15/2019 6:30:00 AM,Johnson & Johnson to Host Earnings Call,Accesswire,/news/stocks/johnson-johnson-to-host-earnings-call-1028602062,positive,0.9404258728027344
864,10/15/2019 7:41:02 AM,"RETA Surges On Trial Data, RVNC On Track, All Eyes On RLMD Today ",RTTNews,/news/stocks/reta-surges-on-trial-data-rvnc-on-track-all-eyes-on-rlmd-today-1028598042,negative,0.5599358677864075
865,10/15/2019 12:50:05 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1028598775,negative,0.6677944660186768
866,10/15/2019 1:00:00 PM,Johnson & Johnson Boosts FY19 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy19-outlook-quick-facts-1028598788,negative,0.9181004166603088
867,10/15/2019 3:53:53 PM,"Johnson & Johnson Stock Has Good Numbers, But Bad Verdicts",InvestorPlace,/news/stocks/johnson-johnson-stock-has-good-numbers-but-bad-verdicts-1028601982,neutral,0.9627055525779724
868,10/15/2019 8:16:30 PM,Stock Market Today: Bring on the Earnings¬†,InvestorPlace,/news/stocks/stock-market-today-bring-on-the-earnings-1028601963,positive,0.9211692214012146
869,10/15/2019 8:33:27 PM,Dow Jones Today: Earnings Boosts Across the Board,InvestorPlace,/news/stocks/dow-jones-today-earnings-boosts-across-the-board-1028601962,negative,0.9234060049057007
870,10/16/2019 4:26:00 AM,Major Drug Distributors In Talks To Settle Opioid Litigation For $18 Bln : WSJ ,RTTNews,/news/stocks/major-drug-distributors-in-talks-to-settle-opioid-litigation-for-18-bln-wsj-1028601751,positive,0.6609814763069153
871,10/16/2019 2:16:08 PM,Missouri Appeals Court Reverses $110 Mln Talc Verdict Against J&J ,RTTNews,/news/stocks/missouri-appeals-court-reverses-110-mln-talc-verdict-against-j-j-1028603481,neutral,0.9093305468559265
872,10/18/2019 1:35:01 PM,"J&J Offers $4 Bln, Teva $15 Bln To Settle Opioid Claims Ahead Of Trial ",RTTNews,/news/stocks/j-j-offers-4-bln-teva-15-bln-to-settle-opioid-claims-ahead-of-trial-1028610613,positive,0.8724142909049988
873,10/18/2019 2:55:44 PM,Johnson & Johnson Consumer Recalls Single Lot Of Baby Powder In U.S. ,RTTNews,/news/stocks/johnson-johnson-consumer-recalls-single-lot-of-baby-powder-in-u-s-1028610926,neutral,0.9511260986328125
874,10/18/2019 3:03:31 PM,Trade Johnson and Johnson Stock to New Highs,InvestorPlace,/news/stocks/trade-johnson-and-johnson-stock-to-new-highs-1028611576,negative,0.7441659569740295
875,10/18/2019 3:30:03 PM,3 Earnings Reports to Watch Next Week,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-earnings-calendar-1028224242,positive,0.891125500202179
876,10/18/2019 3:39:03 PM,Johnson & Johnson recalled a batch of baby powder after a test found asbestos. The company says the product is safe. (JNJ),Business Insider,https://www.businessinsider.com/johnson-and-johnson-jnj-baby-powder-recall-asbestos-in-talc-2019-10,positive,0.7775114178657532
877,10/18/2019 7:59:28 PM,"5 Top Stock Trades for Monday: BA, MSFT, JNJ, SNAP, AXP",InvestorPlace,/news/stocks/5-top-stock-trades-for-monday-ba-msft-jnj-snap-axp-1028612006,positive,0.9286305904388428
878,10/18/2019 8:07:43 PM,Stock Market Today: High-Growth Hiccup Causes Worries,InvestorPlace,/news/stocks/stock-market-today-high-growth-hiccup-causes-worries-1028612005,neutral,0.9477109909057617
879,10/18/2019 8:22:05 PM,"Dow Jones Today: Not Upbeat, But Not Too Downbeat",InvestorPlace,/news/stocks/dow-jones-today-not-upbeat-but-not-too-downbeat-1028612172,positive,0.46953484416007996
880,10/21/2019 1:20:59 PM,Case Closed: Johnson and Johnson Stock Is a Short,InvestorPlace,/news/stocks/case-closed-johnson-and-johnson-stock-is-a-short-1028615525,positive,0.5142785310745239
881,10/21/2019 1:25:49 PM,"Monday‚Äôs Vital Data: Johnson & Johnson, Coca-Cola and Boeing",InvestorPlace,/news/stocks/mondays-vital-data-johnson-johnson-coca-cola-and-boeing-1028615524,positive,0.8904942274093628
882,10/22/2019 11:24:06 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Adobe, and Applied Materials",InvestorPlace,/news/stocks/3-big-stock-charts-tuesday-johnson-johnson-adobe-applied-materials-1028618545,positive,0.9328401684761047
883,10/22/2019 12:20:31 PM,Litigation Dip Is a Buying Opportunity for Johnson and Johnson Stock,InvestorPlace,/news/stocks/buy-the-litigation-dip-in-jnj-stock-1028619588,positive,0.676546573638916
884,10/22/2019 5:50:49 PM,7 Safe Stocks to Buy and Hold Through 2020,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-and-hold-through-2020-1028620495,positive,0.9206299781799316
885,10/22/2019 6:58:47 PM,Splunk Stock Could Hit New 2019 Lows,InvestorPlace,/news/stocks/splunk-stock-could-hit-new-2019-lows-1028620786,neutral,0.9572835564613342
886,10/23/2019 12:04:34 PM,Trade of the Day: Johnson and Johnson Stock‚Äôs Dip Is Signal for the Bulls,InvestorPlace,/news/stocks/trade-of-the-day-johnson-and-johnson-stocks-dip-is-signal-for-the-bulls-1028622955,neutral,0.8398712277412415
887,10/23/2019 6:24:39 PM,2 Sells and 1 Buy in Opioid Stocks,InvestorPlace,/news/stocks/2-sells-and-1-buy-in-opioid-stocks-1028624856,positive,0.866977870464325
888,10/24/2019 8:00:00 PM,Johnson & Johnson -- Moody's: J&J's proposed opioid agreement credit negative,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-s-proposed-opioid-agreement-credit-negative-1028629001,positive,0.8436587452888489
889,10/25/2019 11:10:52 AM,Investors Should Short JNJ Stock and Buy Boeing Stock,InvestorPlace,/news/stocks/investors-should-short-jnj-stock-buy-boeing-stock-1028631236,positive,0.9138069748878479
890,10/28/2019 6:00:19 PM,Can Johnson and Johnson Survive this Latest Controversy?,InvestorPlace,/news/stocks/can-johnson-and-johnson-survive-this-latest-controversy-1028636605,positive,0.8497632741928101
891,10/29/2019 5:28:44 PM,7 Dividend Stocks That Could Struggle to Continue Payout Hikes,InvestorPlace,/news/stocks/7-dividend-stocks-payout-hikes-1028641102,neutral,0.895197331905365
892,10/29/2019 8:31:06 PM,Dow Jones Today: Struggling at the Highs,InvestorPlace,/news/stocks/merck-and-pfizer-boosted-the-dow-jones-today-thanks-to-upped-guidance-1028641490,neutral,0.9591390490531921
893,10/30/2019 2:56:02 PM,Johnson & Johnson Says New Tests Found No Asbestos In Baby Powder ,RTTNews,/news/stocks/johnson-johnson-says-new-tests-found-no-asbestos-in-baby-powder-1028644202,positive,0.7696431279182434
894,10/30/2019 7:45:08 PM,"4 Top Stock Trades for Thursday: FB, JNJ, EA,¬†AMD",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-fb-jnj-ea-amd-1028645841,positive,0.9283624887466431
895,10/30/2019 8:21:32 PM,Stock Market Today: Fed Cuts Rates as Stocks Hit Record Highs,InvestorPlace,/news/stocks/stock-market-today-fed-cuts-rates-as-stocks-hit-record-highs-1028645840,neutral,0.9478957056999207
896,10/30/2019 8:24:41 PM,Dow Jones Today: Another Tepid Reaction to a Fed Rate Cut,InvestorPlace,/news/stocks/the-fed-provided-a-modest-assist-to-the-dow-jones-today-1028645839,neutral,0.8353989124298096
897,10/31/2019 10:12:04 PM,Ethicon Recalls ECHELON FLEX ENDOPATH Staplers ,RTTNews,/news/stocks/ethicon-recalls-echelon-flex-endopath-staplers-1028650012,positive,0.922482967376709
898,11/5/2019 5:56:46 PM,Consider Purchasing Microsoft Stock While It Is Still a Buy,InvestorPlace,/news/stocks/consider-purchasing-microsoft-stock-buy-1028661616,positive,0.9336426854133606
899,11/12/2019 4:56:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1028681878,positive,0.8464629650115967
900,11/13/2019 3:35:57 PM,Should Investors Buy Pfizer Stock Before Next Year‚Äôs Huge Shake Up?,InvestorPlace,/news/stocks/should-investors-buy-pfizer-stock-before-next-years-huge-shake-up-1028686378,positive,0.9238095283508301
901,11/13/2019 7:34:42 PM,Should Investors Add Johnson & Johnson Stock to Their Shopping Lists?,InvestorPlace,/news/stocks/should-investors-add-johnson-johnson-stock-to-their-shopping-lists-1028686949,positive,0.9315013289451599
902,11/18/2019 4:39:09 PM,9 Tantalizing Dividend Stocks for 2020,InvestorPlace,/news/stocks/9-tantalizing-dividend-stocks-for-2020-1028697526,positive,0.8452248573303223
903,11/19/2019 3:04:26 PM,"Rebounding Teva Stock Could Climb Higher, But Risks Remain",InvestorPlace,/news/stocks/rebounding-teva-stock-climb-higher-but-risks-remain-1028700876,negative,0.9010089039802551
904,11/19/2019 3:24:11 PM,Reduced Opioid Payout Is No Reason to Buy Johnson and Johnson Stock,InvestorPlace,/news/stocks/payout-buy-johnson-and-johnson-stock-1028701422,positive,0.7671210169792175
905,11/20/2019 9:22:07 PM,Stock Market Today: Is It Time to Get Worried?¬†,InvestorPlace,/news/stocks/stock-market-today-is-it-time-to-get-worried-1028706167,positive,0.6108413338661194
906,11/20/2019 9:32:09 PM,Dow Jones Today: Investors Desperate for a Trade Deal,InvestorPlace,/news/stocks/dow-jones-today-investors-desperate-for-a-trade-deal-1028706165,positive,0.7805256843566895
907,11/21/2019 4:31:08 PM,J&J Subsidiary Ethicon Loses Class Action Suit In Australia ,RTTNews,/news/stocks/j-j-subsidiary-ethicon-loses-class-action-suit-in-australia-1028708636,neutral,0.9066476821899414
908,11/22/2019 9:31:54 PM,"Dow Jones Today: Trade Progress Pushes Stocks, Healthcare Helps Dow",InvestorPlace,/news/stocks/dow-jones-today-trade-progress-pushes-stocks-healthcare-helps-dow-1028712595,negative,0.9252076745033264
909,11/26/2019 3:44:36 PM,7 Unsteady Stocks Investors Should Consider Selling Before 2020,InvestorPlace,/news/stocks/7-stocks-to-sell-investors-selling-2020-1028719195,positive,0.8592533469200134
910,12/4/2019 9:36:35 PM,Dow Jones Today: A Trade Redemption Story,InvestorPlace,/news/stocks/dow-jones-today-a-trade-redemption-story-1028738868,positive,0.9136745929718018
911,12/5/2019 9:29:26 PM,Dow Jones Today: Trade Influenced Stocks More Than Impeachment News,InvestorPlace,/news/stocks/dow-jones-today-trade-influenced-stocks-more-than-impeachment-news-1028742731,positive,0.765224039554596
912,12/6/2019 2:06:42 PM,10 Stocks That Should Be Every Young Investor‚Äôs First Choice,InvestorPlace,/news/stocks/10-stocks-that-should-be-every-young-investors-first-choice-1028326562,positive,0.9038465619087219
913,12/9/2019 3:55:21 AM,Janssen To Buy Investigational Bermekimab From XBiotech ,RTTNews,/news/stocks/janssen-to-buy-investigational-bermekimab-from-xbiotech-1028745938,positive,0.836329460144043
914,12/12/2019 1:09:45 PM,9 Best Dividend Stocks to Buy for Every Investor,InvestorPlace,/news/stocks/best-dividend-stocks-buy-every-investment-strategy-1028237147,positive,0.8878700733184814
915,12/17/2019 9:25:49 PM,Stock Market Today: Roku‚Äôs CFO Stepping Down; Buy Microsoft?,InvestorPlace,/news/stocks/stock-market-today-roku-cfo-buy-microsoft-stock-1028770587,positive,0.6185455918312073
916,12/17/2019 9:32:10 PM,Dow Jones Today: Stocks Continue Building Momentum,InvestorPlace,/news/stocks/dow-jones-today-stocks-continue-building-momentum-1028770586,negative,0.9442622065544128
917,12/19/2019 7:03:33 PM,Why Microsoft Stock Might Take a Pause in 2020,InvestorPlace,/news/stocks/why-microsoft-stock-might-take-a-pause-in-2020-1028777014,positive,0.9024615287780762
918,12/19/2019 9:23:44 PM,Dow Jones Today: The Great Melt Up Continues,InvestorPlace,/news/stocks/stocks-advanced-again-as-some-surprises-lifted-the-dow-jones-today-1028777572,neutral,0.8627321720123291
919,12/20/2019 12:58:16 PM,Johnson & Johnson To Acquire Remaining Stake In Verb Surgical - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-remaining-stake-in-verb-surgical-quick-facts-1028778683,positive,0.9402570128440857
920,12/20/2019 4:09:49 PM,7 Best Vanguard ETFs for 2020,InvestorPlace,/news/stocks/7-best-vanguard-etfs-2020-1028779761,positive,0.7777143120765686
921,12/20/2019 6:50:00 PM,"LifeScan Global Corporation -- Moody's revises LifeScan's outlook to negative, affirms B2 CFR",Moodys,/news/bonds/lifescan-global-corporation-moody-s-revises-lifescan-s-outlook-to-negative-affirms-b2-cfr-1028779871,neutral,0.5515680909156799
922,12/23/2019 11:40:50 AM,"After Moving Higher, Apple May Stop Bearing Fruit While It Corrects",InvestorPlace,/news/stocks/moving-higher-apple-stock-corrects-1028782105,positive,0.5009089112281799
923,12/26/2019 10:01:54 AM,Embattled TEVA Has Made Headlines for All of the Wrong Reasons,InvestorPlace,/news/stocks/embattled-teva-has-made-headlines-for-all-of-the-wrong-reasons-1028785016,neutral,0.8971842527389526
924,1/3/2020 12:40:18 PM,Stay on the Sidelines as the Future Looks Potentially Bleak for Teva Stock,InvestorPlace,/news/stocks/future-looks-bleak-teva-stock-1028793227,neutral,0.6191732883453369
925,1/3/2020 6:38:44 PM,"After Lackluster 2019, Pfizer Stock Could Rebound in 2020",InvestorPlace,/news/stocks/after-lackluster-2019-pfizer-stock-could-rebound-in-2020-1028793896,negative,0.95452880859375
926,1/6/2020 5:18:24 PM,7 Investing Resolutions to Follow in 2020,InvestorPlace,/news/stocks/7-investing-resolutions-to-follow-in-2020-1028797249,positive,0.9337491393089294
927,1/6/2020 7:03:48 PM,A 2019 Review of Dow Jones Stocks (And What 2020 May Bring),InvestorPlace,/news/stocks/a-2019-review-of-dow-jones-stocks-and-what-2020-may-bring-1028797244,positive,0.9407529830932617
928,1/7/2020 4:27:34 PM,Ignore the Analysts: Johnson & Johnson Faces Serious Legal Liability,InvestorPlace,/news/stocks/johnson-johnson-stock-serious-legal-liability-1028800497,neutral,0.9379374980926514
929,1/7/2020 9:35:58 PM,Dow Jones Today: Middle East Focus Factors Into The Equation Again,InvestorPlace,/news/stocks/boeing-supported-the-dow-jones-today-as-a-most-of-the-index-dropped-1028801231,positive,0.9064908027648926
930,1/8/2020 2:47:00 PM,The Diagnosis for Teva Stock Still Looks Grim,InvestorPlace,/news/stocks/the-diagnosis-for-teva-stock-still-looks-grim-1028803509,positive,0.4788687229156494
931,1/8/2020 5:33:00 PM,"Jabil Inc. -- Moody's rates Jabil's new notes Baa3, outlook stable",Moodys,/news/bonds/jabil-inc-moody-s-rates-jabil-s-new-notes-baa3-outlook-stable-1028803822,positive,0.877144455909729
932,1/8/2020 6:03:01 PM,Scandal-Ridden Teva Pharmaceutical Is Fishing for a Bottom,InvestorPlace,/news/stocks/scandals-opioid-teva-stock-fishing-bottom-1028804210,positive,0.5781758427619934
933,1/10/2020 4:51:43 PM,3 Biotech Stocks to Bank on for Buyouts in 2020,InvestorPlace,/news/stocks/3-biotech-stocks-buyouts-2020-1028809868,positive,0.8042193651199341
934,1/10/2020 5:08:08 PM,7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-or-sell-as-pricing-pressures-mount-1028809866,neutral,0.7713858485221863
935,1/10/2020 5:18:36 PM,Should Investors Buy Johnson & Johnson Stock Prior to Earnings?,InvestorPlace,/news/stocks/should-investors-buy-johnson-johnson-stock-prior-to-earnings-1028810096,positive,0.9430213570594788
936,1/13/2020 9:21:57 PM,Dow Jones Today: Tech Lifts Stocks as Trade Deal Signing Nears,InvestorPlace,/news/stocks/dow-jones-today-tech-lifts-stocks-as-trade-deal-signing-nears-1028814122,negative,0.8567444086074829
937,1/14/2020 7:02:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1028817171,positive,0.8684381246566772
938,1/15/2020 4:37:07 PM,Pfizer Stock Offers Good Value to Patient Investors,InvestorPlace,/news/stocks/pfizer-stock-offers-good-value-investors-1028820483,negative,0.7911884784698486
939,1/21/2020 9:24:41 PM,Dow Jones Today: China Virus Provides an Excuse for Sellers to Sell,InvestorPlace,/news/stocks/dow-jones-today-china-virus-provides-an-excuse-for-sellers-to-sell-1028834066,positive,0.6959263682365417
940,1/22/2020 12:35:41 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1028835192,negative,0.7201688289642334
941,1/22/2020 1:32:43 PM,Johnson & Johnson Q4 Profit Beats Estimates; Adj. Operational Sales Up 3.4% ,RTTNews,/news/stocks/johnson-johnson-q4-profit-beats-estimates-adj-operational-sales-up-3-4-1028835473,negative,0.9367613792419434
942,1/22/2020 5:20:08 PM,Johnson & Johnson Stock Will Continue To Rally Into 2020,InvestorPlace,/news/stocks/jnj-stock-will-continue-to-rally-into-2020-1028837164,negative,0.9441300630569458
943,1/22/2020 8:16:02 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower on Q4 Results,InvestorPlace,/news/stocks/johnson-johnson-earnings-drop-jnj-stock-1028837410,neutral,0.9628430008888245
944,1/22/2020 9:16:11 PM,Stock Market Today: Apple‚Äôs New iPhone; Tesla at $100 Billion,InvestorPlace,/news/stocks/stock-market-today-apples-new-iphone-tesla-at-100-billion-1028837680,positive,0.8762010931968689
945,1/22/2020 9:16:44 PM,Dow Jones Today: Stocks Still Rise Despite Mixed Bag With Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-still-rise-despite-mixed-bag-with-earnings-1028837679,negative,0.9261822700500488
946,1/27/2020 9:26:45 PM,Stock Market Today: Beyond Meat Grows Partnerships; Coronavirus Cure?,InvestorPlace,/news/stocks/stock-market-today-beyond-meat-grows-partnerships-coronavirus-cure-1028848288,positive,0.8881845474243164
947,1/27/2020 9:29:18 PM,"Dow Jones Today: Virus Spreads, Impeachment Proceedings Infect Stocks",InvestorPlace,/news/stocks/defensives-lead-the-dow-jones-today-but-not-much-else-worked-1028848287,neutral,0.9115419387817383
948,1/28/2020 5:42:09 PM,J&J CEO Alex Gorsky testifies that he trusted internal experts as the company remains embroiled in legal disputes over baby powder (JNJ),Business Insider,https://www.businessinsider.com/jj-ceo-alex-gorsky-baby-powder-claims-trusted-internal-experts-2020-1,neutral,0.4943521320819855
949,1/29/2020 1:27:00 PM,Did Investors Miss Their Chance with Shopify Stock?,InvestorPlace,/news/stocks/did-investors-miss-chance-shopify-stock-1028855888,neutral,0.7138839364051819
950,1/30/2020 4:40:54 PM,How Disease Outbreaks Affect Stock Prices,InvestorPlace,/news/stocks/how-disease-outbreaks-affect-stock-prices-1028860905,positive,0.9026889204978943
951,1/31/2020 3:57:33 AM,Johnson & Johnson Ordered To Pay $344 Mln In California Pelvic Mesh Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-344-mln-in-california-pelvic-mesh-case-1028861914,neutral,0.9497367739677429
952,2/4/2020 12:30:56 PM,Johnson & Johnson Stock Looks Like a Safe Place to Hide Out,InvestorPlace,/news/stocks/jnj-stock-looks-safe-place-hide-1028871756,positive,0.8869536519050598
953,2/5/2020 4:43:16 PM,Coronavirus cases remain modest in U.S.,Seeking Alpha,https://seekingalpha.com/news/3538634-coronavirus-cases-remain-modest-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4481508731842041
954,2/6/2020 1:13:09 PM,Why Johnson & Johnson Is Deceptively Boring,InvestorPlace,/news/stocks/why-jnj-stock-is-deceptively-boring-1028881947,positive,0.7666877508163452
955,2/6/2020 10:59:27 PM,Johnson & Johnson told to pay $750M in New Jersey talc case,Seeking Alpha,https://seekingalpha.com/news/3539564-johnson-johnson-told-to-pay-750m-in-new-jersey-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.881700336933136
956,2/7/2020 1:19:14 PM,Can JNJ Stock Keep on Its Current Growth Track?,InvestorPlace,/news/stocks/can-jnj-stock-keep-growing-1028885182,positive,0.6110998392105103
957,2/7/2020 2:47:42 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3539712-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9446426630020142
958,2/7/2020 4:30:20 PM,Coronavirus cases inch up in U.S. but still very light,Seeking Alpha,https://seekingalpha.com/news/3539753-coronavirus-cases-inch-up-in-u-s-still-light?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7748228311538696
959,2/7/2020 6:53:04 PM,Johnson & Johnson Ordered To Pay $750 Mln In New Jersey Baby Powder Case ,RTTNews,/news/stocks/johnson-johnson-ordered-to-pay-750-mln-in-new-jersey-baby-powder-case-1028885636,neutral,0.9327622652053833
960,2/7/2020 7:09:24 PM,With Alibaba Stock the Waiting Is the Hardest Part,InvestorPlace,/news/stocks/with-alibaba-stock-the-waiting-is-the-hardest-part-1028885754,positive,0.8417930006980896
961,2/10/2020 8:35:52 PM,"Coronavirus outbreak continues to spread, still largely restricted to Hubei province",Seeking Alpha,https://seekingalpha.com/news/3540190-coronavirus-outbreak-continues-to-spread-still-largely-restricted-to-hubei-province?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.42718085646629333
962,2/11/2020 3:59:54 PM,7 Low-Volatility Stocks to Buy In Jittery Times,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-in-jittery-times-1028894771,positive,0.7698948383331299
963,2/13/2020 10:01:01 AM,Is the Bad News Already Baked into Boeing Stock? Maybe,InvestorPlace,/news/stocks/boeing-stock-appears-to-be-on-the-mend-and-may-be-a-tepid-buy-here-1028902147,positive,0.5686270594596863
964,2/13/2020 7:25:33 PM,3 Dow Jones Industrial Average Stocks to Sell,InvestorPlace,/news/stocks/3-dow-jones-industrial-average-stocks-to-sell-1028904779,positive,0.9174598455429077
965,2/13/2020 9:23:53 PM,Dow Jones Today: Coronavirus Controversy Reemerges,InvestorPlace,/news/stocks/dow-jones-today-coronavirus-controversy-reemerges-1028905225,neutral,0.5799043774604797
966,2/14/2020 12:14:37 PM,J&J's Stelara shows positive action in late-stage Crohn's study,Seeking Alpha,https://seekingalpha.com/news/3542140-j-and-js-stelara-shows-positive-action-in-late-stage-crohns-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9358772039413452
967,2/14/2020 9:20:40 PM,Dow Jones Today: A Day for Safe Havens,InvestorPlace,/news/stocks/dow-jones-today-a-day-for-safe-havens-1028908217,positive,0.8009321093559265
968,2/18/2020 12:57:08 PM,Opioid-related payouts to less than expected - NYT,Seeking Alpha,https://seekingalpha.com/news/3542632-opioid-related-payouts-to-less-expected-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9246281981468201
969,2/19/2020 4:55:25 PM,Molecular Templates up 8% on ETB advancement,Seeking Alpha,https://seekingalpha.com/news/3543320-molecular-templates-up-8-on-etb-advancement?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9509281516075134
970,2/21/2020 2:32:53 PM,Dems attack Trump over stalled efforts to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3544481-dems-attack-trump-over-stalled-efforts-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9021157026290894
971,2/24/2020 4:18:27 PM,3 Healthcare Stocks to Buy This Year,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-this-year-1028932507,positive,0.8341861963272095
972,2/27/2020 2:36:23 PM,Fighting The Deadly Coronavirus ,RTTNews,/news/stocks/fighting-the-deadly-coronavirus-1028945765,positive,0.888126015663147
973,3/2/2020 4:32:41 PM,J&J gene therapy nabs accelerated review status in Europe for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3547547-j-and-j-gene-therapy-nabs-accelerated-review-status-in-europe-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6769625544548035
974,3/2/2020 5:51:53 PM,FDA OKs Sanofi drug for previously treated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3547590-fda-oks-sanofi-drug-for-previously-treated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5526721477508545
975,3/3/2020 12:01:05 AM,"J&J should separate CEO and chairman roles, shareholder says",Seeking Alpha,https://seekingalpha.com/news/3547836-j-and-j-should-separate-ceo-and-chairman-roles-shareholder-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9245535135269165
976,3/3/2020 6:42:24 PM,"Coronavirus plays - vaccines, drugs & infection control products",Seeking Alpha,https://seekingalpha.com/news/3548189-coronavirus-plays-vaccines-drugs-infection-control-products?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9463247656822205
977,3/3/2020 9:31:46 PM,Dow Jones Today: Misery Returns as Fed Cuts Fail to Save the Day,InvestorPlace,/news/stocks/dow-jones-today-misery-returns-as-fed-cuts-fail-to-save-the-day-1028961702,neutral,0.9445366859436035
978,3/4/2020 1:50:04 PM,5 ETFs That Will Help Lower Your Taxes,InvestorPlace,/news/stocks/5-etfs-that-will-help-lower-your-taxes-1028628623,positive,0.7150942087173462
979,3/4/2020 4:22:38 PM,8 Stocks to Buy in March for a Coronavirus Rebound,InvestorPlace,/news/stocks/8-stocks-to-buy-in-march-for-a-coronavirus-rebound-1028965222,positive,0.6642267107963562
980,3/4/2020 9:15:44 PM,"Dow Jones Today: Primary Results, Stimulus Speculation Prove Potent",InvestorPlace,/news/stocks/dow-jones-today-primary-results-stimulus-speculation-prove-potent-1028966188,negative,0.5126901268959045
981,3/5/2020 12:37:07 PM,New sell-side coverage - healthcare,Seeking Alpha,https://seekingalpha.com/news/3548949-new-sell-side-coverage-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8478836417198181
982,3/9/2020 2:43:27 PM,ViiV Healthcare reports positive data on less-frequent dosing of HIV regimen,Seeking Alpha,https://seekingalpha.com/news/3549766-viiv-healthcare-reports-positive-data-on-less-frequent-dosing-of-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9549173712730408
983,3/9/2020 8:31:49 PM,Biotech Stocks: Coronavirus Response Shows How Far We‚Äôve Come ‚Ä¶,InvestorPlace,/news/stocks/biotech-stocks-coronavirus-response-how-far-we-have-come-1028978308,negative,0.57014000415802
984,3/10/2020 2:29:46 PM,Its Powerful Pipeline Shows Pfizer Stock Is Undervalued by 15%,InvestorPlace,/news/stocks/pfe-stock-is-undervalued-by-at-least-15-1028981675,negative,0.8663246035575867
985,3/10/2020 3:30:36 PM,9 Recession-Proof Stocks to Disinfect the Coronavirus,InvestorPlace,/news/stocks/9-recession-proof-stocks-to-disinfect-the-coronavirus-1028982558,positive,0.7820135951042175
986,3/11/2020 4:06:44 PM,MMM Is a Free Cash Flow Giant Poised to Do Well This Year,InvestorPlace,/news/stocks/mmm-stock-free-cash-flow-giant-1028986979,negative,0.9434819221496582
987,3/12/2020 12:07:00 PM,"Moody's ‚Äì More opioid settlements likely in 2020, with mainly negative credit impact for defendants",Moodys,/news/bonds/moody-s-more-opioid-settlements-likely-in-2020-with-mainly-negative-credit-impact-for-defendants-1028989071,neutral,0.8975092768669128
988,3/12/2020 3:27:26 PM,3 Stocks to Buy That Will Dodge Any Volatile Market,InvestorPlace,/news/stocks/3-stocks-to-buy-that-will-dodge-any-volatile-market-1028990968,positive,0.7573486566543579
989,3/13/2020 2:00:29 PM,J&J launches COVID-19 vaccine program,Seeking Alpha,https://seekingalpha.com/news/3551589-j-and-j-launches-covidminus-19-vaccine-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7495699524879456
990,3/13/2020 3:00:51 PM,J&J Collaborates With BIDMC To Accelerate COVID-19 Vaccine Development ,RTTNews,/news/stocks/j-j-collaborates-with-bidmc-to-accelerate-covid-19-vaccine-development-1028994178,negative,0.879200279712677
991,3/13/2020 5:57:01 PM,There‚Äôs Still Time To Buy the Dip in Shopify Stock,InvestorPlace,/news/stocks/theres-still-time-to-buy-the-dip-in-shopify-stock-1028995279,positive,0.7664799094200134
992,3/16/2020 11:14:02 AM,U.S. stocks set to gap down at open,Seeking Alpha,https://seekingalpha.com/news/3551922-u-s-stocks-set-to-gap-down-open?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9542070627212524
993,3/16/2020 2:58:00 PM,Darunavir unlikely to be effective against COVID-19 - J&J,Seeking Alpha,https://seekingalpha.com/news/3552069-darunavir-unlikely-to-be-effective-against-covidminus-19-j-and-j?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8082849979400635
994,3/16/2020 3:17:06 PM,10 Do‚Äôs and Don‚Äôts for Avoiding the Coronavirus,InvestorPlace,/news/stocks/10-dos-and-donts-for-avoiding-the-coronavirus-1029000781,positive,0.7038614153862
995,3/16/2020 4:02:41 PM,7 Dividend Stocks to Watch for Stable Income,InvestorPlace,/news/stocks/7-dividend-stocks-to-watch-for-stable-income-1029000778,positive,0.8340676426887512
996,3/17/2020 11:34:20 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, J.M. Smucker, and Zscaler",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-j-m-smucker-and-zscaler-1029004002,positive,0.9265962243080139
997,3/17/2020 1:22:25 PM,Use Johnson & Johnson for Quick Income,InvestorPlace,/news/stocks/use-johnson-johnson-for-quick-income-1029004683,positive,0.9382830262184143
998,3/17/2020 4:34:34 PM,J&J Says No Proof To Support Use Of Darunavir For COVID-19 ,RTTNews,/news/stocks/j-j-says-no-proof-to-support-use-of-darunavir-for-covid-19-1029004811,positive,0.8870719075202942
999,3/19/2020 6:16:38 AM,"FDA Says No To Epilepsy Drug, IMV Advances COVID-19 Vaccine, ISEE Delays Study ",RTTNews,/news/stocks/fda-says-no-to-epilepsy-drug-imv-advances-covid-19-vaccine-isee-delays-study-1029011073,positive,0.4814063012599945
1000,3/19/2020 5:00:38 PM,Profit-taking pressures Moderna after Hahn comments on vaccine timeline,Seeking Alpha,https://seekingalpha.com/news/3553448-profit-taking-pressures-moderna-after-hahn-comments-on-vaccine-timeline?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9628137350082397
1001,3/20/2020 11:40:07 AM,"TSLA Stock Didn‚Äôt Catch an Unlucky Break, Its Luck Just Ran Out",InvestorPlace,/news/stocks/tsla-stock-luck-ran-out-1029017044,positive,0.742529571056366
1002,3/20/2020 3:23:46 PM,Key events next week - healthcare,Seeking Alpha,https://seekingalpha.com/news/3553839-key-events-next-week-healthcare?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9446426630020142
1003,3/23/2020 5:14:44 PM,Why Shopify Stock Is a Buy on This Pullback,InvestorPlace,/news/stocks/why-shopify-stock-is-a-buy-on-this-pullback-1029024220,positive,0.8993766903877258
1004,3/24/2020 12:58:32 PM,J&J finance chief warns on reliability of guidance amid Covid-19 outbreak,Seeking Alpha,https://seekingalpha.com/news/3554647-j-and-j-finance-chief-warns-on-reliability-of-guidance-amid-covidminus-19-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9380122423171997
1005,3/27/2020 2:19:32 PM,CHMP thumbs up for label extensions in Europe,Seeking Alpha,https://seekingalpha.com/news/3555893-chmp-thumbs-up-for-label-extensions-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7633069753646851
1006,3/30/2020 11:31:28 AM,J&J picks lead Covid-19 vaccine candidate; shares up 4% premarket,Seeking Alpha,https://seekingalpha.com/news/3556197-j-and-j-picks-lead-covidminus-19-vaccine-candidate-shares-up-4-premarket?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8969965577125549
1007,3/30/2020 1:58:25 PM,Johnson & Johnson Identifies Lead COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/johnson-johnson-identifies-lead-covid-19-vaccine-candidate-1029044192,positive,0.5822126865386963
1008,3/30/2020 3:15:04 PM,"J&J just sped up the timeline for its coronavirus vaccine, and said it could be ready for emergency use early next year (JNJ)",Business Insider,https://www.businessinsider.com/jj-coronavirus-vaccine-research-timeline-and-emergency-use-2020-3,positive,0.742063045501709
1009,3/30/2020 3:38:45 PM,7 Stocks to Buy for a Dovish Federal Reserve,InvestorPlace,/news/stocks/7-stocks-to-buy-dovish-federal-reserve-1029045589,positive,0.6505231857299805
1010,3/30/2020 7:03:03 PM,Johnson & Johnson News: JNJ Stock Jumps 8% on Coronavirus Vaccine Hopes,InvestorPlace,/news/stocks/johnson-johnson-news-coronavirus-vaccine-jnj-stock-up-1029046271,negative,0.9072995185852051
1011,3/30/2020 8:00:15 PM,Johnson & Johnson surges 9% after saying its coronavirus vaccine will begin human testing by September (JNJ),Business Insider,https://markets.businessinsider.com/news/stocks/johnsonjohnson-stock-price-gains-coronavirus-vaccine-timeline-human-testing-september-2020-3-1029045913,negative,0.9268048405647278
1012,3/30/2020 8:16:47 PM,Stock Market Today: Healthcare Stocks Leads the Way; Buy Zoom?,InvestorPlace,/news/stocks/stock-market-today-healthcare-stocks-leads-the-way-buy-zoom-1029046564,positive,0.8414232134819031
1013,3/30/2020 8:42:07 PM,"Dow Jones Today: Healthcare Help, Hopes Worst May be Over Lift Stocks",InvestorPlace,/news/stocks/dow-jones-today-healthcare-help-hopes-worst-may-be-over-lift-stocks-1029046563,neutral,0.43877658247947693
1014,3/31/2020 6:03:52 AM,"AMRN Loses Legal Fight, AKRO Awaits Big Day, JNJ's Covid-19 Vaccine Study In Sep ",RTTNews,/news/stocks/amrn-loses-legal-fight-akro-awaits-big-day-jnj-s-covid-19-vaccine-study-in-sep-1029046989,positive,0.7181842923164368
1015,3/31/2020 11:32:18 AM,"3 Big Stock Charts for Tuesday: Abbott Laboratories, Johnson & Johnson, and Regeneron Pharmaceuticals",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-abbott-laboratories-johnson-johnson-and-regeneron-pharmaceuticals-1029048681,positive,0.9266859889030457
1016,3/31/2020 7:33:07 PM,'Like warp speed': J&J's top scientist told us how the pharma giant plans to rapidly test a potential coronavirus vaccine and pump out 1 billion doses (JNJ),Premium,/news/stocks/jj-coronavirus-vaccine-interview-timetable-testing-manufacturing-2020-3,positive,0.5138806104660034
1017,4/1/2020 11:50:43 AM,7 Biotech Stocks to Buy That Could Beat the Coronavirus,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-that-could-beat-the-coronavirus-1028882437,negative,0.6657755374908447
1018,4/1/2020 2:24:14 PM,Any COVID-19 Vaccine Upside Already Is Built Into MRNA Stock,InvestorPlace,/news/stocks/covid-19-upside-built-into-mrna-stock-1029055594,positive,0.9224926233291626
1019,4/1/2020 3:04:17 PM,Avoid Buying General Electric Despite Upside Potential,InvestorPlace,/news/stocks/avoid-buying-ge-stock-despite-upside-potential-1029055588,positive,0.8984320759773254
1020,4/1/2020 8:49:52 PM,J&J postpones medical device review,Seeking Alpha,https://seekingalpha.com/news/3557541-j-and-j-postpones-medical-device-review?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6637706756591797
1021,4/2/2020 8:20:35 PM,Dow Jones Today: Stocks Backflip as Unemployment Picture Darkens,InvestorPlace,/news/stocks/dow-jones-today-stocks-backflip-as-unemployment-picture-darkens-1029060946,neutral,0.9544925093650818
1022,4/2/2020 9:00:17 PM,Fate Therapeutics up 23% after-hours on J&J cell therapy deal,Seeking Alpha,https://seekingalpha.com/news/3558035-fate-therapeutics-up-23-after-hours-on-j-and-j-cell-therapy-deal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9480670094490051
1023,4/3/2020 4:37:17 AM,"Fate Therapeutics Seals Deal With JNJ For Cancer Immunotherapies, Stock Jumps ",RTTNews,/news/stocks/fate-therapeutics-seals-deal-with-jnj-for-cancer-immunotherapies-stock-jumps-1029061143,positive,0.8077495694160461
1024,4/6/2020 2:38:38 PM,Healthcare firms pile on initiatives as COVID-19 pandemic advances,Seeking Alpha,https://seekingalpha.com/news/3558642-healthcare-firms-pile-on-initiatives-covidminus-19-pandemic-advances?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5490674376487732
1025,4/6/2020 6:26:48 PM,Moderna Emerges as Coronavirus Vaccine Leader,InvestorPlace,/news/stocks/moderna-is-soaring-on-covid-19-hopes-but-those-hopes-are-risky-1029069273,positive,0.8007520437240601
1026,4/8/2020 3:30:48 PM,"Amazon, Nike and Goldfish big winners in teen survey",Seeking Alpha,https://seekingalpha.com/news/3559378-amazon-nike-and-goldfish-big-winners-in-teen-survey?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4939536154270172
1027,4/8/2020 6:59:50 PM,Piper Sandler Survey: Top Teen Brands for Spring 2020,InvestorPlace,/news/stocks/top-teen-brands-for-spring-2020-1029077615,positive,0.8951520919799805
1028,4/9/2020 5:20:58 PM,Dividend Investors Should Buy Johnson & Johnson Stock On Pullbacks,InvestorPlace,/news/stocks/dividend-investors-should-buy-jnj-stock-on-pullbacks-1029081336,positive,0.920042872428894
1029,4/10/2020 7:25:11 PM,J&J drops deal for Takeda's TachoSil surgical patch,Seeking Alpha,https://seekingalpha.com/news/3559944-j-and-j-drops-deal-for-takedas-tachosil-surgical-patch?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7350356578826904
1030,4/13/2020 3:01:20 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q1-1029085741,positive,0.9296786785125732
1031,4/13/2020 4:07:20 PM,"INO Stock May Fade After the Virus, but It Could Rocket to $20 First",InvestorPlace,/news/stocks/ino-stock-could-rocket-20-1029086362,negative,0.5253950357437134
1032,4/13/2020 8:23:31 PM,Stock Market Today: Amazon Hiring Spree; Disney Turmoil?,InvestorPlace,/news/stocks/stock-market-today-amazon-hiring-spree-disney-turmoil-1029087117,neutral,0.924579918384552
1033,4/13/2020 8:42:28 PM,Dow Jones Today: Stocks Decline Anticipating Q1 Earnings,InvestorPlace,/news/stocks/dow-jones-today-stocks-decline-anticipating-q1-earnings-1029087115,neutral,0.971025288105011
1034,4/13/2020 9:30:21 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3560221-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
1035,4/13/2020 9:30:48 PM,Johnson & Johnson Q1 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3560239-johnson-and-amp-johnson-q1-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7770807147026062
1036,4/14/2020 11:19:02 AM,J&J delivers strong Q1 but lowers guidance amid COVID-19 headwinds,Seeking Alpha,https://seekingalpha.com/news/3560398-j-and-j-delivers-strong-q1-lowers-guidance-amid-covidminus-19-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9727838635444641
1037,4/14/2020 12:36:30 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1029088737,negative,0.7109436988830566
1038,4/14/2020 1:25:39 PM,J&J Q1 Results Top Estimates; Cuts 2020 Outlook Due To COVID-19 Impact ,RTTNews,/news/stocks/j-j-q1-results-top-estimates-cuts-2020-outlook-due-to-covid-19-impact-1029088933,neutral,0.9379528164863586
1039,4/14/2020 6:38:47 PM,Johnson & Johnson Earnings: JNJ Stock Jumps 5% on Strong Q1,InvestorPlace,/news/stocks/johnson-johnson-earnings-boost-jnj-stock-up-1029091260,negative,0.9420449733734131
1040,4/14/2020 8:46:49 PM,Stock Market Today: Earnings Season Begins; Chesapeake Reverse Split,InvestorPlace,/news/stocks/stock-market-today-earnings-season-begins-chesapeake-reverse-split-1029091585,positive,0.6685740351676941
1041,4/14/2020 8:49:16 PM,"5 Top Stock Trades for Wednesday: BAC, GS, JNJ, SPCE, SHOP",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-bac-gs-jnj-spce-shop-1029091584,positive,0.930719792842865
1042,4/14/2020 11:03:00 PM,Johnson & Johnson -- Moody's: Coronavirus will temporarily pressure J&J's earnings,Moodys,/news/bonds/johnson-johnson-moody-s-coronavirus-will-temporarily-pressure-j-j-s-earnings-1029091502,neutral,0.9345195293426514
1043,4/15/2020 11:40:35 AM,"2 Pros, 2 Cons for Investing in Moderna as It Develops Coronavirus Vaccine",InvestorPlace,/news/stocks/mrna-stock-and-coronavirus-vaccine-1029093779,positive,0.8621031045913696
1044,4/15/2020 11:48:29 AM,"3 Big Stock Charts for Wednesday: Apple, Paypal, and Johnson & Johnson",InvestorPlace,/news/stocks/3-big-stock-charts-for-wednesday-apple-paypal-and-johnson-johnson-1029093778,positive,0.899908721446991
1045,4/15/2020 3:13:45 PM,RemeGen candidate Fast Track'd for lupus,Seeking Alpha,https://seekingalpha.com/news/3560931-remegen-candidate-fast-trackd-for-lupus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7099936008453369
1046,4/15/2020 4:48:31 PM,5 Stocks to Buy For Big Gains On CARES Act Stimulus,InvestorPlace,/news/stocks/5-stocks-to-buy-for-big-gains-on-cares-act-stimulus-1029095722,negative,0.7233671545982361
1047,4/15/2020 7:22:26 PM,Johnson & Johnson Stock Is Your Shelter From the Storm,InvestorPlace,/news/stocks/jnj-stock-shelter-from-storm-coronavirus-1029096024,positive,0.9029497504234314
1048,4/16/2020 3:19:42 PM,10 Best Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/10-best-stocks-to-buy-and-hold-forever-1028240913,positive,0.9141502976417542
1049,4/20/2020 1:46:26 PM,"Trading at 52-Week Highs, LLY Stock Is Already Priced to Perfection",InvestorPlace,/news/stocks/hold-off-overvalued-lly-stock-1029107790,negative,0.5579317212104797
1050,4/20/2020 6:09:37 PM,Money flow spikes in COVID-19 vaccine players amid rush for early data,Seeking Alpha,https://seekingalpha.com/news/3562210-money-flow-spikes-in-covidminus-19-vaccine-players-amid-rush-for-early-data?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7037768363952637
1051,4/21/2020 7:56:51 PM,FDA OK new use of AbbVie's Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3562765-fda-ok-new-use-of-abbvies-imbruvica?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6404172778129578
1052,4/22/2020 11:38:49 AM,BofA likes Johnson & Johnson in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3562964-bofa-likes-johnson-johnson-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7967446446418762
1053,4/23/2020 11:30:59 AM,Moderna Faces Tough Threats in the Short and Long Term,InvestorPlace,/news/stocks/moderna-faces-tough-threats-in-the-short-and-long-term-1029122410,negative,0.47916945815086365
1054,4/23/2020 10:53:28 PM,"Big universities, others to return $350M of PPP loans: coronavirus briefing",Seeking Alpha,https://seekingalpha.com/news/3564009-big-universities-others-to-return-350m-of-ppp-loans-coronavirus-briefing?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.776811957359314
1055,4/24/2020 3:20:52 AM,J&J to partner with Emergent Bio on coronavirus vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3564016-j-and-j-to-partner-emergent-bio-on-coronavirus-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7191788554191589
1056,4/24/2020 5:05:19 AM,J&J To Expand Manufacturing Capabilities For COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/j-j-to-expand-manufacturing-capabilities-for-covid-19-vaccine-candidate-1029125206,negative,0.9349794983863831
1057,4/24/2020 7:43:19 AM,"SAVA Gets Funding For AD Drug, JNJ Hits All-time High, ENZ On Watch ",RTTNews,/news/stocks/sava-gets-funding-for-ad-drug-jnj-hits-all-time-high-enz-on-watch-1029125551,negative,0.8711331486701965
1058,4/24/2020 1:26:36 PM,J&J files U.S. applications for expanded use of IV golimumab,Seeking Alpha,https://seekingalpha.com/news/3564182-j-and-j-files-u-s-applications-for-expanded-use-of-iv-golimumab?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9041345119476318
1059,4/24/2020 8:14:04 PM,Stock Market Today: Facebook vs. Zoom; AT&T CEO Leaves,InvestorPlace,/news/stocks/stock-market-today-facebook-vs-zoom-att-ceo-leaves-1029128556,positive,0.89278644323349
1060,4/27/2020 8:35:40 AM,Heartburn meds for COVID-19? NY is trying it,Seeking Alpha,https://seekingalpha.com/news/3564475-heartburn-meds-for-covidminus-19-ny-is-trying?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8303530216217041
1061,4/27/2020 10:10:49 AM,J&J files application in Japan for subcutaneous formulation of Darzalex,Seeking Alpha,https://seekingalpha.com/news/3564504-j-and-j-files-application-in-japan-for-subcutaneous-formulation-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5003964900970459
1062,4/27/2020 1:52:56 PM,Don‚Äôt Let Negative Data Dissuade You from Gilead Sciences,InvestorPlace,/news/stocks/dont-let-negative-data-dissuade-you-from-gilead-sciences-1029133468,positive,0.6423469185829163
1063,4/27/2020 7:16:56 PM,J&J must face talc lawsuits - New Jersey court,Seeking Alpha,https://seekingalpha.com/news/3564835-j-and-j-must-face-talc-lawsuits-new-jersey-court?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7272198796272278
1064,4/27/2020 7:52:32 PM,How to Invest With Deflation on the Horizon,InvestorPlace,/news/stocks/how-to-invest-with-deflation-on-horizon-1029134529,positive,0.8992782831192017
1065,4/28/2020 9:01:07 AM,The AbbVie Buyout is Not a Sure Thing for Allergan Stock Investors,InvestorPlace,/news/stocks/the-abbvie-buyout-is-not-a-sure-thing-for-allergan-stock-investors-1029137151,positive,0.9339045286178589
1066,4/28/2020 11:28:34 AM,"3 Big Stock Charts for Tuesday: Johnson & Johnson, Merck, and Bristol-Myers Squibb",InvestorPlace,/news/stocks/3-big-stock-charts-for-tuesday-johnson-johnson-merck-and-bristol-myers-squibb-1029137983,positive,0.9059588313102722
1067,4/28/2020 11:32:55 AM,Wells softens view on Edwards Lifesciences in premarket analyst action,Seeking Alpha,https://seekingalpha.com/news/3565181-wells-softens-view-on-edwards-lifesciences-in-premarket-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.751943051815033
1068,4/28/2020 11:44:49 AM,UBS heads to sidelines on J&J after big rally,Seeking Alpha,https://seekingalpha.com/news/3565191-ubs-heads-to-sidelines-on-j-and-j-after-big-rally?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7344501614570618
1069,4/28/2020 12:51:00 PM,9 Healthcare Stocks to Buy Even After the Coronavirus Fades,InvestorPlace,/news/stocks/9-healthcare-stocks-buy-even-after-coronavirus-1029139171,negative,0.5128858685493469
1070,4/28/2020 4:56:14 PM,"Pfizer to make ""hundreds of millions"" doses of COVID-19 vaccine next year - CEO",Seeking Alpha,https://seekingalpha.com/news/3565400-pfizer-to-make-hundreds-of-millions-doses-of-covidminus-19-vaccine-next-year-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.82470703125
1071,4/28/2020 9:37:18 PM,9 Stocks to Buy to Weather the Recession,InvestorPlace,/news/stocks/9-stocks-to-buy-to-weather-the-recession-1029055060,positive,0.7990171909332275
1072,4/29/2020 12:51:50 AM,COVID-19 vaccine could be ready for emergency use by fall,Seeking Alpha,https://seekingalpha.com/news/3565740-covidminus-19-vaccine-be-ready-for-emergency-use-fall?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8471664190292358
1073,4/29/2020 6:00:46 PM,What Lies Ahead for Vaccine Development and INO Stock in May?,InvestorPlace,/news/stocks/what-lies-ahead-for-vaccine-development-and-ino-stock-in-may-1029146509,positive,0.9380711913108826
1074,4/30/2020 10:00:55 AM,"Moderna Stock Is Near Highs, But Faces Risk",InvestorPlace,/news/stocks/moderna-stock-is-near-highs-but-faces-risk-1029149020,negative,0.724486231803894
1075,5/1/2020 2:58:48 AM,Shot Roster: COVID-19 Vaccines In Human Trials ,RTTNews,/news/stocks/shot-roster-covid-19-vaccines-in-human-trials-1029154136,positive,0.8697241544723511
1076,5/1/2020 2:27:51 PM,10 Dow Jones Stocks to Keep Your Portfolio Afloat,InvestorPlace,/news/stocks/10-dow-jones-stocks-to-keep-your-portfolio-afloat-1029155699,positive,0.8516220450401306
1077,5/1/2020 6:41:32 PM,FDA OKs subcutaneous version of J&J's Darzalex,Seeking Alpha,https://seekingalpha.com/news/3567772-fda-oks-subcutaneous-version-of-j-and-js-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8165947794914246
1078,5/4/2020 12:55:21 PM,iBio Stock Is Too Risky,InvestorPlace,/news/stocks/ibio-is-in-the-coronavirus-vaccine-mix-but-its-still-risky-1029160950,positive,0.5480599403381348
1079,5/5/2020 6:18:48 PM,3 Healthcare Stocks Popping Off Support,InvestorPlace,/news/stocks/3-healthcare-stocks-popping-off-support-1029167820,neutral,0.9234455227851868
1080,5/5/2020 8:35:00 PM,"LifeScan Global Corporation -- Moody's downgrades LifeScan's CFR to B3, stable outlook",Moodys,/news/bonds/lifescan-global-corporation-moody-s-downgrades-lifescan-s-cfr-to-b3-stable-outlook-1029167567,neutral,0.747166633605957
1081,5/7/2020 8:42:45 PM,Dow Jones Today: Jobless Claims Soar But Stocks Do Too,InvestorPlace,/news/stocks/tech-lifted-the-dow-jones-today-as-nasdaq-goes-green-on-the-year-1029180374,neutral,0.8955984115600586
1082,5/11/2020 5:59:24 PM,7 Winning Stocks and 3 Losing Stocks to Watch Right Now,InvestorPlace,/news/stocks/winning-stocks-losing-stocks-watch-right-now-coronavirus-1029188685,positive,0.8666110038757324
1083,5/12/2020 12:38:10 PM,7 Dividend Stocks That You Can Still Bank On,InvestorPlace,/news/stocks/7-dividend-stocks-that-you-can-still-bank-on-1029192814,positive,0.9323616623878479
1084,5/13/2020 1:45:18 PM,7 Tech Industry Dividend Stocks for Growth and Income,InvestorPlace,/news/stocks/7-tech-industry-dividend-stocks-1028478920,positive,0.9232316017150879
1085,5/13/2020 3:05:47 PM,FDA accepts Arbor Pharma application for ADHD med AR19,Seeking Alpha,https://seekingalpha.com/news/3573965-fda-accepts-arbor-pharma-application-for-adhd-med-ar19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7356624007225037
1086,5/14/2020 8:10:17 PM,Halozyme bags $15M milestone from J&J under Enhanze license,Seeking Alpha,https://seekingalpha.com/news/3574681-halozyme-bags-15m-milestone-from-j-and-j-under-enhanze-license?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7907896637916565
1087,5/18/2020 1:13:47 PM,"If You‚Äôre Bullish on the Internet, Be Bullish on Shopify Stock",InvestorPlace,/news/stocks/if-youre-bullish-on-the-internet-be-bullish-on-shopify-stock-1029211448,positive,0.9331527352333069
1088,5/18/2020 8:30:31 PM,Dow Jones Today: Vaccine News And Fed Talk Powered Markets Higher,InvestorPlace,/news/stocks/dow-jones-today-vaccine-news-and-fed-talk-powered-markets-higher-1029212694,positive,0.8665386438369751
1089,5/19/2020 9:09:36 PM,Does Moderna Stock‚Äôs Rally Hold Up Under the Microscope?,InvestorPlace,/news/stocks/mrna-stock-rally-microscope-coronavirus-vaccine-1029217325,positive,0.8170806765556335
1090,5/20/2020 4:32:25 AM,Johnson & Johnson To Stop Selling Talc-based Baby Powder In North America ,RTTNews,/news/stocks/johnson-johnson-to-stop-selling-talc-based-baby-powder-in-north-america-1029217492,neutral,0.7780940532684326
1091,5/20/2020 8:58:59 PM,Dow Jones Today: Pent Up Demand and Reopening in Sight,InvestorPlace,/news/stocks/dow-jones-today-pent-up-demand-and-reopening-in-sight-1029221833,negative,0.6912160515785217
1092,5/21/2020 9:16:53 AM,The Virus Vaccine Race is Fueling Moderna Stock to New Highs,InvestorPlace,/news/stocks/the-virus-vaccine-race-is-fueling-moderna-stock-to-new-highs-1029222715,negative,0.700281023979187
1093,5/21/2020 1:54:41 PM,7 Dow Jones Stocks to Buy With Fortress-Like Balance Sheets,InvestorPlace,/news/stocks/7-dow-jones-stocks-to-buy-with-fortress-like-balance-sheets-1029223935,positive,0.9113541841506958
1094,5/21/2020 3:00:43 PM,The Rewards Outweigh the Risks for Moderna Stock,InvestorPlace,/news/stocks/the-rewards-outweigh-the-risks-for-moderna-stock-1029224348,negative,0.8328325152397156
1095,5/27/2020 11:48:12 AM,Why Did Lincoln Park Capital Just Buy a Million Shares of iBio Stock?,InvestorPlace,/news/stocks/why-lincoln-park-capital-bought-million-shares-ibio-stock-1029237335,positive,0.9287681579589844
1096,5/29/2020 11:34:37 AM,European advisory group backs J&J Ebola vaccine regimen,Seeking Alpha,https://seekingalpha.com/news/3578594-european-advisory-group-backs-j-and-j-ebola-vaccine-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8582988381385803
1097,5/29/2020 3:33:21 PM,J&J Gets Positive CHMP Opinion For Investigational Preventive Ebola Vaccine Regimen ,RTTNews,/news/stocks/j-j-gets-positive-chmp-opinion-for-investigational-preventive-ebola-vaccine-regimen-1029263538,negative,0.9437631964683533
1098,5/29/2020 4:34:10 PM,"'99%' chance Covid-19 vaccine will be effective, Sinovac claims",Seeking Alpha,https://seekingalpha.com/news/3578690-99-percent-chance-covidminus-19-vaccine-will-be-effective-sinovac-claims?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9143039584159851
1099,6/2/2020 11:35:10 AM,Sanofi's isatuximab OK'd in Europe for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3579477-sanofis-isatuximab-okd-in-europe-for-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5782665610313416
1100,6/2/2020 1:16:22 PM,The Best 5 Stocks to Buy on the Next Dip,InvestorPlace,/news/stocks/5-stocks-to-buy-next-dip-1029273033,positive,0.8994381427764893
1101,6/4/2020 6:37:03 AM,"List Of 'Operation Warp Speed' Finalists, SAVA To Reassess AD Study Results; KZR Jumps  On MISSION ",RTTNews,/news/stocks/list-of-operation-warp-speed-finalists-sava-to-reassess-ad-study-results-kzr-jumps-on-mission-1029279089,positive,0.5100464224815369
1102,6/5/2020 1:52:42 PM,China in thick of race for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3580791-china-in-thick-of-race-for-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.748111367225647
1103,6/8/2020 4:08:25 PM,Inovio Slumps as Its Setbacks Pile Up,InvestorPlace,/news/stocks/inovio-slumps-as-its-setbacks-pile-up-1029289728,neutral,0.9717625379562378
1104,6/8/2020 4:14:39 PM,The Odds For Long Shot Inovio Stock Just Got Longer,InvestorPlace,/news/stocks/the-odds-for-long-shot-ino-stock-just-got-longer-1029290046,positive,0.5252552628517151
1105,6/9/2020 3:10:56 PM,Aggressive Investors Can Do Much Better Than Merck Stock,InvestorPlace,/news/stocks/aggressive-investors-better-mrk-stock-1029293865,negative,0.7292519211769104
1106,6/9/2020 3:49:54 PM,7 Pharmaceutical Stocks to Buy for Post-Pandemic Gains,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-buy-coronavirus-gains-1029293862,positive,0.8380296230316162
1107,6/10/2020 1:54:15 PM,Johnson & Johnson accelerates start of COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3581918-johnson-johnson-accelerates-start-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5126861929893494
1108,6/10/2020 3:19:36 PM,Three key studies of COVID-19 vaccines to launch in summer,Seeking Alpha,https://seekingalpha.com/news/3581971-three-key-studies-of-covidminus-19-vaccines-to-launch-in-summer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8121580481529236
1109,6/10/2020 4:04:48 PM,Johnson & Johnson To Begin First-in-human Trial Of COVID-19 Vaccine Candidate In July ,RTTNews,/news/stocks/johnson-johnson-to-begin-first-in-human-trial-of-covid-19-vaccine-candidate-in-july-1029297243,positive,0.6364567875862122
1110,6/11/2020 3:22:25 PM,Momentum mover candidates on a down market day,Seeking Alpha,https://seekingalpha.com/news/3582348-momentum-mover-candidates-on-down-market-day?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.571069598197937
1111,6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the COVID-19 recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covidminus-19-recession?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9437114596366882
1112,6/14/2020 1:10:57 AM,Barron's touts eight dividend stocks for the covid recession,Seeking Alpha,https://seekingalpha.com/news/3582836-barrons-touts-eight-dividend-stocks-for-covid-recession?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9435603022575378
1113,6/15/2020 9:49:26 AM,Janssen: Long-term Trial Shows TREMFYA As Efficacious Therapy In Plaque Psoriasis ,RTTNews,/news/stocks/janssen-long-term-trial-shows-tremfya-as-efficacious-therapy-in-plaque-psoriasis-1029307015,negative,0.8997483253479004
1114,6/15/2020 1:37:36 PM,Band-Aid To Launch Black And Brown Bandages For Diverse Skin ,RTTNews,/news/stocks/band-aid-to-launch-black-and-brown-bandages-for-diverse-skin-1029307775,positive,0.7087944746017456
1115,6/15/2020 4:56:24 PM,5 Cheap Growth Stocks With Attractive Dividend Yields,InvestorPlace,/news/stocks/5-cheap-growth-stocks-attractive-dividend-yields-1029309729,negative,0.5384666919708252
1116,6/16/2020 5:49:43 PM,Pfizer and Merck's diabetes med Steglatro shows mixed results in cardiovascular outcomes study,Seeking Alpha,https://seekingalpha.com/news/3583523-pfizer-and-mercks-diabetes-med-steglatro-shows-mixed-results-in-cardiovascular-outcomes-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9532431364059448
1117,6/18/2020 10:16:36 AM,"3 Pros, 3 Cons For Buying iBio Stock Right Now",InvestorPlace,/news/stocks/3-pros-cons-of-buying-ibio-stock-right-now-1029321599,positive,0.9115537405014038
1118,6/18/2020 2:08:10 PM,Stay Safe on the Sidelines With Inovio Stock,InvestorPlace,/news/stocks/pandemic-fading-hold-off-ino-stock-1029322421,positive,0.827573835849762
1119,6/18/2020 4:05:39 PM,10 Robotics Stocks on the Technological Cutting Edge,InvestorPlace,/news/stocks/10-robotics-stocks-cutting-edge-1029322986,positive,0.47101688385009766
1120,6/18/2020 6:06:48 PM,3 Reasons Clorox Stock Is a Buy Right Now,InvestorPlace,/news/stocks/3-reasons-clorox-clx-stock-is-a-buy-right-now-1029323448,positive,0.8860664963722229
1121,6/18/2020 6:07:14 PM,3 Dow Jones Companies to Buy as Markets Get Volatile,InvestorPlace,/news/stocks/3-dow-jones-companies-to-buy-as-markets-get-volatile-1029323447,positive,0.9084373712539673
1122,6/22/2020 12:00:59 PM,Ride Out the Choppy Seas and Buy Royal Caribbean,InvestorPlace,/news/stocks/ride-out-the-choppy-seas-and-buy-royal-caribbean-rcl-stock-1029329112,positive,0.9230867624282837
1123,6/23/2020 9:15:26 PM,J&J Damages Cut By More Than Half In Talcum Powder Cancer Suit ,RTTNews,/news/stocks/j-j-damages-cut-by-more-than-half-in-talcum-powder-cancer-suit-1029335440,neutral,0.7916200757026672
1124,6/26/2020 2:16:18 AM,10 Recession-Proof Stocks to Weather the Storm,InvestorPlace,/news/stocks/10-stocks-to-buy-to-weather-the-recession-1029173355,negative,0.7430034279823303
1125,6/26/2020 1:59:03 PM,Alibaba Stock Won‚Äôt Be Left Behind Smaller Rivals Forever,InvestorPlace,/news/stocks/alibaba-stock-wont-be-left-behind-smaller-rivals-forever-1029346118,positive,0.9094232320785522
1126,6/30/2020 3:56:56 AM,9 All-Around Dividend Stocks to Tough It Out,InvestorPlace,/news/stocks/best-dividend-stocks-to-buy-for-every-investor-1028788633,positive,0.8424763083457947
1127,6/30/2020 2:47:33 PM,3 Reasons to Buy the Ad Boycott Dip in FB Stock,InvestorPlace,/news/stocks/3-reasons-buy-ad-boycott-dip-fb-stock-1029355526,positive,0.8457431197166443
1128,7/2/2020 2:04:27 PM,Buy Opko Stock For Two Ways to Play the Ongoing Pandemic,InvestorPlace,/news/stocks/buy-opko-stock-for-two-ways-to-play-the-ongoing-pandemic-1029363124,positive,0.8705251216888428
1129,7/2/2020 5:02:06 PM,"Keep an Eye on Royalty Pharma Stock, 2020‚Äôs Biggest IPO",InvestorPlace,/news/stocks/keep-eye-rprx-stock-2020-1029363917,positive,0.9034902453422546
1130,7/6/2020 10:40:08 AM,Royalty Pharma Stock Is Likely to Reach New Highs in the Coming Years,InvestorPlace,/news/stocks/rprx-stock-is-likely-to-reach-new-highs-coming-years-1029368649,negative,0.9159573912620544
1131,7/6/2020 1:07:37 PM,Emergent Signs 5-yr Manufacturing Deal For Johnson & Johnson's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/emergent-signs-5-yr-manufacturing-deal-for-johnson-johnson-s-covid-19-vaccine-candidate-1029368443,negative,0.9271517992019653
1132,7/6/2020 5:56:43 PM,7 Healthcare ETFs Which Should Continue Growing Into 2021,InvestorPlace,/news/stocks/7-healthcare-etfs-growing-into-2021-1029369965,negative,0.5999964475631714
1133,7/6/2020 6:43:12 PM,Moderna Stock Has a Bright Future After the Coronavirus,InvestorPlace,/news/stocks/moderna-mrna-stock-coronavirus-vaccine-drug-discovery-1029370223,negative,0.7788195610046387
1134,7/6/2020 7:05:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new senior notes,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-senior-notes-1029369827,positive,0.8179425597190857
1135,7/10/2020 5:10:55 PM,INO Stock Could Receive Operation Warp Speed Funding Soon,InvestorPlace,/news/stocks/ino-stock-could-receive-operation-warp-speed-funding-soon-1029384591,negative,0.6464561820030212
1136,7/10/2020 7:19:51 PM,A Safer Way to Play IBio Stock Could Spread Like the Coronavirus¬†,InvestorPlace,/news/stocks/a-safer-way-to-play-ibio-stock-could-spread-like-the-coronavirus-1029384769,positive,0.8445013165473938
1137,7/14/2020 1:13:14 PM,"With Earnings in Sight, Johnson & Johnson Stock Looks Perfectly Healthy",InvestorPlace,/news/stocks/with-earnings-in-sight-jnj-stock-looks-perfectly-healthy-1029392989,negative,0.706118643283844
1138,7/14/2020 1:19:36 PM,Quick Income from a Put Write on Johnson & Johnson,InvestorPlace,/news/stocks/quick-income-from-a-put-write-on-johnson-johnson-1029392988,positive,0.7121952772140503
1139,7/15/2020 3:01:26 PM,What Wall Street expects from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-quarter-earnings-preview-q2-1029397198,positive,0.9296786785125732
1140,7/16/2020 12:44:01 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1029400773,negative,0.6643639206886292
1141,7/16/2020 12:59:11 PM,Johnson & Johnson Boosts FY20 Outlook - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-boosts-fy20-outlook-quick-facts-1029400798,negative,0.9036993384361267
1142,7/16/2020 6:28:20 PM,JNJ Stock: 4 Things to Know About Johnson & Johnson Q2 Earnings,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-q2-earnings-1029403303,positive,0.9325655698776245
1143,7/17/2020 1:55:45 PM,3 Best Long-Term Stocks to Set and Forget,InvestorPlace,/news/stocks/the-best-long-term-stocks-feature-growth-and-lower-volatility-1029405444,positive,0.8802533149719238
1144,7/21/2020 5:25:42 PM,4 Top Blue-Chip Stocks for Peace of Mind,InvestorPlace,/news/stocks/4-top-blue-chip-stocks-for-peace-of-mind-1029416248,positive,0.8331030011177063
1145,7/22/2020 12:27:19 PM,The Curtain Is Coming Down on Inovio Pharmaceuticals‚Äô Vaccine Candidate,InvestorPlace,/news/stocks/curtain-coming-down-on-ino-stock-1029420801,positive,0.5067680478096008
1146,7/22/2020 1:54:28 PM,Sell Overpriced Novavax Stock While You Still Can,InvestorPlace,/news/stocks/why-you-should-sell-nvax-stock-while-you-still-can-1029420794,positive,0.9357196688652039
1147,7/23/2020 10:31:35 AM,History and Competition Suggest Caution Toward Inovio Stock,InvestorPlace,/news/stocks/history-competition-caution-ino-stock-1029424603,positive,0.8366189002990723
1148,7/27/2020 1:25:18 PM,iBio Stock Has Tripled in a Few Weeks. Here‚Äôs What‚Äôs Next,InvestorPlace,/news/stocks/ibio-stock-tripled-now-what-1029434265,positive,0.9211769700050354
1149,7/28/2020 2:07:24 PM,Sintx Joins List of Highly Speculative Covid-19 Plays,InvestorPlace,/news/stocks/sintx-technologies-stock-speculative-covid-19-play-1029439555,positive,0.8739502429962158
1150,7/29/2020 3:53:42 PM,5 Dental Stocks to Buy For Big Smiles As Coronavirus Fears Ease,InvestorPlace,/news/stocks/5-dental-stocks-to-buy-for-big-smiles-as-coronavirus-fears-ease-1029446842,positive,0.6891562342643738
1151,7/30/2020 11:26:46 AM,Buy Exxon Stock at $44 Before It Recovers,InvestorPlace,/news/stocks/xom-stock-exxon-mobil-recover-soon-1029451792,positive,0.9399980902671814
1152,7/30/2020 11:58:29 AM,J&J's Single Dose COVID-19 Vaccine Candidate Shows Robust Protection In Pre-clinical Studies ,RTTNews,/news/stocks/j-j-s-single-dose-covid-19-vaccine-candidate-shows-robust-protection-in-pre-clinical-studies-1029449823,negative,0.9487558603286743
1153,7/30/2020 12:14:19 PM,A More Sustainable Business Model Doesn‚Äôt Make iBio Stock Less Risky,InvestorPlace,/news/stocks/sustainable-business-model-ibio-stock-risky-1029451784,positive,0.5610909461975098
1154,8/3/2020 2:54:47 PM,5 Healthcare Stocks for Good (Portfolio) Health,InvestorPlace,/news/stocks/5-healthcare-stocks-for-good-portfolio-health-1029462755,positive,0.8538077473640442
1155,8/4/2020 3:55:00 PM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029467707,positive,0.6268328428268433
1156,8/4/2020 5:08:35 PM,Don‚Äôt Count on Inovio To Deliver a Covid-19 Vaccine,InvestorPlace,/news/stocks/dont-count-on-inovio-pharmaceuticals-ino-stock-covid-19-vaccine-1029478836,positive,0.8281463384628296
1157,8/5/2020 4:21:00 AM,Emergent BioSolutions Inc. -- Moody's assigns Ba2 CFR to Emergent BioSolutions,Moodys,/news/bonds/emergent-biosolutions-inc-moody-s-assigns-ba2-cfr-to-emergent-biosolutions-1029469394,positive,0.6268328428268433
1158,8/5/2020 2:48:51 PM,Janssen Pharma Enters Deal With U.S. Government On 100 Mln Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/janssen-pharma-enters-deal-with-u-s-government-on-100-mln-doses-of-covid-19-vaccine-1029472652,negative,0.8292239904403687
1159,8/6/2020 12:10:24 PM,"As a Vaccine Looks More Likely, Moderna Stock Still Is a Good Bet",InvestorPlace,/news/stocks/vaccine-looks-likely-mrna-stock-still-is-a-good-bet-1029478835,negative,0.6246477365493774
1160,8/6/2020 1:38:49 PM,The Best Dividend Stocks to Buy in 9 Sectors,InvestorPlace,/news/stocks/the-best-dividend-stocks-to-buy-in-9-sectors-1029478830,positive,0.7222043871879578
1161,8/6/2020 5:51:20 PM,5 Biotech Stocks That Offer Long-Term Growth and Value,InvestorPlace,/news/stocks/5-biotech-stocks-that-offer-long-term-growth-and-value-1029479695,positive,0.7105634212493896
1162,8/7/2020 9:09:38 PM,The Top 7 Blue-Chip Stocks for the Rest of 2020,InvestorPlace,/news/stocks/the-top-7-blue-chip-stocks-for-the-rest-of-2020-1029497294,positive,0.9131118655204773
1163,8/12/2020 5:59:57 AM,U.S. Reaches Deal With Moderna For 100 Million Doses Of COVID-19 Vaccine ,RTTNews,/news/stocks/u-s-reaches-deal-with-moderna-for-100-million-doses-of-covid-19-vaccine-1029494061,negative,0.8192676901817322
1164,8/12/2020 3:25:00 PM,The 10 Top Stocks to Buy and Hold Into 2021,InvestorPlace,/news/stocks/the-10-top-stocks-to-buy-and-hold-into-2021-1029497764,positive,0.9069892764091492
1165,8/12/2020 7:30:33 PM,7 of the Best Index Funds to Buy on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-index-funds-to-buy-on-the-market-today-1029498343,positive,0.7787944674491882
1166,8/14/2020 4:38:20 PM,10 Nasdaq Stocks to Buy and Hold for the Long Haul,InvestorPlace,/news/stocks/10-nasdaq-stocks-to-buy-and-hold-for-the-long-haul-1029505887,positive,0.8678792715072632
1167,8/19/2020 12:46:56 PM,Johnson & Johnson To Acquire Momenta Pharmaceuticals - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-momenta-pharmaceuticals-quick-facts-1029516037,positive,0.9386734962463379
1168,8/19/2020 2:39:01 PM,Momenta Pharmaceuticals spikes 69% after agreeing to $6.5 billion Johnson & Johnson takeover,Business Insider,https://www.businessinsider.com/momenta-pharmaceuticals-stock-price-johnson-johnson-acquisition-deal-autoimmune-drugs-2020-8,negative,0.9197976589202881
1169,8/19/2020 5:26:00 PM,Johnson & Johnson -- Moody's affirms J&J's Aaa rating; negative outlook,Moodys,/news/bonds/johnson-johnson-moody-s-affirms-j-j-s-aaa-rating-negative-outlook-1029517573,neutral,0.9038949608802795
1170,8/19/2020 5:29:31 PM,Buying iBio As a Vaccine Winner Is a Waste of Money,InvestorPlace,/news/stocks/ibio-stock-is-a-waste-of-money-as-covid-19-vaccine-winner-1029518046,neutral,0.5068504214286804
1171,8/19/2020 6:46:01 PM,Momenta Pharmaceuticals News: MNTA Stock Rockets 69% on JNJ Deal,InvestorPlace,/news/stocks/momenta-pharmaceuticals-news-sends-mnta-stock-soaring-1029518297,negative,0.7791556715965271
1172,8/20/2020 8:43:27 AM,"JNJ Acquires MNTA, FDA Strikes Down BMRN's Gene Therapy, BLRX's GENESIS On Track, TPTX On Watch ",RTTNews,/news/stocks/jnj-acquires-mnta-fda-strikes-down-bmrn-s-gene-therapy-blrx-s-genesis-on-track-tptx-on-watch-1029519157,neutral,0.8946521282196045
1173,8/20/2020 6:17:00 PM,Johnson & Johnson -- Moody's assigns Aaa to J&J's sr. notes; outlook negative,Moodys,/news/bonds/johnson-johnson-moody-s-assigns-aaa-to-j-j-s-sr-notes-outlook-negative-1029521758,negative,0.5004869103431702
1174,8/21/2020 5:34:04 AM,Amgen : FDA Approves New KYPROLIS For Multiple Myeloma ,RTTNews,/news/stocks/amgen-fda-approves-new-kyprolis-for-multiple-myeloma-1029522678,negative,0.8566513061523438
1175,8/21/2020 10:31:25 AM,There Are Still Too Many Risks In iBio Stock,InvestorPlace,/news/stocks/still-too-many-risks-ibio-stock-1029523762,neutral,0.5564561486244202
1176,8/21/2020 3:31:12 PM,Eli Lilly (Still) Looks Like the Best Buy in Large-Cap Pharma,InvestorPlace,/news/stocks/lly-stock-still-looks-like-best-buy-large-cap-pharma-1029524567,negative,0.805871844291687
1177,8/21/2020 4:04:40 PM,7 Safe Stocks to Buy That Can Shrug Off the Growing Volatility,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-that-can-shrug-off-the-growing-volatility-1029524563,positive,0.6372417211532593
1178,8/24/2020 11:19:04 PM,20 Stable Stocks to Buy If You‚Äôre Still Betting on America to Thrive,InvestorPlace,/news/stocks/20-stocks-to-buy-if-youre-betting-on-america-1029203418,positive,0.8488996028900146
1179,8/25/2020 7:05:31 PM,"Inovio Stock Is a Sideshow, Not a Serious Investment",InvestorPlace,/news/stocks/inovio-stock-is-a-sideshow-not-a-serious-investment-1029533338,positive,0.9258228540420532
1180,8/26/2020 11:16:15 AM,Buyout Excitement Is Already Priced Into Momenta Pharmaceuticals,InvestorPlace,/news/stocks/buyout-excitement-is-already-priced-into-momenta-pharmaceuticals-stock-1029535445,positive,0.7021470069885254
1181,8/26/2020 12:04:28 PM,3 Key Questions to Ask Before Buying Novavax,InvestorPlace,/news/stocks/3-key-questions-before-buying-nvax-stock-1029535441,positive,0.9474856853485107
1182,8/26/2020 7:42:20 PM,CureVac Is a Bet on a Safe and Effective Vaccine,InvestorPlace,/news/stocks/curevac-stock-bet-on-covid-19-vaccine-could-produce-68-percent-roi-1029537603,positive,0.7192503809928894
1183,8/26/2020 9:30:05 PM,30 Dividend Stocks to Buy Now for 20 Years of Income Growth,InvestorPlace,/news/stocks/30-dividend-stocks-to-buy-for-20-years-of-income-growth-1029537832,positive,0.8688682317733765
1184,8/27/2020 11:35:20 AM,"After a 30% Surge, Is It Time to Buy iBio Stock Again?¬†",InvestorPlace,/news/stocks/after-a-30-surge-is-it-time-to-buy-ibio-stock-again-1029539794,positive,0.85486900806427
1185,8/28/2020 2:10:18 PM,7 Companies That Should Split Their Stocks,InvestorPlace,/news/stocks/7-companies-should-have-stock-splits-following-apple-tesla-1029544430,positive,0.9034322500228882
1186,8/31/2020 6:18:04 PM,Why Johnson & Johnson Remains a Risky Bet,InvestorPlace,/news/stocks/johnson-johnson-jnj-stock-remains-a-risky-bet-despite-its-financial-condition-1029549615,positive,0.8753111362457275
1187,8/31/2020 11:44:00 PM,Jabil Inc. -- Moody's affirms Jabil's Baa3 senior unsecured rating; outlook stable,Moodys,/news/bonds/jabil-inc-moody-s-affirms-jabil-s-baa3-senior-unsecured-rating-outlook-stable-1029549821,negative,0.7816991209983826
1188,9/2/2020 11:30:52 AM,Bet on Wild Swings in the Market With the SPXL ETF,InvestorPlace,/news/stocks/bet-on-wild-swings-in-the-market-with-spxl-stock-1029555951,positive,0.8576703667640686
1189,9/2/2020 2:21:45 PM,4 Pharmaceutical Stocks With Deep Pipelines,InvestorPlace,/news/stocks/4-pharmaceutical-stocks-deep-pipelines-coronavirus-1029557234,positive,0.6847983002662659
1190,9/2/2020 2:36:56 PM,"At This Point, iBioPharma Is a Flash in the Pandemic",InvestorPlace,/news/stocks/at-this-point-ibio-stock-is-a-flash-in-the-pandemic-1029557232,positive,0.5494207739830017
1191,9/3/2020 12:54:31 PM,10 Blue-Chip Stocks Ideal for Any Investor,InvestorPlace,/news/stocks/10-blue-chip-stocks-ideal-for-any-investor-1029560529,positive,0.8295894861221313
1192,9/4/2020 11:10:20 PM,COVID-19 vaccine developers prepare joint pledge on safety - WSJ,Seeking Alpha,https://seekingalpha.com/news/3611895-covidminus-19-vaccine-developers-prepare-joint-pledge-on-safety-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5112403631210327
1193,9/7/2020 6:19:22 PM,Trump considers 'decoupling' U.S. from China,Seeking Alpha,https://seekingalpha.com/news/3611949-trump-considers-decoupling-u-s-from-china?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.852777361869812
1194,9/8/2020 3:33:54 AM,EC OKs expanded use of J&J's Imbruvica + Rituximab for leukemia,Seeking Alpha,https://seekingalpha.com/news/3611954-ec-oks-expanded-use-of-j-and-js-imbruvica-rituximab-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8966847062110901
1195,9/9/2020 2:36:39 PM,The Top 7 Healthcare Stocks You Should Be Watching,InvestorPlace,/news/stocks/the-top-7-healthcare-stocks-you-should-be-watching-1029355520,positive,0.9079742431640625
1196,9/10/2020 11:42:10 AM,"As Its Vaccine Dreams Fade, Inovio Stock Will Keep Retreating",InvestorPlace,/news/stocks/ino-stock-retreating-vaccine-1029577589,positive,0.8797113299369812
1197,9/10/2020 1:15:35 PM,"Carnival Is Not Going Bankrupt, But Only Risk-Tolerant Investors Should Buy CCL Stock",InvestorPlace,/news/stocks/go-long-on-ccl-stock-if-you-can-stomach-a-bit-of-risk-1029578640,positive,0.9305046200752258
1198,9/14/2020 5:13:03 PM,7 Coronavirus Vaccine Stocks to Watch as Approval Nears,InvestorPlace,/news/stocks/7-coronavirus-vaccine-stocks-watch-approval-hopefully-nears-1029587809,positive,0.8405252695083618
1199,9/17/2020 2:51:41 PM,6 Dividend Stocks To Buy For Stable Yield And Growth Potential,InvestorPlace,/news/stocks/6-dividend-stocks-to-buy-for-stable-yield-and-growth-potential-1029599920,positive,0.6477497220039368
1200,9/18/2020 9:31:13 AM,20/20 GeneSystems Stock: Leveraging AI for More Accurate Cancer Screening,InvestorPlace,/news/stocks/20-20-genesystems-stock-leveraging-ai-for-more-accurate-cancer-screening-1029601945,positive,0.7066363096237183
1201,9/18/2020 1:51:10 PM,Why Novartis‚Äô Absence From the Covid-19 Vaccine Race Is a Benefit,InvestorPlace,/news/stocks/novartis-stock-absence-covid-19-vaccine-race-benefit-1029602941,positive,0.849791944026947
1202,9/18/2020 3:04:05 PM,6 Long-Term Stocks to See You Through the Bad Times,InvestorPlace,/news/stocks/6-long-term-stocks-to-see-you-through-the-bad-times-1029603332,positive,0.8930366635322571
1203,9/18/2020 3:24:21 PM,"Europe Signs Deal With Sanofi, GSK To Secure Up To 300 Mln COVID-19 Vaccine Doses ",RTTNews,/news/stocks/europe-signs-deal-with-sanofi-gsk-to-secure-up-to-300-mln-covid-19-vaccine-doses-1029602745,negative,0.9281327128410339
1204,9/21/2020 6:21:15 PM,Healthcare stocks plunge amid broad market rout as Ruth Bader Ginsburg's death creates uncertainty around Obamacare,Business Insider,https://www.businessinsider.com/healthcare-stock-prices-ruth-bader-ginsburg-death-obamacare-uncertainty-insurance-2020-9,neutral,0.9551382660865784
1205,9/21/2020 6:28:06 PM,Compass Pathways IPO: 5 Things for Potential CMPS Investors to Know,InvestorPlace,/news/stocks/compass-pathways-ipo-5-things-for-potential-cmps-investors-to-know-1029608581,positive,0.9290791153907776
1206,9/22/2020 5:19:01 PM,"Keep An Eye On Novavax, But Keep Your Money In Your Pocket",InvestorPlace,/news/stocks/keep-an-eye-on-novavax-nvax-stock-but-keep-your-money-in-your-pocket-1029612589,positive,0.9306748509407043
1207,9/23/2020 12:05:31 PM,There Simply Isn‚Äôt Enough Good News for iBio,InvestorPlace,/news/stocks/simply-not-enough-good-news-ibio-stock-1029615057,positive,0.6294528245925903
1208,9/23/2020 1:00:21 PM,JNJ Initiates Pivotal Global Phase 3 Clinical Trial Of Janssen's COVID-19 Vaccine Candidate ,RTTNews,/news/stocks/jnj-initiates-pivotal-global-phase-3-clinical-trial-of-janssen-s-covid-19-vaccine-candidate-1029614548,negative,0.6510124802589417
1209,9/23/2020 1:06:52 PM,Johnson & Johnson News: JNJ Stock Pops on Late-Stage Vaccine Trials,InvestorPlace,/news/stocks/johnson-johnson-news-jnj-stock-pops-on-late-stage-vaccine-trials-1029615936,negative,0.6677065491676331
1210,9/23/2020 5:08:22 PM,Aggressive Investors Have No Excuse for Not Owning Moderna,InvestorPlace,/news/stocks/aggressive-investors-have-no-excuse-for-not-owning-moderna-mrna-stock-at-this-stage-of-the-game-cseo-1029616770,positive,0.9145837426185608
1211,9/23/2020 8:57:04 PM,"4 Top Stock Trades for Thursday: NKE, CHWY, JNJ, WORK",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-nke-chwy-jnj-work-1029617227,positive,0.9376518726348877
1212,9/24/2020 7:21:39 AM,"JNJ Begins Phase 3 COVID-19 Vaccine Trial, Another Headstone In Alzheimer's Graveyard, PFE On Watch ",RTTNews,/news/stocks/jnj-begins-phase-3-covid-19-vaccine-trial-another-headstone-in-alzheimer-s-graveyard-pfe-on-watch-1029617682,positive,0.8442927002906799
1213,9/24/2020 10:10:57 AM,7 of the Best Penny Stocks to Buy Now,InvestorPlace,/news/stocks/7-of-the-best-penny-stocks-to-buy-now-1029330493,positive,0.8300976157188416
1214,9/25/2020 9:16:35 AM,Patient Investors Will Stick With Very Cheap Bristol-Myers Squibb Stock,InvestorPlace,/news/stocks/bmy-stock-worth-46-percent-more-based-on-history-and-comps-1029623231,positive,0.8472944498062134
1215,9/25/2020 5:00:08 PM,NVAX Stock: Novavax Rallies After Entering Phase 3 Vaccine Trials,InvestorPlace,/news/stocks/nvax-stock-novavax-rallies-after-entering-phase-3-vaccine-trials-1029623831,negative,0.9303554892539978
1216,9/28/2020 12:40:39 PM,Inovio Stock Still Has Real Promise Despite Faltering in Vaccine Race,InvestorPlace,/news/stocks/ino-stock-promising-despite-vaccine-race-1029627233,negative,0.9424540400505066
1217,9/29/2020 2:48:42 PM,Deep Diving the Complex Narrative Behind Novavax,InvestorPlace,/news/stocks/deep-diving-complex-narrative-nvax-stock-novavax-cseo-1029632023,positive,0.9314523935317993
1218,9/29/2020 6:52:00 PM,Jabil Inc. -- Moody's announces completion of a periodic review of ratings of Jabil Inc.,Moodys,/news/bonds/jabil-inc-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-jabil-inc-1029632178,positive,0.8464629650115967
1219,9/30/2020 12:55:36 PM,The 7 Best 401k Investments to Enrich Your Retirement,InvestorPlace,/news/stocks/the-7-best-401k-investments-to-enrich-your-retirement-1029635832,positive,0.8017431497573853
1220,10/1/2020 5:00:25 AM,Novavax Gains With Start of Phase 3 Vaccine Trial,InvestorPlace,/news/stocks/nvax-stock-gains-with-phase-3-trial-1029641338,negative,0.948647141456604
1221,10/2/2020 12:09:03 PM,"If You‚Äôre Not a Speculator, You Should Avoid iBio",InvestorPlace,/news/stocks/if-youre-not-a-speculator-you-should-avoid-ibio-1029643897,positive,0.8941292762756348
1222,10/2/2020 4:12:40 PM,The Real Value in Novavax Goes Beyond the Coronavirus,InvestorPlace,/news/stocks/influenza-vaccine-gives-nvax-stock-value-cseo-1029645075,positive,0.9021472334861755
1223,10/2/2020 5:01:29 PM,iBio Is a Pure Spec Play That Remains a Day Trader‚Äôs Delight,InvestorPlace,/news/stocks/ibio-stock-is-a-pure-spec-play-that-remains-a-day-traders-delight-1029645068,positive,0.8930780291557312
1224,10/5/2020 1:00:54 PM,7 Sizzling Hot Stocks to Buy Now Amid Even Hotter Politics,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-amid-even-hotter-politics-1029648698,positive,0.8602467179298401
1225,10/5/2020 2:24:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648147,positive,0.7283362150192261
1226,10/5/2020 2:25:32 PM,This Is Why I‚Äôd Still Avoid IBio for Now,InvestorPlace,/news/stocks/this-is-why-id-still-avoid-vaccine-stock-ibio-for-now-cseo-1029649209,positive,0.9063957333564758
1227,10/5/2020 2:41:00 PM,Smith & Nephew plc -- Moody's assigns Baa2 issuer rating to Smith & Nephew plc; outlook stable,Moodys,/news/bonds/smith-nephew-plc-moody-s-assigns-baa2-issuer-rating-to-smith-nephew-plc-outlook-stable-1029648241,positive,0.7283362150192261
1228,10/5/2020 5:43:41 PM,Moderna Is Ready To Rally After 2-Month Market Correction,InvestorPlace,/news/stocks/moderna-mrna-stock-is-ready-to-rally-after-2-month-market-correction-1029649495,negative,0.9448305368423462
1229,10/5/2020 6:28:38 PM,Investors Should Proceed With Caution in Sorrento Stock,InvestorPlace,/news/stocks/investors-should-proceed-with-caution-in-sorrento-stock-1029662225,positive,0.8986226916313171
1230,10/6/2020 2:12:30 PM,FDA Ad Com this month to clarify COVID-19 vaccine authorization requirements,Seeking Alpha,https://seekingalpha.com/news/3620151-fda-ad-com-this-month-to-clarify-covidminus-19-vaccine-authorization-requirements?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9083845615386963
1231,10/6/2020 2:15:27 PM,J&J's Biosense Webster gets FDA nod for ablation catheter for atrial fibrillation,Seeking Alpha,https://seekingalpha.com/news/3620137-j-and-js-biosense-webster-gets-fda-nod-for-ablation-catheter-for-atrial-fibrillation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8641644716262817
1232,10/6/2020 2:44:51 PM,The 7 Best New Stocks From 2020 to Buy Now,InvestorPlace,/news/stocks/the-7-best-new-stocks-from-2020-to-buy-now-1029653691,positive,0.8444294929504395
1233,10/6/2020 3:22:31 PM,"Psychedelics the ""next big thing"" in treating mental health disorders",Seeking Alpha,https://seekingalpha.com/news/3619871-psychedelics-next-big-thing-in-treating-mental-health-disorders?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8302556276321411
1234,10/6/2020 6:12:37 PM,The Deep Price Pullback Is Your Signal to Buy Novavax,InvestorPlace,/news/stocks/the-deep-price-pullback-is-your-signal-to-buy-nvax-stock-1029654462,positive,0.8166105151176453
1235,10/6/2020 6:36:01 PM,Get Out of IBIO Stock Before It‚Äôs Too Late,InvestorPlace,/news/stocks/get-out-of-ibio-stock-before-its-too-late-cseo-1029658676,positive,0.905656099319458
1236,10/6/2020 9:13:19 PM,7 High-Growth Value Stocks for a Post-Pandemic Future,InvestorPlace,/news/stocks/7-value-stocks-to-buy-post-pandemic-future-1029654705,positive,0.7316826581954956
1237,10/7/2020 9:31:16 AM,5 Blue-chip Stocks to Buy on a Discount to Fortify Portfolios,InvestorPlace,/news/stocks/wmt-pfe-jpm-ko-jnj-5-blue-chip-stocks-to-buy-1029656064,positive,0.8645325899124146
1238,10/7/2020 12:28:15 PM,Inovio Pharmaceuticals Does Not Need Any More Misfortune,InvestorPlace,/news/stocks/ino-stock-needs-change-fortunes-1029657681,positive,0.9155678749084473
1239,10/7/2020 2:11:17 PM,Does Sorrento Therapeutics Meet the ‚ÄòSAD‚Äô Criteria for Vaccines?,InvestorPlace,/news/stocks/does-srne-stock-meet-sad-criteria-for-covid-vaccines-1029657676,positive,0.8289647698402405
1240,10/7/2020 4:27:48 PM,7 Biotech Stocks To Buy For Profit From The Vaccine Crunch,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-for-profit-from-the-vaccine-crunch-1029658673,positive,0.8608307242393494
1241,10/8/2020 11:28:38 AM,Spinal Elements to issue 7.7M shares in IPO at $13-$15 per share,Seeking Alpha,https://seekingalpha.com/news/3620718-spinal-elements-to-issue-7_7m-shares-in-ipo-13-15-per-share?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9327147603034973
1242,10/8/2020 11:55:08 AM,The Risk-to-Reward Proposition for Sorrento Has Gone Bad,InvestorPlace,/news/stocks/the-risk-to-reward-proposition-for-sorrento-therapeutics-srne-stock-has-gone-negative-1029661288,negative,0.5604221224784851
1243,10/8/2020 12:04:17 PM,J&J to supply up to 400M doses of COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3620741-j-and-j-to-supply-up-to-400m-doses-of-covidminus-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5544466972351074
1244,10/8/2020 2:10:04 PM,Johnson & Johnson: European Commission Approves Agreement To Supply COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-european-commission-approves-agreement-to-supply-covid-19-vaccine-1029661273,negative,0.9138827323913574
1245,10/9/2020 10:45:57 AM,7 Index Funds to Hold Through Thick and Thin,InvestorPlace,/news/stocks/7-index-funds-to-hold-through-thick-and-thin-1029665545,positive,0.43010562658309937
1246,10/9/2020 12:13:20 PM,7 Stocks You Can Buy to Help Save the Planet,InvestorPlace,/news/stocks/esg-investing-7-stocks-buy-help-save-the-planet-environment-1029621059,positive,0.8986085653305054
1247,10/9/2020 7:00:01 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3621193-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1248,10/12/2020 8:38:11 AM,Janssen reports long-term results from late-stage IM-UNITI study in inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/3621286-janssen-reports-long-term-results-from-late-stage-im-uniti-study-in-inflammatory-bowel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5382954478263855
1249,10/12/2020 10:48:20 AM,Head of Operation Warp Speed sees emergency authorization vaccine request around Thanksgiving,Seeking Alpha,https://seekingalpha.com/news/3621297-head-of-operation-warp-speed-sees-emergency-authorization-vaccine-request-around-thanksgiving?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8216387629508972
1250,10/12/2020 3:01:20 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1029669986,positive,0.9130299687385559
1251,10/12/2020 3:35:50 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3621436-notable-earnings-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
1252,10/12/2020 5:12:04 PM,Johnson & Johnson Q3 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3621474-johnson-johnson-q3-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7508317232131958
1253,10/12/2020 7:06:31 PM,Novavax Is Incredibly Risky but Worth a Small Allocation,InvestorPlace,/news/stocks/nvax-stock-is-incredibly-risky-but-worth-a-small-allocation-1029671346,positive,0.8218441605567932
1254,10/12/2020 8:17:47 PM,Q3 earnings ringing in; FactSet sees drop in earnings across sectors,Seeking Alpha,https://seekingalpha.com/news/3621517-q3-earnings-ringing-in-factset-sees-drop-in-earnings-across-sectors?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9727944731712341
1255,10/12/2020 8:58:31 PM,7 Highly Rated Pharmaceutical Stocks for Q4,InvestorPlace,/news/stocks/7-highly-rated-pharmaceutical-stocks-for-q4-1029679826,positive,0.8309608697891235
1256,10/12/2020 11:30:42 PM,Johnson & Johnson sued over Auris Health payouts,Seeking Alpha,https://seekingalpha.com/news/3621554-johnson-johnson-sued-over-auris-health-payouts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9539359211921692
1257,10/13/2020 2:33:03 AM,J&J vaccine study paused due to unexplained illness in participant,Seeking Alpha,https://seekingalpha.com/news/3621557-j-and-j-vaccine-study-paused-due-to-unexplained-illness-in-participant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9313555955886841
1258,10/13/2020 5:14:47 AM,J&J Pauses Late-stage COVID-19 Vaccine Trial On Unexplained Illness ,RTTNews,/news/stocks/j-j-pauses-late-stage-covid-19-vaccine-trial-on-unexplained-illness-1029671663,neutral,0.7113345861434937
1259,10/13/2020 8:32:35 AM,First case of COVID-19 reinfection confirmed in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3621570-first-case-of-covidminus-19-reinfection-confirmed-in-u-s?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7349666357040405
1260,10/13/2020 10:41:23 AM,"Johnson & Johnson beats on earnings, raises FY20 guidance",Seeking Alpha,https://seekingalpha.com/news/3621594-johnson-johnson-beats-on-earnings-raises-fy20-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8533239364624023
1261,10/13/2020 11:12:02 AM,J&J Darzalex sales up 44%; FY20 outlook raise tops consensus,Seeking Alpha,https://seekingalpha.com/news/3621605-j-and-j-darzalex-sales-up-44-fy20-outlook-raise-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9510959386825562
1262,10/13/2020 12:44:27 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1029673178,negative,0.6677944660186768
1263,10/13/2020 1:26:14 PM,Johnson & Johnson Q3 Results Top Estimates; Boosts FY20 Outlook ,RTTNews,/news/stocks/johnson-johnson-q3-results-top-estimates-boosts-fy20-outlook-1029673428,negative,0.9335116147994995
1264,10/13/2020 2:57:02 PM,Johnson & Johnson falls despite earnings beat after pausing COVID-19 vaccine trial over 'unexplained illness',Business Insider,https://www.businessinsider.com/johnson-and-johnson-stock-price-jnj-earnings-covid19-vaccine-illness-2020-10,neutral,0.9676204919815063
1265,10/13/2020 3:35:23 PM,Novavax Stock Stalemate Is About to Catch Fire,InvestorPlace,/news/stocks/nvax-stock-stalemate-is-about-to-catch-fire-1029675475,positive,0.6122852563858032
1266,10/13/2020 3:37:22 PM,Johnson & Johnson Earnings: JNJ Stock Ticks Lower as Vaccine Trial Pause Overshadows Q3 Beat,InvestorPlace,/news/stocks/johnson-johnson-earnings-jnj-stock-ticks-lower-as-vaccine-trial-pause-overshadows-q3-beat-1029675474,neutral,0.9665097594261169
1267,10/13/2020 4:30:12 PM,Inovio Stock Is a Great Long Setup for an Overreaction Trade,InvestorPlace,/news/stocks/ino-stock-is-a-great-long-setup-for-an-overreaction-trade-1029675876,positive,0.681062638759613
1268,10/14/2020 8:31:39 AM,"LLY Pauses COVID-19 Antibody Trial, JNJ Boosts Annual Outlook, Double Whammy For GOSS ",RTTNews,/news/stocks/lly-pauses-covid-19-antibody-trial-jnj-boosts-annual-outlook-double-whammy-for-goss-1029677498,negative,0.9347585439682007
1269,10/14/2020 1:03:22 PM,Health care holding up despite COVID setbacks: At the Open,Seeking Alpha,https://seekingalpha.com/news/3622071-health-care-holding-up-despite-covid-setbacks-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7862377762794495
1270,10/15/2020 11:30:19 PM,9 Stocks to Buy for a Wild Ride in October,InvestorPlace,/news/stocks/9-stocks-to-buy-for-a-wild-ride-in-july-1029381606,positive,0.7964711785316467
1271,10/16/2020 11:58:35 AM,Biden Town Hall: 4 Key Investing Takeaways,InvestorPlace,/news/stocks/biden-town-hall-4-key-investing-takeaways-1029688135,positive,0.9202543497085571
1272,10/16/2020 1:03:00 PM,7 Short-Term Stocks to Make a Quick Buck,InvestorPlace,/news/stocks/7-short-term-stocks-to-buy-for-quick-buck-1029688757,positive,0.8304802775382996
1273,10/16/2020 2:37:50 PM,GSK Says Viiv Healthcare Gets Positive CHMP Opinion For Long-acting HIV Regimen ,RTTNews,/news/stocks/gsk-says-viiv-healthcare-gets-positive-chmp-opinion-for-long-acting-hiv-regimen-1029688318,negative,0.9543236494064331
1274,10/16/2020 5:53:26 PM,Can Cytonics Pivot Successfully to Covid-19 Therapeutics?,InvestorPlace,/news/stocks/cytonics-stock-pivot-coronavirus-therapeutics-1029689508,positive,0.7348707318305969
1275,10/16/2020 5:53:36 PM,Novavax Stock Looks Volatile As Vaccine Enthusiasm Wanes,InvestorPlace,/news/stocks/nvax-stock-looks-volatile-as-vaccine-enthusiasm-wanes-1029689507,neutral,0.9606714248657227
1276,10/16/2020 7:30:50 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3622976-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1277,10/19/2020 4:58:50 PM,Pfizer and Moderna pivotal studies on COVID-19 vaccines near enrollment targets,Seeking Alpha,https://seekingalpha.com/news/3623326-pfizer-and-moderna-pivotal-studies-on-covidminus-19-vaccines-near-enrollment-targets?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9210036396980286
1278,10/19/2020 5:25:37 PM,Why the FDA‚Äôs Inquiry of Inovio Is More Critical Than You Think,InvestorPlace,/news/stocks/why-fda-inquiry-very-critical-ino-stock-1029694935,positive,0.9059134125709534
1279,10/19/2020 5:50:56 PM,The Low-Hanging Fruit for Covid-19 Vaccines Is Gone for iBio,InvestorPlace,/news/stocks/ibio-stock-no-more-low-hanging-fruit-1029694932,positive,0.8469913005828857
1280,10/20/2020 7:18:42 AM,Moderna not far behind Pfizer on vaccine emergency authorization,Seeking Alpha,https://seekingalpha.com/news/3623490-moderna-not-far-behind-pfizer-on-vaccine-emergency-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6286377310752869
1281,10/21/2020 2:10:42 PM,OxyContin maker Purdue Pharma to plead guilty to three criminal charges,Seeking Alpha,https://seekingalpha.com/news/3624251-oxycontin-maker-purdue-pharma-to-plead-guilty-to-three-criminal-charges?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7724971175193787
1282,10/21/2020 4:35:08 PM,"While Risky, Sorrento Therapeutics Has Many Options to Win",InvestorPlace,/news/stocks/while-risky-sorrento-therapeutics-has-many-options-to-win-1029706542,positive,0.8506829142570496
1283,10/21/2020 5:43:16 PM,FDA Ad Com tomorrow on development/authorization of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3624369-fda-ad-com-tomorrow-on-development-authorization-of-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9219729900360107
1284,10/21/2020 7:49:40 PM,Key U.S. COVID-19 vaccine trials set to resume,Seeking Alpha,https://seekingalpha.com/news/3624430-key-u-s-covidminus-19-vaccine-trials-set-to-resume?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7897342443466187
1285,10/21/2020 7:50:43 PM,Sorrento Therapeutics Is a Vaccine Movie That Investors Have Already Seen,InvestorPlace,/news/stocks/lack-of-covid-19-focus-could-hinder-srne-stock-1029706960,positive,0.8901838064193726
1286,10/21/2020 9:05:18 PM,J&J's daratumumab extends survival in first-line multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3624549-j-and-js-daratumumab-extends-survival-in-first-line-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9460107088088989
1287,10/22/2020 5:31:38 PM,Is It Too Late for Novavax to Profit From a Covid-19 Vaccine?,InvestorPlace,/news/stocks/is-it-too-late-for-novavax-to-profit-from-a-covid-19-vaccine-1029712056,positive,0.827395498752594
1288,10/22/2020 6:08:42 PM,Time Is Running Out on Inovio as Other Vaccine Candidates Advance,InvestorPlace,/news/stocks/time-is-running-out-on-ino-stock-as-other-vaccine-candidates-advance-1029712050,positive,0.8938280940055847
1289,10/22/2020 6:21:39 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3624985-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9304965734481812
1290,10/23/2020 3:25:03 PM,FDA getting cold feet on EUA nod for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3625386-fda-getting-cold-feet-on-eua-nod-for-covidminus-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4357973337173462
1291,10/23/2020 6:23:01 PM,Can Novavax Stock Overcome Growing Vaccine Distrust?,InvestorPlace,/news/stocks/novavax-nvax-stock-not-a-win-on-astrazeneca-blunder-1029716054,negative,0.4967092275619507
1292,10/23/2020 10:11:16 PM,J&J to resume pivotal study of COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3625481-j-and-j-to-resume-pivotal-study-of-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.786370575428009
1293,10/26/2020 10:41:53 AM,"Fauci Says Covid Vaccine's Safety, Efficacy Will Be Known By Dec ",RTTNews,/news/stocks/fauci-says-covid-vaccine-s-safety-efficacy-will-be-known-by-dec-1029719925,positive,0.8476759791374207
1294,10/26/2020 5:03:44 PM,3 Blue Chip Stocks to Buy for Safe Dividends,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-safe-dividends-1029722331,positive,0.9144216775894165
1295,10/27/2020 1:34:57 PM,7 Cheap Index Funds for the Careful Investor,InvestorPlace,/news/stocks/7-cheap-index-funds-to-buy-for-the-careful-investor-1029728195,positive,0.9057947993278503
1296,10/27/2020 9:10:05 PM,Don‚Äôt Be Fazed by the Recent Market Volatility,InvestorPlace,/news/stocks/why-im-not-fazed-by-the-recent-market-volatility-1029729497,positive,0.8584647178649902
1297,10/28/2020 11:52:24 AM,Vaccine Hopeful Novavax Could Be Worth a Shot,InvestorPlace,/news/stocks/vaccine-hopeful-novavax-could-be-worth-a-shot-1029734122,negative,0.6186031699180603
1298,10/28/2020 4:39:57 PM,"U.S. COVID-19 cases on the rise, key vaccine data expected in November",Seeking Alpha,https://seekingalpha.com/news/3627364-u-s-covidminus-19-cases-on-rise-key-vaccine-data-expected-in-november?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5762848854064941
1299,10/29/2020 11:53:30 AM,IBIO Stock Remains a Speculative Biopharma Play,InvestorPlace,/news/stocks/ibio-stock-remains-a-speculative-biopharma-play-1029741060,positive,0.8162073493003845
1300,10/29/2020 4:46:15 PM,Why Palantir May Be a Solid Covid-19 Play,InvestorPlace,/news/stocks/why-palantir-may-be-a-solid-covid-19-play-1029742932,positive,0.7000253200531006
1301,10/30/2020 10:44:17 AM,"Protagonist Therapeutics, Janssen advance oral IL-23 receptor antagonists program",Seeking Alpha,https://seekingalpha.com/news/3628947-protagonist-therapeutics-janssen-advance-oral-ilminus-23-receptor-antagonists-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8172664046287537
1302,10/30/2020 3:21:03 PM,Regeneron : IDMC Recommends To Hold Enrollment In Hospitalized High Risk COVID-19 Patients ,RTTNews,/news/stocks/regeneron-idmc-recommends-to-hold-enrollment-in-hospitalized-high-risk-covid-19-patients-1029746946,positive,0.8544440865516663
1303,10/30/2020 6:43:02 PM,J&J to test coronavirus vaccine in youngsters,Seeking Alpha,https://seekingalpha.com/news/3629207-j-and-j-to-test-coronavirus-vaccine-in-youngsters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8158525228500366
1304,10/31/2020 6:00:00 AM,"Vaccine developers take varied approaches to COVID-19, next-gen platforms may not be better than more traditional technologies",Seeking Alpha,https://seekingalpha.com/news/3629098-vaccine-developers-take-varied-approaches-to-covidminus-19-next-gen-platforms-may-not-be?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7795732617378235
1305,11/2/2020 12:14:11 PM,J&J files U.S. application for twice yearly dosing of schizophrenia med,Seeking Alpha,https://seekingalpha.com/news/3629520-j-and-j-files-u-s-application-for-twice-yearly-dosing-of-schizophrenia-med?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8925284743309021
1306,11/2/2020 1:14:27 PM,A Lot of News Isn‚Äôt Necessarily Good News for Sorrento Therapeutics,InvestorPlace,/news/stocks/lot-news-good-news-srne-stock-1029754095,positive,0.8521668910980225
1307,11/2/2020 4:11:03 PM,5 Industries Biden Would Destroy as President,InvestorPlace,/news/stocks/election-stocks-sell-5-industries-threatened-biden-victory-1029754646,positive,0.8998605608940125
1308,11/2/2020 8:19:18 PM,7 Hot Stocks¬†To Buy With Mega-Cap Status,InvestorPlace,/news/stocks/7-hot-stocks-to-buy-with-mega-cap-status-1029755365,positive,0.8822281360626221
1309,11/3/2020 1:04:10 PM,Sorrento Therapeutics Is Charming But Read the Label,InvestorPlace,/news/stocks/srne-stock-charming-but-read-label-1029758584,positive,0.8833617568016052
1310,11/3/2020 6:32:00 PM,Brazil on board with resumption of J&J COVID-19 vaccine study,Seeking Alpha,https://seekingalpha.com/news/3630627-brazil-on-board-resumption-of-j-and-j-covidminus-19-vaccine-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8493168354034424
1311,11/3/2020 8:13:53 PM,J&J strikes out with appeal of $2.1B talc judgement in Missouri,Seeking Alpha,https://seekingalpha.com/news/3630709-j-and-j-strikes-out-appeal-of-2_1b-talc-judgement-in-missouri?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8745066523551941
1312,11/5/2020 2:46:54 PM,India races ahead with COVID-19 vaccine as AstraZeneca deliveries lag,Seeking Alpha,https://seekingalpha.com/news/3632254-india-races-ahead-covidminus-19-vaccine-astrazeneca-deliveries-lag?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8641549348831177
1313,11/5/2020 8:06:56 PM,Cytonics: Invest In A Startup That‚Äôs Targeting Osteoarthritis,InvestorPlace,/news/stocks/cytonics-invest-in-a-startup-thats-targeting-osteoarthritis-1029772608,positive,0.8583500385284424
1314,11/6/2020 1:49:30 PM,J&J to host device update November 19,Seeking Alpha,https://seekingalpha.com/news/3633158-j-and-j-to-host-device-update-november-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9328522086143494
1315,11/6/2020 3:34:01 PM,Drug wholesalers and J&J agree to tentative $26B deal to settle opioid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3633211-drug-wholesalers-and-j-and-j-agree-to-tentative-26b-deal-to-settle-opioid-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9239859580993652
1316,11/7/2020 5:30:00 AM,Biogen's long and winding road in Alzheimer's hits wall,Seeking Alpha,https://seekingalpha.com/news/3633230-biogens-long-and-winding-road-in-alzheimers-hits-wall?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5482168793678284
1317,11/9/2020 11:08:28 AM,5 Real Estate Stocks to Buy for a Hot Housing Market,InvestorPlace,/news/stocks/5-real-estate-stocks-to-buy-for-a-hot-housing-market-dhi-are-invh-low-tsco-1029780301,positive,0.8556708097457886
1318,11/9/2020 12:07:49 PM,"Pfizer/BioNTech COVID-19 vaccine 90% effective, U.S. EUA application expected this month",Seeking Alpha,https://seekingalpha.com/news/3633509-pfizer-biontech-covidminus-19-vaccine-90-effective-u-s-eua-application-expected-this-month?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8656361103057861
1319,11/9/2020 6:32:14 PM,Don‚Äôt Expect Massive Short-Term Gains in Novavax Stock Right Now,InvestorPlace,/news/stocks/dont-expect-massive-short-term-gains-in-novavax-nvax-stock-1029783007,negative,0.5166043043136597
1320,11/9/2020 6:52:11 PM,"Despite Ethical Issues, Palantir Is a Can‚Äôt-Miss Opportunity",InvestorPlace,/news/stocks/despite-ethical-issues-pltr-stock-is-a-cant-miss-opportunity-1029783005,positive,0.5794498324394226
1321,11/9/2020 8:30:43 PM,3 Dividend Stocks With Super-Safe Payouts,InvestorPlace,/news/stocks/3-dividend-stocks-with-super-safe-payouts-jnj-1029783354,positive,0.8441782593727112
1322,11/10/2020 1:02:00 PM,Novavax Steals Some of Pfizer‚Äôs Thunder With Fast Track Designation,InvestorPlace,/news/stocks/novavax-nvax-stock-steals-pfizers-thunder-with-fast-track-designation-1029786505,positive,0.7748199701309204
1323,11/10/2020 7:24:22 PM,7 Dividend Stocks To Buy For Post-Election Volatility,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-post-election-volatility-1029789073,positive,0.9147449135780334
1324,11/11/2020 2:24:45 PM,9 Outbreak-Fueled Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-second-coronavirus-wave-1029421408,positive,0.7889739274978638
1325,11/11/2020 4:50:34 PM,7 Biotech Penny Stocks Worth a Gamble,InvestorPlace,/news/stocks/7-biotech-stocks-to-gamble-with-1029793010,positive,0.7899965047836304
1326,11/11/2020 6:40:36 PM,Good News for Society Isn‚Äôt Necessarily So for Slack Stock,InvestorPlace,/news/stocks/good-news-for-society-is-not-great-for-slack-stock-1029793372,positive,0.8632276654243469
1327,11/12/2020 9:49:16 AM,"Amid cold-storage hurdle, Sanofi and J&J may beat logistical challenges",Seeking Alpha,https://seekingalpha.com/news/3635295-amid-cold-storage-hurdle-sanofi-and-j-and-j-may-beat-logistical-challenges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9465422630310059
1328,11/12/2020 12:22:36 PM,J&J files applications for subcutaneous Darzalex in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3635397-j-and-j-files-applications-for-subcutaneous-darzalex-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9177826642990112
1329,11/12/2020 6:48:30 PM,Emergent BioSolutions in focus on upcoming 60 Minutes episode,Seeking Alpha,https://seekingalpha.com/news/3635657-emergent-biosolutions-in-focus-on-upcoming-60-minutes-episode?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8982797861099243
1330,11/13/2020 4:29:50 PM,Acceleron's sotatercept shows positive action in mid-stage pulmonary arterial hypertension studies,Seeking Alpha,https://seekingalpha.com/news/3636208-accelerons-sotatercept-shows-positive-action-in-mid-stage-pulmonary-arterial-hypertension?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9302709102630615
1331,11/13/2020 6:05:40 PM,7 Value Stocks That Could Make You the Next Warren Buffett,InvestorPlace,/news/stocks/7-value-stocks-that-could-make-you-the-next-warren-buffett-1029802378,positive,0.9161631464958191
1332,11/13/2020 8:00:17 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3636251-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1333,11/14/2020 5:00:41 PM,"J&J, U.S. Expand Agreement To Support Next Phase Of COVID-19 Vaccine R&D ",RTTNews,/news/stocks/j-j-u-s-expand-agreement-to-support-next-phase-of-covid-19-vaccine-r-d-1029803409,negative,0.8206349611282349
1334,11/15/2020 5:29:46 PM,J&J expands partnership with HHS in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3636401-j-and-j-expands-partnership-hhs-in-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9431540966033936
1335,11/16/2020 8:45:14 AM,COVID-19 Vaccines - The Blues And Ease Of Cold Storage ,RTTNews,/news/stocks/covid-19-vaccines-the-blues-and-ease-of-cold-storage-1029804652,positive,0.8237765431404114
1336,11/16/2020 12:20:35 PM,"Moderna shares jump 12% as COVID-19 vaccine shows 94.5% efficacy, expects EUA submission shortly",Seeking Alpha,https://seekingalpha.com/news/3636472-moderna-shares-jump-12-covidminus-19-vaccine-shows-94_5-efficacy-expects-eua-submission?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9234064221382141
1337,11/16/2020 12:49:36 PM,"Moderna's COVID-19 vaccine candidate has longer shelf life, to remain stable at 2¬∞ to 8¬∞C",Seeking Alpha,https://seekingalpha.com/news/3636496-modernas-covidminus-19-vaccine-candidate-longer-shelf-life-to-remain-stable-2-to-8-c?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8388635516166687
1338,11/16/2020 4:00:50 PM,7 Vanguard Funds With Ultra Low Expenses,InvestorPlace,/news/stocks/7-vanguard-funds-with-ultra-low-expenses-1029807476,positive,0.867620587348938
1339,11/17/2020 7:55:22 AM,J&J tests new two-dose regimen for COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3636937-j-and-j-tests-new-two-dose-regimen-for-covidminus-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5661359429359436
1340,11/17/2020 8:10:16 AM,"ADMP Snubbed Again, FDA Delay's Decision On BMY's Liso-cel, MRNA's COVID-19 Vaccine 94.5% Effective ",RTTNews,/news/stocks/admp-snubbed-again-fda-delay-s-decision-on-bmy-s-liso-cel-mrna-s-covid-19-vaccine-94-5-effective-1029809234,negative,0.8710684776306152
1341,11/17/2020 11:45:38 AM,Is messenger RNA technology in COVID-19 a new tool to success?,Seeking Alpha,https://seekingalpha.com/news/3636976-is-messenger-rna-technology-in-covidminus-19-new-tool-to-success?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7902471423149109
1342,11/17/2020 3:10:41 PM,7 Pharmaceutical Stocks to Buy for 2021 and Beyond¬†,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-2021-and-beyond-1029811903,positive,0.9023517370223999
1343,11/17/2020 7:36:43 PM,Sell Novavax Stock After Its Huge Gain,InvestorPlace,/news/stocks/sell-novavax-stock-after-its-huge-gain-1029813268,positive,0.8138289451599121
1344,11/17/2020 9:22:53 PM,J&J expects data for U.S. authorization of COVID-19 vaccine by February - Reuters,Seeking Alpha,https://seekingalpha.com/news/3637280-j-and-j-expects-data-for-u-s-authorization-of-covidminus-19-vaccine-february-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9262533783912659
1345,11/19/2020 10:01:06 AM,5 Index Funds That Belong In Any Portfolio Seeking Diversification,InvestorPlace,/news/stocks/5-index-funds-vfiax-vgt-vti-swppx-gold-that-help-you-sleep-soundly-1029819756,positive,0.9354581832885742
1346,11/19/2020 10:02:20 AM,FDA plans early advisory meetings in December to discuss COVID-19 vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3637799-fda-plans-early-advisory-meetings-in-december-to-discuss-covidminus-19-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.930812418460846
1347,11/19/2020 6:40:32 PM,CDC warns against Thanksgiving travel amid COVID spike,Seeking Alpha,https://seekingalpha.com/news/3638052-cdc-warns-against-thanksgiving-travel-amid-covid-spike?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8023213744163513
1348,11/20/2020 7:59:23 AM,"EU may approve BioNtech, Moderna vaccines in December, could pay $10B for doses",Seeking Alpha,https://seekingalpha.com/news/3638224-eu-may-approve-biontech-moderna-vaccines-in-december-pay-10b-for-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5250717401504517
1349,11/20/2020 1:02:28 PM,Inovio Gets the Go-Ahead But It‚Äôs Probably Too Late,InvestorPlace,/news/stocks/ino-stock-gets-go-ahead-but-probably-too-late-1029824918,positive,0.8834108710289001
1350,11/20/2020 5:50:42 PM,7 Hot Stocks to Buy Before 2021 Ushers in Change,InvestorPlace,/news/stocks/7-of-the-hot-stocks-to-buy-before-2021-ushers-in-change-1029826116,positive,0.90118008852005
1351,11/22/2020 2:12:08 PM,Vaccine access and distribution a big topic at G20,Seeking Alpha,https://seekingalpha.com/news/3638524-vaccine-access-and-distribution-big-topic-g20?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8874895572662354
1352,11/23/2020 8:02:44 AM,"All eyes on AstraZeneca-Oxford shot after strong Pfizer, Moderna results",Seeking Alpha,https://seekingalpha.com/news/3638538-all-eyes-on-astrazeneca-oxford-shot-after-strong-pfizer-moderna-results?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7594830989837646
1353,11/23/2020 5:40:46 PM,Slack Shares Might Start to Slack Off,InvestorPlace,/news/stocks/slack-stock-shares-might-start-to-slack-off-1029831155,neutral,0.9355032444000244
1354,11/23/2020 7:17:19 PM,Johnson & Johnson sized up favorably after positive medical devices update,Seeking Alpha,https://seekingalpha.com/news/3638793-johnson-johnson-sized-up-favorably-after-positive-medical-devices-update?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9473861455917358
1355,11/24/2020 2:50:06 PM,Johnson & Johnson Is an Excellent Dividend Growth Stock,InvestorPlace,/news/stocks/johnson-johnson-is-an-excellent-dividend-1029834845,negative,0.8951849341392517
1356,11/24/2020 7:21:41 PM,"Pfizer, Moderna Lead the Vaccine Race: Here‚Äôs Where 7 Other Top Vaccine Stocks Stand",InvestorPlace,/news/stocks/7-biotech-stocks-locked-in-the-race-for-a-vaccine-1029836075,positive,0.9004662036895752
1357,11/25/2020 8:49:37 AM,Purdue Pharma pleads guilty to criminal opioid crisis charges,Seeking Alpha,https://seekingalpha.com/news/3639300-purdue-pharma-pleads-guilty-to-criminal-opioid-crisis-charges?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.708125114440918
1358,11/25/2020 6:06:07 PM,Overlook Novavax at the Risk of Incurring an Opportunity Cost,InvestorPlace,/news/stocks/overlook-nvax-stock-at-your-own-risk-1029839833,neutral,0.5209403038024902
1359,11/25/2020 8:47:28 PM,AstraZeneca skids another 2% as confusion remains over vaccine,Seeking Alpha,https://seekingalpha.com/news/3639522-astrazeneca-skids-another-2-confusion-remains-over-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9577127695083618
1360,11/30/2020 11:55:00 AM,"The Case for iBio Stock Is Real, but Leaves a Key Question Unanswered",InvestorPlace,/news/stocks/ibio-stock-presents-investors-with-key-question-1029848699,positive,0.8902006149291992
1361,12/2/2020 1:15:24 PM,Just Say No to Inovio Pharmaceuticals Stock,InvestorPlace,/news/stocks/just-say-no-to-inovio-pharmaceuticals-stock-1029858306,positive,0.9311157464981079
1362,12/2/2020 1:46:56 PM,J&J acquires rights to gene therapy for vision loss disorder,Seeking Alpha,https://seekingalpha.com/news/3640789-j-and-j-acquires-rights-to-gene-therapy-for-vision-loss-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7579396963119507
1363,12/2/2020 1:49:15 PM,Kinnate Biopharma increases IPO size by 25% to $213M,Seeking Alpha,https://seekingalpha.com/news/3640795-kinnate-biopharma-increases-ipo-size-25-to-213m?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9479063153266907
1364,12/3/2020 6:37:33 AM,"BCRX Awaits FDA Decision, JNJ On Watch, Pfizer/BioNTech's COVID-19 Vaccine Gets Green Light In UK ",RTTNews,/news/stocks/bcrx-awaits-fda-decision-jnj-on-watch-pfizer-biontech-s-covid-19-vaccine-gets-green-light-in-uk-1029860123,negative,0.8735619783401489
1365,12/3/2020 8:55:24 AM,U.S. could immunize one-third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-one-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8466517925262451
1366,12/3/2020 8:55:24 AM,U.S. could immunize third of population within three months,Seeking Alpha,https://seekingalpha.com/news/3641217-u-s-immunize-third-of-population-within-three-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8187563419342041
1367,12/3/2020 10:16:13 AM,7 Undervalued Stocks to Snap Up Today,InvestorPlace,/news/stocks/undervalued-stocks-are-out-there-including-some-familiar-names-1029860944,negative,0.5279099345207214
1368,12/3/2020 12:12:52 PM,J&J files U.S. application for bispecific antibody for type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/3641279-j-and-j-files-u-s-application-for-bispecific-antibody-for-type-of-lung-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7342573404312134
1369,12/3/2020 12:20:28 PM,J&J sells ex-U.S. rights to transdermal contraceptive patch to Gedeon Richter,Seeking Alpha,https://seekingalpha.com/news/3641284-j-and-j-sells-ex-u-s-rights-to-transdermal-contraceptive-patch-to-gedeon-richter?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9155998826026917
1370,12/3/2020 6:53:40 PM,3 Dividend Stocks for Big Total Returns in 2021,InvestorPlace,/news/stocks/3-dividend-stocks-for-big-total-returns-in-2021-abbv-jnj-mdt-1029863076,negative,0.7688309550285339
1371,12/4/2020 6:32:46 AM,"FDA Nod For BCRX - Decision In Japan, Europe Next, ENLV Soars On COVID Trial Data, STRO Abuzz ",RTTNews,/news/stocks/fda-nod-for-bcrx-decision-in-japan-europe-next-enlv-soars-on-covid-trial-data-stro-abuzz-1029863959,negative,0.6276431083679199
1372,12/4/2020 12:55:11 PM,Sell-siders bullish on Moderna COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3641671-sell-siders-bullish-on-moderna-covidminus-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4227292835712433
1373,12/4/2020 6:26:02 PM,J&J's daratumumab shows clinical benefit in multiple myeloma study,Seeking Alpha,https://seekingalpha.com/news/3641796-j-and-js-daratumumab-shows-clinical-benefit-in-multiple-myeloma-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9369551539421082
1374,12/7/2020 10:52:00 AM,Moody's - Outlook for global pharmaceutical industry revised to positive as COVID-19 vaccines and treatments boost earnings,Moodys,/news/bonds/moody-s-outlook-for-global-pharmaceutical-industry-revised-to-positive-as-covid-19-vaccines-and-treatments-boost-earnings-1029868484,negative,0.9331789612770081
1375,12/7/2020 5:20:23 PM,Johnson & Johnson sees positive data from pair of multiple myeloma approaches at ASH,Seeking Alpha,https://seekingalpha.com/news/3642175-johnson-johnson-sees-positive-data-from-pair-of-multiple-myeloma-approaches-ash?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9478275179862976
1376,12/8/2020 8:41:39 AM,U.K. rolls out COVID-19 vaccine to public - report,Seeking Alpha,https://seekingalpha.com/news/3642355-u-k-rolls-out-covidminus-19-vaccine-to-public-report?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7050290107727051
1377,12/8/2020 7:03:42 PM,7 Blue-Chip Stocks You Can Trust,InvestorPlace,/news/stocks/blue-chip-stocks-7-blue-chip-stocks-you-can-trust-1029874779,positive,0.9113309383392334
1378,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca for vaccine delivery, inoculation expected by mid 2021 - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-for-vaccine-delivery-inoculation-expected-mid-2021-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8593608736991882
1379,12/9/2020 9:07:53 AM,"U.S. banks on J&J, AstraZeneca shots to vaccinate Americans",Seeking Alpha,https://seekingalpha.com/news/3642766-u-s-banks-on-j-and-j-astrazeneca-shots-to-vaccinate-americans?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7954001426696777
1380,12/9/2020 3:30:11 PM,Investment Breakdown: The Best Stock in Each Sector of the Market,InvestorPlace,/news/stocks/breakdown-the-best-stock-in-each-sector-of-the-market-1029878480,positive,0.8835943341255188
1381,12/10/2020 10:01:49 AM,7 Cheap Stocks Under $20 To Buy That Span Industries,InvestorPlace,/news/stocks/7-cheap-stocks-to-buy-now-under-20-to-buy-that-span-industry-doyu-znga-arcc-hbi-veco-pdce-bcov-1029880669,positive,0.8280788660049438
1382,12/11/2020 1:15:04 PM,Janssen: CHMP Recommends Expanded Use Of SPRAVATO - Quick Facts ,RTTNews,/news/stocks/janssen-chmp-recommends-expanded-use-of-spravato-quick-facts-1029885074,positive,0.6914961934089661
1383,12/12/2020 11:05:53 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643900-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9489516019821167
1384,12/12/2020 11:06:41 PM,J&J cuts the size of its COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3643901-j-and-j-cuts-size-of-covidminus-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9489516019821167
1385,12/14/2020 11:55:50 AM,Novavax Far From Finished In the Race for a Vaccine,InvestorPlace,/news/stocks/novavax-far-from-finished-in-the-race-for-a-vaccine-nvax-stock-1029889699,negative,0.704472541809082
1386,12/14/2020 5:48:04 PM,8 Retirement Stocks You Can Rely On,InvestorPlace,/news/stocks/8-retirement-investments-you-can-rely-on-1029891268,positive,0.9319970607757568
1387,12/15/2020 6:35:20 AM,First COVID-19 shot given in U.S. as roll-out begins - WSJ,Seeking Alpha,https://seekingalpha.com/news/3644277-first-covidminus-19-shot-given-in-u-s-roll-out-begins-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7453948259353638
1388,12/15/2020 2:16:41 PM,7 Value Stocks Ready for Rotation,InvestorPlace,/news/stocks/7-value-stocks-ready-for-rotation-1029894555,positive,0.8775713443756104
1389,12/15/2020 2:49:15 PM,Veracyte broadens the collaboration with JNJ in early cancer detection,Seeking Alpha,https://seekingalpha.com/news/3644460-veracyte-broadens-collaboration-jnj-in-early-cancer-detection?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8508148193359375
1390,12/15/2020 3:56:35 PM,7 Undervalued Stocks That You Shouldn‚Äôt Pass On,InvestorPlace,/news/stocks/7-undervalued-stocks-that-you-shouldnt-pass-on-1029895193,positive,0.8288981914520264
1391,12/15/2020 4:01:00 PM,Johnson & Johnson -- Moody's announces completion of a periodic review of ratings of Johnson & Johnson,Moodys,/news/bonds/johnson-johnson-moody-s-announces-completion-of-a-periodic-review-of-ratings-of-johnson-johnson-1029894522,positive,0.8684381246566772
1392,12/16/2020 8:59:10 AM,American public to get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-american-public-to-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.803569495677948
1393,12/16/2020 8:59:10 AM,Most of American public may get vaccine by end of February - HHS Secretary Azar,Seeking Alpha,https://seekingalpha.com/news/3644749-of-american-public-may-get-vaccine-end-of-february-hhs-secretary-azar?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8804348707199097
1394,12/16/2020 10:47:45 AM,Micro-cap oncology biotech Scopus Biopharma prices downsized $2.75M IPO,Seeking Alpha,https://seekingalpha.com/news/3644762-micro-cap-oncology-biotech-scopus-biopharma-prices-downsized-2_75m-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4526408910751343
1395,12/17/2020 12:49:50 PM,"The Vaccine Race Is Far From Over, And That‚Äôs Good News for Novavax",InvestorPlace,/news/stocks/vaccine-race-far-from-over-good-news-for-nvax-stock-1029902118,negative,0.9128111004829407
1396,12/17/2020 6:51:04 PM,7 Long-Term Stocks for Buffett-Like Investors,InvestorPlace,/news/stocks/7-long-term-stocks-for-buffett-like-investors-1029904001,positive,0.9292078614234924
1397,12/18/2020 4:23:05 AM,J&J says late-stage COVID vaccine trial fully enrolled,Seeking Alpha,https://seekingalpha.com/news/3645594-j-and-j-says-late-stage-covid-vaccine-trial-fully-enrolled?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49625328183174133
1398,12/18/2020 11:33:08 AM,EU set to rollout COVID-19 vaccine from December 27 - NYT,Seeking Alpha,https://seekingalpha.com/news/3645629-eu-set-to-rollout-covidminus-19-vaccine-from-december-27-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5515856146812439
1399,12/18/2020 4:21:54 PM,7 of the Best Dividend Aristocrats on the Market¬†,InvestorPlace,/news/stocks/7-of-the-best-stocks-with-dividends-to-own-dividend-aristocrats-1029907361,positive,0.7460082173347473
1400,12/21/2020 9:13:37 AM,GSK: ViiV Healthcare's Vocabria Gets EU Approval To Be Used With Janssen's Rekambys And Edurant ,RTTNews,/news/stocks/gsk-viiv-healthcare-s-vocabria-gets-eu-approval-to-be-used-with-janssen-s-rekambys-and-edurant-1029909538,negative,0.8931984305381775
1401,12/21/2020 10:07:08 AM,"ViiV, Janssen's cabotegravir + rilpivirine wins marketing approval in Europe for HIV treatment",Seeking Alpha,https://seekingalpha.com/news/3646055-viiv-janssens-cabotegravir-rilpivirine-wins-marketing-approval-in-europe-for-hiv-treatment?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9421626329421997
1402,12/21/2020 8:00:47 PM,"Janssen, begins rolling submission of marketing application for BCMA Car-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3646305-janssen-begins-rolling-submission-of-marketing-application-for-bcma-car-t-therapy-in-multiple?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8480441570281982
1403,12/22/2020 12:32:35 AM,"'Pennies: Going In Raw' Hosts Hugh Henne, Dan Deity Join Benzinga's Power Hour",Benzinga,/news/stocks/pennies-going-in-raw-hosts-hugh-henne-dan-deity-join-benzinga-s-power-hour-1029912354,positive,0.9095210433006287
1404,12/22/2020 10:00:56 AM,Will vaccines work against the U.K. coronavirus variant?,Seeking Alpha,https://seekingalpha.com/news/3646502-will-vaccines-work-against-u-k-coronavirus-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.85740727186203
1405,12/22/2020 12:55:04 PM,Health Canada OK's JNJ unit Janssen's Darzalex combination regimen in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3646563-health-canada-oks-jnj-unit-janssens-darzalex-combination-regimen-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.83840411901474
1406,12/22/2020 4:34:09 PM,Veracyte and Bayer collaborate in precision oncology; shares jump +17%,Seeking Alpha,https://seekingalpha.com/news/3646727-veracyte-and-bayer-collaborate-in-precision-oncology-shares-jumpplus-17?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9163143038749695
1407,12/22/2020 5:09:32 PM,4 Dividend Stocks to Help You Prepare for Retirement,InvestorPlace,/news/stocks/4-stocks-with-dividend-to-help-you-prepare-for-retirement-kn-qdf-stor-wba-1029914787,positive,0.8927891254425049
1408,12/23/2020 3:49:06 PM,The 12 Best Stocks to Buy for a Whole New Year of Returns in 2021,InvestorPlace,/news/stocks/12-best-stocks-to-buy-for-a-whole-new-year-of-returns-in-2021-1029866334,positive,0.6599870324134827
1409,12/28/2020 11:35:55 AM,"As Vaccine Excitement Fades, Buy the Pullback in Pfizer",InvestorPlace,/news/stocks/vaccine-excitement-fades-buy-pullback-pfizer-pfe-stock-1029921274,positive,0.8600408434867859
1410,12/29/2020 12:53:33 PM,EMA says AstraZeneca/Oxford COVID-19 jab unfit for January approval,Seeking Alpha,https://seekingalpha.com/news/3647663-ema-says-astrazeneca-oxford-covidminus-19-jab-unfit-for-january-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.787582278251648
1411,12/29/2020 5:47:41 PM,Is Now a Good Time to Buy Moderna Stock?,InvestorPlace,/news/stocks/is-now-a-good-time-to-buy-moderna-stock-1029923962,positive,0.9269354343414307
1412,12/30/2020 10:01:36 AM,7 Great Index Funds To Help Investors Minimize Risk in a Volatile World,InvestorPlace,/news/stocks/7-great-index-funds-to-help-investors-minimize-risk-in-a-volatile-world-1029924929,positive,0.7723698019981384
1413,12/31/2020 3:16:42 PM,8 Dental Stocks If You Want to Clean Up,InvestorPlace,/news/stocks/8-dental-stocks-to-buy-if-you-want-to-clean-up-1029927337,positive,0.9182091355323792
1414,12/31/2020 7:19:38 PM,Why Pfizer is the Cheapest Coronavirus Vaccine Play,InvestorPlace,/news/stocks/pfe-stock-pfizer-does-not-include-value-biontech-and-vaccine-1029927517,positive,0.868235170841217
1415,12/31/2020 9:34:42 PM,COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021,Seeking Alpha,https://seekingalpha.com/news/3648143-covidminus-19-vaccine-makers-looking-back-on-2020-seeking-insights-for-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7941462397575378
1416,1/1/2021 1:07:48 PM,Israel leads world in COVID vaccinations per capita,Seeking Alpha,https://seekingalpha.com/news/3648167-israel-leads-world-in-covid-vaccinations-per-capita?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5381584167480469
1417,1/4/2021 1:32:36 PM,Johnson & Johnson declares $1.01 dividend,Seeking Alpha,https://seekingalpha.com/news/3648294-johnson-johnson-declares-1_01-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9304965734481812
1418,1/5/2021 7:36:32 PM,7 Coronavirus Stocks to Buy to Make Mass Vaccination Possible,InvestorPlace,/news/stocks/7-coronavirus-stocks-to-buy-to-make-mass-vaccination-possible-1029935369,positive,0.8918885588645935
1419,1/6/2021 1:30:57 PM,"The Daily Biotech Pulse: Aerpio Reviews Strategic Options, Hologic Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-aerpio-reviews-strategic-options-hologic-goes-shopping-1029936895,positive,0.9425970911979675
1420,1/7/2021 2:20:50 PM,"The Daily Biotech Pulse: CureVac COVID-19 Vaccine Deal, Argenx Out-Licenses Neuromuscular Disorder Drug, Xencor's Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-curevac-covid-19-vaccine-deal-argenx-out-licenses-neuromuscular-disorder-drug-xencor-s-oncology-collaboration-1029940542,positive,0.875293493270874
1421,1/8/2021 11:02:18 AM,Oncology Biotech company Cullinan Management prices upsized IPO above expected range,Seeking Alpha,https://seekingalpha.com/news/3649849-oncology-biotech-company-cullinan-management-prices-upsized-ipo-above-expected-range?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8862262964248657
1422,1/8/2021 12:06:38 PM,EU secures 300M more doses of Pfizer-BioNTech jab,Seeking Alpha,https://seekingalpha.com/news/3649872-eu-secures-300m-doses-of-pfizer-biontech-jab?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9031217098236084
1423,1/8/2021 1:25:06 PM,"The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-sarepta-gene-therapy-study-readout-novavax-vaccine-supply-deal-2-ipos-1029943328,positive,0.9024242162704468
1424,1/8/2021 3:41:14 PM,"As Competition Rises, the Bull Case for Moderna Stock Is Beginning to Fade",InvestorPlace,/news/stocks/bull-case-mrna-stock-beginning-to-fade-1029944159,positive,0.6915823817253113
1425,1/8/2021 5:44:30 PM,SPY Stock Is Headed Higher Over Time,InvestorPlace,/news/stocks/spy-stock-is-headed-higher-over-time-1029944373,negative,0.8601381182670593
1426,1/11/2021 12:56:47 PM,JNJ‚Äôs single-dose COVID-19 vaccine viewed favorably by analysts,Seeking Alpha,https://seekingalpha.com/news/3650208-jnj-s-single-dose-covidminus-19-vaccine-viewed-favorably-analysts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9441752433776855
1427,1/11/2021 3:32:35 PM,NVAX Stock Is Worth a Small Position but Vaccine Race Is Tightening,InvestorPlace,/news/stocks/nvax-stock-is-worth-a-small-position-but-vaccine-race-is-tightening-1029956501,positive,0.5928695201873779
1428,1/11/2021 4:19:50 PM,Stocks That Hit 52-Week Highs On Monday,Benzinga,/news/stocks/stocks-that-hit-52-week-highs-on-monday-1029956096,positive,0.6719298958778381
1429,1/11/2021 4:59:22 PM,The Top 7 Pharmaceutical Stocks for the Next 10 Years¬†,InvestorPlace,/news/stocks/the-top-7-pharmaceutical-stocks-for-the-next-10-years-1029956488,positive,0.8569135069847107
1430,1/11/2021 6:22:46 PM,Novavax executives sold $46M worth company shares in 2020 ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3650426-novavax-executives-sold-46m-worth-company-shares-in-2020-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9496198296546936
1431,1/11/2021 8:36:50 PM,8 Value Stocks That Could Perform Surprisingly Well In 2021,InvestorPlace,/news/stocks/8-value-stocks-that-could-perform-surprisingly-well-in-2021-1029957111,negative,0.8532675504684448
1432,1/12/2021 1:49:49 PM,South Korea nears deal to buy Novavax COVID-19 Vaccines - report,Seeking Alpha,https://seekingalpha.com/news/3650682-south-korea-nears-deal-to-buy-novavax-covidminus-19-vaccines-report?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5854173898696899
1433,1/12/2021 2:15:54 PM,"The Daily Biotech Pulse: GSK, Vir To Start COVID-19 Antibody Study, Novartis In-Licenses BeiGene's Cancer Drug, Earnings Preannouncements Continue",Benzinga,/news/stocks/the-daily-biotech-pulse-gsk-vir-to-start-covid-19-antibody-study-novartis-in-licenses-beigene-s-cancer-drug-earnings-preannouncements-continue-1029959657,positive,0.9257159233093262
1434,1/12/2021 7:05:42 PM,The 7 Best Startups You Can Buy on SeedInvest Right Now,InvestorPlace,/news/stocks/the-7-best-startups-you-can-buy-on-seedinvest-right-now-invest-in-startups-1029798071,positive,0.9125546813011169
1435,1/12/2021 10:22:17 PM,JNJ's COVID-19 jab could receive emergency approval by next month: Official,Seeking Alpha,https://seekingalpha.com/news/3650838-jnjs-covidminus-19-jab-receive-emergency-approval-next-month-official?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6049853563308716
1436,1/13/2021 1:25:58 PM,Johnson & Johnson's Imbruvica combo OK'd in Canada in CLL setting,Seeking Alpha,https://seekingalpha.com/news/3651021-johnson-johnsons-imbruvica-combo-okd-in-canada-in-cll-setting?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8355768322944641
1437,1/13/2021 1:35:02 PM,ESSA Pharma and Janssen to test combo treatments in prostate cancer setting,Seeking Alpha,https://seekingalpha.com/news/3651023-essa-pharma-and-janssen-to-test-combo-treatments-in-prostate-cancer-setting?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5366958975791931
1438,1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9454995393753052
1439,1/13/2021 4:42:10 PM,"Johnson & Johnson vaccine results to arrive, supply lags - NYT (Updated)",Seeking Alpha,https://seekingalpha.com/news/3651149-johnson-johnson-vaccine-results-to-arrive-supply-lags-nyt-updated?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7761887311935425
1440,1/13/2021 7:51:59 PM,7 Pharmaceutical Stocks With Exciting Plans for 2021,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-with-exciting-plans-for-2021-1029966098,positive,0.7265651226043701
1441,1/13/2021 10:47:43 PM,JNJ‚Äôs COVID-19 vaccine data published in Medical Journal,Seeking Alpha,https://seekingalpha.com/news/3651315-jnj-s-covidminus-19-vaccine-data-published-in-medical-journal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9214857220649719
1442,1/14/2021 10:41:17 AM,"5 Stocks To Watch For January 14, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-january-14-2021-1029967453,positive,0.8921882510185242
1443,1/14/2021 11:15:53 AM,"Johnson & Johnson's Covid-19 Vaccine Safe, Well-tolerated ",RTTNews,/news/stocks/johnson-johnson-s-covid-19-vaccine-safe-well-tolerated-1029967588,negative,0.8248218297958374
1444,1/14/2021 12:09:08 PM,"A Peek Into The Markets: US Stock Futures Mostly Higher Ahead Of Jobless Claims, Fed's Powell Speech",Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mostly-higher-ahead-of-jobless-claims-fed-s-powell-speech-1029967735,negative,0.6287519931793213
1445,1/14/2021 1:56:59 PM,"The Daily Biotech Pulse: Alexion Pauses COVID-19 Study, NantKwest Readout, Organogenesis Jumps On Guidance, Trial Updates",Benzinga,/news/stocks/the-daily-biotech-pulse-alexion-pauses-covid-19-study-nantkwest-readout-organogenesis-jumps-on-guidance-trial-updates-1029968277,positive,0.9080525040626526
1446,1/14/2021 5:59:22 PM,7 Great Index Funds To Buy With Super Low Fees,InvestorPlace,/news/stocks/7-great-index-funds-with-super-low-fees-1029970330,positive,0.902972400188446
1447,1/14/2021 8:34:12 PM,Invitae teams up with healthcare giants to develop MRD detection panel,Seeking Alpha,https://seekingalpha.com/news/3651590-invitae-teams-up-healthcare-giants-to-develop-mrd-detection-panel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7389792799949646
1448,1/14/2021 9:32:48 PM,Netflix Stock Remains Well Ahead of the Competition,InvestorPlace,/news/stocks/netflix-nflx-stock-remains-well-ahead-of-the-competition-1029971027,negative,0.8825386762619019
1449,1/15/2021 1:32:12 PM,"The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges",Benzinga,/news/stocks/the-daily-biotech-pulse-dbv-s-positive-fda-feedback-pfizer-s-cancer-drug-gets-label-expansion-applied-dna-covid-testing-volume-surges-1029972538,negative,0.9414128661155701
1450,1/15/2021 8:01:15 PM,Genmab's therapy for AL amyloidosis receives FDA approval,Seeking Alpha,https://seekingalpha.com/news/3651950-genmabs-therapy-for-al-amyloidosis-receives-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8854876756668091
1451,1/19/2021 4:50:45 PM,"Why Aclaris, Tenax, Gritstone, Merus, Minerva And Celyad Are Rallying Today",Benzinga,/news/stocks/why-aclaris-tenax-gritstone-merus-minerva-and-celyad-are-rallying-today-1029982313,negative,0.6973766088485718
1452,1/19/2021 8:27:33 PM,B.Riley downgrades Arcturus on 'broken narrative' for its ARCT-021 COVID-19 vaccine candidate,Seeking Alpha,https://seekingalpha.com/news/3652405-briley-downgrades-arcturus-on-broken-narrative-for-its-arct-021-covid-19-vaccine-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9456909894943237
1453,1/19/2021 8:48:27 PM,The 7 Best Stocks To Buy In The Dow Jones¬†Today,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-in-the-dow-jones-today-1029983307,positive,0.8546460270881653
1454,1/20/2021 1:32:35 PM,"The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-greenlights-merck-s-heart-failure-drug-histogen-hit-with-clinical-hold-aptorum-gets-nod-for-commencing-human-study-1029985849,positive,0.48656928539276123
1455,1/20/2021 3:24:21 PM,The 7 Best Healthcare Stocks to Buy for 2021,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-buy-for-2021-1029987247,positive,0.817572295665741
1456,1/20/2021 4:03:11 PM,9 Beginner Stocks for First-Time Investors,InvestorPlace,/news/stocks/9-beginner-stocks-for-first-time-investors-to-buy-1029987242,positive,0.9392744898796082
1457,1/20/2021 4:52:55 PM,Covid-19 Vaccine Roundup: 5 Pharma Stocks Making the Biggest Headlines Today,InvestorPlace,/news/stocks/covid-19-vaccine-5-pharma-stocks-headlines-today-nvax-stock-bntx-stock-1029987235,positive,0.7466526627540588
1458,1/21/2021 7:32:45 AM,"Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy",Seeking Alpha,https://seekingalpha.com/news/3652974-addex-janssen-pharma-on-go-with-phase-2a-study-of-jnj-40411813-adx71149-in-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5288474559783936
1459,1/21/2021 2:05:24 PM,"The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping",Benzinga,/news/stocks/the-daily-biotech-pulse-addex-jumps-on-positive-data-for-out-licensed-drug-covid-19-vaccine-developer-inovio-announces-150m-follow-on-offering-boston-scientific-goes-shopping-1029990203,negative,0.7720292210578918
1460,1/21/2021 2:59:40 PM,Epilepsy Drug News: Why Addex Therapeutics (ADXN) Stock Is Soaring Today,InvestorPlace,/news/stocks/epilepsy-drug-news-why-addex-therapeutics-adxn-stock-is-soaring-today-1029991037,negative,0.9405460357666016
1461,1/22/2021 4:51:44 AM,FDA OK's Janssen's HIV drug combo Cabenuva,Seeking Alpha,https://seekingalpha.com/news/3653426-fda-oks-janssens-hiv-drug-combo-cabenuva?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5732345581054688
1462,1/22/2021 9:20:13 AM,Why is the U.S. vaccine rollout taking longer than expected?,Seeking Alpha,https://seekingalpha.com/news/3653444-why-is-us-vaccine-rollout-taking-longer-than-expected?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6498687863349915
1463,1/22/2021 1:22:34 PM,"The Daily Biotech Pulse: Fluidigm's Saliva-Based COVID Test Approved In Europe, China Backs Amarin's Vascepa",Benzinga,/news/stocks/the-daily-biotech-pulse-fluidigm-s-saliva-based-covid-test-approved-in-europe-china-backs-amarin-s-vascepa-1029993832,positive,0.8599371910095215
1464,1/22/2021 10:13:36 PM,The Best 4 Pharmaceutical Stocks to Buy in Any Climate,InvestorPlace,/news/stocks/the-best-4-pharmaceutical-stocks-to-buy-in-any-climate-1030014921,positive,0.7539841532707214
1465,1/22/2021 10:36:45 PM,"'Halftime Report' Picks For January 22: Apple, KLA And More",Benzinga,/news/stocks/halftime-report-picks-for-january-22-apple-kla-and-more-1029995458,positive,0.9432129859924316
1466,1/23/2021 3:14:04 PM,"The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-24-30-j-j-lilly-to-kickstart-big-pharma-earnings-amgen-fda-decision-and-more-1029996049,negative,0.6939177513122559
1467,1/24/2021 3:01:22 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-earnings-preview-stock-1029996631,positive,0.9182448983192444
1468,1/24/2021 3:46:36 PM,COVID vaccines for kids? Trials are underway,Seeking Alpha,https://seekingalpha.com/news/3653738-covid-vaccines-for-kids-trials-are-underway?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.901797354221344
1469,1/25/2021 3:43:35 PM,5 Biden-Friendly Warren Buffett Stocks to Load Up On,InvestorPlace,/news/stocks/5-biden-friendly-warren-buffett-stocks-to-load-up-on-ko-gm-jnj-tmus-mco-1030000374,negative,0.8157926201820374
1470,1/25/2021 6:19:43 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3654000-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
1471,1/25/2021 6:27:17 PM,Johnson & Johnson Q4 2020 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3654012-johnson-amp-johnson-q4-2020-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7879984378814697
1472,1/25/2021 10:21:16 PM,"4 Top Stock Trades for Tuesday: GME, CLX, JNJ, MCD",InvestorPlace,/news/stocks/4-top-stock-trades-for-tuesday-gme-clx-jnj-mcd-1030001230,positive,0.9240512847900391
1473,1/26/2021 11:00:58 AM,Can GameStop Short Squeeze Bring Down The Market? What The Experts Are Saying,Benzinga,/news/stocks/can-gamestop-short-squeeze-bring-down-the-market-what-the-experts-are-saying-1030003051,positive,0.613983154296875
1474,1/26/2021 11:44:00 AM,"Johnson & Johnson EPS beats by $0.03, beats on revenue, guides FY21 above consensus",Seeking Alpha,https://seekingalpha.com/news/3654230-johnson-amp-johnson-eps-beats-by-003-beats-on-revenue-guides-fy21-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9039778709411621
1475,1/26/2021 12:11:30 PM,"J&J tops Q4 forecast, guides FY2021 outlook above consensus",Seeking Alpha,https://seekingalpha.com/news/3654249-jj-tops-q4-forecast-guides-fy2021-outlook-above-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8779654502868652
1476,1/26/2021 12:46:16 PM,Johnson & Johnson Q4 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q4-adjusted-earnings-beat-estimates-1030003402,negative,0.7201688289642334
1477,1/26/2021 12:59:52 PM,Johnson & Johnson Projects 2021 Adjusted Operational EPS Growth Of 16.4% - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-projects-2021-adjusted-operational-eps-growth-of-16-4-quick-facts-1030003424,negative,0.9125193357467651
1478,1/26/2021 1:53:45 PM,MeiraGTx's AAV-CNGA3 Fast Track'd in U.S. for inherited retinal disease,Seeking Alpha,https://seekingalpha.com/news/3654336-meiragtxs-aav-cnga3-fast-trackd-in-us-for-inherited-retinal-disease?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8919892907142639
1479,1/26/2021 2:07:40 PM,"The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market",Benzinga,/news/stocks/the-daily-biotech-pulse-novartis-misses-j-j-beats-in-big-pharma-earnings-vaccine-developer-curevac-taps-equity-market-1030004007,negative,0.7611163854598999
1480,1/26/2021 4:16:59 PM,"Johnson & Johnson expects to release COVID-19 vaccine results next week, CFO tells CNBC",Seeking Alpha,https://seekingalpha.com/news/3654321-johnson-johnson-expects-to-release-covid-19-vaccine-results-next-week-cfo-tells-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8813974857330322
1481,1/26/2021 5:38:19 PM,JNJ earnings release brightens U.S. biopharma outlook - BofA,Seeking Alpha,https://seekingalpha.com/news/3654484-jnj-earnings-release-brightens-us-biopharma-outlook-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.363226979970932
1482,1/27/2021 8:56:46 AM,"AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch ",RTTNews,/news/stocks/agio-s-activate-t-hits-goals-edsa-catches-eye-jnj-provides-rosy-outlook-vxrt-on-watch-1030008289,negative,0.8746792674064636
1483,1/27/2021 1:35:59 PM,"The Daily Biotech Pulse: Sorrento, Immutep Surge On COVID-19 Study Data, T2 Biosystems Sinks On Preannouncement",Benzinga,/news/stocks/the-daily-biotech-pulse-sorrento-immutep-surge-on-covid-19-study-data-t2-biosystems-sinks-on-preannouncement-1030009241,positive,0.8347625136375427
1484,1/27/2021 2:15:11 PM,"As It Hits $100M In Assets Under Management, XOUT Proves Exclusion Matters",Benzinga,/news/etf/as-it-hits-100m-in-assets-under-management-xout-proves-exclusion-matters-1030009668,negative,0.45896273851394653
1485,1/27/2021 2:19:05 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1030009667,positive,0.8142690658569336
1486,1/27/2021 2:41:14 PM,First Psychedelics ETF Debuts On NEO Exchange,Benzinga,/news/stocks/first-psychedelics-etf-debuts-on-neo-exchange-1030009809,positive,0.9312703609466553
1487,1/27/2021 3:52:54 PM,"Johnson & Johnson could have 'tens of millions' of COVID-19 doses by end of February, Gottlieb says",Seeking Alpha,https://seekingalpha.com/news/3654948-johnson-johnson-could-have-tens-of-millions-of-covid-19-doses-by-end-of-march-gottlieb-says?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7929227948188782
1488,1/27/2021 6:43:34 PM,7 Reliable Index Funds To Set And Forget For The Long Term,InvestorPlace,/news/stocks/7-reliable-index-funds-to-set-and-forget-for-the-long-term-1030011503,positive,0.8705222010612488
1489,1/28/2021 5:03:51 PM,How to Ride the Covid-19 Bull with Moderna,InvestorPlace,/news/stocks/how-to-ride-covid-19-bull-moderna-stock-1030016518,positive,0.9071888327598572
1490,1/29/2021 12:02:52 AM,"Major pharma set for strong 2021, and trading at a 35% discount to market - J.P. Morgan",Seeking Alpha,https://seekingalpha.com/news/3655985-major-pharma-set-for-strong-2021-and-trading-at-a-35-discount-to-market-jp-morgan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.795691967010498
1491,1/29/2021 10:20:35 AM,"Once approved, J&J to initiate U.S. supply of COVID-19 vaccine with 2M doses - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3656030-once-approved-jj-to-initiate-us-supply-of-covid-19-vaccine-with-2m-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4999227523803711
1492,1/29/2021 1:16:24 PM,Johnson & Johnson COVID-19 vaccine 66% effective in global trial,Seeking Alpha,https://seekingalpha.com/news/3656132-johnson-johnson-covid-19-vaccine-66-effective-in-global-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9030655026435852
1493,1/29/2021 1:46:43 PM,"Moderna, BioNTech, Pfizer surge after JNJ COVID-19 vaccine data",Seeking Alpha,https://seekingalpha.com/news/3656159-moderna-biontech-pfizer-surge-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7786161303520203
1494,1/29/2021 1:53:34 PM,NVAX Stock: Why Novavax Shares Are Shooting Higher Today,InvestorPlace,/news/stocks/nvax-stock-why-novavax-shares-are-shooting-higher-today-1030020363,negative,0.8415887355804443
1495,1/29/2021 2:19:28 PM,Inovio climbs in premarket after JNJ COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3656197-inovio-climbs-in-premarket-after-jnj-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8005190491676331
1496,1/29/2021 2:31:10 PM,"J&J COVID-19 Vaccine Shows Complete Protection Against Hospitalization, 28 Days Post-vaccination ",RTTNews,/news/stocks/j-j-covid-19-vaccine-shows-complete-protection-against-hospitalization-28-days-post-vaccination-1030019893,negative,0.9198630452156067
1497,1/29/2021 3:33:02 PM,Dow slides 200 points on concerns of retail investors' speculative trading,Business Insider,https://www.businessinsider.com/stock-market-news-today-indexes-reddit-trader-speculation-vaccine-data-2021-1,neutral,0.9311949014663696
1498,1/29/2021 6:19:49 PM,JNJ COVID-19 vaccine will be a key contributor to normalcy ‚Äì BofA,Seeking Alpha,https://seekingalpha.com/news/3656303-jnj-covid-19-vaccine-will-be-key-contributor-for-normalcy-bofa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.636991024017334
1499,1/29/2021 8:30:31 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3656322-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1500,1/30/2021 7:19:15 PM,"The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-merck-pfizer-in-earnings-mix-plus-adamas-mallinckrodt-fda-decisions-ipos-and-more-1030022250,positive,0.8783656358718872
1501,1/31/2021 2:31:04 PM,Don‚Äôt Overlook These 3 Dividend Kings,InvestorPlace,/news/stocks/dont-overlook-these-3-dividend-kings-1030023138,positive,0.898318350315094
1502,2/1/2021 1:05:13 PM,"Moderna cut to underperform at BofA, with sales estimates 'unrealistic'",Seeking Alpha,https://seekingalpha.com/news/3656554-moderna-downgraded-to-underperform-at-bofa-citing-valuation?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9607189893722534
1503,2/1/2021 3:09:27 PM,CanSino to further advance late-stage trial for COVID-19 shot after interim analysis,Seeking Alpha,https://seekingalpha.com/news/3656650-cansino-to-further-advance-late-stage-trial-for-covid-19-shot-after-interim-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8015657663345337
1504,2/1/2021 4:40:03 PM,7 Blue Chip Stocks to Help Prepare For Your Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-help-prepare-your-retirement-1030028811,positive,0.8655568361282349
1505,2/1/2021 6:29:28 PM,Moderna Analyst: Unrealistic COVID-19 Vaccine Expectations Create Unfavorable Setup,Benzinga,/news/stocks/moderna-analyst-unrealistic-covid-19-vaccine-expectations-create-unfavorable-setup-1030028936,neutral,0.9562428593635559
1506,2/2/2021 9:58:12 AM,"Dosing underway in Janssen, Exonate's study of EXN 407 in diabetic macular oedema",Seeking Alpha,https://seekingalpha.com/news/3657037-dosing-underway-in-janssen-exonates-study-of-exn-407-in-diabetic-macular-oedema?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6009299159049988
1507,2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-jnj-sjm-por-bokf-iff-o-avgo-cmcsa-1030034395,positive,0.8395258784294128
1508,2/2/2021 3:09:53 PM,8 Dividend Stocks With a Decade of Dividend Increases,InvestorPlace,/news/stocks/8-dividend-stocks-decade-dividend-increases-1030033865,positive,0.8395258784294128
1509,2/2/2021 4:22:56 PM,7 Stocks to Buy for the Long Run,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-long-run-1030034388,positive,0.8695151209831238
1510,2/2/2021 9:11:16 PM,JNJ receives FDA approval for monofocal intraocular lens,Seeking Alpha,https://seekingalpha.com/news/3657456-jnj-receives-fda-approval-for-monofocal-intraocular-lens?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9305832982063293
1511,2/3/2021 10:16:07 AM,Read the Label Carefully Before Gambling on Ocugen Stock,InvestorPlace,/news/stocks/read-label-carefully-ocgn-stock-1030037523,positive,0.9292657375335693
1512,2/4/2021 12:52:45 PM,"Sana prices upsized IPO at $25, above the expected range, trades today",Seeking Alpha,https://seekingalpha.com/news/3658334-sana-prices-upsized-ipo-at-25-above-the-expected-range-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8467879891395569
1513,2/4/2021 10:55:26 PM,Johnson & Johnson applies for emergency use OK for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3658893-johnson-johnson-applies-for-emergency-use-ok-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8062297701835632
1514,2/5/2021 2:55:57 AM,J&J Seeks FDA Emergency Authorization For World's First Single-dose Covid-19 Vaccine ,RTTNews,/news/stocks/j-j-seeks-fda-emergency-authorization-for-world-s-first-single-dose-covid-19-vaccine-1030046218,negative,0.7679899334907532
1515,2/5/2021 8:38:02 AM,"JNJ Single-shot COVID-19 Vaccine At FDA Altar, KPTI Expands Xpovio's Footprint, OTLK On Track ",RTTNews,/news/stocks/jnj-single-shot-covid-19-vaccine-at-fda-altar-kpti-expands-xpovio-s-footprint-otlk-on-track-1030047435,negative,0.9038209319114685
1516,2/5/2021 10:23:40 AM,"8 Stocks To Watch For February 5, 2021",Benzinga,/news/stocks/8-stocks-to-watch-for-february-5-2021-1030047675,positive,0.8677322268486023
1517,2/5/2021 11:13:17 AM,Bolt Biotherapeutics raises $230M in IPO,Seeking Alpha,https://seekingalpha.com/news/3658964-bolt-biotherapeutics-raises-230m-in-ipo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6293289065361023
1518,2/5/2021 11:58:38 AM,"Cell therapy biotech Vor Biopharma prices upsized IPO at $18/share, trades today",Seeking Alpha,https://seekingalpha.com/news/3658982-cell-therapy-biotech-vor-biopharma-prices-upsized-ipo-at-18share-trades-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8695681095123291
1519,2/5/2021 1:44:38 PM,"The Daily Biotech Pulse: J&J Files For COVID-19 Vaccine Approval, Zimmer Biomet's Spin-Off, IPO Deluge Hits Street",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-covid-19-vaccine-approval-zimmer-biomet-s-spin-off-ipo-deluge-hits-street-1030048263,positive,0.7921019792556763
1520,2/5/2021 7:23:28 PM,3 Downtrodden Stocks to Buy as the Crowds Return,InvestorPlace,/news/stocks/3-downtrodden-stocks-to-buy-as-the-crowds-return-1030049778,positive,0.7549920678138733
1521,2/9/2021 12:16:24 PM,JNJ‚Äôs Erleada yields positive data in late-stage trial for prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3659881-jnjs-erleada-yields-positive-data-in-late-stage-trial-for-prostate-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9539298415184021
1522,2/9/2021 1:50:53 PM,7 Blue-Chip Stocks With Gains and Pedigree,InvestorPlace,/news/stocks/7-blue-chip-stocks-with-gains-and-pedigree-1030061482,negative,0.7797932028770447
1523,2/9/2021 6:27:58 PM,7 Safe Stocks for Reddit‚Äôs WSB Bull Gang,InvestorPlace,/news/stocks/7-safe-stocks-for-reddits-wsb-bull-gang-rkt-ibm-baba-mmm-jnj-ko-net-1030062358,positive,0.9133845567703247
1524,2/10/2021 7:56:54 AM,"South Africa to discontinue AstraZeneca vaccine, will give J&J shots",Seeking Alpha,https://seekingalpha.com/news/3660358-south-africa-to-discontinue-astrazeneca-vaccine-will-give-jj-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9134742021560669
1525,2/10/2021 9:02:19 AM,Expect annual COVID shots for the next several years - Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3660361-expect-annual-covid-shots-for-the-next-several-years-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8858148455619812
1526,2/10/2021 6:10:49 PM,PhaseBio shares spike 22% in afternoon trading,Seeking Alpha,https://seekingalpha.com/news/3660706-phasebio-shares-spike-22-in-afternoon-trading?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9363282918930054
1527,2/10/2021 8:45:02 PM,JNJ cloud transition leads BTIG to raise Model N to buy,Seeking Alpha,https://seekingalpha.com/news/3660770-jnj-cloud-transition-leads-btig-to-raise-model-n-to-buy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.577089786529541
1528,2/11/2021 1:40:41 PM,AC Immune and JNJ‚Äôs Alzheimer‚Äôs jab succeeds in early-stage study,Seeking Alpha,https://seekingalpha.com/news/3661202-ac-immune-and-jnjs-alzheimers-jab-succeeds-in-early-stage-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8600291013717651
1529,2/11/2021 2:16:05 PM,AC Immune's Alzheimer's Vaccine Candidate Elicit Response In Early-Stage Study; Shares Rally,Benzinga,/news/stocks/ac-immune-s-alzheimer-s-vaccine-candidate-elicit-response-in-early-stage-study-shares-rally-1030072705,negative,0.8289855718612671
1530,2/11/2021 3:14:41 PM,ACIU Stock: Why AC Immune Shares Are Rocketing Higher Today,InvestorPlace,/news/stocks/aciu-stock-why-ac-immune-shares-are-rocketing-higher-today-1030073976,negative,0.8638250231742859
1531,2/11/2021 5:11:17 PM,Cardiff Oncology's Onvansertib Combo Associated With Two-Fold Increase Disease Control Rate In Prostate Cancer Study,Benzinga,/news/stocks/cardiff-oncology-s-onvansertib-combo-associated-with-two-fold-increase-disease-control-rate-in-prostate-cancer-study-1030073754,neutral,0.45165950059890747
1532,2/11/2021 5:25:26 PM,COVID-19 vaccination to cover 75% of U.S. adults by mid-summer: Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/3661304-covid-19-vaccination-to-cover-three-quarters-of-us-adults-by-summer-morgan-stanley?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6417354345321655
1533,2/11/2021 8:57:13 PM,Biden to announce a deal for another 200M doses of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3661377-biden-to-announce-a-deal-for-another-200m-doses-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7597874402999878
1534,2/13/2021 9:00:00 PM,"Pharmas engaged in Alzheimer's, the 'holy grail' of drug development",Seeking Alpha,https://seekingalpha.com/news/3661766-pharmas-engaged-in-alzheimers-the-holy-grail-of-drug-development?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8926677107810974
1535,2/15/2021 12:42:46 PM,South Africa gives green light to J&J's vaccine implementation study,Seeking Alpha,https://seekingalpha.com/news/3661980-south-africa-gives-green-light-to-jjs-vaccine-implementation-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8674964308738708
1536,2/16/2021 3:18:43 PM,Novavax U.S. trial enrollment for COVID-19 shot is nearing completion: CEO,Seeking Alpha,https://seekingalpha.com/news/3662269-novavax-us-trial-enrollment-for-covid-19-shot-is-nearing-completion-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6466667652130127
1537,2/16/2021 6:07:34 PM,JNJ files for conditional approval for COVID-19 vaccine in Europe,Seeking Alpha,https://seekingalpha.com/news/3662377-jnj-seeks-conditional-approval-for-covid-19-vaccine-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7011615037918091
1538,2/17/2021 7:56:35 PM,7 Blue-Chip Stocks That Aren‚Äôt a Gamble,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-arent-a-gamble-1030094166,positive,0.9075457453727722
1539,2/18/2021 11:45:43 AM,COVID-19 vaccine developers to benefit from supply constraints and uneven distribution,Seeking Alpha,https://seekingalpha.com/news/3663356-covid-19-vaccine-developers-to-benefit-from-supply-constraints-and-uneven-distribution?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7471115589141846
1540,2/18/2021 2:23:25 PM,Here's Why High Dividend Stocks Remain An Attractive Choice,Benzinga,/news/stocks/here-s-why-high-dividend-stocks-remain-an-attractive-choice-1030097073,positive,0.7893080115318298
1541,2/18/2021 7:55:46 PM,NVAX Stock Is the Most Undervalued Vaccine Maker for Endemic Covid-19,InvestorPlace,/news/stocks/nvax-stock-most-undervalued-vaccine-maker-endemic-covid-19-1030099038,neutral,0.6225293874740601
1542,2/19/2021 12:59:04 PM,JNJ seeks WHO emergency use nod for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3663893-jnj-seeks-who-emergency-use-nod-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8651227355003357
1543,2/19/2021 2:02:36 PM,Johnson & Johnson Seeks Emergency WHO Nod For Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-seeks-emergency-who-nod-for-single-dose-covid-19-vaccine-1030101439,positive,0.7020785212516785
1544,2/20/2021 3:36:28 PM,"The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings",Benzinga,/news/stocks/the-week-ahead-in-biotech-j-j-vaccine-adcom-meeting-sarepta-fda-decision-and-plenty-of-earnings-1030104010,positive,0.8801164627075195
1545,2/21/2021 4:18:07 AM,A new model shows U.S. could reach COVID-19 herd immunity by July,Seeking Alpha,https://seekingalpha.com/news/3664177-a-new-model-shows-us-could-reach-covid-19-herd-immunity-by-july?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6344996094703674
1546,2/22/2021 11:32:32 AM,Sanofi to support JNJ in manufacturing of COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3664218-sanofi-to-support-jnj-in-manufacturing-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8440603613853455
1547,2/22/2021 2:07:58 PM,Six stocks hedge funds and mutual funds love (and 20 they don't): At the Open,Seeking Alpha,https://seekingalpha.com/news/3664311-six-stocks-hedge-funds-and-mutual-funds-love?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9283661842346191
1548,2/23/2021 2:25:13 AM,"J&J sets aside $3.9B for talc verdict, settlements",Seeking Alpha,https://seekingalpha.com/news/3664687-jj-sets-aside-39b-for-talc-verdict-settlements?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9045209884643555
1549,2/23/2021 3:38:06 AM,"Johnson & Johnson Sets Aside $3.9 Bln For Baby Powder Verdict, Settlements ",RTTNews,/news/stocks/johnson-johnson-sets-aside-3-9-bln-for-baby-powder-verdict-settlements-1030109923,positive,0.7789359092712402
1550,2/23/2021 5:41:49 PM,Johnson & Johnson plans 20M COVID-19 vaccine doses by end of March,Seeking Alpha,https://seekingalpha.com/news/3665028-johnson-johnson-plans-20m-covid-19-vaccine-doses-by-end-of-march?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9038834571838379
1551,2/23/2021 7:02:29 PM,Why You Should Keep Your Distance from Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-stay-your-distance-from-ocugen-1030114797,positive,0.9112824201583862
1552,2/24/2021 1:17:19 PM,RLFTF: Why Little-Known Relief Therapeutics Is Climbing Today,InvestorPlace,/news/stocks/rlftf-why-little-known-relief-therapeutics-is-climbing-today-brpa-stock-1030119085,negative,0.6067991852760315
1553,2/24/2021 1:44:53 PM,FDA staff finds J&J COVID vaccine effective ahead of review,Seeking Alpha,https://seekingalpha.com/news/3665494-jnj-covid-19-vaccine-fda-releases-briefing-documents-ahead-of-review?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9339909553527832
1554,2/24/2021 3:03:19 PM,What Will the Stock Market Do Today? 4 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-big-stories-rfltf-stock-wkhs-stock-fsr-stock-1030119078,positive,0.928909957408905
1555,2/24/2021 4:08:48 PM,"United Airlines, Royal Caribbean lead travel and leisure stocks higher",Seeking Alpha,https://seekingalpha.com/news/3665590-united-airlines-royal-caribbean-lead-travel-and-leisure-stocks-higher?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9054610729217529
1556,2/24/2021 5:52:47 PM,"Airline Stocks: 2 Big Reasons AAL, DAL and UAL Stock Are Soaring Today",InvestorPlace,/news/stocks/airline-stocks-2-big-reasons-aal-dal-and-ual-stock-are-soaring-today-1030119942,neutral,0.5683377981185913
1557,2/24/2021 7:57:21 PM,ABNB Stock: Why Airbnb Is Booking Big Gains Today,InvestorPlace,/news/stocks/abnb-stock-why-airbnb-is-booking-big-gains-today-q4-earnings-1030120277,negative,0.9073722958564758
1558,2/25/2021 7:29:12 AM,Johnson & Johnson Single-dose COVID Vaccine Safe And Effective: FDA ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-vaccine-safe-and-effective-fda-1030121922,positive,0.792874276638031
1559,2/25/2021 3:22:19 PM,5 Surefire Stocks If the Market Crashes,InvestorPlace,/news/stocks/5-surefire-stocks-if-the-market-crash-1030125308,positive,0.870312511920929
1560,2/26/2021 12:00:07 PM,J&J‚Äôs COVID-19 vaccine set to undergo FDA review; EU review set for early March,Seeking Alpha,https://seekingalpha.com/news/3667041-jjs-covid-19-vaccine-set-to-undergo-fda-review-eu-review-set-for-early-march?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8958115577697754
1561,2/26/2021 2:16:52 PM,"The Daily Biotech Pulse: Adcom Test Awaits J&J's COVID-19 Vaccine, Lilly To Supply Additional Antibody Therapy Doses To US, Regulatory Setback For Tricida",Benzinga,/news/stocks/the-daily-biotech-pulse-adcom-test-awaits-j-j-s-covid-19-vaccine-lilly-to-supply-additional-antibody-therapy-doses-to-us-regulatory-setback-for-tricida-1030129439,neutral,0.9285117387771606
1562,2/26/2021 3:20:06 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-hmbl-tsnp-stock-tsnpd-jnj-abnb-stock-1030130462,positive,0.9298974871635437
1563,2/26/2021 10:10:23 PM,Johnson & Johnson rises as COVID-19 vaccine clears FDA panel vote,Seeking Alpha,https://seekingalpha.com/news/3667371-johnson-johnson-rises-as-covid-19-vaccine-clears-fda-panel-vote?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6096546053886414
1564,2/27/2021 3:53:56 PM,FDA Says 'rapidly Works Toward' Emergency Use Approval Of J&J's Single-shot COVID-19 Vaccine ,RTTNews,/news/stocks/fda-says-rapidly-works-toward-emergency-use-approval-of-j-j-s-single-shot-covid-19-vaccine-1030131785,negative,0.895912230014801
1565,2/27/2021 11:21:57 PM,Johnson & Johnson COVID-19 vaccine wins FDA's emergency-use approval,Seeking Alpha,https://seekingalpha.com/news/3667403-johnson-johnson-covid-19-vaccine-wins-fdas-emergency-use-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.920475423336029
1566,2/28/2021 3:04:59 AM,JNJ to deliver fewer COVID-19 vaccine doses amid production problems: FT,Seeking Alpha,https://seekingalpha.com/news/3667406-jnj-to-deliver-fewer-covid-19-vaccine-doses-amid-production-problems-ft?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7871137857437134
1567,2/28/2021 5:52:51 AM,FDA Authorizes Emergency Use Of Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/fda-authorizes-emergency-use-of-johnson-johnson-s-single-dose-covid-19-vaccine-1030131930,positive,0.8950533270835876
1568,3/1/2021 6:05:10 AM,CDC recommends JNJ's single-shot COVID-19 vaccine in U.S.,Seeking Alpha,https://seekingalpha.com/news/3667418-cdc-recommends-jnjs-first-single-shot-covid-19-vaccine-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6686902642250061
1569,3/1/2021 11:51:19 AM,JNJ COVID-19 vaccine distribution started: McKesson,Seeking Alpha,https://seekingalpha.com/news/3667462-jnj-covid-19-vaccine-distribution-started-mckesson?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9332539439201355
1570,3/1/2021 12:02:57 PM,A Peek Into The Markets: US Stock Futures Rise; J&J Secures Emergency Authorization for Covid-19 Vaccine,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-rise-j-j-secures-emergency-authorization-for-covid-19-vaccine-1030134387,negative,0.8418796062469482
1571,3/1/2021 1:58:08 PM,"Here's Why Apple, Microsoft, Disney, Plug Power Are Moving",Benzinga,/news/stocks/here-s-why-apple-microsoft-disney-plug-power-are-moving-1030134973,positive,0.9387088418006897
1572,3/1/2021 3:16:25 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-warren-buffett-bitcoin-nio-stock-doge-ccl-sos-1030136574,positive,0.9298974871635437
1573,3/1/2021 4:13:09 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Receives FDA Approval For COVID-19 Vaccine,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-receives-fda-approval-for-covid-19-vaccine-1030136012,negative,0.9409385919570923
1574,3/1/2021 5:02:52 PM,"What's Moving The Market Monday? US, Asian Stocks Higher, Europe Stocks Lower",Benzinga,/news/stocks/what-s-moving-the-market-monday-us-asian-stocks-higher-europe-stocks-lower-1030136260,negative,0.45953139662742615
1575,3/1/2021 6:16:55 PM,Mid-Day Market Update: Dow Jumps Over 600 Points; CorMedix Shares Plummet,Benzinga,/news/stocks/mid-day-market-update-dow-jumps-over-600-points-cormedix-shares-plummet-1030136675,neutral,0.9594452381134033
1576,3/1/2021 7:11:23 PM,7 Value Stocks Ready for the Next 10 Years,InvestorPlace,/news/stocks/7-value-stocks-ready-for-the-next-10-years-1030136985,positive,0.8458631038665771
1577,3/1/2021 8:37:10 PM,Mid-Afternoon Market Update: Crud Oil Down Over 1%; Morphic Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-crud-oil-down-over-1-morphic-shares-spike-higher-1030137126,neutral,0.9100152850151062
1578,3/1/2021 10:11:05 PM,3 Penny Stocks To Buy According To Top Stock Market Analysts,Benzinga,/news/stocks/3-penny-stocks-to-buy-according-to-top-stock-market-analysts-1030137366,positive,0.8910472989082336
1579,3/1/2021 10:59:00 PM,Johnson & Johnson -- Moody's: J&J vaccine emergency authorization is credit positive,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-vaccine-emergency-authorization-is-credit-positive-1030137651,positive,0.821104884147644
1580,3/2/2021 1:21:01 PM,Merck to help Johnson & Johnson in COVID-19 vaccine production,Seeking Alpha,https://seekingalpha.com/news/3668226-merck-to-help-johnson-johnson-in-covid-19-vaccine-production?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6223598718643188
1581,3/2/2021 3:00:28 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-warren-wealth-tax-gme-rkt-stock-1030141280,positive,0.9298974871635437
1582,3/2/2021 10:01:45 PM,Merck to receive $269 million for production of COVID-19 vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3668535-merck-to-receive-269-million-for-production-of-covid-19-vaccines-and-drugs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.826619565486908
1583,3/2/2021 10:11:13 PM,"Texas, Mississippi roll back mask mandates, pandemic business restrictions",Seeking Alpha,https://seekingalpha.com/news/3668542-texas-mississippi-roll-back-mask-mandates-pandemic-business-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8283343315124512
1584,3/3/2021 1:46:17 PM,"The Daily Biotech Pulse: KemPharm ADHD Drug Gets The Nod, MediciNova Shelves Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-kempharm-adhd-drug-gets-the-nod-medicinova-shelves-vaccine-study-1030144928,positive,0.7064564228057861
1585,3/3/2021 2:31:53 PM,7 Blue-Chip Stocks That May Be Perfect For Retirement,InvestorPlace,/news/stocks/7-blue-chip-stocks-that-may-be-perfect-for-retirement-1030146050,positive,0.8465081453323364
1586,3/3/2021 4:18:10 PM,7 Stocks for Any Retiree to Consider,InvestorPlace,/news/stocks/7-stocks-for-any-retiree-to-consider-1030146542,positive,0.9370339512825012
1587,3/3/2021 4:31:27 PM,JNJ takes its talc verdict battle to U.S. Supreme Court,Seeking Alpha,https://seekingalpha.com/news/3668841-jnj-takes-its-talc-verdict-battle-to-supreme-court?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8683717250823975
1588,3/3/2021 5:02:46 PM,"U.S. government to provide $100M to Merck, J&J to double COVID-19 vaccine output",Seeking Alpha,https://seekingalpha.com/news/3668862-us-government-to-provide-100m-to-merck-johnson-and-johnson-to-double-covid-19-vaccine-output?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9191229343414307
1589,3/3/2021 8:12:22 PM,JNJ cut to hold at CFRA citing reopening trade and lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/3669029-jnj-cut-to-hold-at-cfra-citing-reopening-trade-and-lack-of-catalysts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9283291697502136
1590,3/4/2021 1:50:49 PM,Big Tech and non-tech valuations may be closer than they appear: At the Open,Seeking Alpha,https://seekingalpha.com/news/3669326-big-tech-and-non-tech-valuations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7399551868438721
1591,3/4/2021 5:45:36 PM,Avoid Johnson & Johnson Shares Like the Plague,InvestorPlace,/news/stocks/jnj-stock-avoid-johnson-johnson-shares-like-the-plague-1030152096,positive,0.8476832509040833
1592,3/4/2021 7:38:08 PM,Johnson & Johnson Is One of the Best Healthcare Plays on the Market,InvestorPlace,/news/stocks/jnj-stock-is-one-of-the-best-healthcare-on-the-market-1030152430,negative,0.5902022123336792
1593,3/5/2021 2:29:28 PM,JNJ receives Health Canada approval for COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3669924-jnj-receives-health-canada-approval-for-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8766621947288513
1594,3/5/2021 3:27:45 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-oil-stocks-opec-gme-reddit-ipo-1030155707,positive,0.9259525537490845
1595,3/5/2021 4:50:37 PM,7 Mega-Cap Stocks Standing Above the Fray,InvestorPlace,/news/stocks/7-mega-cap-stocks-standing-above-the-fray-1030155694,negative,0.6427069902420044
1596,3/5/2021 8:15:12 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3669995-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1597,3/5/2021 8:55:23 PM,Carnival Is Climbing Too High Too Fast,InvestorPlace,/news/stocks/ccl-stock-moving-too-high-too-fast-1030156156,positive,0.5624954700469971
1598,3/8/2021 11:15:46 AM,Is Ocugen Worth $18 or Just a Couple of Bucks?,InvestorPlace,/news/stocks/is-ocgn-stock-worth-18-or-just-a-couple-of-bucks-1030159343,positive,0.933696448802948
1599,3/8/2021 4:25:05 PM,Sell Inovio While You Still Can,InvestorPlace,/news/stocks/sell-ino-stock-while-you-still-can-1030160441,positive,0.9125025868415833
1600,3/8/2021 5:51:34 PM,"Biden event with J&J, Merck moved over Emergent controversy - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3670344-biden-event-with-jj-merck-moved-over-emergent-controversy-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7927644848823547
1601,3/8/2021 8:58:27 PM,Johnson & Johnson Is a Stock to Buy and Hold Forever,InvestorPlace,/news/stocks/jnj-stock-johnson-johnson-is-a-stock-to-buy-and-hold-forever-1030161050,positive,0.9522393941879272
1602,3/9/2021 4:03:06 PM,Supply issues may impact J&J EU COVID-19 vaccine supply goal - Reuters,Seeking Alpha,https://seekingalpha.com/news/3670757-supply-issues-may-impact-johnson-and-johnson-q2-eu-covid-19-vaccine-supply-goal-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5972892045974731
1603,3/9/2021 9:42:55 PM,Market Recap: The Real Driver Behind Today‚Äôs Strength,InvestorPlace,/news/stocks/market-recap-the-real-driver-behind-tuesday-market-strength-1030166121,positive,0.867275059223175
1604,3/10/2021 12:38:38 PM,Pfizer/BioNTech to supply extra 4M vaccine doses to EU to tackle virus border clusters,Seeking Alpha,https://seekingalpha.com/news/3671111-pfizerbiontech-to-supply-extra-4m-vaccine-doses-to-eu-to-tackle-virus-border-clusters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7414291501045227
1605,3/10/2021 2:58:14 PM,Biden to order 100 million additional J&J COVID-19 vaccine doses - NBC News,Seeking Alpha,https://seekingalpha.com/news/3671220-biden-to-order-100-million-additional-jj-covid-19-vaccine-doses-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7856127619743347
1606,3/11/2021 12:51:15 PM,More Doses Of Johnson & Johnson's Covid-19 Vaccine For US ,RTTNews,/news/stocks/more-doses-of-johnson-johnson-s-covid-19-vaccine-for-us-1030172649,positive,0.8758217096328735
1607,3/11/2021 1:28:47 PM,JNJ‚Äôs COVID-19 vaccine recommended for European approval,Seeking Alpha,https://seekingalpha.com/news/3671687-jnjs-covid-19-vaccine-recommended-for-european-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7996926307678223
1608,3/11/2021 4:22:47 PM,Johnson & Johnson' Single-dose COVID-19 Vaccine Recommended For Use In EU ,RTTNews,/news/stocks/johnson-johnson-single-dose-covid-19-vaccine-recommended-for-use-in-eu-1030174234,positive,0.6332618594169617
1609,3/11/2021 4:46:06 PM,J&J's COVID-19 vaccine gets European Commission conditional marketing authorization,Seeking Alpha,https://seekingalpha.com/news/3671830-jjs-covid-19-vaccine-gets-european-commission-conditional-marketing-authorization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49696046113967896
1610,3/11/2021 9:05:27 PM,Why UAL Stock Will Continue to Fly High,InvestorPlace,/news/stocks/ual-stock-why-united-airlines-will-continue-to-fly-high-1030175430,positive,0.898987889289856
1611,3/11/2021 9:08:32 PM,JNJ to produce up to 3 billion COVID-19 vaccine doses in 2022,Seeking Alpha,https://seekingalpha.com/news/3671942-jnj-to-produce-up-to-3-billion-covid-19-vaccine-doses-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5254356265068054
1612,3/11/2021 9:44:40 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-cpng-stock-ocgn-stock-stimulus-1030175736,positive,0.9254742860794067
1613,3/12/2021 3:27:50 AM,Johnson & Johnson's Single-dose COVID-19 Vaccine Gets Conditional Marketing Authorization In EU ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-gets-conditional-marketing-authorization-in-eu-1030175963,negative,0.7321785688400269
1614,3/12/2021 9:30:53 AM,Biden says all U.S. adults to be eligible for vaccines by May 1,Seeking Alpha,https://seekingalpha.com/news/3672131-biden-says-all-us-adults-to-be-eligible-for-vaccines-by-may-1?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8409744501113892
1615,3/12/2021 10:01:15 AM,7 of the Best Value Stocks on the Market Today,InvestorPlace,/news/stocks/7-of-the-best-value-stocks-on-the-market-today-1030177716,positive,0.8045743703842163
1616,3/12/2021 11:17:58 AM,Novavax (NVAX) shares continue to climb after robust COVID-19 vaccine data,Seeking Alpha,https://seekingalpha.com/news/3672149-novavax-nvax-shares-continue-to-climb-on-covid-19-vaccine-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9462754726409912
1617,3/12/2021 3:07:40 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ride-stock-nvax-stock-infrastructure-nflx-1030179712,positive,0.9298974871635437
1618,3/12/2021 4:40:51 PM,WHO authorizes Johnson & Johnson vaccine for emergency use worldwide,Seeking Alpha,https://seekingalpha.com/news/3672319-who-authorizes-johnson-johnson-vaccine-for-emergency-use-worldwide?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9355335831642151
1619,3/12/2021 4:43:05 PM,7 Healthcare Stocks to Buy and Hold for the Long Term,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-and-hold-for-the-long-term-1030180655,positive,0.9046281576156616
1620,3/12/2021 6:28:30 PM,Johnson & Johnson's Single-Shot COVID Vaccine Issued Emergency Use Listing By WHO ,RTTNews,/news/stocks/johnson-johnson-s-single-shot-covid-vaccine-issued-emergency-use-listing-by-who-1030180848,positive,0.9342151284217834
1621,3/12/2021 10:06:30 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-vaccines-nvax-wkhs-ride-stock-chpt-stock-nfts-1030182966,positive,0.9254742860794067
1622,3/14/2021 5:40:20 AM,"Big Pharma is pushing back the pandemic, but its stocks are cheap - Barron's",Seeking Alpha,https://seekingalpha.com/news/3672437-big-pharma-is-pushing-back-the-pandemic-but-its-stocks-are-cheap-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6729742884635925
1623,3/15/2021 10:16:28 AM,Ocugen Needs Pieces To Fall Into Place Before It‚Äôs a Solid Vaccine Play,InvestorPlace,/news/stocks/ocgn-stock-is-purely-a-speculative-covid-19-vaccine-play-1030203068,positive,0.8894945383071899
1624,3/15/2021 12:02:14 PM,Takeda to support manufacturing of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3672551-takeda-to-support-manufacturing-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.508534848690033
1625,3/15/2021 12:24:06 PM,The Top Reason to Consider iBio Stock in the Long Term,InvestorPlace,/news/stocks/the-top-reason-to-consider-ibio-stock-in-the-long-term-1030204312,positive,0.898812472820282
1626,3/15/2021 4:30:50 PM,8 of the Best Index Funds With Ultra-Low Fees,InvestorPlace,/news/stocks/8-of-the-best-index-funds-with-ultra-low-fees-1030206599,negative,0.6150591373443604
1627,3/15/2021 6:18:28 PM,Sell Ocugen Stock Now Before It Sinks Even Further,InvestorPlace,/news/stocks/sell-ocgn-stock-now-before-it-sinks-even-further-1030207527,positive,0.9194988012313843
1628,3/15/2021 6:19:30 PM,Ocugen plans to sell 100M doses of COVID-19 vaccine in U.S. in 2021 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3672781-ocugen-plans-to-sell-100m-doses-of-covid-19-vaccine-in-us-in-2021-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6109246611595154
1629,3/15/2021 6:59:36 PM,OCGN Stock: Red-Hot Ocugen Eyes U.S. Vaccine Launch in Q2,InvestorPlace,/news/stocks/ocgn-stock-red-hot-ocugen-eyes-u-s-vaccine-launch-in-q2-1030207522,positive,0.8990409970283508
1630,3/15/2021 8:12:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-ocgn-stock-sndl-ccl-aal-tlry-amc-stock-1030208455,positive,0.9254742860794067
1631,3/16/2021 10:41:48 AM,J&J's Tremfya shows efficacy in psoriatic arthritis study through two years,Seeking Alpha,https://seekingalpha.com/news/3672990-jnjs-jnj-tremfya-shows-efficacy-in-late-stage-psoriatic-arthritis-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9286270141601562
1632,3/16/2021 1:17:20 PM,"The Daily Biotech Pulse: Fulgent Nabs CDC Contract, Enzo Rallies, Solid Biosciences Releases Gene Therapy Data, Moderna Begins Pediatric Vaccine Study",Benzinga,/news/stocks/the-daily-biotech-pulse-fulgent-nabs-cdc-contract-enzo-rallies-solid-biosciences-releases-gene-therapy-data-moderna-begins-pediatric-vaccine-study-1030214585,positive,0.8733969330787659
1633,3/16/2021 2:35:36 PM,Investing in Moderna Has Little Upside At This Point,InvestorPlace,/news/stocks/investing-in-mrna-stock-has-little-upside-at-this-point-1030215865,positive,0.9287043213844299
1634,3/17/2021 3:55:14 PM,7 Growth Stocks With Compelling Stories,InvestorPlace,/news/stocks/7-growth-stocks-with-compelling-stories-1030220806,positive,0.57472825050354
1635,3/18/2021 6:28:52 PM,Microvision Isn‚Äôt the Second Coming,InvestorPlace,/news/stocks/microvision-mvis-stock-isnt-the-second-coming-1030225541,positive,0.9199715852737427
1636,3/19/2021 12:35:38 PM,FDA approves Johnson & Johnson's multiple sclerosis drug ponesimod,Seeking Alpha,https://seekingalpha.com/news/3674381-fda-approves-johnson-johnson-multiple-sclerosis-drug-ponvory-ponesimod?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5450810790061951
1637,3/19/2021 1:42:55 PM,Ocugen Stock Is Not One to Trust With Nest Egg Funds,InvestorPlace,/news/stocks/ocgn-stock-ocugen-not-one-to-trust-with-nest-egg-funds-1030228419,positive,0.930368185043335
1638,3/22/2021 11:47:30 AM,AstraZeneca COVID-19 shot shows 79% efficacy; shares rise 2.5%,Seeking Alpha,https://seekingalpha.com/news/3674697-moderna-and-biontech-lower-after-astrazeneca-releases-us-trial-data-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.948603630065918
1639,3/22/2021 2:16:56 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ev-stocks-cciv-stock-gme-stock-sprt-1030232941,positive,0.9298974871635437
1640,3/23/2021 1:02:44 PM,3 Key Reasons to Be Bullish on Airbnb Stock,InvestorPlace,/news/stocks/3-key-reasons-to-be-bullish-on-airbnb-stock-1030236613,positive,0.8414599299430847
1641,3/23/2021 3:55:22 PM,Ocugen Looks Very Dicey at Current Levels,InvestorPlace,/news/stocks/ocugen-ocgn-stock-looks-very-dicey-at-current-levels-1030237828,positive,0.6844010353088379
1642,3/23/2021 4:46:16 PM,Drug pricing legislation introduced by Sanders weighs on pharmas,Seeking Alpha,https://seekingalpha.com/news/3675361-drug-pricing-legislation-introduced-by-sanders-weighs-on-pharmas?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8964442610740662
1643,3/23/2021 6:34:36 PM,JNJ COVID-19 vaccine deliveries to rise as Catalent facility in Indiana gets FDA nod,Seeking Alpha,https://seekingalpha.com/news/3675408-jnj-covid-19-vaccine-deliveries-to-rise-as-catalent-facility-in-indiana-gets-fda-nod?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9461833238601685
1644,3/24/2021 9:23:46 AM,EU set to curb COVID-19 vaccine export to U.K. - Reuters,Seeking Alpha,https://seekingalpha.com/news/3675539-eu-set-to-curb-covid-19-vaccines-export-to-uk-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.48424220085144043
1645,3/24/2021 7:25:44 PM,7 Value Stocks Everyone Is Ignoring,InvestorPlace,/news/stocks/7-value-stocks-everyone-is-ignoring-1030242954,positive,0.9038963913917542
1646,3/25/2021 11:40:48 AM,"Ocugen Stock Has Way More Downside, Even After This Deep Correction",InvestorPlace,/news/stocks/ocgn-stock-more-downside-deep-correction-1030245902,positive,0.524740993976593
1647,3/25/2021 3:55:26 PM,Biden to announce new vaccine goal of 200M shots - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676327-biden-to-announce-new-vaccine-goal-of-200m-shots-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8850842118263245
1648,3/26/2021 12:48:45 PM,J&J's multiple sclerosis drug Ponvory receives positive CHMP opinion,Seeking Alpha,https://seekingalpha.com/news/3676745-johnson-johnson-multiple-sclerosis-drug-ponvory-receives-positive-chmp-opinion?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9393585324287415
1649,3/26/2021 2:02:46 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-gme-stock-nio-stock-wework-ipo-1030250431,positive,0.9298974871635437
1650,3/26/2021 3:53:41 PM,Is Approval Even Enough for Ocugen Stock?,InvestorPlace,/news/stocks/for-ocgn-stock-question-whether-approval-enough-1030250787,positive,0.8683006167411804
1651,3/26/2021 6:30:51 PM,9 First Stocks a New Investor Should Buy,InvestorPlace,/news/stocks/9-first-stocks-new-investor-should-buy-1030251108,positive,0.8350268006324768
1652,3/26/2021 9:17:45 PM,White House considers lifting IP protections for vaccines - CNBC,Seeking Alpha,https://seekingalpha.com/news/3676977-white-house-considers-lifting-ip-protections-for-vaccines-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7832401990890503
1653,3/28/2021 6:12:53 AM,Barron's touts 10 stocks to build retirement income stream,Seeking Alpha,https://seekingalpha.com/news/3677018-barrons-touts-10-stocks-to-build-retirement-income-stream?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8739600777626038
1654,3/29/2021 8:15:24 AM,JNJ to supply up to 400M doses of COVID-19 vaccine to Africa,Seeking Alpha,https://seekingalpha.com/news/3677033-jnj-to-supply-up-to-400m-doses-of-covid-19-vaccine-to-africa?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5018511414527893
1655,3/29/2021 10:57:30 AM,Johnson & Johnson To Supply Up To 400 Mln Doses Of COVID-19 Vaccine Candidate To Africa ,RTTNews,/news/stocks/johnson-johnson-to-supply-up-to-400-mln-doses-of-covid-19-vaccine-candidate-to-africa-1030253605,negative,0.5970836281776428
1656,3/29/2021 4:33:06 PM,J&J will begin delivering vaccine to Europe on April 19 - AFP,Seeking Alpha,https://seekingalpha.com/news/3677266-johnson-johnson-will-begin-delivering-vaccine-to-europe-on-april-19-afp?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8730621337890625
1657,3/29/2021 6:09:45 PM,Ocugen Stock Will Continue to Climb in Anticipation of Vaccine Launch,InvestorPlace,/news/stocks/ocgn-stock-will-continue-to-climb-in-run-up-to-vaccine-launch-1030255859,negative,0.9484990239143372
1658,3/29/2021 11:56:24 PM,7 Reddit Penny Stocks That Are Moving Higher,InvestorPlace,/news/stocks/7-reddit-penny-stocks-that-are-moving-higher-1030265510,positive,0.7790457010269165
1659,3/31/2021 4:52:56 PM,10 Great Dividend Stocks Under $25,InvestorPlace,/news/stocks/10-great-dividend-stocks-under-25-1030265503,positive,0.44901981949806213
1660,3/31/2021 9:57:53 PM,"Manufacturing snafu ruins 15M J&J vaccine doses, delays shipments - New York Times",Seeking Alpha,https://seekingalpha.com/news/3678350-manufacturing-snafu-ruins-15m-johnson-johnson-vaccine-doses-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.941970705986023
1661,4/1/2021 4:30:26 AM,Johnson & Johnson Says COVID-19 Vaccine Batch Fails To Meet Quality Standards ,RTTNews,/news/stocks/johnson-johnson-says-covid-19-vaccine-batch-fails-to-meet-quality-standards-1030266860,neutral,0.9674542546272278
1662,4/1/2021 1:32:55 PM,Johnson & Johnson: Ride Out the Tech Selloff with this Dividend King,InvestorPlace,/news/stocks/johnson-johnson-ride-out-the-tech-selloff-with-this-dividend-king-1030269518,positive,0.7548316121101379
1663,4/1/2021 2:12:16 PM,Emergent‚Äôs plant implicated in vaccine mix-up had issues cited by FDA in 2020: AP,Seeking Alpha,https://seekingalpha.com/news/3678593-emergents-plant-implicated-in-vaccine-mix-up-had-issues-even-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8459296226501465
1664,4/1/2021 6:29:05 PM,7 Healthcare Stocks to Buy to Prepare Your Portfolio For The Next Pandemic,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-to-prepare-your-portfolio-for-the-next-pandemic-1030270707,positive,0.9073498249053955
1665,4/1/2021 6:33:23 PM,Expect American Airlines Stock to Take Off by Summer as Bookings Soar,InvestorPlace,/news/stocks/aal-stock-expect-american-airlines-stock-take-off-bookings-soar-1030270705,negative,0.6062846183776855
1666,4/1/2021 7:51:27 PM,General Electric Will Surge if Spending Plan Goes Through,InvestorPlace,/news/stocks/ge-stock-will-surge-if-spending-plan-goes-through-1030270693,negative,0.6906005144119263
1667,4/2/2021 3:15:15 PM,7 Robinhood Stocks Even Billionaires Want in Their Portfolios,InvestorPlace,/news/stocks/7-robinhood-stocks-even-billionaires-want-in-their-portfolios-1030272181,positive,0.9208254814147949
1668,4/2/2021 4:06:09 PM,American Airlines Stock May Lose More Altitude,InvestorPlace,/news/stocks/american-airlines-stock-may-lose-more-altitude-1030272174,neutral,0.9632146954536438
1669,4/4/2021 1:12:36 AM,Tailwinds for air lines as CDC updates travel guidance,Seeking Alpha,https://seekingalpha.com/news/3679001-tailwinds-for-air-lines-as-cdc-updates-travel-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9184090495109558
1670,4/4/2021 1:15:45 AM,Johnson & Johnson inoculates adolescents in COVID-19 vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3679003-johnson-johnson-inoculates-adolescents-in-covid-19-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7843081951141357
1671,4/4/2021 3:47:01 AM,HHS puts J&J in charge of Emergent BioSolutions plant behind vaccine foul-up - NYT,Seeking Alpha,https://seekingalpha.com/news/3679006-hhs-puts-johnson-johnson-in-charge-of-emergent-biosolutions-plant-behind-vaccine-foul-up-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8852920532226562
1672,4/5/2021 4:06:46 AM,Emergent Bio receives modified task order for expansion of JNJ's COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3679014-emergent-bio-receives-modified-task-order-for-expansion-of-jnjs-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.49221116304397583
1673,4/5/2021 12:28:40 PM,Cidara shares gain 15% on antiviral conjugates development deal with Janssen,Seeking Alpha,https://seekingalpha.com/news/3679090-cidara-shares-gain-15-on-antiviral-conjugates-development-deal-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9427723288536072
1674,4/5/2021 1:26:05 PM,"Janssen Pharma Gets Worldwide Rights To Cidara's CD388, Other Influenza Antiviral Conjugates ",RTTNews,/news/stocks/janssen-pharma-gets-worldwide-rights-to-cidara-s-cd388-other-influenza-antiviral-conjugates-1030273393,negative,0.542197048664093
1675,4/5/2021 2:27:00 PM,3 Consumer Staples Stocks Rising From the Ashes,InvestorPlace,/news/stocks/3-consumer-staples-stocks-rising-from-the-ashes-1030274336,negative,0.8596561551094055
1676,4/5/2021 3:10:04 PM,The 7 Best Startups You Can Buy on Republic Right Now,InvestorPlace,/news/stocks/the-7-best-startups-to-invest-in-on-republic-right-now-1029859065,positive,0.9151148200035095
1677,4/5/2021 7:28:00 PM,3 Reasons Why the General Electric Comeback Is Real,InvestorPlace,/news/stocks/ge-stock-3-reasons-why-the-general-electric-comeback-is-real-1030274740,positive,0.9295555949211121
1678,4/6/2021 8:58:28 AM,Fauci says government won't mandate vaccine passports,Seeking Alpha,https://seekingalpha.com/news/3679359-fauci-says-government-wont-mandate-vaccine-passports?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9195986986160278
1679,4/6/2021 9:32:45 AM,EU may reach herd immunity by July 14: Commissioner Thierry Breton,Seeking Alpha,https://seekingalpha.com/news/3679363-eu-may-reach-herd-immunity-by-july-14-commissioner-thierry-breton?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8422364592552185
1680,4/6/2021 2:03:27 PM,8 Retirement Stocks to Buy for Any Market Conditions,InvestorPlace,/news/stocks/8-retirement-stocks-to-buy-for-any-market-conditions-1030277583,positive,0.9273015260696411
1681,4/6/2021 3:50:56 PM,7 Cheap Stocks That Won‚Äôt Be on Discount for Long,InvestorPlace,/news/stocks/7-cheap-stocks-that-wont-be-on-discount-for-long-linc-jd-cto-intu-bgfv-eqc-gsk-1030278180,positive,0.8381310105323792
1682,4/6/2021 5:01:57 PM,Emergent plant at center of vaccine troubles had issues in the past - NYT,Seeking Alpha,https://seekingalpha.com/news/3679596-emergent-plant-at-center-of-vaccine-troubles-had-issues-in-the-past-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6422939300537109
1683,4/6/2021 5:58:49 PM,Dividend payment net changes nearly doubled to $18B in Q1,Seeking Alpha,https://seekingalpha.com/news/3679618-sp-dow-jones-indices-dividend-payments-increases-18b-doubled-qq-growth?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9428568482398987
1684,4/7/2021 10:03:19 AM,JNJ inks deal to manufacture contact lenses for myopia in children,Seeking Alpha,https://seekingalpha.com/news/3679721-jnj-inks-deal-to-manufacture-contact-lenses-for-myopia-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8685437440872192
1685,4/7/2021 3:23:00 PM,Jabil Inc. -- Moody's assigns Baa3 to Jabil's new note offering,Moodys,/news/bonds/jabil-inc-moody-s-assigns-baa3-to-jabil-s-new-note-offering-1030281672,positive,0.8428990244865417
1686,4/7/2021 6:19:30 PM,7 Great ETFs to Buy Now for Momentum Going Into Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-going-into-q2-1030283106,negative,0.6457496881484985
1687,4/8/2021 11:02:36 AM,AstraZeneca vaccine woes could derail global vaccination drive,Seeking Alpha,https://seekingalpha.com/news/3680226-astrazeneca-vaccine-woes-could-derail-global-vaccination-drive?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9659634232521057
1688,4/8/2021 11:49:26 AM,Ocugen Stock Is an Excellent Day Trade as Long as You Get Out in Time,InvestorPlace,/news/stocks/ocgn-stock-excellent-day-trade-get-out-in-time-1030285246,positive,0.5905544757843018
1689,4/8/2021 12:15:35 PM,The 7 Best Startups You Can Buy on StartEngine Right Now,InvestorPlace,/news/stocks/the-7-best-equity-crowdfunding-startups-you-can-buy-on-startengine-right-now-1029812989,positive,0.9054226875305176
1690,4/8/2021 5:49:44 PM,States will begin to feel J&J vaccine pinch with 86% decline in doses next week,Seeking Alpha,https://seekingalpha.com/news/3680469-states-will-begin-to-feel-johnson-johnson-vaccine-pinch-with-86-decline-in-doses-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7832155227661133
1691,4/8/2021 6:43:55 PM,Johnson & Johnson adverse reaction prompts closure of Colorado COVID-19 vaccine site,Seeking Alpha,https://seekingalpha.com/news/3680484-jnj-covid-19-shot-closes-vaccine-site-in-colorado?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9344580173492432
1692,4/8/2021 10:17:48 PM,Colorado Covid Vaccination Center Shuts Early Due To 11 Adverse Reaction Cases ,RTTNews,/news/stocks/colorado-covid-vaccination-center-shuts-early-due-to-11-adverse-reaction-cases-1030287409,neutral,0.9642685651779175
1693,4/9/2021 2:03:56 PM,Johnson & Johnson‚Äôs COVID-19 shot under review in EU over blood clots,Seeking Alpha,https://seekingalpha.com/news/3680703-johnson-johnsons-covid-19-shot-under-review-in-eu-over-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8038825988769531
1694,4/9/2021 2:34:02 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-nio-stock-ppi-1030289838,positive,0.9298974871635437
1695,4/9/2021 3:59:20 PM,7 Dividend Stocks With 50 Years of Dividend Increases,InvestorPlace,/news/stocks/7-dividend-stocks-with-50-years-of-dividend-increases-1030289825,positive,0.9167526960372925
1696,4/9/2021 4:53:25 PM,7 Excellent Index Funds With Juicy Dividends for Income Investors,InvestorPlace,/news/stocks/7-excellent-index-funds-with-juicy-dividends-for-income-investors-1030290105,positive,0.9243808388710022
1697,4/9/2021 8:44:17 PM,JNJ to begin India trial for its COVID-19 vaccine soon,Seeking Alpha,https://seekingalpha.com/news/3680816-jnj-to-begin-trials-for-its-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5654170513153076
1698,4/9/2021 9:35:25 PM,Consumer products' Honest Company files for initial public offering,Seeking Alpha,https://seekingalpha.com/news/3680823-consumer-products-honest-company-files-for-initial-public-offering?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9537556171417236
1699,4/10/2021 1:00:15 PM,WOOF Stock: 3 Reasons To Befriend This Recent IPO,InvestorPlace,/news/stocks/woof-stock-3-reasons-to-befriend-this-recent-ipo-1030290873,positive,0.8351296186447144
1700,4/12/2021 5:02:08 PM,Vaccine Passport Potential Could Boost These 7 Pharmaceutical Stocks,InvestorPlace,/news/stocks/vaccine-passport-potential-could-boost-these-7-pharmaceutical-stocks-1030295137,negative,0.9323841333389282
1701,4/12/2021 5:13:09 PM,Pulmatrix slips 15% after J&J terminates license agreement,Seeking Alpha,https://seekingalpha.com/news/3681040-pulmatrix-slips-15-after-johnson-johnson-terminates-license-agreement?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9681206941604614
1702,4/13/2021 11:10:19 AM,JNJ down after CDC halts the use of its COVID-19 vaccine (Updated),Seeking Alpha,https://seekingalpha.com/news/3681245-jnj-is-down-after-cdc-halts-the-use-of-its-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.855932354927063
1703,4/13/2021 1:28:12 PM,JNJ‚Äôs safety issues lead to gains in other COVID-19 vaccine makers,Seeking Alpha,https://seekingalpha.com/news/3681341-bntx-stock-is-up-after-jnj-safety-issues?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9559531211853027
1704,4/13/2021 1:37:37 PM,JNJ to delay COVID-19 vaccine rollout in Europe,Seeking Alpha,https://seekingalpha.com/news/3681350-johnson-johnson-issues-statement-on-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7644459009170532
1705,4/13/2021 1:56:46 PM,Moderna says its vaccine not associated with blood clots; shares up 9%,Seeking Alpha,https://seekingalpha.com/news/3681363-moderna-says-its-vaccine-not-associated-with-blood-clots-shares-up-9?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9219980239868164
1706,4/13/2021 1:59:51 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-coinbase-ipo-jnj-stock-fda-agc-stock-1030299170,positive,0.9298974871635437
1707,4/13/2021 2:09:54 PM,White House: J&J pause won't significantly impact vaccination efforts (updated),Seeking Alpha,https://seekingalpha.com/news/3681370-white-house-jj-pause-wont-significantly-impact-vaccination-efforts?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8721367120742798
1708,4/13/2021 2:16:36 PM,"The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-leadership-transition-at-amarin-vaccine-setback-for-j-j-fda-nod-for-label-expansion-of-roche-s-asthma-drug-1030298345,negative,0.5212363004684448
1709,4/13/2021 2:48:21 PM,FDA Halts Use Of Johnson & Johnson's COVID-19 Vaccine Over Blood Clot Issues - Quick Facts ,RTTNews,/news/stocks/fda-halts-use-of-johnson-johnson-s-covid-19-vaccine-over-blood-clot-issues-quick-facts-1030298526,neutral,0.7311090230941772
1710,4/13/2021 3:35:08 PM,JNJ COVID-19 vaccine pause could be a ‚Äúmatter of days‚Äù: FDA,Seeking Alpha,https://seekingalpha.com/news/3681414-jnj-covid-19-vaccine-pause-could-be-a-matter-of-days-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.765286386013031
1711,4/13/2021 3:36:03 PM,US stocks trade mixed as investors digest March inflation surge and J&J vaccine pause,Business Insider,/news/stocks/stock-market-news-today-march-inflation-data-jnj-vaccine-pause-2021-4,neutral,0.8616109490394592
1712,4/13/2021 7:36:42 PM,JNJ COVID-19 vaccine use halted in South Africa,Seeking Alpha,https://seekingalpha.com/news/3681494-jnj-covid-19-vaccine-use-halted-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8443533182144165
1713,4/13/2021 8:45:55 PM,FDA Halts Johnson & Johnson's Covid-19 Vaccine Over Clotting Issues ,RTTNews,/news/stocks/fda-halts-johnson-johnson-s-covid-19-vaccine-over-clotting-issues-1030300274,neutral,0.8424038887023926
1714,4/13/2021 8:50:02 PM,Pfizer CEO Alfred Bourla says Pfizer ramping production of COVID-19 vaccine (updated),Seeking Alpha,https://seekingalpha.com/news/3681539-ceo-bourla-says-pfizer-ramping-up-production-of-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7775849103927612
1715,4/13/2021 10:03:07 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-xrp-doge-eth-btc-coinbase-ipo-1030300678,positive,0.9254742860794067
1716,4/14/2021 11:58:27 AM,Denmark to halt the use of AstraZeneca‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3681666-denmark-to-halt-the-use-of-astrazenecas-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6099991202354431
1717,4/14/2021 12:47:21 PM,Pfizer to raise second-quarter EU vaccine deliveries by 25%,Seeking Alpha,https://seekingalpha.com/news/3681700-pfizer-to-raise-second-quarter-eu-vaccine-delivery-target-by-25?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9407769441604614
1718,4/14/2021 1:50:12 PM,EMA expediting review of J&J vaccine amid blood clot cases,Seeking Alpha,https://seekingalpha.com/news/3681740-ema-expediting-review-of-johnson-johnson-vaccine-amid-blood-clot-cases?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6971686482429504
1719,4/14/2021 1:51:00 PM,"The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead",Benzinga,/news/stocks/the-daily-biotech-pulse-novavax-cfo-departs-zai-lab-inks-cancer-drug-collaboration-fda-nod-for-gilead-1030303096,positive,0.9114657044410706
1720,4/14/2021 5:08:08 PM,JNJ to exclude pregnant women in vaccine trial in South Africa; Other trials remain paused,Seeking Alpha,https://seekingalpha.com/news/3681818-jnj-to-exclude-pregnant-women-in-vaccine-trial-in-south-africa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8634838461875916
1721,4/14/2021 8:26:22 PM,Widening 'moat' for mRNA vaccines will benefit Moderna - Jefferies,Seeking Alpha,https://seekingalpha.com/news/3681898-widening-moat-for-mrna-vaccines-will-benefit-moderna-jefferies?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9243830442428589
1722,4/14/2021 9:13:43 PM,JNJ and AstraZeneca suffer setback for COVID-19 vaccine deals in Europe,Seeking Alpha,https://seekingalpha.com/news/3681930-jnj-and-astrazeneca-suffer-set-back-for-covid-19-vaccine-deals-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9291513562202454
1723,4/14/2021 11:10:49 PM,EMA Says Johnson & Johnson's COVID-19 Vaccine's Benefits Outweigh Side Effects ,RTTNews,/news/stocks/ema-says-johnson-johnson-s-covid-19-vaccine-s-benefits-outweigh-side-effects-1030305558,negative,0.9493962526321411
1724,4/14/2021 11:53:30 PM,CDC panel postpones vote on J&J shot as it probes blood clots,Seeking Alpha,https://seekingalpha.com/news/3681948-cdc-panel-postpones-vote-on-jj-shot-as-it-probes-blood-clots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7647814750671387
1725,4/15/2021 12:56:11 PM,"JNJ‚Äôs COVID-19 vaccine woes to benefit mRNA based developers, Needham sizes up telehealth rivals; and more in today‚Äôs analyst action",Seeking Alpha,https://seekingalpha.com/news/3682121-jnjs-covid-19-vaccine-woes-to-benefit-mrna-based-developers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7349256277084351
1726,4/15/2021 1:49:24 PM,"The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-shelves-2-covid-19-studies-bristol-myers-squibb-gets-european-regulatory-nod-inspiremd-s-reverse-split-1030307762,positive,0.8539385199546814
1727,4/15/2021 3:43:38 PM,JNJ COVID-19 vaccine use could involve specific guidelines: Cantor,Seeking Alpha,https://seekingalpha.com/news/3682236-jnj-covid-19-vaccine-use-could-involve-specific-guidelines-cantor?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9465373754501343
1728,4/15/2021 9:11:56 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogecoin-price-predictions-qs-stock-1030310657,positive,0.9254742860794067
1729,4/16/2021 11:43:41 AM,"J&J asked Pfizer, Moderna to help investigate blood clots but declined - WSJ",Seeking Alpha,https://seekingalpha.com/news/3682520-johnson-johnson-asked-pfizer-moderna-to-help-investigate-blood-clots-but-declined-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8816914558410645
1730,4/16/2021 12:12:56 PM,Janssen showcases nipocalimab data in generalized myasthenia gravis at AAN 2021,Seeking Alpha,https://seekingalpha.com/news/3682544-janssen-showcases-nipocalimab-data-in-generalized-myasthenia-gravis-at-aan-2021?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.876347005367279
1731,4/16/2021 5:52:05 PM,7 Reddit Penny Stocks to Buy for a Biotech Boom,InvestorPlace,/news/stocks/7-reddit-penny-stocks-buy-biotech-boom-1030313550,positive,0.8537747263908386
1732,4/16/2021 6:22:10 PM,No evidence to support link between vaccine and blood clots -- J&J researchers,Seeking Alpha,https://seekingalpha.com/news/3682683-no-evidence-to-support-link-between-vaccine-and-blood-clots-johnson-johnson-researchers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8681107759475708
1733,4/16/2021 6:46:59 PM,"Moderna, Pfizer vaccine allocations to rise next week as J&J shot suspended",Seeking Alpha,https://seekingalpha.com/news/3682688-moderna-pfizer-vaccine-allocations-to-rise-next-week-as-johnson-johnson-shot-suspended?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9377162456512451
1734,4/16/2021 7:30:09 PM,Seeking Alpha Catalyst Watch,Seeking Alpha,https://seekingalpha.com/news/3682690-seeking-alpha-catalyst-watch?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8980498313903809
1735,4/17/2021 3:25:15 PM,"The Week Ahead In Biotech: Johnson & Johnson, Biogen Earnings, Neurology Conference And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-johnson-johnson-biogen-earnings-neurology-conference-and-ipos-1030314413,positive,0.9472424983978271
1736,4/18/2021 2:08:03 AM,South African regulator recommends lifting ban on JNJ‚Äôs COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3682764-south-african-regulator-recommends-lifting-ban-on-jnjs-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6372618675231934
1737,4/18/2021 3:01:24 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q1-earnings-preview-1030315086,positive,0.9130299687385559
1738,4/18/2021 3:56:30 PM,Fauci expects J&J vaccinations to resume later this week,Seeking Alpha,https://seekingalpha.com/news/3682773-fauci-expects-jj-vaccinations-to-resume-later-this-week?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.898205041885376
1739,4/18/2021 6:22:14 PM,"Barron's Latest Picks And Pans: Amazon, Coinbase, Disney, Johnson & Johnson And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-amazon-coinbase-disney-johnson-johnson-and-more-1030315209,positive,0.945088803768158
1740,4/19/2021 10:45:46 AM,Drugmakers go on trial for opioid epidemic in California,Seeking Alpha,https://seekingalpha.com/news/3682811-drugmakers-go-on-trial-for-opioid-epidemic-in-california?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5263085961341858
1741,4/19/2021 11:58:02 AM,JNJ's Darzalex combo regimen OK'd in Canada for rare blood cell disorder,Seeking Alpha,https://seekingalpha.com/news/3682852-jnjs-darzalex-combo-regimen-okd-in-canada-for-rare-blood-cell-disorder?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7165833711624146
1742,4/19/2021 1:45:06 PM,J&J vaccine was paused because of concerns over treating blood clots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3682959-johnson-johnson-vaccine-was-paused-because-of-concerns-over-treating-blood-clots-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9119874238967896
1743,4/19/2021 3:08:56 PM,Decision On Resuming Johnson & Johnson Vaccine Expected This Week ,RTTNews,/news/stocks/decision-on-resuming-johnson-johnson-vaccine-expected-this-week-1030318065,positive,0.935887336730957
1744,4/19/2021 4:03:07 PM,Moderna and BioNTech slide as Fauci predicts resumption of JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3683037-moderna-and-biontech-slides-as-fauci-predicts-resumption-of-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.941743016242981
1745,4/19/2021 4:21:32 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3683044-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
1746,4/19/2021 6:06:36 PM,Johnson & Johnson Q1 2021 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3683084-johnson-johnson-q1-2021-earnings-preview?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6954245567321777
1747,4/19/2021 8:30:30 PM,JNJ will not pursue regulatory submission based on prostate cancer study,Seeking Alpha,https://seekingalpha.com/news/3683157-jnj-will-not-pursue-regulatory-submission-based-on-prostate-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9475216269493103
1748,4/19/2021 9:07:19 PM,Emergent Bio hurt by second steepest drop for the year as FDA inspects manufacturing site,Seeking Alpha,https://seekingalpha.com/news/3683186-emergent-bio-drops-as-fda-inspects-manufacturing-site?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9655582904815674
1749,4/19/2021 9:28:14 PM,What Did the Stock Market Do today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-dogeday-next-big-crypto-safemoon-1030319772,positive,0.9254742860794067
1750,4/20/2021 9:47:09 AM,EMA to issue advice on JNJ COVID shot later today,Seeking Alpha,https://seekingalpha.com/news/3683236-ema-to-issue-advice-on-jnj-covid-shot-later-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9251766204833984
1751,4/20/2021 10:31:14 AM,"Johnson & Johnson EPS beats by $0.24, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3683261-johnson-and-amp-johnson-eps-beats-0_24-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7135740518569946
1752,4/20/2021 10:48:23 AM,Johnson & Johnson hikes dividend by 5% to $1.06 per share,Seeking Alpha,https://seekingalpha.com/news/3683259-johnson--johnson-hikes-dividend-by-5-to-106-per-share?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.547257661819458
1753,4/20/2021 11:11:51 AM,JNJ raises 2021 guidance and quarterly dividend after Q1 earnings beat consensus,Seeking Alpha,https://seekingalpha.com/news/3683290-jnj-raises-2021-guidance-and-quarterly-dividend-after-q1-earnings-beat-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5079023241996765
1754,4/20/2021 12:35:10 PM,Johnson & Johnson Q1 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q1-adjusted-earnings-beat-estimates-1030322014,negative,0.7109436988830566
1755,4/20/2021 1:43:16 PM,Johnson & Johnson Q1 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-q1-results-top-estimates-1030322385,positive,0.8381689786911011
1756,4/20/2021 2:06:58 PM,"The Daily Biotech Pulse: Q1 Beat From Johnson & Johnson, KalVista Study Placed On Hold, European Label Expansion For GW Pharma's Epidiolex",Benzinga,/news/stocks/the-daily-biotech-pulse-q1-beat-from-johnson-johnson-kalvista-study-placed-on-hold-european-label-expansion-for-gw-pharma-s-epidiolex-1030322640,positive,0.7906168103218079
1757,4/20/2021 2:35:07 PM,JNJ COVID-19 vaccine: European Medicines Agency highlights positive benefit-risk,Seeking Alpha,https://seekingalpha.com/news/3683459-jnj-covid-19-vaccine-ema-highlights-positive-benefit-risk?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9490113258361816
1758,4/20/2021 3:29:30 PM,Remote Monitoring Telemedicine Company Sees Spiked Growth Of Products And Technology,Benzinga,/news/stocks/remote-monitoring-telemedicine-company-sees-spiked-growth-of-products-and-technology-1030323571,negative,0.8027836084365845
1759,4/20/2021 3:41:41 PM,"JNJ reiterates positive benefit/risk profile of COVID-19 vaccine as CDC probes a ""handful"" of more cases of adverse events",Seeking Alpha,https://seekingalpha.com/news/3683496-jnj-reiterates-positive-benefitrisk-profile-of-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9391221404075623
1760,4/20/2021 4:06:58 PM,J&J to resume vaccine rollout in Europe following EMA review (updated),Seeking Alpha,https://seekingalpha.com/news/3683506-johnson-johnson-to-resume-vaccine-rollout-in-europe-following-ema-review?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8393635749816895
1761,4/20/2021 4:27:10 PM,Ocugen‚Äôs Outlook Is Still Very Bleak,InvestorPlace,/news/stocks/ocgn-stock-outlook-is-still-very-bleak-1030324938,positive,0.7953054308891296
1762,4/20/2021 8:00:03 PM,EMA Says J&J Covid Vaccine's Benefits Outweigh Rare Blood Clot Risks ,RTTNews,/news/stocks/ema-says-j-j-covid-vaccine-s-benefits-outweigh-rare-blood-clot-risks-1030324875,negative,0.9520763754844666
1763,4/20/2021 9:07:08 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-airline-stocks-cruise-stocks-1030325540,positive,0.9254742860794067
1764,4/20/2021 9:16:20 PM,"5 Top Stock Trades for Wednesday: UAL, JNJ, PG, KSU, IBM",InvestorPlace,/news/stocks/5-top-stock-trades-for-wednesday-ual-jnj-pg-ksu-ibm-1030325539,positive,0.931175172328949
1765,4/21/2021 9:48:47 AM,JNJ's VERITAS Vision System secures FDA clearance and CE mark,Seeking Alpha,https://seekingalpha.com/news/3683786-jnjs-veritas-vision-system-secures-fda-clearance-and-ce-mark?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9008581042289734
1766,4/21/2021 12:25:48 PM,OCGN Stock: The Huge COVAXIN News Sending Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-huge-covaxin-news-sending-ocugen-climbing-today-1030329624,negative,0.9418376684188843
1767,4/21/2021 12:48:26 PM,COVID-19 vaccine supply to exceed demand in the coming weeks - report,Seeking Alpha,https://seekingalpha.com/news/3683891-vaccine-supply-to-exceed-demand-in-the-coming-weeks-report?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7725856900215149
1768,4/21/2021 1:19:39 PM,Weekly record for new COVID-19 cases set - WHO,Seeking Alpha,https://seekingalpha.com/news/3683937-weekly-record-for-new-covid-19-cases-set-who?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7298490405082703
1769,4/21/2021 1:55:40 PM,FDA finds multiple deficiencies in inspection of troubled Emergent Biosolutions plant,Seeking Alpha,https://seekingalpha.com/news/3683956-fda-finds-multiple-deficiencies-in-inspection-of-troubled-emergent-biosolutions-plant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9653455018997192
1770,4/21/2021 2:40:05 PM,Abbott Q1 results highlight pressure on COVID-19 test makers as vaccinations ramp up,Seeking Alpha,https://seekingalpha.com/news/3683988-abbott-q1-results-highlights-pressure-on-covid-19-test-makers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9643991589546204
1771,4/21/2021 3:09:49 PM,JNJ reiterates commitment to US COVID-19 vaccine deliveries after FDA inspection of Emergent facility,Seeking Alpha,https://seekingalpha.com/news/3684009-jnj-reiterates-commitment-to-us-covid-19-vaccine-deliveries-after-fda-inspection?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9239122867584229
1772,4/21/2021 3:59:50 PM,"EU not taking up options on additional AstraZeneca, J&J vaccines - Reuters",Seeking Alpha,https://seekingalpha.com/news/3684028-eu-not-taking-up-options-on-additional-astrazeneca-johnson-johnson-vaccines-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9373636841773987
1773,4/21/2021 6:41:11 PM,Pressure mounting on Biden administration to waive COVID-19 vaccine patents,Seeking Alpha,https://seekingalpha.com/news/3684145-pressure-mounting-on-biden-administration-to-waive-covid-19-vaccine-patents?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9097448587417603
1774,4/22/2021 11:18:17 AM,Pfizer in talks with India to supply COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3684453-pfizer-in-talks-with-india-to-supply-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.802666187286377
1775,4/22/2021 1:04:23 PM,JNJ COVID-19 vaccine: South Africa to resume rollout,Seeking Alpha,https://seekingalpha.com/news/3684563-jnj-covid-19-vaccine-south-africa-to-resume-rollout?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7008795142173767
1776,4/22/2021 4:47:42 PM,J&J vaccine found effective against COVID-19 variants,Seeking Alpha,https://seekingalpha.com/news/3684700-johnson-johnson-vaccine-found-effective-against-covid-19-variants?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9383882284164429
1777,4/22/2021 7:47:21 PM,House Democrats reintroduce bill to lower drug prices,Seeking Alpha,https://seekingalpha.com/news/3684755-house-democrats-reintroduce-bill-to-lower-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6614382266998291
1778,4/23/2021 10:36:21 AM,Johnson & Johnson COVID-19 Vaccine Could Make Its Way To India By July,Benzinga,/news/stocks/johnson-johnson-covid-19-vaccine-could-make-its-way-to-india-by-july-1030337765,positive,0.5872179269790649
1779,4/23/2021 10:51:14 AM,India plans to import JNJ's COVID-19 vaccine by July end,Seeking Alpha,https://seekingalpha.com/news/3684994-india-plans-to-import-jnjs-covid-19-vaccine-by-july-end?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6104121804237366
1780,4/23/2021 11:39:04 AM,JNJ COVID-19 vaccine heads for U.S. review today,Seeking Alpha,https://seekingalpha.com/news/3685021-jnj-covid-19-vaccine-heads-for-us-review-today?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8091768026351929
1781,4/23/2021 12:06:48 PM,EU finalizes deal for 1.8B doses of Pfizer-BioNTech COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3685044-eu-finalizes-deal-for-18b-doses-of-pfizer-biontech-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8244154453277588
1782,4/23/2021 2:21:54 PM,"GameStop, AMC, Penny And Crypto Stocks: Top Q1 Trends For Millennials And Gen Z",Benzinga,/news/stocks/gamestop-amc-penny-and-crypto-stocks-top-q1-trends-for-millennials-and-gen-z-1030338567,positive,0.820562481880188
1783,4/23/2021 2:41:58 PM,OCGN Stock: The Big COVAXIN News That Prompted 40% Gains in Ocugen,InvestorPlace,/news/stocks/ocgn-stock-the-big-covaxin-news-that-prompted-40-gains-in-ocugen-1030339413,negative,0.9489784836769104
1784,4/23/2021 3:00:27 PM,7 Great ETFs to Buy to Ride Out Rough Seas,InvestorPlace,/news/stocks/7-great-etfs-to-buy-to-ride-out-rough-seas-1030339410,positive,0.7865896821022034
1785,4/23/2021 3:01:05 PM,8 Dividend Stocks Increasing Payouts in 2021,InvestorPlace,/news/stocks/8-dividend-stocks-increasing-payouts-in-2021-1030339409,negative,0.8952242136001587
1786,4/23/2021 4:16:04 PM,Blood clot cases linked to J&J vaccine rises to 15 - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685169-blood-clot-cases-linked-to-johnson-johnson-vaccine-rises-to-15-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8762068152427673
1787,4/23/2021 6:45:05 PM,Ocugen Looks Less Interesting With Each Passing Shot,InvestorPlace,/news/stocks/ocgn-stock-looks-less-compelling-as-vaccines-increase-1030339903,neutral,0.809840202331543
1788,4/23/2021 8:55:44 PM,CDC advisory committee votes to recommend J&J vaccine with warning (updated),Seeking Alpha,https://seekingalpha.com/news/3685278-cdc-advisory-committee-votes-to-recommend-johnson-johnson-vaccine-following-pause?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9059928059577942
1789,4/23/2021 9:21:35 PM,J&J rekindling plan to sell breast implant division Mentor - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3685283-jj-rekindling-plan-to-sell-breast-implant-division-mentor-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7814677953720093
1790,4/23/2021 11:27:24 PM,FDA and CDC lift J&J vaccine pause (updated),Seeking Alpha,https://seekingalpha.com/news/3685295-fda-and-cdc-lift-jj-vaccine-pause?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7191280722618103
1791,4/24/2021 3:24:00 PM,"The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-25-may-1-fda-decisions-for-sol-gel-protalix-bio-ardelyx-1030340692,positive,0.9154146313667297
1792,4/24/2021 8:00:00 PM,"What might be behind blood clot risk with AstraZeneca, J&J vaccines?",Seeking Alpha,https://seekingalpha.com/news/3685297-what-might-be-behind-blood-clot-risk-with-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8130069375038147
1793,4/25/2021 5:17:06 AM,Ocugen-partnered COVID-19 vaccine shows efficacy against new variant behind India‚Äôs second wave,Seeking Alpha,https://seekingalpha.com/news/3685312-ocugen-partnered-covid-19-vaccine-shows-efficacy-against-new-variant-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.945451557636261
1794,4/26/2021 6:26:26 AM,FDA Lifts Pause On Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-lifts-pause-on-johnson-johnson-s-covid-19-vaccine-1030342587,neutral,0.659433901309967
1795,4/26/2021 7:21:45 AM,World pledges medical aid to India amid surging COVID-19 infections,Seeking Alpha,https://seekingalpha.com/news/3685321-world-pledges-medical-aid-to-india-amid-surging-new-infections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9238783121109009
1796,4/26/2021 12:04:06 PM,Most Americans hesitant about getting J&J vaccine - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3685398-most-americans-hesitant-about-getting-johnson-johnson-vaccine-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8801007270812988
1797,4/26/2021 12:08:37 PM,A Peek Into The Markets: US Stock Futures Mixed; Tesla Earnings In Focus,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-tesla-earnings-in-focus-1030344568,neutral,0.9162915349006653
1798,4/26/2021 12:25:52 PM,OCGN Stock: The White House News That Has Ocugen Climbing Today,InvestorPlace,/news/stocks/ocgn-stock-the-white-house-news-that-has-ocugen-climbing-today-1030346247,negative,0.7591938972473145
1799,4/26/2021 2:38:14 PM,J&J Vaccine Holds Lower Side Effect Risks Than Aspirin: NIH Director ,RTTNews,/news/stocks/j-j-vaccine-holds-lower-side-effect-risks-than-aspirin-nih-director-1030345359,negative,0.5006111264228821
1800,4/26/2021 3:00:47 PM,Decline in new COVID-19 cases could last despite a slowdown in vaccine rollout: Experts,Seeking Alpha,https://seekingalpha.com/news/3685540-decline-in-new-covid-19-cases-could-last-despite-a-slowdown-in-vaccine-rollout-experts?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7110522389411926
1801,4/26/2021 3:18:33 PM,Sanofi Steps In For Fill-Finish 200M Doses Of Moderna's COVID-19 Vaccine,Benzinga,/news/stocks/sanofi-steps-in-for-fill-finish-200m-doses-of-moderna-s-covid-19-vaccine-1030346045,positive,0.8522769808769226
1802,4/26/2021 4:51:43 PM,Over 9 million doses ready to go into arms as states resume JNJ COVID-19 vaccine use,Seeking Alpha,https://seekingalpha.com/news/3685595-over-9-million-doses-ready-to-go-into-arms-as-states-resume-jnj-covid-19-vaccine-use?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.730880618095398
1803,4/26/2021 5:39:37 PM,7 Undervalued Stocks to Buy Before the Bounce,InvestorPlace,/news/stocks/7-undervalued-stocks-to-buy-before-the-bounce-1030347104,negative,0.4834134578704834
1804,4/26/2021 6:22:32 PM,7 Blue-Chip Stocks Everyone Should Watch,InvestorPlace,/news/stocks/7-blue-chip-stocks-everyone-should-watch-1030347421,positive,0.9152199029922485
1805,4/27/2021 1:18:05 PM,Health Canada OKs Johnson & Johnson Vision's daily disposable contact lens,Seeking Alpha,https://seekingalpha.com/news/3686091-health-canada-oks-johnson-johnson-visions-daily-disposable-contact-lens?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9043447375297546
1806,4/27/2021 2:21:20 PM,US To Share Up To 60M AstraZeneca COVID-19 Vaccine Doses,Benzinga,/news/stocks/us-to-share-up-to-60m-astrazeneca-covid-19-vaccine-doses-1030351378,negative,0.5798394083976746
1807,4/27/2021 3:45:31 PM,Two more blood clot cases reported with J&J vaccine - Reuters,Seeking Alpha,https://seekingalpha.com/news/3686185-two-more-blood-clot-cases-reported-with-johnson-johnson-vaccine-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8258306980133057
1808,4/27/2021 4:54:02 PM,CDC updates guidance on mask wearing for people fully vaccinated against COVID-19,Seeking Alpha,https://seekingalpha.com/news/3686236-cdc-updates-guidance-on-mask-wearing-for-people-fully-vaccinated-against-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7350118160247803
1809,4/28/2021 12:34:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354437,negative,0.5797832608222961
1810,4/28/2021 12:38:00 AM,"Bayou Intermediate II, LLC -- Moody's assigns a B2 CFR to Bayou Intermediate II, LLC; outlook stable",Moodys,/news/bonds/bayou-intermediate-ii-llc-moody-s-assigns-a-b2-cfr-to-bayou-intermediate-ii-llc-outlook-stable-1030354444,negative,0.5797832608222961
1811,4/28/2021 10:00:30 AM,A Couple Of Shots in the Arm for Ocugen Stock,InvestorPlace,/news/stocks/a-couple-of-shots-in-the-arm-for-ocugen-stock-1030356996,positive,0.6628854274749756
1812,4/28/2021 2:29:03 PM,7 Pharmaceutical Stocks With Dividends in Hand,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-dividends-in-hand-1030359387,positive,0.926287829875946
1813,4/28/2021 4:15:19 PM,10 Low-Volatility Safe Stocks to Buy Now,InvestorPlace,/news/stocks/10-low-volatility-safe-stocks-to-buy-now-1030359712,positive,0.891793966293335
1814,4/28/2021 5:46:21 PM,"California reports nearly 1,400 COVID-19 cases in fully vaccinated people",Seeking Alpha,https://seekingalpha.com/news/3687105-california-records-about-1400-covid-19-cases-in-fully-vaccinated-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8088371157646179
1815,4/28/2021 6:02:51 PM,7 Great ETFs to Buy for Dividend-Hungry Investors,InvestorPlace,/news/stocks/7-great-etfs-to-buy-for-dividend-hungry-investors-1030359697,positive,0.7809272408485413
1816,4/28/2021 8:23:40 PM,Time100 Most Influential Companies: What 61 Publicly Traded Companies Are On The Inaugural List?,Benzinga,/news/stocks/time100-most-influential-companies-what-61-publicly-traded-companies-are-on-the-inaugural-list-1030359837,positive,0.9378837943077087
1817,4/29/2021 10:00:37 AM,7 Pharmaceutical Stocks To Buy For Valuation Plus Solid Dividends,InvestorPlace,/news/stocks/7-pharmaceutical-stocks-to-buy-for-valuation-plus-solid-dividends-1030363716,negative,0.5524897575378418
1818,4/29/2021 7:06:03 PM,Emergent awaiting FDA OK to release 60M J&J vaccine doses - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3688108-emergent-awaiting-fda-ok-to-release-60m-johnson-johnson-vaccine-doses-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5637158751487732
1819,4/30/2021 10:10:55 AM,Janssen files CAR-T therapy cilta-del application for multiple myeloma in Europe,Seeking Alpha,https://seekingalpha.com/news/3688490-janssen-files-car-t-therapy-cilta-del-application-for-multiple-myeloma-in-europe?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7648647427558899
1820,4/30/2021 4:46:11 PM,"CDC allocating J&J vaccine again, but still at low numbers",Seeking Alpha,https://seekingalpha.com/news/3688786-cdc-allocating-johnson-johnson-vaccine-again-but-still-at-low-numbers?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8627643585205078
1821,4/30/2021 8:30:28 PM,More than 30% of U.S. population fully vaccinated - CDC,Seeking Alpha,https://seekingalpha.com/news/3688921-more-than-30-of-us-population-fully-vaccinated-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8916819095611572
1822,5/2/2021 7:17:07 PM,"To waive COVID vaccine patents, or not, that is the question",Seeking Alpha,https://seekingalpha.com/news/3689015-to-waive-covid-vaccine-patents-or-not-that-is-the-question?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8193982243537903
1823,5/3/2021 10:00:27 AM,"Despite Covaxin News, Ocugen Stock Remains a Long-Shot for US Use",InvestorPlace,/news/stocks/ocgn-stock-remains-gamble-covaxin-news-notwithstanding-1030377582,negative,0.6979934573173523
1824,5/3/2021 11:58:45 AM,"If You Have Ocugen Stock, Now‚Äôs the Time to Take Profits",InvestorPlace,/news/stocks/ocgn-stock-why-you-should-take-profit-1030378125,positive,0.9377833604812622
1825,5/3/2021 3:03:10 PM,Wells Fargo debuts riskier 'Signature Picks' portfolio with four megacaps featured,Seeking Alpha,https://seekingalpha.com/news/3689265-wells-fargo-debuts-riskier-signature-picks-with-four-megacaps-featured?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6918834447860718
1826,5/3/2021 3:40:55 PM,JNJ‚Äôs COVID-19 vaccine left out in Danish vaccine rollout,Seeking Alpha,https://seekingalpha.com/news/3689298-jnjs-covid-19-vaccine-left-out-in-danish-vaccine-rollout?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6416810750961304
1827,5/3/2021 8:11:11 PM,U.S. COVID-19 vaccine demand dips as vaccination rate climbs,Seeking Alpha,https://seekingalpha.com/news/3689695-us-covid-19-vaccine-demand-dips-as-vaccination-rate-climbs?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9711112976074219
1828,5/3/2021 9:45:39 PM,FDA set to OK Pfizer vaccine for adolescents next week - New York Times,Seeking Alpha,https://seekingalpha.com/news/3689831-fda-set-to-ok-pfizer-vaccine-for-adolescents-next-week-new-york-times?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.878096342086792
1829,5/4/2021 3:25:18 PM,8 Blue-Chip Stocks With Strong Earnings,InvestorPlace,/news/stocks/eight-blue-chip-stocks-strong-earnings-1030385989,negative,0.7799855470657349
1830,5/4/2021 3:40:26 PM,Shares of major drug makers in focus as House committees hold hearings on drug pricing bill,Seeking Alpha,https://seekingalpha.com/news/3690229-shares-of-major-drug-makers-in-focus-as-house-committees-hold-hearings-on-drug-pricing-bill?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6773343086242676
1831,5/4/2021 7:09:14 PM,"Biden says vaccination effort will focus on adolescents, hesitant adults (updated)",Seeking Alpha,https://seekingalpha.com/news/3690452-biden-says-vaccination-effort-will-focus-on-adolescents-hesitant-adults?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9069849848747253
1832,5/5/2021 7:35:46 PM,COVID-19 vaccine makers in the red as U.S. to back waiver of IP protections,Seeking Alpha,https://seekingalpha.com/news/3691449-covid-19-vaccine-makers-in-the-red-as-us-to-back-waiver-of-vaccine-ip-protections?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8418429493904114
1833,5/6/2021 1:42:10 PM,"Weighing in on vaccine patent waivers, Alcon and Ultragenyx upgraded at Citi and more in analyst action",Seeking Alpha,https://seekingalpha.com/news/3692234-weighing-in-on-vaccine-patent-waivers-alcon-and-ultragenyx-upgraded-at-citi-and-more-in-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6439561247825623
1834,5/6/2021 2:10:44 PM,What Will the Stock Market Do Today? 3 Big Stories to Watch.,InvestorPlace,/news/stocks/what-will-the-stock-market-do-today-3-big-stories-ocgn-stock-space-stocks-btc-brphf-1030397159,positive,0.9298974871635437
1835,5/6/2021 4:03:03 PM,7 Safe Stocks You Can Leave to Your Children,InvestorPlace,/news/stocks/7-safe-stocks-you-can-leave-your-children-1030397799,positive,0.9264896512031555
1836,5/6/2021 4:39:42 PM,Germany's Merkel opposed to lifting IP protections on vaccines -- Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3692395-germany-merkel-opposed-to-lifting-ip-protections-on-vaccines-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7145804166793823
1837,5/6/2021 7:43:04 PM,Emergent-produced J&J vaccine distribution paused in several countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3692464-emergent-produced-johnson-johnson-vaccine-distribution-paused-in-several-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8662154674530029
1838,5/6/2021 8:41:26 PM,5 Cheap Growth Stocks for Q2 2021,InvestorPlace,/news/stocks/5-cheap-growth-stocks-for-q2-2021-1030399122,positive,0.881212592124939
1839,5/7/2021 6:59:18 AM,"JNJ's Tecnis Synergy and Tecnis Synergy Toric II IOLs OK'd in U.S., Canada",Seeking Alpha,https://seekingalpha.com/news/3692955-jnjs-tecnis-synergy-and-tecnis-synergy-toric-ii-iols-okd-in-us-canada?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9265602827072144
1840,5/11/2021 6:48:00 PM,States won‚Äôt receive JNJ COVID-19 vaccine deliveries next week: Politico,Seeking Alpha,https://seekingalpha.com/news/3694765-states-wont-receive-jnj-covid-19-vaccine-deliveries-next-week-politico?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6523008942604065
1841,5/12/2021 12:55:50 PM,FDA OKs Johnson & Johnson Vision's Acuvue Abiliti Overnight lenses for myopia,Seeking Alpha,https://seekingalpha.com/news/3695232-fda-oks-johnson-johnson-visions-acuvue-abiliti-overnight-lenses-for-myopia?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.739980936050415
1842,5/12/2021 12:59:21 PM,Emergent says it is making improvements to troubled Baltimore vaccine plant,Seeking Alpha,https://seekingalpha.com/news/3695230-emergent-says-it-is-making-improvements-to-troubled-baltimore-vaccine-plant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.839880645275116
1843,5/12/2021 2:23:33 PM,Emergent executives to testify before House coronavirus panel next week,Seeking Alpha,https://seekingalpha.com/news/3695305-emergent-executives-to-testify-before-house-coronavirus-panel-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.92745041847229
1844,5/12/2021 3:26:19 PM,Ethereum (ETH) Price Predictions: Why Some Analysts Think ETH Will Hit $20K in 2025,InvestorPlace,/news/stocks/ethereum-eth-price-predictions-why-some-analysts-see-20k-in-2025-1030422216,positive,0.9031867384910583
1845,5/13/2021 1:05:22 PM,Blood clot risk from J&J vaccine 40 times less than dying from COVID,Seeking Alpha,https://seekingalpha.com/news/3695918-blood-clot-risk-from-johnson-johnson-vaccine-40-times-less-than-dying-from-covid?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6046474575996399
1846,5/13/2021 2:23:31 PM,Ocugen Has a Longer Road To Paying off Than People Think,InvestorPlace,/news/stocks/confusing-trading-leaves-ocgn-stock-interesting-1030426929,positive,0.8299602270126343
1847,5/13/2021 6:41:24 PM,The 7 Best Stocks and Cryptos to Buy in May,InvestorPlace,/news/stocks/the-7-best-stocks-and-cryptos-to-buy-in-may-1030427551,positive,0.9053362011909485
1848,5/14/2021 3:38:44 PM,It Won‚Äôt Take Much for Vaxart Stock to Pop Once Again,InvestorPlace,/news/stocks/vxrt-stock-wont-make-much-to-pop-once-again-1030431453,negative,0.7223111391067505
1849,5/14/2021 5:38:17 PM,J&J vaccines to Latin America could expire before they are fully deployed - FT,Seeking Alpha,https://seekingalpha.com/news/3696723-johnson-johnson-vaccines-to-latin-america-could-expire-before-they-are-fully-deployed-ft?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.851413369178772
1850,5/17/2021 4:35:49 AM,Janssen Pharma's Xarelto + aspirin significantly reduces total ischemic events in peripheral artery disease,Seeking Alpha,https://seekingalpha.com/news/3696894-janssen-pharmas-xarelto-aspirin-significantly-reduces-total-ischemic-events-in-peripheral-artery-disease?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9469411373138428
1851,5/17/2021 11:28:54 AM,AC Immune expands Phase 1b/2a phospho-Tau Alzheimer‚Äôs vaccine trial,Seeking Alpha,https://seekingalpha.com/news/3696962-ac-immune-expands-phase-1b2a-phospho-tau-alzheimers-vaccine-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7375152111053467
1852,5/17/2021 2:36:18 PM,Supreme Court rejects J&J $70M Risperdal award appeal,Seeking Alpha,https://seekingalpha.com/news/3697202-supreme-court-rejects-jj-70m-risperdal-award-appeal?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6037282943725586
1853,5/17/2021 3:55:02 PM,AC Immune Provides Update On Alzheimer's Disease Vaccine Candidate,Benzinga,/news/stocks/ac-immune-provides-update-on-alzheimer-s-disease-vaccine-candidate-1030437016,positive,0.916863739490509
1854,5/17/2021 4:12:11 PM,JNJ to cut vaccine shipments to EU by half this week,Seeking Alpha,https://seekingalpha.com/news/3697248-jnj-to-cut-vaccine-shipments-to-eu-by-half-this-week?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9581863284111023
1855,5/17/2021 5:28:00 PM,U.S. to ship additional 20M vaccine doses abroad in June,Seeking Alpha,https://seekingalpha.com/news/3697271-us-to-ship-additional-20m-vaccine-doses-abroad-abroad-in-june?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6776211857795715
1856,5/17/2021 6:45:29 PM,7 ETFs To Buy if You Want To Try To Outperform Cathie Wood,InvestorPlace,/news/stocks/7-etfs-to-buy-if-you-want-to-try-to-outperform-cathie-wood-1030438262,positive,0.816464900970459
1857,5/18/2021 5:14:32 PM,JNJ confirms it is working with Indian company to manufacture COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3697906-jnj-confirms-it-is-working-with-indian-company-to-manufacture-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8927968144416809
1858,5/18/2021 7:54:31 PM,Why Zomedica Doesn‚Äôt Need Reddit,InvestorPlace,/news/stocks/zom-stock-why-zomedica-doesnt-need-reddit-1030443399,positive,0.9341819286346436
1859,5/19/2021 7:16:02 AM,"AstraZeneca/Oxford's third booster shot induces ""high antibody response"", study shows",Seeking Alpha,https://seekingalpha.com/news/3698071-astrazenecaoxfords-third-booster-shot-induces-high-antibody-response-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.703899085521698
1860,5/19/2021 9:01:32 AM,7 Best Biotech Stocks To Buy in 2021 as Innovation Takes Center Stage,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-as-innovation-takes-center-stage-1030445426,negative,0.6162664890289307
1861,5/19/2021 1:09:13 PM,India's Biological E To Make Johnson & Johnson's COVID-19 Shots: Reuters,Benzinga,/news/stocks/india-s-biological-e-to-make-johnson-johnson-s-covid-19-shots-reuters-1030445754,positive,0.9341815114021301
1862,5/19/2021 2:03:56 PM,House report finds Emergent execs given bonuses despite failing to deliver vaccines,Seeking Alpha,https://seekingalpha.com/news/3698231-house-report-details-relationships-with-emergent-and-members-of-congress?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5543937087059021
1863,5/19/2021 3:24:10 PM,Senate Republicans ask Biden to walk back support of waiving vaccine IP protection,Seeking Alpha,https://seekingalpha.com/news/3698273-senate-republicans-ask-biden-to-walk-back-support-of-waiving-vaccine-ip-protection?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6177008152008057
1864,5/19/2021 7:04:34 PM,Stay On The Sidelines With Ocugen Stock,InvestorPlace,/news/stocks/stay-on-the-sidelines-with-ocgn-stock-1030455829,positive,0.9424134492874146
1865,5/20/2021 2:12:01 PM,"Merck downgraded to hold at Argus, Allogene upped at Truist, and more in today's analyst action",Seeking Alpha,https://seekingalpha.com/news/3698655-merck-downgraded-to-hold-at-argus-allogene-upped-at-truist-and-more-in-todays-analyst-action?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6200331449508667
1866,5/20/2021 5:51:41 PM,JNJ highlights potential of IMBRUVICA as a first-line treatment for leukemia,Seeking Alpha,https://seekingalpha.com/news/3698811-jnj-highlights-potential-of-imbruvica-as-a-first-line-treatment-for-leukemia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8827682733535767
1867,5/20/2021 6:16:48 PM,Moderna Holds the Key to the Future of mRNA Vaccines,InvestorPlace,/news/stocks/mrna-stock-holds-the-key-to-the-future-of-vaccines-1030452921,positive,0.8024299740791321
1868,5/20/2021 6:44:51 PM,Legend Biotech spikes on EMA acceptance of marketing application for cilta-cel,Seeking Alpha,https://seekingalpha.com/news/3698833-legend-biotech-spikes-on-ema-acceptance-of-marketing-application-for-cilta-cel?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5788532495498657
1869,5/21/2021 12:36:52 PM,Gavi to purchase 200M J&J vaccine doses for poorer countries,Seeking Alpha,https://seekingalpha.com/news/3699079-gavi-to-purchase-200m-johnson-johnson-vaccine-doses-for-poorer-countries?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7128233909606934
1870,5/21/2021 1:30:02 PM,EMA advisory group backs Janssen's Darzalex for AL amyloidosis and multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3699117-ema-advisory-group-backs-janssens-darzalex-for-al-amyloidosis-and-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.768876314163208
1871,5/21/2021 2:04:27 PM,"Pfizer, Moderna, and J&J pledge more shots for poorer countries - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3699127-pfizer-moderna-and-johnson-johnson-pledge-more-shots-for-poorer-countries-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5725336074829102
1872,5/21/2021 3:02:52 PM,JNJ wins positive opinion in Europe for expanded use of DARZALEX,Seeking Alpha,https://seekingalpha.com/news/3699162-jnj-wins-positive-opinion-in-europe-for-expanded-use-of-darzalex?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9528484344482422
1873,5/21/2021 4:29:21 PM,Janssen Gets Two Positive CHMP Opinions For Darzalex Subcutaneous Formulation Utilizing Enhanze ,RTTNews,/news/stocks/janssen-gets-two-positive-chmp-opinions-for-darzalex-subcutaneous-formulation-utilizing-enhanze-1030455493,negative,0.9291113018989563
1874,5/21/2021 6:37:07 PM,FDA approves J&J's Rybrevant as targeted therapy for NSCLC patient subset,Seeking Alpha,https://seekingalpha.com/news/3699217-fda-approves-johnson-johnson-rybrevant-as-targeted-therapy-for-nsclc-patient-subset?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.799612283706665
1875,5/22/2021 2:16:04 PM,"'Halftime Report' Traders Share Their Thoughts On Target, Home Depot And More",Benzinga,/news/stocks/halftime-report-traders-share-their-thoughts-on-target-home-depot-and-more-1030456782,positive,0.9369021654129028
1876,5/24/2021 4:51:31 AM,Janssen presents Stelara data from late-stage Seavue study in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3699311-janssen-presents-stelara-data-from-late-stage-seavue-study-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8911897540092468
1877,5/24/2021 6:27:23 AM,Johnson & Johnson seeks COVID-19 vaccine approval in Japan - Reuters,Seeking Alpha,https://seekingalpha.com/news/3699315-johnson-johnson-seeks-covid-19-vaccine-approval-in-japan-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6636518239974976
1878,5/24/2021 6:31:26 PM,3 Healthcare Stocks to Buy as the Sector Breaks Out,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-sector-breaks-out-1030459870,positive,0.7721390128135681
1879,5/25/2021 6:02:06 PM,EU targets more than a billion COVID-19 vaccine doses by September,Seeking Alpha,https://seekingalpha.com/news/3699985-eu-targets-more-than-a-billion-covid-19-vaccine-doses-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8005648255348206
1880,5/25/2021 7:46:23 PM,"With a Stumbling Track Record, All Signs Say Stay Away from Novavax",InvestorPlace,/news/stocks/nvax-stock-stumbling-track-record-all-signs-say-stay-away-1030464342,neutral,0.6971267461776733
1881,5/26/2021 11:10:09 AM,FDA is set to decline new emergency use authorizations for COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3700199-fda-is-set-to-decline-new-emergency-use-authorizations-for-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9127315282821655
1882,5/26/2021 2:02:40 PM,Belgium suspends J&J COVID-19 jab for people under 41 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3700331-belgium-suspends-jj-covid-19-jab-for-people-under-41-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.897201418876648
1883,5/26/2021 3:49:59 PM,7 Top Dividend Stocks Trading at a Discount Worth Snapping Up,InvestorPlace,/news/stocks/7-top-dividend-stocks-trading-discount-worth-snapping-up-1030468041,positive,0.6840509176254272
1884,5/26/2021 5:13:23 PM,7 Defensive ETFs to Protect Yourself From the Tech Sell-Off,InvestorPlace,/news/stocks/7-defensive-etfs-to-protect-yourself-from-the-tech-sell-off-1030468425,positive,0.866117537021637
1885,5/26/2021 6:21:23 PM,FDA May Not Review New COVID-19 Vaccine Emergency Use Requests,Benzinga,/news/stocks/fda-may-not-review-new-covid-19-vaccine-emergency-use-requests-1030468148,positive,0.7860015034675598
1886,5/26/2021 9:41:26 PM,FDA grants J&J multiple myeloma treatment cilta-cel priority review,Seeking Alpha,https://seekingalpha.com/news/3700574-fda-grants-johnson-johnson-multiple-myeloma-treatment-cilta-cel-priority-review?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7377949357032776
1887,5/27/2021 8:41:14 AM,Here's What Is Going On With Ocugen (OCGN) Stock,Benzinga,/news/stocks/here-s-what-is-going-on-with-ocugen-ocgn-stock-1030469868,positive,0.8751086592674255
1888,5/27/2021 2:23:09 PM,"The Daily Biotech Pulse: Vir-GlaxoSmithKline COVID-19 Antibody Treatment Approved, Zosano Spikes On Long-Term Migraine Drug Data, Decision Day For Eton, 2 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-vir-glaxosmithkline-covid-19-antibody-treatment-approved-zosano-spikes-on-long-term-migraine-drug-data-decision-day-for-eton-2-ipos-1030471204,negative,0.7420997619628906
1889,5/27/2021 4:22:40 PM,J&J may miss June vaccine supply target for EU - Dutch broadcaster,Seeking Alpha,https://seekingalpha.com/news/3700892-johnson-johnson-may-miss-june-vaccine-supply-target-for-eu-dutch-broadcaster?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9515789151191711
1890,5/27/2021 9:27:56 PM,"COVID-19 vaccines from Pfizer/BioNTech, JNJ and Moderna set for India entry as India clears hurdles",Seeking Alpha,https://seekingalpha.com/news/3701056-covid-19-vaccines-from-pfizerbiontech-jnj-and-moderna-set-for-india-entry?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5801091194152832
1891,5/28/2021 3:59:49 AM,"J&J, FDA close to deal allowing release of vaccine from troubled Emergent plant - WSJ",Seeking Alpha,https://seekingalpha.com/news/3701095-johnson-johnson-fda-close-to-deal-allowing-release-of-vaccine-from-troubled-emergent-plant-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8789598345756531
1892,5/28/2021 12:02:35 PM,Johnson & Johnson COVID-19 vaccine wins UK approval (updated),Seeking Alpha,https://seekingalpha.com/news/3701176-johnson-johnson-covid-19-vaccine-wins-uk-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7129715085029602
1893,5/28/2021 2:01:46 PM,Biden's goal of 70% Covid vaccination by summer may be in reach - NYT,Seeking Alpha,https://seekingalpha.com/news/3701240-bidens-goal-of-70-covid-vaccination-by-summer-may-be-in-reach-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5080470442771912
1894,5/28/2021 3:00:13 PM,Johnson & Johnson's Single Dose COVID-19 Vaccine Approved In U.K. ,RTTNews,/news/stocks/johnson-johnson-s-single-dose-covid-19-vaccine-approved-in-u-k-1030475349,negative,0.903644323348999
1895,5/30/2021 3:54:17 AM,Companies can require employees to get COVID-19 shot: EEOC,Seeking Alpha,https://seekingalpha.com/news/3701444-companies-can-require-employees-to-get-covid-19-shot-eeoc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8933736681938171
1896,5/31/2021 7:21:08 PM,JNJ‚Äôs delay in meeting COVID-19 vaccine delivery targets only temporary: EU,Seeking Alpha,https://seekingalpha.com/news/3701477-jnjs-delay-in-meeting-covid-19-vaccine-delivery-targets-only-temporary-eu?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5502592921257019
1897,6/1/2021 11:04:05 AM,JNJ to hear from Supreme Court regarding $2 billion talc verdict,Seeking Alpha,https://seekingalpha.com/news/3701563-jnj-to-hear-from-supreme-court-regarding-2-billion-talc-verdict?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8617751598358154
1898,6/1/2021 1:53:05 PM,Johnson & Johnson slips as supreme court rejects appeal in talc case,Seeking Alpha,https://seekingalpha.com/news/3701717-johnson-johnson-slips-as-supreme-court-rejects-appeal-in-talc-case?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9255297183990479
1899,6/1/2021 7:18:38 PM,7 Best Stocks To Buy To Hedge Against A Potential Downturn,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-hedge-against-a-potential-downturn-1030484539,positive,0.8428159952163696
1900,6/1/2021 10:41:40 PM,Supreme Court Dismisses J&J Appeal Against The $2bln Fine ,RTTNews,/news/stocks/supreme-court-dismisses-j-j-appeal-against-the-2bln-fine-1030484758,neutral,0.8007764220237732
1901,6/1/2021 11:31:09 PM,Attention Biotech Investors: Mark Your Calendar For June PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-june-pdufa-dates-1030484849,positive,0.9476439952850342
1902,6/2/2021 9:37:50 AM,European countries roll out digital Covid certificate to ease travel - NYT,Seeking Alpha,https://seekingalpha.com/news/3702175-european-countries-roll-out-digital-covid-certificate-to-ease-travel-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5580695271492004
1903,6/2/2021 10:37:13 AM,NIH begins study to evaluate mix-and-match COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3702194-nih-begins-study-to-evaluate-mix-and-match-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5177181363105774
1904,6/2/2021 4:35:00 PM,Johnson & Johnson -- Moody's: Denial of J&J's talc verdict appeal highlights litigation exposures,Moodys,/news/bonds/johnson-johnson-moody-s-denial-of-j-j-s-talc-verdict-appeal-highlights-litigation-exposures-1030487991,neutral,0.8894079923629761
1905,6/2/2021 8:03:14 PM,AstraZeneca in talks to shift COVID-19 vaccine production from Emergent-owned facility,Seeking Alpha,https://seekingalpha.com/news/3702588-astrazeneca-in-talks-to-shift-covid-19-vaccine-production-from-emergent-owned-facility?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7416180372238159
1906,6/3/2021 8:06:03 AM,Low-income nations secure additional $2.4B to boost access to COVID-19 vaccines - NYT,Seeking Alpha,https://seekingalpha.com/news/3702752-low-income-nations-secures-additional-24b-to-boost-access-to-covid-19-vaccines-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9480469822883606
1907,6/3/2021 3:48:24 PM,4 Best Defensive ETFs to Protect Your Portfolio,InvestorPlace,/news/stocks/4-best-defensive-etfs-to-protect-your-portfolio-1030492368,positive,0.8423519134521484
1908,6/3/2021 5:29:36 PM,I Would Hope Inovio Isn‚Äôt Attracting ANY Serious Money,InvestorPlace,/news/stocks/i-would-hope-inovio-and-ino-stock-isnt-attracting-any-serious-money-1030492714,positive,0.7353726029396057
1909,6/4/2021 7:20:52 PM,"Despite Setbacks, the Future Remains Bright for Novavax Stock",InvestorPlace,/news/stocks/despite-setbacks-the-future-remains-bright-for-novavax-stock-1030496514,negative,0.945648729801178
1910,6/7/2021 7:06:19 AM,Argenx to regain global rights to cusatuzumab from Janssen Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3703535-argenx-to-regain-global-rights-to-cusatuzumab-from-janssen-pharmaceuticals?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6083430051803589
1911,6/7/2021 7:43:19 AM,Argenx To Regain Global Rights To Anti-CD70 Antibody Cusatuzumab From Janssen's Cilag ,RTTNews,/news/stocks/argenx-to-regain-global-rights-to-anti-cd70-antibody-cusatuzumab-from-janssen-s-cilag-1030498269,negative,0.730444073677063
1912,6/7/2021 8:31:19 AM,"Addex, Janssen initiate Phase 2 study of ADX71149 for epilepsy",Seeking Alpha,https://seekingalpha.com/news/3703540-addex-janssen-initiate-phase-2-study-of-adx71149-for-epilepsy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.680630087852478
1913,6/7/2021 10:37:17 AM,U.S. to weigh COVID-19 shots for children as vaccination drive reaches milestone,Seeking Alpha,https://seekingalpha.com/news/3703562-us-to-weigh-covid-19-shots-for-children-as-vaccination-drive-reaches-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7012423872947693
1914,6/7/2021 8:41:33 PM,JNJ faces steep decline in demand for COVID-19 shot in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3703903-jnj-faces-steep-decline-in-demand-for-covid-19-shot-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9712908864021301
1915,6/8/2021 3:18:10 PM,"Could Lilly's donanemab, others for Alzheimer's get a boost from Biogen approval?",Seeking Alpha,https://seekingalpha.com/news/3704152-could-lilly-donanemab-others-for-alzheimers-get-a-boost-from-biogen-approval?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6547841429710388
1916,6/8/2021 5:44:00 PM,There‚Äôs Good Reason to Believe Novavax Will Rise Soon,InvestorPlace,/news/stocks/theres-good-reason-to-believe-nvax-stock-will-rise-soon-1030505029,negative,0.8615055680274963
1917,6/8/2021 8:13:34 PM,JNJ COVID-19 vaccines left unused in U.S.: states urged to seek longer shelf life,Seeking Alpha,https://seekingalpha.com/news/3704323-jnj-covid-19-vaccines-left-unused-in-us-states-urged-to-seek-longer-shelf-life?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4749143719673157
1918,6/9/2021 9:35:12 AM,CDC relaxes COVID-19 travel recommendations to over 100 countries - NYT,Seeking Alpha,https://seekingalpha.com/news/3704419-the-cdc-relaxes-covid-19-travel-recommendations-to-over-100-countries-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.517711341381073
1919,6/9/2021 10:36:44 AM,J&J COVID-19 vaccines at risk of going waste due to expiry in June - NYT,Seeking Alpha,https://seekingalpha.com/news/3704430-jj-covid-19-vaccines-at-risk-of-going-waste-due-to-expiry-in-june-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8846902251243591
1920,6/9/2021 2:30:00 PM,"Johnson & Johnson Releases 2020 Health for Humanity Report Highlighting Performance and Progress on Environmental, Social and Governance Priorities",PR Newswire,/news/stocks/johnson-johnson-releases-2020-health-for-humanity-report-highlighting-performance-and-progress-on-environmental-social-and-governance-priorities-1030507524,negative,0.7032787799835205
1921,6/9/2021 4:59:00 PM,Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-second-quarter-results-1030508454,positive,0.9199506640434265
1922,6/9/2021 7:43:27 PM,"Roivant's Datavant, Ciox Health To Merge In $7B Deal",Benzinga,/news/stocks/roivant-s-datavant-ciox-health-to-merge-in-7b-deal-1030508950,positive,0.8998744487762451
1923,6/9/2021 8:08:33 PM,JNJ CEO sees need for COVID-19 booster vaccines with annual flu shots for several years,Seeking Alpha,https://seekingalpha.com/news/3704764-jnj-ceo-sees-need-for-covid-19-booster-vaccines-with-annual-flu-shots-for-several-years?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6647451519966125
1924,6/10/2021 9:48:41 AM,WTO to initiate vaccine supply negotiations amid patent waiver conflict for Covid drugs - Reuters,Seeking Alpha,https://seekingalpha.com/news/3704887-wto-to-initiate-vaccine-supply-negotiations-on-june-17-amid-patent-waiver-conflict-for-covid-drugs-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6895945072174072
1925,6/10/2021 10:56:35 AM,JNJ COVID-19 vaccine: EU to donate extra doses,Seeking Alpha,https://seekingalpha.com/news/3704904-jnj-covid-19-vaccine-eu-to-donate-extra-doses?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5399389266967773
1926,6/10/2021 3:52:38 PM,JNJ COVID-19 vaccine: shelf life extended by one-and-a-half months,Seeking Alpha,https://seekingalpha.com/news/3705103-jnj-covid-19-vaccine-shelf-life-extended-by-one-and-a-half-months?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8830434083938599
1927,6/10/2021 4:15:23 PM,Anti-Meme Stocks: 7 Value Stock Picks for Common Sense Investors,InvestorPlace,/news/stocks/anti-meme-stocks-7-value-stock-picks-for-common-sense-investors-1030513268,positive,0.9350194334983826
1928,6/11/2021 3:16:57 PM,JNJ will need to trash 60M COVID doses from Emergent plant but can distribute 10M (updated),Seeking Alpha,https://seekingalpha.com/news/3705686-johnson-johnson-will-need-to-discard-60m-covid-doses-made-at-emergent-plant-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.924424946308136
1929,6/14/2021 8:26:35 AM,JNJ/AbbVie's Imbruvica + Venclexta show promising progression-free survival in late-stage blood cancer study,Seeking Alpha,https://seekingalpha.com/news/3705857-jnjabbvies-imbruvicavenclexta-show-promising-progression-free-survival-in-blood-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9435179829597473
1930,6/14/2021 8:55:09 AM,JNJ's DARZALEX combo regime shows significant overall survival benefits in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3705858-jnjs-darzalex-combo-regime-shows-significant-overall-survival-benefits-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9518078565597534
1931,6/14/2021 11:11:05 AM,G7 leaders pledge 1B coronavirus vaccines for developing countries,Seeking Alpha,https://seekingalpha.com/news/3705892-g7-leaders-pledge-1b-coronavirus-vaccines-for-developing-countries?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6061450839042664
1932,6/14/2021 5:43:07 PM,"Seeking vaccination boost, NYC launches $100 referral bonus program for organizations",Seeking Alpha,https://seekingalpha.com/news/3706113-seeking-vaccination-boost-nyc-launches-100-referral-bonus-program-for-organizations?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8781466484069824
1933,6/14/2021 6:11:12 PM,Rivals in the red after Novavax posted strong efficacy data for its COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3706122-rivals-in-the-red-after-novavax-posted-strong-efficacy-data-for-its-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9234724044799805
1934,6/15/2021 2:25:26 PM,Hold Merck for Its Solid Dividend and Covid-19 Treatment Prospects,InvestorPlace,/news/stocks/hold-mrk-stock-for-solid-dividend-and-covid-19-treatment-prospects-1030525034,negative,0.8403745889663696
1935,6/15/2021 4:32:32 PM,"Cramer Weighs In On Johnson & Johnson, ViacomCBS And More",Benzinga,/news/stocks/cramer-weighs-in-on-johnson-johnson-viacomcbs-and-more-1030524603,positive,0.5654669404029846
1936,6/15/2021 5:15:32 PM,"US, EU aim to vaccinate two-thirds of world's population against COVID by end of 2022",Seeking Alpha,https://seekingalpha.com/news/3706544-us-eu-aim-to-vaccinate-two-thirds-of-worlds-population-against-covid-by-end-of-2022?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7000491619110107
1937,6/16/2021 1:50:34 AM,Another 14M J&J vaccine doses from Emergent plant authorized by FDA - Reuters,Seeking Alpha,https://seekingalpha.com/news/3706719-another-14m-johnson-johnson-vaccine-doses-from-emergent-plant-authorized-by-fda-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7550260424613953
1938,6/16/2021 11:04:42 AM,JNJ to miss second quarter target for COVID-19 vaccine deliveries: EU,Seeking Alpha,https://seekingalpha.com/news/3706772-jnj-to-miss-second-quarter-target-for-covid-19-vaccine-deliveries-eu?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.94330894947052
1939,6/16/2021 12:13:20 PM,It‚Äôs Time to Admit Defeat and Dump Ocugen Stock as a Covid Play,InvestorPlace,/news/stocks/ocgn-stock-is-no-covid-play-1030528088,positive,0.8373422026634216
1940,6/16/2021 4:00:34 PM,Is There Still Upside Potential for Novavax Stock?,InvestorPlace,/news/stocks/is-there-still-upside-potential-for-novavax-stock-1030529164,positive,0.5518491268157959
1941,6/17/2021 4:40:21 AM,BioNTech CEO Ugur Sahin warns of possible COVID resurgence from Delta variant - Barron's,Seeking Alpha,https://seekingalpha.com/news/3707136-biontech-ceo-sahin-warns-of-possible-covid-resurgence-from-delta-variant-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8906422257423401
1942,6/17/2021 3:02:39 PM,7 Penny Stocks Under a Penny That Are Worth a Look,InvestorPlace,/news/stocks/7-penny-stocks-under-a-penny-that-are-worth-a-look-1030532972,positive,0.8783378601074219
1943,6/17/2021 9:13:38 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-bitcoin-ride-stock-cvac-stock-1030533935,positive,0.9254742860794067
1944,6/19/2021 6:38:00 PM,"The Facebook trade is crowded, but Apple isn't; here's the global list: Alpha Tactics",Seeking Alpha,https://seekingalpha.com/news/3707855-facebook-is-crowded-but-apple-isnt-global-list?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9311836361885071
1945,6/21/2021 8:39:43 AM,CDC warns Delta variant could become dominant in U.S. this summer,Seeking Alpha,https://seekingalpha.com/news/3707964-cdc-warns-delta-variant-could-become-dominant-in-us-this-summer-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4572985768318176
1946,6/21/2021 10:00:50 AM,Novavax Is a Long-Term Buy for the Continuing Pandemic,InvestorPlace,/news/stocks/nvax-stock-is-a-long-term-buy-for-the-continuing-pandemic-1030538420,positive,0.5151999592781067
1947,6/21/2021 6:20:08 PM,China reaches a milestone in COVID-19 vaccination with 1 billion shots,Seeking Alpha,https://seekingalpha.com/news/3708387-china-reaches-a-milestone-in-covid-19-vaccination-with-1-billion-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8285498023033142
1948,6/22/2021 4:58:56 PM,White House to fall short of July 4 Covid vaccination goal - NBC,Seeking Alpha,https://seekingalpha.com/news/3708788-white-house-to-say-us-could-miss-fourth-of-july-goal-in-covid-19-vaccination-nbc-news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6146945953369141
1949,6/23/2021 6:54:00 AM,Fauci says Delta variant greatest threat to U.S. efforts to eradicate COVID-19,Seeking Alpha,https://seekingalpha.com/news/3708985-fauci-says-delta-variant-greatest-threat-to-united-states-efforts-to-eradicate-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4963109493255615
1950,6/23/2021 3:13:30 PM,J&J Janssen division submits Xarelto NDA for blood clots in children,Seeking Alpha,https://seekingalpha.com/news/3709231-johnson-johnson-janssen-division-submits-xarelto-nda-for-blood-clots-in-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8870201110839844
1951,6/23/2021 3:25:01 PM,Citius Shows a Promising Future as Share Prices Keep Going up,Benzinga,/news/stocks/citius-shows-a-promising-future-as-share-prices-keep-going-up-1030547404,negative,0.9269535541534424
1952,6/24/2021 9:45:14 AM,NIH commences COVID-19 vaccine trial in pregnant women - Reuters,Seeking Alpha,https://seekingalpha.com/news/3709428-nih-commences-covid-19-vaccine-trial-in-pregnant-women-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8806933164596558
1953,6/24/2021 10:06:34 AM,U.S. to supply 3M doses on J&J's COVID-19 vaccine to Brazil,Seeking Alpha,https://seekingalpha.com/news/3709435-us-to-supply-3m-doses-on-jjs-covid-19-vaccine-to-brazil?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7517929673194885
1954,6/24/2021 4:35:43 PM,CDC and WHO weigh in on need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3709736-cdc-and-who-weigh-in-on-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7704358696937561
1955,6/25/2021 1:25:02 PM,"Denmark to continuing banning J&J, AstraZeneca vaccines",Seeking Alpha,https://seekingalpha.com/news/3710130-denmark-to-continuing-banning-johnson-johnson-astrazeneca-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6216728687286377
1956,6/26/2021 3:19:47 PM,J&J to stop selling opioid meds as part of $230M settlement with New York,Seeking Alpha,https://seekingalpha.com/news/3710315-johnson-johnson-to-stop-selling-opioid-meds-as-part-of-230m-settlement-with-new-york?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8859214782714844
1957,6/26/2021 4:49:24 PM,Johnson & Johnson Agrees To Settle New York Opioid Lawsuit : Reports ,RTTNews,/news/stocks/johnson-johnson-agrees-to-settle-new-york-opioid-lawsuit-reports-1030556564,positive,0.6438404321670532
1958,6/27/2021 1:06:49 AM,JNJ COVID-19 vaccine and risks from delta variant: experts are already taking booster shots,Seeking Alpha,https://seekingalpha.com/news/3710324-jnj-covid-19-vaccine-and-risks-from-delta-variant-experts-are-already-taking-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7029075026512146
1959,6/28/2021 10:49:54 AM,"5 Stocks To Watch For June 28, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-june-28-2021-1030557819,positive,0.9067628383636475
1960,6/28/2021 12:09:06 PM,A Peek Into The Markets: US Stock Futures Mixed; Crude Oil Edges Lower,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-crude-oil-edges-lower-1030558050,negative,0.6249955892562866
1961,6/28/2021 12:44:18 PM,"Pfizer, Moderna mRNA vaccines may result in long-lasting immunity: Study",Seeking Alpha,https://seekingalpha.com/news/3710450-pfizer-moderna-mrna-vaccines-may-result-in-long-lasting-immunity-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8322778940200806
1962,6/28/2021 1:18:54 PM,Gates med research CEO transitioning to head vaccines at J&J - Endpoints,Seeking Alpha,https://seekingalpha.com/news/3710491-gates-med-research-ceo-transitioning-to-head-vaccines-role-at-johnson-johnson--endpoints?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9178781509399414
1963,6/28/2021 5:07:04 PM,JNJ's $260M Settlement Could Serve As Global Opioid Deal Template: Analyst,Benzinga,/news/stocks/jnj-s-260m-settlement-could-serve-as-global-opioid-deal-template-analyst-1030559635,positive,0.8175237774848938
1964,6/29/2021 9:14:34 AM,"Amid surge in Delta variant, nations impose new restrictions to curb infections",Seeking Alpha,https://seekingalpha.com/news/3710809-amid-surge-in-delta-variant-nations-impose-new-restrictions-to-curb-infections?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49846151471138
1965,6/29/2021 4:30:14 PM,"Jury trial against drugmakers, drug distributors over opioids begins in N.Y. (updated)",Seeking Alpha,https://seekingalpha.com/news/3711050-jury-trial-against-drugmakers-drug-distributors-over-opioids-begins-in-ny?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.835198700428009
1966,6/29/2021 5:23:41 PM,JNJ COVID-19 shot shows efficacy against variants in lab-based study: NIH,Seeking Alpha,https://seekingalpha.com/news/3711063-jnj-covid-19-shot-shows-efficacy-against-variants-in-lab-based-study-nih?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8672112226486206
1967,6/29/2021 9:24:57 PM,"New York Takes Drugmakers, Drug Retailers To Legal Trial Over Opioid",Benzinga,/news/stocks/new-york-takes-drugmakers-drug-retailers-to-legal-trial-over-opioid-1030564453,positive,0.8192856907844543
1968,6/30/2021 2:51:57 PM,Thailand to purchase 5M Moderna COVID vaccine doses,Seeking Alpha,https://seekingalpha.com/news/3711425-thailand-to-purchase-5m-moderna-covid-vaccine-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6417127847671509
1969,6/30/2021 8:05:08 PM,World Bank to boost financing available for COVID vaccine purchases to $20B,Seeking Alpha,https://seekingalpha.com/news/3711572-world-bank-to-boost-financing-available-for-covid-vaccine-purchase-to-20b?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9494578242301941
1970,6/30/2021 8:27:54 PM,Sell Ocugen Stock Before the Other Shoe Finally Drops,InvestorPlace,/news/stocks/ocgn-stock-sell-ocugen-before-other-shoe-finally-drops-1030569105,positive,0.9403712153434753
1971,7/1/2021 3:35:29 AM,J&J COVID vaccine may protect against Delta variant - US Surgeon General,Seeking Alpha,https://seekingalpha.com/news/3711660-jj-covid-vaccine-may-protect-against-delta-variant-us-surgeon-general?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8075571656227112
1972,7/1/2021 10:51:13 AM,U.K. COVID-19 cases reach the highest since January as Delta variant becomes dominant,Seeking Alpha,https://seekingalpha.com/news/3711713-uk-covid-19-cases-reach-the-highest-since-january-as-delta-variant-becomes-dominant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9074461460113525
1973,7/1/2021 9:16:41 PM,WHO chief urges every nation to vaccinate at least 10% of population by September,Seeking Alpha,https://seekingalpha.com/news/3712248-who-chief-urges-every-nation-to-vaccinate-at-least-10-of-population-by-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8444913029670715
1974,7/2/2021 1:59:00 AM,Positive New Data for Johnson & Johnson Single-Shot COVID-19 Vaccine on Activity Against Delta Variant and Long-lasting Durability of Response,PR Newswire,/news/stocks/positive-new-data-for-johnson-johnson-single-shot-covid-19-vaccine-on-activity-against-delta-variant-and-long-lasting-durability-of-response-1030573808,negative,0.8950044512748718
1975,7/2/2021 3:12:05 AM,J&J Says Data Shows Its Single-shot COVID-19 Vaccine Effective Against Delta And Other Variants ,RTTNews,/news/stocks/j-j-says-data-shows-its-single-shot-covid-19-vaccine-effective-against-delta-and-other-variants-1030573838,negative,0.9483696222305298
1976,7/2/2021 11:34:30 AM,COVAX urges all governments for equal recognition of COVID-19 vaccines for travel,Seeking Alpha,https://seekingalpha.com/news/3712318-covax-urges-all-governments-for-equal-recognition-of-covid-19-vaccines-for-travel?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.657991886138916
1977,7/2/2021 1:14:04 PM,"Gottlleb says OK for vaccinated Americans gather with friends, family for July 4 - CNBC",Seeking Alpha,https://seekingalpha.com/news/3712370-gottlleb-says-ok-for-vaccinated-americans-gather-with-friends-family-for-july-4-cnbc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9041555523872375
1978,7/2/2021 1:58:09 PM,COVID-19 response teams being deployed across U.S. to combat Delta variant,Seeking Alpha,https://seekingalpha.com/news/3712399-covid-19-response-teams-being-deployed-across-us-to-combat-delta-variant?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5611690878868103
1979,7/2/2021 4:25:53 PM,"Biden not concerned about major COVID outbreak, but wants to see more vaccinations",Seeking Alpha,https://seekingalpha.com/news/3712520-biden-not-concerned-about-major-covid-outbreak-but-wants-to-see-more-vaccinations?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7372595071792603
1980,7/2/2021 7:33:18 PM,JNJ COVID-19 vaccine snafu at Emergent plant: FDA clears another batch of doses,Seeking Alpha,https://seekingalpha.com/news/3712668-jnj-covid-19-vaccine-snafu-at-emergent-plant-fda-clears-another-batch-of-doses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6709405779838562
1981,7/4/2021 1:14:17 AM,Scientists not alarmed by deaths due to COVID-19 Delta variant among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3712735-deaths-due-to-covid-19-delta-variant-among-fully-vaccinated-scientists-are-not-alarmed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6125161051750183
1982,7/5/2021 10:00:22 AM,NVAX Stock Is Not For The Faint Of Heart,InvestorPlace,/news/stocks/nvax-stock-is-not-for-the-faint-of-heart-1030578313,positive,0.9399634599685669
1983,7/6/2021 6:29:48 AM,Israel sees decrease in Pfizer vaccine effectiveness against COVID-19 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3712766-israel-sees-decrease-in-pfizer-vaccine-effectiveness-against-covid-19-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9608821868896484
1984,7/6/2021 10:00:14 AM,"Ocugen Has Had a Good Run, but the Math Says It‚Äôs Over",InvestorPlace,/news/stocks/ocgn-stock-has-had-good-run-but-math-says-its-over-1030581139,negative,0.5612901449203491
1985,7/6/2021 10:01:16 AM,7 Safe Harbor Stocks To Buy Ahead of the Potential Volatility,InvestorPlace,/news/stocks/7-safe-harbor-stocks-to-buy-ahead-potential-volatility-1030581134,positive,0.7031267881393433
1986,7/6/2021 5:53:53 PM,JNJ to deliver nearly 40M of additional COVID-19 vaccine doses to EU,Seeking Alpha,https://seekingalpha.com/news/3713042-jnj-to-deliver-nearly-40m-of-additional-covid-19-vaccine-doses-to-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7534467577934265
1987,7/6/2021 7:56:28 PM,"Biden ramping up vaccination efforts, focusing on adolescents, pediatricians, and workplaces",Seeking Alpha,https://seekingalpha.com/news/3713077-biden-ramping-up-vaccination-efforts-focusing-on-adolescents-pediatricians-and-workplaces?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8103123903274536
1988,7/7/2021 4:31:44 AM,New Zealand OK's use of J&J COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3713159-new-zealand-oks-use-of-jj-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8985034823417664
1989,7/7/2021 7:47:11 AM,"U.K. Health secretary warns daily COVID-19 cases could reach 100,000",Seeking Alpha,https://seekingalpha.com/news/3713163-uk-health-secretary-warns-daily-covid-19-cases-could-reach-100000?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9133965373039246
1990,7/7/2021 10:49:38 AM,Mid-size pharmaceutical firms lead bigger rivals in acquisitions this year,Seeking Alpha,https://seekingalpha.com/news/3713185-mid-size-pharmaceutical-firms-lead-bigger-rivals-in-acquisitions-this-year?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6112593412399292
1991,7/7/2021 5:13:09 PM,Latest CDC data show COVID-19 Delta variant is now dominant in U.S.,Seeking Alpha,https://seekingalpha.com/news/3713403-latest-cdc-data-show-covid-19-delta-variant-is-now-dominant-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6076704263687134
1992,7/8/2021 12:09:05 PM,Vor Biopharma teams up with Janssen Biotech to develop leukemia therapy,Seeking Alpha,https://seekingalpha.com/news/3713574-vor-biopharma-teams-up-with-janssen-biotech-to-develop-leukemia-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7620905637741089
1993,7/8/2021 2:42:54 PM,Fifteen states reach agreement with Purdue over bankruptcy plan - NYT,Seeking Alpha,https://seekingalpha.com/news/3713666-fifteen-states-reach-agreement-with-purdue-over-bankruptcy-plan-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8544976711273193
1994,7/8/2021 2:52:13 PM,Global COVID-19 death toll surpasses 4M,Seeking Alpha,https://seekingalpha.com/news/3713684-global-covid-19-death-roll-surpasses-4m?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6976553797721863
1995,7/8/2021 3:28:49 PM,"Vor Biopharma, Janssen Team Up To Develop Combination Therapies For Acute Myeloid Leukemia",Benzinga,/news/stocks/vor-biopharma-janssen-team-up-to-develop-combination-therapies-for-acute-myeloid-leukemia-1030589987,negative,0.6867847442626953
1996,7/8/2021 4:27:00 PM,Stay Away From Low-Growth Organon,InvestorPlace,/news/stocks/low-growth-weak-catalysts-ogn-stock-unattractive-1030590811,positive,0.9079623818397522
1997,7/8/2021 5:56:17 PM,Scientists weigh in on reimplementation of COVID-19 restrictions in under-vaccinated areas,Seeking Alpha,https://seekingalpha.com/news/3713742-scientists-weigh-in-on-reimplementation-of-covid-19-restrictions-in-under-vaccinated-areas?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7959216833114624
1998,7/8/2021 7:38:27 PM,"House Oversight report says pharmas spend more on buybacks, dividends than R&D",Seeking Alpha,https://seekingalpha.com/news/3713778-house-oversight-report-says-pharmas-spend-more-on-buybacks-dividends-than-research-development?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8492424488067627
1999,7/9/2021 11:35:41 AM,CDC and FDA: No need for COVID-19 booster shots at this time for fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3713918-cdc-and-fda-there-is-no-need-for-covid-19-booster-shots-at-this-time-for-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8758231401443481
2000,7/9/2021 12:40:27 PM,EMA finds link possible between heart inflammation and mRNA COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3713951-ema-finds-link-possible-between-heart-inflammation-and-mrna-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6032859683036804
2001,7/9/2021 2:00:00 PM,Johnson & Johnson Launches Network of Global Health Discovery Centers that Aim to Speed Up Science and Tackle Pandemic Threats,PR Newswire,/news/stocks/johnson-johnson-launches-network-of-global-health-discovery-centers-that-aim-to-speed-up-science-and-tackle-pandemic-threats-1030592893,negative,0.6652523279190063
2002,7/9/2021 2:58:08 PM,7 Travel Stocks to Sell if the Delta Variant Slows the Reopening Rally,InvestorPlace,/news/stocks/7-travel-stocks-to-sell-if-delta-variant-slows-reopening-rally-1030593455,neutral,0.8868439197540283
2003,7/9/2021 3:42:37 PM,JNJ posts encouraging three-year data for STELARA in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3714032-jnj-posts-encouraging-three-year-data-for-stelara-in-ulcerative-colitis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9517862200737
2004,7/9/2021 4:02:14 PM,Watch Out for a Selloff in Vaxart Stock,InvestorPlace,/news/stocks/watch-out-for-a-selloff-in-vaxart-stock-1030593691,positive,0.5398297905921936
2005,7/9/2021 4:53:01 PM,CDC updates guidance for schools recommending indoor masking for unvaccinated children and teachers,Seeking Alpha,https://seekingalpha.com/news/3714051-cdc-updates-guidance-for-schools-recommending-indoor-masking-for-unvaccinated-children-and-teachers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7573947310447693
2006,7/10/2021 10:51:53 PM,Alector leads weekly healthcare gainers; gene-editing stocks fall after Intellia-driven rally,Seeking Alpha,https://seekingalpha.com/news/3714135-alector-leads-weekly-healthcare-gainers-gene-editing-stocks-fall-after-intellia-driven-rally?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9623830318450928
2007,7/11/2021 2:29:21 AM,"New daily COVID-19 cases exceed 48,000 in U.S., highest since May",Seeking Alpha,https://seekingalpha.com/news/3714138-new-daily-covid-19-cases-exceed-48000-in-us-highest-since-may?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6676762104034424
2008,7/12/2021 10:50:13 AM,"Chinese COVID-19 shots have nearly 70% efficacy against Delta variant, scientist says",Seeking Alpha,https://seekingalpha.com/news/3714180-chinese-covid-19-shots-have-nearly-70-efficacy-against-delta-variant-scientist-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.915778398513794
2009,7/12/2021 12:24:53 PM,FDA approves Janssen's Darzalex Faspro combo in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3714230-fda-approves-janssens-darzalex-faspro-combo-in-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.773773729801178
2010,7/12/2021 6:01:46 PM,JNJ vaccine linked to new side effect; FDA to add warning to indicate risk,Seeking Alpha,https://seekingalpha.com/news/3714421-jnj-vaccine-linked-to-new-side-effect-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6179938912391663
2011,7/12/2021 6:29:48 PM,"France to require health pass for bars, cafes, attractions and travel",Seeking Alpha,https://seekingalpha.com/news/3714430-france-to-require-health-pass-for-bars-cafes-attractions-and-travel?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9183841347694397
2012,7/12/2021 9:38:05 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-spce-stock-johnson-and-johnson-1030598854,positive,0.9254742860794067
2013,7/12/2021 11:36:14 PM,J&J's Covid Vaccine Linked To Rare Neurological Condition; FDA Might Issue Warning ,RTTNews,/news/stocks/j-j-s-covid-vaccine-linked-to-rare-neurological-condition-fda-might-issue-warning-1030598846,positive,0.6496466398239136
2014,7/13/2021 11:17:08 AM,New warning added to Johnson & Johnson COVID-19 shot to reflect risk of rare side effect,Seeking Alpha,https://seekingalpha.com/news/3714604-new-warning-added-to-jnj-covid-19-shot-to-reflect-risk-of-rare-side-effect?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5404702425003052
2015,7/13/2021 11:44:01 AM,"JNJ, AstraZeneca explore modifications for COVID-19 shots to address clotting risk: WSJ",Seeking Alpha,https://seekingalpha.com/news/3714620-jnj-astrazeneca-explore-modifications-to-covid-19-shots-to-address-clotting-risk-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5176551938056946
2016,7/13/2021 2:05:06 PM,"The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data",Benzinga,/news/stocks/the-daily-biotech-pulse-equillium-issues-positive-regulatory-update-biogen-in-licenses-multiple-sclerosis-drug-aridis-releases-covid-19-antibody-cocktail-data-1030601329,positive,0.7802436947822571
2017,7/13/2021 3:32:41 PM,"J&J, AstraZeneca Exploring Fixes To Rare Blood Clots Linked To Their Vaccines: WSJ ",RTTNews,/news/stocks/j-j-astrazeneca-exploring-fixes-to-rare-blood-clots-linked-to-their-vaccines-wsj-1030602027,positive,0.7038729190826416
2018,7/13/2021 5:18:16 PM,More data needed on potential side effects of COVID-19 booster shots: CDC official,Seeking Alpha,https://seekingalpha.com/news/3714823-more-data-needed-on-potential-side-effects-of-covid-19-booster-shots-cdc-official?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9113450050354004
2019,7/14/2021 2:07:15 PM,7 Stocks to Buy if You‚Äôre Worried About the Pandemic Like Warren Buffett,InvestorPlace,/news/stocks/7-stocks-to-buy-if-worried-like-warren-buffett-about-pandemic-1030607187,positive,0.9034628868103027
2020,7/14/2021 5:08:48 PM,"Europe adds warnings on Pfizer, Moderna COVID-19 shots to reflect risk of heart inflammation",Seeking Alpha,https://seekingalpha.com/news/3715227-europe-adds-warnings-on-pfizer-moderna-covid-19-shots-to-reflect-risk-of-heart-inflammation?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8227540850639343
2021,7/14/2021 6:00:21 PM,EMA says too early to determine if COVID booster shots will be needed,Seeking Alpha,https://seekingalpha.com/news/3715240-ema-says-too-early-to-determine-if-covid-booster-shots-will-be-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9369086623191833
2022,7/14/2021 9:30:12 PM,JNJ to recall certain NEUTROGENA and AVEENO sunscreen products citing carcinogen,Seeking Alpha,https://seekingalpha.com/news/3715331-jnj-to-recall-certain-neutrogena-and-aveeno-sunscreen-products-citing-carcinogen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9445621967315674
2023,7/14/2021 11:00:00 PM,Johnson & Johnson Consumer Inc. Issues Voluntary Recall of Specific NEUTROGENA¬Æ and AVEENO¬Æ Aerosol Sunscreen Products Due to the Presence of Benzene,PR Newswire,/news/stocks/johnson-johnson-consumer-inc-issues-voluntary-recall-of-specific-neutrogena-and-aveeno-aerosol-sunscreen-products-due-to-the-presence-of-benzene-1030608381,neutral,0.9460066556930542
2024,7/15/2021 12:45:34 AM,Johnson & Johnson Recalls Certain Sunscreen Products Due To Benzene Presence ,RTTNews,/news/stocks/johnson-johnson-recalls-certain-sunscreen-products-due-to-benzene-presence-1030608536,neutral,0.945310115814209
2025,7/15/2021 1:34:43 PM,CDC to discuss need for COVID-19 booster doses in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3715544-cdc-to-discuss-need-for-covid-19-booster-doses-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.826088011264801
2026,7/15/2021 2:07:56 PM,"The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-sinks-on-data-j-j-recalls-sunscreen-products-fibrogen-awaits-adcom-verdict-3-ipos-1030610817,positive,0.6488502025604248
2027,7/15/2021 4:00:51 PM,CVS Health pulls two sunburn products citing cancer-causing agent,Seeking Alpha,https://seekingalpha.com/news/3715639-cvs-health-pulls-two-sunburn-products?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9619598984718323
2028,7/15/2021 8:35:26 PM,Medtech firm HeartFlow agrees to $2.4B SPAC merger with Longview Acquisition Corp. II,Seeking Alpha,https://seekingalpha.com/news/3715766-heartflow-agrees-to-spac-merger-with-longview-acquisition-corp-ii?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6371498107910156
2029,7/16/2021 2:17:21 PM,MRNA Stock: 10 Things to Know About Moderna as It Gets Ready to Join the S&P 500,InvestorPlace,/news/stocks/mrna-stock-10-things-to-know-about-moderna-as-it-gets-ready-to-join-the-sp-500-1030615504,positive,0.9003422260284424
2030,7/16/2021 4:10:20 PM,7 Best Dividend Stocks to Buy to Juice Your Portfolio Yield,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-to-juice-your-portfolio-yield-1030615780,positive,0.8995172381401062
2031,7/16/2021 8:21:41 PM,FDA now investigating cause of benzene contamination in J&J sunscreens,Seeking Alpha,https://seekingalpha.com/news/3716107-fda-now-investigating-cause-of-benzene-contamination-in-jj-sunscreens?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4901571273803711
2032,7/17/2021 8:00:00 PM,"Interest in ""shroom stocks"" rises as investors see potential of psychedelics as therapy",Seeking Alpha,https://seekingalpha.com/news/3716128-interest-in-shroom-stocks-rises-as-investors-see-potential-of-psychedelics-as-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7474513649940491
2033,7/18/2021 4:25:56 PM,"The Week Ahead In Biotech: Earnings Kickstart With J&J And Biogen, Albireo Awaits FDA Decisions, More IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-earnings-kickstart-with-j-j-and-biogen-albireo-awaits-fda-decisions-more-ipos-1030617574,negative,0.5948063731193542
2034,7/19/2021 3:56:18 AM,J&J may put talc liabilities into new business that files bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3716153-jj-may-put-talc-liabilities-into-new-business-that-files-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9145601391792297
2035,7/19/2021 5:25:57 AM,Johnson & Johnson Considering Plan To Put Talc Liabilities Into Bankruptcy : Report ,RTTNews,/news/stocks/johnson-johnson-considering-plan-to-put-talc-liabilities-into-bankruptcy-report-1030617774,positive,0.7988709211349487
2036,7/19/2021 3:01:28 PM,Here's what to expect from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-q2-quarterly-earnings-preview-stock-1030620368,positive,0.9278756380081177
2037,7/19/2021 4:39:12 PM,"Johnson & Johnson declares $1.06 dividend, stock yields 2.6%",Seeking Alpha,https://seekingalpha.com/news/3716448-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.664578914642334
2038,7/19/2021 6:35:00 PM,Johnson & Johnson Announces Quarterly Dividend for Third Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-third-quarter-2021-1030621320,neutral,0.673792839050293
2039,7/19/2021 8:21:37 PM,60% of people admitted to hospitals due to COVID-19 are unvaccinated - U.K. chief scientific adviser,Seeking Alpha,https://seekingalpha.com/news/3716576-60-of-people-admitted-to-hospitals-due-to-covid-19-are-unvaccinated-uk-chief-scientific-adviser?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7849373817443848
2040,7/20/2021 2:20:32 AM,"U.S. is said to near $26B opioid settlement with drug distributors, J&J",Seeking Alpha,https://seekingalpha.com/news/3716659-us-is-said-to-near-26b-opioid-settlement-with-drug-distributors-jj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9007070660591125
2041,7/20/2021 1:15:26 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/3716864-notable-earnings-before-wednesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855887770652771
2042,7/20/2021 4:08:50 PM,COVID-19 Delta variant now accounts for 83% of new cases - CDC Director,Seeking Alpha,https://seekingalpha.com/news/3716985-covid-19-delta-variant-now-accounts-for-83-of-new-cases-cdc-director?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8862178921699524
2043,7/20/2021 4:10:18 PM,Three Drug Distributors To Pay Up To $1.18 Bln To Settle New York Opioid Claims ,RTTNews,/news/stocks/three-drug-distributors-to-pay-up-to-1-18-bln-to-settle-new-york-opioid-claims-1030625917,negative,0.4366303086280823
2044,7/20/2021 5:06:36 PM,"JNJ, drug distributors favored on Street as they near $26B opioid settlement with U.S.",Seeking Alpha,https://seekingalpha.com/news/3717024-jnj-drug-distributors-favored-on-street-as-they-near-26b-opioid-settlement-with-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4966955780982971
2045,7/20/2021 8:52:56 PM,7 Top Defensive Stocks To Buy For Q2 Earnings Season,InvestorPlace,/news/stocks/7-top-defensive-stocks-to-buy-for-q2-earnings-season-1030627206,positive,0.8670820593833923
2046,7/21/2021 10:31:17 AM,"Johnson & Johnson EPS beats by $0.19, beats on revenue",Seeking Alpha,https://seekingalpha.com/news/3717239-johnson-and-johnson-eps-beats-0_19-beats-on-revenue?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7389788627624512
2047,7/21/2021 11:16:44 AM,Johnson & Johnson boosts 2021 guidance after Q2 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3717274-johnson-johnson-boosts-2021-guidance-after-q2-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6926049590110779
2048,7/21/2021 12:25:00 PM,Johnson & Johnson Reports Q2 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q2-2021-results-1030629526,positive,0.7140592932701111
2049,7/21/2021 12:34:47 PM,Johnson & Johnson Q2 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q2-adjusted-earnings-beat-estimates-1030629548,negative,0.6643639206886292
2050,7/21/2021 1:08:46 PM,Johnson & Johnson Raises FY21 View Above Market As Q2 Results Top Estimates ,RTTNews,/news/stocks/johnson-johnson-raises-fy21-view-above-market-as-q2-results-top-estimates-1030629771,negative,0.8983301520347595
2051,7/21/2021 1:52:07 PM,"The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-novartis-report-solid-results-chembio-soars-on-covid-test-order-lumos-signals-clinical-trial-delay-1030629917,negative,0.8773144483566284
2052,7/21/2021 5:58:30 PM,U.S life expectancy cut by a year and a half in 2020 due to COVID-19,Seeking Alpha,https://seekingalpha.com/news/3717587-us-life-expectancy-cut-by-a-year-and-a-half-in-2020-due-to-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9592799544334412
2053,7/21/2021 8:47:49 PM,What Did the Stock Market Do Today? 3 Big Stories to Catch Up On.,InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-10-1030632297,positive,0.9254742860794067
2054,7/21/2021 9:43:35 PM,"4 Top Stock Trades for Thursday: SQ, JNJ, KO, CMG",InvestorPlace,/news/stocks/4-top-stock-trades-for-thursday-sq-jnj-ko-cmg-1030632487,positive,0.9167636036872864
2055,7/21/2021 11:44:50 PM,"Johnson & Johnson, Drug Distributors Settle $26 Bln Opioid Deal ",RTTNews,/news/stocks/johnson-johnson-drug-distributors-settle-26-bln-opioid-deal-1030632399,negative,0.39797917008399963
2056,7/23/2021 12:18:20 PM,Johnson & Johnson's VERITAS Vision System available globally,Seeking Alpha,https://seekingalpha.com/news/3718535-johnson-johnsons-veritas-vision-system-available-globally?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9313092827796936
2057,7/23/2021 4:16:35 PM,"Snap, Twitter Earnings Impress, Potentially Setting Table For Facebook Next Week",Benzinga,/news/stocks/snap-twitter-earnings-impress-potentially-setting-table-for-facebook-next-week-1030639365,neutral,0.7198363542556763
2058,7/23/2021 5:57:32 PM,"Pfizer/BioNTech COVID-19 shot is 39% effective with prevalence of Delta variant, Israel says",Seeking Alpha,https://seekingalpha.com/news/3718702-pfizerbiontech-covid-19-shot-is-39-effective-with-prevalence-of-delta-variant-israel-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8483459949493408
2059,7/23/2021 8:17:00 PM,Johnson & Johnson -- Moody's: J&J opioid settlement adds financial leverage but reduces uncertainty,Moodys,/news/bonds/johnson-johnson-moody-s-j-j-opioid-settlement-adds-financial-leverage-but-reduces-uncertainty-1030639924,negative,0.9453246593475342
2060,7/25/2021 3:14:39 AM,COVID-19 cases are rising in every U.S. state amid vaccine hesitancy,Seeking Alpha,https://seekingalpha.com/news/3718822-covid-19-cases-are-rising-in-every-us-state-amid-vaccine-hesitancy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8902133107185364
2061,7/25/2021 3:26:31 PM,"The Week Ahead In Biotech: Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More",Benzinga,/news/stocks/the-week-ahead-in-biotech-july-25-31-big-pharma-earnings-iterum-fda-decision-alzheimer-s-conference-ipos-and-more-1030641744,positive,0.9177685976028442
2062,7/26/2021 10:00:41 AM,3 Blue-Chip Dividend Stocks for a Bear Market,InvestorPlace,/news/stocks/3-blue-chip-dividend-stocks-for-a-bear-market-1030643974,positive,0.8821025490760803
2063,7/26/2021 10:00:58 AM,Novavax Stock May Not Get the Delta Varient Bump Investors Need,InvestorPlace,/news/stocks/novavax-stock-may-not-get-the-delta-varient-bump-investors-need-1030643966,positive,0.7728195190429688
2064,7/26/2021 11:21:36 AM,Biden officials contemplate the need of COVID-19 booster shots in vulnerable Americans,Seeking Alpha,https://seekingalpha.com/news/3718902-biden-officials-contemplate-the-need-of-covid-19-booster-shots-in-vulnerable-americans?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8326242566108704
2065,7/26/2021 8:42:19 PM,Data from Israel suggest impact of vaccines on severe COVID-19 despite uptick in cases,Seeking Alpha,https://seekingalpha.com/news/3719325-data-from-israel-highlight-impact-of-vaccines-on-severe-covid-19-despite-uptick-in-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9212672114372253
2066,7/27/2021 10:45:49 AM,"Vaccine mandates announced in NYC, California and Department of Veterans Affairs",Seeking Alpha,https://seekingalpha.com/news/3719480-vaccine-mandates-announced-in-nyc-california-and-department-of-veterans-affairs?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8609801530838013
2067,7/27/2021 2:05:24 PM,Israel to offer COVID-19 vaccines to at-risk children - Jerusalem Post,Seeking Alpha,https://seekingalpha.com/news/3719701-israel-to-offer-covid-19-vaccines-to-at-risk-children-jerusalem-post?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5542243123054504
2068,7/27/2021 6:23:20 PM,7 Cheap Value Stocks to Buy for August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-1030652138,positive,0.9190972447395325
2069,7/27/2021 7:52:39 PM,CDC recommends masks in public spaces in areas with substantial and high COVID-19 transmission,Seeking Alpha,https://seekingalpha.com/news/3719958-cdc-mandates-masks-in-public-spaces-in-areas-with-substantial-high-covid-19-transmission?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8540837168693542
2070,7/27/2021 8:09:11 PM,U.S. is weighing vaccine mandates for all federal employees,Seeking Alpha,https://seekingalpha.com/news/3719984-us-is-weighing-vaccine-mandates-for-all-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8368843197822571
2071,7/27/2021 10:10:00 PM,Johnson & Johnson to Participate in the Virtual Wells Fargo Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-virtual-wells-fargo-healthcare-conference-1030652364,positive,0.8388641476631165
2072,7/28/2021 6:10:09 PM,White House tells federal agencies to mandate masks indoors in high COVID areas - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720745-white-house-tells-federal-agencies-to-mandate-masks-indoors-in-high-covid-areas-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8978102803230286
2073,7/28/2021 8:12:09 PM,J&J asked by U.S. House subcommittee to provide info on plans to put talc liabilities into bankruptcy - Reuters,Seeking Alpha,https://seekingalpha.com/news/3720863-j-asked-by-us-house-subcommittee-to-provide-info-on-plans-to-put-talc-liabilities-into-bankruptcy-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9348461031913757
2074,7/29/2021 5:28:16 AM,FDA Extends Shelf-life Of Johnson & Johnson's COVID-19 Vaccine ,RTTNews,/news/stocks/fda-extends-shelf-life-of-johnson-johnson-s-covid-19-vaccine-1030659292,negative,0.6577462553977966
2075,7/29/2021 10:46:54 AM,Emergent to restart COVID-19 vaccine production at Baltimore Plant,Seeking Alpha,https://seekingalpha.com/news/3721278-emergent-to-restart-covid-19-vaccine-production-at-baltimore-plant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9206722974777222
2076,7/29/2021 5:14:00 PM,"Women Cancer Victims Opposed to Johnson & Johnson's 'Texas Two-Step' Bankruptcy Ploy Urge Passage of Reforms Introduced by Warren, Durbin, Nadler, Blumenthal, and Maloney",PR Newswire,/news/stocks/women-cancer-victims-opposed-to-johnson-johnson-s-texas-two-step-bankruptcy-ploy-urge-passage-of-reforms-introduced-by-warren-durbin-nadler-blumenthal-and-maloney-1030663440,negative,0.7458425164222717
2077,7/29/2021 5:14:59 PM,AstraZeneca and J&J are yet to see need for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3721739-astrazeneca-and-jj-are-yet-to-see-need-for-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5511691570281982
2078,7/29/2021 8:38:54 PM,7 Best ETFs To Buy Now if You‚Äôre Looking for Safety,InvestorPlace,/news/stocks/7-best-etfs-to-buy-now-for-safety-1030664554,positive,0.9192031025886536
2079,7/30/2021 8:12:18 AM,Is a third COVID-19 vaccine dose necessary? What you need to know about boosters,Seeking Alpha,https://seekingalpha.com/news/3722140-is-a-third-covid-19-vaccine-dose-necessary-what-you-need-to-know-about-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9243147969245911
2080,7/30/2021 11:00:10 AM,"COVID-19 Delta variant is as contagious as chickenpox, CDC report says - NYT",Seeking Alpha,https://seekingalpha.com/news/3722207-covid-19-delta-variant-is-as-contagious-as-chickenpox-cdc-report-says-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7013037204742432
2081,7/30/2021 12:43:53 PM,FDA OKs Janssen Pharma's Uptravi for intravenous use in adults with PAH,Seeking Alpha,https://seekingalpha.com/news/3722343-fda-oks-janssen-pharmas-uptravi-for-intravenous-use-in-adults-with-pah?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7159883975982666
2082,7/30/2021 1:53:58 PM,"The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs",Benzinga,/news/stocks/the-daily-biotech-pulse-erytech-jumps-on-fast-track-designation-glaxosmithkline-fda-nod-alnylam-s-clinical-collaboration-4-ipos-1030667906,negative,0.7937849164009094
2083,7/30/2021 2:23:34 PM,"Elon Musk, Jeff Bezos & Richard Branson: Which Market Leaders Will Make Up The Cannabis Industry Space Race?",Benzinga,/news/stocks/elon-musk-jeff-bezos-richard-branson-which-market-leaders-will-make-up-the-cannabis-industry-space-race-1030668073,positive,0.9424586892127991
2084,7/30/2021 5:29:08 PM,Johnson & Johnson agrees to delay bankruptcy plan for talc liabilities,Seeking Alpha,https://seekingalpha.com/news/3722555-johnson-johnson-agrees-to-delay-bankruptcy-plan-for-talc-liabilities?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.668016254901886
2085,7/30/2021 6:30:04 PM,Fully vaccinated people made up 74% of cases in a COVID-19 outbreak in Massachusetts - CDC,Seeking Alpha,https://seekingalpha.com/news/3722589-fully-vaccinated-people-made-up-74-of-cases-in-a-covid-19-outbreak-in-massachusetts-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8357453346252441
2086,8/2/2021 8:06:26 AM,U.S. lockdown unlikely despite surge in Covid cases: Fauci,Seeking Alpha,https://seekingalpha.com/news/3722777-us-lockdown-unlikely-despite-surge-in-covid-cases-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.42814913392066956
2087,8/2/2021 10:14:30 AM,J&J pulls back proposal for expedited COVID-19 vaccine approval in India,Seeking Alpha,https://seekingalpha.com/news/3722794-jj-pulls-back-proposal-for-expedited-covid-19-vaccine-approval-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8918823003768921
2088,8/2/2021 11:31:33 AM,"CDC reports over 6,000 COVID-19 hospitalizations in U.S. among fully vaccinated",Seeking Alpha,https://seekingalpha.com/news/3722831-cdc-reports-over-6000-covid-19-hospitalizations-in-us-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8329269289970398
2089,8/2/2021 3:33:59 PM,"Pfizer, Moderna raise COVID-19 vaccine prices in the EU",Seeking Alpha,https://seekingalpha.com/news/3723066-pfizer-moderna-raise-covid-19-vaccine-prices-in-the-eu?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.742526650428772
2090,8/2/2021 3:54:58 PM,"Throw in The Towel, Ocugen Stock is Not Coming Back",InvestorPlace,/news/stocks/ocgn-stock-throw-in-towel-not-coming-back-1030677286,positive,0.7624982595443726
2091,8/3/2021 11:12:27 AM,Britain and Germany to offer COVID-19 booster shots; U.S. seeks more data,Seeking Alpha,https://seekingalpha.com/news/3723709-britain-and-germany-to-offer-covid-19-booster-shots-us-waits-for-more-data?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7890743017196655
2092,8/3/2021 2:50:39 PM,"DeBlasio: NYC requiring vaccination proof for restaurants, gyms, and entertainment venues",Seeking Alpha,https://seekingalpha.com/news/3723960-deblasio-nyc-requiring-vaccination-proof-for-restaurants-gyms-and-entertainment-venues?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9112750887870789
2093,8/3/2021 5:01:31 PM,7 Cheap Value Stocks To Buy For August 2021,InvestorPlace,/news/stocks/7-cheap-value-stocks-to-buy-for-august-2021-2-1030684926,positive,0.9190972447395325
2094,8/4/2021 9:19:16 AM,Final FDA approval for Pfizer's COVID-19 vaccine expected by early September,Seeking Alpha,https://seekingalpha.com/news/3724672-final-fda-approval-for-pfizers-covid-19-vaccine-expected-by-early-september?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7865221500396729
2095,8/4/2021 1:52:10 PM,"The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-s-positive-readout-nrx-strikes-r-d-collaboration-with-mannkind-cerus-invitae-jump-on-earnings-1030688766,negative,0.7550449371337891
2096,8/4/2021 2:37:31 PM,WHO calls for COVID vaccine booster moratorium so poorer countries can get shots,Seeking Alpha,https://seekingalpha.com/news/3724983-who-calls-for-covid-booster-moratorium-so-poorer-countries-can-get-shots-wapo?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.533158004283905
2097,8/4/2021 5:08:27 PM,7 Stocks to Buy for Responsibility and Sustainability,InvestorPlace,/news/stocks/7-stocks-to-buy-for-responsibility-and-sustainability-1030690642,positive,0.8951490521430969
2098,8/4/2021 6:29:01 PM,"Pfizer, Moderna COVID-19 shots offered in San Francisco to Johnson & Johnson vaccine recipients",Seeking Alpha,https://seekingalpha.com/news/3725234-pfizer-moderna-covid-19-shots-offered-in-san-francisco-to-johnson-johnson-vaccine-recipients?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8261359930038452
2099,8/5/2021 9:48:09 AM,Global COVID-19 cases top 200M as Delta variant rages,Seeking Alpha,https://seekingalpha.com/news/3725762-global-covid-19-cases-top-200m-as-delta-variant-rages?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5814623236656189
2100,8/5/2021 2:07:56 PM,"The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-positive-keytruda-readout-moderna-slips-despite-q2-beat-bayer-to-buy-vividion-for-up-to-2b-glycomimetics-gets-new-ceo-1030695873,negative,0.8679100871086121
2101,8/5/2021 6:08:03 PM,Fauci warns COVID-19 variants more severe than delta could emerge,Seeking Alpha,https://seekingalpha.com/news/3726300-fauci-warns-covid-19-variants-more-severe-than-delta-could-emerge?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9177864193916321
2102,8/6/2021 10:31:15 AM,Johnson & Johnson COVID-19 shot offers 71% protection when Delta variant dominates - Study,Seeking Alpha,https://seekingalpha.com/news/3726850-johnson-johnson-covid-19-shot-offers-71-protection-when-delta-variant-dominates-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6931583881378174
2103,8/6/2021 10:48:30 AM,Johnson & Johnson seeks emergency use approval of COVID-19 vaccine in India,Seeking Alpha,https://seekingalpha.com/news/3726866-johnson-johnson-seeks-emergency-use-approval-of-covid-19-vaccine-in-india?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7589818835258484
2104,8/6/2021 3:49:09 PM,"Despite Novavax‚Äôs Challenges, NVAX Stock Could Still Pop",InvestorPlace,/news/stocks/nvax-stock-despite-challenges-could-still-pop-from-here-1030702070,negative,0.9330615997314453
2105,8/6/2021 5:32:31 PM,Latest CDC report shows a slight uptick in COVID-19 cases among fully vaccinated,Seeking Alpha,https://seekingalpha.com/news/3727132-latest-cdc-report-shows-a-slight-uptick-in-covid-19-cases-among-fully-vaccinated?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.564365029335022
2106,8/6/2021 8:00:09 PM,Bioethicist Ezekiel Emanuel under consideration for FDA commissioner - Politico,Seeking Alpha,https://seekingalpha.com/news/3727179-bioethicist-ezekiel-emanuel-under-consideration-for-fda-commissioner-politico?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.935555636882782
2107,8/8/2021 7:11:35 PM,India Approves Johnson & Johnson's Single-dose COVID-19 Vaccine ,RTTNews,/news/stocks/india-approves-johnson-johnson-s-single-dose-covid-19-vaccine-1030704408,negative,0.7088813781738281
2108,8/8/2021 9:35:13 PM,Fauci hopes FDA will give full approval for COVID-19 vaccine in next few weeks,Seeking Alpha,https://seekingalpha.com/news/3727253-fauci-hopes-fda-will-give-full-approval-for-covid-19--vaccine-in-next-few-weeks?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7232925295829773
2109,8/9/2021 6:04:30 AM,Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey,Seeking Alpha,https://seekingalpha.com/news/3727278-pfizer-vaccine-booster-shot-has-similar-side-effects-to-2nd-dose-israeli-survey?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8921642303466797
2110,8/9/2021 3:07:00 PM,Johnson & Johnson to Participate in Barclays Global Consumer Staples Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-barclays-global-consumer-staples-virtual-conference-1030708907,positive,0.8503884077072144
2111,8/9/2021 3:17:59 PM,Why These Biotech Stocks Are Soaring,InvestorPlace,/news/stocks/why-these-biotech-stocks-are-soaring-1030710695,positive,0.9273127317428589
2112,8/10/2021 8:14:31 AM,Moderna COVID-19 vaccine may be better than Pfizer against Delta variant; breakthrough cases rise with time,Seeking Alpha,https://seekingalpha.com/news/3727988-moderna-covid-19-vaccine-may-be-better-than-pfizer-against-delta-variant-breakthrough-cases-rise-with-time?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9368888139724731
2113,8/10/2021 12:57:28 PM,COVID-19 during pregnancy associated with higher risk of preterm birth: U.S. Study,Seeking Alpha,https://seekingalpha.com/news/3728176-covid-19-during-pregnancy-associated-with-higher-risk-of-preterm-birth-us-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.5115487575531006
2114,8/10/2021 8:40:24 PM,Dr. Scott Gottlieb says current COVID-19 surge could be the ‚Äúfinal wave‚Äù in U.S.,Seeking Alpha,https://seekingalpha.com/news/3728500-dr-scott-gottlieb-says-current-covid-19-surge-could-be-the-final-wave-in-us?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6829950213432312
2115,8/11/2021 10:00:50 AM,Novavax Is Looking More Like a Bet Worth Taking,InvestorPlace,/news/stocks/nvax-stock-is-looking-more-like-a-bet-worth-taking-1030717837,positive,0.8606456518173218
2116,8/11/2021 4:57:52 PM,7 Biotech Stocks to Buy Amid the Delta Variant‚Äôs Onslaught,InvestorPlace,/news/stocks/7-biotech-stocks-to-buy-amid-rising-covid-19-cases-1030719978,positive,0.5603509545326233
2117,8/11/2021 6:30:41 PM,7 Best Bear Market Stocks to Buy Now in Preparation for a Downturn,InvestorPlace,/news/stocks/7-best-bear-market-stocks-to-buy-now-in-preparation-for-a-downturn-1030720182,positive,0.7811884880065918
2118,8/12/2021 11:01:31 AM,AstraZeneca COVID-19 shot did not lead to new cases of rare clots after age restrictions - study,Seeking Alpha,https://seekingalpha.com/news/3729425-astrazeneca-covid-19-shot-did-not-lead-to-new-cases-of-rare-clots-after-age-restrictions-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7271391153335571
2119,8/12/2021 3:14:00 PM,Johnson & Johnson to Participate in the Morgan Stanley 19th Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-morgan-stanley-19th-annual-global-healthcare-conference-1030724612,positive,0.6497131586074829
2120,8/12/2021 4:07:52 PM,CytoSorbents' Antithrombotic Removal System Scores Second FDA Breakthrough Device Tag,Benzinga,/news/stocks/cytosorbents-antithrombotic-removal-system-scores-second-fda-breakthrough-device-tag-1030724927,negative,0.7559815645217896
2121,8/12/2021 11:18:53 PM,Why This Fundamentally Superior Biotech Is Soaring,InvestorPlace,/news/stocks/why-this-fundamentally-superior-biotech-is-soaring-1030735292,positive,0.8504866361618042
2122,8/13/2021 10:07:10 AM,Pfizer/BioNTech and Moderna win FDA nod for COVID-19 booster shots,Seeking Alpha,https://seekingalpha.com/news/3730157-pfizerbiontech-and-moderna-win-fda-nod-in-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9133623242378235
2123,8/13/2021 1:43:02 PM,"The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-vaccine-produces-durable-response-against-variants-fda-approves-jazz-s-sleep-disorder-drug-dermata-ipo-1030728962,negative,0.8680629730224609
2124,8/13/2021 7:43:28 PM,Novavax: Bronze Medal May Be Good Enough in COVID Race,InvestorPlace,/news/stocks/nvax-stock-bronze-medal-may-be-good-enough-in-covid-race-1030730157,negative,0.9052910804748535
2125,8/13/2021 9:01:38 PM,"Pfizer, Moderna to enjoy first mover advantage as COVID-19 expected to become endemic",Seeking Alpha,https://seekingalpha.com/news/3730492-pfizer-moderna-to-enjoy-first-mover-advantage-as-covid-19-expected-to-become-endemic?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8873966932296753
2126,8/15/2021 2:52:53 AM,Plans underway in U.S. to widen access to COVID-19 boosters as early as fall - NYT,Seeking Alpha,https://seekingalpha.com/news/3730532-plans-underway-in-us-to-widen-access-to-covid-19-boosters-as-early-as-fall-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9078192710876465
2127,8/16/2021 6:35:52 AM,Texas Supreme Court temporarily halts local mask mandates,Seeking Alpha,https://seekingalpha.com/news/3730569-texas-supreme-court-temporarily-halts-local-mask-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8446748852729797
2128,8/17/2021 2:28:53 PM,"The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business",Benzinga,/news/stocks/the-daily-biotech-pulse-lilly-reorganizes-business-units-in-neuroscience-focus-helius-medical-spikes-on-breakthrough-designation-ra-medical-sells-dermatology-business-1030738023,positive,0.9126444458961487
2129,8/18/2021 2:06:17 AM,COVID-19 Delta variant is linked to higher risk of hospitalizations - WHO,Seeking Alpha,https://seekingalpha.com/news/3731680-covid-19-delta-variant-is-linked-to-higher-risk-of-hospitalizations-who?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.42758429050445557
2130,8/18/2021 7:35:29 AM,Los Angeles to require masks at large outdoor events,Seeking Alpha,https://seekingalpha.com/news/3731693-los-angeles-to-require-masks-at-large-outdoor-events-us-transport-mask-mandate-extended?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9152795076370239
2131,8/18/2021 1:37:56 PM,"The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline",Benzinga,/news/stocks/the-daily-biotech-pulse-azurrx-jumps-on-data-agios-regulatory-application-for-mitapivat-accepted-for-priority-review-fda-nod-for-glaxosmithkline-1030741574,negative,0.5053824782371521
2132,8/18/2021 2:28:03 PM,Pfizer's third COVID-19 shot 86% effective in people over 60: Israeli healthcare provider,Seeking Alpha,https://seekingalpha.com/news/3731878-pfizers-third-covid-19-shot-86-effective-in-people-over-60s-israeli-healthcare-provider?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6488715410232544
2133,8/19/2021 8:18:01 AM,Biden administration to require nursing home workers get COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3732117-biden-administration-to-require-nursing-home-workers-get-covid-19-vaccine-amid-delta-surge?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9040305614471436
2134,8/19/2021 11:14:21 AM,Biden's booster shots recommendation questioned by some health experts,Seeking Alpha,https://seekingalpha.com/news/3732172-bidens-booster-shots-recommendation-causes-distress-among-scientists-and-health-experts?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.80850750207901
2135,8/19/2021 11:18:00 PM,"Alex Gorsky to Serve as Executive Chairman and Transition Role of Chief Executive Officer of Johnson & Johnson to Joaquin Duato, Effective January 3, 2022",PR Newswire,/news/stocks/alex-gorsky-to-serve-as-executive-chairman-and-transition-role-of-chief-executive-officer-of-johnson-johnson-to-joaquin-duato-effective-january-3-2022-1030747372,positive,0.9495425224304199
2136,8/20/2021 2:14:06 AM,Acting FDA head Woodcock ruled out as permanent nominee - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3732564-acting-fda-head-woodcock-ruled-out-as-permanent-nominee-bloomberg?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7850372195243835
2137,8/20/2021 5:00:34 AM,Alex Gorsky To Step Down As J&J's CEO And Joaquin Duato To Take Over CEO Role ,RTTNews,/news/stocks/alex-gorsky-to-step-down-as-j-j-s-ceo-and-joaquin-duato-to-take-over-ceo-role-1030747568,positive,0.7465010285377502
2138,8/20/2021 8:52:08 AM,Texas Supreme Court to temporarily keep school mask mandates in place,Seeking Alpha,https://seekingalpha.com/news/3732584-texas-supreme-court-to-temporarily-keep-school-mask-mandates-in-place?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7449678778648376
2139,8/20/2021 1:45:43 PM,"The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen's Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-announces-ceo-transition-fibrogen-s-roxadustat-approved-in-europe-geovax-sorrento-announce-covid-19-vaccine-data-1030748705,positive,0.8679837584495544
2140,8/20/2021 1:54:10 PM,"Israel expands COVID-19 booster shot eligibility to people over 40, teachers",Seeking Alpha,https://seekingalpha.com/news/3732705-israel-expands-covid-19-booster-shot-eligibility-to-people-over-40-teachers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.511626124382019
2141,8/20/2021 3:22:23 PM,"Novavax Stock Could Remain a Winner, Despite its ‚ÄòAlso Ran‚Äô Status",InvestorPlace,/news/stocks/nvax-stock-could-remain-winner-despite-also-ran-status-1030749369,negative,0.7404914498329163
2142,8/20/2021 8:36:39 PM,"What Did the Stock Market Do Today, Aug. 20? 3 Big Stories to Catch Up On.",InvestorPlace,/news/stocks/what-did-the-stock-market-do-today-3-big-stories-to-catch-up-on-13-2-2-1030749919,positive,0.931075930595398
2143,8/20/2021 9:30:57 PM,Pfizer/BioNTech COVID-19 vaccine set to win full FDA approval on Monday - NYT,Seeking Alpha,https://seekingalpha.com/news/3732860-pfizerbiontech-covid-19-vaccine-set-to-win-full-fda-approval-on-monday-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6256344318389893
2144,8/22/2021 1:58:42 AM,Pfizer/BioNTech COVID-19 vaccine protection dropped faster than AstraZeneca‚Äôs - study,Seeking Alpha,https://seekingalpha.com/news/3732884-pfizerbiontech-covid-19-vaccine-protection-dropped-faster-than-astrazenecas-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9235166311264038
2145,8/22/2021 3:01:25 PM,"The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-cara-fda-decision-ascendis-earnings-aileron-data-presentation-and-more-1030750711,positive,0.9420926570892334
2146,8/23/2021 8:45:22 PM,COVID-19 vaccine mandates in NYC schools and Pentagon after FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733298-covid-19-vaccine-mandates-in-nyc-schools-and-pentagon-after-full-fda-approval-for-pfizerbiontech-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8030846118927002
2147,8/24/2021 11:17:10 AM,Biden calls on companies to require COVID-19 vaccines after Pfizer's FDA approval,Seeking Alpha,https://seekingalpha.com/news/3733404-biden-calls-on-companies-to-require-covid-19-vaccines-after-pfizers-fda-approval?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8398863673210144
2148,8/24/2021 12:06:50 PM,Theravance draws downgrade and target cuts after setback in ulcerative colitis trial,Seeking Alpha,https://seekingalpha.com/news/3733435-theravance-draws-downgrade-and-target-cuts-after-setback-in-ulcerative-colitis-trial?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9538887143135071
2149,8/24/2021 12:16:48 PM,Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study,Benzinga,/news/stocks/theravance-stock-plunges-as-jak-inhibitor-flops-ulcerative-colitis-study-1030754399,neutral,0.9535878896713257
2150,8/24/2021 10:05:03 PM,Why BioNTech Is the Better Biotech Buy,InvestorPlace,/news/stocks/why-biontech-is-the-better-biotech-buy-1030759223,positive,0.8715742826461792
2151,8/24/2021 11:40:00 PM,Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan,PR Newswire,/news/stocks/ovarian-cancer-victims-ask-court-to-block-johnson-johnson-s-texas-two-step-bankruptcy-plan-1030756167,neutral,0.7986293435096741
2152,8/25/2021 10:45:43 AM,COVID-19 vaccine protection wanes within six months: U.K. study,Seeking Alpha,https://seekingalpha.com/news/3733837-covid-19-vaccine-protection-wanes-with-six-months-uk-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4411334693431854
2153,8/25/2021 12:45:00 PM,Johnson & Johnson Announces Data to Support Boosting its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-data-to-support-boosting-its-single-shot-covid-19-vaccine-1030757202,negative,0.9388585090637207
2154,8/25/2021 1:38:31 PM,J&J COVID-19 Vaccine Booster Dose Rapidly Boosted Spike-binding Antibodies ,RTTNews,/news/stocks/j-j-covid-19-vaccine-booster-dose-rapidly-boosted-spike-binding-antibodies-1030757361,negative,0.9467253684997559
2155,8/25/2021 4:08:19 PM,7 Best Biotech Stocks to Buy in 2021 with Huge Upside,InvestorPlace,/news/stocks/7-best-biotech-stocks-to-buy-in-2021-with-huge-upside-1030758448,negative,0.5626565217971802
2156,8/25/2021 4:33:06 PM,Pfizer/BioNTech start rolling submission for FDA approval of booster COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3734101-pfizerbiontech-start-rolling-submission-for-fda-approval-of-booster-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7656390070915222
2157,8/26/2021 9:17:50 AM,Risk of heart inflammation higher after COVID-19 than post vaccination: Study,Seeking Alpha,https://seekingalpha.com/news/3734298-risk-of-heart-inflammation-higher-after-covid-19-than-post-vaccination-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5795729756355286
2158,8/26/2021 3:15:00 PM,Johnson & Johnson to Participate in the Cantor Virtual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cantor-virtual-global-healthcare-conference-1030760955,positive,0.6552425622940063
2159,8/26/2021 6:03:01 PM,"Illinois Gov. Pritzker issues vaccine, masks requirement in healthcare settings, schools",Seeking Alpha,https://seekingalpha.com/news/3734594-illinois-gov-pritzker-issues-vaccine-masks-requirement-in-healthcare-settings-schools?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9364863038063049
2160,8/26/2021 10:30:00 PM,"Johnson & Johnson Seeks Global Nominees for Award Geared at Female Researchers Working in Science, Technology, Engineering, Math, Manufacturing and Design",PR Newswire,/news/stocks/johnson-johnson-seeks-global-nominees-for-award-geared-at-female-researchers-working-in-science-technology-engineering-math-manufacturing-and-design-1030762105,positive,0.5030319094657898
2161,8/27/2021 10:00:26 AM,Longshot Covid Play Vaxart Stock Is Too Risky at These Prices,InvestorPlace,/news/stocks/longshot-covid-play-vxrt-stock-is-too-risky-at-these-prices-1030763261,positive,0.7545990943908691
2162,8/27/2021 10:30:00 AM,7 Safe Stocks To Buy for an Increasingly Unstable World,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-for-an-increasingly-unstable-world-1030763320,positive,0.7229267954826355
2163,8/27/2021 10:55:26 AM,"Singapore nears target of inoculating 80% of population, rolls out COVID-19 test kits",Seeking Alpha,https://seekingalpha.com/news/3734757-singapore-nears-target-of-inoculating-80-of-population-rolls-out-covid-19-test-kits?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6661990880966187
2164,8/27/2021 1:35:25 PM,"The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration",Benzinga,/news/stocks/the-daily-biotech-pulse-morphosys-incyte-snag-european-nod-immutep-granted-chinese-patent-bolt-biotherapeutics-strike-oncology-collaboration-1030763431,negative,0.5113007426261902
2165,8/27/2021 2:45:49 PM,3 Top-Quality Dividend Stocks for a Secure Retirement,InvestorPlace,/news/stocks/3-top-quality-dividend-stocks-for-a-secure-retirement-1030763866,negative,0.5301343202590942
2166,8/30/2021 8:54:01 AM,Fauci says COVID-19 vaccine mandates in school 'a good idea',Seeking Alpha,https://seekingalpha.com/news/3735055-fauci-says-covid-19-vaccine-mandates-in-school-a-good-idea?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7898477911949158
2167,8/30/2021 1:43:57 PM,Novavax Looks Like a Good Stock to Trade,InvestorPlace,/news/stocks/novavax-looks-like-a-good-stock-to-trade-1030767134,negative,0.566575825214386
2168,8/31/2021 12:45:00 PM,Johnson & Johnson and Global Partners Announce Results from Phase 2b Imbokodo HIV Vaccine Clinical Trial in Young Women in Sub-Saharan Africa,PR Newswire,/news/stocks/johnson-johnson-and-global-partners-announce-results-from-phase-2b-imbokodo-hiv-vaccine-clinical-trial-in-young-women-in-sub-saharan-africa-1030769172,negative,0.6534802317619324
2169,8/31/2021 1:13:54 PM,Johnson & Johnson: HIV Vaccine Candidate Fails To Provide Protection; To Discontinue Imbokodo Study ,RTTNews,/news/stocks/johnson-johnson-hiv-vaccine-candidate-fails-to-provide-protection-to-discontinue-imbokodo-study-1030769299,neutral,0.8308385014533997
2170,8/31/2021 5:41:24 PM,7 Dividend Aristocrat Stocks to Buy in September for Gains and Stability,InvestorPlace,/news/stocks/7-dividend-aristocrat-stocks-to-buy-in-september-for-gains-and-stability-1030770935,positive,0.7393564581871033
2171,8/31/2021 7:03:00 PM,Outcry Continues to Grow for Johnson & Johnson to Resolve Talc-Cancer Claims After Latest Jury Verdict,PR Newswire,/news/stocks/outcry-continues-to-grow-for-johnson-johnson-to-resolve-talc-cancer-claims-after-latest-jury-verdict-1030770850,negative,0.9081156253814697
2172,8/31/2021 7:28:37 PM,"7 Stocks To Watch For Tech, Fintech and Inflation Catalysts",InvestorPlace,/news/stocks/7-stocks-to-watch-for-tech-fintech-and-inflation-catalysts-1030771062,positive,0.9173950552940369
2173,8/31/2021 8:25:48 PM,"Novo Nordisk, Pfizer lead monthly gainers among large-cap pharma; Elanco, Amgen trail",Seeking Alpha,https://seekingalpha.com/news/3735840-novo-nordisk-pfizer-lead-monthly-gainers-among-large-cap-pharma-elanco-amgen-trail?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7700788974761963
2174,9/1/2021 10:07:34 AM,"Pennsylvania Gov. Tom Wolf issues mask requirements for schools, child care centers",Seeking Alpha,https://seekingalpha.com/news/3735929-pennsylvania-gov-tom-wolf-issues-mask-requirements-for-schools-child-care-centers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.890673041343689
2175,9/1/2021 2:56:51 PM,FDA OK's Janssen Pharmaceutical's INVEGA HAFYERA To Treat Adults With Schizophrenia - Quick Facts ,RTTNews,/news/stocks/fda-ok-s-janssen-pharmaceutical-s-invega-hafyera-to-treat-adults-with-schizophrenia-quick-facts-1030773101,negative,0.5476256608963013
2176,9/1/2021 4:43:35 PM,WHO warns of a new COVID-19 variant with potential to evade vaccine-driven immunity,Seeking Alpha,https://seekingalpha.com/news/3736184-who-warns-of-a-new-covid-19-variant-with-potential-to-evade-vaccine-driven-immunity?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9303123950958252
2177,9/2/2021 9:06:04 AM,FDA advisory panel to discuss Pfizer's booster shot application on Sept. 17,Seeking Alpha,https://seekingalpha.com/news/3736545-fda-advisory-panel-to-discuss-pfizers-booster-shot-application-on-sept-17?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.916094958782196
2178,9/2/2021 10:44:38 AM,Risk of long COVID reduces by 50% in fully vaccinated people: Study,Seeking Alpha,https://seekingalpha.com/news/3736578-risk-of-long-covid-reduces-by-50-in-fully-vaccinated-people-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5588123202323914
2179,9/2/2021 3:25:30 PM,Moderna COVID-19 booster strategy triggers debate on dose level,Seeking Alpha,https://seekingalpha.com/news/3736801-moderna-covid-19-booster-strategy-leads-to-mixed-views-on-dose-level?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5834460258483887
2180,9/2/2021 5:34:14 PM,7 Healthcare Stocks to Buy Before $3.5 Trillion Floods In¬†,InvestorPlace,/news/stocks/7-healthcare-stocks-to-buy-before-3-5-trillion-floods-in-1030777655,positive,0.8197962045669556
2181,9/2/2021 8:16:10 PM,Fauci says COVID-19 full vaccine regimen is unlikely to exceed three shots,Seeking Alpha,https://seekingalpha.com/news/3736990-fauci-says-covid-19-full-vaccine-regimen-is-unlikely-to-exceed-three-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.767877995967865
2182,9/2/2021 10:07:00 PM,"Battle Against Johnson & Johnson ""Texas Two-Step"" Ploy Moves to New Jersey",PR Newswire,/news/stocks/battle-against-johnson-johnson-texas-two-step-ploy-moves-to-new-jersey-1030777921,positive,0.8232707977294922
2183,9/7/2021 4:02:32 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-7-2021-1030784466,neutral,0.5165023803710938
2184,9/8/2021 10:00:31 AM,Vaxart Stock Is One Vaccine Also-Ran Worth Another Look,InvestorPlace,/news/stocks/vxrt-stock-is-one-vaccine-also-ran-worth-another-look-1030786409,positive,0.8450998067855835
2185,9/8/2021 10:59:23 AM,"WHO says coronavirus is ‚Äúhere to stay‚Äù, elimination unlikely",Seeking Alpha,https://seekingalpha.com/news/3737810-who-says-coronavirus-is-here-to-stay-elimination-unlikely?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8685398697853088
2186,9/8/2021 11:28:20 AM,"Fed's Kaplan traded millions of dollars in stocks in 2020, including megacaps - WSJ",Seeking Alpha,https://seekingalpha.com/news/3737825-dallas-fed-president-robert-kaplan-traded-millions-in-stocks-in-2020?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9379438757896423
2187,9/8/2021 11:39:46 AM,Pfizer chief scientist rejects criticism on COVID-19 booster push; defends jab‚Äôs potency,Seeking Alpha,https://seekingalpha.com/news/3737836-pfizer-chief-scientist-rejects-criticism-on-covid-19-booster-push-defends-jabs-potency?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6993917226791382
2188,9/8/2021 4:25:03 PM,7 Busted Biotech Stocks Due for a Rebound,InvestorPlace,/news/stocks/7-busted-biotech-stocks-due-for-a-rebound-1030787940,neutral,0.5655414462089539
2189,9/8/2021 4:37:46 PM,WHO chief urges richer nations to halt COVID-19 booster shot rollouts till end of the year,Seeking Alpha,https://seekingalpha.com/news/3738021-who-chief-urges-richer-nations-to-halt-covid-19-booster-shot-rollouts-till-end-of-the-year?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6981648802757263
2190,9/10/2021 1:31:21 PM,Endo Shares Move Higher On Settlement Of New York State Opioid Cases,Benzinga,/news/stocks/endo-shares-move-higher-on-settlement-of-new-york-state-opioid-cases-1030792398,negative,0.8947304487228394
2191,9/14/2021 12:30:00 AM,Johnson & Johnson Ebola Vaccine Regimen Demonstrated Robust and Durable Immune Response in Adults and Children in Data Published in The Lancet Infectious Diseases,PR Newswire,/news/stocks/johnson-johnson-ebola-vaccine-regimen-demonstrated-robust-and-durable-immune-response-in-adults-and-children-in-data-published-in-the-lancet-infectious-diseases-1030796874,negative,0.948612630367279
2192,9/14/2021 4:41:59 AM,Johnson & Johnson Ebola Vaccine Data Shows Strong Immune Response ,RTTNews,/news/stocks/johnson-johnson-ebola-vaccine-data-shows-strong-immune-response-1030796943,negative,0.9489777088165283
2193,9/14/2021 1:50:13 PM,"The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-nrx-rises-on-covid-19-drug-collaboration-amgen-s-lung-cancer-drug-conditionally-approved-in-canada-coherus-data-readout-1030798122,negative,0.8988337516784668
2194,9/14/2021 8:42:17 PM,Novavax Has More Room to Run as the Vaccination Push Carries On,InvestorPlace,/news/stocks/nvax-stock-more-room-to-run-as-vaccination-push-carries-on-1030799785,negative,0.6767743229866028
2195,9/14/2021 9:28:13 PM,7 Great Stocks to Buy for an Income-Rich Retirement,InvestorPlace,/news/stocks/7-great-stocks-to-buy-for-an-income-rich-retirement-1030799872,positive,0.847540557384491
2196,9/15/2021 8:51:37 PM,7 Great Dividend Stocks To Buy In September For Insulation from Volatility,InvestorPlace,/news/stocks/7-great-dividend-stocks-to-buy-in-september-for-insulation-from-volatility-1030803003,positive,0.8150762915611267
2197,9/16/2021 8:41:05 PM,"With the European Union Buying Doses, Novavax Has Plenty of Upside Left",InvestorPlace,/news/stocks/with-european-union-buying-doses-nvax-stock-plenty-upside-left-1030805836,negative,0.6231831312179565
2198,9/16/2021 11:54:00 PM,Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-third-quarter-results-1030805914,positive,0.9196440577507019
2199,9/17/2021 7:40:14 PM,3 Value Dividend Stocks for High Total Returns,InvestorPlace,/news/stocks/3-value-dividend-stocks-for-high-total-returns-1030807937,negative,0.6146935224533081
2200,9/19/2021 3:46:51 PM,"The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-sept-19-25-incyte-verrica-fda-decisions-and-conference-presentations-in-the-spotlight-1030808489,positive,0.941505491733551
2201,9/20/2021 10:00:23 AM,It‚Äôs OK to Sell the News on Ocugen and Covaxin,InvestorPlace,/news/stocks/sell-the-news-on-ocgn-stock-1030809323,positive,0.9287483096122742
2202,9/20/2021 12:21:15 PM,Mauna Kea in pact with Lung Cancer Initiative at Johnson & Johnson for biopsy guidance tool,Seeking Alpha,https://seekingalpha.com/news/3741122-mauna-kea-in-pact-with-lung-cancer-initiative-at-johnson-johnson-in-lung-cancer-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6280719041824341
2203,9/20/2021 8:11:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810876,positive,0.511945903301239
2204,9/20/2021 8:24:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030810940,positive,0.511945903301239
2205,9/20/2021 9:41:00 PM,"Robert Wood Johnson Foundation, NJ -- Moody's assigns initial Aaa issuer rating to Robert Wood Johnson Foundation (NJ); outlook stable",Moodys,/news/bonds/robert-wood-johnson-foundation-nj-moody-s-assigns-initial-aaa-issuer-rating-to-robert-wood-johnson-foundation-nj-outlook-stable-1030811057,positive,0.511945903301239
2206,9/21/2021 7:30:37 AM,Fauci says COVID-19 vaccine for kids ages 5 to 11 could be available before Halloween,Seeking Alpha,https://seekingalpha.com/news/3741645-covid-19-vaccine-for-kids-ages-5-to-11-could-be-available-before-halloween?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8656450510025024
2207,9/21/2021 12:30:00 PM,Johnson & Johnson Announces Real-World Evidence and Phase 3 Data Confirming Strong and Long-Lasting Protection of Single-Shot COVID-19 Vaccine in the U.S.,PR Newswire,/news/stocks/johnson-johnson-announces-real-world-evidence-and-phase-3-data-confirming-strong-and-long-lasting-protection-of-single-shot-covid-19-vaccine-in-the-u-s-1030812150,negative,0.938206672668457
2208,9/21/2021 1:08:01 PM,AC Immune granted U.S. patent covering Alzheimer's Disease candidate,Seeking Alpha,https://seekingalpha.com/news/3741817-ac-immune-granted-us-patent-covering-alzheimers-disease-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8235868811607361
2209,9/21/2021 1:18:50 PM,J&J: Real-world Data Confirms Efficacy Of Vaccine In The U.S.; Booster Shows 94% Protection ,RTTNews,/news/stocks/j-j-real-world-data-confirms-efficacy-of-vaccine-in-the-u-s-booster-shows-94-protection-1030812309,negative,0.9272862672805786
2210,9/21/2021 2:12:37 PM,"India to decline Pfizer/BioNTech, Moderna COVID-19 shots amid local supplies - Reuters",Seeking Alpha,https://seekingalpha.com/news/3741869-india-to-decline-pfizerbiontech-moderna-covid-19-shots-amid-local-supplies-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7918586134910583
2211,9/21/2021 2:20:50 PM,"The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data",Benzinga,/news/stocks/the-daily-biotech-pulse-aprea-jumps-on-esmo-presentation-verrica-sinks-on-regulatory-setback-aerie-ceo-quits-j-j-touts-positive-covid-19-booster-shot-data-1030812654,neutral,0.6769793629646301
2212,9/21/2021 8:40:12 PM,7 Stocks to Buy Following Vaccine Victories,InvestorPlace,/news/stocks/7-stocks-to-buy-following-vaccine-victories-1030814227,positive,0.9253915548324585
2213,9/22/2021 4:12:01 PM,"After Today's Fed Meeting, Investors Are Stuck With Contradictory Reports On Evergrande And The Debt Ceiling",Benzinga,/news/stocks/after-today-s-fed-meeting-investors-are-stuck-with-contradictory-reports-on-evergrande-and-the-debt-ceiling-1030816331,neutral,0.9310272932052612
2214,9/22/2021 5:51:34 PM,Is Ketamine A Psychedelic? Depends On Who You Ask,Benzinga,/news/stocks/is-ketamine-a-psychedelic-depends-on-who-you-ask-1030816611,positive,0.9043107628822327
2215,9/23/2021 2:55:26 PM,7 Robinhood Stocks to Buy for Newbie Investors,InvestorPlace,/news/stocks/7-robinhood-stocks-to-buy-for-newbie-investors-1030819480,positive,0.9085613489151001
2216,9/23/2021 4:19:45 PM,7 High-Yield Dividend Stocks That Will Please Any Income Lover,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-please-any-income-lover-1030819743,positive,0.8400516510009766
2217,9/23/2021 6:50:44 PM,10 Oversold Stocks to Buy for the Final Quarter,InvestorPlace,/news/stocks/10-oversold-stocks-to-buy-for-the-final-quarter-1030820052,neutral,0.8969273567199707
2218,9/25/2021 6:58:09 PM,"Barron's Latest Picks And Pans: Healthcare Roundtable Picks, Dividend Aristocrats And More",Benzinga,/news/stocks/barron-s-latest-picks-and-pans-healthcare-roundtable-picks-dividend-aristocrats-and-more-1030823039,positive,0.935904860496521
2219,9/27/2021 4:22:37 PM,Novavax and the Changing Covid-19 Vaccine Game,InvestorPlace,/news/stocks/nvax-stock-and-the-changing-covid-vaccine-game-1030830062,positive,0.8475068807601929
2220,9/28/2021 1:00:00 PM,Johnson & Johnson Celebrates COVID-19 Vaccine Science Superheroes,PR Newswire,/news/stocks/johnson-johnson-celebrates-covid-19-vaccine-science-superheroes-1030827585,positive,0.880035936832428
2221,9/28/2021 7:30:23 PM,7 Biotech Stocks Entering the Golden Boom Phase,InvestorPlace,/news/stocks/7-biotech-stocks-entering-the-golden-boom-phase-1030829968,positive,0.7444129586219788
2222,9/30/2021 11:13:47 AM,Meet members of the 2021 IPO class: Healthcare - 1,Seeking Alpha,https://seekingalpha.com/news/3746473-meet-members-of-the-2021-ipo-class-healthcare-1?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9424605965614319
2223,9/30/2021 11:17:26 AM,Meet members of the 2021 IPO class: Healthcare - 2,Seeking Alpha,https://seekingalpha.com/news/3746475-meet-members-of-the-2021-ipo-class-healthcare-2?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.944514811038971
2224,10/1/2021 11:14:01 AM,Pharmacy chains to face first U.S. legal trial related to opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3746868-pharmacy-chains-to-face-first-us-legal-trial-on-opioid-crisis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5080064535140991
2225,10/1/2021 2:30:32 PM,Merck data for coronavirus pill pressures developers of antibody therapies,Seeking Alpha,https://seekingalpha.com/news/3747028-merck-data-for-coronavirus-pill-pressure-developers-of-antibody-therapies?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.897942841053009
2226,10/3/2021 2:13:12 AM,Moderna COVID-19 shot linked to higher rates of heart inflammation - Canada,Seeking Alpha,https://seekingalpha.com/news/3747415-moderna-covid-19-shot-linked-to-higher-rates-of-heart-inflammation-canada?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.45011916756629944
2227,10/4/2021 1:00:15 PM,Merck extends gains after data for COVID-19 pill as vaccine makers retreat,Seeking Alpha,https://seekingalpha.com/news/3748031-merck-extends-gains-after-data-for-covid-19-pill-as-vaccine-makers-retreat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8916258811950684
2228,10/4/2021 2:21:35 PM,Teva pulls over 2.5M vials of U.S. made drugs after FDA concerns on contamination,Seeking Alpha,https://seekingalpha.com/news/3748104-teva-pulls-over-25m-vials-of-us-made-drugs-after-fda-concerns-on-contamination?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8791787028312683
2229,10/4/2021 4:27:19 PM,"JNJ, Xencor Sign $1.3B Licensing Deal For B-Cell Malignancies-Targeted Bispecific Antibody",Benzinga,/news/stocks/jnj-xencor-sign-1-3b-licensing-deal-for-b-cell-malignancies-targeted-bispecific-antibody-1030841141,negative,0.9057363867759705
2230,10/4/2021 5:53:01 PM,It‚Äôs Time To Drop Ocugen Stock While You Still Can,InvestorPlace,/news/stocks/its-time-to-drop-ocugen-ocgn-stock-while-you-still-can-1030841717,neutral,0.5398222804069519
2231,10/5/2021 5:05:51 AM,Pfizer/BioNTech's COVID-19 vaccine efficacy wanes after 6 months: Study,Seeking Alpha,https://seekingalpha.com/news/3748432-pfizers-covid-19-vaccine-90-effective-in-preventing-hospitalizations-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8951582908630371
2232,10/5/2021 12:30:00 PM,Johnson & Johnson Announces Submission of Emergency Use Authorization Amendment to the U.S. FDA to Support Booster of its Single-Shot COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-submission-of-emergency-use-authorization-amendment-to-the-u-s-fda-to-support-booster-of-its-single-shot-covid-19-vaccine-1030843189,negative,0.5814045071601868
2233,10/5/2021 12:57:45 PM,Johnson & Johnson Submits Data To FDA To Support Booster Of Single-Shot COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-submits-data-to-fda-to-support-booster-of-single-shot-covid-19-vaccine-1030843243,positive,0.7604514360427856
2234,10/5/2021 2:01:45 PM,"The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-files-for-booster-dose-authorization-gemini-restructures-strata-skin-cfo-departs-kaleido-reports-positive-readout-1030843466,positive,0.4234638512134552
2235,10/5/2021 5:16:48 PM,Merck‚Äôs Good News Doesn‚Äôt End the Bullish Story for Novavax,InvestorPlace,/news/stocks/mercks-good-news-doesnt-end-the-bullish-story-for-novavax-1030844852,positive,0.3743163049221039
2236,10/6/2021 5:00:00 PM,Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature,PR Newswire,/news/stocks/janssen-announces-novel-mechanism-of-action-that-shows-promise-against-dengue-in-data-published-in-nature-1030847834,negative,0.6799183487892151
2237,10/6/2021 5:58:57 PM,Merck's Oral COVID-19 Treatment Could Be Game-Changer: BofA Analyst,Benzinga,/news/stocks/merck-s-oral-covid-19-treatment-could-be-game-changer-bofa-analyst-1030848005,positive,0.9073443412780762
2238,10/6/2021 8:08:19 PM,Janssen Pharmaceuticals' New Early-Stage Compound Shows Promise Against Dengue ,RTTNews,/news/stocks/janssen-pharmaceuticals-new-early-stage-compound-shows-promise-against-dengue-1030848355,negative,0.9373409152030945
2239,10/8/2021 11:44:04 AM,Novavax Stock Looks Interesting as the World Still Needs Vaccines,InvestorPlace,/news/stocks/novavax-stock-looks-interesting-as-the-world-still-needs-vaccines-1030852726,positive,0.5224453806877136
2240,10/8/2021 3:43:24 PM,7 Defensive Stocks to Buy and Forget About In Times of Volatility,InvestorPlace,/news/stocks/7-defensive-stocks-to-buy-and-forget-about-in-times-of-volatility-1030853320,positive,0.9234777688980103
2241,10/8/2021 6:30:13 PM,"Catalyst Watch for next week: JPMorgan leads out big bank earnings; eyes on Plug Power, Alibaba and HubSpot",Seeking Alpha,https://seekingalpha.com/news/3751002-catalyst-watch-for-next-week-jpmorgan-leads-out-big-bank-earnings-eyes-on-plug-power-alibaba-and-hubspot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5077347159385681
2242,10/11/2021 10:45:00 PM,Johnson & Johnson to Participate in the Credit Suisse 30th Annual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-credit-suisse-30th-annual-healthcare-conference-1030857049,negative,0.5094069242477417
2243,10/12/2021 10:00:08 AM,"Novavax Stock Will Find Its Bottom, But Probably not Soon",InvestorPlace,/news/stocks/nvax-stock-will-find-its-bottom-but-probably-not-soon-1030858438,neutral,0.6969290375709534
2244,10/12/2021 10:00:43 AM,Don‚Äôt Buy Too Much Into the WHO Hype Surrounding Ocugen Stock,InvestorPlace,/news/stocks/ocgn-stock-dont-buy-too-much-into-the-who-hype-1030858436,positive,0.9197484254837036
2245,10/12/2021 12:45:00 PM,"Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire,  Effective December 31, 2021",PR Newswire,/news/stocks/dr-paul-stoffels-vice-chairman-of-the-executive-committee-and-chief-scientific-officer-of-johnson-johnson-to-retire-effective-december-31-2021-1030858511,positive,0.8425989151000977
2246,10/12/2021 2:12:28 PM,WHO recommends an additional COVID-19 vaccine for immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3752012-who-recommends-an-additional-covid-19-vaccine-for-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7509061098098755
2247,10/12/2021 10:15:00 PM,Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations,PR Newswire,/news/stocks/johnson-johnson-announces-jessica-moore-as-vice-president-of-investor-relations-1030860395,positive,0.9161936044692993
2248,10/13/2021 12:45:00 PM,Johnson & Johnson to Host Business Review Highlighting Pharmaceuticals,PR Newswire,/news/stocks/johnson-johnson-to-host-business-review-highlighting-pharmaceuticals-1030862351,positive,0.9344198107719421
2249,10/14/2021 7:19:45 PM,Moderna gains with unanimous AdCom backing for COVID-19 booster shot,Seeking Alpha,https://seekingalpha.com/news/3752981-moderna-gains-with-unanimous-adcom-backing-for-covid-19-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9181937575340271
2250,10/14/2021 7:48:29 PM,FDA Panel Convenes To Discuss Requirement Of Moderna Vaccine Booster Shots ,RTTNews,/news/stocks/fda-panel-convenes-to-discuss-requirement-of-moderna-vaccine-booster-shots-1030867537,positive,0.8871015310287476
2251,10/14/2021 11:55:00 PM,Johnson & Johnson Takes Steps to Equitably Resolve All Current and Future Talc Claims,PR Newswire,/news/stocks/johnson-johnson-takes-steps-to-equitably-resolve-all-current-and-future-talc-claims-1030867970,negative,0.8059064745903015
2252,10/15/2021 4:38:00 AM,Johnson & Johnson Ovarian Cancer Victims Vow Fight to Stop J&J's Bankruptcy Scheme,PR Newswire,/news/stocks/johnson-johnson-ovarian-cancer-victims-vow-fight-to-stop-j-j-s-bankruptcy-scheme-1030868065,negative,0.6764748692512512
2253,10/15/2021 1:44:03 PM,"The Daily Biotech Pulse: Moderna's Booster Shot Gets FDA Panel Backing, Decision Day For Avadel, Silence Therapeutics Strikes Licensing Deal, MiNK IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-moderna-s-booster-shot-gets-fda-panel-backing-decision-day-for-avadel-silence-therapeutics-strikes-licensing-deal-mink-ipo-1030869318,positive,0.7786534428596497
2254,10/15/2021 2:43:00 PM,"Johnson & Johnson -- Moody's: J&J talc costs are credit negative, but channeling injunction process will reduce uncertainty",Moodys,/news/bonds/johnson-johnson-moody-s-j-j-talc-costs-are-credit-negative-but-channeling-injunction-process-will-reduce-uncertainty-1030869543,negative,0.689139723777771
2255,10/15/2021 4:45:33 PM,Health Care Sector Appears to Be a Drag on Positive UnitedHealth Earnings,Benzinga,/news/stocks/health-care-sector-appears-to-be-a-drag-on-positive-unitedhealth-earnings-1030869859,neutral,0.9385509490966797
2256,10/15/2021 10:11:00 PM,Johnson & Johnson COVID-19 Vaccine Booster Shot Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-unanimously-recommended-for-emergency-use-authorization-by-u-s-fda-advisory-committee-1030870403,negative,0.8484925627708435
2257,10/15/2021 10:47:45 PM,FDA Panel Unanimously Recommends J&J Covid Booster Shot ,RTTNews,/news/stocks/fda-panel-unanimously-recommends-j-j-covid-booster-shot-1030870461,positive,0.7547883987426758
2258,10/17/2021 3:01:19 PM,Here's what to expect from Johnson Johnson's earnings,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-1030871254,positive,0.9379589557647705
2259,10/18/2021 1:34:17 PM,"The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-18-23-j-j-biogen-kickstart-big-pharma-earnings-regeneron-sanofi-roche-await-fda-decisions-and-ipos-1030873336,positive,0.7243751883506775
2260,10/18/2021 2:58:07 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3754116-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
2261,10/18/2021 3:47:21 PM,MeiraGTx climbs to a 52-week high after positive mention on Barron‚Äôs,Seeking Alpha,https://seekingalpha.com/news/3754135-meiragtx-climbs-to-a-52-week-high-after-positive-mention-on-barrons?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9303818941116333
2262,10/18/2021 4:46:00 PM,"LifeScan Global Corporation -- Moody's assigns B3 rating to LifeScan's proposed first lien term loan and secured notes, Ba3 to proposed super-priority revolver",Moodys,/news/bonds/lifescan-global-corporation-moody-s-assigns-b3-rating-to-lifescan-s-proposed-first-lien-term-loan-and-secured-notes-ba3-to-proposed-super-priority-revolver-1030874192,positive,0.6777031421661377
2263,10/19/2021 10:41:12 AM,"5 Stocks To Watch For October 19, 2021",Benzinga,/news/stocks/5-stocks-to-watch-for-october-19-2021-1030876483,positive,0.9061943888664246
2264,10/19/2021 12:25:00 PM,Johnson & Johnson Reports Q3 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q3-2021-results-1030876705,positive,0.7926418781280518
2265,10/19/2021 12:29:15 PM,Johnson & Johnson Q3 adjusted earnings Beat Estimates,RTTNews,/news/stocks/johnson-johnson-q3-adjusted-earnings-beat-estimates-1030876709,negative,0.6677944660186768
2266,10/19/2021 12:58:49 PM,A Peek Into The Markets: US Stock Futures Gain Ahead Of Earnings Reports,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-gain-ahead-of-earnings-reports-1030876820,negative,0.8861258029937744
2267,10/19/2021 1:28:38 PM,Johnson & Johnson Q3 Earnings Top Estimates; Lifts FY21 View Above Market ,RTTNews,/news/stocks/johnson-johnson-q3-earnings-top-estimates-lifts-fy21-view-above-market-1030876942,negative,0.9324821829795837
2268,10/19/2021 2:23:01 PM,"The Daily Biotech Pulse: Entasis, Dermata Spike Higher On Positive Readouts, J&J Q3 EPS Beats Estimates, Wave Life Sciences Regains Right To CNS Portfolio",Benzinga,/news/stocks/the-daily-biotech-pulse-entasis-dermata-spike-higher-on-positive-readouts-j-j-q3-eps-beats-estimates-wave-life-sciences-regains-right-to-cns-portfolio-1030877269,negative,0.9359005689620972
2269,10/19/2021 2:33:19 PM,Will FDA Allow 'mix And Match' Of Covid Booster Shots? ,RTTNews,/news/stocks/will-fda-allow-mix-and-match-of-covid-booster-shots-1030877340,positive,0.9246798753738403
2270,10/19/2021 4:08:55 PM,Mid-Morning Market Update: Markets Open Higher; Johnson & Johnson Boosts FY21 Guidance,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-johnson-johnson-boosts-fy21-guidance-1030878014,negative,0.943692684173584
2271,10/19/2021 4:32:45 PM,Lower Than Expected Housing Starts and Building Permits Could Be Problems for Homebuilders,Benzinga,/news/stocks/lower-than-expected-housing-starts-and-building-permits-could-be-problems-for-homebuilders-1030878068,neutral,0.9702366590499878
2272,10/19/2021 6:10:09 PM,Abbott Laboratories Q3 earnings preview and review,Seeking Alpha,https://seekingalpha.com/news/3755153-abbott-laboratories-q3-earnings-preview-and-review?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8984233736991882
2273,10/19/2021 6:11:39 PM,Mid-Day Market Update: Silver Surges 3%; Galera Therapeutics Shares Plunge,Benzinga,/news/stocks/mid-day-market-update-silver-surges-3-galera-therapeutics-shares-plunge-1030878384,negative,0.8829429745674133
2274,10/19/2021 8:35:47 PM,Mid-Afternoon Market Update: Dow Surges Over 100 Points; Harmony Biosciences Shares Spike Higher,Benzinga,/news/stocks/mid-afternoon-market-update-dow-surges-over-100-points-harmony-biosciences-shares-spike-higher-1030878699,negative,0.9215229749679565
2275,10/19/2021 9:10:23 PM,3 Biopharma Stocks To Watch Following Johnson & Johnson's Earnings Beat,Benzinga,/news/stocks/3-biopharma-stocks-to-watch-following-johnson-johnson-s-earnings-beat-1030878749,positive,0.8914384841918945
2276,10/20/2021 12:45:09 PM,"28 Stocks To Benefit From Inflation, According To Jim Cramer",Benzinga,/news/stocks/28-stocks-to-benefit-from-inflation-according-to-jim-cramer-1030881145,negative,0.9265294075012207
2277,10/20/2021 4:51:39 PM,"Thinking About Buying Stock In Qualcomm, Microsoft, Micron, Johnson & Johnson Or BP?",Benzinga,/news/stocks/thinking-about-buying-stock-in-qualcomm-microsoft-micron-johnson-johnson-or-bp-1030882415,positive,0.9310546517372131
2278,10/21/2021 12:38:00 AM,Johnson & Johnson COVID-19 Vaccine Booster Shot Authorized for Emergency Use by U.S. FDA,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-booster-shot-authorized-for-emergency-use-by-u-s-fda-1030883560,positive,0.8381713032722473
2279,10/21/2021 3:51:48 AM,FDA Authorizes Johnson & Johnson And Moderna Booster Shots ,RTTNews,/news/stocks/fda-authorizes-johnson-johnson-and-moderna-booster-shots-1030883612,positive,0.9288361072540283
2280,10/21/2021 10:42:29 AM,Pfizer/BioNTech COVID vaccine 'highly effective' against Delta variant in Israel study-Reuters,Seeking Alpha,https://seekingalpha.com/news/3755955-pfizerbiontech-covid-vaccine-highly-effective-against-delta-variant-in-israel-study-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8898314833641052
2281,10/21/2021 11:02:39 AM,Pfizer/BioNTech post promising data from late-stage COVID-19 booster study,Seeking Alpha,https://seekingalpha.com/news/3755971-pfizerbiontech-post-promising-data-from-late-stage-covid-19-booster-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9446895718574524
2282,10/21/2021 12:49:12 PM,Moderna leads COVID-19 vaccine makers as Piper Sandler favors its booster shot,Seeking Alpha,https://seekingalpha.com/news/3756089-moderna-leads-covid-19-vaccine-makers-as-piper-sandler-favors-its-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5400654673576355
2283,10/21/2021 2:05:16 PM,"The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-authorizes-moderna-j-j-booster-shots-regulatory-approvals-for-bristol-myers-squibb-sanofi-regeneron-ventyx-ipo-1030885538,positive,0.8053774833679199
2284,10/21/2021 3:22:09 PM,UK says rare nerve disorder possible side effect of AstraZeneca COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3756200-uk-says-rare-nerve-disorder-possible-side-effect-of-astrazeneca-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7890667915344238
2285,10/21/2021 4:48:37 PM,7 Safe Stocks to Own to Hedge Against Inflation,InvestorPlace,/news/stocks/7-safe-stocks-to-own-to-hedge-against-inflation-1030886760,positive,0.9000861644744873
2286,10/21/2021 5:40:58 PM,EU to issue decision on Moderna COVID-19 booster shot next week,Seeking Alpha,https://seekingalpha.com/news/3756271-eu-to-issue-decision-on-moderna-booster-shot-next-week?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8366607427597046
2287,10/21/2021 6:27:10 PM,Sight Sciences shares up 11% after releasing data on TearCare system,Seeking Alpha,https://seekingalpha.com/news/3756283-sights-sciences-shares-up-11-after-releasing-data-on-tearcare-system?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9249030351638794
2288,10/21/2021 8:38:00 PM,Johnson & Johnson Announces Quarterly Dividend for Fourth Quarter 2021,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-fourth-quarter-2021-1030886959,neutral,0.6720970273017883
2289,10/22/2021 1:48:00 AM,U.S. CDC Advisory Committee Unanimously Recommends Johnson & Johnson COVID-19 Vaccine as a Booster for All Eligible Individuals Who Receive Authorized COVID-19 Vaccines,PR Newswire,/news/stocks/u-s-cdc-advisory-committee-unanimously-recommends-johnson-johnson-covid-19-vaccine-as-a-booster-for-all-eligible-individuals-who-receive-authorized-covid-19-vaccines-1030887453,negative,0.6412501931190491
2290,10/22/2021 3:18:16 AM,CDC Panel Backs Johnson & Johnson COVID-19 Booster Shot ,RTTNews,/news/stocks/cdc-panel-backs-johnson-johnson-covid-19-booster-shot-1030887480,positive,0.68793785572052
2291,10/22/2021 1:39:28 PM,Moderna and Johnson & Johnson COVID booster shots now available at Walgreens stores,Seeking Alpha,https://seekingalpha.com/news/3756635-moderna-and-johnson-johnson-covid-booster-shots-now-available-at-walgreens-stores?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8723058700561523
2292,10/22/2021 3:01:56 PM,7 of the Best Dividend Stocks for Passive Income,InvestorPlace,/news/stocks/7-of-the-best-dividend-stocks-for-passive-income-1030889458,positive,0.5811654329299927
2293,10/22/2021 4:02:03 PM,Walgreens Offers Moderna And Johnson & Johnson COVID-19 Vaccine Booster Shots In U.S. ,RTTNews,/news/stocks/walgreens-offers-moderna-and-johnson-johnson-covid-19-vaccine-booster-shots-in-u-s-1030889295,positive,0.5392051935195923
2294,10/24/2021 5:45:47 PM,"The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-oct-24-30-eyenovia-ani-pharma-clearside-medical-fda-decisions-merck-bristol-myers-squibb-earnings-ipos-and-more-1030891741,positive,0.9414970874786377
2295,10/25/2021 5:10:05 PM,EMA committee says Moderna boosters can be used in those 18 and over,Seeking Alpha,https://seekingalpha.com/news/3757582-ema-committee-says-moderna-boosters-can-be-used-in-those-18-and-over?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8141580820083618
2296,10/25/2021 7:20:44 PM,"Novavax is Now a Riskier Play, but Still One to Keep Your Eye On",InvestorPlace,/news/stocks/nvax-stock-is-now-a-riskier-play-but-still-one-to-keep-your-eye-on-1030896008,positive,0.8857182860374451
2297,10/27/2021 2:19:00 PM,Teva Pharmaceutical Finance Netherlands II BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharmaceutical-finance-netherlands-ii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905015,positive,0.8066306114196777
2298,10/27/2021 2:44:00 PM,Teva Pharma Finance Netherlands III BV -- Moody's rates Teva's new unsecured notes offering Ba2,Moodys,/news/bonds/teva-pharma-finance-netherlands-iii-bv-moody-s-rates-teva-s-new-unsecured-notes-offering-ba2-1030905145,positive,0.7895193099975586
2299,10/28/2021 11:24:41 AM,"GlaxoSmithKline, Pfizer owned ViiV says EU greenlighted a simpler HIV regimen",Seeking Alpha,https://seekingalpha.com/news/3759886-glaxosmithkline-pfizer-owned-viiv-says-eu-greenlighted-a-simpler-hiv-regimen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7418090105056763
2300,10/28/2021 2:26:10 PM,"The Daily Biotech Pulse: Merck Reports Beat-And-Raise Quarter, Pfizer-BioNTech Snag Orders For Additional Vaccine Doses, HCW Cleared For Phase 1 Study Of Pancreatic Cancer Drug",Benzinga,/news/stocks/the-daily-biotech-pulse-merck-reports-beat-and-raise-quarter-pfizer-biontech-snag-orders-for-additional-vaccine-doses-hcw-cleared-for-phase-1-study-of-pancreatic-cancer-drug-1030910260,negative,0.8363469839096069
2301,10/28/2021 9:56:30 PM,"FDA Restricts Sale, Approves New Labeling Of Breast Implants",Benzinga,/news/stocks/fda-restricts-sale-approves-new-labeling-of-breast-implants-1030911878,positive,0.6530255079269409
2302,10/29/2021 2:14:43 PM,Aurinia Pharma may be worth $45-$53/share in a potential sale - analyst,Seeking Alpha,https://seekingalpha.com/news/3760897-aurinia-pharma-may-be-worth-45-53share-in-a-potential-sale-analyst?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9303962588310242
2303,10/29/2021 7:00:57 PM,"Catalyst watch for next week: FOMC and OPEC meetings, Beyond Meat hits McDonald's stores and more eyes on crypto",Seeking Alpha,https://seekingalpha.com/news/3760981-catalyst-watch-for-next-week-fomc-and-opec-meetings-beyond-meat-hits-mcdonalds-stores-and-more-eyes-on-crypto?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9212965965270996
2304,11/1/2021 10:00:10 AM,"Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated",InvestorPlace,/news/stocks/novavax-stock-rises-as-uk-covid-vax-okay-sought-other-growth-anticipated-1030920758,negative,0.9438596963882446
2305,11/1/2021 2:01:23 PM,Aurinia Pharma drops after GlaxoSmithKline denies report on potential bid,Seeking Alpha,https://seekingalpha.com/news/3761428-aurinia-pharma-drops-after-glaxosmithkline-denies-report-on-potential-bid?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9460808038711548
2306,11/2/2021 10:57:42 AM,"Teva, Endo among firms beating $50B opioid case in California in an industry first",Seeking Alpha,https://seekingalpha.com/news/3762662-teva-endo-among-firms-beating-50b-opioid-case-in-california-in-an-industry-first?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8367448449134827
2307,11/2/2021 12:21:00 PM,California Judge Rules For Drugmakers In Major Opioid Litigation,Benzinga,/news/stocks/california-judge-rules-for-drugmakers-in-major-opioid-litigation-1030925651,positive,0.6099182963371277
2308,11/2/2021 12:52:53 PM,"The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-solid-q3-earnings-regulatory-setback-for-legend-lilly-to-supply-additional-covid-19-antibody-cocktails-to-us-1030925781,negative,0.9155561327934265
2309,11/2/2021 3:30:16 PM,Attention Biotech Investors: Mark Your Calendar For November PDUFA Dates,Benzinga,/news/stocks/attention-biotech-investors-mark-your-calendar-for-november-pdufa-dates-1030927142,positive,0.9458097219467163
2310,11/2/2021 4:11:31 PM,Ocugen hits six-month high ahead of key WHO meeting on partner‚Äôs COVID-19 vaccine,Seeking Alpha,https://seekingalpha.com/news/3763060-ocgn-stock-hits-six-month-high-ahead-of-key-who-meeting-on-partners-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7430815100669861
2311,11/2/2021 6:03:40 PM,7 Stocks to Set Your Sights on as the ‚ÄòHyperinflation‚Äô Debate Stirs Up,InvestorPlace,/news/stocks/7-stocks-to-set-your-sights-on-as-the-hyperinflation-debate-stirs-up-1030927812,positive,0.874175488948822
2312,11/2/2021 10:00:48 PM,Darzalex sales royalties help propel Halozyme Therapeutics to Q3 2021 earnings beat,Seeking Alpha,https://seekingalpha.com/news/3763536-darzalex-sales-royalties-help-propel-halozyme-therapeutics-to-q3-2021-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.928527295589447
2313,11/4/2021 1:00:58 PM,Moderna drags COVID-19 vaccine developers lower after slashing outlook,Seeking Alpha,https://seekingalpha.com/news/3765159-moderna-drags-covid-19-vaccine-developers-lower-after-slashing-outlook?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9672327041625977
2314,11/4/2021 4:56:43 PM,7 Safe Stocks that are Immune from China‚Äôs Market Volatility,InvestorPlace,/news/stocks/7-safe-stocks-that-are-immune-from-chinas-market-volatility-1030938455,positive,0.8009188175201416
2315,11/4/2021 5:27:37 PM,7 Stocks to Buy to Hone in on Ray Dalio‚Äôs Reliable Favorites,InvestorPlace,/news/stocks/7-stocks-to-buy-to-hone-in-on-ray-dalio-reliable-favorites-1030938626,negative,0.7804809212684631
2316,11/4/2021 6:27:12 PM,This Are The 5 Largest European Stocks,Benzinga,/news/stocks/this-are-the-5-largest-european-stocks-1030938555,positive,0.9295487999916077
2317,11/4/2021 6:40:59 PM,Novavax Looks Primed and Ready for a Vaccine Comeback,InvestorPlace,/news/stocks/nvax-stock-looks-primed-and-ready-for-a-vaccine-comeback-1030938703,negative,0.7199612259864807
2318,11/5/2021 3:44:57 AM,Emergent shares fall 15% after U.S. government ends vaccine contract early,Seeking Alpha,https://seekingalpha.com/news/3765897-emergent-shares-fall-15-after-us-government-ends-vaccine-contract-early?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9653365015983582
2319,11/5/2021 10:00:00 AM,The Novavax Rebound Is Just Warming Up,InvestorPlace,/news/stocks/nvax-stock-rebound-is-just-warming-up-1030942042,positive,0.7882605195045471
2320,11/5/2021 11:10:23 AM,Pfizer data on COVID-19 pill pressures rival Merck and vaccine developers,Seeking Alpha,https://seekingalpha.com/news/3766005-pfizer-data-on-covid-19-pill-pressure-rival-merck-and-vaccine-developers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.46351781487464905
2321,11/5/2021 8:38:57 PM,Emergent Biosolutions granted FDA clearance for two more COVID-19 vaccine batches,Seeking Alpha,https://seekingalpha.com/news/3766453-emergent-biosolutions-granted-fda-clearance-for-two-more-covid-19-vaccine-batches?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9360600709915161
2322,11/5/2021 9:24:38 PM,See Why Emergent BioSolutions Stock Plunged 37% On Friday?,Benzinga,/news/stocks/see-why-emergent-biosolutions-stock-plunged-37-on-friday-1030943698,neutral,0.8557435274124146
2323,11/8/2021 9:52:49 PM,Alkermes slips as Johnson & Johnson moves to end licensing pact,Seeking Alpha,https://seekingalpha.com/news/3767304-alkermes-slips-as-johnson-johnson-moves-to-end-licensing-pact?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9338300824165344
2324,11/9/2021 11:00:39 AM,7 Stocks to Buy That Could Be the Next Trillion-Dollar Company¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-that-could-be-the-next-trillion-dollar-company-1030952970,positive,0.9256399273872375
2325,11/9/2021 2:13:10 PM,"The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data",Benzinga,/news/stocks/the-daily-biotech-pulse-double-dose-of-positive-tidings-for-merck-alkermes-slips-on-partial-termination-of-j-j-licensing-deal-amgen-migraine-drug-data-1030953661,neutral,0.8833059072494507
2326,11/9/2021 6:14:33 PM,Oklahoma Supreme Court overturns $465M opioid judgment against J&J - Reuters,Seeking Alpha,https://seekingalpha.com/news/3767931-oklahoma-supreme-court-overturns-465m-opioid-judgment-against-johnson-johnson-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.920985758304596
2327,11/9/2021 8:32:11 PM,OCGN Stock Alert: The Earnings News That Has Ocugen Slipping Today,InvestorPlace,/news/stocks/ocgn-stock-alert-the-earnings-news-that-has-ocugen-slipping-today-1030955404,neutral,0.931200385093689
2328,11/9/2021 10:30:00 PM,Johnson & Johnson Endows Research!America Outstanding Achievement in Public Health Awards,PR Newswire,/news/stocks/johnson-johnson-endows-research-america-outstanding-achievement-in-public-health-awards-1030955761,negative,0.7454628944396973
2329,11/10/2021 4:58:57 PM,7 Defensive Stocks To Add Portfolio Stability in the Fourth Quarter,InvestorPlace,/news/stocks/7-defensive-stocks-to-add-portfolio-stability-in-fourth-quarter-1030960556,negative,0.914441704750061
2330,11/10/2021 7:35:31 PM,Johnson & Johnson wins court ruling on request to halt tens of thousands of talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3768884-johnson-johnson-wins-court-ruling-on-request-to-halt-tens-of-thousands-of-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7567013502120972
2331,11/10/2021 10:32:01 PM,J&J agrees to provide its COVID vaccine through COVAX Humanitarian Buffer,Seeking Alpha,https://seekingalpha.com/news/3769224-johnson-johnson-agrees-to-provide-its-covid-vaccine-through-covax-humanitarian-buffer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6167377829551697
2332,11/10/2021 11:14:00 PM,Johnson & Johnson Enters into Agreement to Provide its Single-Shot COVID-19 Vaccine for the World's Most Vulnerable People through Novel Humanitarian Buffer,PR Newswire,/news/stocks/johnson-johnson-enters-into-agreement-to-provide-its-single-shot-covid-19-vaccine-for-the-world-s-most-vulnerable-people-through-novel-humanitarian-buffer-1030961668,negative,0.9293126463890076
2333,11/12/2021 11:29:03 AM,Johnson & Johnson stock jumps on report it will split into two public companies,Seeking Alpha,https://seekingalpha.com/news/3769919-johnson-johnson-stock-jumps-on-report-it-will-split-into-two-public-companies?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8521776795387268
2334,11/12/2021 12:30:00 PM,"Johnson & Johnson Announces Plans to Accelerate Innovation, Serve Patients and Consumers, and Unlock Value through Intent to Separate Consumer Health Business",PR Newswire,/news/stocks/johnson-johnson-announces-plans-to-accelerate-innovation-serve-patients-and-consumers-and-unlock-value-through-intent-to-separate-consumer-health-business-1030969511,negative,0.7651333808898926
2335,11/12/2021 1:25:01 PM,J&J Plans To Form Separate Consumer Health Company ,RTTNews,/news/stocks/j-j-plans-to-form-separate-consumer-health-company-1030969749,positive,0.9515060782432556
2336,11/12/2021 1:40:21 PM,"The Daily Biotech Pulse: J&J To Spin-off Consumer Health Business, AstraZeneca Earnings, Embattled Emergent To Buy Back Shares",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-to-spin-off-consumer-health-business-astrazeneca-earnings-embattled-emergent-to-buy-back-shares-1030969817,positive,0.8889020681381226
2337,11/12/2021 3:11:19 PM,JNJ Split: 10 Things for Investors to Know About Johnson & Johnson‚Äôs Breakup Plans,InvestorPlace,/news/stocks/jnj-split-10-things-for-investors-to-know-about-johnson-johnsons-breakup-plans-1030970444,positive,0.9449582695960999
2338,11/12/2021 3:27:10 PM,Johnson & Johnson gains as analysts cheer consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3770123-johnson-johnson-gains-as-analysts-cheer-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8513222932815552
2339,11/12/2021 3:48:16 PM,SNDL Stock: The Good News That Has Cannabis Play Sundial Growers Heading Higher Today,InvestorPlace,/news/stocks/sndl-stock-the-good-news-that-has-cannabis-play-sundial-growers-heading-higher-today-1030970565,negative,0.9421656727790833
2340,11/12/2021 5:45:42 PM,Biden nominates former commissioner Robert Califf to head FDA,Seeking Alpha,https://seekingalpha.com/news/3770181-biden-nominates-former-commissioner-robert-califf-to-head-fda?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9311440587043762
2341,11/12/2021 8:00:04 PM,"Catalyst watch for next week: Lucid earnings volatility and big events for Qualcomm, ADP, Teladoc and Palo Alto Networks",Seeking Alpha,https://seekingalpha.com/news/3770226-catalyst-watch-for-next-week-lucid-earnings-volatility-and-big-events-for-qualcomm-adp-teladoc-and-palo-alto-networks?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8227662444114685
2342,11/13/2021 3:00:00 PM,Tech Roundup: Disney+ Day leads a week highlighted by streaming TV,Seeking Alpha,https://seekingalpha.com/news/3770330-tech-roundup-disney-day-leads-a-week-highlighted-by-streaming-tv?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.909171998500824
2343,11/14/2021 3:57:21 PM,"The Week Ahead In Biotech (Nov. 14-Nov. 20): BioMarin FDA Decision, Tapering Earnings News Flow, Conference Presentations And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-nov-14-nov-20-biomarin-fda-decision-tapering-earnings-news-flow-conference-presentations-and-more-1030972118,neutral,0.9391729235649109
2344,11/15/2021 8:06:40 PM,Arrowhead posts mid-stage data for hep B candidate advanced by Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3770859-arrowhead-posts-mid-stage-data-for-hep-b-candidate-advanced-by-johnson-johnson?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8940600752830505
2345,11/16/2021 2:04:33 PM,Pfizer moves to allow cheaper COVID-19 pills sending shares of rivals lower,Seeking Alpha,https://seekingalpha.com/news/3771400-pfizer-moves-to-allow-cheaper-covid-19-pills-sending-shares-of-rivals-lower?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9393699169158936
2346,11/17/2021 2:17:11 PM,"Arrowhead, Janssen's JNJ-75220795 in development for NASH",Seeking Alpha,https://seekingalpha.com/news/3771913-arrowhead-janssens-jnj-75220795-in-development-for-nash?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8965556621551514
2347,11/18/2021 2:33:44 PM,J&J expects to file for 14 new drugs by 2025 - Reuters,Seeking Alpha,https://seekingalpha.com/news/3772449-johnson-johnson-janssen-expects-to-file-for-14-new-drugs-by-2025-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8713215589523315
2348,11/19/2021 11:29:05 AM,7 Dividend Stocks to Buy for 2022 and Hold Forever,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-2022-and-hold-forever-1030881013,positive,0.94387286901474
2349,11/19/2021 3:34:38 PM,3 Recent Spin-Off Stocks Worth A Spot in Your Portfolio,InvestorPlace,/news/stocks/3-recent-spin-off-stocks-worth-a-spot-in-your-portfolio-1030991913,positive,0.8516474366188049
2350,11/22/2021 11:00:16 AM,7 Stocks to Buy for Their Resistance to the 6.2% Monthly Inflation,InvestorPlace,/news/stocks/7-stocks-to-buy-for-their-resistance-to-the-6-2-monthly-inflation-1030994239,negative,0.45518118143081665
2351,11/23/2021 8:16:33 PM,Pfizer's COVID-19 Franchise Could Push Revenue Past $100B In 2022: Analyst,Benzinga,/news/stocks/pfizer-s-covid-19-franchise-could-push-revenue-past-100b-in-2022-analyst-1030999039,negative,0.9382447600364685
2352,11/24/2021 8:29:48 AM,Philogen collaborates with Janssen Biotech to discover small molecule therapeutics,Seeking Alpha,https://seekingalpha.com/news/3774089-philogen-collaborates-with-janssen-biotech-to-discover-small-molecule-therapeutics?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6541993021965027
2353,11/24/2021 11:18:46 AM,EU health agency considers COVID-19 vaccine booster shots for all adults - Reuters,Seeking Alpha,https://seekingalpha.com/news/3774171-eu-health-agency-considers-covid-19-vaccine-booster-shots-for-all-adults-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8619682788848877
2354,11/24/2021 12:52:00 PM,Health Canada approves JNJ's COVID-19 vaccine in people 18 years of age and above,Seeking Alpha,https://seekingalpha.com/news/3774209-health-canada-approves-jnjs-covid-19-vaccine-in-people-18-years-of-age-and-above?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5122615098953247
2355,11/24/2021 2:37:59 PM,Health Canada Approves Johnson & Johnson COVID-19 Vaccine - Quick Facts ,RTTNews,/news/stocks/health-canada-approves-johnson-johnson-covid-19-vaccine-quick-facts-1031000995,positive,0.6371485590934753
2356,11/26/2021 7:30:01 AM,New COVID-19 variant detected in South Africa prompts renewed travel restrictions,Seeking Alpha,https://seekingalpha.com/news/3774462-new-covid-19-variant-detected-in-south-africa-prompts-renewed-travel-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9275062084197998
2357,11/26/2021 2:05:34 PM,WHO meets today as new COVID variant poised to become new threat,Seeking Alpha,https://seekingalpha.com/news/3774583-who-meets-today-as-new-covid-variant-poised-to-become-new-threat?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8418369293212891
2358,11/26/2021 2:19:14 PM,U.S. must study data before deciding on travel ban over new COVID-19 variant: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774591-us-must-study-data-before-deciding-on-travel-ban-over-new-covid-19-variant-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.908190906047821
2359,11/26/2021 2:26:32 PM,Most J&J COVID vaccine recipients switch to another shot for booster - WSJ,Seeking Alpha,https://seekingalpha.com/news/3774595-most-johnson-johnson-covid-vaccine-recipients-switch-to-another-shot-for-booster-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9234042763710022
2360,11/27/2021 6:52:48 PM,Meme stocks and megacaps make UBS list of most and least crowded trades: Alpha Tactics,Seeking Alpha,https://seekingalpha.com/news/3773977-meme-stocks-and-megacaps-make-ubs-list-of-most-and-least-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9410699605941772
2361,11/28/2021 12:10:44 AM,New COVID-19 variant found in U.K. and Germany; Israel shuts borders for foreigners,Seeking Alpha,https://seekingalpha.com/news/3774702-new-covid-19-variant-found-in-uk-and-germany-israel-shuts-borders-for-foreigners?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6722967624664307
2362,11/28/2021 1:16:20 PM,Moderna says new vaccine for Omicron could be ready for early next year,Seeking Alpha,https://seekingalpha.com/news/3774708-moderna-says-new-vaccine-for-omicron-could-be-ready-for-early-next-year?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6501122117042542
2363,11/29/2021 7:34:54 AM,"Japan, Morocco ban foreign travelers as Omicron spreads; new cases reported in Netherlands, Canada, Australia",Seeking Alpha,https://seekingalpha.com/news/3774719-japan-morocco-bans-foreign-travelers-as-omicron-spreads-new-cases-reported-in-netherlands-canada-australia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8972809910774231
2364,11/29/2021 8:45:39 AM,U.S. readies fight against Omicron variant but too soon for lockdowns: Fauci,Seeking Alpha,https://seekingalpha.com/news/3774720-us-readies-fight-against-omicron-variant-but-too-soon-for-lockdowns-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8291778564453125
2365,11/29/2021 12:56:03 PM,Novavax Working On New COVID-19 Vaccine To Combat Omicron Variant,Benzinga,/news/stocks/novavax-working-on-new-covid-19-vaccine-to-combat-omicron-variant-1031008391,negative,0.5156734585762024
2366,11/29/2021 2:35:56 PM,"Vaccine Makers Investigate New Covid Variant, To Adapt Shots If Needed ",RTTNews,/news/stocks/vaccine-makers-investigate-new-covid-variant-to-adapt-shots-if-needed-1031008838,positive,0.7871178984642029
2367,11/29/2021 4:44:03 PM,J&J researching Omicron-specific COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3774973-johnson-johnson-researching-omicron-specific-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8317428231239319
2368,11/29/2021 6:19:36 PM,5 Vaccine Stocks to Watch as New Covid-19 Variant Strikes the Market,InvestorPlace,/news/stocks/5-vaccine-stocks-to-watch-as-new-covid-19-variant-strikes-the-market-1031009824,positive,0.7251970767974854
2369,11/29/2021 7:15:07 PM,Biden to direct regulators to use ‚Äòfastest process available‚Äù to clear vaccines against Omicron,Seeking Alpha,https://seekingalpha.com/news/3775031-biden-to-direct-regulators-to-use-fastest-process-available-to-clear-vaccines-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5281215906143188
2370,11/29/2021 9:31:27 PM,"Amid Omicron, CDC now says everyone 18 and older should get COVID booster shot",Seeking Alpha,https://seekingalpha.com/news/3775092-amid-omicron-cdc-now-says-everyone-18-and-older-should-get-covid-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.875824511051178
2371,11/30/2021 3:06:35 AM,CDC Strengthens Booster Recommendation For All Adults Due To Omicron Variant Concerns ,RTTNews,/news/stocks/cdc-strengthens-booster-recommendation-for-all-adults-due-to-omicron-variant-concerns-1031010292,negative,0.6120551228523254
2372,11/30/2021 8:47:49 AM,England to impose mask mandates to curb spread of Omicron - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775168-england-to-impose-mask-mandates-to-curb-spread-omicron-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7565428018569946
2373,11/30/2021 10:55:45 AM,EU expects to approve shot against Omicron in 3-4 months,Seeking Alpha,https://seekingalpha.com/news/3775204-eu-expects-to-approve-shot-against-omicron-in-3-4-months?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5946268439292908
2374,11/30/2021 4:17:16 PM,"FDA working with other agencies, private industry on potential impact from Omicron",Seeking Alpha,https://seekingalpha.com/news/3775445-fda-working-with-other-agencies-private-industry-on-potential-impact-from-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8703819513320923
2375,11/30/2021 7:29:27 PM,7 Drug Stocks to Buy Now While They‚Äôre Still on Sale,InvestorPlace,/news/stocks/7-drug-stocks-to-buy-now-while-theyre-still-on-sale-1031013701,positive,0.8935650587081909
2376,11/30/2021 7:47:10 PM,Street analysts have mixed views on Omicron impact on COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3775526-street-analysts-have-mixed-views-on-omicron-impact-on-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9090571999549866
2377,11/30/2021 10:49:08 PM,Have the Markets Overreacted to Omicron?,InvestorPlace,/news/stocks/have-the-markets-overreacted-to-omicron-1031017944,neutral,0.8583032488822937
2378,12/1/2021 8:15:42 AM,South African disease expert says Omicron variant could outweigh Delta - Reuters,Seeking Alpha,https://seekingalpha.com/news/3775645-south-african-disease-expert-says-omicron-variant-could-outweigh-delta-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5830768942832947
2379,12/1/2021 5:20:42 PM,"Johnson & Johnson, Amgen win FDA approval for drug combo targeting multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3775966-johnson-johnson-amgen-win-fda-approval-for-drug-combo-targeting-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9382338523864746
2380,12/1/2021 7:48:03 PM,VXRT Stock: Other Vaccine Stocks Are Gaining But Jim Cramer Just Sent Vaxart Down,InvestorPlace,/news/stocks/vxrt-stock-other-vaccine-stocks-are-gaining-but-jim-cramer-just-sent-vaxart-down-1031017418,negative,0.8836966753005981
2381,12/2/2021 4:36:02 AM,Amgen : FDA Approves Kyprolis Combination Regimen For Multiple Myeloma Treatment ,RTTNews,/news/stocks/amgen-fda-approves-kyprolis-combination-regimen-for-multiple-myeloma-treatment-1031017923,negative,0.8889809250831604
2382,12/2/2021 2:32:57 PM,3 Sickly Covid Stocks to Buy as Omicron Gets Around,InvestorPlace,/news/stocks/3-sickly-covid-stocks-to-buy-1031020211,positive,0.8426560163497925
2383,12/2/2021 4:06:41 PM,Aurinia Pharmaceuticals gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3776494-aurinia-pharmaceuticals-gains-on-takeover-speculation?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9189054369926453
2384,12/2/2021 8:09:52 PM,Scientists find reason behind rare blood clots linked to AstraZeneca COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3776636-scientists-find-reason-behind-rare-blood-clots-linked-to-astrazeneca-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7874378561973572
2385,12/2/2021 9:00:37 PM,More Omicron cases found in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3776657-more-omicron-cases-found-in-the-us?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7973804473876953
2386,12/2/2021 9:38:52 PM,Protagonist chooses candidate to advance into phase 2 in collaboration with Janssen,Seeking Alpha,https://seekingalpha.com/news/3776679-protagonist-chooses-candidate-to-advance-into-phase-2-in-collaboration-with-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8327937126159668
2387,12/3/2021 1:33:09 PM,J&J's Tremfya shows durable response in psoriatric arthritis in late-stage trial,Seeking Alpha,https://seekingalpha.com/news/3776881-johnson-johnson-tremfya-shows-durable-response-in-psoriatric-arthritis-in-late-stage-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9549739956855774
2388,12/3/2021 1:40:11 PM,"The Daily Biotech Pulse: Protagonist Pulls Plug On Phase 1 Asset, Xenon Aces Mid-Stage Epilepsy Study, Esperion Prices Offering",Benzinga,/news/stocks/the-daily-biotech-pulse-protagonist-pulls-plug-on-phase-1-asset-xenon-aces-mid-stage-epilepsy-study-esperion-prices-offering-1031022833,positive,0.8068130016326904
2389,12/3/2021 3:23:59 PM,"Protagonist To Go Ahead With Oral Peptide PN-235, Discontinues Phase 1 Candidate",Benzinga,/news/stocks/protagonist-to-go-ahead-with-oral-peptide-pn-235-discontinues-phase-1-candidate-1031023141,positive,0.9019888043403625
2390,12/3/2021 4:15:06 PM,WHO says no evidence yet Omicron requires adjustments to existing COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3776979-who-says-no-evidence-yet-omicron-requires-adjustments-to-existing-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8745612502098083
2391,12/3/2021 7:02:42 PM,House Oversight Committee schedules Dec. 9 hearing on prescription drug prices,Seeking Alpha,https://seekingalpha.com/news/3777032-house-oversight-committee-schedules-dec-9-hearing-on-prescription-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8558977246284485
2392,12/4/2021 1:24:00 AM,Janssen to Showcase Progress on Respiratory Syncytial Virus (RSV) Vaccine Candidate at ESWI 2021,PR Newswire,/news/stocks/janssen-to-showcase-progress-on-respiratory-syncytial-virus-rsv-vaccine-candidate-at-eswi-2021-1031024126,negative,0.5552991032600403
2393,12/5/2021 11:03:00 PM,"Johnson & Johnson COVID-19 Booster, Administered Six Months After Two-Dose Regimen of BNT162b2, Shows Substantial Increase in Antibody and T-cell Responses",PR Newswire,/news/stocks/johnson-johnson-covid-19-booster-administered-six-months-after-two-dose-regimen-of-bnt162b2-shows-substantial-increase-in-antibody-and-t-cell-responses-1031024672,negative,0.9459743499755859
2394,12/6/2021 2:43:14 AM,Johnson & Johnson Says Its COVID-19 Booster Shows Increase In Antibody And T-cell Responses ,RTTNews,/news/stocks/johnson-johnson-says-its-covid-19-booster-shows-increase-in-antibody-and-t-cell-responses-1031024711,negative,0.9488843083381653
2395,12/6/2021 7:02:43 AM,"J&J's COVID-19 booster shot shows increase in antibody, T-cell responses",Seeking Alpha,https://seekingalpha.com/news/3777145-jjs-covid-19-booster-shot-shows-increase-in-antibody-t-cell-responses?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9259246587753296
2396,12/6/2021 10:59:57 AM,U.S. prepares to fast-track authorization of Omicron COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3777176-us-prepares-to-fast-track-authorization-of-omicron-covid-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8243824243545532
2397,12/6/2021 2:19:00 PM,NDA for J&J's cilta-cel for multiple myeloma submitted to Japanese regulators,Seeking Alpha,https://seekingalpha.com/news/3777264-nda-for-johnson-johnson-cilta-cel-for-multiple-myeloma-submitted-to-japanese-regulators?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9174819588661194
2398,12/6/2021 8:50:20 PM,Biden calls on Senate to pass legislation to tackle 'outrageously expensive' drug prices,Seeking Alpha,https://seekingalpha.com/news/3777526-biden-call-on-senate-to-pass-legislation-to-tackle-outrageously-expensive-drug-prices?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6551856398582458
2399,12/7/2021 8:37:17 AM,New York City to impose vaccine mandate for all private employees,Seeking Alpha,https://seekingalpha.com/news/3777604-new-york-city-to-impose-vaccine-mandate-for-all-private-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.872247040271759
2400,12/7/2021 11:00:16 AM,7 Stocks to Watch as the Omicron Variant Becomes the Market‚Äôs New Wildcard,InvestorPlace,/news/stocks/7-stocks-to-watch-as-the-omicron-variant-becomes-the-markets-new-wildcard-1031028496,negative,0.5960684418678284
2401,12/7/2021 12:09:33 PM,Johnson & Johnson‚Äôs respiratory syncytial virus candidate shows 80% efficacy,Seeking Alpha,https://seekingalpha.com/news/3777661-johnson-johnsons-respiratory-syncytial-virus-candidate-shows-80-efficacy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8205364942550659
2402,12/7/2021 3:44:01 PM,Legend Biotech rises on filing of marketing application for CAR-T therapy in Japan,Seeking Alpha,https://seekingalpha.com/news/3777831-legend-biotech-rises-on-filing-of-marketing-application-for-car-t-therapy-in-japan?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8494313955307007
2403,12/8/2021 12:01:40 PM,"Pfizer, BioNTech say three vaccine doses neutralize Omicron in early lab tests",Seeking Alpha,https://seekingalpha.com/news/3778159-pfizer-biontech-lower-after-early-data-on-omicrons-impact-on-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8044571280479431
2404,12/8/2021 8:14:45 PM,U.S. COVID-19 cases rise amid vaccine milestone,Seeking Alpha,https://seekingalpha.com/news/3778424-us-covid-19-cases-rise-despite-vaccine-milestone?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7187535762786865
2405,12/8/2021 9:34:06 PM,N.Y. judge issues temporary restraining order on NYC public sector vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3778474-ny-judge-issues-temporary-restraining-order-on-nyc-public-sector-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9273136258125305
2406,12/9/2021 12:30:00 PM,Johnson & Johnson Appoints Senior Leaders to Executive Committee,PR Newswire,/news/stocks/johnson-johnson-appoints-senior-leaders-to-executive-committee-1031034957,positive,0.9431009888648987
2407,12/9/2021 2:53:01 PM,Johnson & Johnson makes new Executive Committee appointments,Seeking Alpha,https://seekingalpha.com/news/3778742-johnson-johnson-makes-new-executive-committee-appointments?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8876413106918335
2408,12/9/2021 10:52:49 PM,WHO advisory panel recommends J&J COVID vaccine booster,Seeking Alpha,https://seekingalpha.com/news/3778989-who-advisory-panel-recommends-johnson-johnson-covid-vaccine-booster?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8364192247390747
2409,12/9/2021 11:00:00 PM,World Health Organization Strategic Advisory Group of Experts (SAGE) Interim Recommendation Supports Use of Johnson & Johnson COVID-19 Vaccine as a Booster,PR Newswire,/news/stocks/world-health-organization-strategic-advisory-group-of-experts-sage-interim-recommendation-supports-use-of-johnson-johnson-covid-19-vaccine-as-a-booster-1031037203,positive,0.5796787142753601
2410,12/10/2021 11:00:33 AM,Why You Should Buy Moderna Stock at Every Dip,InvestorPlace,/news/stocks/why-you-should-buy-mrna-stock-at-every-dip-1031038543,positive,0.9308883547782898
2411,12/10/2021 7:08:46 PM,3 Healthcare Stocks for Long-Term Dividend Growth,InvestorPlace,/news/stocks/3-healthcare-stocks-for-long-term-dividend-growth-1031039566,positive,0.9333980679512024
2412,12/10/2021 7:39:00 PM,Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-fourth-quarter-results-1031039532,positive,0.9188656806945801
2413,12/10/2021 10:17:58 PM,FDA advisor: Real-world data on current vaccines will determine if Omicron shots needed,Seeking Alpha,https://seekingalpha.com/news/3779324-fda-advisor-real-world-data-on-current-vaccines-will-determine-if-omicron-covbid-shots-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8905700445175171
2414,12/13/2021 7:32:25 PM,Why does Pfizer's $6.7B acquisition of Arena Pharmaceuticals make sense? Etrasimod,Seeking Alpha,https://seekingalpha.com/news/3779629-why-does-pfizer-67b-acquisition-of-arena-pharmaceuticals-make-sense-etrasimod?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.917937159538269
2415,12/13/2021 8:15:41 PM,Supreme Court blocks challenge to N.Y. COVID mandate for healthcare workers (updated),Seeking Alpha,https://seekingalpha.com/news/3779642-supreme-court-blocks-challenge-to-ny-covid-vaccine-mandate-for-health-workers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7136786580085754
2416,12/13/2021 11:24:29 PM,J&J Talcum Powder Woes Continue As SC Declines To Hear The Company ,RTTNews,/news/stocks/j-j-talcum-powder-woes-continue-as-sc-declines-to-hear-the-company-1031042458,neutral,0.9644210934638977
2417,12/14/2021 11:34:08 AM,Johnson & Johnson COVID-19 vaccine study in South Africa finds no Omicron deaths,Seeking Alpha,https://seekingalpha.com/news/3779804-johnson-johnson-covid-19-vaccine-study-in-south-africa-finds-no-omicron-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.734598696231842
2418,12/14/2021 7:27:38 PM,"10 Stocks to Buy if You Have $5,000 in Starter Money",InvestorPlace,/news/stocks/10-stocks-to-buy-if-you-have-5000-dollars-in-starter-money-1031044495,positive,0.9384512901306152
2419,12/14/2021 8:04:38 PM,WHO chief says there is a ‚Äúsmall decline‚Äù in effectiveness of COVID-19 vaccines,Seeking Alpha,https://seekingalpha.com/news/3780074-who-chief-says-there-is-a-small-decline-in-effectiveness-of-covid-19-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9691348075866699
2420,12/15/2021 11:19:35 AM,EMA recommends Johnson & Johnson COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3780235-ema-recommends-johnson-johnson-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8723170161247253
2421,12/15/2021 12:53:33 PM,EMA Recommends Covid-19 Vaccine Janssen Booster Shot For Adults ,RTTNews,/news/stocks/ema-recommends-covid-19-vaccine-janssen-booster-shot-for-adults-1031046724,positive,0.8202400207519531
2422,12/15/2021 1:34:01 PM,Study finds COVID booster shots significantly increase Omicron neutralization,Seeking Alpha,https://seekingalpha.com/news/3780324-study-finds-covid-booster-shots-significantly-increase-omicron-neutralization?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9183441996574402
2423,12/15/2021 2:32:00 PM,Johnson & Johnson Announces Positive CHMP Opinion for a Booster Shot of its COVID-19 Vaccine,PR Newswire,/news/stocks/johnson-johnson-announces-positive-chmp-opinion-for-a-booster-shot-of-its-covid-19-vaccine-1031047251,negative,0.9456380009651184
2424,12/15/2021 2:46:14 PM,Johnson & Johnson Receives Positive CHMP Opinion For Booster Shot Of COVID-19 Vaccine ,RTTNews,/news/stocks/johnson-johnson-receives-positive-chmp-opinion-for-booster-shot-of-covid-19-vaccine-1031047303,negative,0.9420915246009827
2425,12/15/2021 5:27:38 PM,3 Consumer Staples Stocks to Buy for Safety,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-buy-for-safety-1031048130,positive,0.9131319522857666
2426,12/16/2021 5:53:14 PM,Legend now up 4% following ADS offering pricing after initially falling,Seeking Alpha,https://seekingalpha.com/news/3780935-legend-now-up-4-following-ads-offering-pricing-after-initially-falling?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9358142614364624
2427,12/16/2021 11:12:30 PM,J&J says its COVID vaccine remains crucial after CDC advisors vote in favor of mRNA shots,Seeking Alpha,https://seekingalpha.com/news/3781137-jj-says-its-covid-vaccine-remains-crucial-after-cdc-advisors-vote-in-favor-of-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8191997408866882
2428,12/17/2021 3:33:12 AM,"CDC Recommends Pfizer, Moderna COVID-19 Vaccines Over J&J Due To Rare Blood Clots ",RTTNews,/news/stocks/cdc-recommends-pfizer-moderna-covid-19-vaccines-over-j-j-due-to-rare-blood-clots-1031051886,positive,0.6486043334007263
2429,12/17/2021 9:47:05 AM,Biden warns unvaccinated against Omicron; asks Supreme Court to unblock vaccine mandate,Seeking Alpha,https://seekingalpha.com/news/3781179-biden-warns-unvaccinated-against-omicron-asks-supreme-court-to-lift-covid-19-vaccine-mandate?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6527684926986694
2430,12/17/2021 11:47:41 AM,"Pfizer/BioNTech, Moderna COVID-19 shots get CDC backing ahead of J&J‚Äôs",Seeking Alpha,https://seekingalpha.com/news/3781205-pfizerbiontech-moderna-covid-19-shots-get-cdc-backing-ahead-of-jjs?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5955707430839539
2431,12/17/2021 4:17:57 PM,"Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-december-17-2021-1031053650,neutral,0.5951845049858093
2432,12/17/2021 10:15:36 PM,"The Week In Cannabis: Pfizer, Visa, $730M+ In Financings, Malta, EU, Columbia Care, MedMen, Uruguay And More",Benzinga,/news/stocks/the-week-in-cannabis-pfizer-visa-730m+-in-financings-malta-eu-columbia-care-medmen-uruguay-and-more-1031054254,positive,0.8311687707901001
2433,12/20/2021 8:43:28 AM,U.S. appeals court revives Biden administration‚Äôs COVID-19 vaccine mandate for businesses,Seeking Alpha,https://seekingalpha.com/news/3781502-us-appeals-court-revives-biden-administrations-covid-19-vaccine-mandate-for-businesses?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4621276259422302
2434,12/20/2021 12:00:05 PM,Moderna leads COVID-19 vaccine makers after booster data on Omicron,Seeking Alpha,https://seekingalpha.com/news/3781536-moderna-leads-covid-19-vaccine-makers-after-booster-data-on-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7139621376991272
2435,12/21/2021 12:00:59 PM,"Meta hits UBS list of most crowded trades, most megacaps still uncrowded: At the Open",Seeking Alpha,https://seekingalpha.com/news/3781908-meta-hits-ubs-list-of-most-crowded-trades-most-megacaps-still-uncrowded?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6971690654754639
2436,12/21/2021 2:11:20 PM,"The Daily Biotech Pulse: Aldeyra Sinks On Dry Eye Disease Readout, Sanofi Goes Shopping, Regulatory Setback For Aquestive, Aridis Touts Pan-Coronavirus Antibody Cocktail",Benzinga,/news/stocks/the-daily-biotech-pulse-aldeyra-sinks-on-dry-eye-disease-readout-sanofi-goes-shopping-regulatory-setback-for-aquestive-aridis-touts-pan-coronavirus-antibody-cocktail-1031059051,positive,0.6017129421234131
2437,12/21/2021 3:50:16 PM,DYAI: Jumpin' Janssen Jamboree,Benzinga,/news/stocks/dyai-jumpin-janssen-jamboree-1031059462,positive,0.8857550621032715
2438,12/21/2021 5:35:05 PM,Johnson & Johnson nabs two additional pediatric indications for Xarelto,Seeking Alpha,https://seekingalpha.com/news/3782424-johnson-johnson-nabs-two-additional-pediatric-indications-for-xarelto?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5430358648300171
2439,12/21/2021 6:33:44 PM,EMA: Data shows COVID boosters protect against Omicron; altering shots not yet needed,Seeking Alpha,https://seekingalpha.com/news/3782462-ema-data-shows-covid-boosters-protect-against-omicron-altering-shots-not-yet-needed?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8484414219856262
2440,12/21/2021 8:19:03 PM,Biden says country 'not going back to March 2020' in terms of COVID closures (updated),Seeking Alpha,https://seekingalpha.com/news/3782480-biden-says-country-not-going-back-to-march-2020-in-terms-of-covid-closures?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9137389659881592
2441,12/21/2021 9:25:59 PM,"AstraZeneca, Oxford start work on Omicron-specific COVID vaccine - FT",Seeking Alpha,https://seekingalpha.com/news/3782496-astrazeneca-oxford-start-work-on-omicron-specific-covid-vaccine-ft?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7424196004867554
2442,12/22/2021 6:07:58 PM,Study finds mRNA vaccine boosters significantly increase protection against Omicron,Seeking Alpha,https://seekingalpha.com/news/3782789-study-finds-mrna-covid-vaccine-boosters-significantly-increase-protection-against-omicron?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9461206197738647
2443,12/23/2021 8:00:14 AM,Janssen terminates izencitinib deal with Theravance Biopharma,Seeking Alpha,https://seekingalpha.com/news/3782899-janssen-terminates-izencitinib-deal-with-theravance-biopharma?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8456546068191528
2444,12/23/2021 12:27:47 PM,Top 10 Blockbuster Drugs In 2021 ,RTTNews,/news/stocks/top-10-blockbuster-drugs-in-2021-1031063755,positive,0.7226237654685974
2445,12/23/2021 1:13:05 PM,South Africa approves J&J's COVID-19 booster shot - Reuters,Seeking Alpha,https://seekingalpha.com/news/3782987-south-africa-approves-jjs-covid-19-booster-shot-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8205555081367493
2446,12/23/2021 3:07:25 PM,Corporate Cannabis Takeover? Assessing 5 Big Industries Already At The Table,Benzinga,/news/stocks/corporate-cannabis-takeover-assessing-5-big-industries-already-at-the-table-1031064194,positive,0.9278658628463745
2447,12/23/2021 8:53:48 PM,Endo to pay $63M to settle Texas opioid claims,Seeking Alpha,https://seekingalpha.com/news/3783297-endo-to-pay-63m-to-settle-texas-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.847844123840332
2448,12/27/2021 8:18:53 AM,Global COVID-19 cases break records as Omicron variant spreads,Seeking Alpha,https://seekingalpha.com/news/3783344-global-covid-19-cases-break-records-as-omicron-variant-spreads?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5463659763336182
2449,12/27/2021 5:32:41 PM,Number of daily COVID-19 cases now on par when Delta variant was surging,Seeking Alpha,https://seekingalpha.com/news/3783469-number-of-daily-covid-19-cases-now-on-par-when-delta-variant-was-surging?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4611019194126129
2450,12/27/2021 8:11:30 PM,"If You Invested $1,000 In Inovio Stock One Year Ago, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-one-year-ago-here-s-how-much-you-d-have-now-1031067341,positive,0.93653804063797
2451,12/28/2021 9:55:54 AM,New York expands COVID-19 testing as cases continue to rise,Seeking Alpha,https://seekingalpha.com/news/3783547-new-york-expands-covid-19-testing-as-cases-continue-to-rise?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7552236318588257
2452,12/28/2021 11:36:01 AM,Omicron enhances neutralizing immunity against Delta variant: South Africa study,Seeking Alpha,https://seekingalpha.com/news/3783567-omicron-enhances-neutralizing-immunity-against-delta-variant-south-africa-study?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8443624377250671
2453,12/29/2021 9:38:52 AM,NYC schools to ramp up testing to limit classroom closures - NYT,Seeking Alpha,https://seekingalpha.com/news/3783823-nyc-schools-to-ramp-up-testing-to-limit-classroom-closures-nyt?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7124148607254028
2454,12/29/2021 1:29:24 PM,Johnson & Johnson seeks FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3783872-johnson-johnson-seeks-fda-approval-for-multiple-myeloma-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8891640901565552
2455,12/29/2021 2:50:46 PM,COVID-19 cases 7-day moving average reaches level not seen since January,Seeking Alpha,https://seekingalpha.com/news/3783910-covid-19-cases-7-day-moving-average-reaches-level-not-seen-since-january?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8182679414749146
2456,12/30/2021 9:11:05 AM,J&J COVID-19 booster dose slashes Omicron hospital stay: South African study,Seeking Alpha,https://seekingalpha.com/news/3784064-jj-covid-19-booster-dose-slashes-omicron-hospital-stay-south-african-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.4996188282966614
2457,12/30/2021 9:52:37 AM,Omicron COVID surge could peak in U.S. by January end: Fauci,Seeking Alpha,https://seekingalpha.com/news/3784080-omicron-covid-surge-could-peak-in-us-by-january-end-fauci?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8277068734169006
2458,12/30/2021 12:30:00 PM,Johnson & Johnson COVID-19 Vaccine Demonstrates 85 Percent Effectiveness against Hospitalization in South Africa when Omicron was Dominant,PR Newswire,/news/stocks/johnson-johnson-covid-19-vaccine-demonstrates-85-percent-effectiveness-against-hospitalization-in-south-africa-when-omicron-was-dominant-1031071002,negative,0.9503253102302551
2459,12/30/2021 1:11:18 PM,"J&J's COVID-19 Booster Shot 85% Effective Against Hospitalization, In South Africa Phase 3 Study ",RTTNews,/news/stocks/j-j-s-covid-19-booster-shot-85-effective-against-hospitalization-in-south-africa-phase-3-study-1031071067,negative,0.8822844624519348
2460,1/2/2022 5:00:00 PM,Can COVID-19 vaccine makers stellar 2021 continue in 2022?,Seeking Alpha,https://seekingalpha.com/news/3784267-can-covid-19-vaccine-makers-stellar-2021-continue-in-2022?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8817172646522522
2461,1/3/2022 11:00:54 AM,Some Investors Should Buy Novavax Stock on the Dip,InvestorPlace,/news/stocks/some-investors-should-buy-nvax-stock-on-the-dip-1031073881,positive,0.8837240934371948
2462,1/3/2022 4:19:37 PM,Theravance up 9% on 3x higher than normal volume,Seeking Alpha,https://seekingalpha.com/news/3784627-theravance-up-10-on-3x-higher-than-normal-volume?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9502735137939453
2463,1/3/2022 8:55:57 PM,States siding with McKinsey to block local governments' opioid cases,Seeking Alpha,https://seekingalpha.com/news/3784696-states-siding-with-mckinsey-to-block-local-governments-opioid-cases?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6529679298400879
2464,1/4/2022 8:42:50 AM,U.S. schools delay openings amid COVID-19 surge driven by Omicron variant,Seeking Alpha,https://seekingalpha.com/news/3784800-us-schools-delay-openings-amid-covid-19-surge-driven-by-omicron-variant?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9318064451217651
2465,1/4/2022 1:34:30 PM,Johnson & Johnson declares $1.06 dividend,Seeking Alpha,https://seekingalpha.com/news/3784864-johnson-and-johnson-declares-1_06-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9299405813217163
2466,1/4/2022 2:00:00 PM,Johnson & Johnson Announces Quarterly Dividend for First Quarter 2022,PR Newswire,/news/stocks/johnson-johnson-announces-quarterly-dividend-for-first-quarter-2022-1031076008,positive,0.6034670472145081
2467,1/4/2022 4:02:18 PM,CDC backs use of a third Pfizer/BioNTech COVID-19 shot for certain children,Seeking Alpha,https://seekingalpha.com/news/3785056-cdc-backs-use-of-a-third-pfizerbiontech-covid-19-shot-for-certain-children?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7740053534507751
2468,1/4/2022 5:07:32 PM,"Store Capital falls as CNBC commentator sells shares, buys Carlyle Group, recommends Viper Energy (update)",Seeking Alpha,https://seekingalpha.com/news/3785136-store-capital-falls-after-cnbc-commentator-sells-shares-buys-carlyle-group?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8120037913322449
2469,1/4/2022 8:59:04 PM,Biden says vaccinated people shouldn't be 'alarmed' by COVID-19,Seeking Alpha,https://seekingalpha.com/news/3785196-biden-says-vaccinated-people-shouldnt-be-alarmed-by-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7648679614067078
2470,1/5/2022 1:22:15 PM,"Nevada joins Johnson & Johnson, drug distributors $26B opioid settlement",Seeking Alpha,https://seekingalpha.com/news/3785354-johnson-johnson-drug-distributors-win-nevada-for-26b-opioid-deal?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49819469451904297
2471,1/5/2022 7:49:53 PM,Global M&A deals annual volume reach highest level since 2008: Willis Towers,Seeking Alpha,https://seekingalpha.com/news/3785549-global-ma-deals-annual-volume-reach-highest-level-since-2008-willis-towers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9062772393226624
2472,1/5/2022 9:41:23 PM,"J&J Janssen unit, SRI International to collaborate on drug discovery using AI",Seeking Alpha,https://seekingalpha.com/news/3785625-johnson-johnson-janssen-unit-sri-international-to-collaborate-drug-discovery-using-ai?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7386317849159241
2473,1/6/2022 12:33:59 PM,7 Best Stocks to Buy to Kick Off the New Year,InvestorPlace,/news/stocks/7-best-stocks-to-buy-to-kick-off-new-year-1031081283,positive,0.6506024599075317
2474,1/6/2022 12:38:01 PM,"Meta, Netflix move up list of crowded trades, even as funds dump tech: At the Open",Seeking Alpha,https://seekingalpha.com/news/3785535-meta-netflix-move-up-the-list-of-ubs-most-crowded-trades?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.872516930103302
2475,1/6/2022 10:03:32 PM,"J&J touts data on durable protection of COVID shot against infections, hospitalization",Seeking Alpha,https://seekingalpha.com/news/3786033-johnson-johnson-touts-data-on-durable-protection-of-covid-shot-against-infections-hospitalization?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9006164073944092
2476,1/6/2022 10:10:00 PM,"Real World Evidence Shows Johnson & Johnson COVID-19 Vaccine Demonstrates Durable Protection Against Breakthrough Infection, Hospitalization, and Intensive Care Unit Admission in the United States",PR Newswire,/news/stocks/real-world-evidence-shows-johnson-johnson-covid-19-vaccine-demonstrates-durable-protection-against-breakthrough-infection-hospitalization-and-intensive-care-unit-admission-in-the-united-states-1031082512,negative,0.9494941234588623
2477,1/7/2022 4:07:19 AM,Johnson & Johnson Vaccine Protects Up To Six Months Against COVID-19 Breakthrough Infections ,RTTNews,/news/stocks/johnson-johnson-vaccine-protects-up-to-six-months-against-covid-19-breakthrough-infections-1031082696,positive,0.7034173011779785
2478,1/7/2022 5:59:39 PM,Some Supreme Court justices take issue with Biden vaccine mandates,Seeking Alpha,https://seekingalpha.com/news/3786332-some-supreme-court-justices-take-issue-with-biden-vaccine-mandates?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6542562246322632
2479,1/7/2022 6:17:06 PM,Biden administration to ask Congress for more COVID funding - WaPo,Seeking Alpha,https://seekingalpha.com/news/3786338-biden-administration-to-ask-congress-for-more-covid-funding?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7112752199172974
2480,1/7/2022 6:34:48 PM,Judge allows Purdue to immediately appeal bankruptcy settlement rejection,Seeking Alpha,https://seekingalpha.com/news/3786345-judge-gives-purdue-right-to-immediately-appeal-bankruptcy-opioid-settlement-rejection?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.698022723197937
2481,1/11/2022 11:10:02 AM,U.S. COVID-19 hospitalizations surpass last winter record as Omicron surges,Seeking Alpha,https://seekingalpha.com/news/3786959-us-covid-19-hospitalizations-surpass-last-winter-record-as-omicron-surges?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9084089398384094
2482,1/11/2022 8:46:55 PM,FDA mandates warning of risk of blood clotting disorder with J&J COVID vaccine,Seeking Alpha,https://seekingalpha.com/news/3787247-fda-mandates-warning-of-risk-of-blood-clotting-disorder-with-jj-covid-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7607699036598206
2483,1/12/2022 4:57:30 PM,Theravance Biopharma continues slide; down another 12% today,Seeking Alpha,https://seekingalpha.com/news/3787576-theravance-biosciences-continues-slide-down-another-12-today?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9742461442947388
2484,1/13/2022 8:52:18 AM,Calls grow to treat COVID like an 'endemic' illness,Seeking Alpha,https://seekingalpha.com/news/3787737-calls-grow-to-treat-covid-like-an-endemic-illness?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5648321509361267
2485,1/13/2022 6:43:38 PM,FDA document outlines testing of cosmetics containing talc for asbestos,Seeking Alpha,https://seekingalpha.com/news/3788023-fda-document-outlines-testing-of-cosmetics-containing-talc-for-asbestos?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9340897798538208
2486,1/13/2022 7:42:56 PM,"Supreme Court blocks COVID vaccine mandate for businesses, but OK for healthcare workers",Seeking Alpha,https://seekingalpha.com/news/3788042-supreme-court-blocks-covid-vaccine-mandate-for-businesses-but-ok-for-healthcare-workers?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8305374979972839
2487,1/14/2022 5:24:27 PM,What To Expect When Johnson & Johnson Unveils Q4 Performance This Month,Benzinga,/news/stocks/what-to-expect-when-johnson-johnson-unveils-q4-performance-this-month-1031103799,positive,0.9391925930976868
2488,1/14/2022 5:48:39 PM,AstraZeneca COVID-19 vaccine linked to rare spinal condition - European regulator,Seeking Alpha,https://seekingalpha.com/news/3788370-astrazeneca-covid-19-vaccine-linked-to-rare-spinal-condition-european-regulator?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7813329696655273
2489,1/14/2022 6:18:54 PM,Johnson & Johnson set to hear bankruptcy ruling for talc claims by Feb. 28,Seeking Alpha,https://seekingalpha.com/news/3788379-johnson-johnson-set-to-hear-bankruptcy-ruling-for-talc-claims-by-feb-28?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.762315571308136
2490,1/14/2022 8:35:57 PM,Novavax Still Has Not Received an FDA EUA as the Market Waits,InvestorPlace,/news/stocks/nvax-stock-could-be-a-buy-here-before-the-fda-eua-for-its-vaccine-1031104155,positive,0.851963996887207
2491,1/20/2022 3:10:01 PM,CDC study finds prior infection provides better immunity against COVID than vaccines,Seeking Alpha,https://seekingalpha.com/news/3789643-cdc-report-finds-prior-infection-provides-better-immunity-against-covid-than-vaccines?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8891785144805908
2492,1/20/2022 8:33:40 PM,7 Bull Market Stocks to Buy for a Continued Run Higher in 2022¬†,InvestorPlace,/news/stocks/7-bull-market-stocks-to-buy-for-a-continued-run-higher-in-2022-1031117463,negative,0.8758511543273926
2493,1/21/2022 7:04:31 PM,Judge blocks Biden mandate requiring COVID vaccination for federal employees,Seeking Alpha,https://seekingalpha.com/news/3790408-judge-blocks-biden-mandate-requiring-covid-vaccination-for-federal-employees?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7862676978111267
2494,1/21/2022 7:42:11 PM,Worldwide Adoption of Novavax Vaccines Makes It a Winner,InvestorPlace,/news/stocks/worldwide-adoption-of-nvax-stock-vaccines-makes-it-a-winner-1031119838,negative,0.8301923274993896
2495,1/24/2022 3:41:46 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3790744-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
2496,1/24/2022 4:25:26 PM,"AstraZeneca, Pfizer/ BioNTech or J&J shots found to boost effect of Sinovac COVID-19 vaccine",Seeking Alpha,https://seekingalpha.com/news/3790763-astrazeneca-pfizer-biontech-or-jj-shots-found-to-boost-effect-of-sinovac-covid-19-vaccine?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.938286304473877
2497,1/24/2022 5:07:29 PM,"Omicron blunts rise in vaccine sales for 2022, health analytics firm says",Seeking Alpha,https://seekingalpha.com/news/3790796-omicron-blunts-rise-in-vaccine-sales-for-2022-health-analytics-firm-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9460015296936035
2498,1/24/2022 5:58:07 PM,All eyes on J&J Q4 results with new CEO and plans of company split,Seeking Alpha,https://seekingalpha.com/news/3790850-all-eyes-on-jj-q4-results-with-new-ceo-and-plans-of-company-split?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9325414896011353
2499,1/25/2022 8:16:59 AM,New York judge blocks statewide mask mandate - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791053-new-york-judge-blocks-statewide-mask-mandate-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.677754282951355
2500,1/25/2022 11:31:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.13 beats by $0.01, revenue of $24.8B misses by $490M",Seeking Alpha,https://seekingalpha.com/news/3791095-johnson-and-johnson-non-gaap-eps-of-2_13-beats-0_01-revenue-of-24_8b-misses-490m?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7000038027763367
2501,1/25/2022 12:17:12 PM,Johnson & Johnson down 2% on top-line miss; FY22 guidance tops consensus,Seeking Alpha,https://seekingalpha.com/news/3791124-johnson-johnson-down-2-on-top-line-miss-fy22-guidance-tops-consensus?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9721747040748596
2502,1/25/2022 12:25:00 PM,Johnson & Johnson Reports Q4 and Full-Year 2021 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q4-and-full-year-2021-results-1031125670,positive,0.7945525050163269
2503,1/25/2022 12:30:17 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1031125675,negative,0.9294189214706421
2504,1/25/2022 12:59:24 PM,Johnson & Johnson Projects 2022 Adj. Operational EPS Growth Of 9.2% ,RTTNews,/news/stocks/johnson-johnson-projects-2022-adj-operational-eps-growth-of-9-2-1031125779,negative,0.8339579701423645
2505,1/25/2022 1:46:12 PM,"The Daily Biotech Pulse: Pfizer-BioNTech Starts Omicron-Specific Vaccine Study, J&J Misses On Topline, Sierra Oncology Reports Positive Data",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-biontech-starts-omicron-specific-vaccine-study-j-j-misses-on-topline-sierra-oncology-reports-positive-data-1031126033,negative,0.6391013264656067
2506,1/25/2022 2:21:16 PM,Genmab announces Darzalex 2021 sales rise 43.8% Y/Y,Seeking Alpha,https://seekingalpha.com/news/3791243-genmab-announces-darzalex-2021-sales-rise-438-yy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9477241635322571
2507,1/25/2022 2:26:33 PM,"Stocks to Watch Tuesday: What‚Äôs Moving VZ, JNJ, GE, IBM and MMM Today",InvestorPlace,/news/stocks/stocks-to-watch-tuesday-whats-moving-vz-jnj-ge-ibm-and-mmm-today-1031126757,positive,0.922569215297699
2508,1/25/2022 3:01:13 PM,Johnson Johnson earnings preview: what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1031126392,positive,0.9182448983192444
2509,1/25/2022 4:05:21 PM,Mid-Morning Market Update: Markets Open Lower; Johnson & Johnson Sales Miss Views,Benzinga,/news/stocks/mid-morning-market-update-markets-open-lower-johnson-johnson-sales-miss-views-1031126925,neutral,0.9701695442199707
2510,1/25/2022 5:21:17 PM,OSHA withdraws private employee vaccine mandate following Supreme Court ruling,Seeking Alpha,https://seekingalpha.com/news/3791386-osha-withdraws-private-employee-vaccine-mandate-following-supreme-court-ruling?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8788091540336609
2511,1/25/2022 6:14:35 PM,Mid-Day Market Update: Nasdaq Tumbles 300 Points; Sierra Oncology Shares Jump,Benzinga,/news/stocks/mid-day-market-update-nasdaq-tumbles-300-points-sierra-oncology-shares-jump-1031127368,neutral,0.954439640045166
2512,1/25/2022 6:50:12 PM,Biopharmas need to personalize engagement in competitive oncology landscape - Accenture,Seeking Alpha,https://seekingalpha.com/news/3791441-biopharmas-need-to-personalize-engagement-in-competitive-oncology-landscape-accenture?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7529730200767517
2513,1/25/2022 8:30:27 PM,Mid-Afternoon Market Update: Dow Turns Higher; General Electric Shares Slide,Benzinga,/news/stocks/mid-afternoon-market-update-dow-turns-higher-general-electric-shares-slide-1031127641,neutral,0.7643162608146667
2514,1/25/2022 9:07:36 PM,Uncertain Market Conditions And Good News Make Novavax A Cautious Buy,InvestorPlace,/news/stocks/uncertain-market-conditions-and-good-news-make-novavax-a-cautious-buy-1031127797,neutral,0.3703707456588745
2515,1/25/2022 10:11:19 PM,"4 Top Stock Trades for Wednesday: S&P 500, XOM, DOGE, JNJ",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-sp-500-xom-doge-jnj-1031127979,positive,0.9164507985115051
2516,1/26/2022 5:59:16 AM,New York mask mandate temporarily restored by Appeals Court judge - Reuters,Seeking Alpha,https://seekingalpha.com/news/3791615-new-york-mask-mandate-temporarily-restored-by-appeals-court-judge-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7119885683059692
2517,1/26/2022 1:36:25 PM,10 Biggest Price Target Changes For Wednesday,Benzinga,/news/stocks/10-biggest-price-target-changes-for-wednesday-1031130439,positive,0.8142690658569336
2518,1/26/2022 3:51:12 PM,Denmark and Austria become latest European countries to lift COVID restrictions,Seeking Alpha,https://seekingalpha.com/news/3791864-denmark-and-austria-become-latest-european-countries-to-lift-covid-restrictions?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7081277966499329
2519,1/26/2022 9:09:20 PM,Galapagos ropes in former J&J science chief Paul Stoffels as CEO,Seeking Alpha,https://seekingalpha.com/news/3792070-galapagos-ropes-in-paul-stoffels-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9158324003219604
2520,1/27/2022 7:48:36 AM,Two-thirds of Omicron COVID cases are reinfections: English study,Seeking Alpha,https://seekingalpha.com/news/3792249-two-thirds-of-omicron-covid-cases-are-reinfections-english-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8890378475189209
2521,1/27/2022 11:47:08 AM,Most U.S. local governments join opioid deal with J&J and drug distributors,Seeking Alpha,https://seekingalpha.com/news/3792302-most-us-local-governments-join-opioid-deal-with-jj-and-drug-distributors?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8565737009048462
2522,1/27/2022 1:57:50 PM,"The Daily Biotech Pulse: Galapagos Appoints J&J Exec As CEO, Aridis Gets Funding For Antiviral Treatment, Moderna Starts Omicron-Specific Booster Study",Benzinga,/news/stocks/the-daily-biotech-pulse-galapagos-appoints-j-j-exec-as-ceo-aridis-gets-funding-for-antiviral-treatment-moderna-starts-omicron-specific-booster-study-1031135162,positive,0.7180495262145996
2523,1/27/2022 2:01:54 PM,MeiraGTx secures $30M milestone from Janssen under gene therapies collaboration,Seeking Alpha,https://seekingalpha.com/news/3792460-meiragtx-secures-30m-milestone-from-janssen-under-gene-therapies-collaboration?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.889613151550293
2524,1/27/2022 3:56:38 PM,Galapagos at a six-month high after naming former J&J science chief as CEO,Seeking Alpha,https://seekingalpha.com/news/3792569-galapagos-at-a-six-month-high-after-naming-former-jj-science-chief-as-ceo?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7416487336158752
2525,1/27/2022 7:04:30 PM,"Inflation - what have we learned from earnings so far, and which stocks could benefit",Seeking Alpha,https://seekingalpha.com/news/3792652-inflation-what-have-we-learned-from-earnings-so-far-and-who-could-benefit?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8946138620376587
2526,1/27/2022 11:28:00 PM,Johnson & Johnson to Participate in Citi's 2022 Virtual Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-citi-s-2022-virtual-healthcare-conference-1031137355,positive,0.8075878620147705
2527,1/28/2022 7:00:54 AM,COVID-19 boosters give 95% protection from death due to Omicron in people over 50: UKHSA,Seeking Alpha,https://seekingalpha.com/news/3792885-covid-19-boosters-gives-95-protection-from-death-due-to-omicron-in-people-over-50-ukhsa?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8038749694824219
2528,1/28/2022 8:40:11 AM,CDC study finds third dose of COVID-19 vaccine reduce risk of hospitalizations in immunocompromised people,Seeking Alpha,https://seekingalpha.com/news/3792890-cdc-study-finds-third-dose-of-covid-19-vaccine-reduce-risk-of-hospitalizations-in-immunocompromised-people?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.804219663143158
2529,1/28/2022 5:05:31 PM,Novavax Could Be the Biggest Bargain in the Market Right Now,InvestorPlace,/news/stocks/nvax-stock-could-be-biggest-bargain-in-the-market-right-now-1031140035,positive,0.5751535892486572
2530,1/28/2022 6:15:32 PM,7 Technology Stocks Reporting Earnings the Week of January 31,InvestorPlace,/news/stocks/earnings-reports-to-watch-next-week-1028709625,positive,0.5936208367347717
2531,1/29/2022 9:00:00 PM,"Vaccines to dominate pharma sales this year, but Bristol could have most best-sellers",Seeking Alpha,https://seekingalpha.com/news/3793190-vaccines-to-have-highest-pharma-sales-this-year-but-bristol-could-have-most-best-sellers?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7369604706764221
2532,1/31/2022 11:40:24 AM,"Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target",Benzinga,/news/stocks/kaleido-halts-upcoming-phase-2-copd-trial-piper-sandler-cuts-price-target-1031143668,neutral,0.9175761938095093
2533,1/31/2022 2:20:54 PM,"The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News",Benzinga,/news/stocks/the-week-ahead-in-biotech-jan-31-feb-5-merck-bristol-myers-squibb-lilly-novartis-headline-large-cap-biopharma-earnings-news-1031144306,positive,0.9110234379768372
2534,2/1/2022 11:00:48 AM,7 Stocks to Watch in This Current Earnings Season,InvestorPlace,/news/stocks/7-stocks-to-watch-in-this-current-earnings-season-aal-sq-nvax-panw-pins-tgt-wday-1031148366,positive,0.9132385849952698
2535,2/1/2022 2:23:56 PM,ViiV Healthcare announces FDA approval of two-month dosing of Cabenuva for HIV,Seeking Alpha,https://seekingalpha.com/news/3794065-viiv-healthcare-announces-fda-approval-of-two-month-dosing-of-cabenuva-for-hiv?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8925978541374207
2536,2/1/2022 3:29:20 PM,WHO: Omicron subvariant BA.2 not more severe than original variant,Seeking Alpha,https://seekingalpha.com/news/3794130-who-omicron-subvariant-ba2-not-more-severe-than-original-variant?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4296261966228485
2537,2/1/2022 4:51:04 PM,WHO warns on lifting COVID curbs quickly as many countries have not reached Omicron peak,Seeking Alpha,https://seekingalpha.com/news/3794208-who-warns-on-lifting-covid-curbs-as-many-countries-have-not-reached-omicron-peak?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8374761343002319
2538,2/1/2022 5:39:58 PM,"Johnson & Johnson, drug distributors in $590M deal with U.S. tribes to settle opioid claims",Seeking Alpha,https://seekingalpha.com/news/3794268-johnson-johnson-drug-distributors-in-590m-deal-with-us-tribes-to-settle-opioid-claims?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9083292484283447
2539,2/2/2022 4:35:37 PM,GOOG vs. GOOGL: Everything You Need to Know About the Google Stock Split,InvestorPlace,/news/stocks/goog-googl-stock-split-google-stock-split-1030992513,positive,0.9411597847938538
2540,2/2/2022 9:13:21 PM,"Avoid Novavax for Now, Until the Picture Clears Up",InvestorPlace,/news/stocks/avoid-novavax-for-now-until-the-picture-clears-up-1031155602,positive,0.8661519289016724
2541,2/2/2022 11:22:25 PM,J&J to record $610M impairment charge from terminating development of therapy,Seeking Alpha,https://seekingalpha.com/news/3795276-johnson-johnson-to-record-610m-impairment-charge-from-terminating-development-of-therapy?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9527277946472168
2542,2/3/2022 2:07:09 PM,Johnson & Johnson‚Äôs Jannsen unit in pact with Mersana for antibody-drug conjugates,Seeking Alpha,https://seekingalpha.com/news/3795540-johnson-johnsons-jannsen-unit-in-pact-with-mersana-for-antibody-drug-conjugates?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7232825756072998
2543,2/3/2022 2:13:03 PM,"The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation",Benzinga,/news/stocks/the-daily-biotech-pulse-big-pharma-earnings-prove-lackluster-mersana-inks-1b-adc-r-d-deal-syros-gets-orphan-drug-designation-1031158702,neutral,0.9289477467536926
2544,2/3/2022 7:39:45 PM,Janssen Inks Over $1B Pact For Mersana's ADC Technology In Three targets,Benzinga,/news/stocks/janssen-inks-over-1b-pact-for-mersana-s-adc-technology-in-three-targets-1031160035,negative,0.8045796155929565
2545,2/4/2022 9:34:01 PM,"J&J hatched plan, ""Project Plato,"" to stem payouts in talc lawsuits: Reuters",Seeking Alpha,https://seekingalpha.com/news/3796255-johnson-johnson-hatched-plan-project-plato-to-stem-payouts-in-talc-lawsuits-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6912698745727539
2546,2/7/2022 3:20:50 PM,"Teva in $225 million opioid deal with Texas, Attorney General says",Seeking Alpha,https://seekingalpha.com/news/3796575-teva-in-225-million-opioid-deal-with-texas-attorney-general-says?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5596024990081787
2547,2/7/2022 10:51:00 PM,Johnson & Johnson to Participate in the Cowen 42nd Annual Health Care Virtual Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-cowen-42nd-annual-health-care-virtual-conference-1031168722,positive,0.8095105886459351
2548,2/8/2022 4:10:30 PM,J&J shut production of COVID vaccine at only plant making usable batches - NY Times,Seeking Alpha,https://seekingalpha.com/news/3797306-johnson-johnson-shut-production-of-covid-vaccine-at-only-plant-making-usable-batches-ny-times?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.71340411901474
2549,2/8/2022 7:58:13 PM,Take a Leap Into Novavax Stock After Vaccine Sales Start,InvestorPlace,/news/stocks/take-a-leap-into-nvax-stock-after-vaccine-sales-start-1031173149,positive,0.895214855670929
2550,2/8/2022 9:18:39 PM,"J&J Stops Production Of Its COVID-19 Vaccine, Says NYT ",RTTNews,/news/stocks/j-j-stops-production-of-its-covid-19-vaccine-says-nyt-1031173174,neutral,0.9534153938293457
2551,2/9/2022 10:28:00 PM,Johnson & Johnson to Participate in the Raymond James 43rd Annual Institutional Investors Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-raymond-james-43rd-annual-institutional-investors-conference-1031178736,positive,0.8373597264289856
2552,2/10/2022 11:48:15 AM,Teva eyes up to $3.6 billion to settle opioid claims - Reuters,Seeking Alpha,https://seekingalpha.com/news/3798416-teva-stock-lower-as-company-eyes-up-to-36-billion-to-settle-opioid-claims-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6728845834732056
2553,2/10/2022 4:14:05 PM,J&J single-shot COVID vaccine has only ~53% efficacy based on final analysis,Seeking Alpha,https://seekingalpha.com/news/3798678-johnson-johnson-single-shot-vaccine-covid-has-only-53-efficacy-based-on-final-analysis?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9125441908836365
2554,2/11/2022 9:50:14 AM,Purdue's Sacklers mulling to add extra $1B in opioid settlement - Bloomberg News,Seeking Alpha,https://seekingalpha.com/news/3799037-purdues-sacklers-mulling-to-add-extra-1b-in-opioid-settlement-bloomberg-news?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8301587700843811
2555,2/11/2022 1:52:42 PM,Legend Biotech hits two milestones under its deal with Janssen for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3799161-jnj-stock-down-as-legend-biotech-wins-milestones-under-car-t-deal?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9428874850273132
2556,2/11/2022 8:00:38 PM,"Catalyst watch for next week: Spotlight on Nvidia, Intel, 3M, Mattel and Stablecoins",Seeking Alpha,https://seekingalpha.com/news/3799300-catalyst-watch-for-next-week-spotlight-on-nvidia-intel-3m-mattel-and-stablecoins?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9183595180511475
2557,2/12/2022 9:00:00 PM,Cassava Sciences citizen petition saga shines light on alleged abuse of FDA program,Seeking Alpha,https://seekingalpha.com/news/3799281-cassava-sciences-citizen-petition-saga-shines-light-on-alleged-abuse-of-fda-program?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7945619225502014
2558,2/14/2022 11:00:23 AM,7 Defensive Growth Stocks to Buy for February,InvestorPlace,/news/stocks/7-defensive-growth-stocks-to-buy-for-february-1031191037,positive,0.8883937001228333
2559,2/14/2022 1:31:39 PM,Cidara announces FDA acceptance of its request to study the flu candidate,Seeking Alpha,https://seekingalpha.com/news/3799514-cidara-announces-fda-acceptance-of-its-request-to-study-the-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5267717838287354
2560,2/14/2022 3:22:44 PM,COVID-19 vaccine makers decline after delay for FDA decision on vaccines for kids,Seeking Alpha,https://seekingalpha.com/news/3799593-covid-19-vaccine-makers-decline-after-delay-for-fda-decision-on-vaccines-for-kids?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9581161737442017
2561,2/14/2022 7:29:44 PM,7 Dividend Aristocrats That Could Outpace This Volatile Market,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-could-outpace-this-volatile-market-1031192576,positive,0.8186362981796265
2562,2/15/2022 2:14:27 PM,J&J says bankruptcy is best way to resolve talc claims in trial,Seeking Alpha,https://seekingalpha.com/news/3800089-johnson-johnson-says-bankruptcy-is-best-way-to-resolve-talc-claims-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8393345475196838
2563,2/15/2022 8:06:26 PM,The Best Russell 2000 Stocks to Buy Before they Rebound,InvestorPlace,/news/stocks/the-best-russell-2000-stocks-to-buy-before-they-rebound-1031197231,positive,0.8711792230606079
2564,2/15/2022 8:54:13 PM,AC Immune-Janssen Partnered Alzheimer's Vaccine Shows Tau-Specific Antibodies In Early-Stage Trial,Benzinga,/news/stocks/ac-immune-janssen-partnered-alzheimer-s-vaccine-shows-tau-specific-antibodies-in-early-stage-trial-1031197200,negative,0.5086621642112732
2565,2/15/2022 10:30:00 PM,"Johnson & Johnson Names Darius Adamczyk, Chairman and Chief Executive Officer of Honeywell, to its Board of Directors",PR Newswire,/news/stocks/johnson-johnson-names-darius-adamczyk-chairman-and-chief-executive-officer-of-honeywell-to-its-board-of-directors-1031197406,positive,0.9452979564666748
2566,2/16/2022 10:57:17 AM,AstraZeneca COVID vaccine short shelf life complicates roll out in poor nations - Reuters,Seeking Alpha,https://seekingalpha.com/news/3800550-astrazeneca-covid-vaccine-short-shelf-life-complicates-roll-out-in-poor-nations-reuters?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5820590853691101
2567,2/16/2022 3:39:01 PM,3 Desirable Drug Stocks With Very Promising Pipelines,InvestorPlace,/news/stocks/3-desirable-drug-stocks-with-very-promising-pipelines-1031201417,negative,0.905223548412323
2568,2/16/2022 6:31:52 PM,Johnson & Johnson's talc cases bankruptcy strategy attacked by Sen. Durbin,Seeking Alpha,https://seekingalpha.com/news/3800910-johnson-johnson-talc-cases-bankruptcy-strategy-attacked-by-sen-durbin?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.923743724822998
2569,2/16/2022 6:57:55 PM,Novavax Stock Is at Risk Despite Positive Poll Results,InvestorPlace,/news/stocks/nvax-stock-is-at-risk-despite-positive-poll-results-1031201978,neutral,0.8575948476791382
2570,2/17/2022 12:40:36 PM,"DaVita study suggests J&J, Pfizer/BioNTech COVID vaccines at parity for kidney patients",Seeking Alpha,https://seekingalpha.com/news/3801363-davita-study-suggests-jj-pfizerbiontech-covid-vaccines-at-parity-for-kidney-patients?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7366131544113159
2571,2/17/2022 12:57:47 PM,Johnson & Johnson‚Äôs Janssen unit and Remix Therapeutics strikes deal valued at up to $1B,Seeking Alpha,https://seekingalpha.com/news/3801376-johnson-johnsons-janssen-unit-and-remix-therapeutics-strikes-deal-valued-at-up-to-1b?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.49998408555984497
2572,2/17/2022 2:00:05 PM,"The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios",Benzinga,/news/stocks/the-daily-biotech-pulse-j-j-unit-announces-research-collaboration-with-remix-regencell-touts-covid-data-decision-day-for-agios-1031204785,positive,0.8754627704620361
2573,2/17/2022 3:07:36 PM,J&J says it may raise $2B settlement offer for talc cases - WSJ,Seeking Alpha,https://seekingalpha.com/news/3801476-johnson-johnson-says-it-may-raise-2b-settlement-offer-for-talc-cases-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8955899477005005
2574,2/18/2022 9:46:54 AM,GSK pauses trials of RSV vaccine in pregnant women,Seeking Alpha,https://seekingalpha.com/news/3801834-gsk-pauses-trials-of-rsv-vaccine-in-pregnant-women?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5307953357696533
2575,2/18/2022 4:03:41 PM,Ocugen Stock Is a Fairy Tale in Need of a Happy Ending,InvestorPlace,/news/stocks/ocgn-stock-is-a-fairy-tale-in-need-of-a-happy-ending-1031209187,positive,0.7692315578460693
2576,2/18/2022 4:14:58 PM,7 Low Volatility Stocks to Buy to Escape Wild Market Swings,InvestorPlace,/news/stocks/7-low-volatility-stocks-to-buy-to-escape-the-wild-market-swings-1031209185,positive,0.8467487096786499
2577,2/18/2022 4:19:05 PM,Johnson & Johnson‚Äôs Janssen unit posts 48-week data for Tremfya in Crohn‚Äôs disease,Seeking Alpha,https://seekingalpha.com/news/3801991-johnson-johnsons-janssen-unit-posts-48-week-data-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8941490650177002
2578,2/22/2022 6:53:11 PM,J&J argues plaintiffs' attorneys don't support talc bankruptcy plan over more money,Seeking Alpha,https://seekingalpha.com/news/3802738-johnson-johnson-argues-plaintiffs-attorneys-dont-support-talc-bankruptcy-plan-over-more-money?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7239145040512085
2579,2/23/2022 8:29:25 PM,How might a Sanofi-GSK COVID vaccine compete against mRNA shots?,Seeking Alpha,https://seekingalpha.com/news/3804505-how-might-a-sanofi-gsk-covid-vaccine-compete-against-mrna-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8816865086555481
2580,2/25/2022 2:17:56 PM,Johnson & Johnson to pay $5B as part of landmark opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3805932-johnson-johnson-to-pay-5b-as-part-of-landmark-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8307780623435974
2581,2/25/2022 4:46:48 PM,Healthcare leads a rally in S&P 500 amid hopes of Russia - Ukraine talks,Seeking Alpha,https://seekingalpha.com/news/3806014-healthcare-leads-a-rally-in-sp-500-amid-hopes-of-russia-ukraine-talks?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7153167128562927
2582,2/25/2022 4:56:18 PM,Johnson & Johnson given go-ahead for bankruptcy strategy on talc lawsuits,Seeking Alpha,https://seekingalpha.com/news/3806018-johnson-johnson-given-go-ahead-for-bankruptcy-strategy-on-talc-lawsuits?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7700974345207214
2583,2/25/2022 11:47:08 PM,J&J Bankruptcy Ploy Upheld By NJ Court ,RTTNews,/news/stocks/j-j-bankruptcy-ploy-upheld-by-nj-court-1031233558,positive,0.5461242198944092
2584,2/27/2022 3:26:47 PM,"The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight",Benzinga,/news/stocks/the-week-ahead-in-biotech-feb-27-march-5-earnings-multiple-regulatory-decisions-take-the-spotlight-1031235310,positive,0.818364143371582
2585,3/1/2022 12:22:00 PM,"Pathalys Pharma, Inc. Launches with Mission to Address High Priority Needs in Chronic Kidney Disease",PR Newswire,/news/stocks/pathalys-pharma-inc-launches-with-mission-to-address-high-priority-needs-in-chronic-kidney-disease-1031242156,negative,0.8995066285133362
2586,3/1/2022 1:51:14 PM,"The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution",Benzinga,/news/stocks/the-daily-biotech-pulse-legend-biotech-cti-biopharma-receive-fda-approvals-abbvie-announces-delay-in-skyrizi-review-editas-gains-on-crispr-patent-resolution-1031242590,positive,0.7575392723083496
2587,3/2/2022 2:01:03 PM,J&J Acuvue Theravision with Ketotifen contact lens gets FDA nod to prevent eye itch,Seeking Alpha,https://seekingalpha.com/news/3808423-jj-acuvue-theravision-with-ketotifen-contact-lens-gets-fda-nod-to-prevent-eye-itch?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8268510103225708
2588,3/2/2022 5:02:09 PM,White House COVID pandemic plan aims to ease return to normalcy,Seeking Alpha,https://seekingalpha.com/news/3808551-white-house-covid-pandemic-plan-aims-to-ease-return-to-normalcy?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.849583625793457
2589,3/2/2022 8:48:55 PM,36 Stocks To Watch After Biden's First State of The Union Address,Benzinga,/news/stocks/36-stocks-to-watch-after-biden-s-first-state-of-the-union-address-1031248946,positive,0.8909978270530701
2590,3/3/2022 3:57:17 PM,U.S. to share government-backed COVID-19 tech with WHO - Washington Post,Seeking Alpha,https://seekingalpha.com/news/3809199-us-to-share-government-backed-covid-19-tech-with-who-washington-post?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.697287917137146
2591,3/3/2022 6:10:33 PM,7 Funds to Buy to Sidestep the Stock Market Volatility,InvestorPlace,/news/stocks/7-funds-to-buy-to-sidestep-the-stock-market-volatility-1031252665,positive,0.8566225171089172
2592,3/3/2022 7:24:40 PM,"Purdue Pharma, Sacklers reach new $6B opioid settlement with states",Seeking Alpha,https://seekingalpha.com/news/3809272-purdue-pharma-sacklers-reach-new-6b-opioid-settlement-with-states?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9273517727851868
2593,3/4/2022 1:48:11 PM,Humanigen gains as CEO more than doubles stake,Seeking Alpha,https://seekingalpha.com/news/3809582-hgen-stock-gains-as-ceo-more-than-doubles-stake?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8993645906448364
2594,3/4/2022 2:09:47 PM,90% of U.S. counties experiencing low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3809592-90-of-us-counties-experiencing-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7930743098258972
2595,3/4/2022 4:31:07 PM,"New York City to lift indoor vaccine mandate, school mask requirement on Monday",Seeking Alpha,https://seekingalpha.com/news/3809678-new-york-city-to-lift-indoor-vaccine-mandate-school-mask-requirement-on-monday?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8576470613479614
2596,3/6/2022 12:16:50 PM,Johnson & Johnson is in talks for biotech deals in China - FT,Seeking Alpha,https://seekingalpha.com/news/3809928-johnson-johnson-is-in-talks-for-biotech-deals-in-china-ft?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6490351557731628
2597,3/7/2022 4:39:22 PM,U.S. supplies of COVID-19 therapies and vaccines at risk amid funding dispute,Seeking Alpha,https://seekingalpha.com/news/3810273-dispute-with-gop-senators-could-jeopardize-additional-finding-for-covid-19-treatments?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9586585164070129
2598,3/8/2022 4:26:46 PM,Johnson & Johnson inks deal with Aspen as COVID-19 vaccine makers focus on Africa,Seeking Alpha,https://seekingalpha.com/news/3810690-johnson-johnson-inks-deal-with-aspen-for-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8572038412094116
2599,3/8/2022 8:58:16 PM,Mediators appointed in J&J bankruptcy talc case to determine amount of trust fund,Seeking Alpha,https://seekingalpha.com/news/3810788-mediators-appointed-in-johnson-johnson-bankruptcy-talc-case-to-determine-amount-of-trust-fund?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9426356554031372
2600,3/9/2022 1:52:45 PM,"The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-begins-late-stage-pediatric-covid-pill-study-midatech-and-j-j-unit-expand-r-d-collaboration-abbvie-alvotech-settle-humira-dispute-1031266063,negative,0.6761938333511353
2601,3/9/2022 3:37:30 PM,DoJ bankruptcy arm raises concerns with potential Purdue opioid settlement,Seeking Alpha,https://seekingalpha.com/news/3811173-doj-bankruptcy-arm-raises-concerns-with-potential-purdue-opioid-settlement?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9635820388793945
2602,3/10/2022 12:35:12 PM,7 Drug Stocks to Consider After the Viatris Plunge,InvestorPlace,/news/stocks/7-drug-stocks-to-consider-after-the-viatris-plunge-abbv-bmy-gsk-vtrs-jnj-teva-pfe-nvs-mrk-1031269941,positive,0.926745593547821
2603,3/10/2022 5:10:40 PM,J&J extends R&D collaboration with Midatech Pharma on second molecule,Seeking Alpha,https://seekingalpha.com/news/3812267-johnson-johnson-extends-research-development-collaboration-with-midatech-pharma-on-second-molecule?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9028666615486145
2604,3/10/2022 7:41:24 PM,Is Roblox Stock a Game Bulls Want to Play?,InvestorPlace,/news/stocks/is-roblox-stock-a-game-bulls-want-to-play-1031271555,positive,0.9188315868377686
2605,3/11/2022 3:25:40 PM,More than 98% of U.S. in areas with low or medium COVID community spread,Seeking Alpha,https://seekingalpha.com/news/3812745-more-than-98-of-us-in-areas-with-low-or-medium-covid-community-spread?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8515697121620178
2606,3/12/2022 7:20:14 PM,Drugmakers face clinical trial disruptions amid Russia - Ukraine conflict,Seeking Alpha,https://seekingalpha.com/news/3812903-drugmakers-face-clinical-trial-disruptions-amid-russia-ukraine-conflict?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9664651155471802
2607,3/14/2022 2:50:43 PM,"Vaccine makers on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-vaccine-makers-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.6676833033561707
2608,3/14/2022 3:10:39 PM,"Moderna, BioNTech on the rise amid concerns over new variant, China outbreak",Seeking Alpha,https://seekingalpha.com/news/3813149-moderna-biontech-on-the-rise-amid-concerns-over-new-variant-china-outbreak?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8546392321586609
2609,3/14/2022 3:49:29 PM,"J&J, drug distributors draw lawmaker scrutiny over tax benefits linked to opioid deals",Seeking Alpha,https://seekingalpha.com/news/3813166-jj-drug-distributors-draw-lawmaker-scrutiny-on-tax-benefits-for-opioid-deals?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9206870198249817
2610,3/15/2022 1:20:00 PM,Johnson & Johnson to Host Investor Conference Call on First-Quarter Results,PR Newswire,/news/stocks/johnson-johnson-to-host-investor-conference-call-on-first-quarter-results-1031281088,positive,0.9213520288467407
2611,3/16/2022 2:29:24 PM,JNJ's DePuy Synthes adds 2 products to ATTUNE knee restoration portfolio,Seeking Alpha,https://seekingalpha.com/news/3814128-jnjs-unit-depuy-synthes-adds-new-technologies-to-attune-knee-restoration-portfolio?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.573309063911438
2612,3/16/2022 4:05:40 PM,J&J downgraded to market perform at Bernstein on 'uphill battle' for Janssen,Seeking Alpha,https://seekingalpha.com/news/3814195-johnson-johnson-downgraded-to-market-perform-at-bernstein-on-uphill-battle-for-janssen?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9538598656654358
2613,3/16/2022 4:07:50 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-16-2022-1031285835,neutral,0.5048595070838928
2614,3/16/2022 4:08:51 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031285834,positive,0.7854138612747192
2615,3/16/2022 4:15:15 PM,Wednesday Top Stock News: 8 Analyst Upgrades and Downgrades Today,InvestorPlace,/news/stocks/wednesday-top-stock-news-8-analyst-upgrades-and-downgrades-today-1031286037,neutral,0.9303328990936279
2616,3/16/2022 4:47:17 PM,Protagonist Therapeutics Earns $25M Milestone Payment From Janssen Biotech,Benzinga,/news/stocks/protagonist-therapeutics-earns-25m-milestone-payment-from-janssen-biotech-1031285958,negative,0.804243266582489
2617,3/16/2022 5:30:02 PM,Genmab upgraded at UBS; says ‚Äúmost of the pipeline is for free‚Äù,Seeking Alpha,https://seekingalpha.com/news/3814233-genmab-upgraded-at-ubs-says-most-of-the-pipeline-is-for-free?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7088842988014221
2618,3/16/2022 6:03:19 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031286197,positive,0.9169121980667114
2619,3/17/2022 5:58:59 PM,AstraZeneca ready to drop plans for U.S. regulatory approval of COVID-19 shot - FT,Seeking Alpha,https://seekingalpha.com/news/3814697-astrazeneca-to-drop-plans-for-us-regulatory-approval-of-covid-19-shot?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.920452892780304
2620,3/18/2022 11:59:11 AM,7 Stagflation Stocks to Buy to Combat Slow Growth and Inflation,InvestorPlace,/news/stocks/7-stagflation-stocks-to-buy-to-combat-slow-growth-and-inflation-1031291619,positive,0.850549578666687
2621,3/21/2022 1:40:24 PM,FDA to hold AdCom meeting on COVID-19 booster shots next month,Seeking Alpha,https://seekingalpha.com/news/3815361-pfx-bntx-mrna-stocks-gain-on-adcom-meeting-on-covid-19-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9316228628158569
2622,3/22/2022 4:53:13 PM,COVID Omicron subvariant BA.2 accounts for growing share of new cases in the U.S.,Seeking Alpha,https://seekingalpha.com/news/3816112-covid-omicron-subvariant-ba2-accounts-for-growing-share-of-new-cases-in-the-us-cdc?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6759209632873535
2623,3/22/2022 11:06:45 PM,7 Reddit Stocks Likely to Withstand Any Recession in 2022,InvestorPlace,/news/stocks/7-reddit-stocks-likely-to-withstand-any-recession-in-2022-1031299733,negative,0.6739481091499329
2624,3/23/2022 8:25:14 AM,U.S. weighs fourth booster as BA.2 subvariant threatens next COVID wave,Seeking Alpha,https://seekingalpha.com/news/3816282-us-weighs-fourth-booster-as-ba2-subvariant-threatens-next-covid-wave?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.4939180314540863
2625,3/23/2022 12:43:16 PM,"The Daily Biotech Pulse: Pfizer Reports Positive Ulcerative Colitis Study Data, Novavax COVID Shot Authorized For Adolescents In India, Argenx Stock Sale",Benzinga,/news/stocks/the-daily-biotech-pulse-pfizer-reports-positive-ulcerative-colitis-study-data-novavax-covid-shot-authorized-for-adolescents-in-india-argenx-stock-sale-1031301077,positive,0.5290573239326477
2626,3/23/2022 5:36:32 PM,White House mulls fourth COVID-19 shot for older Americans - Politico,Seeking Alpha,https://seekingalpha.com/news/3816601-white-house-mulls-fourth-covid-19-shot-for-older-americans-politico?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9233741164207458
2627,3/25/2022 3:29:01 AM,ViiV Healthcare : FDA Approves Label Update For Long-acting HIV Treatment Cabenuva ,RTTNews,/news/stocks/viiv-healthcare-fda-approves-label-update-for-long-acting-hiv-treatment-cabenuva-1031306584,negative,0.9180295467376709
2628,3/25/2022 7:00:23 PM,"Catalyst watch: Tesla deliveries, XPeng earnings, Five Below event and Netflix at the Oscars",Seeking Alpha,https://seekingalpha.com/news/3817588-catalyst-watch-for-next-week-tesla-deliveries-xpeng-earnings-and-netflix-at-the-oscars?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9132758975028992
2629,3/29/2022 2:53:29 PM,J&J to suspend supply of personal care products in Russia,Seeking Alpha,https://seekingalpha.com/news/3818471-jj-to-suspend-supply-of-personal-care-products-in-russia?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8334856629371643
2630,3/29/2022 7:55:34 PM,Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated),Seeking Alpha,https://seekingalpha.com/news/3818472-pfizerbiontech-and-moderna-granted-fda-ok-for-second-booster-shot?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5794868469238281
2631,3/29/2022 8:11:57 PM,"Ukraine War Update: European ETFs rise, U.S. agriculture stocks fall amid peace talks",Seeking Alpha,https://seekingalpha.com/news/3818236-ukraine-war-update?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9617030620574951
2632,3/30/2022 10:23:32 AM,Novavax Stock Is a Bet on Interest From Unvaccinated People,InvestorPlace,/news/stocks/novavax-stock-is-a-bet-on-interest-from-unvaccinated-people-1031318249,positive,0.9361350536346436
2633,3/30/2022 1:46:42 PM,"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",Benzinga,/news/stocks/the-daily-biotech-pulse-roche-s-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on-positive-covid-antibody-data-amylyx-awaits-adcom-verdict-1031318540,neutral,0.5641264319419861
2634,3/30/2022 9:38:30 PM,"CVS Health, Teva Settle Florida State's Opioid-Related Claims: Report",Benzinga,/news/stocks/cvs-health-teva-settle-florida-state-s-opioid-related-claims-report-1031320117,positive,0.7778938412666321
2635,3/31/2022 1:53:04 PM,Cidara doses first group in phase 1 trial of CD388 for treating/preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3819296-cidara-therapeutics-doses-first-cohort-of-volunteers-in-phase-1-trial-of-antiviral-cd388?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.5139251947402954
2636,4/1/2022 10:37:35 AM,World's 1st COVID human challenge trial suggests spread of virus not correlated to symptoms,Seeking Alpha,https://seekingalpha.com/news/3819725-worlds-1st-covid-human-challenge-trial-suggests-spread-of-virus-not-correlated-to-symptoms?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8839459419250488
2637,4/1/2022 12:56:59 PM,Cidara gains on dosing milestone in early-stage trial for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3819826-cdtx-stock-gains-on-dosing-milestone-in-early-stage-trial-for-flu-candidate?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9503823518753052
2638,4/1/2022 8:02:24 PM,How to Approach Trading Downtrodden Novavax Today,InvestorPlace,/news/stocks/how-to-approach-trading-downtrodden-novavax-nvax-stock-today-1031327433,positive,0.9039692878723145
2639,4/1/2022 10:00:43 PM,3 Low-Risk Mutual Funds to Buy for Volatile Times,InvestorPlace,/news/stocks/3-low-risk-mutual-funds-to-buy-for-volatile-times-1031327542,positive,0.9073951840400696
2640,4/3/2022 4:19:55 PM,"10 Investor Questions About COVID-19, Answered",Benzinga,/news/stocks/10-investor-questions-about-covid-19-answered-1031328140,positive,0.9415953755378723
2641,4/4/2022 11:01:54 AM,DYAI: 2021 Results,Benzinga,/news/stocks/dyai-2021-results-1031329197,positive,0.839296281337738
2642,4/4/2022 12:23:32 PM,Johnson & Johnson's Rybrevant gets conditional approval in Canada for lung cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3820309-johnson-johnsons-rybrevant-gets-conditional-approval-in-canada-for-lung-cancer-subtype?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9030225276947021
2643,4/4/2022 9:00:38 PM,Lawmakers agree on $10 billion additional funding for U.S. COVID response (Updated),Seeking Alpha,https://seekingalpha.com/news/3820489-lawmakers-set-to-announce-10-billion-additional-funding-for-us-covid-response?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6900182366371155
2644,4/4/2022 9:09:14 PM,"West Virginia Says J&J, Teva, AbbVie Caused 'Tsunami' Of Opioid Addiction: Reuters",Benzinga,/news/stocks/west-virginia-says-j-j-teva-abbvie-caused-tsunami-of-opioid-addiction-reuters-1031331125,positive,0.6891766786575317
2645,4/4/2022 9:17:18 PM,Moderna CEO predicts many people will eventually get annual COVID shots,Seeking Alpha,https://seekingalpha.com/news/3820563-moderna-ceo-predicts-many-people-will-eventually-get-annual-covid-booster-shots?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.801128089427948
2646,4/5/2022 3:32:39 PM,3 Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/3-vanguard-etfs-to-buy-now-1031333971,positive,0.9078019857406616
2647,4/5/2022 9:37:56 PM,MindMed Appoints Francois Lilienthal As New CCO,Benzinga,/news/stocks/mindmed-appoints-francois-lilienthal-as-new-cco-1031334555,positive,0.931117832660675
2648,4/6/2022 4:44:05 PM,Is NVAX Stock a Buy at 52-Week Low? Skip the Novavax Portfolio Injection,InvestorPlace,/news/stocks/is-nvax-stock-a-buy-at-52-week-low-skip-the-novavax-portfolio-injection-1031337591,positive,0.5795310735702515
2649,4/6/2022 5:57:27 PM,Royalty Pharma upgraded at Morgan Stanley on valuation,Seeking Alpha,https://seekingalpha.com/news/3821323-rprx-stock-gains-on-morgan-stanley-upgrade?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9007900953292847
2650,4/7/2022 1:37:39 PM,Dear Biotech Investors: Novavax‚Äôs Comparable Vaccine Matters,InvestorPlace,/news/stocks/nvax-stock-dear-biotech-investors-novavaxs-comparable-vaccine-matters-1031340330,positive,0.6512704491615295
2651,4/7/2022 10:30:00 PM,Johnson & Johnson to Participate in the BofA Securities 2022 Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bofa-securities-2022-healthcare-conference-1031341306,positive,0.8624882102012634
2652,4/8/2022 1:52:26 PM,"The Daily Biotech Pulse: Evotec Earns $16M Milestone Payment, Genmab Hit With Adverse Tribunal Ruling, Quidel Announces Above-Consensus Q1 Revenues And More",Benzinga,/news/stocks/the-daily-biotech-pulse-evotec-earns-16m-milestone-payment-genmab-hit-with-adverse-tribunal-ruling-quidel-announces-above-consensus-q1-revenues-and-more-1031342792,negative,0.768592119216919
2653,4/10/2022 1:39:55 PM,Demand for COVID-19 shots falls amid reluctance to boosters,Seeking Alpha,https://seekingalpha.com/news/3822183-demand-for-covid-19-shots-drop-amid-reluctance-to-boosters?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9703908562660217
2654,4/11/2022 11:48:55 AM,Goldman screens companies with best and worst pricing power into earnings season,Seeking Alpha,https://seekingalpha.com/news/3822185-godlman-screens-companies-with-best-and-worst-pricing-power-into-earnings-season?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9079514741897583
2655,4/11/2022 2:25:59 PM,Beigene's Brukinsa bests Imbruvica in overall response in leukemia trial,Seeking Alpha,https://seekingalpha.com/news/3822346-beigene-brukinsa-bests-imbruvica-in-overall-response-in-leukemia-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9112858772277832
2656,4/13/2022 9:59:35 PM,J&J Ordered To Pay $302 Mln Penalty For Wrong Pelvic Mesh Implant Ads ,RTTNews,/news/stocks/j-j-ordered-to-pay-302-mln-penalty-for-wrong-pelvic-mesh-implant-ads-1031354675,neutral,0.960316002368927
2657,4/14/2022 3:13:06 PM,What 6 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-6-analyst-ratings-have-to-say-about-johnson-johnson-1031356974,positive,0.9408949017524719
2658,4/14/2022 9:18:41 PM,7 Earnings Reports to Watch the Week of April 18,InvestorPlace,/news/stocks/7-earnings-reports-to-watch-the-week-of-april-18-1031358951,positive,0.9081539511680603
2659,4/14/2022 9:27:57 PM,Raymond James Thinks Med Tech Investors are Somewhat 'Paralyzed' Ahead Of Q1 Earnings,Benzinga,/news/stocks/raymond-james-thinks-med-tech-investors-are-somewhat-paralyzed-ahead-of-q1-earnings-1031357902,neutral,0.9467341303825378
2660,4/17/2022 4:00:26 PM,Pfizer draws skeptics amid concerns over outlook for COVID-related sales,Seeking Alpha,https://seekingalpha.com/news/3823672-pfe-stock-in-focus-amid-concerns-over-outlook-for-covid-related-sales?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9677929878234863
2661,4/17/2022 8:31:32 PM,"The Week Ahead In Biotech (April 17-April 23): J&J, Abbott Earnings, Adcom Test For TG Therapeutics And More",Benzinga,/news/stocks/the-week-ahead-in-biotech-april-17-april-23-j-j-abbott-earnings-adcom-test-for-tg-therapeutics-and-more-1031359853,positive,0.9330936670303345
2662,4/18/2022 12:54:24 AM,Johnson & Johnson COVID-19 shot holds its ground amid breakthrough cases,Seeking Alpha,https://seekingalpha.com/news/3823676-johnson-johnson-covid-19-shot-holds-its-ground-amid-breakthrough-cases?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6651394963264465
2663,4/18/2022 11:59:23 AM,Eli Lilly expects $165 million in charges related to in-process R&D projects,Seeking Alpha,https://seekingalpha.com/news/3823792-eli-lilly-to-recognize-165-million-in-charges-related-to-in-process-rd-projects?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9416850805282593
2664,4/18/2022 1:42:17 PM,Johnson & Johnson to pay $99M to resolve opioid suits with West Virginia,Seeking Alpha,https://seekingalpha.com/news/3823864-johnson-johnson-to-pay-99m-to-resolve-opioid-suits-with-west-virginia?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8576881885528564
2665,4/18/2022 2:45:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3823892-notable-earnings-before-tuesdays-open?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8660826683044434
2666,4/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1031361015,positive,0.9338979721069336
2667,4/18/2022 4:54:52 PM,J&J to report Q1 result amid lingering pandemic headwinds,Seeking Alpha,https://seekingalpha.com/news/3823909-jj-to-report-q1-result-amid-lingering-pandemic-headwinds?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.883331298828125
2668,4/18/2022 8:27:58 PM,Amgen's biosimilar candidate to Stelara shows no clinically meaningful differences in study,Seeking Alpha,https://seekingalpha.com/news/3824066-amgens-biosimilar-candidate-to-stelara-shows-no-clinically-meaningful-differences-in-study?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6455556154251099
2669,4/19/2022 10:02:33 AM,"5 Stocks To Watch For April 19, 2022",Benzinga,/news/stocks/5-stocks-to-watch-for-april-19-2022-1031363148,positive,0.9184239506721497
2670,4/19/2022 10:26:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.67 beats by $0.10, revenue of $23.4B misses by $210M",Seeking Alpha,https://seekingalpha.com/news/3824178-johnson-amp-johnson-non-gaap-eps-of-267-beats-by-010-revenue-of-234b-misses-by-210m-reaffirms-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6653634309768677
2671,4/19/2022 10:26:18 AM,Johnson & Johnson raises dividend by 6.6% to $1.13,Seeking Alpha,https://seekingalpha.com/news/3824174-johnson-and-johnson-declares-1_13-dividend?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9212923049926758
2672,4/19/2022 11:13:13 AM,A Peek Into The Markets: US Stock Futures Mixed Ahead Of Earnings,Benzinga,/news/stocks/a-peek-into-the-markets-us-stock-futures-mixed-ahead-of-earnings-1031363262,neutral,0.8922845721244812
2673,4/19/2022 11:17:54 AM,Moderna says its first bivalent booster vaccine outperformed current COVID-19 booster,Seeking Alpha,https://seekingalpha.com/news/3824200-moderna-says-first-bivalent-booster-shot-trumped-current-covid-19-booster?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9529901146888733
2674,4/19/2022 11:27:48 AM,"J&J stock rises on Q1 earnings beat; lowers adjusted EPS outlook, suspends COVID vaccine guidance",Seeking Alpha,https://seekingalpha.com/news/3824205-jj-stock-dips-on-q1-revenue-miss-lowers-adjusted-eps-outlook-suspends-covid-vaccine-guidance?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9392329454421997
2675,4/19/2022 12:20:00 PM,Johnson & Johnson Announces Dividend Increase of 6.6%,PR Newswire,/news/stocks/johnson-johnson-announces-dividend-increase-of-6-6-1031363386,negative,0.9070659875869751
2676,4/19/2022 12:25:00 PM,Johnson & Johnson Reports Q1 2022 Results,PR Newswire,/news/stocks/johnson-johnson-reports-q1-2022-results-1031363397,positive,0.9008095860481262
2677,4/19/2022 12:30:45 PM,"Johnson & Johnson Q1 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q1-profit-decreases-but-beats-estimates-1031363436,neutral,0.9713039398193359
2678,4/19/2022 12:53:40 PM,Johnson & Johnson Suspends Guidance On Its COVID-19 Vaccine Sales ,RTTNews,/news/stocks/johnson-johnson-suspends-guidance-on-its-covid-19-vaccine-sales-1031363479,neutral,0.9130454659461975
2679,4/19/2022 1:55:40 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, April 19",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-april-19-1031363748,positive,0.9060149192810059
2680,4/19/2022 2:29:32 PM,Why Is Johnson & Johnson (JNJ) Stock in Focus Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-in-focus-today-1031364592,positive,0.719818115234375
2681,4/19/2022 2:57:17 PM,Why Is ToughBuilt Industries (TBLT) Stock Up 65% Today?,InvestorPlace,/news/stocks/why-is-toughbuilt-industries-tblt-stock-up-65-today-1031364637,negative,0.8866286277770996
2682,4/19/2022 3:05:03 PM,"The Daily Biotech Pulse: Regeneron Acquires Checkmate Pharma, Moderna's Bivalent Booster COVID-19 Vaccine Update, Priority Review For AstraZeneca's Enhertu",Benzinga,/news/stocks/the-daily-biotech-pulse-regeneron-acquires-checkmate-pharma-moderna-s-bivalent-booster-covid-19-vaccine-update-priority-review-for-astrazeneca-s-enhertu-1031364260,positive,0.606448233127594
2683,4/19/2022 3:19:35 PM,AbbVie falls as partner Johnson & Johnson cites pressure on Imbruvica sales,Seeking Alpha,https://seekingalpha.com/news/3824338-abbv-stock-falls-as-johnson--johnson-as-imbruvica-sales-drop?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9588532447814941
2684,4/19/2022 3:32:59 PM,"Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More",Benzinga,/news/stocks/benzinga-s-daily-brief-on-trending-tickers-for-april-19-2022-plug-power-twitter-cassava-sciences-and-more-1031364340,positive,0.9473868012428284
2685,4/19/2022 4:59:32 PM,Mid-Morning Market Update: Markets Open Higher; Dow Jumps 400 Points,Benzinga,/news/stocks/mid-morning-market-update-markets-open-higher-dow-jumps-400-points-1031364642,negative,0.9157249331474304
2686,4/19/2022 5:21:14 PM,Johnson & Johnson‚Äôs MedTech performance rallies industry,Seeking Alpha,https://seekingalpha.com/news/3824408-johnson-johnsons-medtech-performance-rallies-industry?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8827800154685974
2687,4/19/2022 6:37:08 PM,Mid-Day Market Update: Crude Oil Down Over 5%; Checkmate Pharmaceuticals Shares Spike Higher,Benzinga,/news/stocks/mid-day-market-update-crud-oil-down-over-5-checkmate-pharmaceuticals-shares-spike-higher-1031364910,neutral,0.7409908771514893
2688,4/19/2022 8:41:10 PM,Mid-Afternoon Market Update: Nasdaq Surges 200 Points; Dentsply Sirona Shares Plunge,Benzinga,/news/stocks/mid-afternoon-market-update-nasdaq-surges-200-points-dentsply-sirona-shares-plunge-1031365143,negative,0.8773622512817383
2689,4/20/2022 9:03:27 AM,"Alabama reaches $276M settlement with J&J, McKesson, Endo over opioid claims - Waff",Seeking Alpha,https://seekingalpha.com/news/3824600-alabama-reaches-276m-settlement-with-jj-mckesson-endo-over-opioid-claims-waff?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.47748932242393494
2690,4/20/2022 5:03:06 PM,Bank of America is cautious on life sciences companies ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/3824851-bank-of-america-is-cautious-on-life-sciences-companies-ahead-of-earnings?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6708775162696838
2691,4/20/2022 6:42:37 PM,Novavax has plunged amid falling demand for COVID vaccines. Is it time to buy?,Seeking Alpha,https://seekingalpha.com/news/3824544-novavax-has-plunged-amid-falling-demand-for-covid-vaccines-is-it-time-to-buy-pandemic?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8309870362281799
2692,4/20/2022 9:51:56 PM,"JNJ, McKesson, Endo Settle $275M Opioid Claims With Alabama: Reuters",Benzinga,/news/stocks/jnj-mckesson-endo-settle-275m-opioid-claims-with-alabama-reuters-1031369258,positive,0.9004384279251099
2693,4/20/2022 10:30:00 PM,Johnson & Johnson to Participate in the UBS Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-ubs-global-healthcare-conference-1031369405,positive,0.7695393562316895
2694,4/22/2022 4:58:09 PM,Intuitive Surgical sheds over 10% most in over two years despite earnings beat,Seeking Alpha,https://seekingalpha.com/news/3825875-isrg-stock-plunges-despite-earnings-beat?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9702205061912537
2695,4/25/2022 1:30:00 PM,"Johnson & Johnson Launches Next Satellite Center for Global Health Discovery at Holistic Drug Discovery and Development Centre, University of Cape Town, Focused on Antimicrobial Resistance (AMR)",PR Newswire,/news/stocks/johnson-johnson-launches-next-satellite-center-for-global-health-discovery-at-holistic-drug-discovery-and-development-centre-university-of-cape-town-focused-on-antimicrobial-resistance-amr-1031379719,positive,0.5379613637924194
2696,4/25/2022 10:11:22 PM,"San Francisco To Start Opioid Epidemic Trial Against Teva, Walgreen: Reuters",Benzinga,/news/stocks/san-francisco-to-start-opioid-epidemic-trial-against-teva-walgreen-reuters-1031381415,positive,0.8948363661766052
2697,4/26/2022 10:16:16 AM,3 Dividend Stocks for Value Investors Seeking Regular Income,InvestorPlace,/news/stocks/dividend-stocks-investors-seeking-income-1031384022,positive,0.9316470623016357
2698,4/26/2022 12:06:10 PM,Novavax price target lowered at B. Riley amid demand uncertainty for COVID-19 shots,Seeking Alpha,https://seekingalpha.com/news/3826692-nvax-stock-lower-as-b-riley-cuts-target-amid-uncertainty-for-covid-19-shots?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8622012138366699
2699,4/28/2022 10:15:22 AM,7 Long-Term Stocks to Buy for a Robust Retirement,InvestorPlace,/news/stocks/long-term-stocks-7-to-buy-for-a-robust-retirement-1031396460,negative,0.7817785143852234
2700,4/28/2022 2:13:40 PM,J&J seeks approval of Zytiga/Zejula combination for prostate cancer to EMA,Seeking Alpha,https://seekingalpha.com/news/3828664-johnson-johnson-janssen-seeks-approval-of-zytiga-zejula-combination-for-prostate-cancer-to-ema?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8659051060676575
2701,4/29/2022 9:05:06 PM,Emergent BioSolutions Suspends CDMO Guidance As It Awaits Clarity On COVID-19 Vaccine Requirements,Benzinga,/news/stocks/emergent-biosolutions-suspends-cdmo-guidance-as-it-awaits-clarity-on-covid-19-vaccine-requirements-1031403521,neutral,0.9262126684188843
2702,5/2/2022 9:34:31 AM,J&J stockholders reject proposal to discontinue global sales of baby powder,Seeking Alpha,https://seekingalpha.com/news/3829831-jj-stockholders-reject-proposal-to-discontinue-global-sales-of-baby-powder?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.7449496388435364
2703,5/2/2022 3:56:44 PM,First COVID-19 vaccine plant in Africa at risk of closure with no orders,Seeking Alpha,https://seekingalpha.com/news/3830207-aspen-covid-19-vaccine-plant-at-risk-of-closure-with-no-orders?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8862282037734985
2704,5/2/2022 7:55:14 PM,It Pays to Be Greedy,InvestorPlace,/news/stocks/it-pays-to-be-greedy-1031410830,positive,0.9091590642929077
2705,5/2/2022 10:30:00 PM,Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-the-bernstein-38th-annual-strategic-decisions-conference-1031410351,positive,0.8181660175323486
2706,5/3/2022 11:32:50 PM,3 Mighty Mutual Funds to Buy for Q2,InvestorPlace,/news/stocks/3-mighty-mutual-funds-to-buy-for-q2-1031415970,positive,0.9155591130256653
2707,5/5/2022 10:39:18 AM,What ETF Is Best? 7 Great Funds to Consider.,InvestorPlace,/news/stocks/what-etf-is-best-7-great-funds-to-consider-1031424937,positive,0.9087047576904297
2708,5/5/2022 11:33:44 AM,J&J files suit against drug-benefit provider over use of copay assistance program - WSJ,Seeking Alpha,https://seekingalpha.com/news/3833202-jj-files-suit-against-drug-benefit-provider-over-use-of-copay-assistance-program-wsj?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.9036819934844971
2709,5/5/2022 5:46:53 PM,COVID-19 Omicron variant is as severe as previous variants - study,Seeking Alpha,https://seekingalpha.com/news/3833571-covid-19-omicron-variant-is-as-severe-as-previous-variants-study?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.502330482006073
2710,5/5/2022 9:49:27 PM,FDA limits use of J&J COVID-19 vaccine due to risk of blood clot,Seeking Alpha,https://seekingalpha.com/news/3834009-fda-limits-use-of-jj-covid-19-vaccine-due-to-risk-of-blood-clot?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5108425617218018
2711,5/6/2022 5:24:20 AM,FDA Limits Use Of Johnson & Johnson COVID-19 Vaccine Due To Blood Clot Risk ,RTTNews,/news/stocks/fda-limits-use-of-johnson-johnson-covid-19-vaccine-due-to-blood-clot-risk-1031428218,neutral,0.6692816019058228
2712,5/6/2022 2:50:26 PM,"Cramer Gives His Opinion On CoreCivic, SGHC And More",Benzinga,/news/stocks/cramer-gives-his-opinion-on-corecivic-sghc-and-more-1031430970,positive,0.9499825239181519
2713,5/6/2022 2:54:29 PM,"The Daily Biotech Pulse: Limited Use Of JNJ's COVID-19 Shot, Myovant-Pfizer's Relugolix Application Delayed, Gain Therapeutics' Parkinson's Data",Benzinga,/news/stocks/the-daily-biotech-pulse-limited-use-of-jnj-s-covid-19-shot-myovant-pfizer-s-relugolix-application-delayed-gain-therapeutics-parkinson-s-data-1031431013,neutral,0.9153580069541931
2714,5/9/2022 11:10:25 AM,4 Blue-Chip Stocks to Buy for May 2022,InvestorPlace,/news/stocks/4-blue-chip-stocks-to-buy-for-may-2022-1031436095,positive,0.9117697477340698
2715,5/10/2022 4:20:07 PM,More Emergent BioSolutions produced COVID vaccines destroyed than previously reported,Seeking Alpha,https://seekingalpha.com/news/3836074-more-emergent-biosolutions-produced-covid-vaccines-destroyed-than-previously-reported?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4573359191417694
2716,5/11/2022 11:17:13 AM,Johnson & Johnson appoints CEO and CFO for consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3836685-johnson-johnson-appoints-ceo-and-cfo-for-new-consumer-spinoff?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8280380368232727
2717,5/11/2022 12:30:00 PM,Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company,PR Newswire,/news/stocks/johnson-johnson-appoints-thibaut-mongon-as-ceo-designate-of-planned-new-consumer-health-company-1031447377,positive,0.9239774346351624
2718,5/11/2022 12:53:04 PM,"Johnson & Johnson Names CEO, CFO Designates Of New Consumer Health Company ",RTTNews,/news/stocks/johnson-johnson-names-ceo-cfo-designates-of-new-consumer-health-company-1031447454,positive,0.9015927910804749
2719,5/11/2022 2:19:09 PM,Novanta raised to Outperform at William Blair on valuation,Seeking Alpha,https://seekingalpha.com/news/3836853-novt-stock-gains-after-first-bullish-view-on-wall-street?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.847324550151825
2720,5/11/2022 10:06:01 PM,Almost 400M COVID-19 Vaccine Doses Lost Due To Emergent's Baltimore Plant Fiasco,Benzinga,/news/stocks/almost-400m-covid-19-vaccine-doses-lost-due-to-emergent-s-baltimore-plant-fiasco-1031449913,neutral,0.9734441041946411
2721,5/12/2022 2:14:54 PM,Federal flags to fly at half-staff to mark one million COVID deaths,Seeking Alpha,https://seekingalpha.com/news/3837849-federal-flags-to-fly-at-half-staff-to-mark-one-million-covid-deaths?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.9106363654136658
2722,5/12/2022 9:36:40 PM,Read Why HC Wainwright Lowered Price Target On This Small Biotech Stock,Benzinga,/news/stocks/read-why-hc-wainwright-lowered-price-target-on-this-small-biotech-stock-1031455130,positive,0.7953478097915649
2723,5/12/2022 10:30:00 PM,Johnson & Johnson to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference,PR Newswire,/news/stocks/johnson-johnson-to-participate-in-goldman-sachs-43rd-annual-global-healthcare-conference-1031455370,positive,0.7441604137420654
2724,5/14/2022 10:00:15 AM,Johnson & Johnson Stock: A Rare Bright Spot in the Market,InvestorPlace,/news/stocks/jnj-stock-a-rare-bright-spot-in-the-market-1031459931,negative,0.8548750877380371
2725,5/16/2022 3:55:45 PM,"Dalio's Bridgewater invests in Berkshire Hathaway, exits Tesla in Q1",Seeking Alpha,https://seekingalpha.com/news/3839310-dalios-bridgewater-invests-in-berkshire-hathaway-exits-tesla-in-q1?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.8687265515327454
2726,5/16/2022 8:24:57 PM,Inflation May Have Peaked: What to Do Now,InvestorPlace,/news/stocks/inflation-may-have-peaked-what-to-do-now-1031466390,positive,0.5189400315284729
2727,5/16/2022 9:02:02 PM,"Investing Mistakes Were Made on Wall Street, and Now Opportunity Abounds",InvestorPlace,/news/stocks/investing-mistakes-were-made-on-wall-street-and-now-opportunity-abounds-1031466055,positive,0.5214925408363342
2728,5/17/2022 11:26:03 AM,"J&J, BARDA program gives a spot to Australian antiviral nasal spray developer ENA Respiratory",Seeking Alpha,https://seekingalpha.com/news/3839858-jj-barda-program-gives-a-spot-to-australian-antiviral-nasal-spray-developer-ena-respiratory?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.855239748954773
2729,5/17/2022 4:42:38 PM,New York City reaches ‚Äúhigh‚Äù COVID alert level; indoor masking urged,Seeking Alpha,https://seekingalpha.com/news/3840091-new-york-city-reaches-high-covid-alert-level-indoor-masking-urged?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6301854848861694
2730,5/17/2022 5:15:04 PM,8 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/8-analysts-have-this-to-say-about-johnson-johnson-1031469249,positive,0.9010958671569824
2731,5/18/2022 10:00:43 PM,5 Stocks to Buy for the Coming Recession,InvestorPlace,/news/stocks/5-stocks-to-buy-for-the-coming-recession-1031473821,positive,0.8992705345153809
2732,5/19/2022 12:43:36 AM,Sector Rotation And 9 Stocks To Watch During A Recession,Benzinga,/news/stocks/sector-rotation-and-9-stocks-to-watch-during-a-recession-1031473832,positive,0.9143867492675781
2733,5/19/2022 2:34:59 PM,J&J touts Tremfya in-vitro studies differentiating it from AbbVie's Skyrizi,Seeking Alpha,https://seekingalpha.com/news/3840978-johnson-johnson-janssen-touts-tremfya-in-vitro-studies-as-differentiating-it-from-abbvie-skyrizi?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.5675091743469238
2734,5/20/2022 1:32:01 PM,ImmixBio surges on mice data for lead candidate in connective tissue cancer,Seeking Alpha,https://seekingalpha.com/news/3841363-immx-stock-soars-on-mice-data-for-lead-candidate-in-connective-tissue-cancer?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.7588204145431519
2735,5/20/2022 3:02:43 PM,ImmixBio: IMX-110 Shows Improved Survival In Connective Tissue Cancer Soft Tissue Sarcoma Mice Study ,RTTNews,/news/stocks/immixbio-imx-110-shows-improved-survival-in-connective-tissue-cancer-soft-tissue-sarcoma-mice-study-1031478642,negative,0.9560171961784363
2736,5/20/2022 6:19:05 PM,Is Johnson & Johnson a buy amid rising COVID cases and a shift towards defensive stocks?,Seeking Alpha,https://seekingalpha.com/news/3841381-covid-cases-rise-healthcare-defends-against-downturns-so-is-johnson-johnson-a-buy?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.6821417212486267
2737,5/23/2022 6:31:20 PM,"Amid Monkeypox Outbreak, This 3X Leveraged ETF Provides Exposure To Health Sector: What To Watch",Benzinga,/news/etf/amid-monkeypox-outbreak-this-3x-leveraged-etf-provides-exposure-to-health-sector-what-to-watch-1031482614,positive,0.9194398522377014
2738,5/24/2022 1:29:05 PM,COVID-19 sales boom for vaccine and drug makers might be over - analysts,Seeking Alpha,https://seekingalpha.com/news/3842211-covid-19-sales-boom-for-vaccine-and-drug-makers-might-be-over?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.39463990926742554
2739,5/24/2022 1:36:13 PM,Alvotech's biosimilar candidate AVT04 shows therapeutic equivalence to J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/3842220-alvotechs-biosimilar-candidate-avt04-shows-therapeutic-equivalence-to-jjs-stelara?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.8792715072631836
2740,5/24/2022 8:22:39 PM,"4 Top Stock Trades for Wednesday: FB, JNJ, CCL, NCLH",InvestorPlace,/news/stocks/4-top-stock-trades-for-wednesday-fb-jnj-ccl-nclh-1031486514,positive,0.9281864762306213
2741,5/24/2022 9:56:54 PM,J&J's Janssen presents new data at Digestive Disease Week for Tremfya in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3842456-jjs-janssen-presents-new-data-at-digestive-disease-week-for-tremfya-in-crohns-disease?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.823786199092865
2742,5/25/2022 7:57:03 PM,"Long COVID risk drops only slightly after vaccination, large study shows",Seeking Alpha,https://seekingalpha.com/news/3842802-long-covid-risk-drops-only-slightly-after-vaccination-large-study-shows?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6331458687782288
2743,5/27/2022 3:31:11 PM,"Boston Scientific upgraded to buy at Needham on new products, potential M&A target",Seeking Alpha,https://seekingalpha.com/news/3843519-boston-scientific-upgraded-to-buy-at-needham-on-new-products-potential-ma-target?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.7786825895309448
2744,5/31/2022 2:49:12 PM,7 Safe Dividend Stocks With High Yields to Buy Now,InvestorPlace,/news/stocks/7-safe-dividend-stocks-with-high-yields-to-buy-now-1031498852,positive,0.810308039188385
2745,5/31/2022 6:12:38 PM,3 Stocks to Buy if You Think a Recession is Imminent,InvestorPlace,/news/stocks/3-stocks-to-buy-if-you-think-a-recession-is-imminent-1031499549,positive,0.7947937846183777
2746,6/1/2022 10:15:24 AM,3 Biotech Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/3-biotech-stocks-to-buy-before-they-boom-1031501085,positive,0.9286603927612305
2747,6/1/2022 1:18:29 PM,7 Stocks to Buy to Avoid Being Mauled by a Bear Market,InvestorPlace,/news/stocks/7-stocks-to-buy-to-avoid-being-mauled-by-a-bear-market-1031502160,positive,0.8878897428512573
2748,6/1/2022 1:51:49 PM,Johnson & Johnson's Tremfya demonstrates long-term benefit in psoriatric arthritis,Seeking Alpha,https://seekingalpha.com/news/3844409-johnson-johnson-janssen-tremfya-demonstrates-long-term-benefit-in-psoriatric-arthritis?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9507307410240173
2749,6/1/2022 1:52:13 PM,Pfizer To Quit GSK's Consumer Health JV Following Its Spin-Off,Benzinga,/news/stocks/pfizer-to-quit-gsk-s-consumer-health-jv-following-its-spin-off-1031501411,neutral,0.6700361967086792
2750,6/1/2022 4:13:50 PM,Legend Biotech clinical hold on CAR-T lymphoma candidate lifted by FDA,Seeking Alpha,https://seekingalpha.com/news/3844471-legend-biotech-clinical-hold-on-car-t-lymphoma-candidate-lifted-by-fda?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.6795549392700195
2751,6/2/2022 4:25:53 PM,Johnson & Johnson arthritis drug leads to clinical improvement in hospitalized COVID-19,Seeking Alpha,https://seekingalpha.com/news/3845099-johnson-johnson-arthritis-drug-leads-to-clinical-improvement-in-hospitalized-covid-19?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.950898289680481
2752,6/2/2022 9:00:50 PM,3 Value Stocks That Could 2x in a Recession,InvestorPlace,/news/stocks/3-value-stocks-that-could-2x-in-a-recession-1031506774,positive,0.921826183795929
2753,6/3/2022 3:19:26 PM,"J&J/AbbVie's Imbruvica 'significantly' cuts risk of disease progression in rare lymphoma, in trial",Seeking Alpha,https://seekingalpha.com/news/3845546-jjabbvies-imbruvica-significantly-cuts-risk-of-disease-progression-in-rare-lymphoma-in-trial?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9347521662712097
2754,6/6/2022 10:48:57 AM,Curis gains over 20% as majority of patients respond to blood cancer drug,Seeking Alpha,https://seekingalpha.com/news/3845814-cris-stock-gains-as-majority-of-patients-respond-to-blood-cancer-drug?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.9540715217590332
2755,6/6/2022 2:57:39 PM,Jim Cramer Prefers This Oil Stock Over Occidental Petroleum,Benzinga,/news/stocks/jim-cramer-prefers-this-oil-stock-over-occidental-petroleum-1031510963,positive,0.9195356965065002
2756,6/6/2022 3:27:21 PM,J&J's Carvykti demonstrates durable response in heavily pretreated multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/3845973-johnson-johnson-carvykti-demonstrates-durable-response-in-heavily-pretreated-multiple-myeloma?utm_source=markets.businessinsider.com&utm_medium=referral,negative,0.951839029788971
2757,6/6/2022 4:14:08 PM,"Benzinga's Premarket Brief On Trending Tickers: Amazon, Alibaba, DiDi, Solaredge, And More",Benzinga,/news/stocks/benzinga-s-premarket-brief-on-trending-tickers-amazon-alibaba-didi-solaredge-and-more-1031511219,positive,0.945688009262085
2758,6/6/2022 4:55:31 PM,"Johnson & Johnson breached vaccine contract, Emergent says",Seeking Alpha,https://seekingalpha.com/news/3846012-ebs-stock-slips-after-announcing-johnson--johnson-breached-vaccine-contract?utm_source=markets.businessinsider.com&utm_medium=referral,neutral,0.8976998925209045
2759,6/6/2022 5:20:10 PM,Emergent Bio Says Johnson & Johnson Breached COVID-19 Vaccine Contract,Benzinga,/news/stocks/emergent-bio-says-johnson-johnson-breached-covid-19-vaccine-contract-1031511342,neutral,0.940934956073761
2760,6/7/2022 1:35:11 PM,J&J Serves Notice To Emergent For Terminating COVID-19 Shot Contract As Two Accuse Each Other Of Breach Of Agreement,Benzinga,/news/stocks/j-j-serves-notice-to-emergent-for-terminating-covid-19-shot-contract-as-two-accuse-each-other-of-breach-of-agreement-1031513069,neutral,0.9564778208732605
2761,6/7/2022 2:07:41 PM,"Morning Brief: Top Financial Stories Dominating on Tuesday, June 7",Benzinga,/news/stocks/morning-brief-top-financial-stories-dominating-on-tuesday-june-7-1031513234,positive,0.9139136672019958
2762,6/7/2022 4:24:00 PM,Johnson & Johnson posts interim data for cancer drug to indicate 29% overall response,Seeking Alpha,https://seekingalpha.com/news/3846371-jnj-posts-interim-data-for-cancer-drug-to-indicate-29-overall-response?utm_source=markets.businessinsider.com&utm_medium=referral,positive,0.4109152853488922
2763,6/8/2022 10:29:23 AM,7 Dividend Stocks to Buy for a Rich Retirement,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-rich-retirement-mcd-wmt-cat-jnj-gpc-adp-ko-1031515667,positive,0.8789958357810974
2764,6/8/2022 2:00:00 PM,Johnson & Johnson Releases 2021 Health for Humanity Report Highlighting Performance on ESG Priorities and Progress Against Public Commitments,PR Newswire,/news/stocks/johnson-johnson-releases-2021-health-for-humanity-report-highlighting-performance-on-esg-priorities-and-progress-against-public-commitments-1031516039,negative,0.8726725578308105
2765,6/8/2022 3:06:22 PM,NVAX Stock Price Predictions: Where Will Novavax Go From Here?,InvestorPlace,/news/stocks/nvax-stock-price-predictions-where-will-novavax-go-from-here-1031516951,positive,0.9283915162086487
2766,6/9/2022 11:48:19 AM,Novavax slips amid concerns over delay for FDA decision on COVID-19 shot,Seeking Alpha,https://seekingalpha.com/news/3847111-nvax-stock-slips-amid-concerns-over-delay-for-fda-decision-on-covid-19-shot?utm_source=businessinsider&utm_medium=referral,neutral,0.9470019936561584
2767,6/9/2022 10:10:03 PM,Genmab seeks $405M award under new arbitration with J&J over cancer drug,Seeking Alpha,https://seekingalpha.com/news/3847542-genmab-seeks-405m-award-under-new-arbitration-with-jj-over-cancer-drug?utm_source=businessinsider&utm_medium=referral,negative,0.8692787885665894
2768,6/10/2022 2:57:48 PM,7 Great ETFs to Buy Now for Momentum in Q2,InvestorPlace,/news/stocks/7-great-etfs-to-buy-now-for-momentum-in-q2-1031522477,negative,0.6736835837364197
2769,6/13/2022 5:16:00 PM,EU public health agency warns of probable increase in COVID cases in coming weeks,Seeking Alpha,https://seekingalpha.com/news/3848128-eu-public-health-agency-warns-of-probable-increase-in-covid-cases-in-coming-weeks?utm_source=businessinsider&utm_medium=referral,neutral,0.9631182551383972
2770,6/14/2022 1:28:36 PM,Bristol Myers tops S&P 500 with largest intangible adjustment in 2021,Seeking Alpha,https://seekingalpha.com/news/3848429-bristol-myers-tops-sp-500-with-largest-intangible-adjustment-in-2021?utm_source=businessinsider&utm_medium=referral,negative,0.8711010217666626
2771,6/14/2022 1:57:38 PM,Wells Fargo unveils its recession stock portfolio,Seeking Alpha,https://seekingalpha.com/news/3848418-wells-fargo-unveils-its-recession-stock-portfolio?utm_source=businessinsider&utm_medium=referral,positive,0.9255277514457703
2772,6/14/2022 6:37:16 PM,"Newer, more contagious Omicron subvariants gaining traction in U.S.",Seeking Alpha,https://seekingalpha.com/news/3848543-newer-more-contagious-omicron-subvariants-gaining-traction-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.7365714907646179
2773,6/14/2022 6:47:03 PM,"Klobuchar, Porter want investigation into Bristol-Myers Squibb, Pfizer, Janssen price hikes",Seeking Alpha,https://seekingalpha.com/news/3848541-klobuchar-porter-want-investigation-bristol-myers-squibb-pfizer-janssen-price-hikes-stat?utm_source=businessinsider&utm_medium=referral,positive,0.9089166522026062
2774,6/15/2022 10:31:43 AM,3 Super-Safe Dividend Stocks to Buy,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-fdx-jnj-low-1031530085,positive,0.8627343773841858
2775,6/15/2022 6:58:44 PM,Dr. Fauci tests positive for COVID-19,Seeking Alpha,https://seekingalpha.com/news/3848965-dr-fauci-tests-positive-for-covid-19?utm_source=businessinsider&utm_medium=referral,positive,0.8345175385475159
2776,6/17/2022 7:00:44 PM,"Catalyst watch: FedEx earnings, Revlon drama and huge Polestar SPAC deal goes to a vote",Seeking Alpha,https://seekingalpha.com/news/3849682-catalyst-watch-fedex-earnings-revlon-drama-and-huge-polestar-spac-deal-goes-to-a-vote?utm_source=businessinsider&utm_medium=referral,positive,0.8127099871635437
2777,6/17/2022 8:24:28 PM,Legend Biotech Shares Move Higher After Bullish BMO Pitch,Benzinga,/news/stocks/legend-biotech-shares-move-higher-after-bullish-bmo-pitch-1031536189,negative,0.8915047645568848
2778,6/20/2022 10:00:07 AM,"7 Stocks to Buy If You Have $1,000 to Invest",InvestorPlace,/news/stocks/7-stocks-to-buy-if-you-have-1000-to-invest-1031537752,positive,0.9383695125579834
2779,6/21/2022 2:00:00 AM,Johnson & Johnson Opens First Satellite Center for Global Health Discovery in Asia Pacific at Duke-NUS to Advance Dengue Research,PR Newswire,/news/stocks/johnson-johnson-opens-first-satellite-center-for-global-health-discovery-in-asia-pacific-at-duke-nus-to-advance-dengue-research-1031538632,positive,0.5898452997207642
2780,6/21/2022 3:18:22 AM,J&J Opens Satellite Center For Global Health Discovery In Asia Pacific To Advance Dengue Research ,RTTNews,/news/stocks/j-j-opens-satellite-center-for-global-health-discovery-in-asia-pacific-to-advance-dengue-research-1031538650,positive,0.5332503318786621
2781,6/21/2022 2:45:52 PM,"A '70s style recession would push S&P 500 to 2,525 - SocGen",Seeking Alpha,https://seekingalpha.com/news/3850076-a-70s-style-recession-would-push-sp-500-to-2525-socgen?utm_source=businessinsider&utm_medium=referral,neutral,0.9232693910598755
2782,6/22/2022 11:12:49 AM,Bear Market 2022: Is There Anything Left to Invest In?,InvestorPlace,/news/stocks/bear-market-2022-is-there-anything-left-to-invest-in-1031542804,positive,0.9250609278678894
2783,6/22/2022 12:15:20 PM,Economic Hurricane Ahead? 7 Profitable Places to Hide Your Money,InvestorPlace,/news/stocks/economic-hurricane-ahead-7-profitable-places-to-hide-your-money-1031543188,positive,0.8941921591758728
2784,6/23/2022 10:46:58 AM,7 Retirement Stocks to Buy After Age 30,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-after-age-30-v-deo-ecl-amt-nke-mmm-jnj-1031545576,positive,0.9380730986595154
2785,6/23/2022 9:03:48 PM,Why Did HC Wainwright Downgrade Addex Therapeutics,Benzinga,/news/stocks/why-did-hc-wainwright-downgrade-addex-therapeutics-1031547234,positive,0.8334771990776062
2786,6/24/2022 10:46:13 AM,7 Large-Cap Stocks to Buy After the Next Big Correction,InvestorPlace,/news/stocks/7-large-cap-stocks-to-buy-after-the-next-big-correction-ko-tsla-intc-jnj-cvx-cost-cd-1031548398,positive,0.8699838519096375
2787,6/24/2022 2:01:11 PM,EMA panel recommends extending indication for J&J's blood cancer medicine Imbruvica,Seeking Alpha,https://seekingalpha.com/news/3851592-ema-panel-recommends-extending-indication-for-jjs-blood-cancer-medicine-imbruvica?utm_source=businessinsider&utm_medium=referral,positive,0.7502481937408447
2788,6/28/2022 9:08:38 AM,"AmerisourceBergen, McKesson, Cardinal to pay Oklahoma $250M to resolve opioid claims",Seeking Alpha,https://seekingalpha.com/news/3852297-amerisourcebergen-mckesson-cardinal-to-pay-oklahoma-250m-to-resolve-opioid-claims?utm_source=businessinsider&utm_medium=referral,negative,0.6288767457008362
2789,6/28/2022 1:42:09 PM,"Enovis initiated at Argus with a hold citing EPS growth, competition",Seeking Alpha,https://seekingalpha.com/news/3852453-enovis-initiated-at-argus-with-a-hold-citing-eps-growth-competition?utm_source=businessinsider&utm_medium=referral,positive,0.755671501159668
2790,6/28/2022 8:28:42 PM,MeiraGTx Posts Encouraging Gene Therapy Data From Eye Disorder Trial,Benzinga,/news/stocks/meiragtx-posts-encouraging-gene-therapy-data-from-eye-disorder-trial-1031555651,negative,0.9504925608634949
2791,6/29/2022 10:30:13 AM,Novavax Stock Is in Prime Position For Speculation,InvestorPlace,/news/stocks/nvax-stock-is-in-prime-position-for-speculation-1031557041,positive,0.7913817763328552
2792,6/29/2022 1:55:26 PM,J&J multiple myeloma candidate for talquetamab granted Breakthrough Therapy Designation,Seeking Alpha,https://seekingalpha.com/news/3852832-johnson-johnson-janssen-multiple-myeloma-candidate-for-talquetamab-granted-breakthrough-therapy-designation?utm_source=businessinsider&utm_medium=referral,negative,0.7745895981788635
2793,6/30/2022 2:41:30 PM,FDA requests manufacturers to update vaccines for latest Omicron subvariants,Seeking Alpha,https://seekingalpha.com/news/3853297-fda-requests-manufacturers-to-update-vaccines-for-latest-omicron-subvariants?utm_source=businessinsider&utm_medium=referral,positive,0.8827484846115112
2794,7/1/2022 4:34:01 PM,What Companies Will Pay for Abortion Travel?,InvestorPlace,/news/stocks/what-companies-will-pay-for-abortion-travel-1031563754,positive,0.9037445783615112
2795,7/1/2022 10:45:50 PM,"Only 8 Of The 30 Dow Jones Stocks Were Positive In The First Half Of 2022: Chevron Leads, But Who Else Was Up?",Benzinga,/news/etf/only-8-of-the-30-dow-jones-stocks-were-positive-in-the-first-half-of-2022-chevron-leads-but-who-else-was-up-1031564229,positive,0.8625626564025879
2796,7/2/2022 6:00:00 PM,"As amyloid-targeting therapies for Alzheimer's fail, where might success lie?",Seeking Alpha,https://seekingalpha.com/news/3853361-as-amyloid-targeting-therapies-for-alzheimers-fail-where-might-success-lie?utm_source=businessinsider&utm_medium=referral,positive,0.8673624992370605
2797,7/5/2022 9:47:06 AM,US judge rules in favor of drug distributors in West Virginia county opioid suit - AP,Seeking Alpha,https://seekingalpha.com/news/3854023-us-judge-rules-in-favor-of-drug-distributors-in-west-virginia-county-opioid-suit-ap?utm_source=businessinsider&utm_medium=referral,positive,0.5534666776657104
2798,7/5/2022 3:25:45 PM,Geron extends winning streak to reach 52-week high,Seeking Alpha,https://seekingalpha.com/news/3854229-gern-stock-extends-wining-streak-to-reach-52-week-high?utm_source=businessinsider&utm_medium=referral,negative,0.8881868720054626
2799,7/8/2022 2:42:25 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1031575494,positive,0.7854138612747192
2800,7/8/2022 2:58:24 PM,EMA looking into neurodevelopmental risks associated with J&J's seizure med Topamax,Seeking Alpha,https://seekingalpha.com/news/3855388-ema-looking-into-neurodevelopmental-risks-associated-with-johnson-jonhson-seizure-med-topamax?utm_source=businessinsider&utm_medium=referral,positive,0.8624536395072937
2801,7/11/2022 10:25:17 AM,EU recommends second COVID boosters for ages 60-79,Seeking Alpha,https://seekingalpha.com/news/3855582-eu-recommends-second-covid-boosters-for-ages-60-79?utm_source=businessinsider&utm_medium=referral,positive,0.8949840664863586
2802,7/14/2022 2:40:41 PM,What Is Going on With Novavax (NVAX) Stock Today?,InvestorPlace,/news/stocks/what-is-going-on-with-novavax-nvax-stock-today-2-1031588212,neutral,0.6391204595565796
2803,7/14/2022 11:40:15 PM,7 Best S&P 500 Stocks to Buy in July,InvestorPlace,/news/stocks/best-sp-500-stocks-1031588965,positive,0.8335537314414978
2804,7/15/2022 12:15:59 PM,7 Best Long-Term Dividend Stocks to Buy Right Now,InvestorPlace,/news/stocks/best-long-term-dividend-stocks-1031590160,positive,0.9222899675369263
2805,7/18/2022 10:57:31 AM,Top sticky stocks most immune to big earnings misses and beats,Seeking Alpha,https://seekingalpha.com/news/3857382-top-sticky-stocks-most-immune-to-big-earnings-misses-and-beats?utm_source=businessinsider&utm_medium=referral,neutral,0.6961941719055176
2806,7/18/2022 2:31:54 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3857597-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
2807,7/18/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q2-earnings-preview-1031594009,positive,0.9335330724716187
2808,7/18/2022 4:34:51 PM,J&J to report Q2 results amid several macro factors that threaten to diminish near-term growth,Seeking Alpha,https://seekingalpha.com/news/3857655-jj-to-report-q2-result-amid-several-macro-factors-that-threaten-to-diminish-near-term-growth?utm_source=businessinsider&utm_medium=referral,neutral,0.8223974108695984
2809,7/18/2022 6:58:43 PM,Top pharma lobby says R&D spending reached a peak in 2021,Seeking Alpha,https://seekingalpha.com/news/3857699-top-pharma-lobby-says-rd-spending-reached-a-peak-in-2021?utm_source=businessinsider&utm_medium=referral,negative,0.9346281290054321
2810,7/19/2022 9:36:04 AM,"Netflix, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/netflix-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031596292,positive,0.9321652054786682
2811,7/19/2022 10:26:44 AM,"Johnson & Johnson beats on earnings, maintains FY22 Adj. op. EPS and op. sales, cuts FY22 revenue and Adj. EPS guidance",Seeking Alpha,https://seekingalpha.com/news/3857915-johnson-amp-johnson-non-gaap-eps-of-259-beats-by-004-revenue-of-24b-beats-by-180m-cuts-fy22-guidance?utm_source=businessinsider&utm_medium=referral,neutral,0.9676589965820312
2812,7/19/2022 11:00:27 AM,Johnson & Johnson cuts 2022 guidance as MedTech underperforms in 2Q,Seeking Alpha,https://seekingalpha.com/news/3857931-jnj-stock-slips-as-company-cuts-2022-guidance?utm_source=businessinsider&utm_medium=referral,neutral,0.9692668318748474
2813,7/19/2022 11:05:42 AM,Genmab reports Q2 worldwide net sales of DARZALEX $1.99B,Seeking Alpha,https://seekingalpha.com/news/3857936-genmab-reports-q2-worldwide-net-sales-of-darzalex-199b?utm_source=businessinsider&utm_medium=referral,positive,0.8929373621940613
2814,7/19/2022 12:06:34 PM,"US Stock Futures Higher Ahead of J&J, Netflix Earnings",Benzinga,/news/stocks/us-stock-futures-higher-ahead-of-j-j-netflix-earnings-1031596560,negative,0.6534053087234497
2815,7/19/2022 12:35:43 PM,"Johnson & Johnson Q2 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1031596637,neutral,0.9721673130989075
2816,7/19/2022 3:12:33 PM,"The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings",Benzinga,/news/stocks/the-daily-biotech-pulse-fda-tentatively-approves-avadel-s-narcolepsy-drug-european-approval-broadens-astrazeneca-s-enhertu-in-breast-cancer-pharma-giants-earnings-1031597418,negative,0.8786939382553101
2817,7/19/2022 6:18:59 PM,Dow Surges 500 Points; Johnson & Johnson Lowers Guidance,Benzinga,/news/stocks/dow-surges-500-points-johnson-johnson-lowers-guidance-1031598024,neutral,0.4752238094806671
2818,7/19/2022 7:06:34 PM,2 Big Reasons Novavax (NVAX) Stock Is Shooting Higher Today,InvestorPlace,/news/stocks/2-big-reasons-novavax-nvax-stock-is-shooting-higher-today-1031598337,negative,0.9454615712165833
2819,7/19/2022 8:19:52 PM,Johnson & Johnson executive chairman elected to JPMorgan Chase board,Seeking Alpha,https://seekingalpha.com/news/3858273-johnson-johnson-executive-chairman-elected-to-jpmorgan-chase-board?utm_source=businessinsider&utm_medium=referral,positive,0.8991518020629883
2820,7/19/2022 8:30:26 PM,Nasdaq Rises More Than 300 Points; Crude Oil Moves Higher,Benzinga,/news/stocks/nasdaq-rises-more-than-300-points-crude-oil-moves-higher-1031598272,negative,0.8984712362289429
2821,7/20/2022 10:30:37 AM,7 Best Stocks for College Graduates,InvestorPlace,/news/stocks/best-stocks-for-college-graduates-1031600455,positive,0.8849567770957947
2822,7/20/2022 1:41:28 PM,The Valens Company Nominates Independent Director To Board Of Directors,Benzinga,/news/stocks/the-valens-company-nominates-independent-director-to-board-of-directors-1031600634,positive,0.9482685923576355
2823,7/20/2022 1:46:13 PM,JP Morgan Calls For Coca-Cola to $70: Here Are 4 Other Price Target Changes for Wednesday,Benzinga,/news/stocks/jp-morgan-calls-for-coca-cola-to-70-here-are-4-other-price-target-changes-for-wednesday-1031600653,positive,0.9247291088104248
2824,7/20/2022 4:18:23 PM,Arcellx named new buy at Canaccord Genuity on multiple myeloma candidate,Seeking Alpha,https://seekingalpha.com/news/3858614-arcellx-named-new-buy-at-canaccord-genuity-on-multiple-myeloma-candidate?utm_source=businessinsider&utm_medium=referral,positive,0.7260497212409973
2825,7/20/2022 6:02:48 PM,4 Analysts Takeaways From Johnson & Johnson's Quarterly Results: What Investors Need To Know,Benzinga,/news/stocks/4-analysts-takeaways-from-johnson-johnson-s-quarterly-results-what-investors-need-to-know-1031601822,positive,0.9131668210029602
2826,7/22/2022 12:26:47 PM,J&J gets EMA panel nod for conditional approval of Tecvayli for blood cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3859583-jj-gets-ema-panel-nod-for-conditional-approval-of-tecvayli-for-blood-cancer-subtype?utm_source=businessinsider&utm_medium=referral,negative,0.8599416613578796
2827,7/22/2022 1:49:29 PM,7 Seriously Undervalued Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/undervalued-retirement-stocks-1031607886,negative,0.45634281635284424
2828,7/23/2022 8:15:00 PM,"Drug pricing legislation will affect biopharma revenue, but impact is manageable - RBC",Seeking Alpha,https://seekingalpha.com/news/3859761-drug-pricing-legislation-will-affect-biopharma-revenue-but-impact-is-manageable-rbc?utm_source=businessinsider&utm_medium=referral,positive,0.8448383808135986
2829,7/24/2022 4:00:31 PM,"Pfizer, Moderna to see sales decline for COVID shots before recovery",Seeking Alpha,https://seekingalpha.com/news/3859843-pfizer-moderna-to-see-sales-decline-for-covid-shots-before-recovery?utm_source=businessinsider&utm_medium=referral,neutral,0.9530166387557983
2830,7/25/2022 6:35:07 PM,Follow Nancy Pelosi and Watch These 8 Stocks That Lawmakers Are Buying,InvestorPlace,/news/stocks/follow-nancy-pelosi-and-watch-these-8-stocks-that-lawmakers-are-buying-1031612506,positive,0.9443630576133728
2831,7/26/2022 3:17:27 PM,JNJ Stock Alert: What to Know as Johnson & Johnson Releases Clinical Trial Data,InvestorPlace,/news/stocks/jnj-stock-alert-what-to-know-as-johnson-johnson-releases-clinical-trial-data-1031616136,positive,0.9352125525474548
2832,7/27/2022 2:06:05 AM,"Teva Pharmaceutical in $4.35B opioid settlement with states, Native American tribes",Seeking Alpha,https://seekingalpha.com/news/3861061-teva-pharmaceutical-in-435-opioid-settlement-with-states-native-american-tribes?utm_source=businessinsider&utm_medium=referral,negative,0.8210893273353577
2833,7/27/2022 11:10:39 AM,7 Large-Cap Stocks to Buy on the Dip,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-on-the-dip-1031619962,positive,0.7422232031822205
2834,7/27/2022 2:05:04 PM,"Jim Cramer Says This Stock Costs About $3, But 'If You Wait Long Enough' You Can Buy It For $2",Benzinga,/news/stocks/jim-cramer-says-this-stock-costs-about-3-but-if-you-wait-long-enough-you-can-buy-it-for-2-1031620221,positive,0.9445027709007263
2835,7/28/2022 4:37:49 PM,"Daily Biotech Pulse: GSK's Kidney Disease Drug Approved For Children, Tonix Pharma To Launch Monkeypox Vaccine Study In Kenya, Positive Effect Of Cyclerion's Schizophrenia Candidate",Benzinga,/news/stocks/daily-biotech-pulse-gsk-s-kidney-disease-drug-approved-for-children-tonix-pharma-to-launch-monkeypox-vaccine-study-in-kenya-positive-effect-of-cyclerion-s-schizophrenia-candidate-1031626482,negative,0.864479124546051
2836,7/28/2022 8:20:28 PM,Senate Democrats propose $21B funding for next phase of COVID-19 response,Seeking Alpha,https://seekingalpha.com/news/3862718-senate-democrats-propose-21b-funding-for-next-phase-of-covid-19-response?utm_source=businessinsider&utm_medium=referral,negative,0.6786968111991882
2837,7/29/2022 1:50:18 AM,Biden administration mulls updated booster rollout in September ‚Äì NYT,Seeking Alpha,https://seekingalpha.com/news/3862940-biden-administration-mulls-updated-booster-rollout-in-september-nyt?utm_source=businessinsider&utm_medium=referral,positive,0.9154930710792542
2838,7/31/2022 3:21:24 PM,Biotech Investors: August's Key PDUFA Catalysts You Must Know,Benzinga,/news/stocks/biotech-investors-august-s-key-pdufa-catalysts-you-must-know-1031631857,positive,0.8776605129241943
2839,8/1/2022 5:12:52 PM,Johnson & Johnson unit‚Äôs arthritis injection now indicated for children in U.S.,Seeking Alpha,https://seekingalpha.com/news/3863900-johnson-johnson-units-arthritis-injection-now-indicated-for-children-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.6124706864356995
2840,8/1/2022 8:04:35 PM,Is Vanguard Dividend Appreciation ETF (VIG) A Strong ETF Right Now?,Benzinga,/news/stocks/is-vanguard-dividend-appreciation-etf-vig-a-strong-etf-right-now-1031636436,negative,0.5317443609237671
2841,8/1/2022 11:23:06 PM,Emergent BioSolutions misses on top and bottom lines as it swings to quarterly loss,Seeking Alpha,https://seekingalpha.com/news/3864300-emergent-biosolutions-misses-on-top-and-bottom-lines-as-it-swings-to-quarterly-loss?utm_source=businessinsider&utm_medium=referral,neutral,0.889671266078949
2842,8/2/2022 7:50:15 PM,"Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus",Benzinga,/news/stocks/emergent-biosolutions-posts-q2-loss-on-lower-sales-q3-forecasts-below-consensus-1031641002,neutral,0.9742521047592163
2843,8/9/2022 1:38:04 AM,The 3 Best Vanguard Funds to Buy in August,InvestorPlace,/news/stocks/best-vanguard-funds-1031663161,positive,0.8945893049240112
2844,8/9/2022 11:00:11 AM,3 Dividend Stocks to Buy to Beat Runaway Inflation,InvestorPlace,/news/stocks/dividend-stocks-to-buy-to-beat-runaway-inflation-1031665050,positive,0.4956301748752594
2845,8/9/2022 1:35:38 PM,Why Is Novavax (NVAX) Stock Plunging 30%?,InvestorPlace,/news/stocks/why-is-novavax-nvax-stock-plunging-30-1031666251,neutral,0.9357145428657532
2846,8/9/2022 3:00:47 PM,HCA Healthcare Signs Strategic Collaboration With Johnson & Johnson ,RTTNews,/news/stocks/hca-healthcare-signs-strategic-collaboration-with-johnson-johnson-1031665887,negative,0.8088438510894775
2847,8/10/2022 4:36:56 PM,The 3 Best Sectors for a Bear Market,InvestorPlace,/news/stocks/the-3-best-sectors-for-a-bear-market-1031671637,positive,0.8772343397140503
2848,8/10/2022 8:02:05 PM,Johnson & Johnson partner Aspen risks closure of COVID vaccine plant as orders dry up,Seeking Alpha,https://seekingalpha.com/news/3870976-jj-partner-aspen-risks-closure-of-covid-vaccine-plant-as-orders-dry-up?utm_source=businessinsider&utm_medium=referral,neutral,0.9509631991386414
2849,8/11/2022 7:26:06 PM,CDC eases COVID guidance for unvaccinated people,Seeking Alpha,https://seekingalpha.com/news/3871779-cdc-eases-covid-guidance-for-unvaccinated-people?utm_source=businessinsider&utm_medium=referral,neutral,0.8480912446975708
2850,8/11/2022 9:22:02 PM,"J&J, Merck, Regeneron most exposed to Medicare drug price negotiation - Bloomberg",Seeking Alpha,https://seekingalpha.com/news/3871983-johnson-johnson-merck-regeneron-most-exposed-to-medicare-drug-price-negotiation-bloomberg?utm_source=businessinsider&utm_medium=referral,positive,0.9089527726173401
2851,8/11/2022 9:23:05 PM,Johnson & Johnson to end sales of talc-based baby powder globally in 2023,Seeking Alpha,https://seekingalpha.com/news/3872014-johnson--johnson-to-stop-selling-talc-based-baby-powder-globally-in-2023?utm_source=businessinsider&utm_medium=referral,neutral,0.8280429840087891
2852,8/12/2022 9:10:44 AM,Johnson & Johnson To Discontinue Talc-based Baby Powder ,RTTNews,/news/stocks/johnson-johnson-to-discontinue-talc-based-baby-powder-1031679050,positive,0.8274669647216797
2853,8/12/2022 1:28:51 PM,Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant,Seeking Alpha,https://seekingalpha.com/news/3872367-additional-135m-covid-19-vaccine-doses-destroyed-at-emergent-biosolutions-baltimore-plant?utm_source=businessinsider&utm_medium=referral,neutral,0.6232190132141113
2854,8/12/2022 10:45:00 PM,"Johnson & Johnson Ends Global Sales of Cancer-Causing Baby Powder Amid Increased Scrutiny from Consumer Litigation, Science",PR Newswire,/news/stocks/johnson-johnson-ends-global-sales-of-cancer-causing-baby-powder-amid-increased-scrutiny-from-consumer-litigation-science-1031680779,neutral,0.8821864128112793
2855,8/14/2022 5:48:06 PM,Analysts rule out major industry impact from drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3872629-analysts-rule-out-major-industry-impact-from-drug-pricing-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.8447362780570984
2856,8/15/2022 2:41:21 PM,Emergent ticks lower after FDA warning on Baltimore facility,Seeking Alpha,https://seekingalpha.com/news/3872985-emergent-ticks-lower-after-fda-warning-on-baltimore-facility?utm_source=businessinsider&utm_medium=referral,neutral,0.8761321902275085
2857,8/16/2022 8:20:19 AM,AstraZeneca/Merck's Lynparza gets FDA priority review to treat prostate cancer subtype,Seeking Alpha,https://seekingalpha.com/news/3873395-astrazenecamercks-lynparza-gets-fda-priority-review-to-treat-prostate-cancer-subtype?utm_source=businessinsider&utm_medium=referral,negative,0.8315348029136658
2858,8/17/2022 10:54:23 AM,"U.S. govt. to stop buying COVID-19 vaccines, therapies, tests from this fall ‚Äì Jha",Seeking Alpha,https://seekingalpha.com/news/3874012-us-govt-to-stop-buying-covid-19-vaccines-therapies-tests-from-this-fall-jha?utm_source=businessinsider&utm_medium=referral,positive,0.7759352922439575
2859,8/17/2022 5:10:23 PM,CDC seeks reforms to correct COVID missteps,Seeking Alpha,https://seekingalpha.com/news/3874241-cdc-to-implement-reforms-to-correct-covid-missteps?utm_source=businessinsider&utm_medium=referral,negative,0.785580039024353
2860,8/18/2022 4:59:56 PM,7 Stocks That Win When the Fed Hikes Interest Rates,InvestorPlace,/news/stocks/7-stocks-that-win-when-the-fed-hikes-interest-rates-1031693784,positive,0.8210760354995728
2861,8/19/2022 12:31:52 PM,"HHS sets Aug. 30 meeting as costs for COVID products to shift to payors, individuals ‚Äì WSJ",Seeking Alpha,https://seekingalpha.com/news/3875015-hhs-sets-aug-meeting-as-covid-products-head-for-commercialization-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.9202150106430054
2862,8/19/2022 2:17:52 PM,Johnson & Johnson goes ex-dividend on Monday,Seeking Alpha,https://seekingalpha.com/news/3875073-johnson--johnson-goes-ex-dividend-on-monday?utm_source=businessinsider&utm_medium=referral,positive,0.5367691516876221
2863,8/22/2022 11:22:03 AM,Johnson & Johnson to use Texas bankruptcy plan to fight two states‚Äô talc cases,Seeking Alpha,https://seekingalpha.com/news/3875309-johnson-johnson-to-use-texas-bankruptcy-plan-to-fight-two-states-talc-cases?utm_source=businessinsider&utm_medium=referral,positive,0.7610478401184082
2864,8/22/2022 2:28:02 PM,"Benzinga Before The Bell: Apple Employees Resist Calls For Return-To-Office, Tesla About To Hike FSD Prices Again, MGM China Injects $594M Into Macau Unit And Other Top Financial Stories Monday,...",Benzinga,/news/stocks/benzinga-before-the-bell-apple-employees-resist-calls-for-return-to-office-tesla-about-to-hike-fsd-prices-again-mgm-china-injects-594m-into-macau-unit-and-other-top-financial-stories-monday-august-22-1031697874,positive,0.4117203652858734
2865,8/24/2022 10:53:47 AM,JNJ adds former CVS CEO as non-executive chair of new consumer spinoff,Seeking Alpha,https://seekingalpha.com/news/3876108-jnj-adds-former-cvs-ceo-non-executive-chair-new-consumer-spinoff?utm_source=businessinsider&utm_medium=referral,positive,0.9350612163543701
2866,8/24/2022 12:16:25 PM,Pfizer said to have had bidding war with Johnson & Johnson for Global Blood,Seeking Alpha,https://seekingalpha.com/news/3876151-pfizer-said-to-have-had-bidding-war-with-johnson-johnson-for-global-blood?utm_source=businessinsider&utm_medium=referral,positive,0.7914671301841736
2867,8/24/2022 2:40:20 PM,Johnson & Johnson Names Larry Merlo Chair Designate Of Planned New Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-names-larry-merlo-chair-designate-of-planned-new-consumer-health-company-1031703127,positive,0.9368777871131897
2868,8/24/2022 4:30:36 PM,Congressman wants DoJ update on Johnson & Johnson talc powder investigation,Seeking Alpha,https://seekingalpha.com/news/3876289-congressman-wants-doj-update-on-johnson-johnson-talc-powder-investigation?utm_source=businessinsider&utm_medium=referral,positive,0.9358670711517334
2869,8/24/2022 7:45:18 PM,Billionaire Steven Cohen Just Made a Big Bet on Minerva Neurosciences (NERV) Stock,InvestorPlace,/news/stocks/billionaire-steven-cohen-just-made-a-big-bet-on-minerva-neurosciences-nerv-stock-1031704192,positive,0.8234988451004028
2870,8/25/2022 12:53:45 AM,Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary,Benzinga,/news/stocks/recap-of-wednesday-s-biotech-catalysts---end-of-the-day-summary-1031704410,positive,0.9346833229064941
2871,8/25/2022 3:48:30 AM,Ligand : Janssen's Tecvayli Gets Conditional Approval In Europe For R/R Multiple Myeloma Treatment ,RTTNews,/news/stocks/ligand-janssen-s-tecvayli-gets-conditional-approval-in-europe-for-r-r-multiple-myeloma-treatment-1031704454,negative,0.9393502473831177
2872,8/25/2022 9:38:03 AM,"AbbVie, J&J Imbruvica gets FDA nod to treat graft-versus-host disease in kids",Seeking Alpha,https://seekingalpha.com/news/3876504-abbvie-jj-imbruvica-gets-fda-nod-to-treat-graft-versus-host-disease-in-kids?utm_source=businessinsider&utm_medium=referral,negative,0.8829074501991272
2873,8/25/2022 11:12:25 AM,Pfizer posts 86% efficacy for respiratory syncytial virus vaccine,Seeking Alpha,https://seekingalpha.com/news/3876550-pfizer-posts-efficacy-for-respiratory-syncytial-virus-vaccine?utm_source=businessinsider&utm_medium=referral,negative,0.9164322018623352
2874,8/25/2022 4:32:25 PM,Janssen Scores Conditional Approval For Multiple Myeloma Treatment In Pretreated Patients,Benzinga,/news/stocks/janssen-scores-conditional-approval-for-multiple-myeloma-treatment-in-pretreated-patients-1031706261,negative,0.9233114719390869
2875,8/28/2022 4:00:00 PM,Pfizer eyes $10B-plus market for RSV vaccines with two-prong approach,Seeking Alpha,https://seekingalpha.com/news/3877243-pfizer-eyes-10b-plus-market-for-rsv-vaccines-with-pandemic-era-model?utm_source=businessinsider&utm_medium=referral,positive,0.6486809253692627
2876,8/29/2022 4:44:50 PM,"Bristol-Myers falls 5%, most in two years, after mid-stage data for blood thinner",Seeking Alpha,https://seekingalpha.com/news/3877518-bmy-stock-falls-after-mid-stage-data-for-blood-thinner?utm_source=businessinsider&utm_medium=referral,neutral,0.9234603047370911
2877,8/31/2022 3:41:46 PM,Pfizer snatches first chief marketing officer from Google's Verily,Seeking Alpha,https://seekingalpha.com/news/3878965-pfizer-snatches-first-chief-marketing-officer-from-googles-verily?utm_source=businessinsider&utm_medium=referral,positive,0.9217296242713928
2878,8/31/2022 8:52:36 PM,"Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know",Benzinga,/news/stocks/bluebird-bio-seeks-back-to-back-nods-go-or-no-go-for-revance-s-botox-rival-amylyx-twin-hurdles-and-more-september-s-key-pdufa-catalysts-biotech-investors-must-know-1031717312,positive,0.7547863721847534
2879,9/1/2022 2:49:57 PM,Johnson & Johnson to pay $40.5M over opioid claims in New Hampshire,Seeking Alpha,https://seekingalpha.com/news/3879416-johnson-johnson-to-pay-405m-over-opioid-claims-in-new-hampshire?utm_source=businessinsider&utm_medium=referral,neutral,0.8123191595077515
2880,9/2/2022 1:10:56 PM,EMA committee starts review of use of epileptic seizures drug topiramate in pregnancy,Seeking Alpha,https://seekingalpha.com/news/3879806-ema-committee-starts-review-of-use-of-epileptic-seizures-drug-topiramate-in-pregnancy?utm_source=businessinsider&utm_medium=referral,positive,0.8862841129302979
2881,9/4/2022 1:18:40 PM,"M&A may be a tailwind for biotech sector into end of year, analyst says",Seeking Alpha,https://seekingalpha.com/news/3880197-ma-may-be-a-tailwind-for-biotech-sector-into-end-of-year-analyst-says?utm_source=businessinsider&utm_medium=referral,neutral,0.929253339767456
2882,9/6/2022 7:12:48 AM,The 7 Best Vanguard ETFs to Buy Now,InvestorPlace,/news/stocks/the-best-vanguard-etfs-1028807655,positive,0.9007076025009155
2883,9/6/2022 6:00:50 PM,6 Safe Stocks to Buy in September 2022,InvestorPlace,/news/stocks/best-safe-stocks-1031561144,positive,0.9252723455429077
2884,9/6/2022 6:55:35 PM,7 Dow Stocks With Superior Fundamentals,InvestorPlace,/news/stocks/7-dow-stocks-with-superior-fundamentals-1031727239,negative,0.7731004953384399
2885,9/8/2022 2:48:04 PM,Shockwave Medical gains on vague takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3881275-shockwave-medical-gains-on-vague-takeover-speculation?utm_source=businessinsider&utm_medium=referral,negative,0.6442201733589172
2886,9/8/2022 9:01:53 PM,"FDA warns about skin cancer, various lymphomas in scar tissue around breast implants",Seeking Alpha,https://seekingalpha.com/news/3881442-fda-warns-about-skin-cancer-various-lymphomas-in-scar-tissue-around-breast-implants?utm_source=businessinsider&utm_medium=referral,neutral,0.7986806035041809
2887,9/9/2022 5:30:31 AM,The 3 Best Funds for Retirees,InvestorPlace,/news/stocks/best-funds-for-retirees-1031611261,positive,0.8731857538223267
2888,9/11/2022 11:03:19 PM,7 Blue-Chip Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-before-bull-market-returns-1031630381,positive,0.8826735615730286
2889,9/12/2022 9:05:45 AM,J&J reaches A$300M settlement in pelvic mesh implant class lawsuits in Australia,Seeking Alpha,https://seekingalpha.com/news/3881885-jj-reaches-a300m-settlement-in-pelvic-mesh-implant-class-lawsuits-in-australia?utm_source=businessinsider&utm_medium=referral,neutral,0.9155972599983215
2890,9/12/2022 12:36:04 PM,Shine Justice Agrees To Settle Australian J&J/Ethicon Mesh Class Actions ,RTTNews,/news/stocks/shine-justice-agrees-to-settle-australian-j-j-ethicon-mesh-class-actions-1031736803,positive,0.42150622606277466
2891,9/12/2022 11:05:24 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031738400,positive,0.9169121980667114
2892,9/13/2022 3:49:07 PM,Cidara begins dosing of antiviral CD388 in trial for preventing influenza,Seeking Alpha,https://seekingalpha.com/news/3882393-cidara-begins-dosing-in-study-of-antiviral-cd388-for-preventing-influenza?utm_source=businessinsider&utm_medium=referral,negative,0.7078872919082642
2893,9/13/2022 3:50:55 PM,3 Best Index Funds to Buy Now,InvestorPlace,/news/stocks/best-index-funds-1031567253,positive,0.8933942317962646
2894,9/14/2022 10:48:58 AM,J&J plans $5B stock buyback program; affirms FY22 outlook,Seeking Alpha,https://seekingalpha.com/news/3882616-jj-plans-5b-stock-buyback-program-affirms-fy22-outlook?utm_source=businessinsider&utm_medium=referral,negative,0.6116505265235901
2895,9/14/2022 12:52:45 PM,Johnson & Johnson Reaffirms FY22 Outlook; Authorizes Up To $5 Bln Share Buyback ,RTTNews,/news/stocks/johnson-johnson-reaffirms-fy22-outlook-authorizes-up-to-5-bln-share-buyback-1031742257,negative,0.8278266787528992
2896,9/14/2022 2:18:38 PM,"End in sight for COVID-19 pandemic, WHO chief says",Seeking Alpha,https://seekingalpha.com/news/3882728-end-in-sight-for-covid-19-pandemic-who-chief-says?utm_source=businessinsider&utm_medium=referral,positive,0.8521955013275146
2897,9/14/2022 8:24:39 PM,7 Dividend Stocks to Buy and Hold Forever¬†,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-hold-forever-2-1031743860,positive,0.9479726552963257
2898,9/15/2022 1:20:48 AM,The 3 Best Mutual Funds to Buy in September,InvestorPlace,/news/stocks/best-mutual-funds-1031587594,positive,0.8449283838272095
2899,9/17/2022 8:00:18 PM,"BioNTech, Moderna, Pfizer led biopharma revenue growth from 2020-2021",Seeking Alpha,https://seekingalpha.com/news/3883566-biontech-moderna-pfizer-led-biopharma-revenue-growth-from-2020-2021?utm_source=businessinsider&utm_medium=referral,negative,0.9150789380073547
2900,9/19/2022 7:00:53 PM,COVID-19 vaccine makers fall as Biden says pandemic is over (update),Seeking Alpha,https://seekingalpha.com/news/3883793-mrna-stock-lead-selloff-covid-vaccine-makers-biden-says-pandemic-over?utm_source=businessinsider&utm_medium=referral,neutral,0.961385190486908
2901,9/20/2022 3:00:49 PM,Ethicon To Source Eastman Renew Materials For Medical Device Sterile-barrier Packaging ,RTTNews,/news/stocks/ethicon-to-source-eastman-renew-materials-for-medical-device-sterile-barrier-packaging-1031753633,positive,0.8330997228622437
2902,9/21/2022 4:20:56 PM,Want To Invest Like The World's Largest Hedge Fund? 2 High Yielders That Are Recession Proof,Benzinga,/news/stocks/want-to-invest-like-the-world-s-largest-hedge-fund-2-high-yielders-that-are-recession-proof-1031756914,positive,0.8777665495872498
2903,9/22/2022 11:00:14 AM,7 Safe Havens All Investors Should Have Exposure to in 2022,InvestorPlace,/news/stocks/7-safe-havens-for-investors-to-have-exposure-to-in-2022-1031758874,positive,0.9260846376419067
2904,9/22/2022 3:21:17 PM,Gracell Biotechnologies initiated at buy at Citi citing its autologous CAR-T platform,Seeking Alpha,https://seekingalpha.com/news/3885329-gracell-biotechnologies-initiated-at-buy-at-citi-citing-its-autologous-car-t-platform?utm_source=businessinsider&utm_medium=referral,positive,0.8705661296844482
2905,9/22/2022 3:55:15 PM,"WHO chief reiterates belief that COVID-19 pandemic end near, says work still needed",Seeking Alpha,https://seekingalpha.com/news/3885339-who-chief-reiterates-belief-that-covid-19-pandemic-end-near-says-work-still-needed?utm_source=businessinsider&utm_medium=referral,positive,0.5798600316047668
2906,9/22/2022 7:25:05 PM,Healthcare outperforms S&P 500 as large cap pharma rebounds,Seeking Alpha,https://seekingalpha.com/news/3885399-healthcare-outperforms-sp-500-as-large-cap-pharma-rebounds?utm_source=businessinsider&utm_medium=referral,negative,0.6939451098442078
2907,9/23/2022 7:37:13 AM,NervGen Pharma appoints Bill Radvak as interim CEO,Seeking Alpha,https://seekingalpha.com/news/3885493-nervgen-pharma-appoints-bill-radvak-as-interim-ceo?utm_source=businessinsider&utm_medium=referral,positive,0.706206202507019
2908,9/23/2022 11:08:24 AM,Biden administration allocates $1.5B to address U.S. opioid crisis,Seeking Alpha,https://seekingalpha.com/news/3885562-biden-administration-allocates-15b-to-address-us-opioid-crisis?utm_source=businessinsider&utm_medium=referral,negative,0.7172852754592896
2909,9/23/2022 6:25:08 PM,7 Investments to FIRE Up a Fat Stash and Retire Early,InvestorPlace,/news/stocks/7-investments-for-fatfire-movement-1031762591,positive,0.9077175259590149
2910,9/25/2022 6:00:00 PM,The prostate cancer therapy market will soar. Here are the companies that could benefit.,Seeking Alpha,https://seekingalpha.com/news/3885824-the-prostate-cancer-therapy-market-will-soar-here-are-the-companies-that-could-benefit?utm_source=businessinsider&utm_medium=referral,positive,0.9147647023200989
2911,9/26/2022 11:29:08 AM,7 Stocks to Buy Before They Crush Q3 Earnings,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-crush-q3-earnings-1031764320,positive,0.9280515909194946
2912,9/26/2022 4:16:19 PM,3 Dividend Stocks to Buy Before the Bull Market Returns,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-before-the-bull-market-returns-1031765258,positive,0.9164003729820251
2913,9/27/2022 11:15:11 AM,The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/the-7-best-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031766644,positive,0.8398815989494324
2914,9/27/2022 2:29:31 PM,Legend Biotech wins approval of Carvykti for multiple myeloma in Japan,Seeking Alpha,https://seekingalpha.com/news/3886395-legend-biotech-wins-approval-of-carvykti-for-multiple-myeloma-in-japan?utm_source=businessinsider&utm_medium=referral,negative,0.923959493637085
2915,9/27/2022 6:32:56 PM,Investors are pouring money into healthcare and other defensive sectors as market tanks,Seeking Alpha,https://seekingalpha.com/news/3886489-investors-are-pouring-money-into-healthcare-stocks-and-other-defensive-stocks-as-market-tanks?utm_source=businessinsider&utm_medium=referral,positive,0.8531034588813782
2916,9/27/2022 6:50:42 PM,7 Dow Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768144,positive,0.8689265251159668
2917,9/27/2022 11:13:29 PM,3 Blue-Chip Stocks to Buy to Tap Into a Hidden Bull Market,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-to-tap-into-a-hidden-bull-market-1031768461,positive,0.8314662575721741
2918,9/28/2022 12:03:25 PM,Johnson & Johnson names consumer health spinoff 'Kenvue',Seeking Alpha,https://seekingalpha.com/news/3886683-johnson-johnson-names-consumer-health-spinoff-kenvue?utm_source=businessinsider&utm_medium=referral,positive,0.8954996466636658
2919,9/28/2022 1:44:40 PM,Johnson & Johnson wins FDA OK to expand use of myopia lenses,Seeking Alpha,https://seekingalpha.com/news/3886748-johnson-johnson-wins-fda-ok-to-expand-use-of-myopia-lenses?utm_source=businessinsider&utm_medium=referral,negative,0.8908846378326416
2920,9/28/2022 2:06:53 PM,Johnson & Johnson Unveils Kenvue Brand Name For Planned Consumer Health Company ,RTTNews,/news/stocks/johnson-johnson-unveils-kenvue-brand-name-for-planned-consumer-health-company-1031769895,positive,0.8508203625679016
2921,9/28/2022 3:21:40 PM,5 Little-Known Dividend Kings,InvestorPlace,/news/stocks/5-little-known-dividend-kings-1031770642,positive,0.9137551188468933
2922,9/28/2022 10:01:13 PM,"Many Alzheimer's drug developers close significantly higher thanks to Biogen, Eisai data",Seeking Alpha,https://seekingalpha.com/news/3886925-many-alzheimers-drug-developers-close-significantly-higher-thanks-to-biogen-eisai-data?utm_source=businessinsider&utm_medium=referral,negative,0.9467376470565796
2923,9/28/2022 10:45:22 PM,Aligos Therapeutics files court response and counterclaims to J&J's allegations of theft,Seeking Alpha,https://seekingalpha.com/news/3886939-aligos-therapeutics-files-court-response-and-counterclaims-to-jjs-allegations-of-theft?utm_source=businessinsider&utm_medium=referral,neutral,0.7503814101219177
2924,9/29/2022 12:09:01 PM,The 3 Best Dividend Stocks to Buy for Retirement,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-to-buy-for-retirement-1031772709,positive,0.8697974681854248
2925,9/29/2022 8:36:50 PM,"Immunovant's New Candidate Provides Some Strategic Flexibility & Clarity, Analysts Say",Benzinga,/news/stocks/immunovant-s-new-candidate-provides-some-strategic-flexibility-clarity-analysts-say-1031773948,negative,0.8338485360145569
2926,10/2/2022 2:30:26 PM,7 S&P 500 Stocks to Sell Before They Die,InvestorPlace,/news/stocks/7-sp-500-stocks-to-sell-before-they-die-1031779874,positive,0.7082483172416687
2927,10/3/2022 10:14:22 AM,"Svante P√§√§bo gets Nobel Prize for Medicine for discoveries on genome, human evolution",Seeking Alpha,https://seekingalpha.com/news/3887839-svante-pbo-gets-nobel-prize-for-medicine-for-discoveries-on-genome-human-evolution?utm_source=businessinsider&utm_medium=referral,positive,0.7340630292892456
2928,10/3/2022 12:33:53 PM,Clovis stock rises 10% as Rubraca shows survival benefit in prostate cancer in confirmatory trial,Seeking Alpha,https://seekingalpha.com/news/3887902-clovis-stock-rises-as-rubraca-shows-survival-benefit-in-prostate-cancer-in-confirmatory-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9503354430198669
2929,10/3/2022 11:56:59 PM,The Short List Of Dow Jones Stocks That Are Actually Up This Year: Hint ‚Äî It's Very Short,Benzinga,/news/etf/the-short-list-of-dow-jones-stocks-that-are-actually-up-this-year-hint-‚Äî-it-s-very-short-1031780150,positive,0.6578128337860107
2930,10/4/2022 11:04:52 AM,7 Recession-Proof Stocks to Buy in October¬†,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-in-october-1031781197,positive,0.8011834025382996
2931,10/5/2022 4:25:31 PM,Bankruptcy judge temporarily prevents two states from suing J&J over talc safety,Seeking Alpha,https://seekingalpha.com/news/3888954-bankruptcy-judge-temporarily-prevents-two-states-from-suing-johnson-johnson-over-talc-safety?utm_source=businessinsider&utm_medium=referral,neutral,0.9268501996994019
2932,10/5/2022 7:05:49 PM,Ray Dalio Is Stepping Down. Here Are His Top 5 Stock Bets.,InvestorPlace,/news/stocks/ray-dalio-is-stepping-down-here-are-his-top-5-stock-bets-1031785604,positive,0.7984113693237305
2933,10/6/2022 11:26:50 AM,7 Dividend Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/7-dividend-stocks-that-are-too-cheap-to-ignore-1031787020,positive,0.7287653088569641
2934,10/6/2022 6:34:41 PM,Want to Bet Against Jim Cramer? Short These 10 Stocks.,InvestorPlace,/news/stocks/want-to-bet-against-jim-cramer-short-these-10-stocks-1031788455,positive,0.8903867602348328
2935,10/7/2022 5:40:40 PM,Former J&J executive is tipped to become Biogen CEO ‚Äì Stat News,Seeking Alpha,https://seekingalpha.com/news/3889747-former-jj-executive-is-tipped-to-become-biogen-ceo-stat-news?utm_source=businessinsider&utm_medium=referral,positive,0.9377965331077576
2936,10/7/2022 6:02:20 PM,U.S. report says COVID vaccines led to over 300K fewer deaths among Medicare beneficiaries,Seeking Alpha,https://seekingalpha.com/news/3889752-us-report-says-covid-vaccines-led-to-over-300k-fewer-deaths-among-medicare-beneficiaries?utm_source=businessinsider&utm_medium=referral,neutral,0.6736574769020081
2937,10/7/2022 9:46:21 PM,"JNJ, MDT: Are Their ~3% Dividend Yields Worth It?",TipRanks,/news/stocks/jnj-mdt-are-their-~3-dividend-yields-worth-it-1031790938,positive,0.8682147860527039
2938,10/10/2022 10:30:32 AM,This Is the Best Time to Buy These 7 Long-Term Blue-Chip Stocks,InvestorPlace,/news/stocks/this-is-the-best-time-to-buy-these-7-long-term-blue-chip-stocks-1031792717,positive,0.7951264381408691
2939,10/10/2022 3:21:50 PM,Johnson & Johnson highlights long-term effect of ulcerative colitis therapy,Seeking Alpha,https://seekingalpha.com/news/3890049-johnson-johnson-highlights-long-term-effect-of-ulcerative-colitis-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.7018795013427734
2940,10/10/2022 5:35:12 PM,"J&J says Tremfya, Simponi combination effective for ulcerative colitis",Seeking Alpha,https://seekingalpha.com/news/3890091-johnson-johnson-says-tremfya-simponi-combination-effective-for-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral,negative,0.9337751269340515
2941,10/10/2022 6:09:22 PM,GOP senators introduce bill to undo Medicare prescription drug negotiation,Seeking Alpha,https://seekingalpha.com/news/3890099-gop-senators-introduce-bill-to-undo-medicare-prescription-drug-negotiation?utm_source=businessinsider&utm_medium=referral,positive,0.5134317874908447
2942,10/12/2022 11:57:47 AM,BeiGene Brukinsa shows better survival benefit vs Imbruvica in blood cancer patients in trial,Seeking Alpha,https://seekingalpha.com/news/3890655-beigene-brukinsa-shows-better-survival-benefit-vs-imbruvica-in-blood-cancer-patients-in-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9531958699226379
2943,10/12/2022 7:07:29 PM,What 7 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-7-analyst-ratings-have-to-say-about-johnson-johnson-1031800562,positive,0.9396771788597107
2944,10/12/2022 8:19:14 PM,Analyst Casts Doubts On Merus' Lung Candidate Safety Profile,Benzinga,/news/stocks/analyst-casts-doubts-on-merus-lung-candidate-safety-profile-1031800674,neutral,0.8004797697067261
2945,10/13/2022 8:43:29 AM,GSK RSV vaccine for older adults shows 94.1% efficacy in severe disease in phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/3890968-gsk-rsv-vaccine-for-older-adults-shows-941-efficacy-in-severe-disease-in-phase-3-trial?utm_source=businessinsider&utm_medium=referral,negative,0.90916508436203
2946,10/13/2022 10:07:43 AM,J&J's Biosense launches Heliostar balloon ablation catheter in Europe,Seeking Alpha,https://seekingalpha.com/news/3890979-jjs-biosense-launches-heliostar-balloon-ablation-catheter-in-europe?utm_source=businessinsider&utm_medium=referral,positive,0.7248008251190186
2947,10/13/2022 5:28:57 PM,BeiGene upgraded to buy at Guggenheim on improved confidence in Brukinsa potential,Seeking Alpha,https://seekingalpha.com/news/3891157-beigene-upgraded-to-buy-at-guggenheim-on-improved-confidence-in-brukinsa-potential?utm_source=businessinsider&utm_medium=referral,negative,0.9556883573532104
2948,10/13/2022 9:46:53 PM,3 Dow Stocks to Buy if You Are Feeling Greedy,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-if-you-are-feeling-greedy-1031804612,positive,0.928457498550415
2949,10/14/2022 3:55:21 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031804731,positive,0.7781388163566589
2950,10/14/2022 12:24:33 PM,Biden to sign Executive Order tasking HHS to find additional ways to lower drug costs,Seeking Alpha,https://seekingalpha.com/news/3891387-biden-to-sign-executive-order-tasking-hhs-to-find-additional-ways-to-lower-drug-costs-medicare?utm_source=businessinsider&utm_medium=referral,negative,0.8669121861457825
2951,10/14/2022 5:10:04 PM,"Earnings week ahead: Tesla, Netflix, Johnson & Johnson, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3891460-earnings-week-ahead-tesla-netflix-johnson-johnson-att-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9371859431266785
2952,10/14/2022 6:30:00 PM,"Catalyst Watch: Tesla, Netflix, Fisker, TechCrunch Disrupt and Paris Motor Show headline big week",Seeking Alpha,https://seekingalpha.com/news/3891159-catalyst-watch-tesla-netflix-techcrunch-disrupt-and-paris-motor-show-headline-big-week?utm_source=businessinsider&utm_medium=referral,positive,0.8451207876205444
2953,10/17/2022 9:05:30 AM,Bill & Melinda Gates Foundation commits $1.2B to end polio,Seeking Alpha,https://seekingalpha.com/news/3891702-bill-melinda-gates-foundation-commit-12b-to-end-polio?utm_source=businessinsider&utm_medium=referral,negative,0.7355890870094299
2954,10/17/2022 2:43:09 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3891864-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
2955,10/17/2022 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q3-1031810009,positive,0.9338979721069336
2956,10/17/2022 4:15:31 PM,Johnson & Johnson to report Q3 earnings amid macro concerns on guidance,Seeking Alpha,https://seekingalpha.com/news/3891898-johnson-johnson-to-report-q3-earnings-amid-macro-concerns-on-guidance?utm_source=businessinsider&utm_medium=referral,neutral,0.9430225491523743
2957,10/18/2022 10:03:45 AM,"Goldman Sachs, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/goldman-sachs-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1031812521,positive,0.9243103265762329
2958,10/18/2022 10:27:49 AM,"Johnson & Johnson Non-GAAP EPS of $2.55 beats by $0.06, revenue of $23.8B beats by $360M",Seeking Alpha,https://seekingalpha.com/news/3892097-johnson-and-johnson-non-gaap-eps-of-2_55-beats-0_06-revenue-of-23_8b-beats-360m?utm_source=businessinsider&utm_medium=referral,positive,0.587740957736969
2959,10/18/2022 11:07:24 AM,Johnson & Johnson lowers 2022 guidance amid inflationary and forex impact,Seeking Alpha,https://seekingalpha.com/news/3892112-johnson-johnson-lowers-2022-guidance-amid-inflationary-and-forex-impact?utm_source=businessinsider&utm_medium=referral,neutral,0.9669351577758789
2960,10/18/2022 12:04:15 PM,"US Stock Futures Surge Following Monday's Rally; Goldman Sachs, Johnson & Johnson Earnings In Focus",Benzinga,/news/stocks/us-stock-futures-surge-following-monday-s-rally-goldman-sachs-johnson-johnson-earnings-in-focus-1031812722,neutral,0.513957142829895
2961,10/18/2022 12:34:33 PM,"Johnson & Johnson Q3 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q3-profit-increases-beats-estimates-1031812774,negative,0.9267435073852539
2962,10/18/2022 1:10:43 PM,Johnson & Johnson Q3 Profit Beats Estimates; Adj. Operational Sales Up 8.2%; Increases Guidance ,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-adj-operational-sales-up-8-2-increases-guidance-1031812929,negative,0.9485570788383484
2963,10/18/2022 1:15:02 PM,"US Stocks' Momentum Set To Continue Tuesday As Nasdaq Futures Lead Rally ‚Äî Tesla, Goldman, J&J, United Airlines In Focus",Benzinga,/news/stocks/us-stocks-momentum-set-to-continue-tuesday-as-nasdaq-futures-lead-rally-‚Äî-tesla-goldman-j-j-united-airlines-in-focus-1031812959,negative,0.8691237568855286
2964,10/18/2022 1:37:18 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-1031813799,neutral,0.9397314786911011
2965,10/18/2022 1:38:42 PM,"AVEO Pharmaceuticals, Akouos And Some Other Big Stocks Moving Higher In Today's Pre-Market Session",Benzinga,/news/stocks/aveo-pharmaceuticals-akouos-and-some-other-big-stocks-moving-higher-in-today-s-pre-market-session-1031813041,negative,0.9316368103027344
2966,10/18/2022 1:58:42 PM,CANO Stock Jumps Despite Rumors CVS Is Walking Away From Cano Health Acquisition,InvestorPlace,/news/stocks/cano-stock-jumps-despite-rumors-cvs-is-walking-away-from-cano-health-acquisition-1031813930,neutral,0.8338814377784729
2967,10/18/2022 2:30:39 PM,"Complete Exit For Exxon From Russia, Microsoft's Layoffs, Another Setback For Boeing's Potential 737 MAX 7 Approval, Visa & Mastercard Under FTC Probe: Top Stories Tuesday, Oct. 18",Benzinga,/news/stocks/complete-exit-for-exxon-from-russia-microsoft-s-layoffs-another-setback-for-boeing-s-potential-737-max-7-approval-visa-mastercard-under-ftc-probe-top-stories-tuesday-oct-18-1031813286,positive,0.5173636674880981
2968,10/18/2022 4:09:22 PM,Johnson & Johnson weighs job cuts ahead of consumer health spinoff,Seeking Alpha,https://seekingalpha.com/news/3892300-johnson-johnson-weighs-job-cuts-ahead-of-consumer-health-spinoff?utm_source=businessinsider&utm_medium=referral,neutral,0.9445424675941467
2969,10/18/2022 6:03:51 PM,Colgate gains after activist Third Point takes stake (update),Seeking Alpha,https://seekingalpha.com/news/3892236-colgate-gains-on-report-activist-third-point-takes-stake-in-colgate?utm_source=businessinsider&utm_medium=referral,positive,0.8447619080543518
2970,10/18/2022 7:52:05 PM,Legend Biotech climbs as analysts probe JNJ Q3 results to estimate Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/3892388-legn-stock-climbs-as-analysts-parse-jnj-q3-to-estimate-carvykti-sales?utm_source=businessinsider&utm_medium=referral,negative,0.9004184603691101
2971,10/19/2022 12:25:40 PM,Johnson & Johnson (NYSE:JNJ) Eyes Job Cuts as Macro Pressures Persist,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-eyes-job-cuts-as-macro-pressures-persist-1031817309,neutral,0.9503217339515686
2972,10/19/2022 12:35:55 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1031817392,positive,0.5214546322822571
2973,10/19/2022 12:40:36 PM,"Analysts Conflicted on These Healthcare Names: Amarin (AMRN), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-amarin-amrn-johnson-johnson-jnj-and-unitedhealth-unh-1031817383,neutral,0.7145310044288635
2974,10/19/2022 2:56:15 PM,Goldman Sachs To $410? Plus Credit Suisse Predicts $272 For McDonald's,Benzinga,/news/stocks/goldman-sachs-to-410-plus-credit-suisse-predicts-272-for-mcdonald-s-1031817530,negative,0.7087283134460449
2975,10/19/2022 4:32:05 PM,"Analysts Are Neutral on These Healthcare Stocks: Intuitive Surgical (ISRG), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-neutral-on-these-healthcare-stocks-intuitive-surgical-isrg-johnson-johnson-jnj-1031818361,positive,0.5577170252799988
2976,10/19/2022 5:52:27 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-best-blue-chip-stocks-to-buy-now-1031818533,positive,0.8018679618835449
2977,10/20/2022 12:26:56 PM,J&J's Teligen system gets FDA clearance for use in spinal surgeries,Seeking Alpha,https://seekingalpha.com/news/3893113-jjs-teligen-system-gets-fda-clearance-for-use-in-spinal-surgeries?utm_source=businessinsider&utm_medium=referral,negative,0.9062904119491577
2978,10/20/2022 1:36:54 PM,AbbVie to acquire DJS Antibodies for $255M to bolster immunology pipeline,Seeking Alpha,https://seekingalpha.com/news/3893196-abbvie-to-acquire-djs-antibodies-for-255m-to-bolster-immunology-pipeline?utm_source=businessinsider&utm_medium=referral,negative,0.8283438682556152
2979,10/20/2022 5:19:54 PM,Prescription drugs make up a rising share of Medicare spending ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3893317-prescription-drugs-account-for-a-rising-chunk-of-medicare-spending-study?utm_source=businessinsider&utm_medium=referral,positive,0.7574050426483154
2980,10/20/2022 5:52:21 PM,CDC panel recommends adding COVID-19 vaccines to regular immunizations,Seeking Alpha,https://seekingalpha.com/news/3893337-cdc-panel-recommends-adding-covid-19-vaccines-to-regular-immunizations?utm_source=businessinsider&utm_medium=referral,positive,0.8696175217628479
2981,10/20/2022 9:34:45 PM,Johnson & Johnson bags $244M defense logistics contract,Seeking Alpha,https://seekingalpha.com/news/3893508-johnson-johnson-bags-244m-defense-logistics-contract?utm_source=businessinsider&utm_medium=referral,positive,0.6649774312973022
2982,10/21/2022 1:15:41 AM,Credit Suisse Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/credit-suisse-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1031822861,positive,0.671061098575592
2983,10/21/2022 5:56:11 PM,"Talks begin with pharma, health insurers over negotiating drug prices for Medicare",Seeking Alpha,https://seekingalpha.com/news/3893788-talks-begin-with-pharma-health-insurers-over-negotiating-drug-prices-for-medicare?utm_source=businessinsider&utm_medium=referral,positive,0.6700782775878906
2984,10/22/2022 8:00:00 PM,"J&J, Alkermes, AbbVie, others set to benefit from expanding schizophrenia drug market",Seeking Alpha,https://seekingalpha.com/news/3893816-johnson-johnson-alkermes-abbvie-others-set-to-benefit-from-expanding-schizophrenia-drug-market?utm_source=businessinsider&utm_medium=referral,negative,0.7288205027580261
2985,10/23/2022 4:00:00 PM,"Pfizer, Moderna bank on price hikes, updated shots to retain COVID vaccine duopoly",Seeking Alpha,https://seekingalpha.com/news/3893783-pfizer-moderna-bank-on-price-hikes-updated-shots-to-win-covid-vaccine-duopoly?utm_source=businessinsider&utm_medium=referral,positive,0.9074086546897888
2986,10/24/2022 1:58:47 PM,"'Right Now I Don't Want To Back Away From It,' Jim Cramer Says About This Stock Down Only 8% This Year",Benzinga,/news/stocks/right-now-i-don-t-want-to-back-away-from-it-jim-cramer-says-about-this-stock-down-only-8-this-year-1031828185,neutral,0.9358146786689758
2987,10/25/2022 7:01:39 PM,Updated COVID boosters did not outperform original COVID vaccines ‚Äì study,Seeking Alpha,https://seekingalpha.com/news/3895008-updated-covid-boosters-did-not-outperform-original-covid-vaccines-study?utm_source=businessinsider&utm_medium=referral,negative,0.775223433971405
2988,10/25/2022 8:01:58 PM,Johnson & Johnson wins FDA approval for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/3895052-johnson-johnson-wins-fda-approval-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.9013034701347351
2989,10/27/2022 6:06:16 AM,SVB Securities Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1031841991,positive,0.7781388163566589
2990,10/27/2022 8:37:46 PM,"Analyst Sees Market Potential For Arcellx Multiple Myeloma Candidate, Sees 50% Upside In Stock",Benzinga,/news/stocks/analyst-sees-market-potential-for-arcellx-multiple-myeloma-candidate-sees-50-upside-in-stock-1031844903,negative,0.9255241751670837
2991,10/29/2022 10:19:32 AM,"Constructing a Stock Portfolio ‚Äî What to Consider, What to Avoid",TipRanks,/news/stocks/constructing-a-stock-portfolio-‚Äî-what-to-consider-what-to-avoid-1031849725,positive,0.9421131014823914
2992,10/29/2022 8:00:00 PM,"With medical devices market expected to soar, here are companies set to benefit the most",Seeking Alpha,https://seekingalpha.com/news/3897411-with-medical-devices-market-expected-to-soar-here-are-companies-set-to-benefit-the-most?utm_source=businessinsider&utm_medium=referral,positive,0.7235878705978394
2993,10/31/2022 11:15:50 AM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-bear-market-stocks-to-buy-now-1031853131,positive,0.8821819424629211
2994,10/31/2022 12:14:49 PM,ESSA drops 26% as Johnson & Johnson ends trial enrollment for lead asset,Seeking Alpha,https://seekingalpha.com/news/3897672-epix-stock-drops-after-johnson--johnson-setback-for-prostrate-cancer-drug?utm_source=businessinsider&utm_medium=referral,neutral,0.9700499773025513
2995,10/31/2022 12:37:03 PM,Sonnet stock soars 16% on collaboration with J&J for 3 drug compounds,Seeking Alpha,https://seekingalpha.com/news/3897688-sonnet-stock-soars-16-on-collaboration-with-jj-for-3-drug-compounds?utm_source=businessinsider&utm_medium=referral,negative,0.9261900782585144
2996,10/31/2022 4:28:38 PM,7 Blue-Chip Stocks Set to Soar From 52-Week Lows,InvestorPlace,/news/stocks/7-blue-chip-stocks-set-to-soar-from-52-week-lows-1031854441,neutral,0.5441226959228516
2997,10/31/2022 6:30:10 PM,Why Is Sonnet BioTherapeutics (SONN) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-sonnet-biotherapeutics-sonn-stock-up-100-today-1031854886,negative,0.849371612071991
2998,11/1/2022 4:31:30 AM,7 Cash-Rich Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/7-cash-rich-dividend-stocks-to-buy-now-1031855561,positive,0.9057661890983582
2999,11/1/2022 11:54:21 AM,Abiomed climbs 52% on $380/ share buyout deal with Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3898357-abmd-stock-surges-on-buyout-deal-with-johnson--johnson?utm_source=businessinsider&utm_medium=referral,negative,0.9398698210716248
3000,11/1/2022 12:37:04 PM,Abiomed To Be Bought By Johnson & Johnson In $16.6 Bln Deal; Stock Surges In Pre-market ,RTTNews,/news/stocks/abiomed-to-be-bought-by-johnson-johnson-in-16-6-bln-deal-stock-surges-in-pre-market-1031857889,negative,0.4857378900051117
3001,11/1/2022 1:42:21 PM,Why Is Abiomed (ABMD) Stock Up 50% Today?,InvestorPlace,/news/stocks/why-is-abiomed-abmd-stock-up-50-today-1031858696,negative,0.8174915909767151
3002,11/1/2022 1:47:55 PM,Johnson & Johnson said to have approached Abiomed,Seeking Alpha,https://seekingalpha.com/news/3898558-johnson-johnson-said-to-have-approached-abiomed?utm_source=businessinsider&utm_medium=referral,positive,0.9067540168762207
3003,11/1/2022 5:26:53 PM,Legend Biotech initiated at outperform at Cowen on strength of Carvykti,Seeking Alpha,https://seekingalpha.com/news/3898764-legend-biotech-initiated-at-outperform-at-cowen-on-strength-of-carvykti?utm_source=businessinsider&utm_medium=referral,negative,0.9366981983184814
3004,11/1/2022 5:51:17 PM,Abiomed unlikely to see higher bid given size of J&J premium - analyst,Seeking Alpha,https://seekingalpha.com/news/3898849-abiomed-unlikely-to-see-higher-bid-given-size-of-jj-premium-analyst?utm_source=businessinsider&utm_medium=referral,negative,0.9117242693901062
3005,11/1/2022 9:28:16 PM,What To Watch In The S&P Biotech ETF After Johnson & Johnson's $16.6B Abiomed Deal,Benzinga,/news/etf/what-to-watch-in-the-s-p-biotech-etf-after-johnson-johnson-s-16-6b-abiomed-deal-1031860263,positive,0.9295636415481567
3006,11/2/2022 12:25:29 AM,Hurry! 7 Pitiful Nasdaq Stocks to Sell Before 2022 Ends.,InvestorPlace,/news/stocks/hurry-7-pitiful-nasdaq-stocks-to-sell-before-2022-ends-1031860759,neutral,0.8560699224472046
3007,11/3/2022 1:06:27 PM,Cramer's Take On This Stock That's Down 53% Year-To-Date: 'I Think Long-Term. I Don't Want To Own It',Benzinga,/news/stocks/cramer-s-take-on-this-stock-that-s-down-53-year-to-date-i-think-long-term-i-don-t-want-to-own-it-1031870171,neutral,0.8992703557014465
3008,11/3/2022 4:30:26 PM,"Cancer drugs launch prices soaring, straining Medicare, report finds",Seeking Alpha,https://seekingalpha.com/news/3901117-cancer-drugs-launch-prices-soaring-straining-medicare-report-finds?utm_source=businessinsider&utm_medium=referral,neutral,0.5917294025421143
3009,11/3/2022 7:34:14 PM,Why Is Provention Biosciences (PRVB) Stock Up 25% Today?,InvestorPlace,/news/stocks/why-is-provention-biosciences-prvb-stock-up-25-today-1031872165,negative,0.8860520124435425
3010,11/4/2022 5:30:43 PM,"Catalyst watch: CPI downtick, election ripples, Disney and Rivian earnings, Roblox conference call",Seeking Alpha,https://seekingalpha.com/news/3902134-catalyst-watch-cpi-downtick-election-ripples-disney-and-rivian-earnings-roblox-conference-call?utm_source=businessinsider&utm_medium=referral,positive,0.6538464426994324
3011,11/6/2022 2:00:31 PM,"M&A investors have tough, unexpected week with Rogers deal termination, Albertsons dividend",Seeking Alpha,https://seekingalpha.com/news/3902379-ma-investors-have-tough-unexpected-week-with-rogers-deal-termination-albertsons-dividend?utm_source=businessinsider&utm_medium=referral,neutral,0.9502964615821838
3012,11/6/2022 5:00:24 PM,"Off-patent drugs make up 91% of prescriptions, but only 18% of spending - report",Seeking Alpha,https://seekingalpha.com/news/3902378-off-patent-drugs-make-up-91-of-prescriptions-18-of-spending?utm_source=businessinsider&utm_medium=referral,positive,0.8645551800727844
3013,11/7/2022 2:05:19 PM,"Cramer On This Stock Up 138% Year-To-Date: 'Santa Can't Afford That Coal, It's Going Up Too Much'",Benzinga,/news/stocks/cramer-on-this-stock-up-138-year-to-date-santa-can-t-afford-that-coal-it-s-going-up-too-much-1031881232,negative,0.8951486349105835
3014,11/7/2022 8:42:12 PM,Former J&J exec no longer seen as frontrunner for Biogen CEO position  - STAT,Seeking Alpha,https://seekingalpha.com/news/3902997-former-johnson-johnson-exec-no-longer-seen-as-frontrunner-for-biogen-ceo-position-stat?utm_source=businessinsider&utm_medium=referral,positive,0.9084570407867432
3015,11/8/2022 5:50:15 AM,"PFE, JNJ, or CVS: Which Healthcare Stock is a ‚ÄúStrong Buy‚Äù for Wall Street Pros?",TipRanks,/news/stocks/pfe-jnj-or-cvs-which-healthcare-stock-is-a-strong-buy-for-wall-street-pros-1031885165,positive,0.8269262909889221
3016,11/8/2022 7:04:04 PM,The 7 Best Pharma Stocks to Buy Now,InvestorPlace,/news/stocks/the-7-best-pharma-stocks-to-buy-now-1031893081,positive,0.8310678601264954
3017,11/8/2022 8:37:59 PM,Election Day Is Here: Which Politicians Are Profiting (Or Losing) On Stocks?,Benzinga,/news/stocks/election-day-is-here-which-politicians-are-profiting-or-losing-on-stocks-1031888216,positive,0.7142788767814636
3018,11/9/2022 7:19:11 PM,"'Waiting Game Continues' In Emergent BioSolutions, Analysts Cut Price Target",Benzinga,/news/stocks/waiting-game-continues-in-emergent-biosolutions-analysts-cut-price-target-1031893444,neutral,0.8034226298332214
3019,11/11/2022 5:12:10 PM,J&J analysis: Early Tremfya efficacy in psoriatic arthritis can predict long-term response,Seeking Alpha,https://seekingalpha.com/news/3906562-johnson-johnson-analysis-early-tremfya-efficacy-in-psoriatric-arthritis-can-predict-long-term-response?utm_source=businessinsider&utm_medium=referral,negative,0.8279595375061035
3020,11/11/2022 8:16:39 PM,"Healthcare stocks come off lows, worst performing sector among defensive losers (update)",Seeking Alpha,https://seekingalpha.com/news/3906637-healthcare-stocks-fall-across-the-board-as-traders-move-out-of-defensive-sectors?utm_source=businessinsider&utm_medium=referral,neutral,0.8541243672370911
3021,11/11/2022 11:34:31 PM,"These 2 Dividend Paying ETFs Have A Track Record For Increasing Payments, Can Help Diversify Against Industry Risk",Benzinga,/news/etf/these-2-dividend-paying-etfs-have-a-track-record-for-increasing-payments-can-help-diversify-against-industry-risk-1031905724,negative,0.9117457270622253
3022,11/13/2022 1:59:54 AM,U.S. COVID health emergency to stay in place,Seeking Alpha,https://seekingalpha.com/news/3906753-us-covid-health-emergency-to-stay-in-place?utm_source=businessinsider&utm_medium=referral,neutral,0.6932175159454346
3023,11/15/2022 2:37:53 AM,The Top Dividend Stocks to Prepare for Retirement ‚Äì And How to Choose Them,TipRanks,/news/stocks/the-top-dividend-stocks-to-prepare-for-retirement-‚Äì-and-how-to-choose-them-1031912167,positive,0.9443628191947937
3024,11/16/2022 9:52:53 AM,"GSK tops Access to Medicine Index, to invest ¬£100M for initiatives in low income countries",Seeking Alpha,https://seekingalpha.com/news/3908464-gsk-tops-access-to-medicine-index-to-invest-100m-for-initiatives-in-low-income-countries?utm_source=businessinsider&utm_medium=referral,negative,0.7709419131278992
3025,11/18/2022 5:03:50 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031925789,positive,0.9169121980667114
3026,11/18/2022 5:58:37 PM,"Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-november-18-2022-1031925925,neutral,0.5206902027130127
3027,11/18/2022 6:01:11 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1031925921,positive,0.8832271695137024
3028,11/18/2022 8:01:50 PM,7 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/7-analysts-have-this-to-say-about-johnson-johnson-1031926149,positive,0.910438597202301
3029,11/18/2022 8:54:31 PM,Analyst Expects Derisking Required Ahead Of Patent Expiry For This Large Pharma/MedTech Stock,Benzinga,/news/stocks/analyst-expects-derisking-required-ahead-of-patent-expiry-for-this-large-pharma-medtech-stock-1031926255,positive,0.8591317534446716
3030,11/21/2022 2:02:22 PM,7 Must-Own Safe Havens as Market Selloff Accelerates,InvestorPlace,/news/stocks/7-must-own-safe-havens-as-market-selloff-accelerates-1031928733,negative,0.4833277761936188
3031,11/30/2022 3:54:10 PM,Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?,InvestorPlace,/news/stocks/why-is-horizon-therapeutics-hznp-stock-up-30-today-1031945358,negative,0.902595043182373
3032,11/30/2022 7:52:36 PM,Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout,Benzinga,/news/stocks/analyst-forecasts-101-117-share-offer-price-for-horizon-therapeutics-buyout-1031946005,positive,0.919748067855835
3033,12/1/2022 2:42:14 AM,J&J Elects Its CEO Joaquin Duato To Assume Additional Position Of Chairman ,RTTNews,/news/stocks/j-j-elects-its-ceo-joaquin-duato-to-assume-additional-position-of-chairman-1031946511,positive,0.9290662407875061
3034,12/5/2022 4:30:33 PM,Why Is Yumanity Therapeutics (YMTX) Stock Up Today?,InvestorPlace,/news/stocks/why-is-yumanity-therapeutics-ymtx-stock-up-today-1031953540,positive,0.6914397478103638
3035,12/5/2022 8:22:27 PM,7 Iron-Clad Stocks That Will Resist the Market Turmoil,InvestorPlace,/news/stocks/7-iron-clad-stocks-that-will-resist-the-market-turmoil-1031953891,positive,0.8181341886520386
3036,12/6/2022 4:25:35 PM,Morgan Stanley Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1031956250,positive,0.8140203356742859
3037,12/8/2022 1:43:23 PM,Abiomed ticks higher after HSR waiting period for Johnson & Johnson sale expires,Seeking Alpha,https://seekingalpha.com/news/3915276-abiomed-ticks-higher-after-hsr-waiting-period-for-johnson-johnson-sale-expires?utm_source=businessinsider&utm_medium=referral,negative,0.8065860867500305
3038,12/8/2022 7:28:13 PM,"Gracell Biotech Stock Has Over 100% Upside On Next-Gen CAR-T Platforms, Analyst Claims",Benzinga,/news/stocks/gracell-biotech-stock-has-over-100-upside-on-next-gen-car-t-platforms-analyst-claims-1031961324,negative,0.8186195492744446
3039,12/8/2022 7:28:42 PM,EU wants to delay medical device law amid supply challenges - Reuters,Seeking Alpha,https://seekingalpha.com/news/3915442-eu-wants-to-delay-medical-device-law-amid-supply-challenges-reuters?utm_source=businessinsider&utm_medium=referral,neutral,0.830899715423584
3040,12/9/2022 6:56:26 PM,The 7 Best Stocks to Buy This Week,InvestorPlace,/news/stocks/stocks-to-buy-this-week-1031665405,positive,0.8617548942565918
3041,12/11/2022 7:24:02 PM,Amgen said in advanced talks to buy Horizon Therapeutics for well over $20B - WSJ,Seeking Alpha,https://seekingalpha.com/news/3915954-amgen-said-in-advanced-talks-to-buy-horizon-therapeutics-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.8048020005226135
3042,12/12/2022 2:19:47 AM,Sanofi Says Doesn't Intend To Make Offer For Horizon; But Amgen Reportedly In Advanced Talks ,RTTNews,/news/stocks/sanofi-says-doesn-t-intend-to-make-offer-for-horizon-but-amgen-reportedly-in-advanced-talks-1031964257,positive,0.913437008857727
3043,12/12/2022 11:40:45 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Surgery Partners (SGRY) and Reata Pharmaceuticals (RETA)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-surgery-partners-sgry-and-reata-pharmaceuticals-reta-1031965110,neutral,0.8312996029853821
3044,12/12/2022 2:47:43 PM,Horizon Therapeutics (HZNP) Stock Pops on HUGE Amgen Deal,InvestorPlace,/news/stocks/horizon-therapeutics-hznp-stock-pops-on-huge-amgen-deal-1031967131,neutral,0.8790792226791382
3045,12/12/2022 3:03:26 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1031965423,positive,0.9169121980667114
3046,12/12/2022 5:34:15 PM,Allogene down 11% following downgrade to underperform at BofA,Seeking Alpha,https://seekingalpha.com/news/3916226-allogene-down-11-downgraded-to-underperform-at-bofa-on-lack-of-catalysts-competitiveness-concerns?utm_source=businessinsider&utm_medium=referral,neutral,0.9699710011482239
3047,12/13/2022 6:50:12 PM,BeiGene says Brukinsa bests J&J's Imbruvica in progression-free survival for leukemia,Seeking Alpha,https://seekingalpha.com/news/3916643-beigene-says-brukinsa-bests-johnson-johnson-imbruvica-in-progression-free-survival-for-leukemia?utm_source=businessinsider&utm_medium=referral,negative,0.9209824204444885
3048,12/13/2022 7:53:05 PM,The 7 Best Investment Funds to Navigate a Possible Recession,InvestorPlace,/news/stocks/the-7-best-investment-funds-to-navigate-possible-recession-1031970170,positive,0.6435859203338623
3049,12/14/2022 5:23:02 PM,WHO chief hopeful COVID emergency will end next year,Seeking Alpha,https://seekingalpha.com/news/3917016-who-chief-hopeful-covid-emergency-will-end-next-year?utm_source=businessinsider&utm_medium=referral,positive,0.8428406715393066
3050,12/14/2022 7:02:53 PM,Colorado becomes fourth state to ask feds to import drugs from Canada,Seeking Alpha,https://seekingalpha.com/news/3917055-colorado-becomes-fourth-state-to-ask-feds-to-import-drugs-from-canada?utm_source=businessinsider&utm_medium=referral,positive,0.7342972755432129
3051,12/15/2022 9:34:46 AM,FDA extends review of AstraZeneca/Merck's Lynparza's expanded use in prostate cancer,Seeking Alpha,https://seekingalpha.com/news/3917418-fda-extends-review-of-astrazenecamercks-lynparzas-expanded-use-in-prostate-cancer?utm_source=businessinsider&utm_medium=referral,positive,0.8040944337844849
3052,12/15/2022 11:08:17 AM,"J&J, Merck Ebola vaccines show lasting antibody response in kids, adults in trials",Seeking Alpha,https://seekingalpha.com/news/3917434-jj-merck-ebola-vaccines-show-lasting-antibody-response-in-kids-and-adults-in-trials?utm_source=businessinsider&utm_medium=referral,negative,0.85991370677948
3053,12/16/2022 11:25:27 AM,7 Top-Rated Large-Cap Stocks to Buy and Hold,InvestorPlace,/news/stocks/large-cap-stocks-to-buy-and-hold-1031827937,positive,0.8808764219284058
3054,12/16/2022 4:46:26 PM,FDA sets January meeting to consider further updates to COVID shots,Seeking Alpha,https://seekingalpha.com/news/3918097-fda-sets-january-meeting-to-consider-further-updates-to-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.91917884349823
3055,12/16/2022 6:04:34 PM,Time to start nibbling at stocks; 'this is not all gloom and doom' - Hightower's Stephanie Link,Seeking Alpha,https://seekingalpha.com/news/3918108-hightowers-stephanie-link-markets-will-sky-rocket-when-fed-will-pivot-but-not-very-soon?utm_source=businessinsider&utm_medium=referral,positive,0.6496508121490479
3056,12/18/2022 9:34:20 PM,The 7 Best Retirement Stocks to Buy Now,InvestorPlace,/news/stocks/best-retirement-stocks-1031562793,positive,0.8736042380332947
3057,12/19/2022 10:41:09 PM,"Abiomed leaving S&P 500, replaced by Steel Dynamics",Seeking Alpha,https://seekingalpha.com/news/3918757-abiomed-leaving-sp-500-replaced-by-steel-dynamics?utm_source=businessinsider&utm_medium=referral,neutral,0.795813262462616
3058,12/20/2022 12:35:00 AM,Steel Dynamics Set to Join S&P 500; Super Micro Computer to Join S&P MidCap 400,PR Newswire,/news/stocks/steel-dynamics-set-to-join-s-p-500-super-micro-computer-to-join-s-p-midcap-400-1031981302,positive,0.9075058102607727
3059,12/20/2022 1:30:49 AM,Steel Dynamics To Replace Abiomed In S&P 500 ,RTTNews,/news/stocks/steel-dynamics-to-replace-abiomed-in-s-p-500-1031981329,positive,0.5849705934524536
3060,12/20/2022 3:12:22 PM,"CVS, Walgreens limiting purchases of children's pain relief meds on high demand",Seeking Alpha,https://seekingalpha.com/news/3918953-cvs-walgreens-limiting-purchases-of-childrens-pain-relief-meds-on-high-demand?utm_source=businessinsider&utm_medium=referral,neutral,0.7578520774841309
3061,12/20/2022 5:00:22 PM,The 7 Best Bear Market Stocks to Buy Now,InvestorPlace,/news/stocks/best-bear-market-stocks-1031573318,positive,0.8821819424629211
3062,12/21/2022 7:00:40 PM,7 Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/dividend-stocks-to-buy-and-hold-1031557866,positive,0.9479726552963257
3063,12/22/2022 7:44:36 AM,Johnson & Johnson (NYSE:JNJ): This Dividend King is an Appealing Retirement Stock,TipRanks,/news/stocks/johnson-johnson-nyse-jnj-this-dividend-king-is-an-appealing-retirement-stock-1031986408,positive,0.871088981628418
3064,12/22/2022 2:28:07 PM,Johnson & Johnson closes Abiomed acquisition,Seeking Alpha,https://seekingalpha.com/news/3919803-jnj-stock-dips-closes-abiomed-acquisition?utm_source=businessinsider&utm_medium=referral,positive,0.5132481455802917
3065,12/23/2022 4:51:10 PM,Immune-evasive Omicron subvariant XBB rapidly gaining ground in U.S.,Seeking Alpha,https://seekingalpha.com/news/3920398-immune-evasive-omicron-subvariant-xbb-rapidly-gaining-ground-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.9495846629142761
3066,12/23/2022 8:21:12 PM,"Tax-loss selling, window dressing will likely ruin Santa Claus rally - DCLA's Sarat Sethi",Seeking Alpha,https://seekingalpha.com/news/3920543-fed-spooks-santa-claus-rally-dclas-sarat-sethi?utm_source=businessinsider&utm_medium=referral,neutral,0.6500759720802307
3067,12/24/2022 6:17:58 PM,"Barron's Top Weekend Stock Picks: Costco, Johnson & Johnson, And How Tesla Could Become A Value Stock",Benzinga,/news/stocks/barron-s-top-weekend-stock-picks-costco-johnson-johnson-and-how-tesla-could-become-a-value-stock-1031989835,positive,0.9280411005020142
3068,12/26/2022 12:05:59 PM,The 7 Best Warren Buffett Stocks to Buy,InvestorPlace,/news/stocks/best-warren-buffett-stocks-1031570894,positive,0.7930254340171814
3069,12/30/2022 5:45:22 PM,Merck is best performing large U.S. pharma of 2022,Seeking Alpha,https://seekingalpha.com/news/3921306-merck-is-best-performing-large-us-pharma-of-2022?utm_source=businessinsider&utm_medium=referral,negative,0.9400242567062378
3070,12/30/2022 6:19:49 PM,Omicron subvariant XBB becomes dominant COVID strain in U.S.,Seeking Alpha,https://seekingalpha.com/news/3921324-omicron-subvariant-xbb-becomes-dominant-covid-strain-in-us?utm_source=businessinsider&utm_medium=referral,negative,0.8420141339302063
3071,12/31/2022 3:00:00 PM,"Align, Invitae among healthcare stocks SA contributors correctly said to avoid in 2022",Seeking Alpha,https://seekingalpha.com/news/3920820-align-invitae-among-health-names-sa-contributors-correctly-said-to-avoid-in-2022?utm_source=businessinsider&utm_medium=referral,positive,0.8286207318305969
3072,1/2/2023 11:33:02 AM,7 Stocks for Beginners to Buy Now,InvestorPlace,/news/stocks/best-stocks-for-beginners-1031607349,positive,0.9169201254844666
3073,1/3/2023 9:24:44 AM,"J&J, Legend Biotech's Carvykti for multiple myeloma gets review in China",Seeking Alpha,https://seekingalpha.com/news/3921428-jj-legend-biotechs-carvykti-for-multiple-myeloma-gets-review-in-china?utm_source=businessinsider&utm_medium=referral,positive,0.574211061000824
3074,1/3/2023 7:20:31 PM,7 Must-Buy Dividend Stocks for Your January Buy List,InvestorPlace,/news/stocks/7-must-buy-dividend-stocks-for-your-january-buy-list-1031998516,positive,0.9449601769447327
3075,1/3/2023 7:43:16 PM,Immunovant gains as Wells Fargo names as a top SMID cap biotech pick,Seeking Alpha,https://seekingalpha.com/news/3921686-imvt-stock-gains-wells-fargo-names-top-smid-cap-biotech-pick?utm_source=businessinsider&utm_medium=referral,negative,0.9111081957817078
3076,1/4/2023 5:30:15 PM,The 10 Best Dividend Stocks of All Time¬†,InvestorPlace,/news/stocks/best-dividend-stocks-of-all-time-1031596593,positive,0.7762686014175415
3077,1/4/2023 6:55:55 PM,7 Safe Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/safe-stocks-to-buy-and-hold-1031612420,positive,0.9261383414268494
3078,1/4/2023 11:34:40 PM,J&J consumer health spinout Kenvue files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/3922164-jj-consumer-health-spinout-kenvue-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral,positive,0.9252834916114807
3079,1/5/2023 3:39:49 AM,Johnson & Johnson's Consumer Health Unit Kenvue Files For IPO ,RTTNews,/news/stocks/johnson-johnson-s-consumer-health-unit-kenvue-files-for-ipo-1032001078,positive,0.9364380240440369
3080,1/5/2023 10:42:21 PM,"Fate Therapeutics shares crater ~50% on ending tie-up with Janssen, layoffs",Seeking Alpha,https://seekingalpha.com/news/3922552-fate-therapeutics-shares-crater-50-on-ending-tie-up-with-janssen-layoffs?utm_source=businessinsider&utm_medium=referral,neutral,0.9396843314170837
3081,1/6/2023 10:26:55 AM,"Alvotech, Teva get FDA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3922582-alvotech-teva-get-fda-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral,negative,0.8574578762054443
3082,1/6/2023 4:27:19 PM,"Fate Therapeutics Ends Collaboration Deal With Janssen, Cuts Staff",Benzinga,/news/stocks/fate-therapeutics-ends-collaboration-deal-with-janssen-cuts-staff-1032004507,neutral,0.7804031372070312
3083,1/6/2023 5:41:34 PM,Fate faces slew of analyst downgrades after J&J's Janssen unit ends agreement,Seeking Alpha,https://seekingalpha.com/news/3922756-fate-faces-slew-of-analyst-downgrades-after-johnson-johnson-janssen-unit-ends-agreement?utm_source=businessinsider&utm_medium=referral,neutral,0.9644080996513367
3084,1/6/2023 8:48:56 PM,"CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC",InvestorPlace,/news/stocks/crispr-layoffs-2023-job-cuts-hit-gene-editing-stocks-fate-tcrr-ipsc-1032005093,neutral,0.8822422623634338
3085,1/6/2023 11:26:24 PM,5 Top Pharma Stocks of 2022 to Buy for the Long Haul,InvestorPlace,/news/stocks/5-top-pharma-stocks-of-2022-to-buy-for-the-long-haul-1032005182,positive,0.8010979890823364
3086,1/10/2023 11:34:49 AM,7 Warren Buffet Stocks to Buy and Hold for the Next Decade,InvestorPlace,/news/stocks/warren-buffett-stocks-to-buy-and-hold-1031558120,positive,0.9174212217330933
3087,1/10/2023 1:08:28 PM,WHO sets Jan. 27 meeting to decide on COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3923286-who-sets-jan-27-meeting-to-decide-on-covid-emergency?utm_source=businessinsider&utm_medium=referral,positive,0.9474840760231018
3088,1/10/2023 6:45:11 PM,Cosmos extends and updates deal to acquire Cana Laboratories,Seeking Alpha,https://seekingalpha.com/news/3923434-cosmos-extends-and-updates-deal-to-acquire-cana-laboratories?utm_source=businessinsider&utm_medium=referral,positive,0.5548141598701477
3089,1/10/2023 6:48:19 PM,"If You Invested $1,000 In Inovio Stock At Its COVID-19 Pandemic Low, Here's How Much You'd Have Now",Benzinga,/news/stocks/if-you-invested-1-000-in-inovio-stock-at-its-covid-19-pandemic-low-here-s-how-much-you-d-have-now-1032010420,positive,0.9118823409080505
3090,1/11/2023 9:49:15 AM,Alvotech starts study of biosimilar of J&J's rheumatoid arthritis drug Simponi,Seeking Alpha,https://seekingalpha.com/news/3923570-alvotech-starts-study-of-biosimilar-of-jjs-rheumatoid-arthritis-drug-simponi?utm_source=businessinsider&utm_medium=referral,positive,0.7315362691879272
3091,1/11/2023 6:06:37 PM,7 Hot Healthcare Stocks to Watch in 2023,InvestorPlace,/news/stocks/7-hot-healthcare-stocks-to-watch-in-2023-1032013193,positive,0.8813204169273376
3092,1/11/2023 8:35:28 PM,Medicare to publish drugs targeted for pricing negotiations in September,Seeking Alpha,https://seekingalpha.com/news/3923880-medicare-publish-drugs-targeted-pricing-negotiations-in-september?utm_source=businessinsider&utm_medium=referral,positive,0.9117305874824524
3093,1/12/2023 6:52:33 PM,White House COVID coordinator warns winter surges of infections will be new normal,Seeking Alpha,https://seekingalpha.com/news/3924266-white-house-covid-coordinator-warns-winter-surges-of-infections-will-be-new-normal?utm_source=businessinsider&utm_medium=referral,neutral,0.9300765991210938
3094,1/13/2023 3:54:22 PM,Omicron subvariant XBB.1.5 makes up 43% of COVID cases in U.S. ‚Äì CDC,Seeking Alpha,https://seekingalpha.com/news/3924549-omicron-subvariant-xbb15-makes-up-43-of-covid-cases-in-us-cdc?utm_source=businessinsider&utm_medium=referral,positive,0.933558464050293
3095,1/13/2023 4:16:22 PM,Johnson & Johnson is scaling back COVID-19 vaccine production ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3924553-jnj-stock-falls-as-company-scaling-back-covid-19-vaccine-production?utm_source=businessinsider&utm_medium=referral,neutral,0.9495651721954346
3096,1/13/2023 7:22:37 PM,"Johnson & Johnson Cuts Production, Ends Contracts For Not So Successful COVID-19 Shot",Benzinga,/news/stocks/johnson-johnson-cuts-production-ends-contracts-for-not-so-successful-covid-19-shot-1032018165,neutral,0.9613111615180969
3097,1/18/2023 12:34:06 PM,Moderna Gets A 'Booster' Shot: Why Stock Is Up Nearly 7% Today,Benzinga,/news/stocks/moderna-gets-a-booster-shot-why-stock-is-up-nearly-7-today-1032025074,negative,0.9358070492744446
3098,1/18/2023 4:12:04 PM,Johnson & Johnson scraps HIV vaccine program after Phase 3 setback,Seeking Alpha,https://seekingalpha.com/news/3925478-johnson-johnson-scraps-hiv-vaccine-program-after-phase-3-setback?utm_source=businessinsider&utm_medium=referral,neutral,0.8535194993019104
3099,1/19/2023 4:29:43 PM,3 Safe Stock Bets for an Unpredictable Market,InvestorPlace,/news/stocks/3-safe-stock-bets-for-an-unpredictable-market-1032029023,positive,0.8828821182250977
3100,1/19/2023 10:05:01 PM,BeiGene's Brukinsa gains approval for two additional types of leukemia,Seeking Alpha,https://seekingalpha.com/news/3926154-beigene-brukinsa-gains-approval-for-two-additional-types-of-leukemia?utm_source=businessinsider&utm_medium=referral,negative,0.9115498065948486
3101,1/20/2023 12:30:20 PM,Japan to consider downgrading COVID to same level as seasonal flu,Seeking Alpha,https://seekingalpha.com/news/3926268-japan-to-consider-downgrading-covid-to-same-level-as-seasonal-flu?utm_source=businessinsider&utm_medium=referral,positive,0.8910207152366638
3102,1/20/2023 12:31:18 PM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), BeiGene (BGNE)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-beigene-bgne-1032030702,positive,0.4800044596195221
3103,1/20/2023 2:30:47 PM,Draganfly To Rally Around 87%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/draganfly-to-rally-around-87-here-are-10-other-analyst-forecasts-for-friday-1032030827,positive,0.9135152697563171
3104,1/20/2023 4:01:21 PM,What 5 Analyst Ratings Have To Say About Johnson & Johnson,Benzinga,/news/stocks/what-5-analyst-ratings-have-to-say-about-johnson-johnson-1032031057,positive,0.9377719163894653
3105,1/20/2023 5:16:36 PM,"Earnings week ahead: Tesla, Microsoft, AT&T and more",Seeking Alpha,https://seekingalpha.com/news/3926380-earnings-week-ahead-tesla-microsoft-att-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9216915369033813
3106,1/20/2023 7:30:11 PM,"Catalyst watch: Tesla reverberations, Intel earnings, Rocket Lab launch and Macau stocks on holiday",Seeking Alpha,https://seekingalpha.com/news/3926434-catalyst-watch-tesla-reverberations-intel-earnings-rocket-lab-launch-and-macau-stocks-on-holiday?utm_source=businessinsider&utm_medium=referral,positive,0.8929739594459534
3107,1/21/2023 9:40:00 PM,"AstraZeneca, Biogen, Bristol, and Eli Lilly among companies w/ blockbuster potential drugs",Seeking Alpha,https://seekingalpha.com/news/3926479-astrazeneca-biogen-bristol-and-eli-lilly-among-companies-with-blockbuster-potential-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.9066245555877686
3108,1/23/2023 12:15:10 PM,Morphic says Johnson & Johnson unit ended research collaboration,Seeking Alpha,https://seekingalpha.com/news/3926626-morf-stock-slips-johnson--johnson-unit-end-research-deal?utm_source=businessinsider&utm_medium=referral,positive,0.8502250909805298
3109,1/23/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q4-quarterly-earnings-preview-stock-1032033991,positive,0.9335330724716187
3110,1/23/2023 3:01:19 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3926753-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
3111,1/23/2023 3:26:55 PM,"Nasdaq, S&P, and Dow move higher as Wall Street gears up for an earnings-packed week",Seeking Alpha,https://seekingalpha.com/news/3926606-sp500-nasdaq-dow-jones-stock-market?utm_source=businessinsider&utm_medium=referral,negative,0.6438297033309937
3112,1/23/2023 3:33:42 PM,FDA plans an annual schedule for updated COVID shots,Seeking Alpha,https://seekingalpha.com/news/3926754-fda-plans-an-annual-schedule-for-updated-covid-shots?utm_source=businessinsider&utm_medium=referral,positive,0.9269378781318665
3113,1/23/2023 5:05:09 PM,Johnson & Johnson to report Q4 earnings amid macro concerns,Seeking Alpha,https://seekingalpha.com/news/3926788-johnson-johnson-to-report-q4-earnings-amid-macro-concerns?utm_source=businessinsider&utm_medium=referral,neutral,0.9535406827926636
3114,1/23/2023 9:04:41 PM,"Risk-on bet sends Dow, S&P 500, Nasdaq higher",Seeking Alpha,https://seekingalpha.com/news/3926863-risk-on-bet-sends-dow-sp-500-nasdaq-higher?utm_source=businessinsider&utm_medium=referral,negative,0.5778688788414001
3115,1/23/2023 9:53:36 PM,The 7 Best Income Stocks to Buy in January,InvestorPlace,/news/stocks/the-7-best-income-stocks-to-buy-in-january-1032035035,positive,0.9139778017997742
3116,1/24/2023 10:02:31 AM,"Microsoft, Verizon Communications And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/microsoft-verizon-communications-and-3-stocks-to-watch-heading-into-tuesday-1032036073,positive,0.9295194149017334
3117,1/24/2023 11:26:17 AM,"Johnson & Johnson Non-GAAP EPS of $2.35 beats by $0.11, revenue of $23.7B misses by $200M",Seeking Alpha,https://seekingalpha.com/news/3927039-johnson-and-johnson-non-gaap-eps-of-2_35-beats-0_11-revenue-of-23_7b-misses-200m?utm_source=businessinsider&utm_medium=referral,positive,0.7308369874954224
3118,1/24/2023 12:10:41 PM,"J&J trades higher despite Q4 revenue hit by forex, COVID vaccine impact, FY23 outlook above estimates",Seeking Alpha,https://seekingalpha.com/news/3927066-jj-trades-higher-despite-q4-revenue-hit-by-forex-covid-vaccine-impact-fy23-outlook-above-estimates?utm_source=businessinsider&utm_medium=referral,negative,0.9099158644676208
3119,1/24/2023 12:39:27 PM,"Johnson & Johnson Q4 Profit Decreases, but beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1032036379,neutral,0.9718552827835083
3120,1/24/2023 1:23:33 PM,"Johnson & Johnson Q4 Profit Down 26%, But Adj. EPS Tops Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-down-26-but-adj-eps-tops-estimates-1032036523,neutral,0.9724675416946411
3121,1/24/2023 1:41:20 PM,Wall Street Might Open Lower ,RTTNews,/news/stocks/wall-street-might-open-lower-1032036579,positive,0.5649072527885437
3122,1/24/2023 3:07:45 PM,Why Are Stocks Down Today?,InvestorPlace,/news/stocks/why-are-stocks-down-today-14-1032037244,neutral,0.9098419547080994
3123,1/24/2023 3:20:26 PM,"Nasdaq, S&P, and Dow trade lower after sharp rally and stronger manufacturing data",Seeking Alpha,https://seekingalpha.com/news/3927033-sp500-nasdaq-dow-jones-stock-market-earnings?utm_source=businessinsider&utm_medium=referral,neutral,0.956379234790802
3124,1/24/2023 7:36:56 PM,"CDC chief to add new offices, leadership in organizational revamp",Seeking Alpha,https://seekingalpha.com/news/3927373-cdc-chief-to-add-new-offices-leadership-in-organizational-revamp?utm_source=businessinsider&utm_medium=referral,negative,0.5872244238853455
3125,1/24/2023 8:14:48 PM,"Nasdaq, S&P, Dow stumble after two-day win streak as earnings take spotlight",Seeking Alpha,https://seekingalpha.com/news/3927246-nasdaq-sp500-dow-jones-stock-market-earnings-economic-data?utm_source=businessinsider&utm_medium=referral,neutral,0.9303019642829895
3126,1/24/2023 9:06:22 PM,"Dow, S&P 500, Nasdaq finish mixed as earnings season picks up steam",Seeking Alpha,https://seekingalpha.com/news/3927392-dow-sp-500-nasdaq-finish-mixed-as-earnings-season-picks-up-steam?utm_source=businessinsider&utm_medium=referral,neutral,0.9387122988700867
3127,1/25/2023 12:25:24 PM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032040034,positive,0.5214546322822571
3128,1/25/2023 1:37:14 PM,Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday,Benzinga,/news/stocks/union-pacific-to-rally-over-11-here-are-10-other-analyst-forecasts-for-wednesday-1032040092,positive,0.9079694151878357
3129,1/25/2023 4:31:36 PM,"Analysts Offer Insights on Healthcare Companies: Danaher (DHR), Idexx Laboratories (IDXX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-danaher-dhr-idexx-laboratories-idxx-and-johnson-johnson-jnj-1032041134,positive,0.911987841129303
3130,1/26/2023 8:39:21 AM,Evotec Partners With Janssen Biotech To Develop Immune-based Cancer Therapies ,RTTNews,/news/stocks/evotec-partners-with-janssen-biotech-to-develop-immune-based-cancer-therapies-1032042835,negative,0.6961004137992859
3131,1/26/2023 10:52:21 AM,Evotec stock rises on licensing deal with J&J to develop immune-based drugs,Seeking Alpha,https://seekingalpha.com/news/3928233-evotec-stock-rises-on-licensing-deal-with-jj-to-develop-immune-based-drugs?utm_source=businessinsider&utm_medium=referral,negative,0.8805674910545349
3132,1/26/2023 11:06:46 PM,The 3 Best Biotech Stocks Under $1 to Buy for January,InvestorPlace,/news/stocks/the-3-best-biotech-stocks-under-1-to-buy-for-january-1032045234,positive,0.7229993939399719
3133,1/27/2023 1:15:17 AM,Barclays Reaffirms Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-reaffirms-their-hold-rating-on-johnson-johnson-jnj-1032045301,positive,0.7761672735214233
3134,1/27/2023 4:31:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Aurinia Pharmaceuticals (AUPH) and POINT Biopharma Global (PNT)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-aurinia-pharmaceuticals-auph-and-point-biopharma-global-pnt-1032045403,positive,0.9008322954177856
3135,1/27/2023 12:52:31 PM,J&J pulls Imbruvica combo filing in EU as EMA cites potential 'serious side effects',Seeking Alpha,https://seekingalpha.com/news/3928895-jj-pulls-imbruvica-combo-filing-in-eu-as-ema-cites-potential-serious-side-effects?utm_source=businessinsider&utm_medium=referral,neutral,0.9580039381980896
3136,1/27/2023 2:09:13 PM,JNJ/ Legend CAR-T therapy succeeds in Phase 3 multiple myeloma trial,Seeking Alpha,https://seekingalpha.com/news/3928956-jnj-legend-car-t-therapy-succeeds-late-stage-multiple-myeloma-trial?utm_source=businessinsider&utm_medium=referral,negative,0.9411073327064514
3137,1/28/2023 6:00:40 PM,The use of artificial intelligence in medical devices and drug development,Seeking Alpha,https://seekingalpha.com/news/3929184-the-growing-use-of-artificial-intelligence-in-medical-devices-diagnostics-drug-development?utm_source=businessinsider&utm_medium=referral,positive,0.9313576817512512
3138,1/29/2023 5:00:25 PM,AbbVie‚Äôs global bestseller to face knockoffs starting this week,Seeking Alpha,https://seekingalpha.com/news/3929211-abbvies-global-bestseller-to-face-knockoffs-starting-this-week?utm_source=businessinsider&utm_medium=referral,neutral,0.4311627745628357
3139,1/30/2023 9:54:14 AM,Are You Seeking Passive Income? Try These 2 Dividend Kings,TipRanks,/news/stocks/are-you-seeking-passive-income-try-these-2-dividend-kings-1032050273,positive,0.934408962726593
3140,1/30/2023 12:00:56 PM,WHO maintains public health emergency on COVID but sees pandemic at 'transition point',Seeking Alpha,https://seekingalpha.com/news/3929274-who-maintains-public-health-emergency-on-covid-with-3-years-into-pandemic?utm_source=businessinsider&utm_medium=referral,positive,0.743737518787384
3141,1/30/2023 4:28:17 PM,"$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns",Benzinga,/news/stocks/1-000-invested-in-4-of-the-5-vaccine-developers-back-when-who-declared-covid-19-an-emergency-yielded-returns-1032051302,positive,0.8757470846176147
3142,1/30/2023 7:57:21 PM,Why Is Johnson & Johnson (JNJ) Stock Down Today?,InvestorPlace,/news/stocks/why-is-johnson-johnson-jnj-stock-down-today-2-1032051840,neutral,0.9397314786911011
3143,1/30/2023 9:32:36 PM,J&J falls after appeals court rules company can't use bankruptcy to end cancer suits (update),Seeking Alpha,https://seekingalpha.com/news/3929431-jj-falls-after-losing-appeals-court-ruling-in-talc-litigation?utm_source=businessinsider&utm_medium=referral,neutral,0.7513048052787781
3144,1/30/2023 11:04:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032052020,neutral,0.7720081210136414
3145,1/31/2023 10:34:31 AM,Court Rejects J&J Bankruptcy Petition To End Talc Cancer Lawsuits ,RTTNews,/news/stocks/court-rejects-j-j-bankruptcy-petition-to-end-talc-cancer-lawsuits-1032053415,neutral,0.6374338269233704
3146,1/31/2023 12:35:28 PM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032053930,positive,0.9087795615196228
3147,1/31/2023 2:24:45 PM,Haleon said to evaluate potential deals to increase its size - report,Seeking Alpha,https://seekingalpha.com/news/3929851-haleon-said-to-evaluate-potential-deals-to-increase-its-size-report?utm_source=businessinsider&utm_medium=referral,negative,0.914466142654419
3148,1/31/2023 3:29:00 PM,Federal Appellate Court Rejects Controversial J&J Ploy to Dodge Talc Cancer Lawsuits,PR Newswire,/news/stocks/federal-appellate-court-rejects-controversial-j-j-ploy-to-dodge-talc-cancer-lawsuits-1032054544,neutral,0.7720081210136414
3149,1/31/2023 11:17:47 PM,The 7 Best Climate Change Stocks to Buy for 2023,InvestorPlace,/news/stocks/the-7-best-climate-change-stocks-to-buy-for-2023-1032055998,positive,0.8521709442138672
3150,2/1/2023 3:16:38 AM,Johnson & Johnson Stock (NYSE:JNJ): Time Heals All Wounds,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-heals-all-wounds-1032056074,positive,0.8042324185371399
3151,2/1/2023 4:18:52 PM,"Novavax, JNJ dispute pre-payments for canceled COVID shots sought for world‚Äôs poor - NYT",Seeking Alpha,https://seekingalpha.com/news/3930507-novavax-jnj-dispute-pre-payments-cancelled-covid-shots-worlds-poor?utm_source=businessinsider&utm_medium=referral,positive,0.48630255460739136
3152,2/1/2023 4:48:33 PM,The most overbought and oversold S&P 500 stocks to start February,Seeking Alpha,https://seekingalpha.com/news/3930472-tmost-overbought-oversold-sp500-stocks-february?utm_source=businessinsider&utm_medium=referral,neutral,0.9532690048217773
3153,2/2/2023 5:44:50 PM,3 Defensive Stocks to Buy If You Think the Market Is Headed Lower,InvestorPlace,/news/stocks/3-defensive-stocks-to-buy-if-you-think-the-market-is-headed-lower-1032063814,positive,0.895889937877655
3154,2/2/2023 7:11:33 PM,U.K. pharma lobby urges govt. to halt plans to raise revenue recovery rates,Seeking Alpha,https://seekingalpha.com/news/3931486-uk-pharma-lobby-urges-govt-to-halt-plans-to-raise-revenue-recovery-rates?utm_source=businessinsider&utm_medium=referral,neutral,0.9276774525642395
3155,2/2/2023 7:21:22 PM,"Johnson & Johnson's Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst",Benzinga,/news/stocks/johnson-johnson-s-upcoming-lung-cancer-data-could-offer-another-blockbuster-opportunity-says-analyst-1032063869,negative,0.9062609672546387
3156,2/4/2023 9:00:00 PM,"Ambulatory surgery centers, robotics seen as trends for orthopedic devices in 2023",Seeking Alpha,https://seekingalpha.com/news/3932049-ambulatory-surgery-centers-robotics-seen-as-trends-for-orthopedic-devices-in-2023?utm_source=businessinsider&utm_medium=referral,positive,0.637492835521698
3157,2/5/2023 12:13:24 AM,Danaher said to be interested in acquiring contract manufacturer Catalent,Seeking Alpha,https://seekingalpha.com/news/3932097-danaher-shows-takeover-interest-contract-manufacturer-catalent?utm_source=businessinsider&utm_medium=referral,positive,0.8199107646942139
3158,2/5/2023 5:00:57 PM,Drug price inflation continues upward momentum at 3.8% ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3932101-drug-price-inflation-continues-upward-momentum-at-38-report?utm_source=businessinsider&utm_medium=referral,negative,0.9158604145050049
3159,2/6/2023 2:15:33 PM,Johnson & Johnson succeeds in mid-stage trial for fetal disorder candidate,Seeking Alpha,https://seekingalpha.com/news/3932298-johnson-johnson-succeeds-mid-stage-trial-fetal-disorder-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.6848245859146118
3160,2/6/2023 3:48:48 PM,Why Is Catalent (NYSE:CTLT) Stock Up 20% Today?,InvestorPlace,/news/stocks/why-is-catalent-nysectlt-stock-up-20-today-1032070835,negative,0.8154944181442261
3161,2/6/2023 5:56:09 PM,Teva follows AbbVie to leave top pharma industry group,Seeking Alpha,https://seekingalpha.com/news/3932426-teva-follows-abbvie-to-leave-top-pharma-industry-group?utm_source=businessinsider&utm_medium=referral,positive,0.6935389041900635
3162,2/6/2023 6:15:50 PM,How to Score Profits In Every Trade With Minimal Risk,InvestorPlace,/news/stocks/how-to-score-profits-in-every-trade-with-minimal-risk-1032071173,positive,0.9093331098556519
3163,2/6/2023 7:49:01 PM,Arrowhead drops as Cantor flags risks to Johnson & Johnson licensing deal,Seeking Alpha,https://seekingalpha.com/news/3932504-arwr-stock-drops-cantor-flags-risks-johnson-johnson-licensing-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.8852108120918274
3164,2/7/2023 3:01:23 AM,The 3 Best Forever Stocks to Buy for February 2023,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-for-february-2023-1032071770,positive,0.9316399097442627
3165,2/8/2023 11:49:09 AM,Australia to offer fifth COVID shot to all adults later this month,Seeking Alpha,https://seekingalpha.com/news/3933402-australia-to-offer-fifth-covid-shot-to-all-adults-later-this-month?utm_source=businessinsider&utm_medium=referral,positive,0.7316170334815979
3166,2/8/2023 4:26:42 PM,Johnson & Johnson reports positive mid-stage data for rare fetus disease drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/3933603-johnson-johnson-reports-positive-mid-stage-data-for-rare-fetus-disease-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral,negative,0.9470140933990479
3167,2/9/2023 7:36:13 AM,"Roche, Janssen Biotech To Advance Personalised Healthcare Through Companion Diagnostics ",RTTNews,/news/stocks/roche-janssen-biotech-to-advance-personalised-healthcare-through-companion-diagnostics-1032081753,positive,0.7894529700279236
3168,2/9/2023 10:07:22 AM,7 Dividend Stocks to Buy for a Reliable Income Stream,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-for-a-reliable-income-stream-1032082235,positive,0.8049969673156738
3169,2/9/2023 10:39:40 AM,"Alvotech, Stada get EMA review for biosimilar to J&J's Stelara",Seeking Alpha,https://seekingalpha.com/news/3934076-alvotech-stada-get-ema-review-for-biosimilar-to-jjs-stelara?utm_source=businessinsider&utm_medium=referral,positive,0.5783002972602844
3170,2/10/2023 12:18:08 PM,Medicare mulls rebates in 2025 for drug prices rising faster than inflation,Seeking Alpha,https://seekingalpha.com/news/3934728-medicare-mulls-rebates-in-2025-for-drug-prices-rising-faster-than-inflation?utm_source=businessinsider&utm_medium=referral,positive,0.5336910486221313
3171,2/10/2023 4:46:18 PM,"Bristol-Myers, 2seventy post late-stage data for CAR-T therapy in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/3934866-bristol-myers-2seventy-late-stage-data-car-t-therapy-multiple-myeloma?utm_source=businessinsider&utm_medium=referral,negative,0.7861078381538391
3172,2/10/2023 6:19:06 PM,3 of the Best Dividend Stocks to Buy for February¬†,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-february-1032087085,positive,0.7848634719848633
3173,2/12/2023 5:00:59 PM,COVID-19 emergency is ending; What it means for free vaccines and drugs,Seeking Alpha,https://seekingalpha.com/news/3935039-pandemic-emergency-ending-impact-covid-shots-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.908437192440033
3174,2/13/2023 4:11:05 AM,"Alcon, J&J Surgical To Settle Litigation On Femtosecond Laser Assisted Cataract Surgery Devices ",RTTNews,/news/stocks/alcon-j-j-surgical-to-settle-litigation-on-femtosecond-laser-assisted-cataract-surgery-devices-1032088325,positive,0.7195115089416504
3175,2/13/2023 3:57:12 PM,"Wainwright initiates Arcellx with a buy on CAR-T pipeline, partnership with Gilead's Kite",Seeking Alpha,https://seekingalpha.com/news/3935243-wainwright-initiates-arcellx-with-a-buy-on-car-t-pipeline-partnership-with-gilead-kite?utm_source=businessinsider&utm_medium=referral,negative,0.5246882438659668
3176,2/13/2023 7:18:57 PM,"OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships",Seeking Alpha,https://seekingalpha.com/news/3935341-omniab-initiated-with-a-buy-at-hc-wainwright-on-antibody-collaborations-partnerships?utm_source=businessinsider&utm_medium=referral,positive,0.7189428806304932
3177,2/14/2023 10:40:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Mettler-Toledo (MTD) and Bioxcel Therapeutics (BTAI)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-mettler-toledo-mtd-and-bioxcel-therapeutics-btai-1032094127,neutral,0.9326804280281067
3178,2/14/2023 12:21:21 PM,Johnson & Johnson poaches Sanofi R&D head,Seeking Alpha,https://seekingalpha.com/news/3935652-johnson-johnson-poaches-sanofi-rd-head?utm_source=businessinsider&utm_medium=referral,positive,0.9347676038742065
3179,2/14/2023 6:59:53 PM,J&J faces dismissal in talc unit bankruptcy filing after appeals court ruling,Seeking Alpha,https://seekingalpha.com/news/3935926-johnson-johnson-faces-dismissal-in-talc-unit-bankruptcy-filing-after-appeals-court-ruling?utm_source=businessinsider&utm_medium=referral,neutral,0.9546216726303101
3180,2/15/2023 2:12:03 PM,J&J returns rights to NASH RNAi candidate to Arrowhead Pharmaceuticals,Seeking Alpha,https://seekingalpha.com/news/3936329-johnson-johnson-returns-rights-to-nash-rnai-candidate-to-arrowhead-pharmaceuticals?utm_source=businessinsider&utm_medium=referral,positive,0.9146599769592285
3181,2/15/2023 6:14:32 PM,Medicare mulls limiting per month costs for generic drugs at $2,Seeking Alpha,https://seekingalpha.com/news/3936542-medicare-mulls-limiting-per-month-costs-for-generic-drugs-at-2?utm_source=businessinsider&utm_medium=referral,positive,0.4218192398548126
3182,2/15/2023 7:09:07 PM,3 ETFs Investors Can Buy to Weather a Recession,TipRanks,/news/stocks/3-etfs-investors-can-buy-to-weather-a-recession-1032100105,positive,0.854220449924469
3183,2/15/2023 7:15:00 PM,"Immunovant Could Potentially Be An M&A Target, Writes Analyst",Benzinga,/news/stocks/immunovant-could-potentially-be-an-m-a-target-writes-analyst-1032100005,positive,0.7652799487113953
3184,2/16/2023 11:17:26 PM,Johnson & Johnson files for debt securities offering,Seeking Alpha,https://seekingalpha.com/news/3937530-johnson-johnson-files-for-debt-securities-offering?utm_source=businessinsider&utm_medium=referral,neutral,0.5772467255592346
3185,2/17/2023 9:05:38 PM,"S&P 500, Dow, Nasdaq finish mixed as Fed debate continues",Seeking Alpha,https://seekingalpha.com/news/3937828-sp-500-dow-nasdaq-finish-mixed-as-fed-debate-continues?utm_source=businessinsider&utm_medium=referral,neutral,0.8176480531692505
3186,2/19/2023 5:00:10 PM,The next big wave of patent cliffs is ahead; expect biopharma M&A to rise ‚Äì report,Seeking Alpha,https://seekingalpha.com/news/3937885-next-big-wave-of-patent-cliffs-ahead-biopharma-m-and-a-to-rise?utm_source=businessinsider&utm_medium=referral,negative,0.9136704802513123
3187,2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/ko-jnj-mmm-the-3-best-dividend-stocks-for-beginner-investors-1032109636,positive,0.8241354823112488
3188,2/20/2023 7:40:55 PM,The 3 Best Dividend Stocks for Beginner Investors,InvestorPlace,/news/stocks/the-3-best-dividend-stocks-for-beginner-investors-1032109629,positive,0.8241354823112488
3189,2/21/2023 4:15:14 PM,Johnson & Johnson fails in bid to overturn $302M vaginal-mesh award ‚Äì Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3938462-johnson-johnson-fails-overturn-302m-vaginal-mesh-award?utm_source=businessinsider&utm_medium=referral,neutral,0.9332295060157776
3190,2/24/2023 7:12:47 PM,Johnson & Johnson wins EU nod for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3940807-johnson-johnson-wins-eu-nod-for-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8188331127166748
3191,2/25/2023 9:00:00 PM,"Pharmas, medtechs dominate list of innovation leaders thanks to patents",Seeking Alpha,https://seekingalpha.com/news/3940793-pharmas-medtechs-dominate-list-of-innovation-leaders-thanks-to-patents?utm_source=businessinsider&utm_medium=referral,positive,0.6739813089370728
3192,2/27/2023 10:34:00 PM,Emergent BioSolutions off 4% on Q4 2022 bottom line miss,Seeking Alpha,https://seekingalpha.com/news/3941487-emergent-biosolutions-off-4-on-q4-2022-bottom-line-miss?utm_source=businessinsider&utm_medium=referral,neutral,0.9636859893798828
3193,3/1/2023 11:39:48 AM,FBI Director says novel coronavirus likely originated from China lab leak,Seeking Alpha,https://seekingalpha.com/news/3942433-fbi-director-says-novel-coronavirus-likely-originated-from-china-lab-leak?utm_source=businessinsider&utm_medium=referral,positive,0.9219886064529419
3194,3/1/2023 1:00:35 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032135739,positive,0.9169121980667114
3195,3/1/2023 2:12:06 PM,7 Stocks to Protect Against the Massive Inflation Shock of 2023,InvestorPlace,/news/stocks/7-stocks-to-protect-against-the-massive-inflation-shock-of-2023-1032136605,positive,0.6057958006858826
3196,3/1/2023 2:23:39 PM,Cidara stock pops as CD388 helps cut influenza risk in phase 2a trial,Seeking Alpha,https://seekingalpha.com/news/3942600-cidara-stock-pops-as-cd388-helps-cut-influenza-risk-in-phase-2a-trial?utm_source=businessinsider&utm_medium=referral,negative,0.8663569688796997
3197,3/1/2023 3:21:14 PM,"J&J initiated at neutral at Guggenheim on need for pharma, medtech growth visibility",Seeking Alpha,https://seekingalpha.com/news/3942649-johnson-johnson-initiated-at-neutral-at-guggenheim-on-need-for-pharma-medtech-growth-visibility?utm_source=businessinsider&utm_medium=referral,positive,0.7360733151435852
3198,3/1/2023 4:00:51 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-1-2023-1032136808,positive,0.5188173055648804
3199,3/1/2023 7:21:42 PM,"Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional'",Benzinga,/news/stocks/jim-cramer-says-he-s-known-novavax-is-worthless-for-very-long-time-trashes-company-for-being-too-promotional-1032137450,neutral,0.8620643019676208
3200,3/1/2023 8:55:25 PM,JNJ's Consumer Health Business Separation Will Remove Uncertainty Cloud From Company: Why This Analyst Wants Visibility,Benzinga,/news/stocks/jnj-s-consumer-health-business-separation-will-remove-uncertainty-cloud-from-company-why-this-analyst-wants-visibility-1032137596,positive,0.9205654859542847
3201,3/2/2023 1:01:02 PM,"Bristol-Myers, Janssen launch late-stage Librexia program evaluating milvexian",Seeking Alpha,https://seekingalpha.com/news/3943202-bristol-myers-janssen-launch-late-stage-librexia-program-evaluating-milvexian?utm_source=businessinsider&utm_medium=referral,positive,0.6535271406173706
3202,3/2/2023 2:39:19 PM,Merck and AstraZeneca to face FDA AdCom meeting for prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3943282-merck-astrazeneca-face-fda-adcom-meeting-prostate-cancer-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.9068241715431213
3203,3/4/2023 5:21:29 PM,Johnson & Johnson's Stelara demonstrates long-term efficacy in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/3944202-johnson-johnson-stelara-demonstrates-long-term-efficacy-in-crohns-disease?utm_source=businessinsider&utm_medium=referral,negative,0.9443408250808716
3204,3/4/2023 6:45:00 PM,Pharma R&D funding soared to a new record in 2022 as oncology candidates dominate pipelines,Seeking Alpha,https://seekingalpha.com/news/3944195-pharma-research-developmeny-funding-soared-to-a-new-record-in-2022-as-oncology-candidates-dominate-pipelines?utm_source=businessinsider&utm_medium=referral,negative,0.9410833716392517
3205,3/6/2023 3:00:29 PM,"Janssen's macitentan, tadalafil combo improves pulmonary hemodynamics vs. monotherapies",Seeking Alpha,https://seekingalpha.com/news/3944464-janssens-macitentan-tadalafil-combo-improves-pulmonary-hemodynamics-vs-monotherapies?utm_source=businessinsider&utm_medium=referral,negative,0.9429464340209961
3206,3/6/2023 7:24:23 PM,5 Stocks ChatGPT Says Will Make Me Rich in 20 Years,InvestorPlace,/news/stocks/5-growth-stocks-to-buy-according-to-chatgpt-1032148311,positive,0.7920088768005371
3207,3/6/2023 9:51:35 PM,7 Dividend Kings to Buy for an Uncertain Market Environment,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-an-uncertain-market-environment-1032148499,positive,0.6553321480751038
3208,3/6/2023 10:07:52 PM,7 Stocks to Buy for the Worrying Climate Change Crisis,InvestorPlace,/news/stocks/7-stocks-to-buy-for-the-worrying-climate-change-crisis-1032148516,positive,0.8517792224884033
3209,3/7/2023 12:33:25 PM,Biden to announce plan to keep Medicare solvent beyond 2050,Seeking Alpha,https://seekingalpha.com/news/3944823-biden-to-announce-plan-to-keep-medicare-solvent-beyond-2050?utm_source=businessinsider&utm_medium=referral,negative,0.533659815788269
3210,3/7/2023 3:54:10 PM,Why Protagonist Therapeutics Shares Are Trading Higher Today,Benzinga,/news/stocks/why-protagonist-therapeutics-shares-are-trading-higher-today-1032150761,negative,0.7465009689331055
3211,3/8/2023 11:41:29 AM,Sleep-at-night stocks for those hedging or risk averse,Seeking Alpha,https://seekingalpha.com/news/3945026-sleep-at-night-stocks-for-those-hedging-or-risk-averse?utm_source=businessinsider&utm_medium=referral,positive,0.7829471826553345
3212,3/8/2023 12:27:39 PM,Johnson & Johnson in pact with Biocytogen for antibody-based therapeutics,Seeking Alpha,https://seekingalpha.com/news/3945267-johnson-johnson-pact-with-biocytogen-antibody-based-therapeutics?utm_source=businessinsider&utm_medium=referral,negative,0.7741836905479431
3213,3/8/2023 1:31:08 PM,Wall Street Analysts Are Neutral on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-neutral-on-top-healthcare-picks-1032153556,neutral,0.700346827507019
3214,3/8/2023 1:33:18 PM,3 Must-Buy Income Champs as Fed Rates Head to 5%,InvestorPlace,/news/stocks/3-must-buy-income-champs-as-fed-rates-head-to-5-1032153538,negative,0.5246691107749939
3215,3/8/2023 4:35:41 PM,J&J consumer health spinoff Kenvue begins bond sale to fund separation - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3945427-johnson-johnson-consumer-health-spinoff-kenvue-begins-bond-sale-to-fund-separation-bloomberg?utm_source=businessinsider&utm_medium=referral,positive,0.8761563897132874
3216,3/8/2023 9:05:24 PM,7 Stocks at 52-Week Lows and Highly Attractive From Here,InvestorPlace,/news/stocks/7-stocks-at-52-week-lows-and-highly-attractive-from-here-1032154824,neutral,0.8883254528045654
3217,3/9/2023 4:05:45 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032155153,positive,0.7031834125518799
3218,3/9/2023 7:58:02 AM,How to Invest in 2023 If You Are Looking To Avoid Losses,TipRanks,/news/stocks/how-to-invest-in-2023-if-you-are-looking-to-avoid-losses-1032155910,positive,0.9234217405319214
3219,3/9/2023 10:36:32 AM,Kenvue prices $7.75B offering in a series of senior unsecured notes to fund separation,Seeking Alpha,https://seekingalpha.com/news/3945803-kenvue-prices-775b-offering-in-a-series-of-senior-unsecured-notes-to-fund-separation?utm_source=businessinsider&utm_medium=referral,positive,0.9099307656288147
3220,3/10/2023 11:42:47 AM,"3 of the Best Dividend Stocks, According to Analysts‚Äî3/10/2023",TipRanks,/news/stocks/3-of-the-best-dividend-stocks-according-to-analysts‚Äî3-10-2023-1032159708,negative,0.705085039138794
3221,3/10/2023 1:25:42 PM,Zimmer Biomet upgraded at Piper Sandler citing conservative guidance,Seeking Alpha,https://seekingalpha.com/news/3946438-zbh-stock-upgraded-piper-sandler-conservative-guidance?utm_source=businessinsider&utm_medium=referral,negative,0.6740033030509949
3222,3/10/2023 3:59:27 PM,Johnson & Johnson Layoffs 2023: What to Know About the Latest JNJ Job Cuts,InvestorPlace,/news/stocks/johnson-johnson-layoffs-2023-what-to-know-about-the-latest-jnj-job-cuts-1032160387,neutral,0.8327297568321228
3223,3/10/2023 4:17:44 PM,Halted Stocks Alert: Nasdaq Halts Trading in SVB Financial (SIVB) Stock,InvestorPlace,/news/stocks/halted-stocks-alert-nasdaq-halts-trading-in-svb-financial-sivb-stock-1032160421,neutral,0.918716549873352
3224,3/12/2023 2:00:00 PM,Biosimilars expected to save $180B over next five years as more gain approval,Seeking Alpha,https://seekingalpha.com/news/3946583-biosimilars-expected-to-save-180b-over-next-five-years-as-more-gain-approval?utm_source=businessinsider&utm_medium=referral,negative,0.8129683136940002
3225,3/13/2023 2:05:19 AM,7 Blue-Chip Stocks to Buy in March,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-in-march-1032161708,positive,0.8409128189086914
3226,3/13/2023 12:07:25 PM,"Pfizer, AbbVie, BMS among firms at risk of U.S. drug price negotiations - report",Seeking Alpha,https://seekingalpha.com/news/3946793-pfizer-abbvie-bristol-myers-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.6864007115364075
3227,3/15/2023 1:32:54 PM,Halozyme sees no impact on royalties after EU body revokes J&J's Darzalex patent,Seeking Alpha,https://seekingalpha.com/news/3947661-halozyme-sees-no-impact-on-royalties-after-eu-body-revokes-jjs-darzalex-patent?utm_source=businessinsider&utm_medium=referral,positive,0.585515022277832
3228,3/15/2023 2:03:55 PM,3 Blue-Chip Dividend Stocks to Buy on the Dip Now,InvestorPlace,/news/stocks/jnj-low-o-blue-chip-dividend-stocks-to-buy-on-the-dip-now-1032169816,positive,0.7667729258537292
3229,3/15/2023 4:18:45 PM,7 Blue-Chip Stocks to Buy and Hold for Decades,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-and-hold-for-decades-1032170208,positive,0.9110873341560364
3230,3/15/2023 4:40:00 PM,Protagonist Therapeutics Touts Positive Data From Bone Marrow Disorder Study,Benzinga,/news/stocks/protagonist-therapeutics-touts-positive-data-from-bone-marrow-disorder-study-1032170095,negative,0.5547564625740051
3231,3/15/2023 6:07:56 PM,Johnson & Johnson oral dengue therapy enters mid-stage trials,Seeking Alpha,https://seekingalpha.com/news/3947805-johnson-johnson-oral-dengue-therapy-enters-mid-stage-trials?utm_source=businessinsider&utm_medium=referral,positive,0.7046929597854614
3232,3/16/2023 6:15:32 PM,Medicare publishes initial guidance on drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3948265-medicare-publishes-initial-guidance-on-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.9513846635818481
3233,3/19/2023 4:00:30 PM,Pfizer CEO pockets $33M for 2022 after 36% pay hike,Seeking Alpha,https://seekingalpha.com/news/3948694-pfizer-ceo-pockets-33m-for-2022-after-36-percent-pay-hike?utm_source=businessinsider&utm_medium=referral,positive,0.5718112587928772
3234,3/19/2023 7:47:43 PM,Easing COVID pandemic sees many pharmas seeking alternate revenue streams,Seeking Alpha,https://seekingalpha.com/news/3948704-easing-covid-pandemic-pfizer-astrazeneca-seeking-alternate-revenue-streams?utm_source=businessinsider&utm_medium=referral,positive,0.7959105372428894
3235,3/21/2023 4:44:41 PM,FDA may authorize another round of COVID booster shots - WSJ,Seeking Alpha,https://seekingalpha.com/news/3949556-fda-may-authorize-another-round-covid-booster-shots-wsj?utm_source=businessinsider&utm_medium=referral,positive,0.7868639826774597
3236,3/21/2023 10:28:03 PM,Johnson & Johnson‚Äôs (NYSE:JNJ) Decade-Low P/E Ratio Deserves Your Attention,TipRanks,/news/stocks/johnson-johnson-s-nyse-jnj-decade-low-p-e-ratio-deserves-your-attention-1032183355,neutral,0.6601049900054932
3237,3/22/2023 6:21:00 PM,J&J turns to Supreme Court to OK unit bankruptcy plan for talc lawsuits - report,Seeking Alpha,https://seekingalpha.com/news/3950072-jnj-turns-to-supreme-court-ok-unit-bankruptcy-plan-for-talc-lawsuits?utm_source=businessinsider&utm_medium=referral,positive,0.8062599301338196
3238,3/22/2023 9:27:00 PM,Talc Plaintiffs Will Press to Reopen Courthouse Doors,PR Newswire,/news/stocks/talc-plaintiffs-will-press-to-reopen-courthouse-doors-1032186045,positive,0.8477203845977783
3239,3/23/2023 6:33:09 PM,White House seeking alternative supply chains for pharmaceutical ingredients,Seeking Alpha,https://seekingalpha.com/news/3950575-white-house-alternative-supply-chains-pharmaceutical-ingredients-drug-shortages?utm_source=businessinsider&utm_medium=referral,positive,0.6495422124862671
3240,3/23/2023 9:57:53 PM,"J&J, AbbVie's Imbruvica gets expanded blood cancer indication in Canada",Seeking Alpha,https://seekingalpha.com/news/3950766-johnson-johnson-abbvie-imbruvica-expanded-blood-cancer-indication-canada?utm_source=businessinsider&utm_medium=referral,negative,0.8477422595024109
3241,3/24/2023 2:44:49 PM,"Binance Suspends Trading, European Bank Trouble, Twitter To Remove Legacy Verified Checkmarks: Today's Top Stories",Benzinga,/news/stocks/binance-suspends-trading-european-bank-trouble-twitter-to-remove-legacy-verified-checkmarks-today-s-top-stories-1032190957,neutral,0.6646198630332947
3242,3/27/2023 12:20:41 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Eli Lilly & Co (LLY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-eli-lilly-co-lly-and-johnson-johnson-jnj-1032193916,neutral,0.9393702149391174
3243,3/27/2023 10:03:59 PM,3 Blue-Chip Stocks to Buy for Stability and Safety,InvestorPlace,/news/stocks/3-safe-blue-chip-stocks-to-buy-1032195324,positive,0.833436131477356
3244,3/28/2023 10:51:51 AM,argenx sells global rights for cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3951760-argenx-stock-sells-global-rights-for-cancer-therapy?utm_source=businessinsider&utm_medium=referral,positive,0.862882673740387
3245,3/28/2023 4:05:00 PM,WHO updates COVID vaccine guidance; low priority for children and adolescents,Seeking Alpha,https://seekingalpha.com/news/3951932-who-updates-covid-vaccine-guidance-low-priority-for-children?utm_source=businessinsider&utm_medium=referral,positive,0.7901005148887634
3246,3/28/2023 6:29:37 PM,7 Dividend Aristocrats to Buy for Consistent Income Growth,InvestorPlace,/news/stocks/7-dividend-aristocrats-to-buy-for-consistent-income-growth-1032198244,positive,0.8812666535377502
3247,3/29/2023 1:25:57 PM,Johnson & Johnson drops RSV vaccine program,Seeking Alpha,https://seekingalpha.com/news/3952263-jnj-stock-drops-rsv-vaccine-program?utm_source=businessinsider&utm_medium=referral,positive,0.8142870664596558
3248,3/29/2023 4:01:29 PM,Analyst Expectations for Johnson & Johnson's Future,Benzinga,/news/stocks/analyst-expectations-for-johnson-johnson-s-future-1032200727,negative,0.8650717735290527
3249,3/29/2023 5:00:39 PM,"Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-march-29-2023-1032200913,neutral,0.4950524866580963
3250,3/29/2023 8:13:14 PM,J&J unveils long-term data on Rybrevant for non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/3952439-johnson-johnson-unveils-long-term-data-on-rybrevant-for-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral,positive,0.8282194137573242
3251,3/30/2023 2:32:15 PM,The 3 Best Stocks to Buy if You Want to Retire Early,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-if-you-want-to-retire-early-1032204079,positive,0.9333820939064026
3252,3/31/2023 7:00:41 PM,"Catalyst watch: Tesla deliveries, Walmart event and jobs report headline big week",Seeking Alpha,https://seekingalpha.com/news/3953276-catalyst-watch-tesla-deliveries-walmart-event-and-jobs-report-headline-big-week?utm_source=businessinsider&utm_medium=referral,neutral,0.7487083673477173
3253,3/31/2023 8:44:06 PM,3 Top Dividend Stocks to Buy Now for an Income-Based Portfolio,InvestorPlace,/news/stocks/3-top-dividend-stocks-to-buy-now-for-an-income-based-portfolio-1032208246,positive,0.8999696373939514
3254,4/3/2023 9:45:11 AM,Morgan Stanley Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-keeps-their-hold-rating-on-johnson-johnson-jnj-1032210053,positive,0.8963858485221863
3255,4/3/2023 8:47:21 PM,Delaware court finds in favor of Bayer in talc disagreement with Merck,Seeking Alpha,https://seekingalpha.com/news/3953932-delaware-court-finds-in-favor-of-bayer-in-talc-disagreement-with-merck?utm_source=businessinsider&utm_medium=referral,neutral,0.8480780720710754
3256,4/4/2023 4:20:43 PM,Biogen names Adam Keeney to head corporate development,Seeking Alpha,https://seekingalpha.com/news/3954410-biogen-names-adam-keeney-head-corporate-development?utm_source=businessinsider&utm_medium=referral,positive,0.9434018731117249
3257,4/4/2023 5:56:20 PM,JNJ weighs second bankruptcy to halt talc-related cancer suits,Seeking Alpha,https://seekingalpha.com/news/3954443-jnj-weighs-second-bankruptcy-halt-talc-cancer-suits?utm_source=businessinsider&utm_medium=referral,positive,0.513703465461731
3258,4/4/2023 8:26:08 PM,J&J unit refiles for bankruptcy over talc litigation; offers to pay $8.9B,Seeking Alpha,https://seekingalpha.com/news/3954482-johnson-johnson-unit-ltl-refile-bankruptcy-talc-litigation-offers-to-pay-89b?utm_source=businessinsider&utm_medium=referral,neutral,0.6573429703712463
3259,4/4/2023 10:57:02 PM,Johnson & Johnson To Set Aside $8.9 Bln To Resolve Talc-based Cancer Lawsuits ,RTTNews,/news/stocks/johnson-johnson-to-set-aside-8-9-bln-to-resolve-talc-based-cancer-lawsuits-1032215019,negative,0.7969395518302917
3260,4/5/2023 9:05:12 AM,Bank of America Securities Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/bank-of-america-securities-keeps-their-hold-rating-on-johnson-johnson-jnj-1032215938,positive,0.9087795615196228
3261,4/5/2023 1:24:37 PM,JNJ Stock: The $8.9 Billion Reason Johnson & Johnson Is Up Today,InvestorPlace,/news/stocks/jnj-stock-the-8-9-billion-reason-johnson-johnson-is-up-today-1032216845,positive,0.8035880327224731
3262,4/5/2023 2:06:55 PM,InflaRx (IFRX) Stock Pops as FDA Grants Emergency Use Authorization,InvestorPlace,/news/stocks/inflarx-ifrx-stock-pops-as-fda-grants-emergency-use-authorization-1032217011,negative,0.5155966877937317
3263,4/5/2023 2:11:22 PM,J&J's potential talc litigation settlement draws mostly positive Street reaction,Seeking Alpha,https://seekingalpha.com/news/3954668-johnson-johnson-talc-litigation-settlement-mostly-positive-street-reaction?utm_source=businessinsider&utm_medium=referral,negative,0.7541137933731079
3264,4/5/2023 3:55:10 PM,Johnson & Johnson (JNJ) Receives a Hold from Bernstein,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-bernstein-1032217283,positive,0.8810337781906128
3265,4/5/2023 8:38:01 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-april-2023-1032217741,positive,0.7892100811004639
3266,4/5/2023 8:42:41 PM,The 3 Most Undervalued Warren Buffett Stocks to Buy in April 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-warren-buffett-stocks-to-buy-in-april-2023-1032217789,positive,0.8118656277656555
3267,4/5/2023 9:00:58 PM,Why did Johnson & Johnson stock go up today? Renewed hope for talc settlements,Seeking Alpha,https://seekingalpha.com/news/3954829-why-did-johnson-johnson-stock-go-up-today-renewed-hope-talc-settlements?utm_source=businessinsider&utm_medium=referral,negative,0.8943204879760742
3268,4/6/2023 7:50:24 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), AbbVie (ABBV)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-abbvie-abbv-1032218380,negative,0.7094581127166748
3269,4/6/2023 2:14:00 PM,The 3 Best Bargain Stocks to Buy for April 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-for-april-2023-1032219441,positive,0.9225844144821167
3270,4/6/2023 6:14:11 PM,WHO chief expects COVID emergency to end this year,Seeking Alpha,https://seekingalpha.com/news/3955102-who-chief-expects-covid-emergency-end-this-year?utm_source=businessinsider&utm_medium=referral,positive,0.9115643501281738
3271,4/7/2023 6:45:24 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032220374,positive,0.7513439655303955
3272,4/7/2023 9:20:34 PM,S&P 500 Volatility Continues As Investors Digest Latest Labor Market Data,Benzinga,/news/stocks/s-p-500-volatility-continues-as-investors-digest-latest-labor-market-data-1032220884,positive,0.5696756839752197
3273,4/10/2023 6:57:17 PM,3 Best Stocks to Buy in April for the Looming Recession,InvestorPlace,/news/stocks/3-best-stocks-to-buy-in-april-for-the-looming-recession-1032222569,positive,0.7968236804008484
3274,4/10/2023 7:00:37 PM,Morgan Stanley Maintains Equal-Weight Rating for Johnson & Johnson: Here's What You Need To Know,Benzinga,/news/stocks/morgan-stanley-maintains-equal-weight-rating-for-johnson-johnson-here-s-what-you-need-to-know-1032222446,positive,0.9249480366706848
3275,4/11/2023 2:25:44 AM,U.S. launches $5B program to speed up development of next-gen COVID vaccines,Seeking Alpha,https://seekingalpha.com/news/3955481-us-launches-5b-program-develop-next-gen-covid-vaccines?utm_source=businessinsider&utm_medium=referral,negative,0.8896018862724304
3276,4/11/2023 11:30:32 AM,3 Blue-Chip Stocks to Buy at an All-Time Low in April,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-at-an-all-time-low-in-april-1032224051,neutral,0.9109978675842285
3277,4/11/2023 12:00:38 PM,Biden signs bill to end COVID national emergency,Seeking Alpha,https://seekingalpha.com/news/3955581-biden-signs-bill-end-covid-national-emergency?utm_source=businessinsider&utm_medium=referral,neutral,0.536685049533844
3278,4/11/2023 12:56:42 PM,US DOJ asks appeals court to block Texas judge abortion pill ruling,Seeking Alpha,https://seekingalpha.com/news/3955611-us-doj-asks-appeals-court-block-texas-judge-abortion-pill-ruling?utm_source=businessinsider&utm_medium=referral,neutral,0.7583171725273132
3279,4/11/2023 5:40:48 PM,Johnson & Johnson talc victims seek dismissal of latest bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/3955718-jnj-talc-victims-seek-dismissal-latest-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral,neutral,0.8371521830558777
3280,4/13/2023 9:02:47 AM,"Appeals court permits limited access to abortion pill, blocks part of Texas ruling",Seeking Alpha,https://seekingalpha.com/news/3956187-appeals-court-partially-allows-access-abortion-pill?utm_source=businessinsider&utm_medium=referral,positive,0.5150909423828125
3281,4/14/2023 9:32:00 AM,Ghana 1st in world to approve new malaria vaccine by Oxford,Seeking Alpha,https://seekingalpha.com/news/3956507-ghana-1st-in-world-approve-new-malaria-vaccine-oxford?utm_source=businessinsider&utm_medium=referral,negative,0.6195566654205322
3282,4/14/2023 5:30:11 PM,"Catalyst Watch: Earnings season picks up steam, housing data due",Seeking Alpha,https://seekingalpha.com/news/3956620-catalyst-watch-earnings-season-picks-up-steam-housing-data-due?utm_source=businessinsider&utm_medium=referral,positive,0.5577781796455383
3283,4/14/2023 6:30:56 PM,"Earnings Week Ahead: Tesla, AT&T, Charles Schwab, Netflix, and more",Seeking Alpha,https://seekingalpha.com/news/3956682-earnings-week-ahead-tesla-att-charles-schwab-netflix-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9345334768295288
3284,4/15/2023 1:38:31 PM,3 Dividend Stocks to Buy for a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-a-recession-proof-portfolio-1032234092,positive,0.834452748298645
3285,4/17/2023 7:03:15 AM,Could Johnson & Johnson (NYSE:JNJ) Once Again Beat Earnings Forecast?,TipRanks,/news/stocks/could-johnson-johnson-nyse-jnj-once-again-beat-earnings-forecast-1032235509,negative,0.9500194191932678
3286,4/17/2023 7:20:14 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Merck & Company (MRK)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-unitedhealth-unh-johnson-johnson-jnj-and-merck-company-mrk-1032235548,neutral,0.8450902700424194
3287,4/17/2023 1:11:16 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/3956915-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8660826683044434
3288,4/17/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what to expect,Markets Insider Automation,/news/stocks/johnson_johnson-stock-price-q1-earnings-preview-1032236413,positive,0.9338979721069336
3289,4/17/2023 5:27:26 PM,Johnson & Johnson Q1 2023 Earnings Preview,Seeking Alpha,https://seekingalpha.com/news/3957017-johnson-johnson-q1-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral,positive,0.8090160489082336
3290,4/17/2023 5:49:38 PM,JNJ vs. PG: Which Blue-Chip Stock is Better?,TipRanks,/news/stocks/jnj-vs-pg-which-blue-chip-stock-is-better-1032237284,positive,0.8236485123634338
3291,4/18/2023 10:22:27 AM,"Johnson & Johnson Non-GAAP EPS of $2.68 beats by $0.18, revenue of $24.7B beats by $1.09B, raises FY23 guidance",Seeking Alpha,https://seekingalpha.com/news/3957230-johnson-and-johnson-non-gaap-eps-of-2_68-beats-0_18-revenue-of-24_7b-beats-1_09b?utm_source=businessinsider&utm_medium=referral,negative,0.8800495862960815
3292,4/18/2023 10:35:59 AM,3 Dividend Stocks to Sell Before They Get Sued by Customers,InvestorPlace,/news/stocks/3-dividend-stocks-to-sell-before-they-get-sued-by-customers-1032239171,positive,0.6566095352172852
3293,4/18/2023 10:44:16 AM,Johnson & Johnson lifts dividend by 5.3% to $1.19/share,Seeking Alpha,https://seekingalpha.com/news/3957233-johnson--johnson-lifts-dividend-by-53-to-119share?utm_source=businessinsider&utm_medium=referral,negative,0.9097078442573547
3294,4/18/2023 11:18:21 AM,"J&J stock pops as Q1 revenue boosted by Darzalex, COVID vaccine; raises FY23 outlook",Seeking Alpha,https://seekingalpha.com/news/3957246-jj-stock-pops-revenue-boosted-by-darzalex-covid-shot-raises-outlook?utm_source=businessinsider&utm_medium=referral,negative,0.9441673755645752
3295,4/18/2023 12:30:10 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1032239142,positive,0.5952138304710388
3296,4/18/2023 1:04:58 PM,Johnson & Johnson Q1 Profit Tops Estimates; Raises 2023 Guidance Midpoints ,RTTNews,/news/stocks/johnson-johnson-q1-profit-tops-estimates-raises-2023-guidance-midpoints-1032239244,negative,0.9084105491638184
3297,4/18/2023 4:51:53 PM,"Ericsson, Johnson & Johnson, Goldman Sachs And Other Big Stocks Moving Lower On Tuesday",Benzinga,/news/stocks/ericsson-johnson-johnson-goldman-sachs-and-other-big-stocks-moving-lower-on-tuesday-1032240248,neutral,0.9675535559654236
3298,4/18/2023 5:10:07 PM,"Nasdaq, S&P, Dow fluctuate as traders parse earnings reports from major names",Seeking Alpha,https://seekingalpha.com/news/3957380-nasdaq-sp500-dow-jones-stock-market-first-quarter-earnings?utm_source=businessinsider&utm_medium=referral,neutral,0.8083469867706299
3299,4/19/2023 1:20:23 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1032241274,negative,0.8078631162643433
3300,4/19/2023 1:44:12 AM,Judge to decide if he will halt J&J talc lawsuits on Thursday,Seeking Alpha,https://seekingalpha.com/news/3957545-judge-to-decide-if-he-will-halt-jj-talc-lawsuits-on-thursday?utm_source=businessinsider&utm_medium=referral,neutral,0.5278118848800659
3301,4/19/2023 8:45:04 AM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032242698,positive,0.8109607696533203
3302,4/19/2023 10:04:20 AM,Analysts Offer Insights on Healthcare Companies: Intuitive Surgical (ISRG) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-intuitive-surgical-isrg-and-johnson-johnson-jnj-1032242868,positive,0.918074369430542
3303,4/19/2023 11:48:49 AM,Legend Biotech adds 18% after leaked report on JNJ-partnered CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/3957646-jnj-stock-legend-biotech-stock-gain-on-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral,positive,0.7947257161140442
3304,4/19/2023 2:32:27 PM,Legend Biotech announces private placement for ~7.7M shares,Seeking Alpha,https://seekingalpha.com/news/3957778-legend-biotech-stock-private-placement?utm_source=businessinsider&utm_medium=referral,positive,0.8139907717704773
3305,4/19/2023 4:25:57 PM,Atlantic Equities Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032244205,positive,0.5489518642425537
3306,4/19/2023 6:00:09 PM,"Geron, CTI rally after leaked data for Legend Biotech‚Äôs blood cancer drug",Seeking Alpha,https://seekingalpha.com/news/3957879-geron-stock-cti-stock-rally-after-leaked-carvykti-data?utm_source=businessinsider&utm_medium=referral,neutral,0.8521285057067871
3307,4/19/2023 7:00:57 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032244305,positive,0.8832271695137024
3308,4/20/2023 2:07:07 PM,Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names,Benzinga,/news/etf/where-is-the-current-bull-market-scan-of-stocks-gaining-over-20-over-the-past-week-almost-exclusively-yields-biotech-names-1032246765,positive,0.8985138535499573
3309,4/20/2023 4:37:01 PM,Judge extends stay for Johnson & Johnson talc claims another 60 days,Seeking Alpha,https://seekingalpha.com/news/3958357-judge-extends-stay-johnson-johnson-talc-claims-another-60-days?utm_source=businessinsider&utm_medium=referral,positive,0.6576914191246033
3310,4/21/2023 10:55:13 AM,Genmab's claims dismissed by arbitral tribunal in Darzalex royalty feud with J&J,Seeking Alpha,https://seekingalpha.com/news/3958594-genmab-claims-dismissed-arbitral-tribunal-darzalex-royalty-feud-with-jj?utm_source=businessinsider&utm_medium=referral,neutral,0.8423676490783691
3311,4/21/2023 12:30:59 PM,"Analysts Offer Insights on Healthcare Companies: Insmed (INSM), Johnson & Johnson (JNJ) and Lucid Diagnostics (LUCD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-insmed-insm-johnson-johnson-jnj-and-lucid-diagnostics-lucd-1032249875,positive,0.9254685640335083
3312,4/21/2023 2:36:56 PM,OmniAb a new buy at Benchmark on technology to develop monoclonal antibodies,Seeking Alpha,https://seekingalpha.com/news/3958719-omniab-new-buy-benchmark-technology-develop-monoclonal-antibodies?utm_source=businessinsider&utm_medium=referral,negative,0.6924192905426025
3313,4/21/2023 5:09:23 PM,Legend Biotech up 10% on confirming Carvykti multiple myeloma data,Seeking Alpha,https://seekingalpha.com/news/3958762-legend-biotech-up-10-confirming-carvykti-multiple-myeloma-data?utm_source=businessinsider&utm_medium=referral,negative,0.9354594349861145
3314,4/21/2023 5:51:00 PM,Plaintiffs' Attorneys Representing Talc-Cancer Victims Form Ad Hoc Committee to Support J&J Settlement,PR Newswire,/news/stocks/plaintiffs-attorneys-representing-talc-cancer-victims-form-ad-hoc-committee-to-support-j-j-settlement-1032250401,positive,0.8924500942230225
3315,4/22/2023 8:00:00 PM,Ulcerative colitis market set to hit $9.6B by 2031,Seeking Alpha,https://seekingalpha.com/news/3958777-ulcerative-colitis-market-set-to-hit-96b-by-2031?utm_source=businessinsider&utm_medium=referral,negative,0.7096775770187378
3316,4/24/2023 12:50:13 AM,Johnson & Johnson to launch IPO roadshow for consumer health unit ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3958878-johnson-johnson-ipo-roadshow-consumer-health-unit-kenvue?utm_source=businessinsider&utm_medium=referral,positive,0.7828720808029175
3317,4/24/2023 9:37:42 AM,Genmab to file appeal against tribunal award in Darzalex royalty dispute with J&J,Seeking Alpha,https://seekingalpha.com/news/3958915-genmab-file-appeal-tribunal-award-in-darzalex-royalty-dispute-jj?utm_source=businessinsider&utm_medium=referral,neutral,0.9227256774902344
3318,4/24/2023 12:39:37 PM,"Lantheus, POINT Biopharma receive FDA Fast Track status for prostate cancer candidate",Seeking Alpha,https://seekingalpha.com/news/3959032-lantheus-point-biopharma-receive-fda-fast-track-status-prostate-cancer-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.8532596230506897
3319,4/24/2023 1:35:06 PM,DBS Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032254479,positive,0.7421090602874756
3320,4/24/2023 5:22:16 PM,The 3 Greatest Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/the-3-greatest-dividend-stocks-to-buy-now-1032255133,positive,0.8922625184059143
3321,4/24/2023 8:53:12 PM,J&J's Kenvue consumer health spinoff sets IPO terms,Seeking Alpha,https://seekingalpha.com/news/3959418-johnson-johnson-kenvue-consumer-health-spinoff-sets-ipo-terms?utm_source=businessinsider&utm_medium=referral,positive,0.9073187112808228
3322,4/24/2023 9:16:11 PM,Focus On Genmab's Pipeline If Darzalex Arbitration with Janssen Goes Sideways: Analyst,Benzinga,/news/stocks/focus-on-genmab-s-pipeline-if-darzalex-arbitration-with-janssen-goes-sideways-analyst-1032255374,positive,0.6623636484146118
3323,4/25/2023 1:42:32 PM,Alkermes gets tribunal award in J&J license deal arbitration,Seeking Alpha,https://seekingalpha.com/news/3959713-alkermes-gets-tribunal-award-in-jj-license-deal-arbitration?utm_source=businessinsider&utm_medium=referral,negative,0.6557798981666565
3324,4/25/2023 3:38:42 PM,Bipartisan agreement reached in Senate prescription drug price legislation,Seeking Alpha,https://seekingalpha.com/news/3959793-bipartisan-agreement-reached-senate-prescription-drug-price-legislation?utm_source=businessinsider&utm_medium=referral,negative,0.8105085492134094
3325,4/25/2023 6:40:22 PM,3 Dividend Aristocrats to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-buy-for-consistent-income-1032259710,positive,0.8953859806060791
3326,4/26/2023 5:15:33 PM,"Pfizer, BioNTech hit new 52-week lows",Seeking Alpha,https://seekingalpha.com/news/3960630-pfizer-stock-biontech-stock-hit-new-52-week-lows?utm_source=businessinsider&utm_medium=referral,neutral,0.8583164215087891
3327,4/26/2023 5:21:35 PM,Democratic senators introduce bill to enhance CMS drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/3960629-democratic-senators-introduce-bill-enhance-cms-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,negative,0.8721349239349365
3328,4/26/2023 9:35:22 PM,7 Stocks That Are Strong Buys on the Heels of Impressive Earnings,InvestorPlace,/news/stocks/7-stocks-that-are-strong-buys-on-the-heels-of-impressive-earnings-1032265412,negative,0.9171772599220276
3329,4/27/2023 12:50:04 AM,Get Defensive with These 3 Cash Flow Producing Machines,InvestorPlace,/news/stocks/get-defensive-with-these-3-cash-flow-producing-machines-1032265641,positive,0.7586259245872498
3330,4/27/2023 7:16:00 PM,3 Long-Term Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-and-hold-forever-1032270173,positive,0.9384225606918335
3331,4/28/2023 2:51:27 PM,J&J to 'indemnify' Kenvue from any talc-related costs,Seeking Alpha,https://seekingalpha.com/news/3962118-johnson-johnson-indemnify-kenvue-talc-related-costs?utm_source=businessinsider&utm_medium=referral,positive,0.9191358089447021
3332,4/29/2023 8:00:00 PM,"Pfizer, GSK, AbbVie among pharmas set to rise with May catalysts",Seeking Alpha,https://seekingalpha.com/news/3962345-pfizer-gsk-abbvie-among-pharmas-rise-may-catalysts?utm_source=businessinsider&utm_medium=referral,negative,0.9250966310501099
3333,4/29/2023 11:19:13 PM,Here Are The Best Sector ETFs And Major Sector-Moving Stocks In April,Benzinga,/news/etf/here-are-the-best-sector-etfs-and-major-sector-moving-stocks-in-april-1032275372,positive,0.9359045624732971
3334,4/30/2023 6:48:26 PM,7 High-Yield Dividend Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/7-high-yield-dividend-stocks-to-buy-and-hold-forever-1032276200,positive,0.9397075772285461
3335,5/1/2023 4:17:45 PM,Johnson & Johnson reports 73% complete remission for bladder cancer therapy,Seeking Alpha,https://seekingalpha.com/news/3962692-jnj-stock-posts-complete-remission-bladder-cancer-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.7259384989738464
3336,5/1/2023 5:32:54 PM,KVUE Stock IPO: When Does Kenvue Go Public? What Is the Kenvue IPO Price Range?,InvestorPlace,/news/stocks/kvue-stock-ipo-when-does-kenvue-go-public-what-is-the-kenvue-ipo-price-range-1032279016,positive,0.9321879148483276
3337,5/1/2023 6:22:43 PM,The 7 Best Dividend Stocks to Buy for May 2023,InvestorPlace,/news/stocks/7-best-dividend-stocks-to-buy-for-may-2023-1032279106,positive,0.9185826778411865
3338,5/2/2023 1:41:11 AM,"U.S. to end COVID vaccine mandates for foreign travelers, others next week",Seeking Alpha,https://seekingalpha.com/news/3963092-us-to-end-covid-vaccine-mandate-foreign-travelers-others?utm_source=businessinsider&utm_medium=referral,positive,0.7654039263725281
3339,5/2/2023 12:47:50 PM,Johnson & Johnson projects earnings impact from CAR-T deal,Seeking Alpha,https://seekingalpha.com/news/3963317-jnj-stock-projects-earnings-impact-car-t-deal?utm_source=businessinsider&utm_medium=referral,neutral,0.9070720672607422
3340,5/2/2023 6:20:57 PM,"EXCLUSIVE: AMA Moves Toward Psychedelic Therapy Reimbursement, Filing A Gap In Regulations",Benzinga,/news/stocks/exclusive-ama-moves-toward-psychedelic-therapy-reimbursement-filing-a-gap-in-regulations-1032283416,negative,0.850521445274353
3341,5/3/2023 10:08:01 AM,"Fentanyl overdose deaths rose 279%, oxycodone deaths fell in 5 years",Seeking Alpha,https://seekingalpha.com/news/3964240-fentanyl-overdose-deaths-rose-279-oxycodone-deaths-fell-in-5-years?utm_source=businessinsider&utm_medium=referral,negative,0.9210435748100281
3342,5/3/2023 1:43:13 PM,Artificial Intelligence Engine Predicts LYTS Stock to Gain 9% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-lyts-stock-to-gain-9-by-may-30-1032288024,negative,0.9435632824897766
3343,5/3/2023 1:50:11 PM,Artificial Intelligence Engine Predicts HUYA Stock to Gain 6.4% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-huya-stock-to-gain-6-by-may-30-1032288022,negative,0.9391216039657593
3344,5/3/2023 1:57:50 PM,Artificial Intelligence Engine Predicts TCMD Stock to Gain 5.6% by May 30,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tcmd-stock-to-gain-5-by-may-30-1032288068,negative,0.9418113231658936
3345,5/3/2023 3:00:54 PM,KVUE Stock: Should You Buy Into the Kenvue IPO?,InvestorPlace,/news/stocks/kvue-stock-should-you-buy-into-the-kenvue-ipo-1032288193,positive,0.9308770895004272
3346,5/4/2023 1:10:17 AM,"J&J spinout Kenvue raises $3.8B through upsized IPO, making it largest of year",Seeking Alpha,https://seekingalpha.com/news/3965269-jj-spinout-kenvue-raises-4b-through-upsized-ipo-making-it-largest-of-year?utm_source=businessinsider&utm_medium=referral,negative,0.8234386444091797
3347,5/4/2023 9:04:27 AM,3 Must-Buy Blue-Chip Stocks if the Market Retests 2022 Lows,InvestorPlace,/news/stocks/3-must-buy-blue-chip-stocks-if-the-market-retests-2022-lows-1032291477,positive,0.6090185642242432
3348,5/4/2023 10:04:53 AM,Alvotech starts confirmatory patient trial of J&J Simponi biosimilar,Seeking Alpha,https://seekingalpha.com/news/3965372-alvotech-starts-confirmatory-trial-of-jj-simponi-biosimilar?utm_source=businessinsider&utm_medium=referral,positive,0.6271514296531677
3349,5/4/2023 2:42:44 PM,Artificial Intelligence Engine Predicts ATEC Stock to Gain 5.5% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-atec-stock-to-gain-5-by-june-1-1032293386,negative,0.9415457844734192
3350,5/4/2023 2:49:03 PM,Artificial Intelligence Engine Predicts EGHT Stock to Gain 4% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-eght-stock-to-gain-4-by-june-1-1032293385,negative,0.93818199634552
3351,5/4/2023 2:53:11 PM,KVUE Stock Alert: 10 Things to Know as Kenvue Starts Trading,InvestorPlace,/news/stocks/kvue-stock-alert-10-things-to-know-as-kenvue-starts-trading-1032293384,positive,0.9425822496414185
3352,5/4/2023 2:54:21 PM,Artificial Intelligence Engine Predicts ASRT Stock to Gain 3% by June 1,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-asrt-stock-to-gain-3-by-june-1-1032293383,negative,0.9397422075271606
3353,5/4/2023 3:42:31 PM,The 3 Most Undervalued Blue-Chip Stocks to Buy in May 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-blue-chip-stocks-to-buy-in-may-2023-1032293508,positive,0.7964185476303101
3354,5/4/2023 6:28:34 PM,WHO meeting is set to decide whether to end COVID emergency,Seeking Alpha,https://seekingalpha.com/news/3965903-who-meeting-is-set-to-decide-whether-to-end-covid-emergency?utm_source=businessinsider&utm_medium=referral,positive,0.8873199820518494
3355,5/4/2023 6:52:18 PM,SLRN Stock IPO: When Does Acelyrin Go Public? What Is the Acelyrin IPO Price Range?,InvestorPlace,/news/stocks/slrn-stock-ipo-when-does-acelyrin-go-public-what-is-the-acelyrin-ipo-price-range-1032294002,positive,0.9366522431373596
3356,5/4/2023 7:29:16 PM,Which Healthcare Stock Is a Compelling Pick for the Long Haul?,InvestorPlace,/news/stocks/which-healthcare-stock-is-a-compelling-pick-for-the-long-haul-1032294048,positive,0.8750478029251099
3357,5/4/2023 8:19:47 PM,J&J spinout Kenvue shares climb 22% following $3.8B upsized IPO (update),Seeking Alpha,https://seekingalpha.com/news/3965768-jnj-spinout-kenvue-shares-jump-following-upsized-ipo?utm_source=businessinsider&utm_medium=referral,negative,0.5227280855178833
3358,5/4/2023 10:31:43 PM,3 Dividend Stocks to Count on No Matter What the Market Does¬†,InvestorPlace,/news/stocks/3-dividend-stocks-to-count-on-no-matter-what-the-market-does-1032294553,positive,0.8861491680145264
3359,5/5/2023 5:32:36 PM,Rochelle Walensky stepping down as CDC director on June 30,Seeking Alpha,https://seekingalpha.com/news/3966632-rochelle-walensky-stepping-down-cdc-director-june-30?utm_source=businessinsider&utm_medium=referral,neutral,0.6770878434181213
3360,5/5/2023 5:41:20 PM,Artificial Intelligence Engine Predicts GOOG Stock to Gain 2.6% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-goog-stock-to-gain-2-by-june-2-1032298453,negative,0.9432927370071411
3361,5/5/2023 5:45:07 PM,Artificial Intelligence Engine Predicts IQ Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-iq-stock-to-gain-3-by-june-2-1032298452,negative,0.9405496120452881
3362,5/5/2023 5:57:16 PM,Artificial Intelligence Engine Predicts TME Stock to Gain 3% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-tme-stock-to-gain-3-by-june-2-1032298451,negative,0.9378937482833862
3363,5/5/2023 6:07:27 PM,Artificial Intelligence Engine Predicts GENI Stock to Gain 2% by June 2,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-geni-stock-to-gain-2-by-june-2-1032298450,negative,0.9445680975914001
3364,5/5/2023 6:30:34 PM,Kenvue cools off on second trading day,Seeking Alpha,https://seekingalpha.com/news/3966653-kenvue-cools-off-second-trading-day?utm_source=businessinsider&utm_medium=referral,negative,0.7372137904167175
3365,5/5/2023 9:59:37 PM,S&P 500 Finishes Strong Following Wild Week Of Bank Stock Volatility,Benzinga,/news/stocks/s-p-500-finishes-strong-following-wild-week-of-bank-stock-volatility-1032298618,negative,0.9120206236839294
3366,5/8/2023 10:15:58 AM,The 7 Best Long-Term Dividend Stocks to Buy in May,InvestorPlace,/news/stocks/the-7-best-long-term-dividend-stocks-to-buy-in-may-1032301505,positive,0.8631597757339478
3367,5/9/2023 12:43:07 AM,The 7 Best Mutual Funds to Invest in for May 2023,InvestorPlace,/news/stocks/the-7-best-mutual-funds-to-invest-in-for-may-2023-1032303980,positive,0.8613660335540771
3368,5/9/2023 10:45:43 AM,3 Dividend Stocks to Buy as the Healthcare Sector Booms in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-as-the-healthcare-sector-booms-in-2023-1032306053,positive,0.6284603476524353
3369,5/9/2023 11:00:36 AM,"Analysts Offer Insights on Healthcare Companies: Cigna (CI), Johnson & Johnson (JNJ) and Crinetics Pharmaceuticals (CRNX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-cigna-ci-johnson-johnson-jnj-and-crinetics-pharmaceuticals-crnx-1032306181,positive,0.9201361536979675
3370,5/9/2023 12:56:49 PM,Big pharma maps legal strategy against U.S. drug pricing regulation ‚Äì Reuters,Seeking Alpha,https://seekingalpha.com/news/3967966-big-pharma-maps-legal-strategy-against-drug-pricing-regulation?utm_source=businessinsider&utm_medium=referral,positive,0.9252361059188843
3371,5/9/2023 2:38:56 PM,J&J's Tremfya succeeds in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/3968060-johnson-johnson-janssen-tremfya-succeeds-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral,negative,0.925291121006012
3372,5/10/2023 1:19:15 PM,Halozyme gains as Piper Sandler upgrades despite Q1 miss,Seeking Alpha,https://seekingalpha.com/news/3969086-halozyme-stock-gains-piper-sandler-upgrades-despite-q1-miss?utm_source=businessinsider&utm_medium=referral,negative,0.9323762655258179
3373,5/10/2023 2:32:01 PM,Artificial Intelligence Engine Predicts PACW Stock to Gain 11% by June 7,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-pacw-stock-to-gain-11-by-june-7-1032313141,negative,0.9430858492851257
3374,5/10/2023 4:57:05 PM,3 Dividend Stocks Set to Hike Payouts in 2023,InvestorPlace,/news/stocks/3-dividend-stocks-set-to-hike-payouts-in-2023-1032313635,positive,0.4603901207447052
3375,5/10/2023 8:23:34 PM,Shockwave Medical ticks higher amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/3969501-shockwave-medical-ticks-higher-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral,negative,0.4460274279117584
3376,5/10/2023 8:33:44 PM,Is ChatGPT A Better Financial Advisor? We're Going To Find Out,Benzinga,/news/etf/is-chatgpt-a-better-financial-advisor-we-re-going-to-find-out-1032313893,positive,0.8116571307182312
3377,5/11/2023 10:28:29 PM,J&J talc victim group seeking $30B in fraudulent conveyance complaint,Seeking Alpha,https://seekingalpha.com/news/3970598-johnson-johnson-talc-group-seeking-30b-fraudulent-conveyance-complaint?utm_source=businessinsider&utm_medium=referral,neutral,0.8056340217590332
3378,5/12/2023 7:00:44 PM,"Catalyst watch: AI talk, ON Semiconductor event, hedge fund reports and Walmart earnings",Seeking Alpha,https://seekingalpha.com/news/3970895-catalyst-watch-ai-talk-on-semiconductor-event-hedge-fund-reports-and-walmart-earnings?utm_source=businessinsider&utm_medium=referral,positive,0.9315542578697205
3379,5/12/2023 7:14:31 PM,Promising Phase 1 Results: Protagonist Therapeutics and Janssen Biotech Unlock New Potential in Colitis and Inflammation Treatment,Benzinga,/news/stocks/promising-phase-1-results-protagonist-therapeutics-and-janssen-biotech-unlock-new-potential-in-colitis-and-inflammation-treatment-1032323629,negative,0.931587278842926
3380,5/13/2023 8:00:00 PM,Cancer therapies spending set to surge through end of decade,Seeking Alpha,https://seekingalpha.com/news/3971001-cancer-therapies-spending-set-surge-through-end-decade?utm_source=businessinsider&utm_medium=referral,negative,0.9407323002815247
3381,5/14/2023 7:16:13 PM,3 Bargain Dividend Stocks to Boost Your Passive Income,InvestorPlace,/news/stocks/3-bargain-dividend-stocks-to-boost-your-passive-income-1032324953,negative,0.692328929901123
3382,5/14/2023 7:30:40 PM,Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks,InvestorPlace,/news/stocks/investing-for-the-long-term-here-are-7-must-have-dividend-stocks-1032324961,positive,0.943790078163147
3383,5/16/2023 12:52:10 PM,AstraZeneca to exit leading U.S. drug industry group PhRMA,Seeking Alpha,https://seekingalpha.com/news/3972045-astrazeneca-stock-exits-leading-us-drug-lobby-phrma?utm_source=businessinsider&utm_medium=referral,positive,0.6984096169471741
3384,5/16/2023 9:53:16 PM,Don‚Äôt Panic. 3 Defensive Stocks to Diversify Into ASAP,InvestorPlace,/news/stocks/dont-panic-3-defensive-stocks-to-diversify-into-asap-1032332746,negative,0.5954737663269043
3385,5/17/2023 4:55:50 PM,Billionaire Paul Tudor Jones Pours Millions Into These 2 Stocks Amid Recession Fears,TipRanks,/news/stocks/billionaire-paul-tudor-jones-pours-millions-into-these-2-stocks-amid-recession-fears-1032335705,positive,0.8901801109313965
3386,5/18/2023 10:20:56 AM,3 Reliable Dividend Stocks That Fit in Any Investor‚Äôs Portfolio,InvestorPlace,/news/stocks/3-reliable-dividend-stocks-that-fit-in-any-investors-portfolio-1032336948,positive,0.8946051001548767
3387,5/18/2023 11:13:15 AM,7 High-Quality Dow Stocks to Buy on the Dip,InvestorPlace,/news/stocks/7-high-quality-dow-stocks-to-buy-on-the-dip-1032337109,positive,0.8502821922302246
3388,5/18/2023 3:23:30 PM,Arcellx a buy at Truist on unique cancer cell therapies,Seeking Alpha,https://seekingalpha.com/news/3973091-arcellx-buy-at-truist-unique-cancer-cell-therapies?utm_source=businessinsider&utm_medium=referral,positive,0.8696117401123047
3389,5/18/2023 3:50:47 PM,Artificial Intelligence Engine Predicts NVAX Stock to Gain 7% by June 15,InvestorPlace,/news/stocks/artificial-intelligence-engine-predicts-nvax-stock-to-gain-7-by-june-15-1032337978,negative,0.9422798752784729
3390,5/18/2023 4:13:46 PM,Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron,Seeking Alpha,https://seekingalpha.com/news/3973082-supreme-court-rules-against-amgen-rapatha-patent-dispute?utm_source=businessinsider&utm_medium=referral,neutral,0.7930806875228882
3391,5/18/2023 6:13:29 PM,WHO recommends updating COVID shots to add XBB.1 variants,Seeking Alpha,https://seekingalpha.com/news/3973169-who-recommends-updating-covid-shots-to-add-xbb1-variants?utm_source=businessinsider&utm_medium=referral,positive,0.9085717797279358
3392,5/19/2023 11:22:36 AM,"Dividend Roundup: Johnson & Johnson, Northrop Grumman, JPMorgan and more",Seeking Alpha,https://seekingalpha.com/news/3973203-dividend-roundup-johnson--johnson-northrop-grumman-jpmorgan-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9473076462745667
3393,5/19/2023 4:51:21 PM,"WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake",Benzinga,/news/stocks/who-recommends-new-covid-booster-shots-to-target-xbb-variants-despite-slower-uptake-1032340045,negative,0.6635165810585022
3394,5/20/2023 8:32:40 PM,Teva long-acting schizophrenia drug Uzedy reduces relapse risk up to 80%,Seeking Alpha,https://seekingalpha.com/news/3973618-teva-long-acting-schizophrenia-drug-uzedy-reduces-relapse-risk?utm_source=businessinsider&utm_medium=referral,negative,0.9459611773490906
3395,5/21/2023 4:00:17 PM,Billions of dollars at stake as FDA shortcut allows half-proven drugs - report,Seeking Alpha,https://seekingalpha.com/news/3973623-billions-fda-shortcut-allows-half-proven-drugs?utm_source=businessinsider&utm_medium=referral,neutral,0.7357143759727478
3396,5/22/2023 12:58:00 AM,HDV: This Dividend ETF Proves That High Yield Isn‚Äôt Always Best,TipRanks,/news/stocks/hdv-this-dividend-etf-proves-that-high-yield-isn-t-always-best-1032341360,positive,0.7474883198738098
3397,5/23/2023 9:50:11 AM,Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ) and Coherus Biosciences (CHRS),TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-and-coherus-biosciences-chrs-1032344701,neutral,0.6040820479393005
3398,5/23/2023 11:15:28 AM,Debt ceiling crisis is already changing market dynamics - what could come next?,Seeking Alpha,https://seekingalpha.com/news/3974100-debt-ceiling-crisis-is-already-changing-market-dynamics-what-could-come-next?utm_source=businessinsider&utm_medium=referral,neutral,0.5529876351356506
3399,5/23/2023 11:39:57 AM,Goldman Sachs picks top stocks in case of a hard landing,Seeking Alpha,https://seekingalpha.com/news/3973813-goldman-sachs-picks-top-stocks-in-case-of-a-hard-landing?utm_source=businessinsider&utm_medium=referral,positive,0.912303626537323
3400,5/23/2023 6:30:03 PM,"Amgen, J&J settle lawsuit over Stelara biosimilar",Seeking Alpha,https://seekingalpha.com/news/3974310-amgen-johnson-johnson-settle-lawsuit-stelara-biosimilar?utm_source=businessinsider&utm_medium=referral,neutral,0.730513870716095
3401,5/23/2023 11:18:50 PM,7 Safe-Haven Stocks to Buy for Protection From a U.S. Debt Default Disaster,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-for-protection-from-a-u-s-debt-default-disaster-1032346801,positive,0.8192458152770996
3402,5/24/2023 10:33:55 AM,"Alvotech, Advanz Pharma ink pact for five potential biosimilars in Europe",Seeking Alpha,https://seekingalpha.com/news/3974490-alvotech-advanz-pharma-ink-pact-five-potential-biosimilars-in-europe?utm_source=businessinsider&utm_medium=referral,negative,0.8917078375816345
3403,5/24/2023 2:35:39 PM,Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-say-buy-these-3-health-care-stocks-with-over-3-dividend-yields-1032348428,negative,0.5285109281539917
3404,5/25/2023 1:22:09 PM,"Bristol Myers, J&J's blood clot therapy milvexian gets FDA fast track status",Seeking Alpha,https://seekingalpha.com/news/3975069-bristol-myers-jjs-blood-clot-drug-milvexian-gets-fda-fast-track-tag?utm_source=businessinsider&utm_medium=referral,negative,0.8501814603805542
3405,5/25/2023 5:00:55 PM,Legend Biotech a market perform at William Blair on commercial execution,Seeking Alpha,https://seekingalpha.com/news/3975167-legend-biotech-market-perform-william-blair-commercial-execution?utm_source=businessinsider&utm_medium=referral,positive,0.9171212315559387
3406,5/25/2023 6:07:05 PM,J&J files for expanded approval of blood cancer drug Carvykti in EU,Seeking Alpha,https://seekingalpha.com/news/3975181-jj-files-for-expanded-use-of-blood-cancer-drug-carvykti-in-eu?utm_source=businessinsider&utm_medium=referral,negative,0.5963731408119202
3407,5/26/2023 10:38:37 AM,Elon Musk's Neuralink gets FDA nod to start human trial of brain implant,Seeking Alpha,https://seekingalpha.com/news/3975338-elon-musks-neuralink-gets-fda-nod-to-start-human-trial-of-brain-implant?utm_source=businessinsider&utm_medium=referral,negative,0.5858262777328491
3408,5/26/2023 12:03:25 PM,J&J Janssen unit net drug prices decline for sixth straight year,Seeking Alpha,https://seekingalpha.com/news/3975379-johnson-johnson-janssen-net-drug-prices-decline-sixth-straight-year?utm_source=businessinsider&utm_medium=referral,neutral,0.9720507264137268
3409,5/26/2023 6:03:49 PM,3 Dow Stocks Poised for a Roaring Relief Rally,InvestorPlace,/news/stocks/3-dow-stocks-poised-for-a-roaring-relief-rally-1032355012,negative,0.4424181878566742
3410,5/26/2023 7:00:30 PM,"Catalyst watch: C3.ai and Salesforce earnings, Knife River debut, Kenvue ratings & Faraday Future event",Seeking Alpha,https://seekingalpha.com/news/3975507-catalyst-watch-c3ai-and-salesforce-earnings-knife-river-debut-kenvue-ratings-faraday-future-event?utm_source=businessinsider&utm_medium=referral,positive,0.9356293082237244
3411,5/27/2023 8:00:00 PM,Why 2023 is turning into the year of the healthcare spinoff,Seeking Alpha,https://seekingalpha.com/news/3975499-why-2023-turning-into-year-healthcare-spinout?utm_source=businessinsider&utm_medium=referral,positive,0.9217713475227356
3412,5/28/2023 11:27:47 PM,7 Undervalued Blue-Chip Stocks to Buy for June 2023,InvestorPlace,/news/stocks/7-undervalued-blue-chip-stocks-to-buy-for-june-2023-1032355843,positive,0.7179742455482483
3413,5/30/2023 8:55:12 AM,Johnson & Johnson (JNJ) Receives a New Rating from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-new-rating-from-citi-1032357663,negative,0.85773766040802
3414,5/30/2023 10:56:03 AM,Next set of COVID boosters to target new Omicron variants ‚Äì WSJ,Seeking Alpha,https://seekingalpha.com/news/3975713-next-set-of-covid-boosters-to-target-new-omicron-variants?utm_source=businessinsider&utm_medium=referral,positive,0.8483840823173523
3415,5/30/2023 3:17:57 PM,JP Morgan starts coverage of Kenvue with Overweight rating,Seeking Alpha,https://seekingalpha.com/news/3975845-jp-morgan-kenvue-overweight-rating?utm_source=businessinsider&utm_medium=referral,positive,0.8599451184272766
3416,5/30/2023 4:40:22 PM,"Goldman starts Kenvue at neutral, cites J&J divestiture as potential overhang",Seeking Alpha,https://seekingalpha.com/news/3975876-goldman-starts-kenvue-neutral-jj-divestiture-potential-overhang?utm_source=businessinsider&utm_medium=referral,positive,0.671066164970398
3417,5/30/2023 5:59:07 PM,"Citi starts Kenvue at neutral, cites uncertainly around brand performance",Seeking Alpha,https://seekingalpha.com/news/3975904-citi-starts-kenvue-at-neutral-cites-uncertainly-around-brand-performance?utm_source=businessinsider&utm_medium=referral,positive,0.7210701107978821
3418,5/30/2023 6:02:18 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032358850,positive,0.7854138612747192
3419,5/30/2023 7:30:57 PM,Eli Lilly partners with XtalPi on AI drug discovery in up to $250M deal,Seeking Alpha,https://seekingalpha.com/news/3975939-eli-lilly-partners-xtalpi-artificial-intelligence-drug-discovery-250m-deal?utm_source=businessinsider&utm_medium=referral,negative,0.7498099207878113
3420,5/30/2023 7:57:28 PM,Kenvue's Growth Forecast: Exploring The Future Of Johnson & Johnson's Carve-Out,Benzinga,/news/stocks/kenvue-s-growth-forecast-exploring-the-future-of-johnson-johnson-s-carve-out-1032359086,positive,0.8243675827980042
3421,5/30/2023 8:53:50 PM,"RBC Capital starts Kenvue at overweight, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-at-overweight-sees-significant-upside-to-stock?utm_source=businessinsider&utm_medium=referral,neutral,0.5588780641555786
3422,5/30/2023 9:11:02 PM,"RBC Capital starts Kenvue at outperform, sees significant upside to stock",Seeking Alpha,https://seekingalpha.com/news/3975988-rbc-capital-starts-kenvue-outperform-sees-significant-upside-stock?utm_source=businessinsider&utm_medium=referral,neutral,0.5742231011390686
3423,5/31/2023 3:24:07 PM,Johnson & Johnson says Tremfya sustained improvements in psoriatic arthritis,Seeking Alpha,https://seekingalpha.com/news/3976262-jnj-tremfya-sustains-improvements-psoriatic-arthritis?utm_source=businessinsider&utm_medium=referral,negative,0.9559144377708435
3424,6/1/2023 6:25:38 AM,Bernstein Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/bernstein-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032363218,positive,0.8197981119155884
3425,6/1/2023 4:49:40 PM,3 Warren Buffett Stocks to Buy (and Never Sell)¬†,InvestorPlace,/news/stocks/3-warren-buffett-stocks-to-buy-and-never-sell-1032365360,positive,0.9296533465385437
3426,6/1/2023 5:01:15 PM,Eli Lilly beats Johnson & Johnson to become world's most valuable drugmaker,Seeking Alpha,https://seekingalpha.com/news/3976741-lilly-stock-pips-jnj-stock-become-most-valuable-pharma?utm_source=businessinsider&utm_medium=referral,negative,0.8911044597625732
3427,6/1/2023 6:59:10 PM,"AI, Tech Fuel Rebound Of Vanguard Growth ETF, Eroding Value's 2022 Outperformance",Benzinga,/news/etf/ai-tech-fuel-rebound-of-vanguard-growth-etf-eroding-value-s-2022-outperformance-1032365404,neutral,0.6888307332992554
3428,6/2/2023 10:30:45 AM,3 Retirement Stocks to Buy to Sleep Like a Baby,InvestorPlace,/news/stocks/3-retirement-stocks-to-buy-to-sleep-like-a-baby-1032366907,positive,0.917079508304596
3429,6/2/2023 11:20:06 AM,Whistleblower lawsuit against Johnson & Johnson dismissed over leaked trade secrets,Seeking Alpha,https://seekingalpha.com/news/3977056-johnson-johnson-wins-dismissal-whistleblower-case?utm_source=businessinsider&utm_medium=referral,neutral,0.8569040298461914
3430,6/2/2023 3:37:31 PM,Lava Therapeutics up 26% as J&J chooses antibody candidate for development,Seeking Alpha,https://seekingalpha.com/news/3977175-lava-therapeutics-up-26-johnson-johnson-janssen-chooses-antibody-candidate?utm_source=businessinsider&utm_medium=referral,negative,0.9465381503105164
3431,6/2/2023 7:26:08 PM,3 Stocks That High-Yield ETFs Are Betting On,InvestorPlace,/news/stocks/3-stocks-that-high-yield-etfs-are-betting-on-1032368191,positive,0.8910281658172607
3432,6/2/2023 8:18:41 PM,Johnson & Johnson COVID vaccine authorization revoked by FDA,Seeking Alpha,https://seekingalpha.com/news/3977355-johnson-johnson-janssen-covid-vaccine-authorization-revoked-by-fda?utm_source=businessinsider&utm_medium=referral,neutral,0.8185676336288452
3433,6/3/2023 12:55:55 PM,SVB Securities Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-keeps-their-buy-rating-on-johnson-johnson-jnj-1032368564,positive,0.9082261323928833
3434,6/4/2023 2:21:49 PM,The 3 Best Bargain Stocks to Buy in June 2023,InvestorPlace,/news/stocks/the-3-best-bargain-stocks-to-buy-in-june-2023-1032368900,positive,0.9125636219978333
3435,6/4/2023 4:00:08 PM,Morgan Stanley sees broader MedTech impact from weight loss drugs,Seeking Alpha,https://seekingalpha.com/news/3977410-morgan-stanley-sees-medtech-impact-from-weight-loss-drugs?utm_source=businessinsider&utm_medium=referral,positive,0.44781309366226196
3436,6/6/2023 9:11:58 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Sight Sciences (SGHT), Johnson & Johnson (JNJ) and Ultragenyx Pharmaceutical (RARE)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-sight-sciences-sght-johnson-johnson-jnj-and-ultragenyx-pharmaceutical-rare-1032372220,neutral,0.794975757598877
3437,6/6/2023 10:42:00 AM,"Narrow market proving a headwind for mutual funds, opportunity for hedge funds",Seeking Alpha,https://seekingalpha.com/news/3977589-narrow-market-a-headwind-for-active-mutual-funds-opportunity-for-hedge-funds?utm_source=businessinsider&utm_medium=referral,positive,0.5176432132720947
3438,6/6/2023 11:25:55 AM,Alkermes lifts outlook after arbitration payment from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3977816-alkermes-lifts-outlook-after-arbitration-payment-jnj?utm_source=businessinsider&utm_medium=referral,negative,0.8656357526779175
3439,6/6/2023 1:20:37 PM,Alkermes Raises FY23 Guidance With Final Award In Johnson & Johnson Unit Arbitration ,RTTNews,/news/stocks/alkermes-raises-fy23-guidance-with-final-award-in-johnson-johnson-unit-arbitration-1032372582,positive,0.7990694046020508
3440,6/7/2023 9:55:41 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032375291,positive,0.7031834125518799
3441,6/7/2023 1:28:17 PM,3 Defensive Stocks to Guard Against Too Much Market Optimism,InvestorPlace,/news/stocks/3-defensive-stocks-to-guard-against-too-much-market-optimism-1032376095,positive,0.8900690674781799
3442,6/7/2023 4:23:36 PM,J&J's Abiomed unit recalls Impella 5.5 heart pumps over safety concerns,Seeking Alpha,https://seekingalpha.com/news/3978270-jnj-abiomed-unit-recalls-impella-heart-pumps-over-safety-concerns?utm_source=businessinsider&utm_medium=referral,neutral,0.9697669148445129
3443,6/8/2023 10:30:23 AM,The 3 Best Long-Term Dividend Stocks to Buy in June,InvestorPlace,/news/stocks/the-3-best-long-term-dividend-stocks-to-buy-in-june-1032378017,positive,0.8550145626068115
3444,6/8/2023 10:33:33 AM,3 Blue-Chip Stocks to Buy for 100% Returns¬†,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-for-100-returns-1032378016,positive,0.7669543027877808
3445,6/8/2023 3:47:28 PM,3 Bargain Stocks to Buy in June Before They Bounce,InvestorPlace,/news/stocks/3-bargain-stocks-to-buy-in-june-before-they-bounce-1032379049,positive,0.9151998162269592
3446,6/9/2023 1:26:24 PM,"AbbVie, Amgen among firms targeted for Medicare inflation penalties",Seeking Alpha,https://seekingalpha.com/news/3978943-abbvie-among-firms-targeted-for-medicare-inflation-penalties?utm_source=businessinsider&utm_medium=referral,positive,0.5447219014167786
3447,6/11/2023 8:25:20 PM,7 Top Blue-Chip Stocks to Buy in June 2023,InvestorPlace,/news/stocks/7-top-blue-chip-stocks-to-buy-in-june-2023-1032382217,positive,0.9089648127555847
3448,6/12/2023 11:58:31 AM,"Teva, Alvotech in pact with Johnson & Johnson over Stelara knockoff",Seeking Alpha,https://seekingalpha.com/news/3979152-teva-stock-alvotech-pact-jnj-stelara-knockoff?utm_source=businessinsider&utm_medium=referral,negative,0.7931338548660278
3449,6/12/2023 7:43:39 PM,"COVID shots should be updated for XBB variants, FDA says",Seeking Alpha,https://seekingalpha.com/news/3979315-covid-shots-should-reflect-xbb-variants-fda?utm_source=businessinsider&utm_medium=referral,positive,0.8617483973503113
3450,6/12/2023 7:55:55 PM,Build a Millionaire‚Äôs Portfolio With These 3 Dividend-Paying Stocks,InvestorPlace,/news/stocks/build-a-millionaires-portfolio-with-these-3-dividend-paying-stocks-1032384457,positive,0.7952935695648193
3451,6/14/2023 9:57:16 AM,"Biggest stock movers today: MicroVision, UnitedHealth and more",Seeking Alpha,https://seekingalpha.com/news/3979733-biggest-stock-movers-today-microvision-unitedhealth-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.8944840431213379
3452,6/14/2023 2:48:24 PM,Johnson & Johnson wins conditional nod for prostate cancer therapy in Canada,Seeking Alpha,https://seekingalpha.com/news/3979858-jj-stock-wins-canadian-nod-prostate-cancer-drug?utm_source=businessinsider&utm_medium=referral,negative,0.8990927338600159
3453,6/14/2023 3:21:47 PM,3 Long-term Healthcare Stocks to Add to Your Portfolio,InvestorPlace,/news/stocks/3-long-term-healthcare-stocks-to-add-to-your-portfolio-1032389488,positive,0.8907880187034607
3454,6/15/2023 12:51:12 AM,Amgen reportedly hires Moderna chief medical officer as new CMO,Seeking Alpha,https://seekingalpha.com/news/3980001-amgen-reportedly-hires-moderna-chief-medical-officer-as-new-cmo?utm_source=businessinsider&utm_medium=referral,positive,0.9183226227760315
3455,6/15/2023 10:54:18 AM,AbbVie files patent lawsuit over BeiGene‚Äôs cancer drug - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/3980076-beigene-stock-down-abbvie-patent-lawsuit-brukinsa?utm_source=businessinsider&utm_medium=referral,neutral,0.8246316313743591
3456,6/15/2023 11:26:41 AM,What Are the 3 Top Dividend Aristocrat Stocks That Are Too Cheap to Ignore?,TipRanks,/news/stocks/what-are-the-3-top-dividend-aristocrat-stocks-that-are-too-cheap-to-ignore-1032391402,positive,0.8695237636566162
3457,6/16/2023 5:10:44 PM,"3 Stocks to Buy for Long-Term, Life-Changing Returns¬†",InvestorPlace,/news/stocks/3-stocks-to-buy-for-long-term-life-changing-returns-1032394970,positive,0.8141592741012573
3458,6/17/2023 8:00:00 PM,Biologic drugs will lead European pharmas to surpass US counterparts in sales,Seeking Alpha,https://seekingalpha.com/news/3979912-biologic-drugs-lead-european-pharmas-surpass-us-counterparts-sales?utm_source=businessinsider&utm_medium=referral,negative,0.9524824023246765
3459,6/21/2023 3:44:52 PM,Top pharma lobby sues U.S. govt. over Medicare drug pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/3981469-top-pharma-lobby-sues-us-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral,neutral,0.9452309608459473
3460,6/22/2023 9:55:26 AM,SVB Securities Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032403910,positive,0.7513439655303955
3461,6/22/2023 12:51:40 PM,Cidara gains as FDA grants fast track status for flu candidate,Seeking Alpha,https://seekingalpha.com/news/3981898-cidara-stock-gains-fda-fast-track-status-flu-asset?utm_source=businessinsider&utm_medium=referral,negative,0.9368839859962463
3462,6/22/2023 10:25:30 PM,J&J talc bankruptcy unit to establish $750M trust fund with insurers,Seeking Alpha,https://seekingalpha.com/news/3982247-johnson-johnson-talc-bankruptcy-unit-establishes-750m-trust-fund-insurers?utm_source=businessinsider&utm_medium=referral,positive,0.8200181126594543
3463,6/23/2023 2:13:12 PM,"Cramer Says Datadog Will 'Put Up Some Good Numbers,' And 9 More Stock Takes From 'Mad Money' Host",Benzinga,/news/stocks/cramer-says-datadog-will-put-up-some-good-numbers-and-9-more-stock-takes-from-mad-money-host-1032406785,negative,0.8705769777297974
3464,6/23/2023 8:30:41 PM,The AI Tool That Beat Out Top Wall Street Analysts,InvestorPlace,/news/stocks/ai-tool-that-beat-wall-street-analysts-1032407726,positive,0.7457813620567322
3465,6/25/2023 4:00:43 PM,What is behind big pharma's underperformance?,Seeking Alpha,https://seekingalpha.com/news/3982575-pharma-underperforms-amid-regulatory-woes?utm_source=businessinsider&utm_medium=referral,neutral,0.6917394399642944
3466,6/26/2023 3:10:25 PM,J&J submits application to EMA for combination PAH drug,Seeking Alpha,https://seekingalpha.com/news/3982795-johnson-johnson-janssen-submits-application-ema-combination-pah-drug?utm_source=businessinsider&utm_medium=referral,positive,0.8729462027549744
3467,6/29/2023 9:08:31 AM,Morgan Stanley shakes up its global dividend portfolio,Seeking Alpha,https://seekingalpha.com/news/3983853-morgan-stanley-shakes-up-its-global-dividend-portfolio?utm_source=businessinsider&utm_medium=referral,neutral,0.947080135345459
3468,6/29/2023 12:27:46 PM,The 3 Most Undervalued Dow Stocks to Buy Now: June 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-now-june-2023-1032417770,positive,0.8877403140068054
3469,6/29/2023 8:49:59 PM,7 Up-and-Coming Stocks to Buy for the Next Decade,InvestorPlace,/news/stocks/7-up-and-coming-stocks-to-buy-for-the-next-decade-1032418996,positive,0.876754641532898
3470,6/30/2023 4:41:16 PM,Medicare revises guidance on drug price negotiations amid lawsuits,Seeking Alpha,https://seekingalpha.com/news/3984642-medicare-revises-guidance-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.901573121547699
3471,6/30/2023 6:06:43 PM,"15 Stocks Up, 15 Stocks Down: A Look At The Dow Jones Industrial Average Halfway Through 2023",Benzinga,/news/etf/15-stocks-up-15-stocks-down-a-look-at-the-dow-jones-industrial-average-halfway-through-2023-1032421047,positive,0.7704194188117981
3472,6/30/2023 8:34:52 PM,3 Dividend Stocks to Buy Right This Minute,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-right-this-minute-1032421610,positive,0.9140511751174927
3473,7/3/2023 4:25:13 PM,Johnson & Johnson psoriasis pill disappoints in phase 2 trial,Seeking Alpha,https://seekingalpha.com/news/3985036-johnson-johnson-psoriasis-pill-disappoints-phase-2-trial?utm_source=businessinsider&utm_medium=referral,neutral,0.6571669578552246
3474,7/3/2023 7:59:21 PM,3 Long-Term Stocks to Make Your ‚ÄòGet Rich‚Äô Dreams Come True,InvestorPlace,/news/stocks/3-long-term-stocks-to-make-your-get-rich-dreams-come-true-1032424274,positive,0.8697239756584167
3475,7/5/2023 1:33:37 PM,Protagonist Therapeutics-Janssen Partnered Psoriasis Candidate Fall Short Of Rival Treatment,Benzinga,/news/stocks/protagonist-therapeutics-janssen-partnered-psoriasis-candidate-fall-short-of-rival-treatment-1032427164,negative,0.7201300859451294
3476,7/5/2023 4:02:44 PM,Sorrento sees promising phase 2 results for abivertinib for lymphoma,Seeking Alpha,https://seekingalpha.com/news/3985616-sorrento-promising-phase-2-results-abivertinib-lymphoma?utm_source=businessinsider&utm_medium=referral,negative,0.9508057236671448
3477,7/6/2023 7:25:11 AM,Johnson & Johnson (JNJ) Gets a Buy from SVB Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-svb-securities-1032429223,positive,0.7031834125518799
3478,7/6/2023 11:52:22 AM,Bausch + Lomb buys Blink eye drops from Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/3985886-bausch--lomb-buys-blink-eye-drops-from-johnson--johnson?utm_source=businessinsider&utm_medium=referral,positive,0.826025128364563
3479,7/6/2023 3:53:25 PM,3 Super-Safe Dividend Stocks to Buy for the Rest of 2023,InvestorPlace,/news/stocks/3-super-safe-dividend-stocks-to-buy-for-the-rest-of-2023-1032430565,positive,0.9106167554855347
3480,7/6/2023 6:50:32 PM,The 3 Best Defensive Stocks to Buy Now (and Never Sell),InvestorPlace,/news/stocks/the-3-best-defensive-stocks-to-buy-now-and-never-sell-1032430906,positive,0.9005292057991028
3481,7/7/2023 10:07:14 PM,3 Beaten-Down Dividend Stocks Primed for a Profitable Comeback¬†,InvestorPlace,/news/stocks/3-beaten-down-dividend-stocks-primed-for-a-profitable-comeback-1032433010,negative,0.4654228389263153
3482,7/9/2023 4:00:00 PM,Goldman Sachs sees rays of hope in underperforming health sector,Seeking Alpha,https://seekingalpha.com/news/3986286-goldman-sachs-sees-hope-underperforming-health-sector?utm_source=businessinsider&utm_medium=referral,negative,0.937191367149353
3483,7/10/2023 11:46:52 AM,"Dividend Stocks: Here‚Äôs Where to Invest $1,000 Right Now",InvestorPlace,/news/stocks/dividend-stocks-heres-where-to-invest-1000-right-now-1032434675,positive,0.9439989924430847
3484,7/10/2023 12:54:19 PM,Nanobiotix In License Deal With Johnson & Johnson Unit; Stock Climbs In Pre Market ,RTTNews,/news/stocks/nanobiotix-in-license-deal-with-johnson-johnson-unit-stock-climbs-in-pre-market-1032434507,negative,0.880357027053833
3485,7/12/2023 3:26:59 PM,FDA classifies J&J electrode recall as most serious type,Seeking Alpha,https://seekingalpha.com/news/3987100-fda-classifies-johnson-johnson-electrode-recall-most-serious-type?utm_source=businessinsider&utm_medium=referral,neutral,0.5898100137710571
3486,7/13/2023 8:00:47 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032445607,positive,0.7854138612747192
3487,7/14/2023 12:15:24 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1032445946,positive,0.5040156245231628
3488,7/14/2023 9:35:13 AM,SVB Securities Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/svb-securities-remains-a-buy-on-johnson-johnson-jnj-1032446893,positive,0.9401718378067017
3489,7/14/2023 11:21:59 AM,"7 Failing Dividend Stocks to Stay Far, Far Away From",InvestorPlace,/news/stocks/7-failing-dividend-stocks-to-stay-far-far-away-from-1032447153,neutral,0.5381695032119751
3490,7/14/2023 7:00:24 PM,"Catalyst Watch: Microsoft-Activision Blizzard drama, Splunk event and Nasdaq 100 rebalancing countdown",Seeking Alpha,https://seekingalpha.com/news/3987769-catalyst-watch-microsoft-activision-blizzard-drama-splunk-event-and-nasdaq-100-rebalancing-countdown?utm_source=businessinsider&utm_medium=referral,positive,0.9405461549758911
3491,7/15/2023 6:00:00 PM,Atrial fibrillation drug market expected to decline as brand therapies go generic,Seeking Alpha,https://seekingalpha.com/news/3987824-atrial-fibrillation-drug-market-expected-decline-brand-therapies-generic?utm_source=businessinsider&utm_medium=referral,neutral,0.9694817066192627
3492,7/17/2023 2:13:13 PM,"Biggest stock movers today: Ford, BridgeBio Pharma, Acumen Pharmaceuticals and more",Seeking Alpha,https://seekingalpha.com/news/3987892-biggest-stock-movers-today-bridgebio-pharma-zai-lab-argenx-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.8726922869682312
3493,7/18/2023 4:33:38 AM,3 Healthcare Stocks to Buy as the Market Gets Defensive,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-as-the-market-gets-defensive-1032453336,positive,0.7916938066482544
3494,7/18/2023 10:22:03 AM,3 Biotech Stocks for Getting Rich in 2023,InvestorPlace,/news/stocks/3-biotech-stocks-for-getting-rich-in-2023-1032454309,positive,0.7535070776939392
3495,7/18/2023 2:26:11 PM,Nanobiotix partners with J&J's Janssen for radiotherapy treatment,Seeking Alpha,https://seekingalpha.com/news/3988403-nanobiotix-lianbio-partners-johnson-johnson-janssen-radiotherapy?utm_source=businessinsider&utm_medium=referral,positive,0.5920917391777039
3496,7/18/2023 5:33:04 PM,J&J becomes latest Big Pharma to sue over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/3988476-jj-becomes-latest-big-pharma-to-sue-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral,neutral,0.9197932481765747
3497,7/18/2023 11:30:37 PM,"J&J ordered to pay $18.8M over man's talc-cancer claim, jury rules",Seeking Alpha,https://seekingalpha.com/news/3988564-jj-requried-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral,neutral,0.8258025646209717
3498,7/19/2023 12:33:17 AM,"J&J ordered to pay $18.8M over baby powder cancer claim, jury rules (update)",Seeking Alpha,https://seekingalpha.com/news/3988566-jj-ordered-to-pay-188m-over-mans-talc-cancer-claim-jury-rules?utm_source=businessinsider&utm_medium=referral,neutral,0.8142131567001343
3499,7/19/2023 3:01:13 PM,Here's what Wall Street expects from Johnson Johnson's earnings report,Markets Insider Automation,/news/stocks/johnson_johnson-stock-quarter-earnings-preview-q2-1032458861,positive,0.9130299687385559
3500,7/19/2023 3:12:42 PM,Notable earnings before Thursday's open,Seeking Alpha,https://seekingalpha.com/news/3988764-notable-earnings-before-thursdays-open?utm_source=businessinsider&utm_medium=referral,negative,0.8825733065605164
3501,7/19/2023 5:35:35 PM,J&J looks to continue long streak of EPS beats with Q2 results,Seeking Alpha,https://seekingalpha.com/news/3988839-johnson-johnson-looks-continue-long-streak-eps-beats-q2-results?utm_source=businessinsider&utm_medium=referral,negative,0.9243155121803284
3502,7/19/2023 8:20:28 PM,Johnson & Johnson Sues HHS Over Medicare Drug Price Negotiation Program ,RTTNews,/news/stocks/johnson-johnson-sues-hhs-over-medicare-drug-price-negotiation-program-1032460109,neutral,0.9473912715911865
3503,7/20/2023 10:25:11 AM,"Johnson & Johnson Non-GAAP EPS of $2.80 beats by $0.18, revenue of $25.53B beats by $860M",Seeking Alpha,https://seekingalpha.com/news/3989064-johnson-and-johnson-non-gaap-eps-of-2_80-beats-0_18-revenue-of-25_53b-beats-860m?utm_source=businessinsider&utm_medium=referral,positive,0.7653634548187256
3504,7/20/2023 11:07:34 AM,"Johnson & Johnson posts Q2 beat as Pharma, MedTech outperform",Seeking Alpha,https://seekingalpha.com/news/3989091-johnson-johnson-posts-q2-thanks-to-pharma-medtech?utm_source=businessinsider&utm_medium=referral,negative,0.8973808884620667
3505,7/20/2023 12:28:02 PM,"Johnson & Johnson Q2 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q2-profit-increases-beats-estimates-1032461968,negative,0.9324467778205872
3506,7/20/2023 1:12:12 PM,"Johnson & Johnson Raises Guidance For 2023 Adj. Operational EPS, Adj. Operational Sales ",RTTNews,/news/stocks/johnson-johnson-raises-guidance-for-2023-adj-operational-eps-adj-operational-sales-1032462138,positive,0.885025680065155
3507,7/20/2023 1:24:00 PM,"4 stocks to watch on Thursday: Tesla, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989180-4-stocks-to-watch-on-thursday-tesla-johnson-johnson-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9207536578178406
3508,7/20/2023 2:48:21 PM,"Biggest stock movers today: Netflix, American Airlines, Johnson & Johnson and more",Seeking Alpha,https://seekingalpha.com/news/3989052-biggest-stock-movers-today-tesla-discover-financial-services-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9130443930625916
3509,7/20/2023 3:40:59 PM,"J&J could reportedly launch Kenvue exchange offer in ""coming days""",Seeking Alpha,https://seekingalpha.com/news/3989250-jj-could-reportedly-launch-kenvue-exchange-offer-in-coming-days?utm_source=businessinsider&utm_medium=referral,positive,0.9057371020317078
3510,7/20/2023 4:02:29 PM,"Johnson & Johnson, Zions Bancorporation, Heritage-Crystal Clean And Other Big Stocks Moving Higher On Thursday",Benzinga,/news/stocks/johnson-johnson-zions-bancorporation-heritage-crystal-clean-and-other-big-stocks-moving-higher-on-thursday-1032463026,negative,0.918472945690155
3511,7/20/2023 4:30:51 PM,"Johnson & Johnson Rises On Upbeat Quarterly Results, Outlook ",RTTNews,/news/stocks/johnson-johnson-rises-on-upbeat-quarterly-results-outlook-1032463165,negative,0.9007126688957214
3512,7/20/2023 6:12:39 PM,Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings,Benzinga,/news/stocks/dow-surges-300-points-johnson-johnson-posts-upbeat-earnings-1032463441,negative,0.8416123390197754
3513,7/20/2023 6:36:15 PM,Is Johnson & Johnson Giving Up on Kenvue (KVUE) Stock?,InvestorPlace,/news/stocks/is-johnson-johnson-giving-up-on-kenvue-kvue-stock-1032463738,positive,0.8666496872901917
3514,7/20/2023 7:09:02 PM,Legend Biotech up 7% on strong Carvykti Q2 sales,Seeking Alpha,https://seekingalpha.com/news/3989343-legend-biotech-up-7-on-strong-carvykti-q2-sales?utm_source=businessinsider&utm_medium=referral,negative,0.9481697678565979
3515,7/20/2023 8:18:18 PM,3 of the Best Dividend Stocks to Buy for Passive Income Growth,InvestorPlace,/news/stocks/3-of-the-best-dividend-stocks-to-buy-for-passive-income-growth-1032463888,positive,0.8181398510932922
3516,7/20/2023 10:27:30 PM,Cidara says J&J development deal for CD388 remains intact,Seeking Alpha,https://seekingalpha.com/news/3989482-cidara-says-jj-development-deal-for-cd388-remains-intact?utm_source=businessinsider&utm_medium=referral,positive,0.8444859385490417
3517,7/21/2023 10:11:22 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sangamo Biosciences (SGMO), Johnson & Johnson (JNJ) and Intuitive Surgical (ISRG)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sangamo-biosciences-sgmo-johnson-johnson-jnj-and-intuitive-surgical-isrg-1032465400,neutral,0.9344779849052429
3518,7/21/2023 10:21:28 AM,"Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Legend Biotech (LEGN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-teladoc-tdoc-legend-biotech-legn-and-johnson-johnson-jnj-1032465431,positive,0.9020242094993591
3519,7/21/2023 4:00:58 PM,Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD,Benzinga,/news/stocks/jim-cramer-says-it-s-time-to-buy-this-financial-services-stock-down-32-ytd-1032466285,neutral,0.9643928408622742
3520,7/21/2023 4:42:47 PM,J&J sues researchers who wrote talc powder linked to cancer,Seeking Alpha,https://seekingalpha.com/news/3989733-johnson-johnson-sues-researchers-talc-powder-linked-cancer?utm_source=businessinsider&utm_medium=referral,neutral,0.8909030556678772
3521,7/21/2023 7:32:16 PM,"Johnson & Johnson Medtech Business Has Promising Momentum, Analysts Say After Good Q2 Performance",Benzinga,/news/stocks/johnson-johnson-medtech-business-has-promising-momentum-analysts-say-after-good-q2-performance-1032466689,negative,0.9547784328460693
3522,7/23/2023 4:00:31 PM,Johnson & Johnson‚Äôs Q2 is positive for MedTech - Baird,Seeking Alpha,https://seekingalpha.com/news/3989880-johnson-johnson-q2-positive-medtech-baird?utm_source=businessinsider&utm_medium=referral,negative,0.913131058216095
3523,7/24/2023 10:41:39 AM,Johnson & Johnson launches Kenvue exchange offer,Seeking Alpha,https://seekingalpha.com/news/3989959-johnson-johnson-launches-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral,positive,0.9247994422912598
3524,7/24/2023 12:28:09 PM,Syndax and Incyte gain on mid-stage win for immune disorder therapy,Seeking Alpha,https://seekingalpha.com/news/3990001-syndax-stock-incyte-stock-gain-on-mid-stage-win-gvhd?utm_source=businessinsider&utm_medium=referral,negative,0.8599019050598145
3525,7/24/2023 1:10:36 PM,Johnson & Johnson Launches Exchange Offer To Separate Kenvue ,RTTNews,/news/stocks/johnson-johnson-launches-exchange-offer-to-separate-kenvue-1032469717,positive,0.8557503819465637
3526,7/24/2023 1:45:00 PM,Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday,Benzinga,/news/stocks/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday-1032469793,positive,0.9058380126953125
3527,7/24/2023 10:50:38 PM,"Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-alnylam-pharma-alny-biogen-biib-and-johnson-johnson-jnj-1032471681,neutral,0.7018133401870728
3528,7/25/2023 12:20:27 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Tonix Pharma (TNXP) and Gilead Sciences (GILD)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-tonix-pharma-tnxp-and-gilead-sciences-gild-1032474207,positive,0.9122292995452881
3529,7/25/2023 4:25:00 PM,"GSK, J&J tout Cabenuva preference over Gilead's Biktarvy",Seeking Alpha,https://seekingalpha.com/news/3990613-gsk-johnson-johnson-tout-cabenuva-preference-over-gilead-biktarvy?utm_source=businessinsider&utm_medium=referral,negative,0.6511864066123962
3530,7/25/2023 10:30:48 PM,Wall Street Goes the Irrational Route with Kenvue Stock (NYSE:KVUE),TipRanks,/news/stocks/wall-street-goes-the-irrational-route-with-kenvue-stock-nyse-kvue-1032476357,positive,0.9114845991134644
3531,7/27/2023 3:35:45 AM,‚ÄòSet It and Forget It‚Äô With These 3 Stocks to Buy,InvestorPlace,/news/stocks/set-it-and-forget-it-with-these-3-stocks-to-buy-1032482027,positive,0.8908306360244751
3532,7/27/2023 11:00:14 AM,3 Biotech Stocks You Better Be Buying on Each and Every Dip,InvestorPlace,/news/stocks/3-biotech-stocks-you-better-be-buying-on-each-and-every-dip-1032483984,positive,0.9300490617752075
3533,7/27/2023 1:42:27 PM,7 Millionaire-Maker Healthcare Stocks to Buy Before the Window Closes,InvestorPlace,/news/stocks/7-millionaire-maker-healthcare-stocks-to-buy-before-the-window-closes-1032484989,positive,0.8679835796356201
3534,7/28/2023 9:15:20 AM,The 3 Best Blue-Chip Dividend Stocks to Buy for July,InvestorPlace,/news/stocks/the-3-best-blue-chip-dividend-stocks-to-buy-for-july-1032489162,positive,0.7511569857597351
3535,7/28/2023 1:47:07 PM,2seventy bio downgraded at Morgan Stanley after Abecma sales,Seeking Alpha,https://seekingalpha.com/news/3992869-2seventy-bio-stock-downgraded-at-morgan-stanley-abecma?utm_source=businessinsider&utm_medium=referral,positive,0.6446189880371094
3536,7/28/2023 6:00:40 PM,"Catalyst Watch: Amazon earnings, jobs report, and will Apple talk AI?",Seeking Alpha,https://seekingalpha.com/news/3992944-catalyst-watch-amazon-earnings-jobs-report-and-will-apple-talk-ai?utm_source=businessinsider&utm_medium=referral,positive,0.9321873188018799
3537,7/28/2023 9:04:08 PM,J&J talc lawsuits bankruptcy plan rejected for a second time,Seeking Alpha,https://seekingalpha.com/news/3993189-johnson-johnson-talc-bankruptcy-plan-rejected-second-time?utm_source=businessinsider&utm_medium=referral,neutral,0.7905774712562561
3538,7/28/2023 9:32:26 PM,J&J seeks pediatric indication for HIV drug Edurant,Seeking Alpha,https://seekingalpha.com/news/3993196-johnson-johnson-janssen-seeks-pediatric-indication-hiv-drug-edurant?utm_source=businessinsider&utm_medium=referral,negative,0.6746101379394531
3539,7/29/2023 2:01:46 PM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Zoetis (ZTS),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-zoetis-zts-1032491624,positive,0.9071190357208252
3540,7/31/2023 12:55:04 AM,Johnson & Johnson (JNJ) Gets a Buy from Citi,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-citi-1032492468,negative,0.6256198883056641
3541,7/31/2023 1:24:00 PM,"5 stocks to watch on Monday: J&J, ON Semiconductor, Yum China and more",Seeking Alpha,https://seekingalpha.com/news/3993420-5-stocks-to-watch-on-monday-jj-on-semiconductor-yum-china-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9265987873077393
3542,7/31/2023 5:57:09 PM,J&J falls after bankruptcy plan rejected for second time,Seeking Alpha,https://seekingalpha.com/news/3993571-jj-falls-after-bankruptcy-plan-rejected-for-second-time?utm_source=businessinsider&utm_medium=referral,neutral,0.9431638717651367
3543,7/31/2023 6:00:46 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032496288,positive,0.7854138612747192
3544,7/31/2023 7:35:33 PM,"US Stocks Take A Breather, Nasdaq Notches Fifth Straight Month Of Gains: Investors Gear Up For Pivotal Week",Benzinga,/news/etf/us-stocks-take-a-breather-nasdaq-notches-fifth-straight-month-of-gains-investors-gear-up-for-pivotal-week-1032496673,negative,0.8377040028572083
3545,7/31/2023 7:52:35 PM,7 Stocks to Buy Before They Surpass 2021 Highs,InvestorPlace,/news/stocks/7-stocks-to-buy-before-they-surpass-2021-highs-stocks-to-watch-before-new-peaks-1032496877,positive,0.8164246082305908
3546,7/31/2023 10:46:32 PM,Cidara antifungal drug Rezzayo launched in US by partner Melinta,Seeking Alpha,https://seekingalpha.com/news/3993866-cidara-antifungal-drug-rezzayo-launched-in-us-by-partner-melinta?utm_source=businessinsider&utm_medium=referral,positive,0.8020393252372742
3547,8/1/2023 4:20:24 AM,Analysts Offer Insights on Healthcare Companies: OrthoPediatrics (KIDS) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-orthopediatrics-kids-and-johnson-johnson-jnj-1032497694,positive,0.9263849258422852
3548,8/1/2023 3:45:48 PM,3 Cheap Healthcare Stocks That Smart Investors Will Snap Up Now,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-2-1032501863,positive,0.8402848243713379
3549,8/2/2023 1:47:57 PM,3 Consumer Staples Stocks to Dump ASAP,InvestorPlace,/news/stocks/3-consumer-staples-stocks-to-dump-asap-1032507199,positive,0.7634233236312866
3550,8/3/2023 10:00:39 AM,Sell Alert: 3 Healthcare Stocks to Dump ASAP,InvestorPlace,/news/stocks/sell-alert-3-healthcare-stocks-to-dump-asap-1032511779,positive,0.7152862548828125
3551,8/3/2023 11:40:27 AM,"Goldman in, Microsoft out of BofA Alpha Surprise Portfolio",Seeking Alpha,https://seekingalpha.com/news/3996317-goldman-in-microsoft-out-of-bofa-alpha-surprise-portfolio?utm_source=businessinsider&utm_medium=referral,positive,0.6860989332199097
3552,8/3/2023 1:24:55 PM,Buckle Up! 3 Healthcare Stocks Set to Soar to New Heights,InvestorPlace,/news/stocks/buckle-up-3-healthcare-stocks-set-to-soar-to-new-heights-1032512866,negative,0.584620475769043
3553,8/3/2023 11:24:57 PM,Buckle Up! 3 Blue-Chip Stocks Set to Soar to New Heights.¬†,InvestorPlace,/news/stocks/buckle-up-3-blue-chip-stocks-set-to-soar-to-new-heights-1032514745,negative,0.8497392535209656
3554,8/4/2023 1:42:55 PM,Ralph Lauren To Rally 17%? Here Are 10 Other Analyst Forecasts For Friday,Benzinga,/news/stocks/ralph-lauren-to-rally-17-here-are-10-other-analyst-forecasts-for-friday-1032517652,positive,0.8922441005706787
3555,8/4/2023 3:42:21 PM,J&J gets expanded approval for cardiac ablation products,Seeking Alpha,https://seekingalpha.com/news/3997619-jj-gets-expanded-approval-for-cardiac-ablation-products?utm_source=businessinsider&utm_medium=referral,negative,0.9286589622497559
3556,8/4/2023 7:35:57 PM,3 of the Safest Dividend Kings,InvestorPlace,/news/stocks/3-of-the-safest-dividend-kings-1032519166,positive,0.8782748579978943
3557,8/5/2023 8:25:28 AM,Atlantic Equities Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/atlantic-equities-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1032519524,positive,0.5214546322822571
3558,8/8/2023 3:01:25 AM,WKLY: Want Weekly Dividends? Check Out This ETF from SoFi,TipRanks,/news/stocks/wkly-want-weekly-dividends-check-out-this-etf-from-sofi-1032525874,positive,0.9403525590896606
3559,8/8/2023 6:42:48 PM,The 7 Best Warren Buffett Stocks to Buy for August 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-for-august-2023-1032530460,positive,0.9310842156410217
3560,8/9/2023 1:18:29 PM,The Year‚Äôs Top 3 Value ETFs as of August 2023,InvestorPlace,/news/stocks/the-years-top-3-value-etfs-as-of-august-2023-1032535221,positive,0.9192641377449036
3561,8/9/2023 10:26:06 PM,Kenvue set to join S&P 500,Seeking Alpha,https://seekingalpha.com/news/4000663-kenvue-set-to-join-sp500?utm_source=businessinsider&utm_medium=referral,positive,0.9363861680030823
3562,8/10/2023 12:42:00 AM,Kenvue Set to Join S&P 500,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-1032536990,positive,0.9363861680030823
3563,8/10/2023 2:43:43 AM,Kenvue To Join S&P 500 ,RTTNews,/news/stocks/kenvue-to-join-s-p-500-1032537031,positive,0.9384469985961914
3564,8/10/2023 9:15:25 AM,The 7 Safest Stocks to Buy in August,InvestorPlace,/news/stocks/the-7-safest-stocks-to-buy-in-august-1032539574,positive,0.8219918608665466
3565,8/10/2023 12:06:33 PM,Johnson & Johnson wins FDA nod for new multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4000875-johnson-johnson-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8606269955635071
3566,8/10/2023 1:53:32 PM,JNJ's Janssen Pharma Reports FDA Approval For TALVEY To Treat Heavily Pretreated Multiple Myeloma ,RTTNews,/news/stocks/jnj-s-janssen-pharma-reports-fda-approval-for-talvey-to-treat-heavily-pretreated-multiple-myeloma-1032540112,negative,0.9378800988197327
3567,8/10/2023 2:25:52 PM,KVUE Stock Alert: Kenvue to Join the S&P 500,InvestorPlace,/news/stocks/kvue-stock-alert-kenvue-to-join-the-sp-500-1032541132,positive,0.8870499730110168
3568,8/10/2023 3:00:00 PM,Medicare Part D drug price increases far exceed inflation - AARP,Seeking Alpha,https://seekingalpha.com/news/4000101-medicare-part-d-drug-price-increases-far-exceed-inflation?utm_source=businessinsider&utm_medium=referral,negative,0.8962883353233337
3569,8/10/2023 8:38:11 PM,Supreme Court to hear arguments on Purdue Pharma $6B bankruptcy settlement,Seeking Alpha,https://seekingalpha.com/news/4001356-supreme-court-hear-arguments-purdue-pharma-sacklers-6b-bankruptcy-settlement?utm_source=businessinsider&utm_medium=referral,positive,0.7412406206130981
3570,8/11/2023 8:52:36 AM,"Uber Crowded, Battleground and Sweet 16 stock portfolios from Jefferies",Seeking Alpha,https://seekingalpha.com/news/3999208-uber-crowded-battleground-and-sweet-16-stock-portfolios-from-jefferies?utm_source=businessinsider&utm_medium=referral,positive,0.8961217403411865
3571,8/11/2023 6:53:19 PM,Boston Scientific's Farapulse Eyes Stronger US Market Position With Potential FDA Approval,Benzinga,/news/stocks/boston-scientific-s-farapulse-eyes-stronger-us-market-position-with-potential-fda-approval-1032547558,negative,0.9547473788261414
3572,8/12/2023 1:52:53 PM,"HD, MSFT, or JNJ: Which Blue Chip Stock Earns Wall Street‚Äôs ‚ÄúStrong Buy‚Äù Rating?",TipRanks,/news/stocks/hd-msft-or-jnj-which-blue-chip-stock-earns-wall-street-s-strong-buy-rating-1032548261,positive,0.8822726607322693
3573,8/13/2023 4:00:00 PM,Inside COVID-19 vaccine makers: Hope vs hype,Seeking Alpha,https://seekingalpha.com/news/4002033-inside-covid-19-vaccine-makers-hope-vs-hype?utm_source=businessinsider&utm_medium=referral,positive,0.8822358250617981
3574,8/13/2023 6:00:00 PM,Pharma under threat from bill to expand drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4002034-pharma-under-threat-bill-expand-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.5231574177742004
3575,8/14/2023 12:58:36 PM,Johnson & Johnson wins FDA nod for new prostate cancer therapy,Seeking Alpha,https://seekingalpha.com/news/4002230-johnson-johnson-wins-fda-nod-prostate-cancer-drug-akeega?utm_source=businessinsider&utm_medium=referral,negative,0.8312833309173584
3576,8/14/2023 7:08:13 PM,Pfizer wins FDA nod for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4002480-pfizer-wins-fda-nod-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral,negative,0.8381549715995789
3577,8/14/2023 7:38:52 PM,7 Dividend Stocks to Buy as Investor Sentiment Falters,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-as-investor-sentiment-falters-1032552786,neutral,0.9288655519485474
3578,8/14/2023 9:58:46 PM,Catalent accused of misleading investors in shareholder suit,Seeking Alpha,https://seekingalpha.com/news/4002679-catalent-accused-misleading-investors-shareholder-suit?utm_source=businessinsider&utm_medium=referral,positive,0.4857162833213806
3579,8/15/2023 3:17:38 PM,Citi sees Kenvue stock outperforming after exchange offer closes,Seeking Alpha,https://seekingalpha.com/news/4003018-citi-sees-kenvue-stock-outperforming-after-exchange-offer-closes?utm_source=businessinsider&utm_medium=referral,neutral,0.5142238736152649
3580,8/15/2023 5:24:19 PM,"What investors need to know about Johnson & Johnson, Kenvue exchange offer",Seeking Alpha,https://seekingalpha.com/news/4003103-investors-need-know-johnson-johnson-kenvue-exchange-offer?utm_source=businessinsider&utm_medium=referral,positive,0.9408960938453674
3581,8/16/2023 8:14:29 PM,The 3 Most Undervalued Retirement Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-retirement-stocks-to-buy-now-august-2023-1032561164,positive,0.9002804756164551
3582,8/17/2023 6:28:12 AM,Johnson & Johnson finalizes an exchange ratio of 8.0324 in Kenvue split-off,Seeking Alpha,https://seekingalpha.com/news/4003772-johnson-johnson-finalizes-an-exchange-ratio-of-80324-in-kenvue-split-off?utm_source=businessinsider&utm_medium=referral,positive,0.9141678214073181
3583,8/18/2023 2:45:09 PM,Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet,Benzinga,/news/stocks/benzinga-s-stock-whisper-index-5-stocks-investors-are-secretly-monitoring-but-not-talking-about-yet-1032566457,positive,0.9360675811767578
3584,8/20/2023 8:52:21 PM,The 7 Most Undervalued Dividend Stocks to Buy Now: August 2023,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-now-august-2023-1032568162,positive,0.898677408695221
3585,8/21/2023 10:48:51 AM,"Johnson & Johnson, Kenvue share exchange offer oversubscribed",Seeking Alpha,https://seekingalpha.com/news/4004598-johnson-johnson-kenvue-share-exchange-offer-oversubscribed?utm_source=businessinsider&utm_medium=referral,neutral,0.8298049569129944
3586,8/21/2023 1:21:00 PM,"4 stocks to watch on Monday: Kenvue, VMware and more",Seeking Alpha,https://seekingalpha.com/news/4004696-4-stocks-to-watch-on-monday-kenvue-vmware-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9081900119781494
3587,8/21/2023 5:38:12 PM,KVUE Stock Alert: Johnson & Johnson Reveals Results of Kenvue Exchange Offer,InvestorPlace,/news/stocks/kvue-stock-alert-johnson-johnson-reveals-results-of-kenvue-exchange-offer-1032570776,positive,0.9158300757408142
3588,8/21/2023 6:27:40 PM,Kenvue rises on exchange offer oversubscription; JNJ falls,Seeking Alpha,https://seekingalpha.com/news/4004886-kenvue-rises-exchange-offer-oversubscription-jnj-falls?utm_source=businessinsider&utm_medium=referral,neutral,0.6862768530845642
3589,8/21/2023 7:26:37 PM,Lawsuits unlikely to hinder Medicare drug price negotiations ‚Äì UBS,Seeking Alpha,https://seekingalpha.com/news/4004908-lawsuits-wont-hurt-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,neutral,0.8472158908843994
3590,8/21/2023 7:58:31 PM,"Lilly's market cap soared 36% in Q2, eclipsing J&J, Merck, Novo Nordisk",Seeking Alpha,https://seekingalpha.com/news/4004913-lillys-market-cap-soared-in-q2-eclipsing-jnj-merck-novo-nordisk?utm_source=businessinsider&utm_medium=referral,negative,0.9460121989250183
3591,8/21/2023 8:02:32 PM,These Are the ONLY 7 Warren Buffett Stocks to Consider in August 2023,InvestorPlace,/news/stocks/these-are-the-only-7-warren-buffett-stocks-to-consider-in-august-2023-1032570974,positive,0.9501304626464844
3592,8/21/2023 10:12:53 PM,"Kenvue to join S&P 500, replacing Advance Auto Parts",Seeking Alpha,https://seekingalpha.com/news/4004990-kenvue-join-sp-500-replacing-advance-auto-parts?utm_source=businessinsider&utm_medium=referral,positive,0.8982608318328857
3593,8/22/2023 12:01:00 AM,Kenvue Set to Join S&P 500; Advance Auto Parts to Join S&P SmallCap 600,PR Newswire,/news/stocks/kenvue-set-to-join-s-p-500-advance-auto-parts-to-join-s-p-smallcap-600-1032571156,positive,0.9121209979057312
3594,8/22/2023 6:52:24 PM,"Regeneron, J&J receive millions to develop new COVID therapies",Seeking Alpha,https://seekingalpha.com/news/4005267-regeneron-johnson-johnson-receive-millions-develop-covid-therapies?utm_source=businessinsider&utm_medium=referral,negative,0.7993800044059753
3595,8/22/2023 9:00:56 PM,Where Johnson & Johnson Stands With Analysts,Benzinga,/news/stocks/where-johnson-johnson-stands-with-analysts-1032574267,positive,0.9169121980667114
3596,8/22/2023 10:31:00 PM,"Did Apple Shower Warren Buffett With $645M This Year? Yes, They Did: The Power Of Dividends",Benzinga,/news/etf/did-apple-shower-warren-buffett-with-645m-this-year-yes-they-did-the-power-of-dividends-1032574433,positive,0.9092034101486206
3597,8/23/2023 8:25:29 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032575468,positive,0.8143652081489563
3598,8/23/2023 11:00:39 AM,Johnson & Johnson completes Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4005442-johnson-johnson-completes-kenvue-separation?utm_source=businessinsider&utm_medium=referral,positive,0.9327483773231506
3599,8/23/2023 12:06:02 PM,Megacap stocks setting up for potential breakout - Wells Fargo,Seeking Alpha,https://seekingalpha.com/news/4005201-megacap-stocks-setting-up-for-potential-breakout?utm_source=businessinsider&utm_medium=referral,positive,0.7690656781196594
3600,8/23/2023 1:15:00 PM,"4 stocks to watch on Wednesday: NVIDIA, Kohl's and more",Seeking Alpha,https://seekingalpha.com/news/4005510-4-stocks-to-watch-on-wednesday-nvidia-kohls-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9125044941902161
3601,8/23/2023 7:11:32 PM,J&J‚Äôs Janssen said to be closing much of Dutch vaccine division,Seeking Alpha,https://seekingalpha.com/news/4005711-jnj-close-much-dutch-vaccine-division?utm_source=businessinsider&utm_medium=referral,neutral,0.7419089078903198
3602,8/24/2023 1:44:18 PM,Drugs picked for Medicare price negotiations to be announced on Tuesday ‚Äì Politico,Seeking Alpha,https://seekingalpha.com/news/4005992-drug-list-picked-medicare-price-negotiations-due-tuesday?utm_source=businessinsider&utm_medium=referral,positive,0.9293889403343201
3603,8/24/2023 2:12:30 PM,Johnson & Johnson goes ex-dividend tomorrow,Seeking Alpha,https://seekingalpha.com/news/4005984-johnson-and-johnson-declares-missing-dividend?utm_source=businessinsider&utm_medium=referral,positive,0.5648829340934753
3604,8/24/2023 2:55:38 PM,Galapagos cut to Neutral at Citi on lack of catalysts,Seeking Alpha,https://seekingalpha.com/news/4006038-galapagos-stock-cut-neutral-citi-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral,neutral,0.9433589577674866
3605,8/25/2023 1:05:20 PM,J&J submits sBLA for Rybrevant for first-line non-small cell lung cancer,Seeking Alpha,https://seekingalpha.com/news/4006326-johnson-johnson-janssen-sbla-rybrevant-first-line-non-small-cell-lung-cancer?utm_source=businessinsider&utm_medium=referral,positive,0.7817999124526978
3606,8/25/2023 3:54:51 PM,AstraZeneca latest drugmaker to challenge Medicare drug price negotiation,Seeking Alpha,https://seekingalpha.com/news/4006445-astrazeneca-latest-drugmaker-challenge-medicare-drug-price-negotiation?utm_source=businessinsider&utm_medium=referral,neutral,0.43026384711265564
3607,8/26/2023 6:00:00 PM,Crohn's disease drugmakers set to benefit from expected rise in cases,Seeking Alpha,https://seekingalpha.com/news/4006563-crohns-disease-drugmakers-benefit-expected-rise-cases?utm_source=businessinsider&utm_medium=referral,negative,0.9470040202140808
3608,8/27/2023 4:00:00 PM,Wall Street lists potential targets for Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4006581-wall-street-lists-targets-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral,positive,0.8904427886009216
3609,8/27/2023 6:33:00 PM,7 Very Oversold Warren Buffett Stocks to Buy Right Now,InvestorPlace,/news/stocks/7-very-oversold-warren-buffett-stocks-to-buy-right-now-1032584294,neutral,0.7626892924308777
3610,8/28/2023 10:35:42 AM,Hedge and mutual funds rotate from tech; see the stocks they love and shun,Seeking Alpha,https://seekingalpha.com/news/4006637-hedge-and-mutual-funds-rotate-from-tech-see-the-stocks-they-love-and-shun?utm_source=businessinsider&utm_medium=referral,positive,0.6943780183792114
3611,8/28/2023 4:37:09 PM,"Hawaiian Electric Says Power Lines Not Responsible For Deadly Lahaina Fire, China Targets Stock Market Revival, FTC Pauses Legal Battle With Amgen's $28B Horizon Deal: Today's Top Stories",Benzinga,/news/stocks/hawaiian-electric-says-power-lines-not-responsible-for-deadly-lahaina-fire-china-targets-stock-market-revival-ftc-pauses-legal-battle-with-amgen-s-28b-horizon-deal-today-s-top-stories-1032586588,positive,0.9021692872047424
3612,8/28/2023 9:11:59 PM,Johnson & Johnson seeks full approval of Balversa for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4006866-johnson-johnson-janssen-seeks-full-approval-balversa-bladder-cancer?utm_source=businessinsider&utm_medium=referral,negative,0.7911971807479858
3613,8/29/2023 1:58:53 AM,7 Reliable Retirement Stocks to Secure a Golden Future,InvestorPlace,/news/stocks/7-reliable-retirement-stocks-to-secure-a-golden-future-1032587337,negative,0.8095656037330627
3614,8/29/2023 2:36:45 AM,The 7 Most Promising Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/the-7-most-promising-blue-chip-stocks-to-own-now-1032587347,positive,0.752896249294281
3615,8/29/2023 11:45:20 AM,Medicare lists first ten drugs selected for pricing negotiations,Seeking Alpha,https://seekingalpha.com/news/4006764-medicare-lists-first-ten-drugs-picked-pricing-talks?utm_source=businessinsider&utm_medium=referral,positive,0.9310519099235535
3616,8/29/2023 5:29:41 PM,JPMorgan says time to buy MedTech based on past,Seeking Alpha,https://seekingalpha.com/news/4007211-jpmorgan-says-buy-medtech-stocks?utm_source=businessinsider&utm_medium=referral,positive,0.9078740477561951
3617,8/29/2023 6:31:22 PM,Initial Medications Chosen By HHS For Medicare Drug Price Negotiations ,RTTNews,/news/stocks/initial-medications-chosen-by-hhs-for-medicare-drug-price-negotiations-1032590160,positive,0.9237470626831055
3618,8/29/2023 7:29:57 PM,Republicans say Medicare drug negotiations will mean fewer new meds,Seeking Alpha,https://seekingalpha.com/news/4007245-republicans-say-medicare-drug-negotiations-fewer-new-meds?utm_source=businessinsider&utm_medium=referral,neutral,0.8554677963256836
3619,8/30/2023 12:58:15 AM,SPLG: The Market‚Äôs Lowest-Cost S&P 500 ETF,TipRanks,/news/stocks/splg-the-market-s-lowest-cost-s-p-500-etf-1032590792,positive,0.7738195657730103
3620,8/30/2023 11:29:28 AM,Johnson & Johnson updates financials and outlook after Kenvue separation,Seeking Alpha,https://seekingalpha.com/news/4007395-jj-updates-financials-outlook-kenvue-separation?utm_source=businessinsider&utm_medium=referral,positive,0.8613182306289673
3621,8/30/2023 1:07:00 PM,"4 stocks to watch on Wednesday: Salesforce, Texas Instruments and more",Seeking Alpha,https://seekingalpha.com/news/4007444-4-stocks-to-watch-on-wednesday-salesforce-texas-instruments-and-more?utm_source=businessinsider&utm_medium=referral,positive,0.9178857207298279
3622,8/30/2023 1:07:39 PM,"Johnson & Johnson Trims FY23 Earnings, Net Sales Outlook ",RTTNews,/news/stocks/johnson-johnson-trims-fy23-earnings-net-sales-outlook-1032592301,neutral,0.9403153657913208
3623,8/30/2023 9:36:41 PM,Set and Forget: 3 Dividend Stocks Perfect for Your IRA,InvestorPlace,/news/stocks/set-and-forget-3-dividend-stocks-perfect-for-your-ira-1032594347,positive,0.9052367210388184
3624,8/31/2023 12:15:32 AM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1032594434,positive,0.6512175798416138
3625,8/31/2023 12:55:17 AM,Johnson & Johnson (JNJ) Gets a Hold from Bank of America Securities,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-bank-of-america-securities-1032594449,positive,0.8853207230567932
3626,8/31/2023 1:02:33 AM,"Analysts Offer Insights on Healthcare Companies: Patterson Companies (PDCO), BioMarin Pharmaceutical (BMRN) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-patterson-companies-pdco-biomarin-pharmaceutical-bmrn-and-johnson-johnson-jnj-1032594470,positive,0.9202442765235901
3627,8/31/2023 1:10:06 AM,"Analysts‚Äô Top Healthcare Picks: Johnson & Johnson (JNJ), PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-top-healthcare-picks-johnson-johnson-jnj-ptc-therapeutics-ptct-1032594464,negative,0.6867531538009644
3628,8/31/2023 11:00:10 AM,When ChatGPT Misses the Mark: 3 Stocks It Got Very Wrong,InvestorPlace,/news/stocks/when-chatgpt-misses-the-mark-3-stocks-it-got-very-wrong-1032595840,neutral,0.5253122448921204
3629,8/31/2023 6:33:14 PM,3 Brilliant Blue-Chip Stocks for Lucrative Long-Term Growth,InvestorPlace,/news/stocks/3-brilliant-blue-chip-stocks-for-lucrative-long-term-growth-1032597634,positive,0.5362856984138489
3630,9/1/2023 2:47:51 PM,EU regulators warn pregnant women not to use topiramate,Seeking Alpha,https://seekingalpha.com/news/4008363-eu-regulators-warn-pregnant-women-not-to-use-topiramate?utm_source=businessinsider&utm_medium=referral,positive,0.7635950446128845
3631,9/1/2023 4:51:41 PM,7 Cash Cow Stocks for Recession-Resilient Dividends,InvestorPlace,/news/stocks/7-cash-cow-stocks-for-recession-resilient-dividends-1032600357,positive,0.8772011399269104
3632,9/2/2023 6:00:00 PM,"Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag",Seeking Alpha,https://seekingalpha.com/news/4008548-lilly-novo-nordisk-top-pharma-performers-august-astrazeneca-roche-lag?utm_source=businessinsider&utm_medium=referral,negative,0.8847639560699463
3633,9/3/2023 4:00:00 PM,Why is big pharma unmoved despite Medicare pricing threat?,Seeking Alpha,https://seekingalpha.com/news/4008703-why-big-pharma-unmoved-despite-medicare-pricing-threat?utm_source=businessinsider&utm_medium=referral,positive,0.7872201800346375
3634,9/4/2023 2:05:22 AM,Stifel Nicolaus Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1032601422,negative,0.5205009579658508
3635,9/4/2023 4:00:00 PM,AI to represent 11% of healthcare budgets in 2024 - Morgan Stanley,Seeking Alpha,https://seekingalpha.com/news/4008712-ai-eleven-percent-healthcare-budgets-2024-morgan-stanley?utm_source=businessinsider&utm_medium=referral,positive,0.8714701533317566
3636,9/4/2023 4:21:00 PM,"Despite a slower Q2, Needham sees medtech market growing 7% in 2023",Seeking Alpha,https://seekingalpha.com/news/4008713-despite-slower-q2-needham-sees-medtech-market-growing-7-percent-2023?utm_source=businessinsider&utm_medium=referral,negative,0.9523437023162842
3637,9/4/2023 10:21:27 PM,3 Dow Stocks to Sell in September Before They Crash and Burn,InvestorPlace,/news/stocks/3-dow-stocks-to-sell-in-september-before-they-crash-and-burn-1032603561,positive,0.7571301460266113
3638,9/6/2023 12:26:49 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1032607025,positive,0.8143652081489563
3639,9/6/2023 12:26:57 AM,Raymond James Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/raymond-james-remains-a-buy-on-johnson-johnson-jnj-1032607021,positive,0.9435840845108032
3640,9/6/2023 12:27:41 PM,7 Retirement Stocks That Every Long-Term Investor Should Own Now,InvestorPlace,/news/stocks/7-retirement-stocks-that-every-long-term-investor-should-own-now-1032608972,positive,0.9398009777069092
3641,9/6/2023 12:53:21 PM,Idorsia In Deal With JNJ's Janssen Biotech For Return Of Rights For Aprocitentan; Stock Down ,RTTNews,/news/stocks/idorsia-in-deal-with-jnj-s-janssen-biotech-for-return-of-rights-for-aprocitentan-stock-down-1032608309,positive,0.8972314596176147
3642,9/6/2023 3:13:51 PM,Johnson & Johnson succeeds in lung cancer trial for Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4009524-johnson-johnson-wins-lung-cancer-trial-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8125883340835571
3643,9/6/2023 5:00:38 PM,"Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-september-6-2023-1032609929,positive,0.5207832455635071
3644,9/7/2023 11:08:02 AM,7 Pharma Stocks to Buy for Groundbreaking Treatments and Robust Revenue Growth,InvestorPlace,/news/stocks/7-pharma-stocks-to-buy-for-groundbreaking-treatments-and-robust-revenue-growth-1032612381,negative,0.9394681453704834
3645,9/7/2023 7:39:56 PM,Astellas withdraws federal lawsuit over Medicare drug pricing,Seeking Alpha,https://seekingalpha.com/news/4010044-astellas-withdraws-federal-lawsuit-over-medicare-drug-pricing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8975496888160706
3646,9/7/2023 9:29:38 PM,"Canaccord starts Kenvue at buy; cites global reach, consumer demand",Seeking Alpha,https://seekingalpha.com/news/4010111-canaccord-starts-kenvue-at-buy-cites-global-reach-consumer-demand?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7382117509841919
3647,9/8/2023 10:00:13 AM,The 7 Best Dow Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-dow-stocks-to-buy-now-september-2023-1032615597,positive,0.9287469983100891
3648,9/8/2023 10:17:43 AM,3 Shaky Stocks to Sell in September Before It‚Äôs Too Late,InvestorPlace,/news/stocks/3-shaky-stocks-to-sell-in-september-before-its-too-late-1032615594,positive,0.813061535358429
3649,9/8/2023 12:14:43 PM,Janssen Pharma Submits Marketing Authorisation Application For Erdafitinib ,RTTNews,/news/stocks/janssen-pharma-submits-marketing-authorisation-application-for-erdafitinib-1032615568,positive,0.8274354338645935
3650,9/8/2023 3:56:55 PM,September Rally? 3 Healthcare Stocks to Buy Before Liftoff.,InvestorPlace,/news/stocks/september-rally-3-healthcare-stocks-to-buy-before-liftoff-1032616887,negative,0.737704873085022
3651,9/8/2023 11:00:31 PM,Analyst Ratings for Johnson & Johnson,Benzinga,/news/stocks/analyst-ratings-for-johnson-johnson-1032617279,positive,0.8832271695137024
3652,9/8/2023 11:13:21 PM,The 5 Best Healthcare Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-5-best-healthcare-stocks-to-buy-now-september-2023-1032617337,positive,0.9341099262237549
3653,9/10/2023 5:54:29 PM,The 7 Best Warren Buffett Stocks to Buy Now: September 2023,InvestorPlace,/news/stocks/the-7-best-warren-buffett-stocks-to-buy-now-september-2023-1032618280,positive,0.9295059442520142
3654,9/10/2023 7:17:31 PM,"HSBC bullish on IQVIA, Zoetis, bluebird, Actinium; bearish on Gilead",Seeking Alpha,https://seekingalpha.com/news/4010430-hsbc-bullish-on-iqvia-zoetis-bluebird-actinium-bearish-on-gilead?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5512140393257141
3655,9/11/2023 12:28:17 AM,Kenvue shares may gain after FDA comments in Tylenol-Autism warning label  lawsuit,Seeking Alpha,https://seekingalpha.com/news/4010432-kenvue-shares-may-gain-after-fda-comments-in-tylenol-autisim-warning-label-lawsuit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5332737565040588
3656,9/11/2023 10:27:12 AM,3 Bulletproof Stocks to Buy Before the Next Recession Strikes,InvestorPlace,/news/stocks/3-bulletproof-stocks-to-buy-before-the-next-recession-strikes-1032619507,positive,0.9096826910972595
3657,9/11/2023 1:28:48 PM,"Kenvue gains after upgrade, bullish notes on Tylenol-Autism warning label suit",Seeking Alpha,https://seekingalpha.com/news/4010574-kenvue-gains-after-upgrade-bullish-notes-on-tylenol-autism-warning-label-suit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9204012751579285
3658,9/11/2023 4:04:11 PM,Sandoz to commercialize biosimilar to J&J blockbuster drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4010646-sandoz-to-commercialize-biosimilar-to-jnj-blockbuster-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.690517783164978
3659,9/11/2023 7:30:31 PM,AI Integration In Biotech & Pharma: Companies Positioned To Benefit,Benzinga,/news/stocks/ai-integration-in-biotech-pharma-companies-positioned-to-benefit-1032621068,negative,0.5679945945739746
3660,9/11/2023 8:31:10 PM,AstraZeneca's Tagrisso-Chemo Combo Data In Lung Cancer Sets High Bar For Johnson & Johnson's Cancer Drug: Analyst,Benzinga,/news/stocks/astrazeneca-s-tagrisso-chemo-combo-data-in-lung-cancer-sets-high-bar-for-johnson-johnson-s-cancer-drug-analyst-1032621133,negative,0.8292718529701233
3661,9/12/2023 2:22:07 PM,AbbVie's Skyrizi outperforms JNJ‚Äôs Stelara in Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4010983-abbvie-skyrizi-bested-jnj-stelara-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9411659240722656
3662,9/12/2023 10:35:45 PM,"Psychedelic Drugs Market Will Generate Over $12B In Next 12 Years, NY Consulting Firm Predicts",Benzinga,/news/stocks/ny-consulting-firm-predicts-psychedelic-drugs-market-will-generate-over-12b-in-next-12-years-1032624903,negative,0.7848308682441711
3663,9/13/2023 8:23:48 PM,Buy the Dip: 3 Healthcare Stocks to Snag Now for Supercharged Gains,InvestorPlace,/news/stocks/buy-the-dip-3-healthcare-stocks-to-snag-now-for-supercharged-gains-1032628467,positive,0.7510801553726196
3664,9/14/2023 7:05:25 PM,3 Blue-Chip Stocks to Watch in the ‚ÄòGreen Zone‚Äô,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-watch-in-the-tradesmith-green-zone-1032631792,positive,0.6509939432144165
3665,9/15/2023 9:10:49 AM,The 3 Most Undervalued Dow Stocks to Buy in September 2023,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-september-2023-1032632969,positive,0.8288745284080505
3666,9/15/2023 9:26:39 PM,"VTI ETF: This Diversified Powerhouse Owns Over 3,800 Stocks",TipRanks,/news/stocks/vti-etf-this-diversified-powerhouse-owns-over-3-800-stocks-1032634771,positive,0.9168491959571838
3667,9/15/2023 10:39:20 PM,Johnson & Johnson Unveils Modernized Logo After 135 Years ,RTTNews,/news/stocks/johnson-johnson-unveils-modernized-logo-after-135-years-1032634743,positive,0.8629748225212097
3668,9/19/2023 12:15:28 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032638337,positive,0.8271588087081909
3669,9/19/2023 3:36:33 PM,7 Safe and Steady Dividend Stocks to Buy for Volatile Time,InvestorPlace,/news/stocks/7-safe-and-steady-dividend-stocks-to-buy-for-volatile-time-1032641007,positive,0.7342789173126221
3670,9/26/2023 3:13:34 PM,This Is the Holy Grail of Investing,InvestorPlace,/news/stocks/this-is-the-holy-grail-of-investing-1032656835,positive,0.9053852558135986
3671,9/27/2023 7:05:22 PM,What's Going On Pfizer's Subsidiary Biohaven Stock?,Benzinga,/news/stocks/what-s-going-on-pfizer-s-subsidiary-biohaven-stock-1032660550,positive,0.5377773642539978
3672,9/28/2023 7:30:23 PM,What to Note in the AI Megatrend,InvestorPlace,/news/stocks/what-to-note-in-the-ai-megatrend-1032664425,positive,0.9303689002990723
3673,9/29/2023 1:52:14 AM,SCHX ETF: A Large-Cap ETF for Large Gains,TipRanks,/news/stocks/schx-etf-a-large-cap-etf-for-large-gains-1032664747,positive,0.9166260957717896
3674,9/29/2023 10:01:12 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Maravai Lifesciences Holdings (MRVI), Johnson & Johnson (JNJ) and Amicus (FOLD)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-maravai-lifesciences-holdings-mrvi-johnson-johnson-jnj-and-amicus-fold-1032665877,neutral,0.7983158826828003
3675,9/29/2023 12:12:49 PM,Don‚Äôt Miss Out: 3 Dividend Stocks to Buy on EVERY. SINGLE. DIP.,InvestorPlace,/news/stocks/dont-miss-out-3-dividend-stocks-to-buy-on-every-single-dip-1032666285,positive,0.9223251342773438
3676,9/29/2023 12:31:59 PM,Recession-Proof Royals: 3 Stocks That Thrive in Tough Economic Times,InvestorPlace,/news/stocks/recession-proof-royals-3-stocks-that-thrive-in-tough-economic-times-1032666337,positive,0.8587891459465027
3677,10/1/2023 2:32:42 AM,"LLY, ISRG, or JNJ: Which Healthcare Stock Could Generate the Best Returns?",TipRanks,/news/stocks/lly-isrg-or-jnj-which-healthcare-stock-could-generate-the-best-returns-1032668067,positive,0.8824886679649353
3678,10/2/2023 9:31:15 AM,Food Stocks: Worth a Bite,TipRanks,/news/stocks/food-stocks-worth-a-bite-1032669628,positive,0.6609485149383545
3679,10/3/2023 4:15:23 AM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1032672066,positive,0.941351056098938
3680,10/3/2023 3:13:57 PM,"Higher Rates, Lower Leverage: Growth Stocks To Struggle While AI Offers Hope, Goldman Sachs Analysts Say",Benzinga,/news/stocks/higher-rates-lower-leverage-growth-stocks-to-struggle-while-ai-offers-hope-goldman-sachs-analysts-say-1032674601,negative,0.9077003598213196
3681,10/3/2023 4:11:21 PM,"'Airbnb Has Foundational Cracks', Disney+ Follows Netflix On Subscription Sharing Crackdown, Microsoft's Nadella Criticizes Google's Exclusive Content Deals: Today's Top Stories",Benzinga,/news/stocks/airbnb-has-foundational-cracks-disney+-follows-netflix-on-subscription-sharing-crackdown-microsoft-s-nadella-criticizes-google-s-exclusive-content-deals-today-s-top-stories-1032675117,neutral,0.9165230989456177
3682,10/5/2023 12:08:41 AM,7 Top Healthcare Stocks That Pay Dividends,InvestorPlace,/news/stocks/7-top-healthcare-stocks-that-pay-dividends-1032679547,positive,0.934146523475647
3683,10/5/2023 2:01:04 PM,Expert Ratings for Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1032681119,positive,0.7854138612747192
3684,10/5/2023 5:00:46 PM,"Benzinga's Top Ratings Upgrades, Downgrades For October 5, 2023",Benzinga,/news/stocks/benzinga-s-top-ratings-upgrades-downgrades-for-october-5-2023-1032682175,positive,0.5183945298194885
3685,10/5/2023 6:40:12 PM,"Johnson & Johnson Has Potential To Drive Its Pharma And MedTech Franchises, Says Bullish Analyst",Benzinga,/news/stocks/johnson-johnson-has-potential-to-drive-its-pharma-and-medtech-franchises-says-bullish-analyst-1032682493,negative,0.9369539618492126
3686,10/8/2023 12:00:48 PM,3 Pharma Stocks to Dump Before the Damage Is Done,InvestorPlace,/news/stocks/3-pharma-stocks-to-dump-before-the-damage-is-done-1032686332,positive,0.842827558517456
3687,10/8/2023 7:18:42 PM,J&J : Data Suggest Esketamine More Effective Than Typical Treatments In Major Depressive Disorder ,RTTNews,/news/stocks/j-j-data-suggest-esketamine-more-effective-than-typical-treatments-in-major-depressive-disorder-1032686618,negative,0.939738929271698
3688,10/9/2023 6:46:32 PM,3 Artificial Intelligence Stocks That Could Outperform the ‚ÄòGodfather of AI‚Äô,InvestorPlace,/news/stocks/3-artificial-intelligence-stocks-that-could-outperform-the-godfather-of-ai-1032689930,positive,0.5206442475318909
3689,10/10/2023 4:20:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Bristol-Myers Squibb (BMY), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-bristol-myers-squibb-bmy-johnson-johnson-jnj-1032690640,positive,0.5469275116920471
3690,10/10/2023 5:55:05 AM,Johnson & Johnson (JNJ) Receives a Hold from DBS,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-dbs-1032690762,positive,0.7648761868476868
3691,10/12/2023 5:52:18 PM,7 High-Growth S&P 500 Stocks to Buy Now,InvestorPlace,/news/stocks/7-high-growth-sp-500-stocks-to-buy-now-1032701698,positive,0.8599167466163635
3692,10/12/2023 6:41:33 PM,Beat the Market With These 7 Warren Buffett Stocks,InvestorPlace,/news/stocks/beat-the-market-with-these-7-warren-buffett-stocks-1032701803,positive,0.752809464931488
3693,10/13/2023 10:33:32 PM,"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets",Benzinga,/news/etf/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets-1032705050,neutral,0.5841986536979675
3694,10/14/2023 1:00:44 PM,Johnson & Johnson Stock: Is Now the Time to Sell?,InvestorPlace,/news/stocks/johnson-johnson-stock-is-now-the-time-to-sell-1032705305,positive,0.8125900030136108
3695,10/16/2023 3:01:13 PM,Johnson Johnson is about to announce its earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q3-earnings-preview-stock-1032708397,positive,0.9335330724716187
3696,10/16/2023 10:50:24 PM,"Analysts Conflicted on These Healthcare Names: Merus (MRUS), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-merus-mrus-elevance-health-elv-and-johnson-johnson-jnj-1032710047,neutral,0.7575352191925049
3697,10/17/2023 9:45:54 AM,"Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-johnson-johnson-and-3-stocks-to-watch-heading-into-tuesday-1032711225,positive,0.9264112114906311
3698,10/17/2023 12:28:37 PM,Johnson & Johnson Q3 Profit Beats Estimates,RTTNews,/news/stocks/johnson-johnson-q3-profit-beats-estimates-1032711846,negative,0.5837085247039795
3699,10/17/2023 12:56:57 PM,"Johnson & Johnson Lifts 2023 Guidance Midpoints For Sales, Adj. EPS ",RTTNews,/news/stocks/johnson-johnson-lifts-2023-guidance-midpoints-for-sales-adj-eps-1032711920,positive,0.4933285415172577
3700,10/17/2023 6:57:12 PM,Johnson & Johnson‚Äôs Strong Q3 Performance and Upward Guidance Evokes Buy Rating: An Analysis of the Innovative Medicine Sector‚Äôs Influence,TipRanks,/news/stocks/johnson-johnson-s-strong-q3-performance-and-upward-guidance-evokes-buy-rating-an-analysis-of-the-innovative-medicine-sector-s-influence-1032713926,positive,0.541881799697876
3701,10/17/2023 7:46:33 PM,"Stocks Rise On Positive Earnings; Treasury Volatility Returns, Nvidia Stumbles: What's Driving Markets Tuesday?",Benzinga,/news/stocks/stocks-rise-on-positive-earnings-treasury-volatility-returns-nvidia-stumbles-what-s-driving-markets-tuesday-1032713829,neutral,0.5387641191482544
3702,10/18/2023 1:01:28 AM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Johnson & Johnson (JNJ) and Thermo Fisher (TMO)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-johnson-johnson-jnj-and-thermo-fisher-tmo-1032714341,positive,0.9067949652671814
3703,10/18/2023 6:27:59 AM,Hold Rating for Johnson & Johnson: A Balance of Strong Performance and Ongoing Challenges,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-a-balance-of-strong-performance-and-ongoing-challenges-1032715487,negative,0.9066936373710632
3704,10/18/2023 6:36:32 AM,Positive Analyst Outlook on Johnson & Johnson: Accelerated Growth and Raised Guidance Despite Potential Challenges,TipRanks,/news/stocks/positive-analyst-outlook-on-johnson-johnson-accelerated-growth-and-raised-guidance-despite-potential-challenges-1032715508,negative,0.9550530314445496
3705,10/18/2023 2:01:37 PM,"Analysts Are Bullish on Top Healthcare Stocks: Ligand Pharma (LGND), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-ligand-pharma-lgnd-johnson-johnson-jnj-1032717614,negative,0.5795172452926636
3706,10/18/2023 8:44:06 PM,Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug,Benzinga,/news/stocks/positive-outlook-on-johnson-johnson-s-partner-legend-biotech-analyst-confident-on-blood-cancer-drug-1032718213,negative,0.6799641251564026
3707,10/19/2023 12:15:26 AM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1032718609,positive,0.8271588087081909
3708,10/19/2023 10:45:10 AM,7 Dividend Aristocrats That Are Built to Last,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-are-built-to-last-1032720311,positive,0.8798192143440247
3709,10/19/2023 12:00:23 PM,Johnson & Johnson‚Äôs Stock Receives Buy Rating Amid Promising MARIPOSA Trial Results and Potential Market Share Gain,TipRanks,/news/stocks/johnson-johnson-s-stock-receives-buy-rating-amid-promising-mariposa-trial-results-and-potential-market-share-gain-1032720633,negative,0.9526111483573914
3710,10/19/2023 8:11:36 PM,7 Healthcare Stocks That Can Cure a Lackluster Portfolio,InvestorPlace,/news/stocks/healthcare-stocks-to-buy-4-1032722294,positive,0.7649615406990051
3711,10/19/2023 8:36:20 PM,The 7 Best Forever Stocks To Buy Now: October 2023,InvestorPlace,/news/stocks/7-best-forever-stocks-to-buy-now-october-2023-1032722370,positive,0.9350666403770447
3712,10/20/2023 1:53:35 PM,3 Mutual Funds to Invest in for Pro Management and Low Fees,InvestorPlace,/news/stocks/3-mutual-funds-to-invest-in-for-pro-management-and-low-fees-1032724440,positive,0.8983345627784729
3713,10/24/2023 12:15:53 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1032734736,positive,0.9096185564994812
3714,10/24/2023 10:56:18 AM,Johnson & Johnson‚Äôs Stock: A Stable Transition and Promising Future Despite Leadership Change,TipRanks,/news/stocks/johnson-johnson-s-stock-a-stable-transition-and-promising-future-despite-leadership-change-1032735321,negative,0.9448173642158508
3715,10/25/2023 1:43:12 AM,VTV: A Must-Watch ETF for Value Investors,TipRanks,/news/stocks/vtv-a-must-watch-etf-for-value-investors-1032739060,positive,0.8936381340026855
3716,10/25/2023 6:18:06 AM,Positive Prospects for Johnson & Johnson: Buy Rating Assigned Due to Superior Performance of Rybrevant in MARIPOSA Trials,TipRanks,/news/stocks/positive-prospects-for-johnson-johnson-buy-rating-assigned-due-to-superior-performance-of-rybrevant-in-mariposa-trials-1032740152,negative,0.957366943359375
3717,10/25/2023 10:15:00 AM,The 7 Best Forever Stocks to Buy for October 2023,InvestorPlace,/news/stocks/the-7-best-forever-stocks-to-buy-for-october-2023-1032737998,positive,0.9330435395240784
3718,10/25/2023 8:04:04 PM,Dow Jones Bear Market: 3 Cheap Stocks to Buy Now,InvestorPlace,/news/stocks/dow-jones-bear-market-3-cheap-stocks-to-buy-now-1032740344,positive,0.8925117254257202
3719,10/26/2023 5:21:52 PM,3 Stocks to Buy (and Never Ever Sell),InvestorPlace,/news/stocks/3-stocks-to-buy-and-never-ever-sell-1032745222,positive,0.9382155537605286
3720,10/27/2023 6:19:56 AM,Goldman Sachs Reaffirms Their Sell Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/goldman-sachs-reaffirms-their-sell-rating-on-johnson-johnson-jnj-1032749668,positive,0.7924538850784302
3721,10/27/2023 1:25:10 PM,SNY Stock Sinks 15% as Sanofi Plans Consumer Unit Spinoff,InvestorPlace,/news/stocks/sny-stock-sinks-15-as-sanofi-plans-consumer-unit-spinoff-1032748736,neutral,0.9670206308364868
3722,10/27/2023 1:30:30 PM,"Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Insmed (INSM) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-universal-health-uhs-insmed-insm-and-johnson-johnson-jnj-1032750294,positive,0.9281286001205444
3723,10/30/2023 9:50:50 AM,"Analysts Are Bullish on Top Healthcare Stocks: Arcellx Inc (ACLX), Biogen (BIIB)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-arcellx-inc-aclx-biogen-biib-1032755860,positive,0.4989754855632782
3724,10/31/2023 6:30:49 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Boston Scientific (BSX) and PTC Therapeutics (PTCT)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-boston-scientific-bsx-and-ptc-therapeutics-ptct-1032760969,neutral,0.759350597858429
3725,11/2/2023 7:25:38 PM,"EXCLUSIVE: Roundhill Launches Dividend Kings ETF With 'The Gold Standard Of Dividend Growers,' Companies With 'Incredible Resilience'",Benzinga,/news/etf/exclusive-roundhill-launches-dividend-kings-etf-with-the-gold-standard-of-dividend-growers-companies-with-incredible-resilience-1032771912,negative,0.8681634068489075
3726,11/2/2023 8:01:04 PM,"Amgen Wins Big With FDA, Analyst Sees Soaring Potential",Benzinga,/news/stocks/amgen-wins-big-with-fda-analyst-sees-soaring-potential-1032771966,negative,0.9449009895324707
3727,11/2/2023 10:52:30 PM,Johnson & Johnson Stock (NYSE:JNJ): Time to Buy the Dip?,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-time-to-buy-the-dip-1032775761,positive,0.9170475602149963
3728,11/3/2023 12:42:56 PM,The 3 Best Forever Stocks to Buy in November,InvestorPlace,/news/stocks/the-3-best-forever-stocks-to-buy-in-november-1032776148,positive,0.8903189301490784
3729,11/6/2023 6:30:58 PM,Long-Term Winners: Ray Dalio‚Äôs Top 3 Stock Recommendations for a Prosperous Future,InvestorPlace,/news/stocks/long-term-winners-ray-dalios-top-3-stock-recommendations-for-a-prosperous-future-1032783431,positive,0.7622935771942139
3730,11/8/2023 10:12:22 AM,"Analysts Offer Insights on Healthcare Companies: Bluebird Bio (BLUE), Biogen (BIIB) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-bluebird-bio-blue-biogen-biib-and-johnson-johnson-jnj-1032796738,positive,0.9149227142333984
3731,11/8/2023 11:29:22 AM,Johnson & Johnson‚Äôs Growth Potential: Ottava Robotic System and Untapped General Surgery Robotics Market,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-ottava-robotic-system-and-untapped-general-surgery-robotics-market-1032796865,positive,0.6383072137832642
3732,11/9/2023 10:35:00 AM,3 Dividend Stocks to Buy for Consistent Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-for-consistent-income-1032799884,positive,0.900680422782898
3733,11/9/2023 12:52:37 PM,3 Dividend Stocks That Could Pay for Your Holiday Shopping,InvestorPlace,/news/stocks/3-dividend-stocks-that-could-pay-for-your-holiday-shopping-1032800353,positive,0.9139618873596191
3734,11/9/2023 2:26:17 PM,7 Safe Stocks to Buy if You Think Q3‚Äôs Gangbuster Growth Won‚Äôt Last,InvestorPlace,/news/stocks/7-safe-stocks-to-buy-if-you-think-q3s-gangbuster-growth-wont-last-1032801059,positive,0.7254765033721924
3735,11/15/2023 2:10:36 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Cormedix (CRMD), Immatics (IMTX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-cormedix-crmd-immatics-imtx-and-johnson-johnson-jnj-1032823185,neutral,0.9384737610816956
3736,11/15/2023 3:20:10 AM,It‚Äôs Time to Buy These 3 Dividend Aristocrats Trading Near 52-Week Lows,InvestorPlace,/news/stocks/its-time-to-buy-these-3-dividend-aristocrats-trading-near-52-week-lows-1032819984,positive,0.5707416534423828
3737,11/15/2023 4:23:44 AM,Blue-Chip Bargains: Top 3 Oversold Aristocrats for Value Investors,InvestorPlace,/news/stocks/blue-chip-bargains-top-3-oversold-aristocrats-for-value-investors-1032820035,positive,0.7906444668769836
3738,11/15/2023 7:20:34 AM,Buffett‚Äôs Berkshire Sells JNJ and UPS Stocks; Should You Follow?,TipRanks,/news/stocks/buffett-s-berkshire-sells-jnj-and-ups-stocks-should-you-follow-1032824425,positive,0.9389861226081848
3739,11/16/2023 2:07:22 AM,Storm-Proof Income: 7 Dividend Aristocrats to Fortify Your Portfolio,InvestorPlace,/news/stocks/storm-proof-income-7-dividend-aristocrats-to-fortify-your-portfolio-1032825013,positive,0.902733325958252
3740,11/16/2023 6:09:48 PM,3 Strong-Buy Dividend Stocks That Analysts Love,InvestorPlace,/news/stocks/3-strong-buy-dividend-stocks-that-analysts-love-1032828896,positive,0.7452501654624939
3741,11/16/2023 6:31:57 PM,3 Must-Buy Stocks on Every Market Dip,InvestorPlace,/news/stocks/3-must-buy-stocks-on-every-market-dip-1032828986,positive,0.9271240234375
3742,11/17/2023 8:23:34 PM,7 High-Yield Blue Chips Suitable for Any Retiree,InvestorPlace,/news/stocks/7-high-yield-blue-chip-stocks-suitable-for-any-reitree-1032832622,positive,0.8566922545433044
3743,11/17/2023 9:00:13 PM,21 Analysts Have This to Say About Johnson & Johnson,Benzinga,/news/stocks/21-analysts-have-this-to-say-about-johnson-johnson-1032832598,positive,0.92400062084198
3744,11/18/2023 8:25:40 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032833159,positive,0.8304361701011658
3745,11/28/2023 2:29:47 AM,The Shocking Stock That Warren Buffet Just Bought (and 2 He Sold),InvestorPlace,/news/stocks/the-shocking-stock-that-warren-buffet-just-bought-and-2-he-sold-1032852883,positive,0.9324578642845154
3746,11/28/2023 10:10:00 AM,3 Robotics Stocks That Could Be Multibaggers in the Making,InvestorPlace,/news/stocks/3-robotics-stocks-that-could-be-multibaggers-in-the-making-1032853990,positive,0.8369423747062683
3747,11/28/2023 10:20:30 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Masimo (MASI) and Regeneron (REGN)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-masimo-masi-and-regeneron-regn-1032856472,neutral,0.7661224007606506
3748,11/29/2023 11:42:45 AM,The 7 Biggest Dividend Stocks in Warren Buffett‚Äôs Portfolio,InvestorPlace,/news/stocks/the-7-biggest-dividend-stocks-in-warren-buffetts-portfolio-1032857965,positive,0.9281255006790161
3749,11/30/2023 9:21:06 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864340,positive,0.9027354717254639
3750,11/30/2023 9:31:01 AM,Analysts Offer Insights on Healthcare Companies: Hyperfine (HYPR) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-hyperfine-hypr-and-johnson-johnson-jnj-1032864431,positive,0.9027354717254639
3751,11/30/2023 2:06:00 PM,Fresh on the Market: 3 Top Picks From the Renaissance IPO ETF,InvestorPlace,/news/stocks/fresh-on-the-market-3-top-picks-from-the-renaissance-ipo-etf-1032862745,positive,0.6943173408508301
3752,11/30/2023 3:52:29 PM,"Johnson & Johnson MedTech Completes Laminar Acquisition, Sees $0.15/share Negative Impact In FY24 ",RTTNews,/news/stocks/johnson-johnson-medtech-completes-laminar-acquisition-sees-0-15-share-negative-impact-in-fy24-1032862857,neutral,0.9698891639709473
3753,11/30/2023 4:06:08 PM,Income Kings: 7 Blue-Chip Dividend Stocks for Reliable Returns,InvestorPlace,/news/stocks/income-kings-7-blue-chip-dividend-stocks-for-reliable-returns-1032863431,positive,0.7976710796356201
3754,11/30/2023 5:23:00 PM,"7 Blue-Chip Stocks to Buy for 2024, According to AI",InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-for-2024-according-to-ai-1032863884,positive,0.9224820733070374
3755,12/1/2023 2:40:05 AM,Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ) and Walgreens Boots Alliance (WBA),TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-and-walgreens-boots-alliance-wba-1032866516,neutral,0.7764856219291687
3756,12/1/2023 10:05:34 AM,"Analysts Are Bullish on Top Healthcare Stocks: Johnson & Johnson (JNJ), Humana (HUM)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-johnson-johnson-jnj-humana-hum-1032867703,negative,0.4709128439426422
3757,12/1/2023 12:04:04 PM,"Analysts Offer Insights on Healthcare Companies: Legend Biotech (LEGN), Harmony Biosciences Holdings (HRMY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-legend-biotech-legn-harmony-biosciences-holdings-hrmy-and-johnson-johnson-jnj-1032867821,positive,0.9138999581336975
3758,12/1/2023 1:59:46 PM,Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio,InvestorPlace,/news/stocks/wealth-from-wellness-7-healthcare-stocks-to-inoculate-your-portfolio-1032866432,positive,0.9037390351295471
3759,12/1/2023 7:05:11 PM,Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections,Benzinga,/news/stocks/johnson-johnson-gets-analyst-upgrade-noting-bullish-pharma-medtech-projections-1032867327,negative,0.9138107299804688
3760,12/4/2023 2:21:11 PM,"The 7 Best Ways to Invest $1,000 in the Stock Market Now",InvestorPlace,/news/stocks/the-7-best-ways-to-invest-1000-in-the-stock-market-now-1032870680,positive,0.9286323189735413
3761,12/5/2023 8:56:06 AM,Johnson & Johnson: Navigating Growth and Regulatory Challenges in Medical Technology,TipRanks,/news/stocks/johnson-johnson-navigating-growth-and-regulatory-challenges-in-medical-technology-1032875925,positive,0.7990170121192932
3762,12/5/2023 2:15:16 PM,Johnson & Johnson Guides FY24 Adj. EPS Below Estimates ,RTTNews,/news/stocks/johnson-johnson-guides-fy24-adj-eps-below-estimates-1032874082,positive,0.9216664433479309
3763,12/5/2023 10:40:36 PM,Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3,InvestorPlace,/news/stocks/is-buffett-turning-bearish-7-stocks-warren-completely-dumped-in-q3-1032876122,neutral,0.9592518210411072
3764,12/6/2023 3:06:08 AM,Buy Rating Affirmed for Johnson & Johnson: Long-Term Growth and Strategic Positioning Underpin Optimistic Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-long-term-growth-and-strategic-positioning-underpin-optimistic-outlook-1032878894,negative,0.9499220848083496
3765,12/6/2023 10:20:29 AM,"Analysts Offer Insights on Healthcare Companies: Merus (MRUS), Johnson & Johnson (JNJ) and IGM Biosciences (IGMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-merus-mrus-johnson-johnson-jnj-and-igm-biosciences-igms-1032879903,positive,0.9225835800170898
3766,12/6/2023 11:50:15 AM,"Analysts Offer Insights on Healthcare Companies: Ping An Healthcare and Technology Company (OtherPANHF), Healthequity (HQY) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-ping-an-healthcare-and-technology-company-otherpanhf-healthequity-hqy-and-johnson-johnson-jnj-1032879985,positive,0.9092285633087158
3767,12/6/2023 12:41:32 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), CVS Health (CVS) and Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cvs-health-cvs-and-vertex-pharmaceuticals-vrtx-1032880041,positive,0.905311107635498
3768,12/6/2023 1:56:21 PM,Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential,InvestorPlace,/news/stocks/bargain-buys-7-stocks-lagging-the-sp-500-with-big-potential-1032878330,neutral,0.7779278755187988
3769,12/6/2023 5:23:37 PM,"JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities",Benzinga,/news/stocks/jnj-ceo-signals-no-rush-into-weight-loss-drug-realm-emphasizes-different-priorities-1032879077,positive,0.8401648998260498
3770,12/7/2023 8:02:26 AM,Strong Growth Ahead: Buy Rating for Johnson & Johnson Amid Exceeding Long-Term Projections,TipRanks,/news/stocks/strong-growth-ahead-buy-rating-for-johnson-johnson-amid-exceeding-long-term-projections-1032883435,negative,0.9562548398971558
3771,12/7/2023 12:21:03 PM,"Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Johnson & Johnson (JNJ) and Veeva Systems (VEEV)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-praxis-precision-medicines-prax-johnson-johnson-jnj-and-veeva-systems-veev-1032883851,positive,0.9108095765113831
3772,12/7/2023 12:50:14 PM,"Analysts Offer Insights on Healthcare Companies: Qiagen (QGEN), Johnson & Johnson (JNJ) and Elanco Animal Health (ELAN)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-qiagen-qgen-johnson-johnson-jnj-and-elanco-animal-health-elan-1032883942,positive,0.9157581329345703
3773,12/7/2023 1:19:15 PM,"Vanda Pharmaceuticals Acquires U.S., Canadian Rights To PONVORY From Janssen ",RTTNews,/news/stocks/vanda-pharmaceuticals-acquires-u-s-canadian-rights-to-ponvory-from-janssen-1032881574,positive,0.8584517240524292
3774,12/7/2023 6:53:44 PM,Investing in the Aging Population: 3 Healthcare Stocks to Watch,InvestorPlace,/news/stocks/investing-in-the-aging-population-3-healthcare-stocks-to-watch-1032883283,positive,0.88970947265625
3775,12/8/2023 12:30:00 PM,7 Tech Stocks to Light Up Your Portfolio This Holiday Season,InvestorPlace,/news/stocks/7-tech-stocks-to-light-up-your-portfolio-this-holiday-season-1032885360,positive,0.7529719471931458
3776,12/11/2023 8:33:58 PM,"Blood Cancer Player Arcellx's Lead Product Exceeds Expectations, Analysts Say",Benzinga,/news/stocks/blood-cancer-player-arcellx-s-lead-product-exceeds-expectations-analysts-say-1032890784,negative,0.9527626037597656
3777,12/11/2023 8:42:45 PM,Life-Changing Investments: 3 Stocks That Will Set You Up for the Long Haul,InvestorPlace,/news/stocks/life-changing-investments-3-stocks-that-will-set-you-up-for-the-long-haul-1032890918,positive,0.818962812423706
3778,12/13/2023 12:00:00 PM,Seeking Passive Income? 7 Dividend Stocks You Don‚Äôt Want to Miss.,InvestorPlace,/news/stocks/seeking-passive-income-7-dividend-stocks-you-dont-want-to-miss-1032896670,positive,0.8886902928352356
3779,12/13/2023 12:37:44 PM,Integra LifeSciences To Acquire Acclarent For $275 Mln Cash ,RTTNews,/news/stocks/integra-lifesciences-to-acquire-acclarent-for-275-mln-cash-1032896532,positive,0.9330462217330933
3780,12/13/2023 1:44:23 PM,D.R. Horton To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/d-r-horton-to-rally-around-19-here-are-10-top-analyst-forecasts-for-wednesday-1032896816,positive,0.9061915874481201
3781,12/13/2023 1:44:56 PM,Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability,InvestorPlace,/news/stocks/economic-safety-nets-7-defensive-stocks-providing-portfolio-stability-1032897100,positive,0.8506568670272827
3782,12/14/2023 1:30:00 PM,Ryan Cohen Plans to Save GameStop By Becoming Warren Buffett,InvestorPlace,/news/stocks/ryan-cohen-plans-to-save-gamestop-by-becoming-warren-buffett-1032900985,positive,0.9254056811332703
3783,12/14/2023 7:56:41 PM,3 Dow Stocks I Wouldn‚Äôt Touch With a 10-Foot Pole,InvestorPlace,/news/stocks/3-dow-stocks-i-wouldnt-touch-with-a-10-foot-pole-1032902603,positive,0.9152520298957825
3784,12/15/2023 2:28:33 PM,AC Immune Advances Anti-pTau Active Immunotherapy For Alzheimer's Disease Into Phase 2b Trial ,RTTNews,/news/stocks/ac-immune-advances-anti-ptau-active-immunotherapy-for-alzheimer-s-disease-into-phase-2b-trial-1032904707,negative,0.603276789188385
3785,12/15/2023 4:58:43 PM,"AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial",Benzinga,/news/stocks/ac-immune-raises-50m-its-alzheimer-s-targeting-immunotherapy-advances-into-phase-2b-trial-1032905427,negative,0.861519992351532
3786,12/15/2023 5:26:22 PM,The 7 Most Undervalued Dividend Stocks to Buy in December,InvestorPlace,/news/stocks/the-7-most-undervalued-dividend-stocks-to-buy-in-december-1032905710,positive,0.5166031718254089
3787,12/15/2023 8:01:28 PM,The Dogs of the Dow May Pay Big Dividends in 2024,InvestorPlace,/news/stocks/the-dogs-of-the-dow-may-pay-big-dividends-in-2024-1032905944,positive,0.7251589894294739
3788,12/17/2023 7:00:00 PM,3 of the Most Attractive Dividend Stocks in the Pharma Space,InvestorPlace,/news/stocks/3-of-the-most-attractive-dividend-stocks-in-the-pharma-space-1032907116,negative,0.585765540599823
3789,12/19/2023 1:51:10 PM,7 New Year‚Äôs Stocks to Buy to Get 2024 Off to a Bright Start,InvestorPlace,/news/stocks/7-new-years-stocks-to-buy-to-get-2024-off-to-a-bright-start-1032912438,negative,0.8694549202919006
3790,12/19/2023 10:00:50 PM,Forever Favorites: 7 Dividend Stocks to Buy and Never Sell,InvestorPlace,/news/stocks/forever-favorites-7-dividend-stocks-to-buy-and-never-sell-1032914179,positive,0.9393635988235474
3791,12/21/2023 2:02:22 PM,7 Stocks That Might Win on Election Year Uncertainty,InvestorPlace,/news/stocks/7-stocks-that-might-win-on-election-year-uncertainty-1032919400,positive,0.8125712871551514
3792,12/21/2023 5:11:14 PM,Why Is Eye Disease Related Gene Therapy Focused MeiraGTx Stock Soaring Today?,Benzinga,/news/stocks/why-is-eye-disease-related-gene-therapy-focused-meiragtx-stock-soaring-today-1032920039,positive,0.5965144038200378
3793,12/21/2023 9:45:14 PM,Build Your Future Portfolio: 3 Generous Dividend Stocks,InvestorPlace,/news/stocks/build-your-future-portfolio-3-generous-dividend-stocks-1032920683,positive,0.9033445119857788
3794,12/22/2023 2:53:47 AM,Johnson & Johnson Stock (NYSE:JNJ): A Smart Dividend Pick for 2024,TipRanks,/news/stocks/johnson-johnson-stock-nyse-jnj-a-smart-dividend-pick-for-2024-1032922422,positive,0.5898606181144714
3795,12/26/2023 2:37:48 AM,7 Rock-Solid Dividend Stocks to Trust in Difficult Times,InvestorPlace,/news/stocks/7-rock-solid-dividend-stocks-to-trust-in-difficult-times-1032925151,negative,0.8322290778160095
3796,12/26/2023 10:44:33 AM,LianBio Transfers Rights For NBTXR3 In China And Other Asian Markets To Janssen Pharma; Stock Up ,RTTNews,/news/stocks/lianbio-transfers-rights-for-nbtxr3-in-china-and-other-asian-markets-to-janssen-pharma-stock-up-1032925465,positive,0.6075661182403564
3797,12/27/2023 10:31:53 PM,Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness,InvestorPlace,/news/stocks/healthcare-heroes-3-stocks-innovating-in-medicine-and-wellness-1032928865,positive,0.8069815635681152
3798,12/28/2023 1:33:14 PM,"Eli Lilly, Johnson & Johnson And Other Health Care Stocks From Wall Street's Most Accurate Analysts",Benzinga,/news/stocks/eli-lilly-johnson-johnson-and-other-health-care-stocks-from-wall-street-s-most-accurate-analysts-1032929866,positive,0.8699533939361572
3799,12/28/2023 6:16:37 PM,Safe Havens: 3 Fixed-Income Securities for a Balanced Portfolio in 2024,InvestorPlace,/news/stocks/safe-havens-3-fixed-income-securities-for-a-balanced-portfolio-in-2024-1032930815,positive,0.5472812056541443
3800,12/29/2023 10:01:50 AM,Disaster-Proof Dividends: 3 Stocks with Resilient Payouts in Tough Times,InvestorPlace,/news/stocks/disaster-proof-dividends-3-stocks-with-resilient-payouts-in-tough-times-1032931885,negative,0.6306275725364685
3801,12/31/2023 11:00:00 AM,Legacy Investments: 7 Stocks to Make Your Grandkids Millionaires,InvestorPlace,/news/stocks/legacy-investments-7-stocks-to-make-your-grandkids-millionaires-1032933656,positive,0.9170665144920349
3802,1/1/2024 7:15:07 PM,2024‚Äôs Blue-Chip Winners: Top 3 Stocks for Rock-Solid Returns,InvestorPlace,/news/stocks/2024s-blue-chip-winners-top-3-stocks-for-rock-solid-returns-1032935426,negative,0.7789123058319092
3803,1/2/2024 7:22:32 PM,"Dogs Of The Dow: Top 10 Highest Yielding Dow Jones Stocks, How To Get Dividends Of 3% to 7.4% In 2024",Benzinga,/news/etf/dogs-of-the-dow-top-10-highest-yielding-dow-jones-stocks-how-to-get-dividends-of-3-to-7-4-in-2024-1032937754,positive,0.9235052466392517
3804,1/3/2024 4:26:53 PM,Tech Sell-Off Triggers Market Reset: Value Stocks Reach 7-Month High Versus Growth,Benzinga,/news/etf/tech-sell-off-triggers-market-reset-value-stocks-reach-7-month-high-versus-growth-1032940596,negative,0.8445466160774231
3805,1/3/2024 6:29:31 PM,"This Analyst Downgrades Bristol-Myers Squibb, Cautions Amid Product Launch And Revenue Concerns",Benzinga,/news/stocks/this-analyst-downgrades-bristol-myers-squibb-cautions-amid-product-launch-and-revenue-concerns-1032940889,neutral,0.9435459971427917
3806,1/3/2024 7:43:03 PM,The 3 Best Blue-Chip Stocks to Buy Now,InvestorPlace,/news/stocks/best-blue-chip-stocks-1031627772,positive,0.8018679618835449
3807,1/3/2024 9:00:19 PM,Revenge of the Boring Stocks! Dividends Are Sexy Again.,InvestorPlace,/news/stocks/revenge-of-the-boring-stocks-dividends-are-sexy-again-1032941212,positive,0.7992129921913147
3808,1/3/2024 10:42:40 PM,The 7 Best Meme Stocks to Buy Now,InvestorPlace,/news/stocks/best-meme-stocks-1031269612,positive,0.9085869193077087
3809,1/4/2024 8:15:24 AM,Johnson & Johnson (JNJ) Gets a Buy from Raymond James,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-raymond-james-1032944360,positive,0.5320752859115601
3810,1/4/2024 11:28:12 PM,Still Worried About a 2024 Recession? 7 Stocks to Watch.,InvestorPlace,/news/stocks/still-worried-about-a-2024-recession-7-stocks-to-watch-1032944595,neutral,0.6595360636711121
3811,1/6/2024 8:00:00 PM,Dow Darlings: Top 3 Stocks That Will Lead the Charge in 2024,InvestorPlace,/news/stocks/dow-darlings-top-3-stocks-that-will-lead-the-charge-in-2024-1032947480,positive,0.8988954424858093
3812,1/8/2024 1:57:22 PM,Johnson & Johnson To Acquire Ambrx For $28.00 Per Share - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-to-acquire-ambrx-for-28-00-per-share-quick-facts-1032950099,positive,0.9276779890060425
3813,1/8/2024 4:18:52 PM,Today Is Cancer-Focused Deals Day: Johnson & Johnson Scoops Up Ambrx Biopharma As Merck Boosts Cancer Portfolio With Harpoon Deal,Benzinga,/news/stocks/today-is-cancer-focused-deals-day-johnson-johnson-scoops-up-ambrx-biopharma-as-merck-boosts-cancer-portfolio-with-harpoon-deal-1032950939,negative,0.5216545462608337
3814,1/8/2024 5:22:00 PM,Why Is Ambrx Biopharma (AMAM) Stock Up 100% Today?,InvestorPlace,/news/stocks/why-is-ambrx-biopharma-amam-stock-up-100-today-1032951235,negative,0.8520811200141907
3815,1/9/2024 10:06:31 AM,Johnson & Johnson: A Steady Hold Amidst Strategic Expansion and Pipeline Potential,TipRanks,/news/stocks/johnson-johnson-a-steady-hold-amidst-strategic-expansion-and-pipeline-potential-1032955160,negative,0.9275664687156677
3816,1/9/2024 12:20:15 PM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Prothena (PRTA), Johnson & Johnson (JNJ) and Zimmer Biomet Holdings (ZBH)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-prothena-prta-johnson-johnson-jnj-and-zimmer-biomet-holdings-zbh-1032955314,neutral,0.9387432932853699
3817,1/10/2024 10:22:51 PM,7 Stable Stocks to Buy No Matter What Happens to Interest Rates,InvestorPlace,/news/stocks/7-stable-stocks-to-buy-no-matter-what-happens-to-interest-rates-1032958678,positive,0.9042826890945435
3818,1/10/2024 10:49:21 PM,3 Unshakeable Dividend Stocks for Lifelong Wealth,InvestorPlace,/news/stocks/3-unshakeable-dividend-stocks-for-lifelong-wealth-1032958695,positive,0.8588070273399353
3819,1/11/2024 6:37:42 AM,Buy Rating on Johnson & Johnson: Strategic Oncology Acquisition Promises Growth,TipRanks,/news/stocks/buy-rating-on-johnson-johnson-strategic-oncology-acquisition-promises-growth-1032959789,negative,0.897979736328125
3820,1/11/2024 8:05:07 PM,Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation,InvestorPlace,/news/stocks/dividend-dynasty-7-high-yield-stocks-for-long-term-wealth-accumulation-1032961916,positive,0.9331802129745483
3821,1/13/2024 1:11:11 PM,"Analysts Conflicted on These Healthcare Names: UnitedHealth (UNH), Johnson & Johnson (JNJ) and Idexx Laboratories (IDXX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-unitedhealth-unh-johnson-johnson-jnj-and-idexx-laboratories-idxx-1032965145,neutral,0.6438877582550049
3822,1/14/2024 11:15:00 AM,Hidden High-Yielders: 7 Overlooked Stocks with Attractive Dividends¬†,InvestorPlace,/news/stocks/7-overlooked-high-yield-dividend-stocks-for-your-2024-portfolio-1032965321,positive,0.8044857382774353
3823,1/15/2024 10:29:48 PM,The 3 Most Undervalued Value Stocks to Buy in January,InvestorPlace,/news/stocks/the-3-most-undervalued-value-stocks-to-buy-in-january-1032968457,positive,0.5055683255195618
3824,1/16/2024 1:50:47 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), GoodRx Holdings (GDRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-arrowhead-pharmaceuticals-arwr-goodrx-holdings-gdrx-and-johnson-johnson-jnj-1032968640,neutral,0.9448198080062866
3825,1/18/2024 7:17:40 PM,7 Must-Have Stocks for Serious Wealth Accumulation,InvestorPlace,/news/stocks/7-must-have-stocks-for-serious-wealth-accumulation-1032978135,positive,0.7609946131706238
3826,1/18/2024 10:24:47 PM,3 Reasons to Rely on Dividend Stocks,InvestorPlace,/news/stocks/3-reasons-to-rely-on-dividend-stocks-1032978398,positive,0.9319899082183838
3827,1/19/2024 1:05:15 PM,Senate panel to consider subpoenas for J&J and Merck CEOs,Seeking Alpha,https://seekingalpha.com/news/4056351-sen-bernie-sanders-weighs-subpoenas-jj-merck-ceos?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.576749861240387
3828,1/19/2024 4:18:03 PM,Eli Lilly production plant said to be under renewed FDA scrutiny,Seeking Alpha,https://seekingalpha.com/news/4056498-eli-lilly-plant-renewed-fda-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.529183030128479
3829,1/19/2024 8:00:29 PM,"Catalyst Watch: Tesla, Netflix and Procter & Gamble head into the earnings confessional",Seeking Alpha,https://seekingalpha.com/news/4056553-catalyst-watch-tesla-netflix-and-procter-gamble-head-into-the-earnings-confessional?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9108691811561584
3830,1/19/2024 8:10:19 PM,"Alvotech stock jumps 15% on Stelara, Humira biosimilars updates (update)",Seeking Alpha,https://seekingalpha.com/news/4056530-fda-flags-possible-violation-at-alvotech-biosimilars-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.838801383972168
3831,1/19/2024 8:39:27 PM,Johnson & Johnson wins full FDA approval for bladder cancer therapy Balversa,Seeking Alpha,https://seekingalpha.com/news/4056579-johnson--johnson-fda-approval-for-bladder-cancer-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9164639711380005
3832,1/21/2024 1:00:00 PM,"Earnings week ahead: Tesla, Netflix, AT&T, Johnson & Johnson, GE and more",Seeking Alpha,https://seekingalpha.com/news/4056510-earnings-week-ahead-tesla-netflix-att-johnson-johnson-general-electric-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9366969466209412
3833,1/21/2024 5:00:01 PM,Anti-obesity meds can expand the market for weight loss surgery: Bernstein,Seeking Alpha,https://seekingalpha.com/news/4056663-glp-1s-can-expand-market-weight-loss-surgery-bernstein?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.820827305316925
3834,1/21/2024 6:30:00 PM,New ADHD drugs could pay off for pharmaceutical companies,Seeking Alpha,https://seekingalpha.com/news/4056645-new-adhd-drugs-could-pay-off-pharmaceutical-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9085959792137146
3835,1/22/2024 3:01:13 PM,Johnson Johnson earnings preview: what Wall Street is expecting,Markets Insider Automation,/news/stocks/johnson_johnson-stock-q4-earnings-preview-1032983615,positive,0.9109315872192383
3836,1/22/2024 3:23:05 PM,"BoFA picks Johnson & Johnson, Halliburton and Tesla for options opportunity ahead of earnings",Seeking Alpha,https://seekingalpha.com/news/4056847-bofa-picks-johnson-johnson-halliburton-and-tesla-for-options-opportunity-ahead-of-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8573930263519287
3837,1/22/2024 3:55:24 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4056909-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8660826683044434
3838,1/22/2024 4:48:10 PM,JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report,Seeking Alpha,https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9445784687995911
3839,1/22/2024 5:21:31 PM,Johnson & Johnson to kick off pharma earnings season amid talc overhang,Seeking Alpha,https://seekingalpha.com/news/4056961-johnson-johnson-q4-2023-earnings-preview?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9020550847053528
3840,1/22/2024 7:34:59 PM,"S&P 500, Nasdaq, Dow Jones Strike All-Time Highs Ahead Of Key Earnings This Week: What's Driving Markets Monday?",Benzinga,/news/etf/stock-indexes-trade-at-all-time-highs-ahead-of-key-earnings-this-week-what-s-driving-markets-monday-1032984660,positive,0.7300135493278503
3841,1/23/2024 4:09:28 AM,CAR-T therapies to get boxed warning on blood cancer risk,Seeking Alpha,https://seekingalpha.com/news/4057175-car-t-therapies-get-boxed-warning-blood-cancer-risk?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7862139940261841
3842,1/23/2024 11:24:18 AM,Johnson & Johnson beats top and bottom line estimates; reaffirms FY24 outlook,Seeking Alpha,https://seekingalpha.com/news/4057235-johnson-johnson-beats-top-and-bottom-line-estimates-reaffirms-fy24-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8630642294883728
3843,1/23/2024 11:41:22 AM,Johnson & Johnson in charts: MedTech segment sales surged 13% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4057244-johnson-johnson-in-charts-medtech-segment-sales-surged-13-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9549142122268677
3844,1/23/2024 12:08:06 PM,Johnson & Johnson posts Q4 beat as pharma and MedTech outperform,Seeking Alpha,https://seekingalpha.com/news/4057264-johnson-johnson-posts-q4-beat-pharma-medtech-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6140129566192627
3845,1/23/2024 12:36:49 PM,"Johnson & Johnson Q4 Profit Increases, beats estimates",RTTNews,/news/stocks/johnson-johnson-q4-profit-increases-beats-estimates-1032986879,negative,0.9294189214706421
3846,1/23/2024 12:56:29 PM,Johnson & Johnson wins arbitration appeal against Genmab,Seeking Alpha,https://seekingalpha.com/news/4057288-johnson-johnson-wins-arbitration-appeal-against-genmab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6583639979362488
3847,1/23/2024 1:29:22 PM,Teva raised to Buy at Jefferies citing a positive setup ahead of 2024 outlook,Seeking Alpha,https://seekingalpha.com/news/4057313-teva-stock-raised-buy-jefferies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8827788829803467
3848,1/23/2024 1:51:06 PM,"Johnson & Johnson Backs FY24 Earnings View, Sales To Rise ",RTTNews,/news/stocks/johnson-johnson-backs-fy24-earnings-view-sales-to-rise-1032987558,negative,0.9462853670120239
3849,1/23/2024 2:18:00 PM,"5 stocks to watch on Tuesday: 3M, Johnson & Johnson, Netflix and more",Seeking Alpha,https://seekingalpha.com/news/4057367-5-stocks-to-watch-on-tuesday-3m-johnson-johnson-netflix-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9314147233963013
3850,1/23/2024 2:35:39 PM,Strong Performance and Growth Prospects Justify Buy Rating for Johnson & Johnson,TipRanks,/news/stocks/strong-performance-and-growth-prospects-justify-buy-rating-for-johnson-johnson-1032989073,negative,0.8342694640159607
3851,1/23/2024 5:23:49 PM,Johnson & Johnson‚Äôs MedTech performance augurs well for industry: analysts,Seeking Alpha,https://seekingalpha.com/news/4057471-johnson--johnsons-medtech-beat-augurs-well-industry?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8705817461013794
3852,1/23/2024 5:29:14 PM,J&J may pay $700M to settle state AG probe into talcum powder marketing,Seeking Alpha,https://seekingalpha.com/news/4057476-jj-may-pay-700m-to-settle-state-ag-probe-into-talcum-powder-marketing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.570830225944519
3853,1/23/2024 8:07:44 PM,"US Stocks Pause As Treasury Yields, Dollar Surge On Trimmed Fed Rate Cut Bets: What's Driving Markets Tuesday?",Benzinga,/news/etf/us-stocks-pause-as-treasury-yields-dollar-surge-on-trimmed-fed-rate-cut-bets-what-s-driving-markets-tuesday-1032989224,neutral,0.6083821654319763
3854,1/24/2024 4:15:44 AM,Cantor Fitzgerald Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1032990861,positive,0.8304361701011658
3855,1/24/2024 4:20:18 AM,Wall Street Analysts Are Bullish on Top Healthcare Picks,TipRanks,/news/stocks/wall-street-analysts-are-bullish-on-top-healthcare-picks-1032990859,negative,0.5521676540374756
3856,1/24/2024 12:15:16 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1032993143,positive,0.9046739339828491
3857,1/24/2024 12:36:46 PM,Hold Rating on Johnson & Johnson Amid Moderate Growth Projections and Upcoming Exclusivity Challenges,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-moderate-growth-projections-and-upcoming-exclusivity-challenges-1032993190,neutral,0.8443668484687805
3858,1/24/2024 8:57:44 PM,Johnson & Johnson inks ~$150M deal with Washington State to settle opioid claims,Seeking Alpha,https://seekingalpha.com/news/4058114-jj-inks-150m-deal-washington-state-opioid-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8612924814224243
3859,1/24/2024 9:31:05 PM,JNJ Agrees To $700 Mln Settlement To Resolve Talc Consumer Protection Claims ,RTTNews,/news/stocks/jnj-agrees-to-700-mln-settlement-to-resolve-talc-consumer-protection-claims-1032993979,negative,0.9157108068466187
3860,1/24/2024 10:01:32 PM,The Analyst Verdict: Johnson & Johnson In The Eyes Of 12 Experts,Benzinga,/news/stocks/the-analyst-verdict-johnson-johnson-in-the-eyes-of-12-experts-1032994021,positive,0.890099287033081
3861,1/25/2024 8:55:30 AM,Market-Perform Rating for Johnson & Johnson Amid Mixed Financial Signals and MedTech Margin Concerns,TipRanks,/news/stocks/market-perform-rating-for-johnson-johnson-amid-mixed-financial-signals-and-medtech-margin-concerns-1032996242,neutral,0.8497253656387329
3862,1/25/2024 11:22:00 AM,7 Dividend Stocks to Buy and Never Sell: January 2024 Edition,InvestorPlace,/news/stocks/7-dividend-stocks-to-buy-and-never-sell-january-2024-edition-1032996124,positive,0.9479760527610779
3863,1/26/2024 5:50:28 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Elevance Health (ELV), Johnson & Johnson (JNJ) and Abbott Labs (ABT)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-elevance-health-elv-johnson-johnson-jnj-and-abbott-labs-abt-1032999669,neutral,0.933806836605072
3864,1/26/2024 12:16:34 PM,PBMs ramp up lobbying efforts amid growing public scrutiny,Seeking Alpha,https://seekingalpha.com/news/4058952-pbms-ramp-up-lobbying-amid-growing-public-scrutiny?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9376139640808105
3865,1/26/2024 10:03:52 PM,Dividend Dynamos- 7 Stocks Delivering Consistent Cash Flow This Year,InvestorPlace,/news/stocks/dividend-dynamos-7-stocks-delivering-consistent-cash-flow-this-year-1033002407,negative,0.9497070908546448
3866,1/27/2024 12:24:31 AM,JNJ Stock: What to Consider Before Its Next Dividend Hike,TipRanks,/news/stocks/jnj-stock-what-to-consider-before-its-next-dividend-hike-1033002499,positive,0.9422739744186401
3867,1/28/2024 5:00:53 PM,Big Pharma earnings season in spotlight amid positive sentiment,Seeking Alpha,https://seekingalpha.com/news/4059361-big-pharma-earnings-spotlight-positive-sentiment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8954368233680725
3868,1/29/2024 1:30:18 PM,AbbVie raised to Outperform at William Blair ahead of earnings,Seeking Alpha,https://seekingalpha.com/news/4059465-abbvie-stock-upgraded-william-blair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8045328855514526
3869,1/29/2024 6:28:50 PM,"Evolus, Alvotech gain as Barclays raises to Ovrweight",Seeking Alpha,https://seekingalpha.com/news/4059650-evolus-stock-alvotech-stock-gain-barclays-upgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.915669322013855
3870,1/29/2024 9:02:31 PM,Hedge Fund Favorites: 7 Stocks the Big Money Is Loving Now,InvestorPlace,/news/stocks/hedge-fund-favorites-7-stocks-the-big-money-is-loving-now-1033007086,positive,0.8953908681869507
3871,1/30/2024 7:14:41 PM,Buy Alert: 3 Healthcare Stocks Sitting in the Sweet Spot,InvestorPlace,/news/stocks/buy-alert-3-healthcare-stocks-sitting-in-the-sweet-spot-1033011521,positive,0.7686212658882141
3872,1/30/2024 9:40:26 PM,J&J seeks expanded FDA approval of Darzalex Faspro for multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4060348-jj-seeks-expanded-fda-approval-of-darzalex-faspro-for-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8494064211845398
3873,1/31/2024 4:56:52 PM,The 7 Best Blue-Chip Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-blue-chip-stocks-to-invest-in-for-big-gains-in-2024-1033016372,negative,0.8946983814239502
3874,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-ppening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49058476090431213
3875,2/1/2024 3:13:39 PM,U.S. govt. opens bids in Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4061377-opening-bids-sent-drugs-picked-medicare-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49058476090431213
3876,2/1/2024 6:22:16 PM,"Lilly, Zoetis, Abbott least shorted stocks in S&P 500 health sector in mid-Jan",Seeking Alpha,https://seekingalpha.com/news/4061498-lilly-zoetis-abbott-least-shorted-stocks-in-health-sector-till-mid-jan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7107202410697937
3877,2/4/2024 5:00:49 PM,Pharma giants turn to China in search of targeted cancer drugs,Seeking Alpha,https://seekingalpha.com/news/4062374-pharma-antibody-drug-conjugates-china?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8160377740859985
3878,2/5/2024 3:24:50 PM,Johnson & Johnson succeeds in trials for autoimmune drug,Seeking Alpha,https://seekingalpha.com/news/4062626-johnson-johnson-wins-studies-autoimmune-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8428158164024353
3879,2/5/2024 9:08:41 PM,J&J releases positive data on PFA system for arrhythmia,Seeking Alpha,https://seekingalpha.com/news/4062841-jj-releases-positive-data-on-pfa-system-for-arrhythmia?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7533019185066223
3880,2/6/2024 11:15:00 AM,The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024,InvestorPlace,/news/stocks/the-7-best-healthcare-stocks-to-invest-in-for-big-gains-in-2024-1033035941,negative,0.8954083323478699
3881,2/6/2024 12:38:17 PM,GSK blood cancer therapy nearly triples survival in late stage trial,Seeking Alpha,https://seekingalpha.com/news/4063050-gsk-blood-cancer-therapy-nearly-triples-survival?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5269635319709778
3882,2/6/2024 12:46:21 PM,Johnson & Johnson (JNJ) Gets a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-cantor-fitzgerald-1033036045,positive,0.6512175798416138
3883,2/6/2024 2:11:29 PM,7 Dividend Stocks Worth Holding for the Long Haul,InvestorPlace,/news/stocks/7-dividend-stocks-worth-holding-for-the-long-haul-1033035440,positive,0.8526890873908997
3884,2/6/2024 3:07:57 PM,Johnson & Johnson sued over mismanaging company‚Äôs health plan,Seeking Alpha,https://seekingalpha.com/news/4063173-johnson-johnson-sued-over-mismanaging-companys-health-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9531071782112122
3885,2/8/2024 7:07:57 PM,The Watch List: Is Warren Buffett Still Selling These 3 Stocks?,InvestorPlace,/news/stocks/the-watch-list-is-warren-buffett-still-selling-these-3-stocks-1033048002,positive,0.8674056529998779
3886,2/9/2024 11:30:00 AM,3 Dividend Stocks to Cling to This Year,InvestorPlace,/news/stocks/3-dividend-stocks-to-cling-to-this-year-1033050512,positive,0.6638264656066895
3887,2/9/2024 12:24:06 PM,Pharma CEOs defend high drug prices; blame PBMs at Senate hearing,Seeking Alpha,https://seekingalpha.com/news/4065061-pharma-ceos-defend-high-drug-prices-blame-pbms-senate-hearing?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6773600578308105
3888,2/9/2024 1:27:08 PM,Johnson & Johnson antibody therapy gets FDA breakthrough designation for HDFN indication,Seeking Alpha,https://seekingalpha.com/news/4065092-johnson-johnson-antibody-therapy-gets-fda-breakthrough-designation-for-hdfn-indication?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9108508229255676
3889,2/9/2024 1:57:00 PM,"7 stocks to watch on Friday: Major drugmakers on Senate hearing, PepsiCo and more",Seeking Alpha,https://seekingalpha.com/news/4065116-7-stocks-to-watch-on-friday-major-drugmakers-on-senate-hearing-pepsico-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9030511379241943
3890,2/9/2024 2:12:32 PM,Dividend Dynasties: 3 Stocks Set to Deliver Consistent Income,InvestorPlace,/news/stocks/dividend-dynasties-3-stocks-set-to-deliver-consistent-income-1033051230,negative,0.9241904616355896
3891,2/12/2024 11:10:00 AM,Passive Income Powerhouses: 7 Blue-Chip Stocks to Own Now,InvestorPlace,/news/stocks/passive-income-powerhouses-7-blue-chip-stocks-to-own-now-1033056427,positive,0.8919640779495239
3892,2/13/2024 2:01:27 AM,Federal judge dismisses PhRMA challenge to Medicare price negotiations,Seeking Alpha,https://seekingalpha.com/news/4065840-federal-judge-tosses-phrma-lawsuit-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6178923845291138
3893,2/13/2024 2:30:44 PM,GSK raised to Buy at Citi after cancer drug data,Seeking Alpha,https://seekingalpha.com/news/4066061-gsk-stock-raised-buy-citi-blenrep-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6113845705986023
3894,2/13/2024 7:13:49 PM,7 Stable Dividend Stocks to Ease Lingering Market Jitters,InvestorPlace,/news/stocks/7-stable-dividend-stocks-to-ease-lingering-market-jitters-1033062743,negative,0.6929715871810913
3895,2/14/2024 6:07:31 PM,Johnson & Johnson wins FDA nod for first frostbite therapy,Seeking Alpha,https://seekingalpha.com/news/4066959-jj-wins-fda-nod-first-frostbite-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.830553412437439
3896,2/14/2024 9:14:33 PM,"Dalio's Bridgewater adds Apple, Wells Fargo; exits Netflix, Thermo Fisher",Seeking Alpha,https://seekingalpha.com/news/4067120-dalios-bridgewater-adds-apple-wells-fargo-exits-netflix-thermo-fisher?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8667407035827637
3897,2/15/2024 2:05:35 AM,Buy Rating Justified by Johnson & Johnson‚Äôs Strong Performance and Growth Prospects,TipRanks,/news/stocks/buy-rating-justified-by-johnson-johnson-s-strong-performance-and-growth-prospects-1033068841,negative,0.9120550155639648
3898,2/15/2024 3:04:10 PM,7 Small-Cap Stocks With Significant Upside Potential in 2024,InvestorPlace,/news/stocks/7-small-cap-stocks-with-significant-upside-potential-in-2024-1033072455,negative,0.841797411441803
3899,2/15/2024 3:10:42 PM,Johnson & Johnson settles with Alvotech for off-patent Stelara,Seeking Alpha,https://seekingalpha.com/news/4067680-alvotech-stock-gains-deals-jj-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5497578978538513
3900,2/15/2024 4:57:01 PM,The 3 Biotech Stocks That Could Make Your February Unforgettable,InvestorPlace,/news/stocks/the-3-biotech-stocks-that-could-make-your-february-unforgettable-1033073000,positive,0.8924350142478943
3901,2/18/2024 5:00:00 PM,Medtronic Q3 in focus amid MedTech‚Äôs post-COVID gains,Seeking Alpha,https://seekingalpha.com/news/4068521-medtronic-q3-in-focus-amid-medtechs-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6916518211364746
3902,2/18/2024 6:49:00 PM,Steady Eddies: 3 Blue-Chip Stocks to Buy for the Long Haul,InvestorPlace,/news/stocks/steady-eddies-3-blue-chip-stocks-to-buy-for-the-long-haul-1033078317,positive,0.821129322052002
3903,2/20/2024 11:25:00 AM,Income Lover‚Äôs Paradise: 3 Dividend Stocks with Stellar Track Records,InvestorPlace,/news/stocks/income-lovers-paradise-3-dividend-stocks-with-stellar-track-records-1033082598,positive,0.6894158720970154
3904,2/20/2024 6:54:06 PM,Top 7 Contenders to Join the Trillion-Dollar Club,InvestorPlace,/news/stocks/top-7-contenders-to-join-the-trillion-dollar-club-1033084666,positive,0.8761575818061829
3905,2/20/2024 9:39:11 PM,"Cantor starts CG Oncology at overweight, cites bladder cancer treatment",Seeking Alpha,https://seekingalpha.com/news/4069286-cantor-starts-cg-oncology-at-overweight-cites-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8835944533348083
3906,2/20/2024 10:13:56 PM,FDA approves biweekly dosing of J&J multiple myeloma drug,Seeking Alpha,https://seekingalpha.com/news/4069329-fda-approves-biweekly-dosing-of-jj-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8577064871788025
3907,2/21/2024 8:20:05 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-vertex-pharmaceuticals-vrtx-1033087099,negative,0.5155614018440247
3908,2/22/2024 2:40:53 PM,Ambrx Biopharma ticks higher as HSR waiting period for J&J deal expires,Seeking Alpha,https://seekingalpha.com/news/4070360-ambrx-biopharma-ticks-higher-as-hsr-waiting-period-for-jj-deal-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8999304175376892
3909,2/22/2024 10:33:00 PM,3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List,InvestorPlace,/news/stocks/3-undervalued-small-cap-stocks-to-add-to-your-must-buy-list-1033095199,positive,0.7965868711471558
3910,2/23/2024 1:03:10 PM,Janssen Pharma's Carvykti Gets Positive CHMP Opinion For Earlier Multiple Myeloma Treatment ,RTTNews,/news/stocks/janssen-pharma-s-carvykti-gets-positive-chmp-opinion-for-earlier-multiple-myeloma-treatment-1033097034,negative,0.9466877579689026
3911,2/23/2024 2:58:33 PM,Johnson & Johnson wins EU backing to expand labeling for CAR-T therapy,Seeking Alpha,https://seekingalpha.com/news/4071098-jj-wins-eu-backing-expand-labeling-car-t-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9276671409606934
3912,2/23/2024 6:22:45 PM,Legend Biotech stock rises after EU backs label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4071255-legend-biotech-stock-rises-after-eu-backs-label-expansion-for-multiple-myeloma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7345453500747681
3913,2/23/2024 7:08:15 PM,"BMO upgrades Genmab to outperform, cites diversification potential",Seeking Alpha,https://seekingalpha.com/news/4071279-bmo-upgrades-genmab-to-outperform-cites-diversification-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9533355236053467
3914,2/24/2024 1:30:00 PM,Pension Plan Redux: 3 Companies That Could Take a Page From IBM‚Äôs Playbook,InvestorPlace,/news/stocks/pension-plan-redux-3-companies-that-could-take-a-page-from-ibms-playbook-1033099231,positive,0.9334598779678345
3915,2/25/2024 7:30:22 PM,7 Stocks to Buy Now if You Think the S&P 500‚Äôs Winning Streak Will Continue,InvestorPlace,/news/stocks/7-stocks-to-buy-now-if-you-think-the-sp-500s-winning-streak-will-continue-1033099958,positive,0.7368114590644836
3916,2/25/2024 11:50:34 PM,"Needham sees orthopedics market slowing; favors Enovis, Paragon 28",Seeking Alpha,https://seekingalpha.com/news/4071389-needham-sees-orthopedics-market-slowing-favors-enovis-paragon-28?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7138683795928955
3917,2/26/2024 5:53:41 PM,3 Dividend Stocks That Are Too Good to Ignore: Q1 Edition,InvestorPlace,/news/stocks/3-dividend-stocks-that-are-too-good-to-ignore-q1-edition-1033104041,positive,0.8810006380081177
3918,2/27/2024 9:00:02 PM,"Waters, Moderna most shorted stocks in S&P 500 health sector till Jan-end",Seeking Alpha,https://seekingalpha.com/news/4072568-waters-moderna-most-shorted-stocks-in-sp-500-health-sector-till-jan-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5255063772201538
3919,2/27/2024 10:12:21 PM,7 Dividend Stocks Every Investor Should Own to Survive a Market Crash,InvestorPlace,/news/stocks/7-dividend-stocks-every-investor-should-own-to-survive-a-market-crash-2-1033109768,positive,0.9202568531036377
3920,2/28/2024 9:52:49 AM,Biotech Stocks Facing FDA Decision In March 2024 ,RTTNews,/news/stocks/biotech-stocks-facing-fda-decision-in-march-2024-1033111344,positive,0.9174318909645081
3921,2/28/2024 10:38:50 AM,Hold Rating on Johnson & Johnson Amid Anticipated Varipulse Approval and Afib Market Dynamics,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-anticipated-varipulse-approval-and-afib-market-dynamics-1033112661,negative,0.687635600566864
3922,2/28/2024 12:23:37 PM,"Analysts Offer Insights on Healthcare Companies: Viridian Therapeutics (VRDN), Masimo (MASI) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-viridian-therapeutics-vrdn-masimo-masi-and-johnson-johnson-jnj-1033113716,positive,0.9184691309928894
3923,2/28/2024 5:00:16 PM,Beyond The Numbers: 13 Analysts Discuss Johnson & Johnson Stock,Benzinga,/news/stocks/beyond-the-numbers-13-analysts-discuss-johnson-johnson-stock-1033114014,positive,0.9462097883224487
3924,2/29/2024 11:32:10 AM,Barclays Keeps Their Hold Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/barclays-keeps-their-hold-rating-on-johnson-johnson-jnj-1033118567,positive,0.9075490236282349
3925,2/29/2024 7:26:32 PM,Don‚Äôt Panic! 7 Smart Stocks to Buy if the Markets Take a Tumble.,InvestorPlace,/news/stocks/dont-panic-7-smart-stocks-to-buy-if-the-markets-take-a-tumble-1033120307,positive,0.8638187050819397
3926,3/1/2024 6:10:27 PM,Medicare price negotiations survive another legal challenge,Seeking Alpha,https://seekingalpha.com/news/4074801-medicare-price-negotiations-survive-legal-challenge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8509966135025024
3927,3/1/2024 9:30:02 PM,J&J gets full approval for Rybrevant for EGFR exon 20 lung cancer,Seeking Alpha,https://seekingalpha.com/news/4074903-jnj-gets-full-approval-for-rebrevant-for-egfr-exon-20-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9122889041900635
3928,3/1/2024 10:34:27 PM,Johnson & Johnson's Rybrevant Gets FDA Approval For Lung Cancer Treatment ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-gets-fda-approval-for-lung-cancer-treatment-1033125304,negative,0.9090990424156189
3929,3/4/2024 11:25:00 AM,Secure Your Future: 7 Dividend Kings with Solid Growth Potential,InvestorPlace,/news/stocks/7-dividend-kings-that-offer-more-than-just-a-pretty-dividend-1033127903,negative,0.8111752867698669
3930,3/4/2024 7:08:25 PM,Biden says drugmakers to continue to engage in Medicare drug price negoiations,Seeking Alpha,https://seekingalpha.com/news/4075531-biden-says-drugmakers-continue-engage-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8006861805915833
3931,3/5/2024 9:08:02 PM,7 No-Frills Dividend Stocks for Your Must-Own List,InvestorPlace,/news/stocks/7-no-frills-dividend-stocks-for-your-must-own-list-1033134714,positive,0.9344366788864136
3932,3/6/2024 11:17:00 AM,The Top 7 Dividend Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-march-2024-1033136900,positive,0.9411417245864868
3933,3/6/2024 3:18:51 PM,J&J Seeks EMA Approval For DARZALEX Quadruplet Therapy For Multiple Myeloma ,RTTNews,/news/stocks/j-j-seeks-ema-approval-for-darzalex-quadruplet-therapy-for-multiple-myeloma-1033137717,negative,0.9085598587989807
3934,3/6/2024 7:31:39 PM,ViiV‚Äôs long-acting HIV therapy outperforms daily therapy in Phase 3 trial,Seeking Alpha,https://seekingalpha.com/news/4076783-viivs-long-acting-hiv-therapy-outperforms-daily-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9460234045982361
3935,3/6/2024 10:40:54 PM,Biden to push for expanding Medicare drug pricing program,Seeking Alpha,https://seekingalpha.com/news/4076912-biden-to-push-for-expanding-medicare-drug-pricing-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7659493088722229
3936,3/7/2024 2:48:43 PM,Johnson & Johnson Buys Ambrx Biopharma In $2 Bln Cash Deal ,RTTNews,/news/stocks/johnson-johnson-buys-ambrx-biopharma-in-2-bln-cash-deal-1033142226,positive,0.8821579813957214
3937,3/7/2024 3:50:14 PM,J&J completes $2B acquisition of ADC developer Ambrx,Seeking Alpha,https://seekingalpha.com/news/4077247-jj-completes-acquisition-of-adc-developer-ambrx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7245926856994629
3938,3/7/2024 4:11:38 PM,The Top 3 Blue-Chip Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-blue-chip-stocks-to-buy-in-march-2024-1033143201,positive,0.9116477370262146
3939,3/7/2024 5:27:11 PM,The Top 3 Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-healthcare-stocks-to-buy-in-march-2024-1033143533,positive,0.9201725125312805
3940,3/7/2024 8:52:40 PM,"Arcellx's Lead Asset Can Potentially Outperform Bristol-Myers Squibb, Johnson & Johnson's Multiple Myeloma Cell Therapies: Morgan Stanley",Benzinga,/news/stocks/arcellx-s-lead-asset-can-potentially-outperform-bristol-myers-squibb-johnson-johnson-s-multiple-myeloma-cell-therapies-morgan-stanley-1033143791,negative,0.6205340027809143
3941,3/8/2024 9:32:49 PM,3 Dividend Aristocrat Stocks to Buy And Hold: March 2024,InvestorPlace,/news/stocks/3-dividend-aristocrat-stocks-to-buy-and-hold-march-2024-1033147709,positive,0.9455958604812622
3942,3/9/2024 6:00:00 PM,The Top 3 Pharma Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-top-3-pharma-stocks-to-buy-in-march2024-1033148079,positive,0.9020588397979736
3943,3/9/2024 6:34:43 PM,Johnson & Johnson highlights psoriasis candidate with long-term data,Seeking Alpha,https://seekingalpha.com/news/4077809-jj-psoriasis-drug-long-term-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5312958359718323
3944,3/10/2024 5:08:00 PM,Cantor sees strong year ahead for oncology M&A,Seeking Alpha,https://seekingalpha.com/news/4077812-patent-cliffs-could-fuel-increased-ma-in-oncology-this-year-cantor-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9445049166679382
3945,3/11/2024 4:03:46 PM,The Dow‚Äôs Best Friends: 3 ‚ÄòDogs‚Äô Ready to Fetch Huge Returns,InvestorPlace,/news/stocks/the-dows-best-friends-3-dogs-ready-to-fetch-huge-returns-1033151926,positive,0.853887677192688
3946,3/11/2024 10:10:18 PM,J&J submits sBLA for Tremfya for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4078241-johnson-johnson-submits-sbla-tremfya-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9233540892601013
3947,3/12/2024 12:09:00 PM,3 Must-Have Dividend Kings for a Steady Income Stream,InvestorPlace,/news/stocks/3-must-have-dividend-kings-for-a-steady-income-stream-1033154748,positive,0.6209182739257812
3948,3/12/2024 7:41:22 PM,7 High-Quality Blue-Chip Stocks to Buy if You‚Äôre Looking for Stability,InvestorPlace,/news/stocks/7-high-quality-blue-chip-stocks-to-buy-if-youre-looking-for-stability-1033156716,positive,0.9206485748291016
3949,3/13/2024 1:44:45 PM,"J&J, Bristol Myers slip as FDA comments on CAR-T drugs ahead of AdCom",Seeking Alpha,https://seekingalpha.com/news/4078882-jj-bristol-myers-slip-fda-comments-car-t-drugs-adcom?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9218679070472717
3950,3/14/2024 4:15:21 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033162448,positive,0.5040156245231628
3951,3/14/2024 12:02:33 PM,The 3 Most Undervalued Healthcare Stocks to Buy in March 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-healthcare-stocks-to-buy-in-march-2024-1033163673,positive,0.7171444892883301
3952,3/15/2024 1:29:14 PM,"Johnson & Johnson, Boston Scientific least shorted stocks in S&P 500 healthcare sector for Feb-end",Seeking Alpha,https://seekingalpha.com/news/4079885-johnson-johnson-boston-scientific-least-shorted-stocks-in-sp-500-healthcare-sector-for-feb-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6527519226074219
3953,3/15/2024 4:56:13 PM,The Taxman Cometh: 3 Stocks to Soften the Blow and Grow Your Dough,InvestorPlace,/news/stocks/the-taxman-cometh-3-stocks-to-soften-the-blow-and-grow-your-dough-1033169255,positive,0.779474139213562
3954,3/15/2024 5:25:53 PM,Johnson & Johnson wins FDA AdCom backing for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4080088-jj-wins-fda-adcom-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8676283955574036
3955,3/16/2024 11:58:13 AM,Bristol Myers wins FDA AdCom backing for Abecma label expansion,Seeking Alpha,https://seekingalpha.com/news/4080229-bristol-myers-wins-fda-adcom-backing-abecma-labeling?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8285631537437439
3956,3/16/2024 7:00:00 PM,Guardians of Your Golden Years: 7 Stocks Every Retiree Needs to Own,InvestorPlace,/news/stocks/guardians-of-your-golden-years-7-stocks-every-retiree-needs-to-own-1033169872,positive,0.9161512851715088
3957,3/18/2024 10:50:06 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Aveanna Healthcare Holdings (AVAH),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-aveanna-healthcare-holdings-avah-1033172494,positive,0.9175691604614258
3958,3/19/2024 5:18:58 PM,"Johnson & Johnson, Nvidia ink AI deal for surgical applications",Seeking Alpha,https://seekingalpha.com/news/4081225-johnson-johnson-nvidia-ink-ai-deal-for-surgical-applications?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9136435985565186
3959,3/19/2024 5:40:16 PM,MS drug developer Contineum files for $150M IPO,Seeking Alpha,https://seekingalpha.com/news/4081227-ms-drug-developer-contineum-files-for-150m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9261872172355652
3960,3/19/2024 6:18:28 PM,7 Defensive Stocks to Build a Moat Around Your Portfolio,InvestorPlace,/news/stocks/7-defensive-stocks-to-build-a-moat-around-your-portfolio-1033177894,positive,0.9084606170654297
3961,3/19/2024 7:25:59 PM,A New Frontier: Nvidia Reveals the ‚ÄòWorld‚Äôs Most Powerful‚Äô AI Chip,InvestorPlace,/news/stocks/a-new-frontier-nvidia-reveals-the-worlds-most-powerful-ai-chip-1033178025,positive,0.7236117720603943
3962,3/20/2024 1:35:50 PM,J&J alleges ex-staffer downloaded thousands of files in move to Pfizer,Seeking Alpha,https://seekingalpha.com/news/4081583-jj-alleges-staffer-downloaded-thousands-files-pfizer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.528218150138855
3963,3/21/2024 4:17:03 PM,"Dear 3M Stock Fans, Mark Your Calendars for April 1",InvestorPlace,/news/stocks/dear-3m-stock-fans-mark-your-calendars-for-april-1-1033185826,positive,0.9394966959953308
3964,3/21/2024 8:03:47 PM,Johnson & Johnson stock closes in red for a seventh consecutive session,Seeking Alpha,https://seekingalpha.com/news/4082384-johnson-and-johnson-stock-closes-in-red-for-seventh-consecutive-session?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9520699381828308
3965,3/22/2024 2:14:46 AM,Wall Street‚Äôs Favorite Long-Term Stocks? 3 Names That Could Make You Filthy Rich,InvestorPlace,/news/stocks/wall-streets-favorite-long-term-stocks-3-names-that-could-make-you-filthy-rich-1033186874,positive,0.8669960498809814
3966,3/22/2024 6:42:10 PM,3M Stock Alert: 7 Things to Know About the Upcoming 3M Healthcare Spinoff,InvestorPlace,/news/stocks/3m-stock-alert-7-things-to-know-about-the-upcoming-3m-healthcare-spinoff-1033189957,positive,0.9421712160110474
3967,3/23/2024 12:44:57 PM,"J&J wins FDA nod for blood vessel disorder therapy, Opsynvi",Seeking Alpha,https://seekingalpha.com/news/4083065-jj-wins-fda-nod-blood-vessel-disorder-therapy-opsynvi?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9152442216873169
3968,3/24/2024 2:13:20 PM,7 Dividend Darlings to Scoop Up Every Time the Market Dips,InvestorPlace,/news/stocks/7-dividend-darlings-to-scoop-up-every-time-the-market-dips-1033191000,positive,0.46912363171577454
3969,3/25/2024 2:47:11 PM,Hot Stocks: The 3 Best Opportunities for Investing in the S&P 500¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†¬†,InvestorPlace,/news/stocks/hot-stocks-the-3-best-opportunities-for-investing-in-the-sp-500-1033193515,positive,0.8056526184082031
3970,3/26/2024 12:24:47 PM,J&J experimental therapy gets FDA fast track status to reduce FNAIT in pregnancy,Seeking Alpha,https://seekingalpha.com/news/4083654-jj-experimental-therapy-gets-fda-fast-track-to-reduce-fnait-in-pregnancy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9419540166854858
3971,3/26/2024 5:30:34 PM,7 Dividend Aristocrats That Can Safeguard Your Income Through Any Crisis,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-can-safeguard-your-income-through-any-crisis-1033198293,positive,0.8984200358390808
3972,3/26/2024 6:01:03 PM,Cytokinetics gains amid renewed takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4083918-cytokinetics-gains-amid-renewed-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9322801232337952
3973,3/26/2024 7:12:20 PM,Shockwave Medical surges as Johnson & Johnson in talks to acquire - report,Seeking Alpha,https://seekingalpha.com/news/4083938-shockwave-medical-surges-johnson-johnson-talks-acquire?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5301522016525269
3974,3/27/2024 12:02:08 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Healthequity (HQY) and Bluebird Bio (BLUE)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-healthequity-hqy-and-bluebird-bio-blue-1033199008,positive,0.9078885912895203
3975,3/27/2024 10:00:00 AM,7 Dow Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/7-dow-stocks-to-buy-on-the-dip-march-2024-1033200339,positive,0.9031175971031189
3976,3/27/2024 1:13:34 PM,Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields-1033200819,positive,0.7807832360267639
3977,3/27/2024 1:50:45 PM,Merck hits all-time high after FDA nod for lung disease therapy,Seeking Alpha,https://seekingalpha.com/news/4084361-merck-stock-jumps-fda-nod-winrevair?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.705170750617981
3978,3/27/2024 7:04:20 PM,J&J-Shockwave deal makes strategic sense: analysts,Seeking Alpha,https://seekingalpha.com/news/4084616-shockwave-medical-stock-gains-jj-deal-makes-sense?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8605664968490601
3979,3/27/2024 8:14:11 PM,Johnson & Johnson gets major break in talc cancer link cases,Seeking Alpha,https://seekingalpha.com/news/4084630-johnson-johnson-gets-major-break-talc-cancer-link-cases?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8642125725746155
3980,3/27/2024 9:23:27 PM,"Johnson & Johnson Strong Strategic Fit For Shockwave Medical, But Medtronic, Boston Scientific Could Be Other Bidder, Says Analyst",Benzinga,/news/stocks/johnson-johnson-strong-strategic-fit-for-shockwave-medical-but-medtronic-boston-scientific-could-be-other-bidder-says-analyst-1033202897,negative,0.861524760723114
3981,3/28/2024 2:28:44 PM,J&J to settle Mississippi baby powder suit for $75M: report,Seeking Alpha,https://seekingalpha.com/news/4084978-jj-to-settle-mississippi-baby-powder-suit-for-75m-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8610200881958008
3982,3/28/2024 4:55:21 PM,J&J Agrees To Pay $75 Mln In Mississippi's Baby Powder Case ,RTTNews,/news/stocks/j-j-agrees-to-pay-75-mln-in-mississippi-s-baby-powder-case-1033206269,positive,0.6169882416725159
3983,3/28/2024 6:46:33 PM,3 Value Stocks to Buy on the Dip: March 2024,InvestorPlace,/news/stocks/3-value-stocks-to-buy-on-the-dip-march-2024-1033206804,positive,0.9236919283866882
3984,3/28/2024 7:00:00 PM,"Catalyst Watch: Tesla deliveries, Disney board vote, DJT drama and Fortinet event",Seeking Alpha,https://seekingalpha.com/news/4084622-catalyst-watch-tesla-deliveries-disney-board-vote-djt-drama-and-fortinet-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9371159076690674
3985,4/1/2024 4:17:16 PM,Teva and Viatris revives chance to dispute J&J's schizophrenia drug patent,Seeking Alpha,https://seekingalpha.com/news/4085739-teva-and-viatris-revives-chance-to-dispute-jjs-schizophrenia-drug-patent?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6067003011703491
3986,4/4/2024 12:48:00 AM,Rich Returns at a Discount: 3 Dividend Aristocrats Trading at 52-Week Lows,InvestorPlace,/news/stocks/rich-returns-at-a-discount-3-dividend-aristocrats-trading-at-52-week-lows-1033220639,neutral,0.940869927406311
3987,4/5/2024 12:41:50 AM,Johnson & Johnson urges shareholders to rebuff TRC Capital mini-tender,Seeking Alpha,https://seekingalpha.com/news/4087441-johnson-johnson-urges-shareholders-rebuff-trc-capital-mini-tender?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.566009521484375
3988,4/5/2024 1:00:19 PM,Johnson & Johnson To Buy Shockwave In $13.1 Bln Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-shockwave-in-13-1-bln-deal-1033225311,positive,0.9261618256568909
3989,4/5/2024 1:13:00 PM,"4 stocks to watch on Friday: SWAV on JNJ deal, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4087566-4-stocks-to-watch-on-friday-swav-on-jnj-deal-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9346986413002014
3990,4/5/2024 1:31:18 PM,SWAV Stock Alert: Shockwave Medical Lands Big Buyer in Johnson & Johnson,InvestorPlace,/news/stocks/swav-stock-alert-shockwave-medical-lands-big-buyer-in-johnson-johnson-1033225858,negative,0.549612283706665
3991,4/5/2024 2:00:01 PM,Johnson & Johnson to acquire Shockwave Medical for $13.1B (update),Seeking Alpha,https://seekingalpha.com/news/4087511-johnson--johnson-acquire-shockwave-medical-13b-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9432154297828674
3992,4/5/2024 5:20:47 PM,Contineum Therapeutics stock slides 10% following $110M IPO,Seeking Alpha,https://seekingalpha.com/news/4087646-contineum-therapeutics-stock-slides-following-110m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9595815539360046
3993,4/5/2024 8:30:00 PM,The 7 Most Undervalued Russell 2000 Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-russell-2000-stocks-to-buy-in-april-1033226998,positive,0.7935512661933899
3994,4/6/2024 12:38:09 PM,Johnson & Johnson wins FDA nod for Carvykti label expansion,Seeking Alpha,https://seekingalpha.com/news/4087716-jj-wins-fda-nod-carvykti-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8747883439064026
3995,4/7/2024 5:31:00 PM,Morgan Stanley sees Fed rate cut fueling biotech stocks,Seeking Alpha,https://seekingalpha.com/news/4087727-fed-rate-cut-should-fuel-biotech-outperformance-morgan-stanley-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5271168947219849
3996,4/8/2024 7:27:10 PM,"Johnson & Johnson's $13B Shockwave Medical Deal Accelerates MedTech Strategy, Analyst Says",Benzinga,/news/stocks/johnson-johnson-s-13b-shockwave-medical-deal-accelerates-medtech-strategy-analyst-says-1033230884,negative,0.9131452441215515
3997,4/8/2024 8:19:36 PM,Johnson & Johnson's Carvykti Stands Ahead Of Bristol Myers' Rival Blood Cancer Therapy With FDA Approval For Wider Population,Benzinga,/news/stocks/johnson-johnson-s-carvykti-stands-ahead-of-bristol-myers-rival-blood-cancer-therapy-with-fda-approval-for-wider-population-1033230972,negative,0.7435803413391113
3998,4/9/2024 8:15:32 PM,Johnson and Johnson traded in the green after six day of losses,Seeking Alpha,https://seekingalpha.com/news/4088363-johnson-and-johnson-traded-in-the-green-after-six-day-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5100764036178589
3999,4/10/2024 6:21:13 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Axsome Therapeutics (AXSM) and Premier (PINC)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-axsome-therapeutics-axsm-and-premier-pinc-1033236272,positive,0.9106098413467407
4000,4/10/2024 10:25:00 AM,"If You Can Only Buy One Dividend Stock in April, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dividend-stock-in-april-it-better-be-one-of-these-3-names-1033236532,positive,0.9411826133728027
4001,4/10/2024 4:10:12 PM,"Analysts Conflicted on These Healthcare Names: Shattuck Labs (STTK), Johnson & Johnson (JNJ) and Tilray (TLRY)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-shattuck-labs-sttk-johnson-johnson-jnj-and-tilray-tlry-1033238690,neutral,0.8158345222473145
4002,4/10/2024 4:50:16 PM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), PainReform (PRFX) and IN8bio (INAB)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-painreform-prfx-and-in8bio-inab-1033238738,positive,0.8915200233459473
4003,4/10/2024 5:22:18 PM,7 Healthcare Stocks to Keep Your Portfolio in Tip-Top Shape,InvestorPlace,/news/stocks/7-healthcare-stocks-to-keep-your-portfolio-in-tip-top-shape-1033238450,positive,0.9137315154075623
4004,4/10/2024 7:27:29 PM,Johnson & Johnson cough syrup recalled in Nigeria over toxicity concerns,Seeking Alpha,https://seekingalpha.com/news/4088708-johnson-johnson-cough-syrup-recalled-in-nigeria-over-toxicity-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9556944370269775
4005,4/10/2024 9:45:00 PM,Wall Street Favorites: 3 Dividend Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-dividend-stocks-with-strong-buy-ratings-for-april-2024-1033238979,positive,0.5842986106872559
4006,4/11/2024 1:08:17 AM,Maintaining Stability Amidst Challenges: Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/maintaining-stability-amidst-challenges-hold-rating-for-johnson-johnson-1033239177,positive,0.8066762685775757
4007,4/11/2024 1:45:35 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033239503,positive,0.7207152843475342
4008,4/11/2024 10:50:00 AM,Joby‚Äôs $3.5B Air Taxi Dream Worth Less Than Trump‚Äôs Truth Social Nightmare?,InvestorPlace,/news/stocks/jobys-3-5b-air-taxi-dream-worth-less-than-trumps-truth-social-nightmare-1033240436,positive,0.8324087858200073
4009,4/11/2024 11:00:37 AM,Rallybio shares gain on investment from J&J for rare fetal condition treatment,Seeking Alpha,https://seekingalpha.com/news/4088840-rallybio-shares-gain-on-investment-from-jj-for-rare-fetal-condition-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.839691698551178
4010,4/11/2024 11:19:51 AM,Today‚Äôs Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on¬†Thursday,InvestorPlace,/news/stocks/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-thursday-april-11th-1033240549,neutral,0.48035502433776855
4011,4/11/2024 11:43:59 AM,Why Is Rallybio (RLYB) Stock Up 93% Today?,InvestorPlace,/news/stocks/why-is-rallybio-rlyb-stock-up-93-today-1033240640,negative,0.6625139117240906
4012,4/11/2024 1:47:56 PM,The $5 BILLION Reason Alpine Immune Sciences (ALPN) Stock Is Up 30% Today,InvestorPlace,/news/stocks/the-5-billion-reason-alpine-immune-sciences-alpn-stock-is-up-30-today-1033241236,negative,0.9471536874771118
4013,4/11/2024 4:17:59 PM,All-Time High Flyers: 7 Stocks to Buy as the Market Peaks,InvestorPlace,/news/stocks/all-time-high-flyers-7-stocks-to-buy-as-the-market-peaks-1033242102,negative,0.5958545804023743
4014,4/11/2024 5:10:22 PM,Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for April 2024,InvestorPlace,/news/stocks/wall-street-favorites-3-biotech-stocks-with-strong-buy-ratings-for-april-2024-1033242187,negative,0.8188539743423462
4015,4/12/2024 5:17:44 PM,"Short interest in S&P 500 health stocks rises, Moderna among most shorted companies in March",Seeking Alpha,https://seekingalpha.com/news/4089272-short-interest-in-sp-500-healthcare-sector-rises-lilly-least-shorted-industry-at-march-end?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8770027160644531
4016,4/12/2024 7:00:09 PM,"Catalyst Watch: Boeing hearing, Bitcoin halving event and new eyes on Reddit",Seeking Alpha,https://seekingalpha.com/news/4089283-catalyst-watch-boeing-hearing-bitcoin-halving-event-and-new-eyes-on-reddit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9150035381317139
4017,4/13/2024 7:56:54 PM,J&J cough syrup recall classified as most serious in South Africa,Seeking Alpha,https://seekingalpha.com/news/4089418-jj-cough-syrup-recall-most-serious-south-africa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8986766934394836
4018,4/14/2024 12:00:00 PM,"Earnings week ahead: BAC, JNJ, TSM, UNH, ABT, SLB, UAL, PG, NFLX and more",Seeking Alpha,https://seekingalpha.com/news/4089249-earnings-week-ahead-bac-jnj-tsm-unh-abt-slb-ual-pg-nflx-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9342080354690552
4019,4/14/2024 1:00:00 PM,The 3 Best Stocks to Buy to Survive the Coming S&P 500 Crash,InvestorPlace,/news/stocks/the-3-best-stocks-to-buy-to-survive-the-coming-sp-500-crash-1033246554,positive,0.7446087002754211
4020,4/15/2024 11:45:10 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033250034,positive,0.9096185564994812
4021,4/15/2024 3:01:13 PM,Johnson Johnson is about to announce earnings ‚Äî here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-q1-quarterly-earnings-preview-stock-1033249247,positive,0.9342256188392639
4022,4/15/2024 3:36:45 PM,Tanzania and Rwanda join its African counterparts to recall J&J's cough syrup - report,Seeking Alpha,https://seekingalpha.com/news/4089679-tanzania-and-rwanda-join-its-african-counterparts-to-recall-jjs-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7760087251663208
4023,4/15/2024 4:11:23 PM,Notable earnings before Tuesday's open,Seeking Alpha,https://seekingalpha.com/news/4089690-notable-earnings-before-tuesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8660826683044434
4024,4/15/2024 5:01:07 PM,A Closer Look at 9 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/a-closer-look-at-9-analyst-recommendations-for-johnson-johnson-1033250047,positive,0.9109458327293396
4025,4/15/2024 5:49:52 PM,JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results,Seeking Alpha,https://seekingalpha.com/news/4089736-jnj-q1-earnings-preview-a-lot-of-moving-factors-expected-to-bring-in-line-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.861086368560791
4026,4/15/2024 8:42:59 PM,"Medical Device Manufacture Integer To Gain From Expanding Pulsed Field Ablation Market, Earns Upgrade From BofA",Benzinga,/news/stocks/medical-device-manufacture-integer-to-gain-from-expanding-pulsed-field-ablation-market-earns-upgrade-from-bofa-1033250649,negative,0.9486805200576782
4027,4/16/2024 8:09:47 AM,Fear & Greed Index Moves To 'Fear' Zone; S&P 500 Down Over 1%,Benzinga,/news/stocks/fear-greed-index-moves-to-fear-zone-s-p-500-down-over-1-1033251804,neutral,0.9559407830238342
4028,4/16/2024 8:10:20 AM,"Bank of America, Morgan Stanley And 3 Stocks To Watch Heading Into Tuesday",Benzinga,/news/stocks/bank-of-america-morgan-stanley-and-3-stocks-to-watch-heading-into-tuesday-1033251803,positive,0.9294854402542114
4029,4/16/2024 8:15:29 AM,Johnson & Johnson Likely To Report Higher Q1 Earnings; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts,Benzinga,/news/stocks/johnson-johnson-likely-to-report-higher-q1-earnings-here-are-the-recent-forecast-changes-from-wall-street-s-most-accurate-analysts-1033251805,positive,0.8407147526741028
4030,4/16/2024 9:32:32 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Amylyx Pharmaceuticals Inc (AMLX) and Rhythm Pharmaceuticals (RYTM)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-amylyx-pharmaceuticals-inc-amlx-and-rhythm-pharmaceuticals-rytm-1033253120,positive,0.9184883236885071
4031,4/16/2024 10:21:57 AM,"Johnson & Johnson Non-GAAP EPS of $2.71 beats by $0.06, revenue of $21.4B in-line",Seeking Alpha,https://seekingalpha.com/news/4089941-johnson-and-johnson-non-gaap-eps-of-2_71-beats-0_06-revenue-of-21_4b-in-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6028456687927246
4032,4/16/2024 10:44:48 AM,Johnson & Johnson raises dividend by 4% to $1.24,Seeking Alpha,https://seekingalpha.com/news/4089942-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9272827506065369
4033,4/16/2024 10:46:28 AM,Johnson & Johnson in charts: Q1 Y/Y revenue growth slows across all categories,Seeking Alpha,https://seekingalpha.com/news/4089946-johnson-johnson-in-charts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9680745601654053
4034,4/16/2024 11:20:23 AM,J&J sets guidance below consensus as MedTech underperforms,Seeking Alpha,https://seekingalpha.com/news/4089962-jj-stock-slips-medtech-underperforms?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9453667402267456
4035,4/16/2024 12:15:24 PM,Balancing Act: Hold Rating on Johnson & Johnson Amid Steady Growth and Legal Challenges,TipRanks,/news/stocks/balancing-act-hold-rating-on-johnson-johnson-amid-steady-growth-and-legal-challenges-1033254214,negative,0.6636519432067871
4036,4/16/2024 12:25:00 PM,Buyback Bonanza: The Top 7 ETFs to Profit From Corporate Cash Splurges,InvestorPlace,/news/stocks/buyback-bonanza-the-top-7-etfs-to-profit-from-corporate-cash-splurges-1033253162,negative,0.9295156002044678
4037,4/16/2024 12:26:20 PM,Johnson & Johnson Q1 Earnings Summary,RTTNews,/news/stocks/johnson-johnson-q1-earnings-summary-1033252603,positive,0.5952138304710388
4038,4/16/2024 1:17:00 PM,"4 stocks to watch on Tuesday: JNJ, BAC and more",Seeking Alpha,https://seekingalpha.com/news/4090040-4-stocks-to-watch-on-tuesday-jnj-bac-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9160826206207275
4039,4/16/2024 1:19:00 PM,Genmab's Q1 Darzalex Sales By Johnson & Johnson Reach $2.692 Bln ,RTTNews,/news/stocks/genmab-s-q1-darzalex-sales-by-johnson-johnson-reach-2-692-bln-1033252793,negative,0.700702965259552
4040,4/16/2024 1:22:39 PM,"Johnson & Johnson Updates FY24 Earnings, Sales Outlook - Update ",RTTNews,/news/stocks/johnson-johnson-updates-fy24-earnings-sales-outlook-update-1033252806,positive,0.8971284627914429
4041,4/16/2024 2:45:00 PM,Johnson & Johnson hosts conference call for investors,Markets Insider Automation,/news/stocks/johnson_johnson_conference-1032643375,positive,0.9340065717697144
4042,4/16/2024 2:52:55 PM,"JNJ Stock Earnings: Johnson & Johnson Beats EPS, Misses Revenue for Q1 2024",InvestorPlace,/news/stocks/jnj-stock-earnings-johnson-johnson-for-q1-of-2024-1033254073,negative,0.5507773160934448
4043,4/16/2024 4:23:16 PM,Bayer dethroned as Germany‚Äôs top drugmaker,Seeking Alpha,https://seekingalpha.com/news/4090165-bayer-beaten-top-german-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4228775203227997
4044,4/16/2024 5:30:12 PM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Cullinan Management (CGEM), Johnson & Johnson (JNJ) and UnitedHealth (UNH)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-cullinan-management-cgem-johnson-johnson-jnj-and-unitedhealth-unh-1033255011,neutral,0.8386659622192383
4045,4/16/2024 5:35:45 PM,Steady Performance and Aligned Guidance Justify Hold Rating for Johnson & Johnson,TipRanks,/news/stocks/steady-performance-and-aligned-guidance-justify-hold-rating-for-johnson-johnson-1033255008,negative,0.6981500387191772
4046,4/16/2024 7:28:15 PM,"Stocks Grapple With Geopolitical Pressures, Gold Eyes $2,400, Bitcoin Falls Below $62,000: What's Driving Markets Tuesday?",Benzinga,/news/etf/stocks-grapple-with-geopolitical-pressures-gold-eyes-2-400-bitcoin-falls-below-62-000-what-s-driving-markets-tuesday-1033254617,positive,0.5798726081848145
4047,4/16/2024 10:22:06 PM,FDA approves Alvotech biosimilar of J&J top-selling drug Stelara,Seeking Alpha,https://seekingalpha.com/news/4090292-fda-approves-alvotech-biosimilar-of-jj-top-selling-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8266173601150513
4048,4/17/2024 7:59:36 AM,RBC Capital Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033257341,positive,0.7240329384803772
4049,4/17/2024 9:20:09 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Intra-Cellular Therapies (ITCI),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-intra-cellular-therapies-itci-1033257677,positive,0.9179285168647766
4050,4/17/2024 12:58:00 PM,"Put $10,000 in These 3 Dividend Stocks by 2025",InvestorPlace,/news/stocks/put-10000-in-these-3-dividend-stocks-by-2025-1033257941,positive,0.9497616291046143
4051,4/17/2024 2:21:45 PM,Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday,Benzinga,/news/stocks/visa-to-rally-around-18-here-are-10-top-analyst-forecasts-for-wednesday-1033257667,positive,0.9166499376296997
4052,4/17/2024 4:55:22 PM,Invest Like a Hawk: 7 Stocks to Own If the Fed Stays Tough,InvestorPlace,/news/stocks/invest-like-a-hawk-7-stocks-to-own-if-the-fed-stays-tough-1033259055,positive,0.9229928851127625
4053,4/17/2024 7:51:24 PM,Johnson & Johnson Analysts Cut Their Forecasts After Q1 Results,Benzinga,/news/stocks/johnson-johnson-analysts-cut-their-forecasts-after-q1-results-1033259210,neutral,0.9550800919532776
4054,4/17/2024 8:35:54 PM,Scotiabank upgrades Legend Biotech to sector outperform,Seeking Alpha,https://seekingalpha.com/news/4090714-scotiabank-upgrades-legend-biotech-to-sector-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9255075454711914
4055,4/17/2024 9:37:35 PM,"Johnson & Johnson Shares Hold Steady After Q1 Earnings, Analysts Optimistic About Future",Benzinga,/news/stocks/johnson-johnson-shares-hold-steady-after-q1-earnings-analysts-optimistic-about-future-1033259391,negative,0.9223556518554688
4056,4/18/2024 4:30:44 AM,"Analysts Offer Insights on Healthcare Companies: Savara (SVRA), Johnson & Johnson (JNJ) and Lantheus (LNTH)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-savara-svra-johnson-johnson-jnj-and-lantheus-lnth-1033260721,positive,0.9123190641403198
4057,4/18/2024 5:56:25 AM,"Hold Rating on Johnson & Johnson Amidst Growth, Competition, and Legal Challenges",TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amidst-growth-competition-and-legal-challenges-1033261085,positive,0.8242540955543518
4058,4/18/2024 2:23:15 PM,Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.,InvestorPlace,/news/stocks/want-to-double-your-tax-refund-in-2024-7-stocks-to-buy-now-1033262864,positive,0.8406462669372559
4059,4/18/2024 4:08:11 PM,Recession-Proof Riches: 3 Stocks That Thrive in Any Economy,InvestorPlace,/news/stocks/recession-proof-riches-3-stocks-that-thrive-in-any-economy-1033263265,positive,0.9118908643722534
4060,4/19/2024 10:13:03 AM,FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk,Seeking Alpha,https://seekingalpha.com/news/4091378-fda-requires-changes-car-t-cell-therapy-boxed-warning?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9190294742584229
4061,4/19/2024 12:13:02 PM,"Dividend Roundup: Johnson & Johnson, Dell, Lowe‚Äôs, Qualcomm and more",Seeking Alpha,https://seekingalpha.com/news/4091414-dividend-roundup-johnson-johnson-dell-lowes-qualcomm-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9432070255279541
4062,4/19/2024 3:51:54 PM,Johnson & Johnson wins trial over talc-related cancer claim in Florida,Seeking Alpha,https://seekingalpha.com/news/4091543-johnson-johnson-wins-trial-talc-related-cancer-claim-florida?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.4959624111652374
4063,4/19/2024 6:30:20 PM,These 3 Small-Cap Stocks Are Up 304% in 2024. Can They Run Higher?,InvestorPlace,/news/stocks/these-3-small-cap-stocks-are-up-304-in-2024-can-they-run-higher-1033267239,negative,0.692104697227478
4064,4/19/2024 6:48:52 PM,WHO considering safety alert on Kenvue kids cough syrup (update),Seeking Alpha,https://seekingalpha.com/news/4091569-who-considering-safety-alert-on-kenvue-kids-cough-syrup?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8983694314956665
4065,4/19/2024 7:00:19 PM,"Catalyst Watch: Tesla, Boeing and General Motors brace for earnings fireworks",Seeking Alpha,https://seekingalpha.com/news/4091531-catalyst-watch-tesla-boeing-and-general-motors-brace-for-earnings-fireworks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8319826126098633
4066,4/20/2024 10:37:00 AM,Investing for the Long-Term: 3 Stocks With Proven Track Records,InvestorPlace,/news/stocks/investing-for-the-long-term-3-stocks-with-proven-track-records-1033267570,positive,0.6395675539970398
4067,4/20/2024 7:38:42 PM,J&J and Kenvue ordered to pay $45M in latest talc-related cancer claim,Seeking Alpha,https://seekingalpha.com/news/4091712-jj-kenvue-told-pay-45m--talc-related-cancer-claim?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9596075415611267
4068,4/21/2024 6:42:04 PM,Goldman picks top capex and R&D stocks,Seeking Alpha,https://seekingalpha.com/news/4091724-goldman-picks-top-capex-and-rd-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9173789024353027
4069,4/22/2024 12:00:00 PM,5 Crash-Proof Stocks to Buy Immediately,InvestorPlace,/news/stocks/5-crash-proof-stocks-to-buy-immediately-1033270786,positive,0.8640132546424866
4070,4/22/2024 12:00:00 PM,3 Dividend Kings Down 11% You‚Äôll Regret Not Buying on the Dip,InvestorPlace,/news/stocks/3-dividend-kings-down-11-youll-regret-not-buying-on-the-dip-1033270787,neutral,0.9647071361541748
4071,4/22/2024 2:59:00 PM,3 Dividend Stocks to Buy Now for Lifelong Income,InvestorPlace,/news/stocks/3-dividend-stocks-to-buy-now-for-lifelong-income-1033272979,positive,0.9048329591751099
4072,4/22/2024 6:21:51 PM,WHO no longer planning safety alert on Kenvue cough syrup: report,Seeking Alpha,https://seekingalpha.com/news/4092121-who-no-longer-planning-safety-alert-on-kenvue-cough-syrup-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9229658842086792
4073,4/23/2024 5:32:13 PM,Sanofi reportedly lining up banks for consumer products spinoff,Seeking Alpha,https://seekingalpha.com/news/4092701-sanofi-reportedly-lining-up-banks-for-consumer-products-spinoff?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.762651264667511
4074,4/23/2024 8:30:00 PM,Warning! These 3 Blue-Chip Stocks Will Have You Seeing Red,InvestorPlace,/news/stocks/warning-these-3-blue-chip-stocks-will-have-you-seeing-red-1033278030,positive,0.8795260190963745
4075,4/24/2024 11:25:00 AM,The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth,InvestorPlace,/news/stocks/the-top-7-dividend-stocks-to-buy-in-2024-to-build-lasting-wealth-1033281279,negative,0.722620964050293
4076,4/24/2024 3:59:30 PM,Neurocrine Biosciences upgraded at Wells Fargo on pipeline,Seeking Alpha,https://seekingalpha.com/news/4093140-neurocrine-bioscienes-upgraded-wells-fargo-pipeline?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8787781596183777
4077,4/24/2024 8:45:57 PM,"Cidara stock rallies amid $240M private placement, drug update",Seeking Alpha,https://seekingalpha.com/news/4093687-cidara-stock-rallies-amid-240m-private-placement-drug-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5627372860908508
4078,4/24/2024 10:40:03 PM,Surprise! These 3 Dividend Giants Are at 52-Week Lows. Buy Them Before They Soar,InvestorPlace,/news/stocks/surprise-these-3-dividend-giants-are-at-52-week-lows-buy-them-before-they-soar-1033284469,neutral,0.5322868824005127
4079,4/25/2024 10:00:00 AM,Medtech Marvels: 3 Groundbreaking Medical Device Stocks to Watch in 2024,InvestorPlace,/news/stocks/medtech-marvels-3-groundbreaking-medical-device-stocks-to-watch-in-2024-1033286961,positive,0.7955983281135559
4080,4/25/2024 10:50:00 AM,7 Blue-Chip Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/7-blue-chip-stocks-to-buy-on-the-dip-april-2024-1033287300,positive,0.8795626759529114
4081,4/25/2024 3:14:00 PM,3 Long-Term Stocks to Buy on the Dip: April 2024,InvestorPlace,/news/stocks/3-long-term-stocks-to-buy-on-the-dip-april-2024-1033290693,positive,0.9089170098304749
4082,4/25/2024 7:00:00 PM,The Top 3 Small-Cap Stocks to Buy in April 2024,InvestorPlace,/news/stocks/the-top-3-small-cap-stocks-to-buy-in-april-2024-1033290120,positive,0.917322039604187
4083,4/26/2024 10:00:00 AM,How Much Will $10k Invested in These Dividend Aristocrats Grow to by 2025?,InvestorPlace,/news/stocks/how-much-will-10k-invested-in-these-dividend-aristocrats-grow-to-by-2025-1033293175,positive,0.9260013103485107
4084,4/26/2024 10:00:00 AM,Steady Eddies: 7 Rock-Solid Stocks to Anchor Your Portfolio in April,InvestorPlace,/news/stocks/steady-eddies-7-rock-solid-stocks-to-anchor-your-portfolio-in-april-1033293172,positive,0.7653397917747498
4085,4/26/2024 3:41:48 PM,JNJ Receives Positive CHMP Opinion For Rybrevant For Treatment Of Patients With Advanced NSCLC ,RTTNews,/news/stocks/jnj-receives-positive-chmp-opinion-for-rybrevant-for-treatment-of-patients-with-advanced-nsclc-1033294244,negative,0.9503191709518433
4086,4/27/2024 10:00:00 AM,Generational Wealth Builders: 3 Stocks to Own for Decades of Gains,InvestorPlace,/news/stocks/three-stocks-to-own-for-decades-of-gains-1033296018,positive,0.9077433347702026
4087,4/27/2024 10:38:00 AM,7 Stocks to Buy if Inflation Continues to Reign in 2024¬†,InvestorPlace,/news/stocks/7-stocks-to-buy-if-inflation-continues-to-be-a-problem-in-2024-1033296028,positive,0.8385607600212097
4088,4/28/2024 5:00:22 PM,"J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade",Seeking Alpha,https://seekingalpha.com/news/4095228-johnson-johnson-roche-astrazeneca-poised-have-highest-orphan-drug-sales-by-end-decade?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9317450523376465
4089,4/29/2024 2:03:13 PM,7 Retirement Stocks to Buy at a 52-Week Low in April,InvestorPlace,/news/stocks/7-retirement-stocks-to-buy-at-a-52-week-low-in-april-1033300969,neutral,0.8338459134101868
4090,4/29/2024 3:20:01 PM,EU regulators recommend full approval for J&J TB drug Sirturo,Seeking Alpha,https://seekingalpha.com/news/4095555-eu-regulators-recommend-full-approval-for-jj-tb-drug-sirturo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5746025443077087
4091,4/29/2024 4:01:27 PM,Addex stock plunges 50% on failed study for epilepsy drug,Seeking Alpha,https://seekingalpha.com/news/4095619-addex-stock-plunges-50-on-failed-study-for-epilepsy-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9640822410583496
4092,4/29/2024 9:07:42 PM,Cutting Edge Picks: 3 Med Tech Stocks With Room to Run,InvestorPlace,/news/stocks/cutting-edge-picks-3-med-tech-stocks-with-room-to-run-1033302252,positive,0.5270050168037415
4093,4/30/2024 11:17:00 AM,Slump Survivors: 3 Stocks That Will Outlast the S&P 500 Downturn,InvestorPlace,/news/stocks/slump-survivors-3-stocks-that-will-outlast-the-sp-500-downturn-1033305592,positive,0.7039685249328613
4094,4/30/2024 1:42:51 PM,Stock Market Crash Warning: Don‚Äôt Get Caught Holding These 3 Healthcare Stocks,InvestorPlace,/news/stocks/stock-market-crash-warning-dont-get-caught-holding-these-3-healthcare-stocks-1033306829,positive,0.4905930757522583
4095,4/30/2024 1:49:06 PM,"J&J, Bristol Myers latest to lose bids to halt Medicare price negotiations",Seeking Alpha,https://seekingalpha.com/news/4096283-jj-bristol-myers-lose-bid-halt-medicare-price-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9564803242683411
4096,4/30/2024 5:10:58 PM,"Stifel, Morgan Stanley bullish on newly public Contineum",Seeking Alpha,https://seekingalpha.com/news/4096594-stifel-morgan-stanley-bullish-on-newly-public-contineum?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7740723490715027
4097,4/30/2024 8:30:00 PM,7 Dividend Aristocrats Paying Sky-High Yields: April 2024,InvestorPlace,/news/stocks/7-dividend-aristocrats-paying-sky-high-yields-april-2024-1033308879,positive,0.9212493300437927
4098,5/1/2024 11:45:36 AM,J&J seeks over $6B settlement to resolve talc-related cancer claims,Seeking Alpha,https://seekingalpha.com/news/4097160-jj-plans-6b-deal-talc-related-cancer-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.903874397277832
4099,5/1/2024 12:18:08 PM,J&J's proposed $6B+ talc settlement negatively impacts some Q1 results,Seeking Alpha,https://seekingalpha.com/news/4097204-johnson-johnson-proposed-6b-talc-settlement-negatively-impacts-some-q1-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9620087742805481
4100,5/1/2024 3:26:33 PM,JNJ Stock: J&J Proposes $6.5 Billion Settlement for Talc Cancer Lawsuits,InvestorPlace,/news/stocks/jnj-stock-jj-proposes-6-5-billion-settlement-for-talc-cancer-lawsuits-1033314430,positive,0.4038107991218567
4101,5/1/2024 3:43:59 PM,Why Is CytomX (CTMX) Stock Up 180% Today?,InvestorPlace,/news/stocks/why-is-cytomx-ctmx-stock-up-180-today-1033314629,negative,0.7880538105964661
4102,5/1/2024 4:11:15 PM,"Cannabis Stocks CGC, ACB, TLRY Drop After Huge Rescheduling Rally",InvestorPlace,/news/stocks/cannabis-stocks-cgc-acb-tlry-drop-after-huge-rescheduling-rally-1033314763,neutral,0.9616373777389526
4103,5/1/2024 7:57:17 PM,Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge,InvestorPlace,/news/stocks/stock-market-crash-alert-3-must-buy-healthcare-stocks-when-prices-plunge-1033315341,positive,0.7271759510040283
4104,5/1/2024 8:12:21 PM,"BeiGene, AbbVie patent spat to get trial from USPTO appeals board",Seeking Alpha,https://seekingalpha.com/news/4097839-beigene-abbvie-patent-spat-get-trial-uspto-appeals-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6186614036560059
4105,5/1/2024 9:09:50 PM,J&J Proposes $6.475 Bln To Settle Ovarian Cancer Lawsuits ,RTTNews,/news/stocks/j-j-proposes-6-475-bln-to-settle-ovarian-cancer-lawsuits-1033315188,positive,0.5723960399627686
4106,5/2/2024 9:16:46 AM,Hold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement Efforts,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-ongoing-talc-litigation-uncertainties-and-settlement-efforts-1033319546,neutral,0.9092866778373718
4107,5/2/2024 9:19:33 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-for-ovarian-cancer-talc-claims-financial-implications-and-outlook-1033319538,positive,0.9104186296463013
4108,5/3/2024 5:04:03 PM,J&J releases new Erleada data buoying benefit of prostate cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4099835-johnson-johnson-releases-new-erleada-data-buoying-benefit-prostate-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5652520060539246
4109,5/4/2024 7:30:00 PM,Pharma R&D productivity seen improving for the first time in years - Deloitte,Seeking Alpha,https://seekingalpha.com/news/4099974-pharma-research-development-productivity-improving-first-time-years?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9528807997703552
4110,5/5/2024 10:45:44 AM,Johnson & Johnson‚Äôs Strategic Settlement Plan Bolsters Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-strategic-settlement-plan-bolsters-buy-rating-1033329616,negative,0.9511063694953918
4111,5/5/2024 8:50:40 PM,J&J delivers promising phase 1 data for localized bladder cancer treatment,Seeking Alpha,https://seekingalpha.com/news/4100058-jj-delivers-promising-phase-1-data-for-localized-bladder-cancer-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9341225028038025
4112,5/6/2024 10:58:00 AM,Investor Alert: Are These 3 Spinoff Stocks Destined to Sizzle or Fizzle?,InvestorPlace,/news/stocks/investor-alert-are-these-3-spinoff-stocks-destined-to-sizzle-or-fizzle-1033332372,positive,0.7610768675804138
4113,5/6/2024 5:37:50 PM,Steady Dividend Plays: 3 Aristocrat Stocks to Own Now,InvestorPlace,/news/stocks/steady-dividend-plays-3-aristocrat-stocks-to-own-now-1033334877,positive,0.8748056292533875
4114,5/6/2024 6:06:06 PM,How the Medical Industry Could Produce the Biggest AI Stock Winners,InvestorPlace,/news/stocks/how-the-medical-industry-could-produce-the-biggest-ai-stock-winners-1032600921,positive,0.8881736993789673
4115,5/6/2024 6:30:17 PM,3 Biotech Stocks to Double Your Money in the Next 24 Months,InvestorPlace,/news/stocks/3-biotech-stocks-to-double-your-money-in-the-next-24-months-1033334986,negative,0.7702029347419739
4116,5/7/2024 4:15:32 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033337550,positive,0.5040156245231628
4117,5/7/2024 9:16:02 AM,Johnson & Johnson: Navigating Legal Challenges with a Strategic Settlement Outlook,TipRanks,/news/stocks/johnson-johnson-navigating-legal-challenges-with-a-strategic-settlement-outlook-1033339000,negative,0.8645821213722229
4118,5/7/2024 12:03:23 PM,"Analysts Offer Insights on Healthcare Companies: Pliant Therapeutics (PLRX), Johnson & Johnson (JNJ) and Hims & Hers Health (HIMS)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-pliant-therapeutics-plrx-johnson-johnson-jnj-and-hims-hers-health-hims-1033340734,positive,0.9216951131820679
4119,5/7/2024 4:51:32 PM,Kenvue to slash global workforce by 4% in cost savings move,Seeking Alpha,https://seekingalpha.com/news/4101532-kenvue-slash-global-workforc-4-cost-savings-move?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5167420506477356
4120,5/7/2024 7:35:37 PM,Kenvue Layoffs 2024: What to Know About the Latest KVUE Job Cuts,InvestorPlace,/news/stocks/kenvue-layoffs-2024-what-to-know-about-the-latest-kvue-job-cuts-1033341843,neutral,0.8528710007667542
4121,5/7/2024 8:31:51 PM,Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy,Benzinga,/news/stocks/johnson-johnson-s-taris-platform---goldman-sachs-outlines-potential-for-the-bladder-cancer-therapy-1033341693,positive,0.616375207901001
4122,5/8/2024 4:00:05 AM,Buy Rating Affirmed: Johnson & Johnson‚Äôs Bladder Cancer Treatments Poised to Transform Standard of Care,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-s-bladder-cancer-treatments-poised-to-transform-standard-of-care-1033345376,negative,0.8366352915763855
4123,5/8/2024 11:06:13 AM,AstraZeneca is withdrawing COVID shot worldwide due to vaccine glut,Seeking Alpha,https://seekingalpha.com/news/4102264-astrazeneca-withdrawing-covid-shot-vaccine-glut?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9458288550376892
4124,5/8/2024 5:55:30 PM,Steady Dividend Plays: 3 Stocks Promising Reliable Payouts in 2024,InvestorPlace,/news/stocks/three-stocks-promising-reliable-payouts-in-2024-1033349779,negative,0.9295635223388672
4125,5/8/2024 8:39:38 PM,The 3 Most Undervalued S&P 500 Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-sp-500-stocks-to-buy-in-may-2024-1033350343,positive,0.7427201271057129
4126,5/9/2024 10:47:57 AM,Hold Rating on Johnson & Johnson Amid Varipulse PFA Catheter Recall and Approval Uncertainties,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-varipulse-pfa-catheter-recall-and-approval-uncertainties-1033356512,neutral,0.9455832839012146
4127,5/9/2024 10:49:00 AM,Biotech Breakthroughs: 3 Stocks on the Verge of Revolutionizing Medicine,InvestorPlace,/news/stocks/biotech-breakthroughs-3-stocks-on-the-verge-of-revolutionizing-medicine-1033355184,positive,0.7897728085517883
4128,5/9/2024 4:41:08 PM,A Look at Pharma ETFs Post Q1 Earnings,Benzinga,/news/etf/a-look-at-pharma-etfs-post-q1-earnings-1033357001,positive,0.9325221180915833
4129,5/10/2024 10:30:00 AM,3 Biotech Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-biotech-stocks-to-sell-in-may-before-they-crash-burn-1033362353,positive,0.8534220457077026
4130,5/10/2024 11:10:00 AM,The 3 Most Undervalued Stocks to Buy in May 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-stocks-to-buy-in-may-2024-1033362566,positive,0.7456104159355164
4131,5/11/2024 1:46:00 PM,The 3 Best Mutual Funds to Buy in May 2024,InvestorPlace,/news/stocks/the-3-best-mutual-funds-to-buy-in-may-2024-1033365205,positive,0.8726626634597778
4132,5/13/2024 10:00:00 AM,7 Reliable Dividend Stocks to Keep Your Portfolio Upright,InvestorPlace,/news/stocks/7-reliable-dividend-stocks-to-keep-your-portfolio-upright-1033369987,positive,0.8991883397102356
4133,5/13/2024 10:00:00 AM,The 7 Most Undervalued Stocks With Strong Fundamentals to Buy in May 2024,InvestorPlace,/news/stocks/the-7-most-undervalued-stocks-with-strong-fundamentals-to-buy-in-may-2024-1033369992,negative,0.9053456783294678
4134,5/13/2024 11:34:21 AM,Johnson & Johnson to exit Kenvue in debt-for-equity deal,Seeking Alpha,https://seekingalpha.com/news/4105044-johnson-johnson-to-exit-kenvue-in-debt-for-equity-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9484729766845703
4135,5/13/2024 2:39:45 PM,Johnson & Johnson Is Officially Getting Out of Kenvue (KVUE) Stock,InvestorPlace,/news/stocks/johnson-johnson-is-officially-getting-out-of-kenvue-kvue-stock-1033371606,positive,0.8822933435440063
4136,5/15/2024 7:01:54 AM,Kenvue prices secondary stock offering as Johnson & Johnson exits,Seeking Alpha,https://seekingalpha.com/news/4106258-kenvue-prices-secondary-stock-offering-johnson-johnson-exit?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9433025121688843
4137,5/15/2024 2:21:25 PM,"Short interest in S&P 500 healthcare sector dips in April, biotechnology companies most shorted",Seeking Alpha,https://seekingalpha.com/news/4106501-short-interest-in-sp-500-healthcare-sector-dips-in-april-biotechnology-companies-most-shorted?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.96722412109375
4138,5/16/2024 10:30:00 AM,Consumer Staples Standouts: 3 Defensive Gems to Safeguard Your Portfolio,InvestorPlace,/news/stocks/consumer-staples-standouts-3-defensive-gems-to-safeguard-your-portfolio-1033392042,positive,0.8648034930229187
4139,5/16/2024 10:30:53 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033393200,negative,0.4946078658103943
4140,5/16/2024 10:31:42 AM,"Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ), Cullinan Management (CGEM) and Omeros (OMER)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-cullinan-management-cgem-and-omeros-omer-1033393197,positive,0.9176332950592041
4141,5/16/2024 12:24:55 PM,Johnson & Johnson to buy dermatology-focused biotech Proteologix,Seeking Alpha,https://seekingalpha.com/news/4107278-j-j-to-buy-dermatology-biotech-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9180814027786255
4142,5/16/2024 2:18:27 PM,Johnson & Johnson To Acquire Proteologix For $850 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-proteologix-for-850-mln-1033392575,positive,0.9214027523994446
4143,5/16/2024 8:37:23 PM,Divide and Conquer: 3 Stock Spinoffs Set to Trounce the Market,InvestorPlace,/news/stocks/divide-and-conquer-3-stock-spinoffs-set-to-trounce-the-market-1033395145,neutral,0.8440085053443909
4144,5/17/2024 10:24:00 AM,3 Robotics and Automation Stocks to Sell in May Before They Crash & Burn,InvestorPlace,/news/stocks/3-robotics-and-automation-stocks-to-sell-in-may-before-they-crash-burn-1033398672,positive,0.7464287281036377
4145,5/17/2024 10:30:00 AM,3 Cheap Healthcare Stocks to Buy Now: May 2024,InvestorPlace,/news/stocks/3-cheap-healthcare-stocks-to-buy-now-may-2024-1033398668,positive,0.9228615164756775
4146,5/17/2024 11:11:00 AM,7 Value Stocks to Buy and Hold for a Decade of Dominance,InvestorPlace,/news/stocks/7-value-stocks-to-buy-and-hold-for-a-decade-of-dominance-1033398745,positive,0.9146937727928162
4147,5/17/2024 12:04:10 PM,"Dividend Roundup: Home Depot, Alibaba, Johnson & Johnson, Yum! Brands, and more",Seeking Alpha,https://seekingalpha.com/news/4107861-dividend-roundup-home-depot-alibaba-johnson-johnson-yum-brands-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9402797222137451
4148,5/17/2024 9:05:31 PM,Medtronic study of Affera Sphere-9 Catheter meets endpoints,Seeking Alpha,https://seekingalpha.com/news/4108078-medtronic-study-of-affera-sphere-9-catheter-meets-endpoints?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8244133591651917
4149,5/18/2024 12:55:42 PM,Johnson & Johnson-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108103-jj-backed-rapport-therapeutics-seeks-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8918172717094421
4150,5/18/2024 4:19:14 PM,"Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch",Benzinga,/news/stocks/cannabis-meets-prescription-drugs-steroids-and-ketamine-in-schedule-iii-what-it-means-key-stocks-to-watch-1033400987,positive,0.9329438805580139
4151,5/18/2024 6:52:07 PM,"Novo Nordisk, J&J lead R&D rankings in big pharma: report",Seeking Alpha,https://seekingalpha.com/news/4108110-novo-nordisk-j-j-lead-rd-big-pharma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8400077223777771
4152,5/19/2024 6:00:55 PM,Biopharma M&A surges year over year in Q1,Seeking Alpha,https://seekingalpha.com/news/4108148-biopharma-mergers-acquisitions-surges-year-over-year-q1?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.924852192401886
4153,5/19/2024 7:05:03 PM,SA Roundtable: Are Eli Lilly and Novo Nordisk overvalued?,Seeking Alpha,https://seekingalpha.com/news/4108152-sa-roundtable-are-eli-lilly-and-novo-nordisk-overvalued?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8515272736549377
4154,5/20/2024 10:02:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Johnson & Johnson (JNJ), Eli Lilly & Co (LLY) and Coherus Biosciences (CHRS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-johnson-johnson-jnj-eli-lilly-co-lly-and-coherus-biosciences-chrs-1033403373,neutral,0.8155579566955566
4155,5/20/2024 11:17:08 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033403924,positive,0.9060529470443726
4156,5/20/2024 3:51:21 PM,Johnson & Johnson's Tremfya meets goals in late-stage trial for ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4108390-johnson-johnson-tremfya-meets-goals-late-stage-trial-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8924790024757385
4157,5/20/2024 5:22:03 PM,The AI Stock Underdogs: 7 Underappreciated Companies Poised for Greatness,InvestorPlace,/news/stocks/the-ai-stock-underdogs-7-underappreciated-companies-poised-for-greatness-1033404434,positive,0.7527812719345093
4158,5/20/2024 7:18:17 PM,Should You Invest in the Vanguard Health Care ETF?,Benzinga,/news/etf/should-you-invest-in-the-vanguard-health-care-etf-1033404417,positive,0.9077762961387634
4159,5/20/2024 10:40:41 PM,J&J-backed Rapport Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4108575-jj-backed-rapport-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9082726240158081
4160,5/21/2024 10:51:13 AM,"Teva, Alvotech launch biosimilar against AbbVie‚Äôs Humira",Seeking Alpha,https://seekingalpha.com/news/4108668-teva-alvotech-launch-biosimilar-against-humira?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5384867191314697
4161,5/21/2024 5:41:34 PM,7 Dividend Kings to Buy for Royal Passive Income: May Edition,InvestorPlace,/news/stocks/7-dividend-kings-to-buy-for-royal-passive-income-may-edition-1033408667,positive,0.9310621023178101
4162,5/21/2024 7:35:16 PM,Buy Recommendation for Johnson & Johnson on Promising Tremfya Clinical Data and Market Expansion Potential,TipRanks,/news/stocks/buy-recommendation-for-johnson-johnson-on-promising-tremfya-clinical-data-and-market-expansion-potential-1033409089,negative,0.9455034732818604
4163,5/21/2024 8:46:22 PM,Shockwave Medical gains after HSR waiting period for sale to J&J expires,Seeking Alpha,https://seekingalpha.com/news/4109075-shockwave-medical-gains-after-hsr-waiting-period-for-sale-to-jj-expires?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8469676375389099
4164,5/22/2024 10:27:05 AM,RBC Capital Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033411707,positive,0.5954992175102234
4165,5/22/2024 1:48:14 PM,7 Safe-Haven Stocks to Weather Any Storm,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-weather-any-storm-1033411814,positive,0.6809397339820862
4166,5/22/2024 3:11:31 PM,"The 500 Top Stocks to Buy in May, According to AI",InvestorPlace,/news/stocks/the-500-top-stocks-to-buy-in-may-according-to-ai-1033412478,positive,0.9145966172218323
4167,5/22/2024 5:00:57 PM,Expert Ratings For Johnson & Johnson,Benzinga,/news/stocks/expert-ratings-for-johnson-johnson-1033412391,positive,0.7854138612747192
4168,5/23/2024 11:16:29 AM,J&J faces lawsuit over talc-related bankruptcy filings,Seeking Alpha,https://seekingalpha.com/news/4109765-j-j-faces-lawsuit-over-talc-related-bankruptcies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9526470899581909
4169,5/23/2024 3:59:46 PM,Legend Biotech a new buy at Deutsche Bank on Carvykti sales,Seeking Alpha,https://seekingalpha.com/news/4109908-legend-biotech-new-buy-deutsche-bank-carvykti-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.854427695274353
4170,5/23/2024 7:23:43 PM,DD Stock Separation Plan: What to Know as DuPont Splits Into 3 Companies,InvestorPlace,/news/stocks/dd-stock-separation-plan-what-to-know-as-dupont-splits-into-3-companies-1033417299,positive,0.9410980343818665
4171,5/23/2024 7:41:25 PM,The Time Traveler‚Äôs Portfolio: 3 Stocks to Buy Now for Massive Returns by 2034,InvestorPlace,/news/stocks/the-time-travelers-portfolio-3-stocks-to-buy-now-for-massive-returns-by-2034-1033417347,positive,0.8680711984634399
4172,5/23/2024 8:16:31 PM,"ADHD diagnoses increasing, becoming an 'expanding public health concern': CDC",Seeking Alpha,https://seekingalpha.com/news/4110015-adhd-diagnoses-increasing-becoming-expanding-public-health-concern-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9134582877159119
4173,5/24/2024 5:50:59 AM,Optimistic Buy Rating for JNJ‚Äôs Tremfya Based on Strong Market Penetration Potential in IBD,TipRanks,/news/stocks/optimistic-buy-rating-for-jnj-s-tremfya-based-on-strong-market-penetration-potential-in-ibd-1033419153,negative,0.9352254867553711
4174,5/24/2024 5:00:00 PM,3 Stocks to Safeguard Your Investments During a Market Meltdown,InvestorPlace,/news/stocks/3-stocks-to-safeguard-your-investments-during-a-market-meltdown-1033420974,positive,0.9141862988471985
4175,5/25/2024 11:30:00 AM,3 Dow Stocks to Buy on the Dip: May 2024,InvestorPlace,/news/stocks/3-dow-stocks-to-buy-on-the-dip-may-2024-1033421474,positive,0.9106267690658569
4176,5/27/2024 10:00:00 AM,7 Dividend Stocks That Could Soar After Q1 Earnings Reports,InvestorPlace,/news/stocks/7-dividend-stocks-that-could-soar-after-q1-earnings-reports-1033423794,neutral,0.7725815773010254
4177,5/28/2024 12:01:49 PM,J&J to buy eczema drug developer Yellow Jersey for over $1B,Seeking Alpha,https://seekingalpha.com/news/4110675-jj-buy-yellow-jersey-over-1b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8568068146705627
4178,5/28/2024 2:13:43 PM,Johnson & Johnson To Acquire Rights To Numab Therapeutics' Clinical-Stage Bispecific Antibody NM26 ,RTTNews,/news/stocks/johnson-johnson-to-acquire-rights-to-numab-therapeutics-clinical-stage-bispecific-antibody-nm26-1033426797,positive,0.6984294056892395
4179,5/28/2024 6:15:48 PM,HealthTech Heroes: 3 Medical Technology Stocks to Buy Before They Boom,InvestorPlace,/news/stocks/healthtech-heroes-3-medical-technology-stocks-to-buy-before-they-boom-1033428394,positive,0.9281883239746094
4180,5/29/2024 9:10:25 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Insmed (INSM), Arcturus Therapeutics (ARCT) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-insmed-insm-arcturus-therapeutics-arct-and-johnson-johnson-jnj-1033431427,neutral,0.8323367834091187
4181,5/29/2024 12:48:00 PM,Johnson & Johnson depression candidate seltorexant meets phase 3 goals,Seeking Alpha,https://seekingalpha.com/news/4111111-johnson-johnson-depression-candidate-seltorexant-meets-phase-3-goals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.620532214641571
4182,5/30/2024 6:45:27 AM,Sarepta Therapeutics set to join S&P MidCap 400,Seeking Alpha,https://seekingalpha.com/news/4111366-sarepta-therapeutics-set-to-join-sp-midcap-400?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9157518148422241
4183,5/30/2024 11:30:00 AM,Blue-Chip Bubble Trouble: 7 Stocks to Short as Valuations Stretch to the Limit,InvestorPlace,/news/stocks/blue-chip-bubble-trouble-7-stocks-to-short-as-valuations-stretch-to-the-limit-1033435720,neutral,0.9286768436431885
4184,5/30/2024 11:41:20 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Immunovant (IMVT), Johnson & Johnson (JNJ) and American Well (AMWL)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-immunovant-imvt-johnson-johnson-jnj-and-american-well-amwl-1033436795,neutral,0.8602163791656494
4185,5/30/2024 7:03:57 PM,Should You Invest in the iShares U.S. Healthcare ETF?,Benzinga,/news/stocks/should-you-invest-in-the-ishares-u-s-healthcare-etf-1033437375,positive,0.9228521585464478
4186,5/30/2024 9:57:18 PM,"J&J transfers Ponvory FDA applications to Vanda, launch seen in Q3",Seeking Alpha,https://seekingalpha.com/news/4111797-jj-transfers-ponvory-fda-applications-to-vanda-launch-seen-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.659101665019989
4187,5/31/2024 11:00:00 AM,3 Sorry Biotech Stocks to Sell in May While You Still Can,InvestorPlace,/news/stocks/3-sorry-biotech-stocks-to-sell-in-may-while-you-still-can-1033440710,positive,0.7874516844749451
4188,5/31/2024 1:35:26 PM,J&J completes acquisition of cardiac device maker Shockwave,Seeking Alpha,https://seekingalpha.com/news/4111939-jj-completes-acquisition-of-medtech-shockwave?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8457759618759155
4189,5/31/2024 3:00:25 PM,Boring Is Beautiful: 3 Blue-Chip Stocks to Buy and Hold Forever,InvestorPlace,/news/stocks/boring-is-beautiful-3-blue-chip-stocks-to-buy-and-hold-forever-1033441780,positive,0.9015206098556519
4190,5/31/2024 6:05:44 PM,Psychedelic stocks mixed as FDA comments on MDMA therapy (update),Seeking Alpha,https://seekingalpha.com/news/4111983-psychedelic-stocks-mixed-fda-comments-mdma-therapy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6598256826400757
4191,5/31/2024 9:53:13 PM,J&J says Rybrevant combo bests AstraZeneca's Tagrisso in type of lung cancer,Seeking Alpha,https://seekingalpha.com/news/4112105-johnson-johnson-says-rybrevant-combo-bests-astrazeneca-tagrisso-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4514372646808624
4192,6/3/2024 10:00:00 AM,7 Overlooked Stocks That Belong in Every Portfolio¬†,InvestorPlace,/news/stocks/7-must-own-overlooked-stocks-that-can-work-in-any-portfolio-1033445074,positive,0.9365252256393433
4193,6/3/2024 4:03:10 PM,"GSK says Blenrep combo cuts disease progression, death in multiple myeloma",Seeking Alpha,https://seekingalpha.com/news/4112369-gsk-says-belnrep-combo-cuts-disease-progression-death-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.4147903025150299
4194,6/3/2024 5:06:04 PM,J&J-backed Rapport Therapeutics sets terms for $136M IPO,Seeking Alpha,https://seekingalpha.com/news/4112393-jj-backed-rapport-therapeutics-sets-terms-for-136m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9252532720565796
4195,6/3/2024 6:46:53 PM,Sell ideas in Staples and Health Care - Oppenheimer,Seeking Alpha,https://seekingalpha.com/news/4112419-sell-ideas-in-staples-and-health-care-oppenheimer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9165980219841003
4196,6/3/2024 10:09:10 PM,"J&J, Legend release promising results on Carvykti in earlier treatment line",Seeking Alpha,https://seekingalpha.com/news/4112513-johnson-johnson-legend-release-promising-results-carvykti-earlier-treatment-line?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9506963491439819
4197,6/3/2024 10:42:13 PM,Sanofi says Sarclisa improves progression-free survival in some multiple myeloma patients,Seeking Alpha,https://seekingalpha.com/news/4112515-sanofi-says-sarclisa-improves-progression-free-survival-in-some-multiple-myeloma-patients?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9524928331375122
4198,6/4/2024 2:03:20 AM,Oregon jury awards talc plaintiff $260M in verdict against Johnson & Johnson,Seeking Alpha,https://seekingalpha.com/news/4112519-oregon-jury-awards-talc-plaintiff-260m-verdict-against-johnson-johnson?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5113413333892822
4199,6/4/2024 10:00:00 AM,3 Dividend Aristocrats to Scoop Up During Market Pullbacks in June,InvestorPlace,/news/stocks/3-dividend-aristocrats-to-scoop-up-during-market-pullbacks-in-june-1033448656,negative,0.5079541206359863
4200,6/4/2024 12:06:20 PM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033450356,positive,0.7207152843475342
4201,6/4/2024 2:00:00 PM,The 3 Most Undervalued Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-most-undervalued-dow-stocks-to-buy-in-june-2024-1033450053,positive,0.821574330329895
4202,6/4/2024 8:56:46 PM,J&J seeks to expand HIV med Prezcobix indication to children as young as six,Seeking Alpha,https://seekingalpha.com/news/4112875-johnson-johnson-seeks-expand-hiv-med-prezcobix-indication-children-young-six?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7908770442008972
4203,6/5/2024 3:21:33 PM,The most crowded longs and shorts in U.S. Med-Tech for May - UBS,Seeking Alpha,https://seekingalpha.com/news/4113240-the-most-crowded-longs-and-shorts-in-us-med-tech-for-may-ubs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8358550071716309
4204,6/5/2024 9:31:08 PM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Vir Biotechnology (VIR) and Madrigal Pharmaceuticals (MDGL)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-vir-biotechnology-vir-and-madrigal-pharmaceuticals-mdgl-1033455521,neutral,0.6890136003494263
4205,6/6/2024 10:55:44 AM,Sleep Easy: 3 Safe Stocks That Won‚Äôt Have You Stressin‚Äô,InvestorPlace,/news/stocks/sleep-easy-3-safe-stocks-that-wont-have-you-stressin-1033458349,positive,0.8836329579353333
4206,6/6/2024 2:47:18 PM,"Goldman cuts 2seventy bio to neutral, cites competition concerns",Seeking Alpha,https://seekingalpha.com/news/4113699-goldman-cuts-2seventy-bio-to-neutral-cites-competition-concerns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6006223559379578
4207,6/6/2024 4:51:08 PM,Halozyme hits 52-week high as patent win prompts guidance raise,Seeking Alpha,https://seekingalpha.com/news/4113757-halozyme-stock-hits-52-week-guidance-raise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8896648287773132
4208,6/6/2024 9:36:29 PM,Halozyme's ENHANZE Product Gets New Patent Grant in EU,Benzinga,/news/stocks/halozyme-s-enhanze-product-gets-new-patent-grant-in-eu-1033459113,negative,0.7392569780349731
4209,6/7/2024 5:44:02 AM,J&J-backed Rapport Therapeutics prices IPO at $17 per share,Seeking Alpha,https://seekingalpha.com/news/4113928-jj-backed-rapport-therapeutics-prices-ipo-at-17-per-share?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.950134813785553
4210,6/7/2024 11:10:00 AM,The Dividend Darlings: 3 Stocks That Will Shower Your Portfolio with Cash,InvestorPlace,/news/stocks/the-dividend-darlings-3-stocks-that-will-shower-your-portfolio-with-cash-1033460743,positive,0.9295212626457214
4211,6/7/2024 12:40:30 PM,J&J cleared to expand use of Velys robotic system in U.S.,Seeking Alpha,https://seekingalpha.com/news/4114053-jj-cleared-expand-use-velys-robotic-system?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8699162602424622
4212,6/7/2024 1:16:13 PM,Halozyme downgraded at Piper Sandler despite guidance raise,Seeking Alpha,https://seekingalpha.com/news/4114090-halozyme-stock-slips-piper-sandler-downgrades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8291918635368347
4213,6/7/2024 4:04:12 PM,Rapport Therapeutics starts trading above IPO price,Seeking Alpha,https://seekingalpha.com/news/4114176-rapport-therapeutics-starts-trading-above-ipo-price?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8803954124450684
4214,6/7/2024 4:39:04 PM,The 3 Best Dow Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-3-best-dow-stocks-to-buy-in-june-2024-1033462133,positive,0.9145510792732239
4215,6/10/2024 10:00:00 AM,The Safety Net Seven: 7 Stocks to Own for Unshakeable Returns,InvestorPlace,/news/stocks/the-safety-net-seven-7-stocks-to-own-for-unshakeable-returns-1033464998,positive,0.8958709836006165
4216,6/10/2024 10:36:12 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1033465708,positive,0.9046739339828491
4217,6/11/2024 1:20:17 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Johnson & Johnson (JNJ), Oculis Holding (OCS) and Moderna (MRNA)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-johnson-johnson-jnj-oculis-holding-ocs-and-moderna-mrna-1033467355,neutral,0.9350317120552063
4218,6/11/2024 8:33:48 AM,Alvotech and Stada add to strategic alliance through denosumab partnership,Seeking Alpha,https://seekingalpha.com/news/4114679-alvotech-and-stada-add-to-strategic-alliance-through-denosumab-partnership?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8855556845664978
4219,6/11/2024 5:00:00 PM,The 3 Most Undervalued Robinhood Stocks to Buy in June 2024,InvestorPlace,/news/stocks/undervalued-robinhood-stocks-3-names-skeptics-may-not-expect-1033470123,positive,0.8524706363677979
4220,6/11/2024 6:04:25 PM,J&J in $700M settlement with states over marketing of talc products,Seeking Alpha,https://seekingalpha.com/news/4114930-johnson-johnson-700m-settlement-states-marketing-talc-products?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.874549150466919
4221,6/11/2024 6:49:39 PM,7 Recession-Proof Stocks to Buy Now for Peace of Mind,InvestorPlace,/news/stocks/7-recession-proof-stocks-to-buy-now-for-peace-of-mind-1033470311,positive,0.8757135272026062
4222,6/12/2024 6:41:22 AM,"Analysts Are Bullish on These Healthcare Stocks: Johnson & Johnson (JNJ), Insmed (INSM)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-johnson-johnson-jnj-insmed-insm-1033471867,positive,0.7040002346038818
4223,6/12/2024 3:15:53 PM,Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-spotlight-on-3-health-care-stocks-delivering-high-dividend-yields-1033472721,negative,0.7499571442604065
4224,6/12/2024 7:34:26 PM,Cancer victims seek court order to block J&J‚Äôs bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4115339-cancer-victims-seek-court-order-block-jjs-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7384099960327148
4225,6/13/2024 11:10:00 AM,Dividend Heaven: 7 Standout Stocks for Income Investors to Buy in June,InvestorPlace,/news/stocks/dividend-heaven-7-standout-stocks-for-income-investors-to-buy-in-june-1033475672,positive,0.8555639982223511
4226,6/13/2024 6:23:10 PM,Payout Powerhouses: 7 Dividend Stocks to Buy Now,InvestorPlace,/news/stocks/payout-powerhouses-7-dividend-stocks-to-buy-now-1033477569,positive,0.9005997180938721
4227,6/13/2024 7:02:59 PM,Xencor to regain rights from J&J for plamotamab,Seeking Alpha,https://seekingalpha.com/news/4115886-xencor-to-regain-rights-from-jj-for-plamotamab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6350571513175964
4228,6/14/2024 2:25:58 PM,Johnson & Johnson Reports Long-term Data From Phase 1/2 Study With TALVEY ,RTTNews,/news/stocks/johnson-johnson-reports-long-term-data-from-phase-1-2-study-with-talvey-1033479488,positive,0.9045435786247253
4229,6/14/2024 3:23:25 PM,J&J's Talvey demonstrates robust long-term response in multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4116283-johnson-johnson-talvey-demonstrates-robust-long-term-response-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9522587060928345
4230,6/14/2024 7:55:36 PM,EU to require additional cancer risk labeling on CAR T therapies,Seeking Alpha,https://seekingalpha.com/news/4116402-eu-to-require-additional-cancer-risk-labeling-on-car-t-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8998953700065613
4231,6/15/2024 10:00:00 AM,Blue-Chip Jackpots: 3 Top-Notch Stocks at Bottom-Barrel Prices,InvestorPlace,/news/stocks/blue-chip-jackpots-3-top-notch-stocks-at-bottom-barrel-prices-1033481228,positive,0.8667090535163879
4232,6/15/2024 10:42:00 AM,The 7 Best Under $20 Stocks to Buy in June 2024,InvestorPlace,/news/stocks/the-7-best-under-20-stocks-to-buy-in-june-2024-1033481242,positive,0.8961836695671082
4233,6/16/2024 12:05:29 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033481640,positive,0.8372873663902283
4234,6/17/2024 10:40:58 AM,RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-sticks-to-its-buy-rating-for-johnson-johnson-jnj-1033483787,positive,0.7207152843475342
4235,6/17/2024 3:25:08 PM,J&J Submits BLA For Subcutaneous Amivantamab Combination In EGFR-mutated NSCLC Patients ,RTTNews,/news/stocks/j-j-submits-bla-for-subcutaneous-amivantamab-combination-in-egfr-mutated-nsclc-patients-1033483713,positive,0.7109976410865784
4236,6/17/2024 4:01:29 PM,In-Depth Examination Of 11 Analyst Recommendations For Johnson & Johnson,Benzinga,/news/stocks/in-depth-examination-of-11-analyst-recommendations-for-johnson-johnson-1033484211,positive,0.8954976201057434
4237,6/17/2024 6:15:06 PM,"Legend Biotech's Cancer Drug, 'The Most Attractive Product,' Set For Growth: Analyst",Benzinga,/news/stocks/legend-biotech-s-cancer-drug-the-most-attractive-product-set-for-growth-analyst-1033484619,negative,0.6228742599487305
4238,6/20/2024 11:30:00 AM,7 High-Value Blue-Chip Stocks to Boost Your Wealth by 2027,InvestorPlace,/news/stocks/7-high-value-blue-chip-stocks-to-boost-your-wealth-by-2027-1033492560,negative,0.8014839887619019
4239,6/20/2024 12:39:51 PM,3 Healthcare Stocks to Buy Now: June 2024,InvestorPlace,/news/stocks/3-healthcare-stocks-to-buy-now-june-2024-1033492821,positive,0.9365811347961426
4240,6/20/2024 2:29:07 PM,J&J Phase 3 study shows subcutaneous Tremfya effective in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4117538-jnj-phase-3-study-shows-subcutaneous-tremfya-effective-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6943619847297668
4241,6/20/2024 2:32:08 PM,Johnson & Johnson: TREMFYA Phase 3 Study Meets Primary And Secondary Endpoints ,RTTNews,/news/stocks/johnson-johnson-tremfya-phase-3-study-meets-primary-and-secondary-endpoints-1033492766,positive,0.9017640948295593
4242,6/20/2024 9:11:21 PM,J&J applies for FDA approval of Tremfya for Crohn's disease,Seeking Alpha,https://seekingalpha.com/news/4117764-jj-applies-for-fda-approval-of-tremfya-for-crohns-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5259234309196472
4243,6/21/2024 3:00:32 AM,Johnson & Johnson Seeks FDA Approval For Tremfya For Moderate To Severe Crohn's Disease ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-tremfya-for-moderate-to-severe-crohn-s-disease-1033494558,negative,0.9123551845550537
4244,6/21/2024 4:25:45 AM,Cantor Fitzgerald Reaffirms Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-reaffirms-their-buy-rating-on-johnson-johnson-jnj-1033494966,positive,0.8143652081489563
4245,6/21/2024 11:47:27 AM,Johnson & Johnson closes acquisition of biotechnology company Proteologix,Seeking Alpha,https://seekingalpha.com/news/4117872-johnson-johnson-closes-acquisition-of-biotechnology-company-proteologix?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9098750948905945
4246,6/21/2024 9:31:14 PM,"The Zacks Analyst Blog Highlights Pfizer, Johnson & Johnson and Eli Lilly",Benzinga,/news/stocks/the-zacks-analyst-blog-highlights-pfizer-johnson-johnson-and-eli-lilly-1033497156,positive,0.9443087577819824
4247,6/25/2024 7:03:18 PM,J&J mid-stage trial for Tremfya against immune disorder fails,Seeking Alpha,https://seekingalpha.com/news/4119121-jj-stock-drops-as-tremfya-fails-clinical-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5539386868476868
4248,6/26/2024 4:25:57 AM,Cantor Fitzgerald Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-keeps-their-buy-rating-on-johnson-johnson-jnj-1033506194,positive,0.9096185564994812
4249,6/26/2024 4:53:40 PM,The 3 Smartest Dow Stocks to Buy With $1000 Right Now,InvestorPlace,/news/stocks/the-3-smartest-dow-stocks-to-buy-with-1000-right-now-1033508753,positive,0.8763495683670044
4250,6/27/2024 7:22:09 PM,"AbbVie/Genmab's Epkinly FDA Approval Is A Positive Step, Analyst Says Additional Expansion Opportunities Underway",Benzinga,/news/stocks/abbvie-genmab-s-epkinly-fda-approval-is-a-positive-step-analyst-says-additional-expansion-opportunities-underway-1033512703,negative,0.9408528208732605
4251,6/28/2024 1:30:58 PM,Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields,Benzinga,/news/stocks/wall-street-s-most-accurate-analysts-give-their-take-on-3-health-care-stocks-with-over-3-dividend-yields-1033514650,positive,0.9256894588470459
4252,6/28/2024 1:58:24 PM,Janssen-Cilag Says CHMP Recommended Balversa For Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-says-chmp-recommended-balversa-for-urothelial-carcinoma-1033514717,positive,0.705254316329956
4253,6/28/2024 4:45:53 PM,J&J reports positive phase 3 data for nipocalimab for neuromuscular disease,Seeking Alpha,https://seekingalpha.com/news/4120678-johnson-johnson-reports-positive-phase-3-data-nipocalimab-neuromuscular-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9483676552772522
4254,6/28/2024 5:13:58 PM,J&J: Rybrevant In Combination Gets Approval In Europe For First-Line Treatment Of NSCLC ,RTTNews,/news/stocks/j-j-rybrevant-in-combination-gets-approval-in-europe-for-first-line-treatment-of-nsclc-1033515841,negative,0.9460901618003845
4255,6/29/2024 1:11:15 PM,J&J talc claimants lose bid to block company's bankruptcy bid,Seeking Alpha,https://seekingalpha.com/news/4120801-jj-talc-victims-lose-bid-block-bankruptcy-bid?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9375767707824707
4256,6/29/2024 7:44:55 PM,Rising drug costs force a third of Americans to leave prescriptions unfilled: report,Seeking Alpha,https://seekingalpha.com/news/4120808-many-prescriptions-remain-unfilled-amid-soaring-drug-costs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7290322184562683
4257,6/30/2024 2:13:35 PM,Treasure Hunt: 3 Small-Cap Stocks Wall Street Hasn‚Äôt Discovered Yet,InvestorPlace,/news/stocks/treasure-hunt-3-small-cap-stocks-wall-street-hasnt-discovered-yet-1033517243,positive,0.9144801497459412
4258,7/1/2024 12:30:56 AM,"Alnylam, Lilly, AstraZeneca among best performing pharmas, biotechs in Q2",Seeking Alpha,https://seekingalpha.com/news/4120874-alnylam-lilly-astrzeneca-best-performing-pharmas-biotechs-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.770165741443634
4259,7/1/2024 7:31:13 AM,Sandoz To Commercialize Samsung Bioepis' FDA Approved Biosimilar Pyzchiva In US ,RTTNews,/news/stocks/sandoz-to-commercialize-samsung-bioepis-fda-approved-biosimilar-pyzchiva-in-us-1033518094,negative,0.6302042007446289
4260,7/1/2024 10:00:00 AM,Boing! 7 Undervalued Stocks That Could Surprise the Skeptics.,InvestorPlace,/news/stocks/boing-7-undervalued-stocks-that-could-surprise-the-skeptics-1033518931,neutral,0.5502831935882568
4261,7/1/2024 10:08:03 AM,Hold Rating on Johnson & Johnson‚Äôs Nipocalimab: Weighing Efficacy Against Uncertainties and Market Potential,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-s-nipocalimab-weighing-efficacy-against-uncertainties-and-market-potential-1033519619,negative,0.8147923946380615
4262,7/1/2024 4:19:57 PM,3 Dividend Stocks Yielding Over 3% With Multi-Decade Payout Growth Streaks,InvestorPlace,/news/stocks/3-dividend-stocks-yielding-over-3-with-multi-decade-payout-growth-streaks-1033520688,negative,0.9196974039077759
4263,7/1/2024 4:35:40 PM,"Piper downgrades Zimmer to neutral, cites lack of catalysts",Seeking Alpha,https://seekingalpha.com/news/4121268-piper-downgrades-zimmer-to-neutral-cites-lack-of-catalysts?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.4901311993598938
4264,7/1/2024 8:30:00 PM,3 Retirement All-Stars for Steady Growth and Income,InvestorPlace,/news/stocks/3-retirement-all-stars-for-steady-growth-and-income-1033521039,negative,0.5756692290306091
4265,7/2/2024 12:23:40 PM,J&J says Carvykti beat standard drugs in late-stage blood cancer trial,Seeking Alpha,https://seekingalpha.com/news/4121567-jj-carvykti-beat-standard-drugs-blood-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9461308717727661
4266,7/2/2024 1:51:44 PM,J&J Reports Positive Data From Phase 3 CARTITUDE-4 Study Of Carvykti In Multiple Myeloma ,RTTNews,/news/stocks/j-j-reports-positive-data-from-phase-3-cartitude-4-study-of-carvykti-in-multiple-myeloma-1033522603,negative,0.9439728260040283
4267,7/2/2024 8:45:00 PM,7 Dividend Aristocrats That Will Have Investors in High-Yield Heaven,InvestorPlace,/news/stocks/7-dividend-aristocrats-that-will-have-investors-in-high-yield-heaven-1033524556,positive,0.8748617172241211
4268,7/3/2024 2:00:00 PM,7 Safe Haven Stocks to Buy Before the Next Market Correction,InvestorPlace,/news/stocks/7-safe-haven-stocks-to-buy-before-the-next-market-correction-1033527117,positive,0.911262035369873
4269,7/3/2024 2:10:23 PM,Johnson & Johnson Announces Health Canada NOC For RYBREVANT Combination - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-announces-health-canada-noc-for-rybrevant-combination-quick-facts-1033526326,positive,0.8484709858894348
4270,7/3/2024 3:06:31 PM,U.S. indicated dividend payments rose in Q2 led by Alphabet's initiation,Seeking Alpha,https://seekingalpha.com/news/4122113-common-indicated-dividend-payments-rise-in-q2-driven-by-alphabets-initiation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9523624777793884
4271,7/3/2024 7:21:43 PM,Johnson & Johnson receives Canadian approval for Rybrevant in first-line NSCLC,Seeking Alpha,https://seekingalpha.com/news/4122211-johnson-johnson-receives-canadian-approval-for-rybrevant-in-first-line-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8891991376876831
4272,7/3/2024 7:32:59 PM,7 Blue-Chip Cash Cows to Milk for Steady Income,InvestorPlace,/news/stocks/7-blue-chip-cash-cows-to-milk-for-steady-income-1033527829,positive,0.8842485547065735
4273,7/4/2024 4:00:00 PM,Upcoming Stock Spinoffs: Should You Pounce or Pass?¬†,InvestorPlace,/news/stocks/upcoming-stock-spinoffs-should-you-pounce-or-pass-1033530130,positive,0.7419286370277405
4274,7/4/2024 6:13:23 PM,FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals,InvestorPlace,/news/stocks/fda-favorites-3-biotech-stocks-on-the-verge-of-major-approvals-1033530265,negative,0.4162502586841583
4275,7/5/2024 3:32:01 PM,3 Dividend Aristocrats Now Cheaper Than During the 2008 Financial Crisis,InvestorPlace,/news/stocks/3-dividend-aristocrats-now-cheaper-than-during-the-2008-financial-crisis-1033532641,negative,0.6507641673088074
4276,7/5/2024 5:43:24 PM,3 Rock-Solid Income Machines to Hold for Decades,InvestorPlace,/news/stocks/3-rock-solid-income-machines-to-hold-for-decades-1033532857,positive,0.8576841354370117
4277,7/8/2024 9:26:24 AM,Maintaining Hold on JNJ: Anticipated EPS Beat Offset by Medtech and Currency Challenges,TipRanks,/news/stocks/maintaining-hold-on-jnj-anticipated-eps-beat-offset-by-medtech-and-currency-challenges-1033535629,negative,0.9134265780448914
4278,7/8/2024 10:45:00 AM,7 Diversified Income Powerhouses for Lifelong Cash Flow,InvestorPlace,/news/stocks/7-diversified-income-powerhouses-for-lifelong-cash-flow-1033535386,positive,0.7933672666549683
4279,7/8/2024 11:45:19 AM,Johnson & Johnson Q2 Outlook: Steady Growth Amid Challenges with a Hold Rating,TipRanks,/news/stocks/johnson-johnson-q2-outlook-steady-growth-amid-challenges-with-a-hold-rating-1033536453,negative,0.9492027759552002
4280,7/8/2024 2:41:56 PM,Pulse stock rallies 22% on FDA breakthrough designation,Seeking Alpha,https://seekingalpha.com/news/4122631-pulse-stock-rallies-on-fda-breakthrough-designation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8892565965652466
4281,7/9/2024 10:00:29 AM,"Emergent, J&J resolve dispute over COVID vaccine manufacturing deal",Seeking Alpha,https://seekingalpha.com/news/4122799-emergent-jj-resolve-dispute-over-covid-vaccine-manufacturing-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.4864552915096283
4282,7/9/2024 8:53:43 PM,Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs,Benzinga,/news/stocks/johnson-johnson-faces-medtech-challenges-but-is-on-track-to-meet-2024-guidance-goldman-sachs-1033540847,negative,0.5195892453193665
4283,7/10/2024 10:37:55 AM,Wells Fargo Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033543393,positive,0.8170982003211975
4284,7/10/2024 11:00:00 AM,3 Undervalued Stocks Set to Outperform the Market in 2024,InvestorPlace,/news/stocks/3-undervalued-stocks-set-to-outperform-the-market-in-2024-1033542723,negative,0.8598212599754333
4285,7/11/2024 12:45:34 PM,Morgan Stanley Sticks to Their Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/morgan-stanley-sticks-to-their-hold-rating-for-johnson-johnson-jnj-1033548030,positive,0.8109607696533203
4286,7/11/2024 1:17:59 PM,J&J to recognize $1.25B impact from Yellow Jersey acquisition,Seeking Alpha,https://seekingalpha.com/news/4123663-jj-to-recognize-125b-impact-yellow-jersey-acquisition?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8527365326881409
4287,7/12/2024 10:23:00 AM,3 Essential Stocks for Building a Recession-Proof Portfolio,InvestorPlace,/news/stocks/3-essential-stocks-for-building-a-recession-proof-portfolio-1033549924,positive,0.8081365823745728
4288,7/12/2024 11:05:58 AM,Stifel Nicolaus Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/stifel-nicolaus-remains-a-hold-on-johnson-johnson-jnj-1033550894,positive,0.7302680611610413
4289,7/12/2024 6:50:39 PM,Legend Biotech surges amid takeover speculation (update),Seeking Alpha,https://seekingalpha.com/news/4124018-legend-biotech-surges-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7466817498207092
4290,7/12/2024 7:00:29 PM,"Catalyst Watch: Netflix, Taiwan Semi, Amazon, and HashiCorp are in the spotlight",Seeking Alpha,https://seekingalpha.com/news/4123992-catalyst-watch-netflix-taiwan-semi-amazon-and-hashicorp-are-in-the-spotlight?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9270133972167969
4291,7/13/2024 2:47:00 PM,Financial stocks deliver profits in Q2 amid rebound in investments - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4124042-wall-street-closes-higher-as-financials-stocks-deliver-profits-with-a-rebound-in-investments-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9113971590995789
4292,7/13/2024 6:03:47 PM,"Morgan Stanley sees $180B patent cliff, $380B deal capacity fueling biopharma M&A",Seeking Alpha,https://seekingalpha.com/news/4124109-morgan-stanley-sees-180b-patent-cliff-380b-deal-capacity-fueling-biopharma-ma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8902468085289001
4293,7/14/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4124006-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9305751323699951
4294,7/15/2024 9:45:47 AM,Hold Rating Maintained Amid Johnson & Johnson Acquisition and Foreign Exchange Concerns,TipRanks,/news/stocks/hold-rating-maintained-amid-johnson-johnson-acquisition-and-foreign-exchange-concerns-1033555232,neutral,0.936174750328064
4295,7/15/2024 9:08:59 PM,Genmab upgraded at RBC on valuation,Seeking Alpha,https://seekingalpha.com/news/4124419-genmab-upgraded-rbc-valuation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8370265364646912
4296,7/16/2024 10:13:10 AM,"Analysts‚Äô Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Johnson & Johnson (JNJ) and CVS Health (CVS)",TipRanks,/news/stocks/analysts-opinions-are-mixed-on-these-healthcare-stocks-envista-holdings-nvst-johnson-johnson-jnj-and-cvs-health-cvs-1033559368,neutral,0.8213565349578857
4297,7/16/2024 10:15:00 AM,"If You Can Only Buy One Dow Stock in July, It Better Be One of These 3 Names",InvestorPlace,/news/stocks/if-you-can-only-buy-one-dow-stock-in-july-it-better-be-one-of-these-3-names-1033558594,positive,0.9345142245292664
4298,7/16/2024 2:35:17 PM,Johnson & Johnson Q2 Preview: Focus on SWAV deal implications and guidance,Seeking Alpha,https://seekingalpha.com/news/4124636-johnson-johnson-q2-preview-focus-on-swav-deal-implications-and-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9415110945701599
4299,7/16/2024 3:01:13 PM,Johnson Johnson earnings: here's what Wall Street expects,Markets Insider Automation,/news/stocks/johnson_johnson-quarter-earnings-preview-q2-1033559159,positive,0.9340363144874573
4300,7/16/2024 3:29:28 PM,Notable earnings before Wednesday's open,Seeking Alpha,https://seekingalpha.com/news/4124676-notable-earnings-before-wednesdays-open?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.855887770652771
4301,7/16/2024 6:46:17 PM,Johnson & Johnson: Bullish Charts Signal Strong Setup Before Q2 Earnings,Benzinga,/news/stocks/johnson-johnson-bullish-charts-signal-strong-setup-before-q2-earnings-1033560469,negative,0.933714747428894
4302,7/16/2024 7:04:01 PM,3 Safe Dividend Kings to Recession-Proof Your Portfolio,InvestorPlace,/news/stocks/3-safe-dividend-kings-to-recession-proof-your-portfolio-1033560680,positive,0.5513026118278503
4303,7/16/2024 9:07:10 PM,Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?,Benzinga,/news/stocks/johnson-johnson-q2-earnings-preview-can-new-drugs-lift-sagging-stock-1033560686,negative,0.8256776332855225
4304,7/16/2024 9:59:38 PM,"ORIC collaborates with Bayer, J&J on prostate cancer study",Seeking Alpha,https://seekingalpha.com/news/4124823-oric-collaborates-with-bayer-jj-on-prostate-cancer-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8389742970466614
4305,7/17/2024 5:26:18 AM,"ORIC Enters Into Clinical Trial Collaboration And Supply Agreements With Bayer
and J&J; Stock Up ",RTTNews,/news/stocks/oric-enters-into-clinical-trial-collaboration-and-supply-agreements-with-bayer-and-j-j-stock-up-1033561062,negative,0.7721454501152039
4306,7/17/2024 10:22:07 AM,"Johnson & Johnson Non-GAAP EPS of $2.82 beats by $0.12, revenue of $22.4B beats by $60M",Seeking Alpha,https://seekingalpha.com/news/4124888-johnson-and-johnson-non-gaap-eps-of-2_82-beats-0_12-revenue-of-22_4b-beats-60m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.722597599029541
4307,7/17/2024 10:29:46 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4124891-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9268327951431274
4308,7/17/2024 10:40:16 AM,"Earnings Summary: Johnson & Johnson tops consensus in Q2, updates FY2024 outlook",Seeking Alpha,https://seekingalpha.com/news/4124896-earnings-summary-johnson-johnson-tops-consensus-in-q2-updates-fy2024-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7132918834686279
4309,7/17/2024 10:51:43 AM,"Johnson & Johnson in charts: Innovative Medicine, MedTech and total U.S. sales highest in Q2",Seeking Alpha,https://seekingalpha.com/news/4124903-johnson-johnson-in-charts-innovative-medicine-medtech-and-total-us-sales-highest-in-q2?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8125775456428528
4310,7/17/2024 11:05:00 AM,3 Dividend Stocks With 3%+ Yields to Upgrade Your Annual Income,InvestorPlace,/news/stocks/3-dividend-stocks-with-3-yields-to-upgrade-your-annual-income-1033563483,positive,0.711678683757782
4311,7/17/2024 12:27:48 PM,"Johnson & Johnson Q2 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q2-profit-decreases-but-beats-estimates-1033563319,neutral,0.9721673130989075
4312,7/17/2024 1:17:00 PM,"4 stocks to watch on Wednesday: JNJ, UAL and more",Seeking Alpha,https://seekingalpha.com/news/4125011-4-stocks-to-watch-on-wednesday-jnj-ual-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9138116240501404
4313,7/17/2024 1:47:03 PM,"Johnson & Johnson Q2 Adj. EPS Beats View, Cuts FY24 Earnings Forecast ",RTTNews,/news/stocks/johnson-johnson-q2-adj-eps-beats-view-cuts-fy24-earnings-forecast-1033563555,neutral,0.7243630886077881
4314,7/17/2024 1:52:11 PM,J&J beats in Q2 as pharma segment outperforms,Seeking Alpha,https://seekingalpha.com/news/4124925-jj-stock-focus-after-q2-results?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8718147873878479
4315,7/17/2024 3:51:26 PM,"Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Elevance Health (ELV) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-crinetics-pharmaceuticals-crnx-elevance-health-elv-and-johnson-johnson-jnj-1033565293,positive,0.9131538271903992
4316,7/17/2024 6:09:20 PM,Big pharma rally after J&J earnings,Seeking Alpha,https://seekingalpha.com/news/4125149-big-pharma-rally-after-jj-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5109472870826721
4317,7/17/2024 6:15:30 PM,Watchful Optimism: Balancing Johnson & Johnson‚Äôs Innovative Success and MedTech Challenges,TipRanks,/news/stocks/watchful-optimism-balancing-johnson-johnson-s-innovative-success-and-medtech-challenges-1033565874,positive,0.633030354976654
4318,7/17/2024 8:27:47 PM,Nasdaq 100 Suffers Worst Day In 11 Months As Chipmakers Tumble On China Curbs; Magnificent 7 Wipe Out $500B : What's Driving Markets Wednesday?,Benzinga,/news/etf/nasdaq-100-suffers-worst-day-in-11-months-as-chipmakers-tumble-on-china-curbs-magnificent-7-wipe-out-500b-what-s-driving-markets-wednesday-1033565208,neutral,0.9158585071563721
4319,7/17/2024 9:05:24 PM,Buy Rating Affirmed for Johnson & Johnson on Robust Q2 Performance and Strategic Growth Outlook,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-robust-q2-performance-and-strategic-growth-outlook-1033565943,negative,0.951103925704956
4320,7/18/2024 12:37:17 AM,Positive Outlook: Joanne Wuensch Recommends ‚ÄòBuy‚Äô on Johnson & Johnson Amid Strong Q2 Performance and Promising Growth Prospects,TipRanks,/news/stocks/positive-outlook-joanne-wuensch-recommends-buy-on-johnson-johnson-amid-strong-q2-performance-and-promising-growth-prospects-1033566071,negative,0.917246401309967
4321,7/18/2024 12:38:52 AM,Maintaining Hold on Johnson & Johnson: Balancing MedTech Challenges with Pharmaceutical Strengths and Steady Long-Term Growth,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-balancing-medtech-challenges-with-pharmaceutical-strengths-and-steady-long-term-growth-1033566064,negative,0.8863285779953003
4322,7/18/2024 10:39:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033568691,positive,0.6571249961853027
4323,7/18/2024 1:08:04 PM,Balanced Outlook for Johnson & Johnson: Hold Rating Amidst Growth and Challenges,TipRanks,/news/stocks/balanced-outlook-for-johnson-johnson-hold-rating-amidst-growth-and-challenges-1033569703,negative,0.510344922542572
4324,7/18/2024 1:08:41 PM,Johnson & Johnson (JNJ) Receives a Buy from Argus Research,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-argus-research-1033569698,positive,0.49654051661491394
4325,7/18/2024 1:45:20 PM,Maintaining Hold on Johnson & Johnson: A Balanced View Amidst Q2 Results and Future Challenges,TipRanks,/news/stocks/maintaining-hold-on-johnson-johnson-a-balanced-view-amidst-q2-results-and-future-challenges-1033569806,negative,0.5817450881004333
4326,7/18/2024 2:36:47 PM,Microsoft To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Thursday,Benzinga,/news/stocks/microsoft-to-rally-around-12-here-are-10-top-analyst-forecasts-for-thursday-1033568315,positive,0.9142047166824341
4327,7/18/2024 3:00:00 PM,3 Blue-Chip Stocks to Buy If the Dow Crashes,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-if-the-dow-crashes-1033569354,positive,0.9240257740020752
4328,7/18/2024 3:34:12 PM,Med-tech and healthcare stocks with upside during 2Q earnings - Baird,Seeking Alpha,https://seekingalpha.com/news/4125556-med-tech-and-healthcare-stocks-with-upside-during-2q-earnings-baird?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8237011432647705
4329,7/18/2024 6:09:15 PM,3 Dividend Stocks That Demand Investor Attention,InvestorPlace,/news/stocks/3-dividend-stocks-that-demand-investor-attention-1033569948,positive,0.9173887968063354
4330,7/18/2024 6:12:41 PM,These Analysts Revise Their Forecasts On Johnson & Johnson After Q2 Results,Benzinga,/news/stocks/these-analysts-revise-their-forecasts-on-johnson-johnson-after-q2-results-1033569714,positive,0.8847570419311523
4331,7/18/2024 8:51:35 PM,"Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst",Benzinga,/news/stocks/johnson-johnson-prioritizes-sustainable-growth-in-m-a-amid-sector-diversification-says-analyst-1033569993,negative,0.9231750965118408
4332,7/18/2024 9:52:22 PM,J&J ends work on Addex epilepsy drug candidate ADX71149: report,Seeking Alpha,https://seekingalpha.com/news/4125712-jj-ends-work-on-addex-epilepsy-drug-candidate-adx71149-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8010879158973694
4333,7/19/2024 12:05:17 PM,"Dividend Roundup: Goldman Sachs, Johnson & Johnson, Qualcomm, Caterpillar, and more",Seeking Alpha,https://seekingalpha.com/news/4125792-dividend-roundup-goldman-sachs-johnson-johnson-qualcomm-caterpillar-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9485202431678772
4334,7/19/2024 8:45:00 PM,7 Consumer Staples Stocks to Buy at a 52-Week Low in July,InvestorPlace,/news/stocks/7-consumer-staples-stocks-ready-for-sector-rotation-1033573603,neutral,0.9345672130584717
4335,7/19/2024 8:45:00 PM,3 Blue-Chip Stocks to Buy for Christmas in July,InvestorPlace,/news/stocks/blue-chip-stocks-to-buy-3-names-offering-a-gift-to-investors-1033573606,positive,0.9014027118682861
4336,7/21/2024 11:00:00 AM,Here are Big Pharma‚Äôs leading blockbuster makers,Seeking Alpha,https://seekingalpha.com/news/4126044-eli-lilly-astrazeneca-top-blockbuster-makers?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7739253044128418
4337,7/22/2024 1:02:13 AM,Kamala Harris' potential impact on health care stocks,Seeking Alpha,https://seekingalpha.com/news/4126065-kamala-harris-potential-impact-health-care-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.49974918365478516
4338,7/22/2024 5:45:56 AM,Buy Rating Affirmed for Johnson & Johnson on Strong Growth and Strategic Acquisitions,TipRanks,/news/stocks/buy-rating-affirmed-for-johnson-johnson-on-strong-growth-and-strategic-acquisitions-1033576818,negative,0.9514282941818237
4339,7/22/2024 12:33:47 PM,Johnson & Johnson seeks FDA approval of Spravato as depression monotherapy,Seeking Alpha,https://seekingalpha.com/news/4126173-johnson-johnson-seeks-fda-approval-of-its-monotherapy-for-treatment-resistant-depression?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8449520468711853
4340,7/22/2024 2:18:44 PM,Johnson & Johnson Seeks FDA Approval For SPRAVATO Nasal Spray For Treatment-Resistant Depression ,RTTNews,/news/stocks/johnson-johnson-seeks-fda-approval-for-spravato-nasal-spray-for-treatment-resistant-depression-1033577430,negative,0.9152527451515198
4341,7/22/2024 3:34:24 PM,Alvotech launches first biosimilar of J&J's Stelara in Europe,Seeking Alpha,https://seekingalpha.com/news/4126333-alvotech-launches-first-biosimilar-of-johnson-johnson-stelara-europe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6708691716194153
4342,7/22/2024 7:11:56 PM,Oppenheimer starts ArriVent BioPharma at outperform,Seeking Alpha,https://seekingalpha.com/news/4126431-oppenheimer-starts-arrivent-biopharma-at-outperform?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6657828688621521
4343,7/24/2024 5:06:57 PM,Bio-Thera biosimilar to J&J‚Äôs Stelara under FDA review,Seeking Alpha,https://seekingalpha.com/news/4127721-new-biosimilar-jjs-stelara-under-fda-review?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7594791054725647
4344,7/24/2024 9:25:04 PM,Newly-Listed Psoriasis-Focused Alumis Attracts Analysts' Attention With Promising Lead Program And Modest Valuation,Benzinga,/news/stocks/newly-listed-psoriasis-focused-alumis-attracts-analysts-attention-with-promising-lead-program-and-modest-valuation-1033590627,negative,0.9513867497444153
4345,7/25/2024 11:45:00 AM,3 Beaten-Down Value Stocks Poised for a Massive Comeback: July 2024,InvestorPlace,/news/stocks/3-beaten-down-value-stocks-poised-for-a-massive-comeback-july-2024-1033594252,positive,0.7219592928886414
4346,7/25/2024 12:19:08 PM,AbbVie raises outlook as new immunology drugs offset Humira impact,Seeking Alpha,https://seekingalpha.com/news/4128262-abbvie-stock-in-focus-improved-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9508212208747864
4347,7/25/2024 4:51:47 PM,AC Immune stock climbs 7% on FDA fast track status for Alzheimer's drug,Seeking Alpha,https://seekingalpha.com/news/4128487-ac-immune-stock-climbs-on-fda-fast-track-status-for-alzheimers-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9442577362060547
4348,7/25/2024 7:19:00 PM,3 Stocks Reeling From Ruined Reputations: Can They Recover?,InvestorPlace,/news/stocks/3-stocks-reeling-from-ruined-reputations-can-they-recover-1033596326,neutral,0.894749641418457
4349,7/26/2024 2:31:45 AM,J&J talc bankruptcy plan appeal denied,Seeking Alpha,https://seekingalpha.com/news/4128759-johnson-johnson-talc-bankruptcy-plan-appeal-denied?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6504698991775513
4350,7/26/2024 2:18:51 PM,Johnson & Johnson's Yuvanci Gets Positive CHMP Opinion In Europe For Pulmonary Arterial Hypertension ,RTTNews,/news/stocks/johnson-johnson-s-yuvanci-gets-positive-chmp-opinion-in-europe-for-pulmonary-arterial-hypertension-1033599993,negative,0.9511910676956177
4351,7/26/2024 3:55:32 PM,J&J: CHMP Recommends RYBREVANT With Chemo To Treat Advanced EGFR-mutated NSCLC ,RTTNews,/news/stocks/j-j-chmp-recommends-rybrevant-with-chemo-to-treat-advanced-egfr-mutated-nsclc-1033600327,negative,0.894152045249939
4352,7/27/2024 4:00:00 PM,7 Long-Term Stocks to Buy on the Dip: July 2024,InvestorPlace,/news/stocks/7-long-term-stocks-that-may-lead-the-markets-next-move-higher-1033602115,positive,0.9114879965782166
4353,7/28/2024 2:00:00 PM,Most U.S. pharmas don't pay any U.S. income tax,Seeking Alpha,https://seekingalpha.com/news/4129257-most-us-pharmas-dont-pay-any-us-income-tax?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9261671304702759
4354,7/30/2024 10:31:38 AM,Johnson & Johnson (JNJ) Receives a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-rbc-capital-1033612324,negative,0.4946078658103943
4355,7/30/2024 10:34:26 AM,"Analysts Conflicted on These Healthcare Names: Johnson & Johnson (JNJ), Sotera Health (SHC) and Hologic (HOLX)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-johnson-johnson-jnj-sotera-health-shc-and-hologic-holx-1033612314,neutral,0.7883537411689758
4356,7/30/2024 4:35:39 PM,Q3‚Äôs Rising Stars: 3 Dow Stocks for Your Must-Watch List,InvestorPlace,/news/stocks/q3s-rising-stars-3-dow-stocks-for-your-must-watch-list-1033613434,positive,0.8960666060447693
4357,7/30/2024 8:25:28 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033614322,positive,0.941351056098938
4358,7/31/2024 5:34:24 AM,Johnson & Johnson : FDA Approves Darzalex Faspro Combination For Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-fda-approves-darzalex-faspro-combination-for-multiple-myeloma-1033614529,negative,0.9072259068489075
4359,7/31/2024 11:00:00 AM,Kazia Therapeutics Stock: Is KZIA a Buyout Candidate in the Making?,InvestorPlace,/news/stocks/kazia-therapeutics-stock-is-kzia-a-buyout-candidate-in-the-making-1033617326,positive,0.9267992377281189
4360,7/31/2024 12:51:19 PM,J&J wins another FDA label expansion for multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4131026-jj-wins-label-expansion-for-multiple-myeloma-drug?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9137241244316101
4361,7/31/2024 6:30:32 PM,7 Leading MedTech Stocks for Next-Gen Health Solutions,InvestorPlace,/news/stocks/7-leading-medtech-stocks-for-next-gen-health-solutions-1033620457,positive,0.5478201508522034
4362,8/1/2024 2:00:00 PM,Bargain-Hunters Paradise: 7 Value Stocks That Are Too Cheap to Ignore,InvestorPlace,/news/stocks/bargain-hunters-paradise-7-value-stocks-that-are-too-cheap-to-ignore-1033627397,positive,0.9074242115020752
4363,8/6/2024 10:17:00 AM,3 Dividend Growth Stocks to Accumulate on Dips: August Edition,InvestorPlace,/news/stocks/3-dividend-growth-stocks-to-accumulate-on-dips-august-edition-1033644207,positive,0.4781426787376404
4364,8/8/2024 11:00:00 AM,The 3 Best Dividend Aristocrats to Buy for Sustainable Income: August 2024,InvestorPlace,/news/stocks/the-3-best-dividend-aristocrats-to-buy-for-sustainable-income-august-2024-1033660107,positive,0.9145475625991821
4365,8/8/2024 11:35:39 AM,Maintaining Hold on J&J Amid Talc Litigation Developments and Settlement Prospects,TipRanks,/news/stocks/maintaining-hold-on-j-j-amid-talc-litigation-developments-and-settlement-prospects-1033661465,neutral,0.751394510269165
4366,8/8/2024 6:46:23 PM,"J&J, Stryker among potential suitors for Nevro: Wolfe",Seeking Alpha,https://seekingalpha.com/news/4137462-nevro-stock-gains-wolfe-cites-buyout-potential?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.919321596622467
4367,8/10/2024 12:13:27 PM,Gilead exits J&J royalty deal for liver drug ahead of potential FDA nod,Seeking Alpha,https://seekingalpha.com/news/4138389-gilead-exits-jj-royalty-deal-for-liver-drug-ahead-of-potential-fda-nod?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.45769453048706055
4368,8/11/2024 2:27:02 PM,Johnson & Johnson (JNJ): An Undervalued Dividend King With Strong Financials,TipRanks,/news/stocks/johnson-johnson-jnj-an-undervalued-dividend-king-with-strong-financials-1033672043,negative,0.950438916683197
4369,8/12/2024 9:01:06 PM,J&J makes headway in settling talc baby powder litigation: reports,Seeking Alpha,https://seekingalpha.com/news/4138841-jnj-makes-headway-in-settling-talc-baby-powder-litigation-reports?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7629970908164978
4370,8/13/2024 11:30:00 AM,3 Blue-Chip Stocks to Buy on the Dip: August 2024,InvestorPlace,/news/stocks/3-blue-chip-stocks-to-buy-on-the-dip-august-2024-1033681382,positive,0.8941364288330078
4371,8/13/2024 11:55:50 AM,Maintaining Hold on JNJ Amid Progress and Uncertainty in Talc Litigation,TipRanks,/news/stocks/maintaining-hold-on-jnj-amid-progress-and-uncertainty-in-talc-litigation-1033682808,neutral,0.906103253364563
4372,8/13/2024 2:13:11 PM,Buy Rating Affirmed: Johnson & Johnson Nears Resolution of Talc Litigations,TipRanks,/news/stocks/buy-rating-affirmed-johnson-johnson-nears-resolution-of-talc-litigations-1033683489,neutral,0.45365768671035767
4373,8/14/2024 10:44:00 AM,7 Dependable Dividend Stocks for Long-Term Income,InvestorPlace,/news/stocks/7-dependable-dividend-stocks-for-long-term-income-1033687408,positive,0.9273225665092468
4374,8/14/2024 5:12:03 PM,J&J expected to declare voting support for talc bankruptcy plan as early as Friday,Seeking Alpha,https://seekingalpha.com/news/4139924-jnj-to-declare-win-talc-bankruptcy-plan-friday?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.89298015832901
4375,8/15/2024 11:00:00 AM,7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024,InvestorPlace,/news/stocks/7-recession-resistant-stocks-to-hold-onto-for-dear-life-in-2024-1033694445,positive,0.47594550251960754
4376,8/15/2024 11:27:19 AM,U.S. government targets $6B in savings from first Medicare drug price negotiations,Seeking Alpha,https://seekingalpha.com/news/4140341-us-government-targets-6b-in-saving-from-first-medicare-drug-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9052250385284424
4377,8/15/2024 11:44:07 AM,U.S. announces final drug prices after Medicare negotiations,Seeking Alpha,https://seekingalpha.com/news/4140356-us-posts-final-drug-prices-medicare-talks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.802365779876709
4378,8/17/2024 2:09:07 PM,Trending stocks this week as U.S. equities notch their best week of 2024,Seeking Alpha,https://seekingalpha.com/news/4141247-trending-stocks-this-week-as-us-equities-notch-their-best-week-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7283941507339478
4379,8/17/2024 6:00:44 PM,"J&J, Roche come out on top in S&P ratings of strongest pharma companies",Seeking Alpha,https://seekingalpha.com/news/4141255-johnson-johnson-roche-come-out-top-in-ratings-strongest-pharma-companies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8499211668968201
4380,8/20/2024 11:30:03 AM,J&J‚Äôs chemotherapy-free drug combo wins FDA nod for advanced lung cancer,Seeking Alpha,https://seekingalpha.com/news/4141786-jjs-chemotherapy-free-drug-combo-wins-fda-nod-for-advanced-lung-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9194907546043396
4381,8/20/2024 11:49:22 AM,J&J to acquire V-Wave for $600M upfront,Seeking Alpha,https://seekingalpha.com/news/4141793-jj-to-acquire-v-wave-for-600m-upfront?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9001184701919556
4382,8/20/2024 1:51:45 PM,Johnson & Johnson's Chemotherapy-free Lung Cancer Treatment Rybrevant Plus Lazcluze Gets FDA Nod ,RTTNews,/news/stocks/johnson-johnson-s-chemotherapy-free-lung-cancer-treatment-rybrevant-plus-lazcluze-gets-fda-nod-1033706946,negative,0.7813281416893005
4383,8/20/2024 2:09:23 PM,Johnson & Johnson To Acquire V-Wave For Initial Payment Of $600 Mln ,RTTNews,/news/stocks/johnson-johnson-to-acquire-v-wave-for-initial-payment-of-600-mln-1033707027,positive,0.8983802199363708
4384,8/20/2024 6:07:51 PM,"FTC says FDA biosimilar guidance would increase competition, lead to lower prices",Seeking Alpha,https://seekingalpha.com/news/4142026-ftc-says-fda-biosimilar-guidance-would-increase-competition-lead-lower-prices?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5784038305282593
4385,8/23/2024 12:27:22 PM,"Dividend Roundup: Johnson & Johnson, Hyatt, Northrop Grumman, Altria Group, and more",Seeking Alpha,https://seekingalpha.com/news/4143257-dividend-roundup-johnson-johnson-hyatt-northrop-grumman-altria-group-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9443618059158325
4386,8/23/2024 2:51:56 PM,Janssen-Cilag's Balversa Gets EC Approval For Metastatic Urothelial Carcinoma ,RTTNews,/news/stocks/janssen-cilag-s-balversa-gets-ec-approval-for-metastatic-urothelial-carcinoma-1033718013,negative,0.9254757165908813
4387,8/23/2024 7:00:25 PM,J&J faces backlash from hospitals after revised drug-discount program: WSJ,Seeking Alpha,https://seekingalpha.com/news/4143479-jjs-drug-discount-program-criticized-hospitals?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9477694630622864
4388,8/23/2024 7:43:10 PM,J&J reportedly seeking additional support for talc bankruptcy plan,Seeking Alpha,https://seekingalpha.com/news/4143484-jj-additional-support-talc-bankruptcy?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8365815281867981
4389,8/23/2024 8:12:11 PM,Johnson & Johnson continues gains for eight straight sessions,Seeking Alpha,https://seekingalpha.com/news/4143475-johnson-johnson-continues-gains-for-eight-straight-sessions?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9220123887062073
4390,8/25/2024 5:57:37 AM,"Weekly Biotech Buzz: AADI Trims R&D Jobs, JNJ Loosens Purse Strings, FDA Snubs REGN's Myeloma Drug ",RTTNews,/news/stocks/weekly-biotech-buzz-aadi-trims-r-d-jobs-jnj-loosens-purse-strings-fda-snubs-regn-s-myeloma-drug-1033719571,neutral,0.8108912110328674
4391,8/27/2024 3:28:46 PM,Addex stock rallies 45% on Indivior collaboration update,Seeking Alpha,https://seekingalpha.com/news/4144187-addex-stock-rallies-on-indivior-collaboration-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8646681308746338
4392,8/29/2024 10:26:46 AM,"New Medicare drug price caps could help seniors save over $1,000 a year - AARP",Seeking Alpha,https://seekingalpha.com/news/4144962-new-medicare-drug-price-caps-could-help-seniors-save-over-1000-a-year-aarp?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8434954881668091
4393,8/29/2024 2:43:09 PM,J&J Files For FDA Approval Of Nipocalimab To Treat Generalized Myasthenia Gravis ,RTTNews,/news/stocks/j-j-files-for-fda-approval-of-nipocalimab-to-treat-generalized-myasthenia-gravis-1033732590,negative,0.8213387131690979
4394,8/29/2024 3:49:40 PM,J&J submits FDA application for myasthenia gravis drug nipocalimab,Seeking Alpha,https://seekingalpha.com/news/4145151-jj-submits-fda-application-for-myasthenia-gravis-drug-nipocalimab?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7476670145988464
4395,9/1/2024 7:26:06 PM,"Weekly Biotech Buzz: BMRN Cuts Jobs, FDA Approves New Mpox Vaccine, MRK Halts 2 Keytruda Studies ",RTTNews,/news/stocks/weekly-biotech-buzz-bmrn-cuts-jobs-fda-approves-new-mpox-vaccine-mrk-halts-2-keytruda-studies-1033738673,neutral,0.7506183385848999
4396,9/3/2024 11:48:43 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033744314,positive,0.5040156245231628
4397,9/3/2024 7:29:35 PM,Keros gains after trial update on lung disorder therapy,Seeking Alpha,https://seekingalpha.com/news/4146385-keros-stock-gains-trial-update?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.394027978181839
4398,9/4/2024 3:30:13 PM,"J&J owes over $1B in damages related to 2019 Auris deal, judge rules",Seeking Alpha,https://seekingalpha.com/news/4146914-jj-owes-over-1b-linked-auris-deal-judge-rules?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7210623025894165
4399,9/4/2024 8:47:30 PM,J&J talc powder settlement backed by key attorney: report,Seeking Alpha,https://seekingalpha.com/news/4147074-jj-talc-powder-settlement-backed-by-key-attorney-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9013358354568481
4400,9/5/2024 6:07:36 PM,Cigna to offer biosimilar to J&J‚Äôs arthritis drug Stelara at $0 out-of-pocket,Seeking Alpha,https://seekingalpha.com/news/4147414-cigna-touts-biosimilar-jj-arthritis-drug-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7320741415023804
4401,9/6/2024 10:37:24 AM,Balancing Growth and Challenges: A Hold Rating for Johnson & Johnson‚Äôs Medtech Division Amidst China Headwinds,TipRanks,/news/stocks/balancing-growth-and-challenges-a-hold-rating-for-johnson-johnson-s-medtech-division-amidst-china-headwinds-1033753866,negative,0.772025465965271
4402,9/6/2024 7:00:22 PM,"Catalyst Watch: Apple's iPhone event, Oracle earnings, Google antitrust trial, and the August CPI print",Seeking Alpha,https://seekingalpha.com/news/4147709-catalyst-watch-apples-iphone-event-oracle-earnings-google-antitrust-trial-and-the-august-cpi-print?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7490698099136353
4403,9/9/2024 3:06:44 AM,J&J : Phase 3 Data Show RYBREVANT + LAZCLUZE Outperforms Osimertinib In Non-small Cell Lung Cancer ,RTTNews,/news/stocks/j-j-phase-3-data-show-rybrevant-lazcluze-outperforms-osimertinib-in-non-small-cell-lung-cancer-1033755629,negative,0.9441448450088501
4404,9/9/2024 12:25:43 PM,Cantor Fitzgerald Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1033758084,positive,0.8271588087081909
4405,9/9/2024 5:25:27 PM,J&J Rybrevant/Lazcluze study shows superiority over Tagrisso,Seeking Alpha,https://seekingalpha.com/news/4148096-jj-rybrevant-lazcluze-study-shows-superiority-over-tagrisso?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9234210252761841
4406,9/10/2024 10:56:30 PM,16 new GLP-1 weight-loss drugs could be launched by 2029: report,Seeking Alpha,https://seekingalpha.com/news/4148522-16-new-glp-1-weight-loss-drugs-could-be-launched-by-2029-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8558949828147888
4407,9/11/2024 5:39:36 AM,J&J's Dexamethasone Regimen Reduces Infusion Reactions In EGFR-Mutated NSCLC Patients On RYBREVANT ,RTTNews,/news/stocks/j-j-s-dexamethasone-regimen-reduces-infusion-reactions-in-egfr-mutated-nsclc-patients-on-rybrevant-1033762197,negative,0.8002281785011292
4408,9/11/2024 1:56:19 PM,J&J mid-stage trial for lung cancer drug Rybrevant hits main goal,Seeking Alpha,https://seekingalpha.com/news/4148686-jj-trial-lung-cancer-drug-rybrevant-succeeds?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5891922116279602
4409,9/11/2024 8:55:28 PM,Wells Fargo Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/wells-fargo-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1033765212,positive,0.8372873663902283
4410,9/12/2024 3:01:10 AM,J&J's TREMFYA Receives FDA Approval For Moderately To Severely Active Ulcerative Colitis In Adults ,RTTNews,/news/stocks/j-j-s-tremfya-receives-fda-approval-for-moderately-to-severely-active-ulcerative-colitis-in-adults-1033765228,negative,0.9439395070075989
4411,9/12/2024 10:52:10 AM,J&J Tremfya label expanded in the U.S. for inflammatory bowel disease,Seeking Alpha,https://seekingalpha.com/news/4148926-jj-tremfya-us-label-expanded-bowel-disease?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7951905131340027
4412,9/12/2024 3:48:46 PM,Janssen-Cilag Announces First EMA Submission For Nipocalimab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-announces-first-ema-submission-for-nipocalimab-quick-facts-1033767160,positive,0.8568756580352783
4413,9/12/2024 4:28:27 PM,JNJ submits application to EMA for nipocalimab for generalized myasthenia gravis,Seeking Alpha,https://seekingalpha.com/news/4149162-johnson-johnson-submits-application-ema-nipocalimab-generalized-myasthenia-gravis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7764533162117004
4414,9/14/2024 9:54:37 AM,J&J: RYBREVANT + Chemotherapy Shows Strong Benefits And Improved Survival In Phase 3 NSCLC Trial ,RTTNews,/news/stocks/j-j-rybrevant-chemotherapy-shows-strong-benefits-and-improved-survival-in-phase-3-nsclc-trial-1033771563,negative,0.957048237323761
4415,9/14/2024 4:39:16 PM,J&J Announces Promising Phase 1b/2 Data For Amivantamab Combination In Metastatic Colorectal Cancer ,RTTNews,/news/stocks/j-j-announces-promising-phase-1b-2-data-for-amivantamab-combination-in-metastatic-colorectal-cancer-1033771648,negative,0.9336089491844177
4416,9/14/2024 7:37:59 PM,J&J leads H1 healthcare deals as Big Pharma dealmaking returns: report,Seeking Alpha,https://seekingalpha.com/news/4149797-jj-leads-h1-2024-healthcare-dealmaking?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9156707525253296
4417,9/15/2024 10:15:01 AM,J&J's TAR-200 Phase 2b SunRISe-1 Study Shows 84% Complete Response In High-Risk Bladder Cancer ,RTTNews,/news/stocks/j-j-s-tar-200-phase-2b-sunrise-1-study-shows-84-complete-response-in-high-risk-bladder-cancer-1033771793,negative,0.8650369644165039
4418,9/15/2024 2:07:52 PM,Do queasy side effects mean the end of weight-loss drug stock hype?,Seeking Alpha,https://seekingalpha.com/news/4149819-do-nauseating-side-effects-mean-the-end-of-weight-loss-drug-stock-hype?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6545578837394714
4419,9/16/2024 9:33:31 AM,Johnson & Johnson Reports Promising Interim Data From Phase 2 SunRISe-4 Study ,RTTNews,/news/stocks/johnson-johnson-reports-promising-interim-data-from-phase-2-sunrise-4-study-1033772973,negative,0.9425020217895508
4420,9/16/2024 4:46:07 PM,CG Oncology surges 7%; seen benefitting from J&J bladder cancer asset data,Seeking Alpha,https://seekingalpha.com/news/4150038-cg-oncology-surges-7-seen-benefitting-from-johnson-johnson-bladder-cancer-asset-data?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9475256204605103
4421,9/16/2024 4:54:08 PM,Edwards Lifesciences gains amid takeover speculation,Seeking Alpha,https://seekingalpha.com/news/4150042-edwards-lifesciences-gains-amid-takeover-speculation?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8644933104515076
4422,9/18/2024 10:36:38 AM,Citi Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/citi-keeps-their-buy-rating-on-johnson-johnson-jnj-1033780374,positive,0.9060529470443726
4423,9/18/2024 8:18:20 PM,BeiGene initiated at outperform at JMP Securities on strength of Brukinsa,Seeking Alpha,https://seekingalpha.com/news/4150909-beigene-initiated-outperform-jmp-securities-strength-brukinsa?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9050130844116211
4424,9/19/2024 11:50:20 AM,Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (JNJ) and Progyny (PGNY),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-johnson-johnson-jnj-and-progyny-pgny-1033784078,positive,0.9127686023712158
4425,9/20/2024 2:47:43 AM,FDA Okays J&J's RYBREVANT For Advanced Non-Small Cell Lung Cancer In Combination With Chemotherapy ,RTTNews,/news/stocks/fda-okays-j-j-s-rybrevant-for-advanced-non-small-cell-lung-cancer-in-combination-with-chemotherapy-1033784908,negative,0.5209240913391113
4426,9/20/2024 7:10:29 AM,J&J said to boost offer to settle baby powder lawsuits to over $8.2B,Seeking Alpha,https://seekingalpha.com/news/4151443-johnson-johnson-settlement-offer-baby-powder-lawsuits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9422386884689331
4427,9/20/2024 10:47:13 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033786632,positive,0.6571249961853027
4428,9/20/2024 2:04:14 PM,Janssen-Cilag Reports CHMP Recommendation For Daratumumab - Quick Facts ,RTTNews,/news/stocks/janssen-cilag-reports-chmp-recommendation-for-daratumumab-quick-facts-1033786211,positive,0.7960809469223022
4429,9/20/2024 8:07:36 PM,Johnson & Johnson unit seeks third Chapter 11 bankruptcy filing to settle talc claims,Seeking Alpha,https://seekingalpha.com/news/4151707-johnson-johnson-unit-seeks-third-chapter-11-bankruptcy-filing-settle-talc-claims?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.765434741973877
4430,9/20/2024 8:43:49 PM,Sanofi Sarclisa combo gains approval as first-line multiple myeloma treatment,Seeking Alpha,https://seekingalpha.com/news/4151719-sanofi-sarclisa-combo-gains-approval-first-line-multiple-myeloma-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.950284481048584
4431,9/21/2024 7:21:32 AM,J&J's Subsidiary Red River Talc Files For Chapter 11 Bankruptcy To Resolve Ovarian Cancer Claims ,RTTNews,/news/stocks/j-j-s-subsidiary-red-river-talc-files-for-chapter-11-bankruptcy-to-resolve-ovarian-cancer-claims-1033787796,neutral,0.8271327018737793
4432,9/21/2024 8:00:07 PM,Novartis' Pluvicto expected to dominate prostate cancer radiopharmaceutical market,Seeking Alpha,https://seekingalpha.com/news/4151752-novartis-pluvicto-expected-dominate-prostate-cancer-radiopharmaceutical-market?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6771224141120911
4433,9/23/2024 7:17:40 PM,UCB gets expanded FDA approval for psoriasis drug Bimzelx,Seeking Alpha,https://seekingalpha.com/news/4152277-ucb-gets-expanded-fda-approval-for-psoriasis-drug-bimzelx?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9338517189025879
4434,9/24/2024 9:10:15 AM,Analysts Offer Insights on Healthcare Companies: Gilead Sciences (GILD) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-gilead-sciences-gild-and-johnson-johnson-jnj-1033793366,positive,0.9118403792381287
4435,9/24/2024 4:49:21 PM,J&J unit third bankruptcy attempt location to be determined by Texas judge,Seeking Alpha,https://seekingalpha.com/news/4152793-johnson-johnson-unit-third-bankruptcy-attempt-location-determined-texas-judge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9387897253036499
4436,9/25/2024 8:45:35 AM,Strategic Legal Maneuvers Brighten Johnson & Johnson‚Äôs Financial Outlook Amid Talc Litigation,TipRanks,/news/stocks/strategic-legal-maneuvers-brighten-johnson-johnson-s-financial-outlook-amid-talc-litigation-1033796491,negative,0.9263922572135925
4437,9/25/2024 10:49:50 AM,"Bristol Myers, 2seventy bio halt enrollment in Abecma late-stage trial",Seeking Alpha,https://seekingalpha.com/news/4153004-bristol-myers-2seventy-bio-halt-abecma-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7534777522087097
4438,9/26/2024 2:27:34 PM,"J&J to shutter cardiovascular, metabolic drug unit: report",Seeking Alpha,https://seekingalpha.com/news/4153734-jj-to-shutter-cardiovascular-metabolic-drug-unit-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7109410166740417
4439,9/26/2024 8:01:55 PM,J&J snaps six straight sessions of losses,Seeking Alpha,https://seekingalpha.com/news/4153849-jj-snaps-six-straight-sessions-of-losses?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8909400105476379
4440,9/27/2024 2:30:36 PM,J&J Reports Data From Investigational Phase 1b RedirecTT-1 Study - Quick Facts ,RTTNews,/news/stocks/j-j-reports-data-from-investigational-phase-1b-redirectt-1-study-quick-facts-1033803603,positive,0.9308199286460876
4441,9/27/2024 2:48:53 PM,Johnson & Johnson Reports New Data From Phase 1b TRIMM-2 Study ,RTTNews,/news/stocks/johnson-johnson-reports-new-data-from-phase-1b-trimm-2-study-1033803657,positive,0.9100856781005859
4442,9/27/2024 5:59:43 PM,"Bristol Cobenfy approval draws optimism from Street, though with caveats",Seeking Alpha,https://seekingalpha.com/news/4154179-bristol-cobenfy-approval-draws-optimism-from-street-though-with-caveats?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.862154483795166
4443,9/27/2024 8:42:26 PM,J&J releases encouraging data on Talvey combination therapies,Seeking Alpha,https://seekingalpha.com/news/4154260-jj-releases-encouraging-data-on-talvey-combination-therapies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.943537712097168
4444,9/27/2024 9:18:34 PM,"J&J, Legend report Carvykti cut death risk by 45% in multiple myeloma study",Seeking Alpha,https://seekingalpha.com/news/4154285-jj-legend-report-carvykti-cut-death-risk-by-45-in-multiple-myeloma-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.95103520154953
4445,9/27/2024 10:26:45 PM,Johnson & Johnson Says Darzalex Regimens Show Meaningful Responses In Patients With Multiple Myeloma ,RTTNews,/news/stocks/johnson-johnson-says-darzalex-regimens-show-meaningful-responses-in-patients-with-multiple-myeloma-1033804874,negative,0.9517240524291992
4446,9/28/2024 8:14:19 AM,J&J : Phase 3 Trial Results Show CARVYKTI Extends Overall Survival In Relapsed Multiple Myeloma ,RTTNews,/news/stocks/j-j-phase-3-trial-results-show-carvykti-extends-overall-survival-in-relapsed-multiple-myeloma-1033805058,negative,0.9528326392173767
4447,9/28/2024 9:01:55 AM,J&J : DARZALEX FASPRO Quadruplet Regimen Improves MRD Negativity In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-darzalex-faspro-quadruplet-regimen-improves-mrd-negativity-in-newly-diagnosed-multiple-myeloma-1033805065,negative,0.940855860710144
4448,9/28/2024 5:06:10 PM,Here are the Medicare Part D drugs expected to face 2025 price negotiations,Seeking Alpha,https://seekingalpha.com/news/4154318-these-medicare-drugs-set-to-face-2025-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.941364049911499
4449,9/30/2024 12:15:10 PM,Cantor Fitzgerald Remains a Buy on Johnson & Johnson (JNJ),TipRanks,/news/stocks/cantor-fitzgerald-remains-a-buy-on-johnson-johnson-jnj-1033808278,positive,0.941351056098938
4450,9/30/2024 3:04:44 PM,Johnson & Johnson Expands Roll-out Of TECNIS Odyssey IOL - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-expands-roll-out-of-tecnis-odyssey-iol-quick-facts-1033807447,positive,0.7847444415092468
4451,9/30/2024 8:42:43 PM,J&J submits supplemental BLA for Darzalex Faspro to FDA,Seeking Alpha,https://seekingalpha.com/news/4154769-jj-submits-supplemental-bla-for-darzalex-faspro-to-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.940132200717926
4452,10/1/2024 8:38:43 AM,Hold Rating on Johnson & Johnson Amid Market Potential and Competitive Positioning Analysis,TipRanks,/news/stocks/hold-rating-on-johnson-johnson-amid-market-potential-and-competitive-positioning-analysis-1033810782,negative,0.8160597681999207
4453,10/1/2024 7:35:29 PM,U.S. port strike expected to have limited impact on healthcare supply chain: HHS,Seeking Alpha,https://seekingalpha.com/news/4155196-us-port-strike-have-limited-impact-medical-supplies?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9400646090507507
4454,10/2/2024 10:42:51 AM,J&J to invest over $2B to build new North Carolina plant,Seeking Alpha,https://seekingalpha.com/news/4155360-johnson-johnson-builds-2b-north-carolina-plant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7378942370414734
4455,10/2/2024 2:07:42 PM,J&J prostate cancer therapy outperforms in real-world study,Seeking Alpha,https://seekingalpha.com/news/4155516-jj-prostate-cancer-therapy-outperforms-in-real-world-study?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8590224981307983
4456,10/2/2024 4:31:17 PM,JNJ's Erleada Shows Statistically Significant Overall Survival In Metastatic Prostate Cancer ,RTTNews,/news/stocks/jnj-s-erleada-shows-statistically-significant-overall-survival-in-metastatic-prostate-cancer-1033815796,negative,0.9453340768814087
4457,10/3/2024 12:02:11 PM,U.S. tweaks 2025 Medicare price negotiation process,Seeking Alpha,https://seekingalpha.com/news/4155891-us-tweaks-2025-medicare-price-negotiations?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7824940085411072
4458,10/4/2024 8:30:19 AM,"Analysts Conflicted on These Healthcare Names: LivaNova (LIVN), Johnson & Johnson (JNJ) and Avidity Biosciences (RNA)",TipRanks,/news/stocks/analysts-conflicted-on-these-healthcare-names-livanova-livn-johnson-johnson-jnj-and-avidity-biosciences-rna-1033820918,neutral,0.6177166104316711
4459,10/4/2024 9:33:39 AM,DBS Remains a Hold on Johnson & Johnson (JNJ),TipRanks,/news/stocks/dbs-remains-a-hold-on-johnson-johnson-jnj-1033821117,positive,0.8509399890899658
4460,10/4/2024 1:28:54 PM,Johnson & Johnson halts mid-stage study for dengue antiviral,Seeking Alpha,https://seekingalpha.com/news/4156465-johnson--johnson-halts-dengue-antiviral-trial?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9374708533287048
4461,10/4/2024 4:55:00 PM,JNJ To Terminate Phase 2 Field Study Of Mosnodenvir For Prevention Of Dengue Virus ,RTTNews,/news/stocks/jnj-to-terminate-phase-2-field-study-of-mosnodenvir-for-prevention-of-dengue-virus-1033821767,positive,0.5871703624725342
4462,10/7/2024 9:04:58 PM,J&J discontinues Phase 2 study for bladder cancer drug TAR-200,Seeking Alpha,https://seekingalpha.com/news/4156861-jj-discontinues-phase-2-study-for-bladder-cancer-drug-tar-200?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7050840258598328
4463,10/8/2024 12:15:50 PM,Johnson & Johnson: Hold Rating Affirmed Amid Balanced Growth and Caution,TipRanks,/news/stocks/johnson-johnson-hold-rating-affirmed-amid-balanced-growth-and-caution-1033828860,negative,0.9525770545005798
4464,10/8/2024 6:03:33 PM,Harris home health care benefit likely funded through Medicare drug negotiations savings,Seeking Alpha,https://seekingalpha.com/news/4157079-harris-home-health-care-benefit-could-funded-through-medicare-drug-negotiations-savings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8432395458221436
4465,10/9/2024 12:26:28 PM,"J&J closes V-Wave deal, to incur IPR&D charge of $600M in Q4",Seeking Alpha,https://seekingalpha.com/news/4157237-jj-closes-v-wave-deal-to-incur-iprd-charge-of-600m-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6603786945343018
4466,10/9/2024 2:32:12 PM,Johnson & Johnson Buys Privately-held V-Wave; Sees In-process R&D Charge Of Around $600 Mln In Q4 ,RTTNews,/news/stocks/johnson-johnson-buys-privately-held-v-wave-sees-in-process-r-d-charge-of-around-600-mln-in-q4-1033831535,negative,0.8456779718399048
4467,10/10/2024 2:47:06 AM,Maintaining Buy Rating on Johnson & Johnson: Promising Pipeline and Financial Prospects Despite Clinical Setback,TipRanks,/news/stocks/maintaining-buy-rating-on-johnson-johnson-promising-pipeline-and-financial-prospects-despite-clinical-setback-1033834010,negative,0.9514312744140625
4468,10/10/2024 9:26:21 AM,Johnson & Johnson: Hold Rating Justified by Subdued EPS Growth and Margin Pressures,TipRanks,/news/stocks/johnson-johnson-hold-rating-justified-by-subdued-eps-growth-and-margin-pressures-1033835260,negative,0.6891876459121704
4469,10/10/2024 1:58:11 PM,J&J Submits For EMA Approval For DARZALEX SC Quadruplet Regimen In Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-submits-for-ema-approval-for-darzalex-sc-quadruplet-regimen-in-newly-diagnosed-multiple-myeloma-1033835175,negative,0.6610318422317505
4470,10/10/2024 3:12:01 PM,J&J Says TREMFYA Showed Strong Results In Biologic-Naive & Refractory Patients With CD And UC ,RTTNews,/news/stocks/j-j-says-tremfya-showed-strong-results-in-biologic-naive-refractory-patients-with-cd-and-uc-1033835517,negative,0.9552667140960693
4471,10/11/2024 12:36:35 PM,Johnson & Johnson (JNJ) Gets a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-morgan-stanley-1033839274,positive,0.8277882933616638
4472,10/11/2024 2:04:36 PM,Texas court rules J&J didn't skirt bankruptcy rules in talc case: report,Seeking Alpha,https://seekingalpha.com/news/4157903-texas-court-rules-jj-didnt-skirt-bankruptcy-rules-in-talc-case-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8444395065307617
4473,10/11/2024 7:00:23 PM,"Catalyst Watch: Netflix earnings, Lenovo tech event, Paris Motor Show, and eyes on oil",Seeking Alpha,https://seekingalpha.com/news/4157956-catalyst-watch-netflix-earnings-lenovo-tech-event-paris-motor-show-and-eyes-on-oil?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9386246800422668
4474,10/13/2024 12:00:00 PM,"Earnings week ahead: BAC, GS, JNJ, TSM, UNH, ABT, UAL, NFLX, PG, AXP and more",Seeking Alpha,https://seekingalpha.com/news/4157923-earnings-week-ahead-bac-gs-jnj-tsm-unh-abt-ual-nflx-pg-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9303746819496155
4475,10/14/2024 2:37:06 PM,Lilly reports positive data for Omvoh versus Stelara in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4158237-lilly-reports-positive-data-for-omvoh-versus-stelara-in-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.922605037689209
4476,10/14/2024 2:42:56 PM,Earnings Scorecard: 7 out of 8 S&P 500 companies deliver EPS wins this week,Seeking Alpha,https://seekingalpha.com/news/4157977-7-out-of-8-sp-500-companies-deliver-eps-wins-this-week?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.816309928894043
4477,10/14/2024 5:51:54 PM,Johnson & Johnson Q3 Preview: Decline in profit is in the cards,Seeking Alpha,https://seekingalpha.com/news/4158319-johnson-johnson-q3-preview-decline-in-profit-is-in-the-cards?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9737696647644043
4478,10/14/2024 10:00:09 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4158228-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9330109357833862
4479,10/15/2024 9:27:16 AM,Johnson & Johnson: Navigating Pharmaceutical Opportunities and Patent Challenges ‚Äì A Hold Rating Analysis,TipRanks,/news/stocks/johnson-johnson-navigating-pharmaceutical-opportunities-and-patent-challenges-‚Äì-a-hold-rating-analysis-1033846642,positive,0.7757495641708374
4480,10/15/2024 10:21:20 AM,"Johnson & Johnson Non-GAAP EPS of $2.42 beats by $0.21, revenue of $22.5B beats by $330M",Seeking Alpha,https://seekingalpha.com/news/4159016-johnson-and-johnson-non-gaap-eps-of-2_42-beats-0_21-revenue-of-22_5b-beats-330m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6936322450637817
4481,10/15/2024 10:31:13 AM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4159095-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9268327951431274
4482,10/15/2024 10:37:10 AM,Johnson & Johnson in charts: Innovative Medicine recorded highest sales in Q3,Seeking Alpha,https://seekingalpha.com/news/4159099-johnson-johnson-in-charts-innovative-medicine-recorded-highest-sales-in-q3?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9165861010551453
4483,10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9296290278434753
4484,10/15/2024 10:39:55 AM,Earnings Snapshot: Johnson & Johnson tops Q3 estimates as Darzalex sales surge; raises FY24 sales outlook,Seeking Alpha,https://seekingalpha.com/news/4159101-earnings-snapshot-johnson-johnson-tops-q3-estimates-as-darzalex-sales-surge-raises-fy24-sales-outlook?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9296290278434753
4485,10/15/2024 12:27:41 PM,"Johnson & Johnson Q3 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q3-profit-decreases-but-beats-estimates-1033846024,neutral,0.9718165993690491
4486,10/15/2024 12:45:15 PM,Johnson & Johnson Hold Rating: Strong Pharma Gains Offset by MedTech Challenges and Acquisition Costs,TipRanks,/news/stocks/johnson-johnson-hold-rating-strong-pharma-gains-offset-by-medtech-challenges-and-acquisition-costs-1033847669,negative,0.9505274295806885
4487,10/15/2024 12:53:22 PM,Johnson & Johnson posts Q3 beat; lowers earnings guidance amid M&A impact,Seeking Alpha,https://seekingalpha.com/news/4159512-jnj-stock-falls-amid-cut-to-earnings-guidance?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9698029160499573
4488,10/15/2024 1:11:42 PM,"Johnson & Johnson Cuts FY24 Earnings View, Lifts Sales Forecast - Update ",RTTNews,/news/stocks/johnson-johnson-cuts-fy24-earnings-view-lifts-sales-forecast-update-1033846179,neutral,0.9088244438171387
4489,10/15/2024 1:18:00 PM,"4 stocks to watch on Tuesday: BAC, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4160035-4-stocks-to-watch-on-tuesday-bac-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9166877865791321
4490,10/15/2024 5:09:53 PM,JNJ releases positive data on nipocalimab for myasthenia gravis in adolescents,Seeking Alpha,https://seekingalpha.com/news/4161434-jnj-releases-positive-data-nipocalimab-myasthenia-gravis-adolescents?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9245691895484924
4491,10/15/2024 6:45:09 PM,"Johnson & Johnson: Strong Performance Yet Fairly Priced, Leading to Hold Rating",TipRanks,/news/stocks/johnson-johnson-strong-performance-yet-fairly-priced-leading-to-hold-rating-1033848306,neutral,0.8912839889526367
4492,10/15/2024 8:25:11 PM,Johnson & Johnson: Strong Q3 Performance and Upward Sales Guidance Bolster Buy Rating,TipRanks,/news/stocks/johnson-johnson-strong-q3-performance-and-upward-sales-guidance-bolster-buy-rating-1033848374,negative,0.9563630223274231
4493,10/15/2024 11:55:13 PM,Johnson & Johnson: Balancing Growth Potential with Market Challenges and Legal Risks,TipRanks,/news/stocks/johnson-johnson-balancing-growth-potential-with-market-challenges-and-legal-risks-1033848437,negative,0.5840322971343994
4494,10/15/2024 11:56:34 PM,Hold Rating Maintained for Johnson & Johnson Amid Mixed Sector Performance and EPS Guidance Concerns,TipRanks,/news/stocks/hold-rating-maintained-for-johnson-johnson-amid-mixed-sector-performance-and-eps-guidance-concerns-1033848428,neutral,0.892629861831665
4495,10/15/2024 11:57:07 PM,Hold Rating for Johnson & Johnson Amid 2024 Growth Deceleration and 2025 Optimism,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-2024-growth-deceleration-and-2025-optimism-1033848461,positive,0.6979542970657349
4496,10/16/2024 10:45:51 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1033851665,positive,0.6571249961853027
4497,10/16/2024 11:26:25 AM,Johnson & Johnson (JNJ) Receives a Buy from Cantor Fitzgerald,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-buy-from-cantor-fitzgerald-1033852068,positive,0.5040156245231628
4498,10/16/2024 12:25:29 PM,Johnson & Johnson‚Äôs Growth Potential Highlighted by Strong Q3 Earnings and Promising Pipeline,TipRanks,/news/stocks/johnson-johnson-s-growth-potential-highlighted-by-strong-q3-earnings-and-promising-pipeline-1033852299,negative,0.9534053802490234
4499,10/16/2024 4:21:34 PM,Least shorted S&P 500 stocks in September,Seeking Alpha,https://seekingalpha.com/news/4166027-least-shorted-sp-500-stocks-in-september?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6412530541419983
4500,10/18/2024 7:37:15 PM,Tyra raised to buy by BofA ahead of TYRA-300 data readout,Seeking Alpha,https://seekingalpha.com/news/4176885-tyra-raised-to-buy-by-bofa-ahead-of-tyra-300-data-readout?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6651464104652405
4501,10/19/2024 1:30:00 PM,Over 60% of companies that reported earnings this week beat EPS and revenue estimates - Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4175834-over-60-of-companies-that-reported-earnings-this-week-beat-eps-and-revenue-estimates-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5201920866966248
4502,10/20/2024 11:05:04 PM,Johnson & Johnson treatment of acute myeloid leukemia granted orphan status,TipRanks,/news/stocks/johnson-johnson-treatment-of-acute-myeloid-leukemia-granted-orphan-status-1033861351,positive,0.8726482391357422
4503,10/21/2024 12:49:18 AM,Activist investor Starboard takes stake in Kenvue - WSJ,Seeking Alpha,https://seekingalpha.com/news/4181820-activist-investor-starboard-takes-stake-in-kenvue-wsj?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9210695624351501
4504,10/21/2024 10:30:16 AM,"Prescriptions Johnson & Johnson‚Äôs Spravato are booming, WSJ reports",TipRanks,/news/stocks/prescriptions-johnson-johnson-s-spravato-are-booming-wsj-reports-1033864764,negative,0.9327869415283203
4505,10/21/2024 2:09:26 PM,"Biggest stock movers Monday: LUMN, VFC, BA, SAVE, and more",Seeking Alpha,https://seekingalpha.com/news/4182108-biggest-stock-movers-monday-ba-save-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9094530940055847
4506,10/21/2024 6:15:19 PM,Boeing machinists announce proposal to end strike: Morning Buzz,TipRanks,/news/stocks/boeing-machinists-announce-proposal-to-end-strike-morning-buzz-1033866571,neutral,0.6957014203071594
4507,10/21/2024 8:08:24 PM,Johnson & Johnson snaps six straight days of gains,Seeking Alpha,https://seekingalpha.com/news/4187020-johnson-johnson-snaps-six-straight-days-of-gains?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7514914870262146
4508,10/22/2024 10:55:28 AM,Kenvue price target raised to $27 from $24 at BofA,TipRanks,/news/stocks/kenvue-price-target-raised-to-27-from-24-at-bofa-1033871030,negative,0.9482653141021729
4509,10/25/2024 12:37:01 PM,Johnson & Johnson reports results from Phase 3b SPECTREM study,TipRanks,/news/stocks/johnson-johnson-reports-results-from-phase-3b-spectrem-study-1033894082,positive,0.8863976001739502
4510,10/25/2024 1:56:25 PM,J&J reports positive data for Tremfya in low body surface area psoriasis,Seeking Alpha,https://seekingalpha.com/news/4204907-jj-reports-positive-data-for-tremfya-in-low-body-surface-area-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9427926540374756
4511,10/25/2024 3:01:57 PM,J&J Phase 3b SPECTREM Study Of Tremfya In Low Body Surface Area Plaque Psoriasis Meets Primary Goal ,RTTNews,/news/stocks/j-j-phase-3b-spectrem-study-of-tremfya-in-low-body-surface-area-plaque-psoriasis-meets-primary-goal-1033892577,positive,0.8876163363456726
4512,10/28/2024 11:35:21 AM,Johnson & Johnson‚Äôs Tremfya shows efficacy in Crohn‚Äôs disease Phase 3 study,TipRanks,/news/stocks/johnson-johnson-s-tremfya-shows-efficacy-in-crohn-s-disease-phase-3-study-1033902176,negative,0.9263942241668701
4513,10/28/2024 12:51:07 PM,Johnson & Johnson says Impella ECP met primary endpoint in high-risk PCI study,TipRanks,/news/stocks/johnson-johnson-says-impella-ecp-met-primary-endpoint-in-high-risk-pci-study-1033902891,negative,0.7132695913314819
4514,10/28/2024 1:21:21 PM,J&J Reports Positive Results From GRAVITI Study Of Tremfya In SC Induction And Maintenance Therapy ,RTTNews,/news/stocks/j-j-reports-positive-results-from-graviti-study-of-tremfya-in-sc-induction-and-maintenance-therapy-1033901277,negative,0.9529915452003479
4515,10/28/2024 3:23:50 PM,JNJ's subcutaneous Tremfya demonstrates efficacy in Crohn's,Seeking Alpha,https://seekingalpha.com/news/4213133-johnson-johnson-subcutaneous-tremfya-demonstrates-efficacy-crohns?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9477083086967468
4516,10/28/2024 3:41:20 PM,J&J Impella ECP heart pump meets primary endpoint,Seeking Alpha,https://seekingalpha.com/news/4214084-johnson-johnson-abiomed-impella-ecp-heart-pump-meets-primary-endpoint?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8315333127975464
4517,10/28/2024 7:33:46 PM,DOJ throws wrench into J&J bankruptcy plan to settle talc suits,Seeking Alpha,https://seekingalpha.com/news/4215334-doj-throws-wrench-into-johnson-johnson-bankruptcy-plan-settle-talc-suits?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.5267012119293213
4518,10/30/2024 12:10:44 PM,AbbVie lifts outlook again on immunology demand; dividend raised,Seeking Alpha,https://seekingalpha.com/news/4222641-abbvie-lifts-outlook-again-on-immunology-demand-dividend-raised?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9375719428062439
4519,11/2/2024 7:36:20 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk‚Äôs-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.836555004119873
4520,11/4/2024 1:36:04 PM,Option Care Health downgraded to Neutral at Goldman on Stelara headwinds,TipRanks,/news/stocks/option-care-health-downgraded-to-neutral-at-goldman-on-stelara-headwinds-1033945678,neutral,0.8751690983772278
4521,11/4/2024 2:50:17 PM,"Roblox, Peloton upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/roblox-peloton-upgraded-wall-street-s-top-analyst-calls-1033946237,positive,0.731393039226532
4522,11/4/2024 6:23:55 PM,Alvotech application for Simponi biosimilar accepted by EMA,Seeking Alpha,https://seekingalpha.com/news/4243237-alvotech-application-simponi-biosimilar-accepted-ema?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7740418910980225
4523,11/4/2024 6:41:14 PM,New study reveals another benefit in using Novo Nordisk‚Äôs Wegovy in obesity,Seeking Alpha,https://seekingalpha.com/news/4238084-novo-nordisk-wegovy-can-heal-joint-pain?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.836555004119873
4524,11/5/2024 6:50:16 PM,Johnson & Johnson Darzalex shows efficacy in early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4250819-johnson-and-johnson-darzalex-shows-efficacy-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9178900122642517
4525,11/6/2024 1:06:49 PM,Johnson & Johnson price target raised to $162 from $156 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-162-from-156-at-guggenheim-1033962578,negative,0.9413931965827942
4526,11/6/2024 8:17:19 PM,SA Asks: How will the U.S. election results impact healthcare stocks?,Seeking Alpha,https://seekingalpha.com/news/4257322-sa-asks-how-will-the-us-election-results-impact-healthcare-stocks?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7067018747329712
4527,11/7/2024 5:48:20 PM,J&J wins approval of Varipulse atrial fibrillation device,Seeking Alpha,https://seekingalpha.com/news/4261997-johnson-and-johnson-wins-approval-varipulse-atrial-fibrillation-device?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9174376726150513
4528,11/8/2024 12:21:33 PM,Johnson & Johnson submits applications for new indications for Darzalex,TipRanks,/news/stocks/johnson-johnson-submits-applications-for-new-indications-for-darzalex-1033983117,positive,0.8712581992149353
4529,11/8/2024 2:59:21 PM,J&J seeks approval of Darzalex for early-stage multiple myeloma,Seeking Alpha,https://seekingalpha.com/news/4266211-johnson-and-johnson-seeks-approval-darzalex-early-stage-multiple-myeloma?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7850333452224731
4530,11/8/2024 3:25:08 PM,"Johnson & Johnson Seeks Approval Of Darzalex Faspro In US, Darzalex In EU For Myeloma Treatment ",RTTNews,/news/stocks/johnson-johnson-seeks-approval-of-darzalex-faspro-in-us-darzalex-in-eu-for-myeloma-treatment-1033982191,negative,0.6586000323295593
4531,11/11/2024 9:10:32 PM,Johnson & Johnson: FDA grants nipocalimab Breakthrough Therapy designation,TipRanks,/news/stocks/johnson-johnson-fda-grants-nipocalimab-breakthrough-therapy-designation-1033994750,negative,0.8926911354064941
4532,11/11/2024 9:28:05 PM,J&J gets FDA breakthrough therapy status for nipocalimab in Sjogren's,Seeking Alpha,https://seekingalpha.com/news/4276778-jj-gets-fda-breakthrough-therapy-status-for-nipocalimab-in-sjogrens?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8977115154266357
4533,11/12/2024 8:43:07 PM,J&J sues HHS over 340B hospital drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4281964-johnson-and-johnson-sues-hhs-over-340-b-hospital-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.8901165723800659
4534,11/12/2024 8:55:09 PM,Johnson & Johnson MedTech receives IDE approval for Ottava system,TipRanks,/news/stocks/johnson-johnson-medtech-receives-ide-approval-for-ottava-system-1034002797,negative,0.9180200099945068
4535,11/13/2024 2:40:32 PM,"J&J sues government agency over payment terms for 340B hospitals, STAT says",TipRanks,/news/stocks/j-j-sues-government-agency-over-payment-terms-for-340b-hospitals-stat-says-1034010502,neutral,0.9355283975601196
4536,11/13/2024 5:16:07 PM,"Charter to acquire Liberty Broadband, Spotify reports Q3 beat: Morning Buzz",TipRanks,/news/stocks/charter-to-acquire-liberty-broadband-spotify-reports-q3-beat-morning-buzz-1034011067,positive,0.8938797116279602
4537,11/14/2024 3:12:05 PM,Johnson & Johnson announces results from analyses of Phase 2 DAHLIAS study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-analyses-of-phase-2-dahlias-study-1034020093,positive,0.8631780743598938
4538,11/14/2024 4:39:41 PM,JNJ's Phase 2 Study Of Nipocalimab Shows Improvement In Disease Activity In Sj√∂gren's Disease ,RTTNews,/news/stocks/jnj-s-phase-2-study-of-nipocalimab-shows-improvement-in-disease-activity-in-sjoegren-s-disease-1034018859,negative,0.955245316028595
4539,11/14/2024 9:15:44 PM,Johnson & Johnson initiated with an Outperform at Wolfe Research,TipRanks,/news/stocks/johnson-johnson-initiated-with-an-outperform-at-wolfe-research-1034021187,neutral,0.6642300486564636
4540,11/14/2024 10:48:03 PM,"Renaissance Tech adds Micron, exits Broadcom, among Q3 trades",Seeking Alpha,https://seekingalpha.com/news/4292581-renaissance-tech-adds-micron-exits-broadcom-among-q3-trades?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8644103407859802
4541,11/14/2024 11:07:05 PM,Vaccine makers close lower amid reports RFK Jr may head HHS (update),Seeking Alpha,https://seekingalpha.com/news/4292433-vaccines-makers-close-lower-on-reports-rfk-jr-may-head-hhs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9338276982307434
4542,11/14/2024 11:50:43 PM,"Wolfe starts J&J at Outperform, sees growth drivers as ‚Äòbest-in-class‚Äô",TipRanks,/news/stocks/wolfe-starts-j-j-at-outperform-sees-growth-drivers-as-best-in-class-1034021597,negative,0.8328937888145447
4543,11/15/2024 12:19:45 PM,Eli Lilly follows JNJ in suing govt. over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4294034-eli-lilly-follows-jnj-suing-over-340-b-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.39144593477249146
4544,11/15/2024 3:32:00 PM,Least shorted S&P 500 stocks in October,Seeking Alpha,https://seekingalpha.com/news/4294512-least-shorted-sp-500-stocks-in-october?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5993219614028931
4545,11/15/2024 5:26:07 PM,"Eli Lilly sues to change hospital drug discount payments, WSJ reports",TipRanks,/news/stocks/eli-lilly-sues-to-change-hospital-drug-discount-payments-wsj-reports-1034026316,neutral,0.7439976930618286
4546,11/15/2024 7:15:09 PM,"Medtech shouldn't be greatly impacted by RFK Jr. at HHS, Wells Fargo says",Seeking Alpha,https://seekingalpha.com/news/4296173-medtech-shouldnt-be-greatly-impacted-by-rfk-jr-at-hhs-wells-fargo-says?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9096673727035522
4547,11/15/2024 7:29:29 PM,U.S. Pharma is largely immune from 'MAHA' impact: Wolfe,Seeking Alpha,https://seekingalpha.com/news/4296178-us-pharma-largely-immune-from-maha-impact-wolfe?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9049097299575806
4548,11/15/2024 8:00:56 PM,"Catalyst Watch: Nvidia earnings, Microsoft Ignite, crypto confidence, and P&G event",Seeking Alpha,https://seekingalpha.com/news/4295258-catalyst-watch-nvidia-earnings-microsoft-ignite-crypto-confidence-and-pg-event?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8805450797080994
4549,11/18/2024 1:25:07 PM,CHMP Recommends Approval Of Lazcluze + Rybrevant In EU For EGFR-mutated Advanced NSCLC ,RTTNews,/news/stocks/chmp-recommends-approval-of-lazcluze-rybrevant-in-eu-for-egfr-mutated-advanced-nsclc-1034029899,negative,0.6874967217445374
4550,11/18/2024 9:36:09 PM,Johnson & Johnson announces results from ICONIC-LEADa Phase 3 study,TipRanks,/news/stocks/johnson-johnson-announces-results-from-iconic-leada-phase-3-study-1034033175,positive,0.8161802887916565
4551,11/18/2024 9:51:09 PM,Protagonist and JNJ say icotrokinra study for PsO meets endpoint,TipRanks,/news/stocks/protagonist-and-jnj-say-icotrokinra-study-for-pso-meets-endpoint-1034033226,positive,0.890049397945404
4552,11/18/2024 9:59:37 PM,J&J unveils positive phase 3 results for icotrokinra for plaque psoriasis,Seeking Alpha,https://seekingalpha.com/news/4304472-johnson-and-johnson-unveils-positive-phase-3-results-icotrokinra-plaque-psoriasis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9279190301895142
4553,11/19/2024 10:56:17 AM,Balanced Hold Rating for JNJ‚Äôs Icotrokinra Amid Efficacy Concerns and Healthcare Policy Uncertainties,TipRanks,/news/stocks/balanced-hold-rating-for-jnj-s-icotrokinra-amid-efficacy-concerns-and-healthcare-policy-uncertainties-1034036356,negative,0.9171438813209534
4554,11/20/2024 9:56:25 AM,Johnson & Johnson‚Äôs M&A Strategy in Cardiovascular Devices Supports Hold Rating,TipRanks,/news/stocks/johnson-johnson-s-m-a-strategy-in-cardiovascular-devices-supports-hold-rating-1034041712,negative,0.6518312692642212
4555,11/20/2024 2:36:50 PM,"Johnson & Johnson, Merck cutting jobs in China, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-merck-cutting-jobs-in-china-bloomberg-reports-1034043953,neutral,0.90489262342453
4556,11/20/2024 5:01:17 PM,"Target reports downbeat Q3, Comcast plans cable TV spinoff: Morning Buzz",TipRanks,/news/stocks/target-reports-downbeat-q3-comcast-plans-cable-tv-spinoff-morning-buzz-1034044336,positive,0.8804399371147156
4557,11/21/2024 6:17:53 AM,Johnson & Johnson‚Äôs Promising Pharmaceutical Developments Justify Buy Rating,TipRanks,/news/stocks/johnson-johnson-s-promising-pharmaceutical-developments-justify-buy-rating-1034047194,negative,0.8480587601661682
4558,11/21/2024 6:45:46 PM,Optimism over global healthcare sector rises: Jefferies,Seeking Alpha,https://seekingalpha.com/news/4318258-optimism-over-global-healthcare-sector-rise?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7575292587280273
4559,11/21/2024 10:29:47 PM,Zevra Niemann-Pick disease type C drug Miplyffa now available,Seeking Alpha,https://seekingalpha.com/news/4319157-zevra-niemann-pick-disease-type-c-drug-miplyffa-now-available?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8179043531417847
4560,11/22/2024 1:42:34 AM,J&J : Canada Approves CARVYKTI For Relapsed Or Refractory Multiple Myeloma After 1-3 Prior Therapies ,RTTNews,/news/stocks/j-j-canada-approves-carvykti-for-relapsed-or-refractory-multiple-myeloma-after-1-3-prior-therapies-1034051780,negative,0.7840625643730164
4561,11/22/2024 1:05:50 PM,JNJ seeks FDA approval of subcutaneous induction regimen of Tremfya,TipRanks,/news/stocks/jnj-seeks-fda-approval-of-subcutaneous-induction-regimen-of-tremfya-1034055824,negative,0.8239419460296631
4562,11/22/2024 1:40:48 PM,"Dividend Roundup: General Mills, Halliburton, Johnson & Johnson, Coca-Cola, and others",Seeking Alpha,https://seekingalpha.com/news/4321067-dividend-roundup-general-mills-halliburton-johnson-johnson-coca-cola-and-others?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9470468759536743
4563,11/22/2024 1:48:17 PM,Johnson & Johnson seeks FDA approval for its ulcerative colitis treatment,Seeking Alpha,https://seekingalpha.com/news/4321118-johnson-johnson-seeks-fda-approval-for-its-ulcerative-colitis-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8708744049072266
4564,11/22/2024 2:39:02 PM,Johnson & Johnson Submits SBLA Seeking Approval Of TREMFYA In Ulcerative Colitis ,RTTNews,/news/stocks/johnson-johnson-submits-sbla-seeking-approval-of-tremfya-in-ulcerative-colitis-1034054545,positive,0.4878986179828644
4565,11/22/2024 4:35:10 PM,"Sanofi planning changes to 340B hospital drug discount plan, WSJ reports",TipRanks,/news/stocks/sanofi-planning-changes-to-340b-hospital-drug-discount-plan-wsj-reports-1034056551,positive,0.9313058257102966
4566,11/22/2024 4:50:49 PM,Sanofi becomes latest drugmaker to challenge HHS over 340B drug-discount program,Seeking Alpha,https://seekingalpha.com/news/4322264-sanofi-becomes-latest-drugmakert-challenge-hhs-340-b-drug-discount-program?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8740205764770508
4567,11/23/2024 2:25:05 AM,"Trump picks surgeon Marty Makary to head FDA, Rep. Dave Weldon to lead CDC",Seeking Alpha,https://seekingalpha.com/news/4323803-trump-picks-surgeon-makary-to-head-fda-rep-dave-weldon-to-lead-cdc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9368929862976074
4568,11/27/2024 9:00:25 PM,Janssen treatment of multiple myeloma granted FDA orphan status,TipRanks,/news/stocks/janssen-treatment-of-multiple-myeloma-granted-fda-orphan-status-1034073527,positive,0.5380871295928955
4569,11/28/2024 3:33:22 PM,AstraZeneca cancer drug Enhertu added for reimbursement in China despite probe,Seeking Alpha,https://seekingalpha.com/news/4344692-astrazeneca-enhertu-added-for-china-reimbursement?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8657416701316833
4570,12/2/2024 1:05:25 PM,J&J seeks U.S. FDA approval for pediatric indications for TREMFYA,TipRanks,/news/stocks/j-j-seeks-u-s-fda-approval-for-pediatric-indications-for-tremfya-1034087206,negative,0.877163827419281
4571,12/2/2024 1:40:00 PM,Johnson & Johnson seeks approval of pediatric indications for TREMFYA,Seeking Alpha,https://seekingalpha.com/news/4353860-johnson-johnson-seeks-approval-of-pediatric-indications-for-tremfya?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.7969831824302673
4572,12/2/2024 2:20:35 PM,Johnson & Johnson Files SBLAs In Pediatric Indications For TREMFYA - Quick Facts ,RTTNews,/news/stocks/johnson-johnson-files-sblas-in-pediatric-indications-for-tremfya-quick-facts-1034085713,positive,0.8039138317108154
4573,12/6/2024 7:30:19 PM,"J&J trial news may have positive read for Neumora Therapeutics, says RBC Capital",TipRanks,/news/stocks/j-j-trial-news-may-have-positive-read-for-neumora-therapeutics-says-rbc-capital-1034110005,negative,0.9379512071609497
4574,12/8/2024 9:30:10 PM,J&J announces new frontline data featuring TECVAYLI fro 2 studies in NDMM,TipRanks,/news/stocks/j-j-announces-new-frontline-data-featuring-tecvayli-fro-2-studies-in-ndmm-1034111198,positive,0.9037200808525085
4575,12/9/2024 1:48:06 AM,"J&J : DARZALEX FASPRO Regimens Improve MRD Negativity, Survival In Newly Diagnosed Multiple Myeloma ",RTTNews,/news/stocks/j-j-darzalex-faspro-regimens-improve-mrd-negativity-survival-in-newly-diagnosed-multiple-myeloma-1034111200,negative,0.8741028904914856
4576,12/9/2024 4:27:45 AM,J&J : TECVAYLI Shows Promise As Frontline Therapy For Newly Diagnosed Multiple Myeloma ,RTTNews,/news/stocks/j-j-tecvayli-shows-promise-as-frontline-therapy-for-newly-diagnosed-multiple-myeloma-1034111388,negative,0.9411664605140686
4577,12/9/2024 9:11:33 PM,Gilead price target raised to $115 from $105 at Oppenheimer,TipRanks,/news/stocks/gilead-price-target-raised-to-115-from-105-at-oppenheimer-1034116246,negative,0.9459822177886963
4578,12/9/2024 9:13:31 PM,Johnson & Johnson snaps six days of losing streak,Seeking Alpha,https://seekingalpha.com/news/4379903-johnson-johnson-snaps-six-days-of-losing-streak?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9022814631462097
4579,12/10/2024 12:50:15 AM,J&J‚Äôs CARVYKTI shows higher rates of minimal residual disease negativity,TipRanks,/news/stocks/j-j-s-carvykti-shows-higher-rates-of-minimal-residual-disease-negativity-1034116663,negative,0.9290938377380371
4580,12/10/2024 1:43:21 AM,J&J : CARVYKTI Shows Higher MRD Negativity Rates Vs. Standard Therapies In Phase 3 Study ,RTTNews,/news/stocks/j-j-carvykti-shows-higher-mrd-negativity-rates-vs-standard-therapies-in-phase-3-study-1034116381,negative,0.9571582674980164
4581,12/10/2024 2:45:24 PM,"eBay downgraded, GM upgraded: Wall Street‚Äôs top analyst calls",TipRanks,/news/stocks/ebay-downgraded-gm-upgraded-wall-street-s-top-analyst-calls-1034120783,positive,0.8453127145767212
4582,12/10/2024 10:01:32 PM,BofA restarts coverage of 11 large-cap biopharmas,Seeking Alpha,https://seekingalpha.com/news/4384456-bofa-restarts-coverage-of-11-large-cap-biopharmas?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8290336728096008
4583,12/13/2024 12:08:04 PM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034135636,positive,0.9046739339828491
4584,12/16/2024 2:51:27 PM,"Johnson & Johnson sues Cigna‚Äôs Express Scripts, Accredo, WSJ reports",TipRanks,/news/stocks/johnson-johnson-sues-cigna-s-express-scripts-accredo-wsj-reports-1034142231,positive,0.49756184220314026
4585,12/16/2024 3:15:24 PM,GSK‚Äôs ViiV Healthcare says the CHMP of EMA issued positive opinion for Vocabria,TipRanks,/news/stocks/gsk-s-viiv-healthcare-says-the-chmp-of-ema-issued-positive-opinion-for-vocabria-1034142336,negative,0.9320905208587646
4586,12/16/2024 4:33:48 PM,J&J submits sBLA for pediatric indication for Simponi in ulcerative colitis,Seeking Alpha,https://seekingalpha.com/news/4386867-johnson-johnson-submits-sbla-pediatric-indication-simponi-ulcerative-colitis?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8067091107368469
4587,12/16/2024 5:01:01 PM,"Honeywell still exploring alternatives, Capri weighs Versace sale: Morning Buzz",TipRanks,/news/stocks/honeywell-still-exploring-alternatives-capri-weighs-versace-sale-morning-buzz-1034142630,positive,0.9130474328994751
4588,12/16/2024 6:05:00 PM,Moderna remains the most shorted among S&P 500 healthcare stocks in November,Seeking Alpha,https://seekingalpha.com/news/4386556-moderna-remains-the-most-shorted-among-sp-500-healthcare-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9052240252494812
4589,12/17/2024 11:48:13 AM,Johnson & Johnson says injectable Rybrevant rejected by FDA,Seeking Alpha,https://seekingalpha.com/news/4387220-johnson-johnson-rybrevant-version-rejected-fda?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.6724575161933899
4590,12/17/2024 1:10:11 PM,Analysts Offer Insights on Healthcare Companies: FibroGen (FGEN) and Johnson & Johnson (JNJ),TipRanks,/news/stocks/analysts-offer-insights-on-healthcare-companies-fibrogen-fgen-and-johnson-johnson-jnj-1034146790,positive,0.9146862626075745
4591,12/17/2024 6:45:36 PM,Barclays fact-checked Trump comments on pharmacy benefit managers,TipRanks,/news/stocks/barclays-fact-checked-trump-comments-on-pharmacy-benefit-managers-1034148099,positive,0.9219222068786621
4592,12/18/2024 2:50:54 PM,"PBMs took payments from manufacturers to allow free flow of opioids, NYT reports",TipRanks,/news/stocks/pbms-took-payments-from-manufacturers-to-allow-free-flow-of-opioids-nyt-reports-1034152640,positive,0.7021377086639404
4593,12/18/2024 2:51:03 PM,FDA approves Celltrion's biosimilar of J&J's Stelara,Seeking Alpha,https://seekingalpha.com/news/4387650-fda-approves-celltrion-biosimilar-of-stelara?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5094977021217346
4594,12/18/2024 3:20:29 PM,Trump Trade: Analyst says Trump win ‚Äònot as positive as you‚Äôd think‚Äô for Tesla,TipRanks,/news/stocks/trump-trade-analyst-says-trump-win-not-as-positive-as-you-d-think-for-tesla-1034152752,positive,0.7262119650840759
4595,12/18/2024 3:37:04 PM,Least shorted S&P 500 stocks in November,Seeking Alpha,https://seekingalpha.com/news/4387575-least-shorted-sp-500-stocks-in-november?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6016121506690979
4596,12/19/2024 10:30:50 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034155967,positive,0.9046739339828491
4597,12/20/2024 12:55:11 AM,RxSight downgraded to Hold from Buy at Stifel,TipRanks,/news/stocks/rxsight-downgraded-to-hold-from-buy-at-stifel-1034159325,positive,0.6151788234710693
4598,12/20/2024 3:43:03 PM,RxSight cut to hold at Stifel on competition concerns,Seeking Alpha,https://seekingalpha.com/news/4389305-rxsight-stock-cut-hold-at-stifel?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9298971891403198
4599,12/23/2024 6:05:07 PM,Johnson & Johnson call volume above normal and directionally bullish,TipRanks,/news/stocks/johnson-johnson-call-volume-above-normal-and-directionally-bullish-1034169499,negative,0.9071224927902222
4600,12/26/2024 1:05:19 PM,Johnson & Johnson licensing STAT6 program from Kaken Pharmaceutical,TipRanks,/news/stocks/johnson-johnson-licensing-stat6-program-from-kaken-pharmaceutical-1034174100,positive,0.7997834086418152
4601,12/26/2024 9:25:06 PM,Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal,TipRanks,/news/stocks/leerink-sees-positive-readthrough-for-kymera-therapeutics-from-j-j-kaken-deal-1034174495,negative,0.9524981379508972
4602,12/26/2024 11:44:47 PM,FDA proposes asbestos-testing standards for talc products (update),Seeking Alpha,https://seekingalpha.com/news/4391021-fda-proposes-testing-talc-products-for-asbestos-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9258228540420532
4603,12/30/2024 11:25:06 AM,Piper lowers sales estimates for Legend Biotech‚Äôs Carvykti,TipRanks,/news/stocks/piper-lowers-sales-estimates-for-legend-biotech-s-carvykti-1034179567,neutral,0.9277219772338867
4604,1/2/2025 1:00:59 PM,Johnson & Johnson declares $1.24 dividend,Seeking Alpha,https://seekingalpha.com/news/4391934-johnson-and-johnson-declares-1_24-dividend?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9268327951431274
4605,1/2/2025 2:20:13 PM,"Neumora trial failure a ‚Äòbig blow‚Äô to bull case, says Stifel",TipRanks,/news/stocks/neumora-trial-failure-a-big-blow-to-bull-case-says-stifel-1034187755,neutral,0.8435478806495667
4606,1/2/2025 4:10:12 PM,RBC downgrades Neumora Therapeutics to Sector Perform after trial failure,TipRanks,/news/stocks/rbc-downgrades-neumora-therapeutics-to-sector-perform-after-trial-failure-1034188027,neutral,0.9204874038696289
4607,1/3/2025 1:29:47 PM,"Dividend Roundup: Johnson & Johnson, JPMorgan, Oracle, Mastercard, and more",Seeking Alpha,https://seekingalpha.com/news/4392264-dividend-roundup-johnson-johnson-jpmorgan-oracle-mastercard-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.949636697769165
4608,1/5/2025 10:32:40 PM,SA Asks: Which biotechs are most likely to be acquired near-term?,Seeking Alpha,https://seekingalpha.com/news/4392553-sa-asks-which-biotechs-are-most-likely-to-be-acquired-near-term?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8929339051246643
4609,1/7/2025 1:05:24 PM,Johnson & Johnson‚Äôs rybrevant plus lazcluze improve survival in lung cancer,TipRanks,/news/stocks/johnson-johnson-s-rybrevant-plus-lazcluze-improve-survival-in-lung-cancer-1034201090,negative,0.9200716614723206
4610,1/7/2025 3:27:12 PM,J&J Rybrevant/Lazcluze combo bests AstraZeneca's Tagrisso in NSCLC,Seeking Alpha,https://seekingalpha.com/news/4393029-johnson-and-johnson-rybrevant-lazcluze-combo-bests-astrazeneca-tagrisso-nsclc?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7883796691894531
4611,1/8/2025 1:46:36 AM,Johnson & Johnson (JNJ) Gets a Buy from RBC Capital,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-buy-from-rbc-capital-1034202968,positive,0.6571249961853027
4612,1/8/2025 10:50:31 AM,Hold Recommendation for Johnson & Johnson Amid Promising Drug Trials and Regulatory Challenges,TipRanks,/news/stocks/hold-recommendation-for-johnson-johnson-amid-promising-drug-trials-and-regulatory-challenges-1034205057,negative,0.9129986763000488
4613,1/8/2025 10:50:50 AM,"Analysts Have Conflicting Sentiments on These Healthcare Companies: Sana Biotechnology (SANA), Immuneering (IMRX) and Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-have-conflicting-sentiments-on-these-healthcare-companies-sana-biotechnology-sana-immuneering-imrx-and-johnson-johnson-jnj-1034205054,neutral,0.9323418736457825
4614,1/8/2025 1:06:04 PM,Johnson & Johnson‚Äôs posdinemab granted FDA Fast Track designation,TipRanks,/news/stocks/johnson-johnson-s-posdinemab-granted-fda-fast-track-designation-1034206392,negative,0.86484694480896
4615,1/8/2025 1:43:55 PM,Johnson & Johnson's posdinemab receives FDA fast track designation for its Alzheimer's treatment,Seeking Alpha,https://seekingalpha.com/news/4393419-johnson-johnsons-posdinemab-receives-fda-fast-track-designation-for-its-alzheimers-treatment?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9372678399085999
4616,1/8/2025 3:26:38 PM,J&J's Posdinemab Granted FDA Fast Track Designation For Alzheimer's Treatment ,RTTNews,/news/stocks/j-j-s-posdinemab-granted-fda-fast-track-designation-for-alzheimer-s-treatment-1034205345,negative,0.9306463599205017
4617,1/8/2025 6:31:34 PM,Johnson & Johnson falls after pausing U.S. Varipulse cases,Seeking Alpha,https://seekingalpha.com/news/4393544-johnson-johnson-stock-slips-varipulse-pause?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9398270845413208
4618,1/8/2025 9:00:26 PM,Johnson & Johnson announces pause of all U.S. Varipulse cases,TipRanks,/news/stocks/johnson-johnson-announces-pause-of-all-u-s-varipulse-cases-1034207742,neutral,0.8646604418754578
4619,1/8/2025 9:11:16 PM,"J&J pause ‚Äòvery good‚Äô for Boston Scientific, says Piper Sandler",TipRanks,/news/stocks/j-j-pause-very-good-for-boston-scientific-says-piper-sandler-1034207729,negative,0.8167751431465149
4620,1/8/2025 11:30:40 PM,Johnson & Johnson price target lowered to $160 from $177 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-177-at-bernstein-1034208061,neutral,0.7236616611480713
4621,1/9/2025 1:25:59 PM,Cautious Outlook on Johnson & Johnson Amid Currency and Legal Challenges,TipRanks,/news/stocks/cautious-outlook-on-johnson-johnson-amid-currency-and-legal-challenges-1034210893,neutral,0.906836748123169
4622,1/9/2025 1:45:16 PM,Johnson & Johnson reports nipocalimab granted FDA Priority Review,TipRanks,/news/stocks/johnson-johnson-reports-nipocalimab-granted-fda-priority-review-1034211009,negative,0.9311649203300476
4623,1/9/2025 1:56:22 PM,"Novo, Eli Lilly to dominate global pharma sales in 2025: report",Seeking Alpha,https://seekingalpha.com/news/4393716-novo-eli-lilly-lead-2025-global-pharma-sales?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6913239359855652
4624,1/9/2025 2:49:28 PM,J&J gets Priority Review designation for nipocalimab BLA,Seeking Alpha,https://seekingalpha.com/news/4393771-jj-gets-priority-review-designation-for-nipocalimab-bla?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8153242468833923
4625,1/9/2025 7:55:26 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034211701,positive,0.9362135529518127
4626,1/10/2025 12:16:44 PM,Boston Scientific upgraded to Buy from Hold at Deutsche Bank,TipRanks,/news/stocks/boston-scientific-upgraded-to-buy-from-hold-at-deutsche-bank-1034215133,positive,0.5168510675430298
4627,1/10/2025 6:39:09 PM,J&J gets EU okay for Dual Energy Thermocool Smarttouch Catheter,Seeking Alpha,https://seekingalpha.com/news/4394094-jj-gets-eu-okay-for-dual-energy-thermocool-smarttouch-catheter?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.638433039188385
4628,1/12/2025 10:40:17 AM,"Analysts Are Bullish on Top Healthcare Stocks: Immuneering (IMRX), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-top-healthcare-stocks-immuneering-imrx-johnson-johnson-jnj-1034217592,negative,0.6631879210472107
4629,1/12/2025 9:50:17 PM,Johnson & Johnson in talks to acquire Intra-Cellular - Bloomberg,Seeking Alpha,https://seekingalpha.com/news/4394354-johnson-johnson-exploring-takeover-of-intra-cellular-bloomberg?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8463228344917297
4630,1/12/2025 10:05:06 PM,"Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports",TipRanks,/news/stocks/johnson-johnson-exploring-bid-for-intra-cellular-therapies-bloomberg-reports-1034217895,positive,0.5851902961730957
4631,1/13/2025 2:49:37 AM,Johnson & Johnson In Talks To Acquire Intra-Cellular Therapies : Report ,RTTNews,/news/stocks/johnson-johnson-in-talks-to-acquire-intra-cellular-therapies-report-1034217902,positive,0.8573676943778992
4632,1/13/2025 10:30:57 AM,"Illumina launches pilot proteomics program with UK Biobank, collaborators",TipRanks,/news/stocks/illumina-launches-pilot-proteomics-program-with-uk-biobank-collaborators-1034220270,negative,0.6957512497901917
4633,1/13/2025 11:35:58 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220740,positive,0.9279617667198181
4634,1/13/2025 11:36:56 AM,Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash,TipRanks,/news/stocks/johnson-johnson-to-acquire-intra-cellular-for-132-00-per-share-in-cash-1034220720,positive,0.9279617667198181
4635,1/13/2025 11:54:36 AM,J&J to buy Intra-Cellular for $132/share in cash,Seeking Alpha,https://seekingalpha.com/news/4394424-jj-to-buy-intra-cellular-for-132share-in-cash?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9091024994850159
4636,1/13/2025 12:49:14 PM,Johnson & Johnson To Buy Intra-Cellular Therapies For $132.00/shr In $14.6 Bln All-cash Deal ,RTTNews,/news/stocks/johnson-johnson-to-buy-intra-cellular-therapies-for-132-00-shr-in-14-6-bln-all-cash-deal-1034219706,positive,0.6398265361785889
4637,1/13/2025 1:30:01 PM,M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal,Seeking Alpha,https://seekingalpha.com/news/4394487-ma-snapshot-johnson-johnson-to-acquire-intra-cellular-therapies-in-146b-cns-focused-deal?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5409807562828064
4638,1/13/2025 1:35:42 PM,Oric Pharmaceuticals announces clinical supply agreement with Janssen,TipRanks,/news/stocks/oric-pharmaceuticals-announces-clinical-supply-agreement-with-janssen-1034221869,negative,0.5754775404930115
4639,1/13/2025 2:06:33 PM,Morning Movers: Intra-Cellular surges following deal to be bought by J&J,TipRanks,/news/stocks/morning-movers-intra-cellular-surges-following-deal-to-be-bought-by-j-j-1034222103,positive,0.6571655869483948
4640,1/13/2025 2:27:15 PM,Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago  - report,Seeking Alpha,https://seekingalpha.com/news/4394546-johnson-and-johnson-made-approach-to-intra-cellular-6-weeks-to-2-months-ago-report?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8613200783729553
4641,1/13/2025 2:46:12 PM,Hold Rating on JNJ Amid Uncertainty over Intra-Cellular Therapies Acquisition Impact,TipRanks,/news/stocks/hold-rating-on-jnj-amid-uncertainty-over-intra-cellular-therapies-acquisition-impact-1034222391,neutral,0.8385757803916931
4642,1/13/2025 3:00:21 PM,Intra-Cellular downgraded to Equal Weight from Overweight at Morgan Stanley,TipRanks,/news/stocks/intra-cellular-downgraded-to-equal-weight-from-overweight-at-morgan-stanley-1034222444,positive,0.49528029561042786
4643,1/13/2025 5:10:43 PM,"J&J to acquire Intra-Cellular, Clearwater to buy Enfusion: Morning Buzz",TipRanks,/news/stocks/j-j-to-acquire-intra-cellular-clearwater-to-buy-enfusion-morning-buzz-1034222650,positive,0.9126174449920654
4644,1/13/2025 7:25:14 PM,BofA moves to No Rating on Intra-Cellular after Johnson & Johnson deal,TipRanks,/news/stocks/bofa-moves-to-no-rating-on-intra-cellular-after-johnson-johnson-deal-1034222909,positive,0.8604658246040344
4645,1/14/2025 1:06:45 AM,Cautious Optimism: Evaluating Johnson & Johnson‚Äôs Hold Rating Amid ITCI Acquisition Uncertainties,TipRanks,/news/stocks/cautious-optimism-evaluating-johnson-johnson-s-hold-rating-amid-itci-acquisition-uncertainties-1034223279,positive,0.667181134223938
4646,1/14/2025 9:57:00 AM,Johnson & Johnson‚Äôs Strategic Acquisition of Intra-Cellular Therapies: Balancing Short-term Dilution with Long-term Growth Potential,TipRanks,/news/stocks/johnson-johnson-s-strategic-acquisition-of-intra-cellular-therapies-balancing-short-term-dilution-with-long-term-growth-potential-1034224942,negative,0.6879042387008667
4647,1/14/2025 1:37:21 PM,ORIC Pharma Stock Climbs On Clinical Supply Deal With J&J's Janssen For ORIC-114 ,RTTNews,/news/stocks/oric-pharma-stock-climbs-on-clinical-supply-deal-with-j-j-s-janssen-for-oric-114-1034224824,negative,0.837266743183136
4648,1/14/2025 2:40:39 PM,"Drugmakers to push Trump to pause price negotiations, Bloomberg reports",TipRanks,/news/stocks/drugmakers-to-push-trump-to-pause-price-negotiations-bloomberg-reports-1034226968,neutral,0.7503699064254761
4649,1/15/2025 7:04:11 AM,Strategic Acquisition Boosts JNJ‚Äôs Neuroscience Portfolio: Analyst Recommends Buy,TipRanks,/news/stocks/strategic-acquisition-boosts-jnj-s-neuroscience-portfolio-analyst-recommends-buy-1034229544,negative,0.9492877125740051
4650,1/15/2025 1:06:38 PM,Johnson & Johnson submits NDA with FDA for TAR-200,TipRanks,/news/stocks/johnson-johnson-submits-nda-with-fda-for-tar-200-1034231461,positive,0.9270707368850708
4651,1/15/2025 2:38:15 PM,Johnson & Johnson Initiates IND Submission Of TAR-200 To Treat High-risk Bladder Cancer ,RTTNews,/news/stocks/johnson-johnson-initiates-ind-submission-of-tar-200-to-treat-high-risk-bladder-cancer-1034230264,positive,0.7623257637023926
4652,1/15/2025 2:47:30 PM,J&J submits NDA for TAR-200 for bladder cancer,Seeking Alpha,https://seekingalpha.com/news/4395303-jj-submits-nda-for-tar-200-for-bladder-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9312337040901184
4653,1/15/2025 3:00:00 PM,Moderna remains the most shorted stock among S&P 500 healthcare stocks in the last month of 2024,Seeking Alpha,https://seekingalpha.com/news/4395003-moderna-remains-the-most-shorted-stock-among-sp-500-healthcare-stocks-in-the-last-month-of-2024?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.78468257188797
4654,1/16/2025 10:19:54 AM,Johnson & Johnson (JNJ) Gets a Hold from Barclays,TipRanks,/news/stocks/johnson-johnson-jnj-gets-a-hold-from-barclays-1034235106,positive,0.8302940726280212
4655,1/16/2025 4:22:28 PM,Johnson & Johnson's RYBREVANT Plus Chemotherapy Approved In Canada For Advanced Lung Cancer ,RTTNews,/news/stocks/johnson-johnson-s-rybrevant-plus-chemotherapy-approved-in-canada-for-advanced-lung-cancer-1034236239,negative,0.6888518333435059
4656,1/16/2025 4:30:04 PM,Least shorted S&P 500 stocks in December,Seeking Alpha,https://seekingalpha.com/news/4395791-least-shorted-sp-500-stocks-in-december?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5818331837654114
4657,1/16/2025 8:15:11 PM,Roth MKM biotech analyst holds an analyst/industry conference call,TipRanks,/news/stocks/roth-mkm-biotech-analyst-holds-an-analyst-industry-conference-call-1034237745,positive,0.9455549716949463
4658,1/17/2025 11:28:17 AM,Hold Rating for Johnson & Johnson Amid Modest Growth Outlook and Legal Uncertainties,TipRanks,/news/stocks/hold-rating-for-johnson-johnson-amid-modest-growth-outlook-and-legal-uncertainties-1034240120,negative,0.5316452980041504
4659,1/17/2025 1:25:47 PM,Johnson & Johnson price target lowered to $160 from $166 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-160-from-166-at-bofa-1034240867,neutral,0.8026601076126099
4660,1/17/2025 7:54:43 PM,Argenx cut to Sell at Deutsche Bank on valuation,Seeking Alpha,https://seekingalpha.com/news/4396303-argenx-stock-cut-sell-deutsche-bank?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.869491696357727
4661,1/17/2025 8:00:19 PM,"Catalyst Watch: Netflix earnings, Monster Beverage event, drug data, and quantum volatility",Seeking Alpha,https://seekingalpha.com/news/4396184-catalyst-watch-netflix-earnings-monster-beverage-event-drug-data-and-quantum-volatility?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8700590133666992
4662,1/17/2025 8:35:26 PM,Sector Spotlight: Big Pharma will push to pause Medicare drug price negotiations,TipRanks,/news/stocks/sector-spotlight-big-pharma-will-push-to-pause-medicare-drug-price-negotiations-1034241772,positive,0.4902459383010864
4663,1/17/2025 9:16:37 PM,Odyssey Therapeutics files for $100M IPO,Seeking Alpha,https://seekingalpha.com/news/4396327-odyssey-therapeutics-files-for-100m-ipo?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.930002748966217
4664,1/17/2025 10:01:19 PM,Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market,TipRanks,/news/stocks/count-on-dividend-king-pepsi-pep-for-stability-in-a-volatile-market-1034241826,negative,0.7234762907028198
4665,1/18/2025 6:05:00 PM,14 out of 20 names post earnings beat with blockbuster wins from banks-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4396193-14-out-of-20-names-post-earnings-beat-with-blockbuster-wins-from-banks-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.5247626900672913
4666,1/19/2025 1:12:00 PM,"Earnings week ahead: JNJ, NFLX, AAL, UAL, AXP, ABT, VZ, PG, and more",Seeking Alpha,https://seekingalpha.com/news/4396093-earnings-week-ahead-jnj-nflx-aal-ual-axp-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.933464527130127
4667,1/21/2025 10:35:22 AM,Nanobiotix doses first patient in CONVERGE study,TipRanks,/news/stocks/nanobiotix-doses-first-patient-in-converge-study-1034249062,positive,0.7712879776954651
4668,1/21/2025 11:26:13 AM,Johnson & Johnson price target lowered to $159 from $160 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-barclays-1034249312,neutral,0.8819014430046082
4669,1/21/2025 1:06:03 PM,Johnson & Johnson announces FDA approves sNDA for Spravato,TipRanks,/news/stocks/johnson-johnson-announces-fda-approves-snda-for-spravato-1034250428,positive,0.7509946227073669
4670,1/21/2025 1:18:09 PM,Johnson & Johnson (JNJ) Receives a Hold from Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-jnj-receives-a-hold-from-morgan-stanley-1034250560,positive,0.8229565620422363
4671,1/21/2025 1:54:12 PM,J&J wins label expansion for depression therapy Spravato,Seeking Alpha,https://seekingalpha.com/news/4396680-jj-stock-in-focus-spravato-label-expansion?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.8369433879852295
4672,1/21/2025 3:22:54 PM,JNJ's SNDA For Spravato Monotherapy Gets FDA Approval For Treatment-Resistant Depression ,RTTNews,/news/stocks/jnj-s-snda-for-spravato-monotherapy-gets-fda-approval-for-treatment-resistant-depression-1034249288,negative,0.9357669353485107
4673,1/21/2025 5:45:00 PM,Top Seeking Alpha Quant picks in Technology ahead of Q4 earnings,Seeking Alpha,https://seekingalpha.com/news/4396470-top-seeking-alpha-quant-picks-in-technology-ahead-of-q4-earnings?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.5815476179122925
4674,1/21/2025 6:25:51 PM,Johnson & Johnson Q4 2024 Earnings Preview: Double-digit decline in profit expected,Seeking Alpha,https://seekingalpha.com/news/4397013-johnson-johnson-q4-2024-earnings-preview-double-digit-decline-in-profit-expected?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9726066589355469
4675,1/21/2025 6:45:12 PM,Notable companies reporting before tomorrow‚Äôs open,TipRanks,/news/stocks/notable-companies-reporting-before-tomorrow-s-open-1034251583,positive,0.9220908284187317
4676,1/21/2025 9:25:51 PM,Intra-Cellular downgraded to Sector Perform from Outperform at RBC Capital,TipRanks,/news/stocks/intra-cellular-downgraded-to-sector-perform-from-outperform-at-rbc-capital-1034251809,neutral,0.9313912391662598
4677,1/21/2025 11:00:20 PM,Here's the major earnings before the open tomorrow,Seeking Alpha,https://seekingalpha.com/news/4396897-heres-the-major-earnings-before-the-open-tomorrow?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9330109357833862
4678,1/22/2025 11:21:13 AM,Reviva Pharmaceuticals price target lowered to $11 from $14 at H.C. Wainwright,TipRanks,/news/stocks/reviva-pharmaceuticals-price-target-lowered-to-11-from-14-at-h-c-wainwright-1034254662,neutral,0.60404372215271
4679,1/22/2025 11:21:18 AM,"Johnson & Johnson Non-GAAP EPS of $2.04 beats by $0.02, revenue of $22.5B beats by $50M",Seeking Alpha,https://seekingalpha.com/news/4397192-johnson-johnson-non-gaap-eps-of-204-beats-by-002-revenue-of-225b-beats-by-50m?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6075138449668884
4680,1/22/2025 11:25:28 AM,Johnson & Johnson sees FY25 operational revenue $90.9B-$91.7B,TipRanks,/news/stocks/johnson-johnson-sees-fy25-operational-revenue-90-9b--91-7b-1034254654,positive,0.5936346650123596
4681,1/22/2025 11:25:51 AM,"Johnson & Johnson sees FY25 adjusted EPS $10.75-$10.95, consensus $10.60",TipRanks,/news/stocks/johnson-johnson-sees-fy25-adjusted-eps-10-75--10-95-consensus-10-60-1034254650,positive,0.6090856194496155
4682,1/22/2025 11:26:33 AM,"Johnson & Johnson reports Q4 adjusted EPS $2.04, consensus $2.02",TipRanks,/news/stocks/johnson-johnson-reports-q4-adjusted-eps-2-04-consensus-2-02-1034254646,neutral,0.6128156781196594
4683,1/22/2025 11:30:26 AM,Genmab reports 2024 net sales of Darzalex $11.67B,TipRanks,/news/stocks/genmab-reports-2024-net-sales-of-darzalex-11-67b-1034254735,positive,0.923292875289917
4684,1/22/2025 11:36:42 AM,Genmab says net sales of DARZALEX in 2024 totalled $11.67B,Seeking Alpha,https://seekingalpha.com/news/4397204-genmab-says-net-sales-of-darzalex-in-2024-totalled-1167b?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9288257360458374
4685,1/22/2025 11:46:50 AM,Johnson & Johnson in Charts: DARZALEX sales surge 20.9% Y/Y in Q4,Seeking Alpha,https://seekingalpha.com/news/4397201-johnson-johnson-in-charts-darzalex-sales-surge-209-yy-in-q4?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9410590529441833
4686,1/22/2025 11:48:43 AM,Earnings Snapshot: Johnson & Johnson tops Q4 earnings estimate; initiates FY25 revenue below estimates,Seeking Alpha,https://seekingalpha.com/news/4397202-earnings-snapshot-johnson-johnson-tops-q4-earnings-estimate-initiates-fy25-revenue-below-estimates?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7954169511795044
4687,1/22/2025 12:09:46 PM,Johnson & Johnson posts Q4 beat as drug sales offset MedTech weakness,Seeking Alpha,https://seekingalpha.com/news/4397193-jnj-stock-flat-despite-q4-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9301350712776184
4688,1/22/2025 12:20:32 PM,Johnson & Johnson sees 2H25 operational sales growth higher than 1H25,TipRanks,/news/stocks/johnson-johnson-sees-2h25-operational-sales-growth-higher-than-1h25-1034255344,negative,0.9570475816726685
4689,1/22/2025 12:32:59 PM,"Johnson & Johnson Q4 Profit Decreases, But Beats Estimates ",RTTNews,/news/stocks/johnson-johnson-q4-profit-decreases-but-beats-estimates-1034253859,neutral,0.9718552827835083
4690,1/22/2025 1:25:43 PM,"Johnson & Johnson Projects 2025 Adj. Operational EPS Growth Of 8.7% At Midpoint, Excl. ITCI ",RTTNews,/news/stocks/johnson-johnson-projects-2025-adj-operational-eps-growth-of-8-7-at-midpoint-excl-itci-1034254050,negative,0.5524223446846008
4691,1/22/2025 1:46:35 PM,Johnson & Johnson says positioned for 5%-7% growth through 2030 and beyond,TipRanks,/news/stocks/johnson-johnson-says-positioned-for-5--7-growth-through-2030-and-beyond-1034255944,negative,0.9421916007995605
4692,1/22/2025 1:55:22 PM,Morning Movers: Netflix shares rise following subscriber blowout,TipRanks,/news/stocks/morning-movers-netflix-shares-rise-following-subscriber-blowout-1034255934,negative,0.65787273645401
4693,1/22/2025 2:47:47 PM,"4 stocks to watch on Wednesday: PG, JNJ and more",Seeking Alpha,https://seekingalpha.com/news/4397307-4-stocks-to-watch-on-wednesday-pg-jnj-and-more?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9242684841156006
4694,1/22/2025 3:30:36 PM,Intra-Cellular ticks higher as J&J forecasts early Q2 close,Seeking Alpha,https://seekingalpha.com/news/4397347-intra-cellular-ticks-higher-as-jj-forecasts-early-q2-close?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6347700953483582
4695,1/22/2025 4:04:42 PM,J&J beats in Q4 with in line guidance; so why is its stock falling?,Seeking Alpha,https://seekingalpha.com/news/4397351-jj-stock-falls-despite-q4-2024-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9330347776412964
4696,1/22/2025 5:05:34 PM,"Netflix, Seagate, J&J report quarterly beats: Morning Buzz",TipRanks,/news/stocks/netflix-seagate-j-j-report-quarterly-beats-morning-buzz-1034256527,positive,0.9156374335289001
4697,1/22/2025 6:46:05 PM,Needham medtech & diagnostics analyst holds analyst/industry conference call,TipRanks,/news/stocks/needham-medtech-diagnostics-analyst-holds-analyst-industry-conference-call-1034256828,positive,0.9362135529518127
4698,1/23/2025 10:57:17 AM,Cautious Hold Rating for Johnson & Johnson Amid Conservative 2025 Outlook and Foreign Exchange Headwinds,TipRanks,/news/stocks/cautious-hold-rating-for-johnson-johnson-amid-conservative-2025-outlook-and-foreign-exchange-headwinds-1034259606,negative,0.7358025908470154
4699,1/23/2025 11:05:55 AM,Balanced Expectations Amid Challenges and Opportunities for Johnson & Johnson: Hold Rating Issued,TipRanks,/news/stocks/balanced-expectations-amid-challenges-and-opportunities-for-johnson-johnson-hold-rating-issued-1034259768,negative,0.564211368560791
4700,1/23/2025 11:20:54 AM,Johnson & Johnson price target lowered to $152 from $166 at Wells Fargo,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-152-from-166-at-wells-fargo-1034259868,neutral,0.9078953266143799
4701,1/23/2025 11:26:06 AM,Johnson & Johnson publishes nipocalimab study results in The Lancet Neurology,TipRanks,/news/stocks/johnson-johnson-publishes-nipocalimab-study-results-in-the-lancet-neurology-1034259858,positive,0.8097347021102905
4702,1/23/2025 11:26:46 AM,Johnson & Johnson price target lowered to $158 from $160 at Bernstein,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-158-from-160-at-bernstein-1034259849,neutral,0.7430306673049927
4703,1/23/2025 11:26:53 AM,Cautious Hold Recommendation for Johnson & Johnson Amid ITCI Acquisition Concerns and Market Challenges,TipRanks,/news/stocks/cautious-hold-recommendation-for-johnson-johnson-amid-itci-acquisition-concerns-and-market-challenges-1034259847,neutral,0.7806583642959595
4704,1/23/2025 11:30:12 AM,"Analysts Are Bullish on These Healthcare Stocks: AbbVie (ABBV), Johnson & Johnson (JNJ)",TipRanks,/news/stocks/analysts-are-bullish-on-these-healthcare-stocks-abbvie-abbv-johnson-johnson-jnj-1034260045,positive,0.6329234838485718
4705,1/23/2025 11:35:51 AM,Johnson & Johnson price target lowered to $163 from $175 at Morgan Stanley,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-163-from-175-at-morgan-stanley-1034260023,neutral,0.8511565327644348
4706,1/23/2025 11:55:20 AM,Johnson & Johnson price target lowered to $159 from $160 at BofA,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-159-from-160-at-bofa-1034260137,neutral,0.8165038824081421
4707,1/23/2025 11:55:52 AM,Johnson & Johnson: Hold Rating Amid Mixed Performance and Future Uncertainties,TipRanks,/news/stocks/johnson-johnson-hold-rating-amid-mixed-performance-and-future-uncertainties-1034260134,neutral,0.9651723504066467
4708,1/23/2025 11:56:45 AM,RBC Capital Keeps Their Buy Rating on Johnson & Johnson (JNJ),TipRanks,/news/stocks/rbc-capital-keeps-their-buy-rating-on-johnson-johnson-jnj-1034260121,positive,0.9046739339828491
4709,1/23/2025 12:30:20 PM,Johnson & Johnson price target lowered to $155 from $170 at Stifel,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-155-from-170-at-stifel-1034260728,neutral,0.7850547432899475
4710,1/23/2025 12:45:29 PM,Johnson & Johnson price target lowered to $165 from $170 at Raymond James,TipRanks,/news/stocks/johnson-johnson-price-target-lowered-to-165-from-170-at-raymond-james-1034260811,neutral,0.8372281789779663
4711,1/24/2025 7:06:51 AM,"‚ÄúJohnson & Johnson: Buy Rating Reaffirmed Despite Price Target Cut, Growth Prospects Highlighted‚Äù",TipRanks,/news/stocks/johnson-johnson-buy-rating-reaffirmed-despite-price-target-cut-growth-prospects-highlighted-1034265012,negative,0.9433929920196533
4712,1/24/2025 1:08:16 PM,Argus Research Sticks to Their Buy Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/argus-research-sticks-to-their-buy-rating-for-johnson-johnson-jnj-1034266886,positive,0.8815224170684814
4713,1/25/2025 6:46:00 PM,Over 80% of companies deliver EPS wins this week-Earnings Scorecard,Seeking Alpha,https://seekingalpha.com/news/4398494-over-80-companies-deliver-eps-wins-this-week-earnings-scorecard?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.6900730729103088
4714,1/27/2025 3:59:54 PM,"FDA accepts Teva, Alvotech BLAs for Simponi biosimilars",Seeking Alpha,https://seekingalpha.com/news/4398859-fda-accepts-teva-alvotech-blas-for-simponi-biosimilars?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6550996899604797
4715,1/27/2025 8:28:45 PM,"J&J talc claimants urge judge to reject $8B settlement, bankruptcy plan",Seeking Alpha,https://seekingalpha.com/news/4399016-johnson-johnson-talc-claimants-urge-judge-to-reject-8b-settlement-bankruptcy-plan?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7643334269523621
4716,1/27/2025 8:30:12 PM,"Johnson & Johnson-backed medical device company seeks U.S. IPO, Bloomberg says",TipRanks,/news/stocks/johnson-johnson-backed-medical-device-company-seeks-u-s-ipo-bloomberg-says-1034274082,positive,0.7354369163513184
4717,1/28/2025 10:10:16 AM,Johnson & Johnson price target raised to $166 from $159 at Barclays,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-159-at-barclays-1034276588,negative,0.9457013010978699
4718,1/29/2025 9:16:26 PM,"Artiva expands Board with appointment of Dan Baker, M.D",TipRanks,/news/stocks/artiva-expands-board-with-appointment-of-dan-baker-m-d-1034284784,positive,0.9234891533851624
4719,1/30/2025 5:19:44 PM,Alumis draws Outperform at Oppenheimer on valuation disconnect,Seeking Alpha,https://seekingalpha.com/news/4400899-alumis-draws-outperform-at-oppenheimer-on-valuation-disconnect?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6401662826538086
4720,1/30/2025 5:27:47 PM,Global stocks with the highest market share within their product groups,Seeking Alpha,https://seekingalpha.com/news/4400904-global-stocks-with-the-highest-market-share-within-their-product-groups?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6993017792701721
4721,1/31/2025 11:25:30 AM,European Commission authorizes Vocabria + Rekambys for HIV treatment,TipRanks,/news/stocks/european-commission-authorizes-vocabria-+-rekambys-for-hiv-treatment-1034294678,positive,0.8628990054130554
4722,1/31/2025 1:25:06 PM,AbbVie swings to Q4 loss amid Cerevel impact; sets in-line guidance,Seeking Alpha,https://seekingalpha.com/news/4401344-abbvie-stock-spikes-q4-revenue-beat?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.9237610697746277
4723,1/31/2025 7:10:17 PM,Opening Day: Infinity Natural Resources valued at $1.3B in market debut,TipRanks,/news/stocks/opening-day-infinity-natural-resources-valued-at-1-3b-in-market-debut-1034297591,positive,0.9314839243888855
4724,2/1/2025 12:53:24 PM,Are healthcare stocks on the rebound?,Seeking Alpha,https://seekingalpha.com/news/4401695-are-healthcare-stocks-rebound?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,neutral,0.7119130492210388
4725,2/1/2025 3:52:02 PM,HHS eyeing over $1B from J&J for talc cancer treatments: govt. attorney,Seeking Alpha,https://seekingalpha.com/news/4401703-hhs-seeks-1b-from-jj-talc-cancer?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.6028178930282593
4726,2/1/2025 5:30:29 PM,SA Asks: Which Big Pharmas would be most impacted by higher tariffs?,Seeking Alpha,https://seekingalpha.com/news/4401641-sa-asks-which-big-pharmas-would-be-most-impacted-by-higher-tariffs?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9071416258811951
4727,2/1/2025 11:45:00 PM,"Notable Healthcare headlines for the week: Moderna, AbbVie, Thermo Fisher, J&J in focus",Seeking Alpha,https://seekingalpha.com/news/4400864-notable-healthcare-headlines-for-the-week-moderna-thermo-fisher-jj-in-focus?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.9122067093849182
4728,2/3/2025 12:36:10 PM,Johnson & Johnson price target raised to $166 from $162 at Guggenheim,TipRanks,/news/stocks/johnson-johnson-price-target-raised-to-166-from-162-at-guggenheim-1034303204,negative,0.9425034523010254
4729,2/3/2025 12:37:41 PM,Guggenheim Sticks to Its Hold Rating for Johnson & Johnson (JNJ),TipRanks,/news/stocks/guggenheim-sticks-to-its-hold-rating-for-johnson-johnson-jnj-1034303197,positive,0.8120633363723755
4730,2/3/2025 12:41:03 PM,Halozyme announces positive opinion in EU for rybrevant with Enhanze technology,TipRanks,/news/stocks/halozyme-announces-positive-opinion-in-eu-for-rybrevant-with-enhanze-technology-1034303178,negative,0.9410951733589172
4731,2/3/2025 3:49:57 PM,J&J gets positive EU opinion for subcutaneous Rybrevant,Seeking Alpha,https://seekingalpha.com/news/4401949-jj-gets-positive-eu-opinion-for-subcutaneous-rybrevant?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,negative,0.9508143663406372
4732,2/4/2025 5:15:16 PM,"Senate panel advances Kennedy‚Äôs nomination for HHS secretary, CNBC reports",TipRanks,/news/stocks/senate-panel-advances-kennedy-s-nomination-for-hhs-secretary-cnbc-reports-1034310628,positive,0.8860395550727844
4733,2/5/2025 4:11:53 PM,Kenvue confirms activist Starboard nominations for board,Seeking Alpha,https://seekingalpha.com/news/4403582-kenvue-confirms-activist-starboard-nominations-for-board?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.8843174576759338
4734,2/6/2025 1:40:33 PM,Kura Oncology price target raised to $36 from $34 at Wedbush,TipRanks,/news/stocks/kura-oncology-price-target-raised-to-36-from-34-at-wedbush-1034322810,negative,0.9485723972320557
4735,2/6/2025 5:07:38 PM,Dr. Reddy‚Äôs in licenses biosimilar for J&J‚Äôs multiple myeloma therapy,Seeking Alpha,https://seekingalpha.com/news/4404547-dr-reddys-licenses-biosimilar-jjs-darzalex?utm_source=businessinsider&utm_medium=referral&feed_item_type=news,positive,0.7299903631210327
4736,2/6/2025 6:35:50 PM,"White House readying order to fire thousands of federal health workers, WSJ says",TipRanks,/news/stocks/white-house-readying-order-to-fire-thousands-of-federal-health-workers-wsj-says-1034324421,neutral,0.9388383626937866
4737,2/7/2025 3:21:13 PM,Trump Trade: President advocates to close carried interest tax loophole,TipRanks,/news/stocks/trump-trade-president-advocates-to-close-carried-interest-tax-loophole-1034328479,positive,0.6031154990196228
